- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST000324
    neg_log_pval: 23.699
    otg_id: GCST000324_3
    pubmed_id: '19185284'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: BCO1 (previously referred to as BCMO1) encodes beta-carotene oxygenase
        1 which uses a molecule of oxygen to produce two molecules of retinol from
        beta-carotene.  Enzyme deficiency results in accumulation of beta-carotene.
      pubmed_id: '11401432'
    gene_id: ENSG00000135697
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '16'
      position: 81264597
    locus_GRCh38:
      chromosome: '16'
      position: 81230992
    rsid: rs6564851
  trait_info:
    ontology:
    - HMDB0000561
    reported_trait_name: Carotenoid and tocopherol levels (beta-carotene)
    standard_trait_name: B-Carotene
- association_info:
    ancestry:
    - unknown
    gwas_catalog_id: GCST000386
    neg_log_pval: 323.301
    otg_id: GCST000386
    pubmed_id: '19414484'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: UGT1A1 encodes an enzyme with bilirubin glucuronidating activity.  Bilirubin
        is derived from biliverdin.
      pubmed_id: 01898728
    gene_id: ENSG00000242366
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '2'
      position: 234672639
    locus_GRCh38:
      chromosome: '2'
      position: 233763993
    rsid: rs6742078
  trait_info:
    ontology:
    - HMDB0000054
    reported_trait_name: Bilirubin levels
    standard_trait_name: Bilirubin
- association_info:
    ancestry:
    - ASW
    - EUR
    gwas_catalog_id: GCST000388
    neg_log_pval: 8.046
    otg_id: GCST000388
    pubmed_id: '19419973'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: G6PD encodes the glucose-6-phosphate dehydrogenase, an enzyme critical
        to red blood cell metabolism.  G6PD deficiency results in accumulation of
        bilirubin, a breakdown product of heme.
      pubmed_id: '11445808'
    gene_id: ENSG00000160211
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: X
      position: 153554404
    locus_GRCh38:
      chromosome: X
      position: 154326058
    rsid: rs766420
  trait_info:
    ontology:
    - HMDB0000054
    reported_trait_name: Bilirubin levels
    standard_trait_name: Bilirubin
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST000493
    neg_log_pval: 65.046
    otg_id: GCST000493_3
    pubmed_id: '19798445'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: SGPP1 encodes a sphingosine-1-phosphate phosphatase which dephosphorylates
        sphingosine-1-phosphate to sphingosine which can then be incorporated into
        sphingomyelin.
      pubmed_id: '10859351'
    gene_id: ENSG00000126821
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '14'
      position: 64235556
    locus_GRCh38:
      chromosome: '14'
      position: 63768838
    rsid: rs7157785
  trait_info:
    ontology:
    - HMDB0012097
    reported_trait_name: Sphingolipid levels (SM 14:0Mol%)
    standard_trait_name: sphingomyelin 14∶0 molar percentage
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST000568
    neg_log_pval: 217.046
    otg_id: GCST000568
    pubmed_id: '20081858'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: G6PC2 encodes a pancreas-specific glucose-6-phosphatase. This enzyme
        influences the fasting glucose set point for basal insulin secretion.
      pubmed_id: '23274894'
    gene_id: ENSG00000152254
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '2'
      position: 169763148
    locus_GRCh38:
      chromosome: '2'
      position: 168906638
    rsid: rs560887
  trait_info:
    ontology:
    - HMDB0000122
    reported_trait_name: Fasting glucose-related traits (FPG)
    standard_trait_name: D-Glucose
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST000697
    neg_log_pval: 108.699
    otg_id: GCST000697
    pubmed_id: '20541252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: GC encodes the vitamin D binding protein which transports multiple
        forms of vitamin D
      pubmed_id: 00049052
    gene_id: ENSG00000145321
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '4'
      position: 72608383
    locus_GRCh38:
      chromosome: '4'
      position: 71742666
    rsid: rs2282679
  trait_info:
    ontology:
    - HMDB0001438
    reported_trait_name: Vitamin D insufficiency
    standard_trait_name: 25-Hydroxyvitamin D2
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST000697
    neg_log_pval: 19.523
    otg_id: GCST000697
    pubmed_id: '20541252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: CYP2R1 encodes the vitamin D 25-hydroxylase which produces the
        detected metabolite.
      pubmed_id: '12867411'
    gene_id: ENSG00000186104
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '11'
      position: 14914878
    locus_GRCh38:
      chromosome: '11'
      position: 14893332
    rsid: rs10741657
  trait_info:
    ontology:
    - HMDB0001438
    reported_trait_name: Vitamin D insufficiency
    standard_trait_name: 25-Hydroxyvitamin D2
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST000697
    neg_log_pval: 26.699
    otg_id: GCST000697
    pubmed_id: '20541252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: DHCR7 encodes 7-dehydrocholesterol reductase, which acts on 7-dehydrocholesterol,
        a precursor of vitamin D.
      pubmed_id: '10807690'
    gene_id: ENSG00000172893
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 71167449
    locus_GRCh38:
      chromosome: '11'
      position: 71456403
    rsid: rs12785878
  trait_info:
    ontology:
    - HMDB0001438
    reported_trait_name: Vitamin D insufficiency
    standard_trait_name: 25-Hydroxyvitamin D2
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST000703
    neg_log_pval: 27.0
    otg_id: GCST000703
    pubmed_id: '20558539'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: ALPL encodes the liver alkaline phosphatase.  Loss of function
        of alkaline phosphatase causes hypophosphatasia.
      pubmed_id: '03174660'
    gene_id: ENSG00000162551
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '1'
      position: 21823292
    locus_GRCh38:
      chromosome: '1'
      position: 21496799
    rsid: rs1697421
  trait_info:
    ontology:
    - HMDB0001315
    reported_trait_name: Phosphorus levels
    standard_trait_name: Phosphorus
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST000703
    neg_log_pval: 8.398
    otg_id: GCST000703
    pubmed_id: '20558539'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: FGF23 encodes a fibroblast growth factor which regulates phosphate
        levels through multiple mechanisms, including regulation of levels of kidney
        phosphate transporters
      pubmed_id: '15863037'
    gene_id: ENSG00000118972
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: A
      reference: T
    locus_GRCh37:
      chromosome: '12'
      position: 4606168
    locus_GRCh38:
      chromosome: '12'
      position: 4497002
    rsid: rs2970818
  trait_info:
    ontology:
    - HMDB0001315
    reported_trait_name: Phosphorus levels
    standard_trait_name: Phosphorus
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST000756
    neg_log_pval: 35.699
    otg_id: GCST000756
    pubmed_id: '20700443'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: MUC1 encodes a mucin protein which forms a mucosal layer in intestines
        and kidney and may regulate absorption of magnesium
      pubmed_id: 01983814
    gene_id: ENSG00000185499
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '1'
      position: 155162067
    locus_GRCh38:
      chromosome: '1'
      position: 155192276
    rsid: rs4072037
  trait_info:
    ontology:
    - HMDB0000547
    reported_trait_name: Magnesium levels
    standard_trait_name: Magneseium
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST000756
    neg_log_pval: 14.097
    otg_id: GCST000756
    pubmed_id: '20700443'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: TRPM6 encodes a cation transporter with demonstrated activity toward
        magnesium.
      pubmed_id: '14576148'
    gene_id: ENSG00000119121
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '9'
      position: 77499796
    locus_GRCh38:
      chromosome: '9'
      position: 74884880
    rsid: rs11144134
  trait_info:
    ontology:
    - HMDB0000547
    reported_trait_name: Magnesium levels
    standard_trait_name: Magnesium
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST000925
    neg_log_pval: 17.523
    otg_id: GCST000925_3
    pubmed_id: '21203500'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: FUT8 encodes a fucosyltransferase that catalyzes the transfer of
        fucose to complex glycopeptides.
      pubmed_id: 00985526
    gene_id: ENSG00000033170
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '14'
      position: 65758642
    locus_GRCh38:
      chromosome: '14'
      position: 65291924
    rsid: rs7159888
  trait_info:
    ontology:
    - EFO_0004999
    reported_trait_name: N-glycan levels (DG1)
    standard_trait_name: N-glycan measurement
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST001049
    neg_log_pval: 51.222
    otg_id: GCST001049
    pubmed_id: '21502573'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: F3 encodes coagulation factor 3, also known as tissue factor, which
        is involved in the initiation of the clotting cascade, which eventually results
        in the production of fibrin.  The D-dimer metabolite is a degredation product
        of fibrin clots.
      pubmed_id: '12223078'
    gene_id: ENSG00000117525
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '1'
      position: 95053353
    locus_GRCh38:
      chromosome: '1'
      position: 94587797
    rsid: rs12029080
  trait_info:
    ontology:
    - EFO_0004507
    reported_trait_name: D-dimer levels
    standard_trait_name: D dimer measurement
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST001049
    neg_log_pval: 13.699
    otg_id: GCST001049
    pubmed_id: '21502573'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: F5 encodes coagulation factor 5, an essential element of the clotting
        cascade, which eventually results in the production of fibrin.  The D-dimer
        metabolite is a degredation product of fibrin clots.
      pubmed_id: '25231258'
    gene_id: ENSG00000198734
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '1'
      position: 169477574
    locus_GRCh38:
      chromosome: '1'
      position: 169508336
    rsid: rs6687813
  trait_info:
    ontology:
    - EFO_0004507
    reported_trait_name: D-dimer levels
    standard_trait_name: D dimer measurement
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST001142
    neg_log_pval: 10.0
    otg_id: GCST001142
    pubmed_id: '21729881'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: CYP4F2 encodes a cytochrome P450 with a special role in the production
        of Vitamin E
      pubmed_id: '11997390'
    gene_id: ENSG00000186115
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '19'
      position: 15990431
    locus_GRCh38:
      chromosome: '19'
      position: 15879621
    rsid: rs2108622
  trait_info:
    ontology:
    - HMDB0001893
    reported_trait_name: Vitamin E levels
    standard_trait_name: Alpha-Tocopherol
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST001179
    neg_log_pval: 43.0
    otg_id: GCST001179
    pubmed_id: '21829377'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: 'ELOVL2 encodes a long chain fatty acid elongase.  The coenzyme
        A derivative of DPA (22:5n3) is both a product and a substrate for the enzyme. '
      pubmed_id: '12371743'
    gene_id: ENSG00000197977
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 10982973
    locus_GRCh38:
      chromosome: '6'
      position: 10982740
    rsid: rs3734398
  trait_info:
    ontology:
    - HMDB0006528
    reported_trait_name: Phospholipid levels (plasma) (DPA)
    standard_trait_name: Docosapentaenoic acid
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST001216
    neg_log_pval: 14.155
    otg_id: GCST001216
    pubmed_id: '21878437'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: 'RBP4 encodes a retinol-binding protein that transports retinol
        in the blood. '
      pubmed_id: '02444024'
    gene_id: ENSG00000138207
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '10'
      position: 95348182
    locus_GRCh38:
      chromosome: '10'
      position: 93588425
    rsid: rs10882272
  trait_info:
    ontology:
    - HMDB0000305
    reported_trait_name: Retinol levels
    standard_trait_name: Vitamin A
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST001216
    neg_log_pval: 13.222
    otg_id: GCST001216
    pubmed_id: '21878437'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: TTR encodes a thyroid hormone-binding protein which transports
        thryroxine and retinol.
      pubmed_id: '04607556'
    gene_id: ENSG00000118271
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '18'
      position: 29187279
    locus_GRCh38:
      chromosome: '18'
      position: 31607316
    rsid: rs1667255
  trait_info:
    ontology:
    - HMDB0000305
    reported_trait_name: Retinol levels
    standard_trait_name: Vitamin A
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST001217
    neg_log_pval: 14.301
    otg_id: GCST001217_23
    pubmed_id: '21886157'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: AHR encodes the aromatic hydrocarbon receptor, a transcription
        factor which activates CYP1A1 and CYP1A2.  These enzymes metabolize caffeine.
      pubmed_id: '10605936'
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: AHR encodes the aromatic hydrocarbon receptor, a transcription
        factor which activates CYP1A1 and CYP1A2.  These enzymes metabolize caffeine.
      pubmed_id: 08095225
    gene_id: ENSG00000106546
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '7'
      position: 17309279
    locus_GRCh38:
      chromosome: '7'
      position: 17269655
    rsid: rs12670403
  trait_info:
    ontology:
    - HMDB0001847
    - HMDB0003072
    reported_trait_name: Metabolic traits (caffeine/quinate + 3 other traits)
    standard_trait_name: Caffeine / Quinic acid
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST001217
    neg_log_pval: 12.155
    otg_id: GCST001217_30
    pubmed_id: '21886157'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: NT5E encodes the ecto-5'-nucleotidase which can generate inosine
      pubmed_id: 06271180
    gene_id: ENSG00000135318
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 86117129
    locus_GRCh38:
      chromosome: '6'
      position: 85407411
    rsid: rs494562
  trait_info:
    ontology:
    - HMDB0000195
    reported_trait_name: Metabolic traits (inosine + 1 other trait)
    standard_trait_name: Inosine
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST001264
    neg_log_pval: 41.0
    otg_id: GCST001264_2
    pubmed_id: '21998597'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: SHBG encodes the sex-hormone binding globulin which binds which
        binds to and transports testosterone.
      pubmed_id: 07626508
    gene_id: ENSG00000129214
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '17'
      position: 7521915
    locus_GRCh38:
      chromosome: '17'
      position: 7618597
    rsid: rs12150660
  trait_info:
    ontology:
    - HMDB0000234
    reported_trait_name: Testosterone levels (Testosterone)
    standard_trait_name: Testosterone
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST001391
    neg_log_pval: 21.523
    otg_id: GCST001391_3
    pubmed_id: '22286219'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: SLC1A4 encodes a neutral amino acid transporter with demonstrated
        activity for alanine, serine, cysteine and threonine.  2-aminobutyrate is
        structurally similar to these amino acids.
      pubmed_id: 07896285
    gene_id: ENSG00000115902
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '2'
      position: 65220910
    locus_GRCh38:
      chromosome: '2'
      position: 64993776
    rsid: rs2160387
  trait_info:
    ontology:
    - HMDB0000161
    - HMDB0000883
    reported_trait_name: Metabolite levels (Ala, Val)
    standard_trait_name: L-Alanine / L-Valine
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST001391
    neg_log_pval: 16.699
    otg_id: GCST001391_10
    pubmed_id: '22286219'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: TAT encodes tyrosine aminotransferase which converts tyrosine to
        4-hydroxyphenylpyruvate.  Enzyme deficiency in this enzyme causes tyrosine
        build up.
      pubmed_id: 01973834
    gene_id: ENSG00000198650
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: T
      reference: A
    locus_GRCh37:
      chromosome: '16'
      position: 71634811
    locus_GRCh38:
      chromosome: '16'
      position: 71600908
    rsid: rs4788815
  trait_info:
    ontology:
    - HMDB0000159
    - HMDB0000158
    reported_trait_name: Metabolite levels (Phe, Tyr)
    standard_trait_name: L-Phenylalanine / L-Tyrosine
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST001392
    neg_log_pval: 11.097
    otg_id: GCST001392_5
    pubmed_id: '22286219'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: CPT1A encodes a carnitine O-palmitoyltransferase which acts the
        CoA version of the free fatty acid metabolite detected here
      pubmed_id: 01865762
    gene_id: ENSG00000110090
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 68562328
    locus_GRCh38:
      chromosome: '11'
      position: 68794860
    rsid: rs2229738
  trait_info:
    ontology:
    - HMDB0000673
    reported_trait_name: Lipid metabolism phenotypes (LA/PUFA)
    standard_trait_name: Linoleic acid
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST001414
    neg_log_pval: 9.097
    otg_id: GCST001414_2
    pubmed_id: '22359512'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: AGPAT1 encodes 1-acyl-sn-glycerol-3-phosphate acyltransferase alpha,
        an enzyme which produces phosphatidic acid.
      pubmed_id: '17707131'
    gene_id: ENSG00000204310
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 32136547
    locus_GRCh38:
      chromosome: '6'
      position: 32168770
    rsid: rs1061808
  trait_info:
    ontology:
    - HMDB0008031
    - HMDB0008003
    reported_trait_name: Phospholipid levels (plasma) (proportions (PC 32∶0/PC 34∶1))
    standard_trait_name: similar to Phosphatidylcholine(18:0/14:0)|Phosphatidylcholine(16:1/18:0)
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST001413
    neg_log_pval: 18.699
    otg_id: GCST001413
    pubmed_id: '22359512'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: ATP10D encodes a phospholipid flippase.  Closely related gene family
        members have demonstrated activity versus phosphatidylcholine.
      pubmed_id: '25947375'
    gene_id: ENSG00000145246
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '4'
      position: 47551863
    locus_GRCh38:
      chromosome: '4'
      position: 47549846
    rsid: rs13106975
  trait_info:
    ontology:
    - 'EFO_0004622 '
    reported_trait_name: Sphingolipid levels (levels)
    standard_trait_name: sphingolipid measurement
- association_info:
    ancestry:
    - SAS
    gwas_catalog_id: GCST001421
    neg_log_pval: 8.523
    otg_id: GCST001421
    pubmed_id: '22383894'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: AS3MT encodes arsenite methyltransferase which acts on methylarsonite
        to produce dimethylarsinate (also known as cacodylate)
      pubmed_id: '20621156'
    gene_id: ENSG00000214435
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 104623578
    locus_GRCh38:
      chromosome: '10'
      position: 102863821
    rsid: rs9527
  trait_info:
    ontology:
    - HMDB0011625
    reported_trait_name: Arsenic metabolism  (DMA%)
    standard_trait_name: Dimethylarsinate
- association_info:
    ancestry:
    - EAS
    gwas_catalog_id: GCST001608
    neg_log_pval: 62.523
    otg_id: GCST001608
    pubmed_id: '22797727'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: SLC22A12 encodes the URAT1 transporter, a kidney urate reuptake
        transporter.  The nearby gene SLC22A11 encodes the hOAT4 transporter which
        primarily transports steroid molecules and has only very weak affinity for
        urea.
      pubmed_id: '12024214'
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: SLC22A12 encodes the URAT1 transporter, a kidney urate reuptake
        transporter.  The nearby gene SLC22A11 encodes the hOAT4 transporter which
        primarily transports steroid molecules and has only very weak affinity for
        urea.
      pubmed_id: '27105641'
    gene_id: ENSG00000197891
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: A
      reference: T
    locus_GRCh37:
      chromosome: '11'
      position: 64464085
    locus_GRCh38:
      chromosome: '11'
      position: 64696613
    rsid: rs504915
  trait_info:
    ontology:
    - HMDB0000294
    reported_trait_name: Renal function-related traits (urea)
    standard_trait_name: Urea
- association_info:
    ancestry:
    - EAS
    gwas_catalog_id: GCST001608
    neg_log_pval: 17.155
    otg_id: GCST001608
    pubmed_id: '22797727'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: SLC14A2 encodes a urea transporter expressed in kidney.
      pubmed_id: '11502588'
    gene_id: ENSG00000132874
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '18'
      position: 43187130
    locus_GRCh38:
      chromosome: '18'
      position: 45607165
    rsid: rs7227483
  trait_info:
    ontology:
    - HMDB0000294
    reported_trait_name: Renal function-related traits (BUN)
    standard_trait_name: Urea
- association_info:
    ancestry:
    - EUR
    neg_log_pval: 17.068
    pubmed_id: '22885924'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: SLC2A2 encodes a glucose transporter (GLUT2)
      pubmed_id: 02479026
    gene_id: ENSG00000163581
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '3'
      position: 170713290
    locus_GRCh38:
      chromosome: '3'
      position: 170995501
    rsid: rs1280
  trait_info:
    ontology:
    - HMDB0000122
    reported_trait_name: MAGIC Fasting Glucose GWAS/Metabochip 2012
    standard_trait_name: D-Glucose
- association_info:
    ancestry:
    - EUR
    neg_log_pval: 7.757
    pubmed_id: '22885924'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: 'IGF2BP2 encodes a protein which binds insulin-like growth factor
        2 mRNA.  '
      pubmed_id: 09891060
    gene_id: ENSG00000073792
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '3'
      position: 185513392
    locus_GRCh38:
      chromosome: '3'
      position: 185795604
    rsid: rs7651090
  trait_info:
    ontology:
    - HMDB0000122
    reported_trait_name: MAGIC Fasting Glucose GWAS/Metabochip 2012
    standard_trait_name: D-Glucose
- association_info:
    ancestry:
    - EUR
    neg_log_pval: 14.991
    pubmed_id: '22885924'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: PCSK1 encodes a protease which is involved in maturation of insulin
      pubmed_id: 01843283
    gene_id: ENSG00000175426
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 95539448
    locus_GRCh38:
      chromosome: '5'
      position: 96203744
    rsid: rs4869272
  trait_info:
    ontology:
    - HMDB0000122
    reported_trait_name: MAGIC Fasting Glucose GWAS/Metabochip 2012
    standard_trait_name: D-Glucose
- association_info:
    ancestry:
    - EUR
    neg_log_pval: 98.541
    pubmed_id: '22885924'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: GCK encodes glucokinase which directly phosphorylates glucose and
        thus contributes to glucose homeostasis
      pubmed_id: 01871135
    gene_id: ENSG00000106633
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '7'
      position: 44231886
    locus_GRCh38:
      chromosome: '7'
      position: 44192287
    rsid: rs6975024
  trait_info:
    ontology:
    - HMDB0000122
    reported_trait_name: MAGIC Fasting Glucose GWAS/Metabochip 2012
    standard_trait_name: D-Glucose
- association_info:
    ancestry:
    - EUR
    neg_log_pval: 214.971
    pubmed_id: '22885924'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: MTNR1B encodes a melatonin receptor.  Melatonin stimulates glucose
        uptake.
      pubmed_id: '16842543'
    gene_id: ENSG00000134640
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 92708710
    locus_GRCh38:
      chromosome: '11'
      position: 92975544
    rsid: rs10830963
  trait_info:
    ontology:
    - HMDB0000122
    reported_trait_name: MAGIC Fasting Glucose GWAS/Metabochip 2012
    standard_trait_name: D-Glucose
- association_info:
    ancestry:
    - EUR
    neg_log_pval: 14.876
    pubmed_id: '22885924'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: PDX1 encodes a pancreas-specific transcription factor which induces
        expression of insulin and SLC2A2 (GLUT2)  which each influence glucose levels
      pubmed_id: 07901001
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: PDX1 encodes a pancreas-specific transcription factor which induces
        expression of insulin and SLC2A2 (GLUT2)  which each influence glucose levels
      pubmed_id: 08923459
    gene_id: ENSG00000139515
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '13'
      position: 28487599
    locus_GRCh38:
      chromosome: '13'
      position: 27913462
    rsid: rs11619319
  trait_info:
    ontology:
    - HMDB0000122
    reported_trait_name: MAGIC Fasting Glucose GWAS/Metabochip 2012
    standard_trait_name: D-Glucose
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST001791
    neg_log_pval: 29.0
    otg_id: GCST001791
    pubmed_id: '23263486'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: PDZK1 encodes a protein that binds to and regulates the activity
        of URAT1 (encoded by SLC22A12), which is a urate transporter.
      pubmed_id: '15304510'
    gene_id: ENSG00000174827
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '1'
      position: 145723739
    locus_GRCh38:
      chromosome: '1'
      position: 145711327
    rsid: rs1471633
  trait_info:
    ontology:
    - HMDB0000289
    reported_trait_name: Urate levels
    standard_trait_name: Uric acid
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST001791
    neg_log_pval: 700.0
    otg_id: GCST001791
    pubmed_id: '23263486'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: SLC2A9 encodes a urate transporter.
      pubmed_id: '18327257'
    gene_id: ENSG00000109667
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '4'
      position: 9944052
    locus_GRCh38:
      chromosome: '4'
      position: 9942428
    rsid: rs12498742
  trait_info:
    ontology:
    - HMDB0000289
    reported_trait_name: Urate levels
    standard_trait_name: Uric acid
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST001791
    neg_log_pval: 134.0
    otg_id: GCST001791
    pubmed_id: '23263486'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: ABCG2 encodes a urate transporter.
      pubmed_id: '19506252'
    gene_id: ENSG00000118777
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '4'
      position: 89052323
    locus_GRCh38:
      chromosome: '4'
      position: 88131171
    rsid: rs2231142
  trait_info:
    ontology:
    - HMDB0000289
    reported_trait_name: Urate levels
    standard_trait_name: Uric acid
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST001840
    neg_log_pval: 8.523
    otg_id: GCST001840
    pubmed_id: '23362303'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: LPGAT1 encodes a lysophosphatidylglycerol acyltransferase which
        transfers long-chain acyl-CoAs to lysophosphatidylglycerol with a demonstrated
        preference for stearoyl-CoA.
      pubmed_id: '15485873'
    gene_id: ENSG00000123684
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: A
      reference: T
    locus_GRCh37:
      chromosome: '1'
      position: 211918244
    locus_GRCh38:
      chromosome: '1'
      position: 211744902
    rsid: rs11119805
  trait_info:
    ontology:
    - HMDB0000827
    reported_trait_name: Stearic acid (18:0) plasma levels
    standard_trait_name: Stearic acid
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST001856
    neg_log_pval: 31.097
    otg_id: GCST001856_4
    pubmed_id: '23408906'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: DIO1 encodes an iodothyronine deiodinase which deiodinates of thyroxine
        (T4) to produce the biologically active hormone T3
      pubmed_id: 01400883
    gene_id: ENSG00000211452
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '1'
      position: 54375570
    locus_GRCh38:
      chromosome: '1'
      position: 53909897
    rsid: rs2235544
  trait_info:
    ontology:
    - HMDB0000248
    reported_trait_name: 'Thyroid hormone levels (FT4: free thyroxine)'
    standard_trait_name: Thyroxine
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST001856
    neg_log_pval: 10.699
    otg_id: GCST001856_4
    pubmed_id: '23408906'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: FOXE1 encodes a transcription factor expressed specifically in
        thyroid gland, the source of the thyroxine (FT4 thyroid hormone)
      pubmed_id: 09214635
    gene_id: ENSG00000178919
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '9'
      position: 100591463
    locus_GRCh38:
      chromosome: '9'
      position: 97829181
    rsid: rs7045138
  trait_info:
    ontology:
    - HMDB0000248
    reported_trait_name: 'Thyroid hormone levels (FT4: free thyroxine)'
    standard_trait_name: Thyroxine
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST001856
    neg_log_pval: 13.699
    otg_id: GCST001856_4
    pubmed_id: '23408906'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: LHX3 encodes pituitary-specific transcription factor which is critical
        for pituitary gland development.  The pituitary gland produces thyroid stimulating
        hormone which directs the thyroid gland to produce thyroxine (T4).
      pubmed_id: 08638120
    gene_id: ENSG00000107187
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '9'
      position: 139089679
    locus_GRCh38:
      chromosome: '9'
      position: 136197833
    rsid: rs7860634
  trait_info:
    ontology:
    - HMDB0000248
    reported_trait_name: 'Thyroid hormone levels (FT4: free thyroxine)'
    standard_trait_name: Thyroxine
- association_info:
    ancestry:
    - AFR
    - EAS
    - EUR
    - ZZ1
    gwas_catalog_id: GCST001914
    neg_log_pval: 7.523
    otg_id: GCST001914
    pubmed_id: '23518928'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: TSPYL5 induces CYP19A1 expression, which in turn encodes a key
        enzyme involved in the biosynthesis of estradiol.
      pubmed_id: '23518928'
    gene_id: ENSG00000180543
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '8'
      position: 98282189
    locus_GRCh38:
      chromosome: '8'
      position: 97269961
    rsid: rs1864729
  trait_info:
    ontology:
    - HMDB0000151
    reported_trait_name: Estradiol plasma levels (breast cancer)
    standard_trait_name: Estradiol
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002041
    neg_log_pval: 19.523
    otg_id: GCST002041
    pubmed_id: '23720494'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: SELENBP1 encodes a selenium-binding protein.  The Arabidopsis ortholog
        (61% identity) has been shown to bind copper.
      pubmed_id: '25274629'
    gene_id: ENSG00000143416
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '1'
      position: 151344741
    locus_GRCh38:
      chromosome: '1'
      position: 151372265
    rsid: rs2769264
  trait_info:
    ontology:
    - HMDB0000657
    reported_trait_name: Blood trace element (Cu levels)
    standard_trait_name: Copper
- association_info:
    ancestry:
    - ASW
    gwas_catalog_id: GCST002043
    neg_log_pval: 9.222
    otg_id: GCST002043
    pubmed_id: '23726366'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: CD36 encodes a platelet glycoprotein which binds HDL
      pubmed_id: 09867808
    gene_id: ENSG00000135218
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '7'
      position: 80340622
    locus_GRCh38:
      chromosome: '7'
      position: 80711306
    rsid: rs2366858
  trait_info:
    ontology:
    - EFO_0004612
    reported_trait_name: HDL cholesterol (AA)
    standard_trait_name: high density lipoprotein cholesterol measurement
- association_info:
    ancestry:
    - EUR
    neg_log_pval: 32.18
    pubmed_id: '23823483'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: DMGDH encodes dimethylglycine dehydrogenase which takes dimethlyglycine
        as a substrate.  Enzyme deficiency results in excess dimethlyglycine.
      pubmed_id: '10102904'
    gene_id: ENSG00000132837
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 78330227
    locus_GRCh38:
      chromosome: '5'
      position: 79034404
    rsid: rs248386
  trait_info:
    ontology:
    - HMDB0000092
    reported_trait_name: Dimethlyglycine
    standard_trait_name: Dimethlyglycine
- association_info:
    ancestry:
    - EUR
    neg_log_pval: 9.854
    pubmed_id: '23823483'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: AGA encodes the enzyme aspartylglucosaminidase which generates
        asparagine from N-acetylglucosamines.  Deficiency results in an accumulation
        of asparagine-linked glycopeptides.
      pubmed_id: 01281977
    gene_id: ENSG00000038002
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '4'
      position: 178361051
    locus_GRCh38:
      chromosome: '4'
      position: 177439897
    rsid: rs4690522
  trait_info:
    ontology:
    - HMDB0000168
    reported_trait_name: Asparagine
    standard_trait_name: L-Asparagine
- association_info:
    ancestry:
    - EUR
    neg_log_pval: 9.119
    pubmed_id: '23823483'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: UMPS encodes uridine monophosphate synthetase, the enzyme which
        converts orotic acid to uridine.  Enzyme deficiency results in accumulation
        of orotic acid.
      pubmed_id: 06893554
    gene_id: ENSG00000114491
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 124451064
    locus_GRCh38:
      chromosome: '3'
      position: 124732217
    rsid: rs9844948
  trait_info:
    ontology:
    - HMDB0000226
    reported_trait_name: Orotic acid
    standard_trait_name: Orotic acid
- association_info:
    ancestry:
    - EUR
    neg_log_pval: 19.886
    pubmed_id: '23823483'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: SERPINA7 encodes the thyroxine-binding globulin protein.
      pubmed_id: 03094014
    gene_id: ENSG00000123561
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: X
      position: 105276609
    locus_GRCh38:
      chromosome: X
      position: 106032618
    rsid: rs7883218
  trait_info:
    ontology:
    - HMDB0000248
    reported_trait_name: Thyroxine
    standard_trait_name: Thyroxine
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002087
    neg_log_pval: 103.398
    otg_id: GCST002087
    pubmed_id: '23824729'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: MTHFR encodes methylenetetrahydrolate reductase, an enzyme that
        catalyzes the conversion of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate,
        which is the methyl donor in the conversion of homocysteine to methionine.  Defects
        in MTHFR lead to homocysteinuria.
      pubmed_id: 05057914
    gene_id: ENSG00000177000
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '1'
      position: 11856378
    locus_GRCh38:
      chromosome: '1'
      position: 11796321
    rsid: rs1801133
  trait_info:
    ontology:
    - HMDB0000742
    reported_trait_name: Homocysteine levels
    standard_trait_name: Homocysteine
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002087
    neg_log_pval: 8.699
    otg_id: GCST002087
    pubmed_id: '23824729'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: MMACHC encodes a cobalamin-binding protein.  Defects in MMACHC
        are a known cause of homocystinuria.
      pubmed_id: '16311595'
    gene_id: ENSG00000132763
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '1'
      position: 45978675
    locus_GRCh38:
      chromosome: '1'
      position: 45513003
    rsid: rs4660306
  trait_info:
    ontology:
    - HMDB0000742
    reported_trait_name: Homocysteine levels
    standard_trait_name: Homocysteine
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002087
    neg_log_pval: 9.699
    otg_id: GCST002087
    pubmed_id: '23824729'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: MTR encodes 5-methyltetrahydrofolate-homocysteine methyltransferase.  The
        enzyme acts on homocysteine to produce methionine
      pubmed_id: 02407589
    gene_id: ENSG00000116984
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '1'
      position: 237048676
    locus_GRCh38:
      chromosome: '1'
      position: 236885376
    rsid: rs2275565
  trait_info:
    ontology:
    - HMDB0000742
    reported_trait_name: Homocysteine levels
    standard_trait_name: Homocysteine
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002087
    neg_log_pval: 9.699
    otg_id: GCST002087
    pubmed_id: '23824729'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: MUT is a cobalamin-dependent enzyme.  Cobalamin is also needed
        in a reaction taking the homocysteine as a substrate
      pubmed_id: 07901104
    gene_id: ENSG00000146085
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 49382193
    locus_GRCh38:
      chromosome: '6'
      position: 49414480
    rsid: rs9369898
  trait_info:
    ontology:
    - HMDB0000742
    reported_trait_name: Homocysteine levels
    standard_trait_name: Homocysteine
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002087
    neg_log_pval: 19.699
    otg_id: GCST002087
    pubmed_id: '23824729'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: FOLH1B encodes a liver-enriched polyglutamylfolate hydrolase which
        will influence folate availability for the conversion of homocysteine to methionine
      pubmed_id: 09816319
    gene_id: ENSG00000134612
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 89148372
    locus_GRCh38:
      chromosome: '11'
      position: 89415204
    rsid: rs7130284
  trait_info:
    ontology:
    - HMDB0000742
    reported_trait_name: Homocysteine levels
    standard_trait_name: Homocysteine
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002087
    neg_log_pval: 42.699
    otg_id: GCST002087
    pubmed_id: '23824729'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: DPEP1 encodes a dipeptidase that acts on glutathione, which is
        a downstream product of homocysteine metabolism. Glutathione and homocysteine
        levels have been shown to be negatively correlated.
      pubmed_id: 06122685
    gene_id: ENSG00000015413
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '16'
      position: 89708096
    locus_GRCh38:
      chromosome: '16'
      position: 89641688
    rsid: rs154657
  trait_info:
    ontology:
    - HMDB0000742
    reported_trait_name: Homocysteine levels
    standard_trait_name: Homocysteine
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002196
    neg_log_pval: 45.0
    otg_id: GCST002196
    pubmed_id: '24047826'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: GATM encodes glycine amidinotransferase.  This enzyme produces
        the Homoarginine when using lysine as a substrate.
      pubmed_id: '23010440'
    gene_id: ENSG00000171766
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '15'
      position: 45652703
    locus_GRCh38:
      chromosome: '15'
      position: 45360505
    rsid: rs1153858
  trait_info:
    ontology:
    - HMDB0000670
    reported_trait_name: Homoarginine levels
    standard_trait_name: Homo-L-arginine
- association_info:
    ancestry:
    - EAS
    gwas_catalog_id: GCST002195
    neg_log_pval: 30.155
    otg_id: GCST002195_2
    pubmed_id: '24049095'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: CYP19A1 encodes aromatase which produces estradiol (the measured
        analyte) from testosterone.
      pubmed_id: '04153532'
    gene_id: ENSG00000137869
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '15'
      position: 51524292
    locus_GRCh38:
      chromosome: '15'
      position: 51232095
    rsid: rs2414095
  trait_info:
    ontology:
    - HMDB0000151
    reported_trait_name: Hormone measurements (Oestradiol)
    standard_trait_name: Estradiol
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002201
    neg_log_pval: 10.097
    otg_id: GCST002201
    pubmed_id: '24068962'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: TRPM8 encodes a calcium-permeable channel activated by menthol
        and cold.
      pubmed_id: '11882888'
    gene_id: ENSG00000144481
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '2'
      position: 234264848
    locus_GRCh38:
      chromosome: '2'
      position: 233356202
    rsid: rs1550532
  trait_info:
    ontology:
    - HMDB0000464
    reported_trait_name: Calcium levels
    standard_trait_name: Calcium
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002201
    neg_log_pval: 85.046
    otg_id: GCST002201
    pubmed_id: '24068962'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: CASR encodes the calcium sensing receptor, a GPCR which binds calcium
        and regulates parathyroid hormone secretion which in turn regulates circulating
        levels of calcium.
      pubmed_id: '11013439'
    gene_id: ENSG00000036828
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '3'
      position: 122003757
    locus_GRCh38:
      chromosome: '3'
      position: 122284910
    rsid: rs1801725
  trait_info:
    ontology:
    - HMDB0000464
    reported_trait_name: Calcium levels
    standard_trait_name: Calcium
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002201
    neg_log_pval: 8.097
    otg_id: GCST002201
    pubmed_id: '24068962'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: GUSB encodes a glucuronidase which induces the opening of the calcium-specific
        kidney-specific channel, TRPV5.
      pubmed_id: '18495742'
    gene_id: ENSG00000169919
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '7'
      position: 65271197
    locus_GRCh38:
      chromosome: '7'
      position: 65806210
    rsid: rs17711722
  trait_info:
    ontology:
    - HMDB0000464
    reported_trait_name: Calcium levels
    standard_trait_name: Calcium
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002201
    neg_log_pval: 11.046
    otg_id: GCST002201
    pubmed_id: '24068962'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: CYP24A1 encodes the 1,25-dihydroxyvitamin D(3) 24-hydroxylase which
        produces the biologically active form of vitamin D, which regulates calcium
        levels.
      pubmed_id: 09333115
    gene_id: ENSG00000019186
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '20'
      position: 52774427
    locus_GRCh38:
      chromosome: '20'
      position: 54157888
    rsid: rs1570669
  trait_info:
    ontology:
    - HMDB0000464
    reported_trait_name: Calcium levels
    standard_trait_name: Calcium
- association_info:
    ancestry:
    - AFR
    - EAS
    - EUR
    - SAS
    gwas_catalog_id: GCST002221
    neg_log_pval: 27.153
    otg_id: GCST002221
    pubmed_id: '24097068'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: IRF2BP2 encodes a protein which binds to the interferon regulatory
        factor 2 transcription factor.  This transcription factor is essential for
        the activation of the ABCA1 cholesterol transporter.
      pubmed_id: '26195219'
    gene_id: ENSG00000168264
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '1'
      position: 234853406
    locus_GRCh38:
      chromosome: '1'
      position: 234717659
    rsid: rs558971
  trait_info:
    ontology:
    - HMDB0000067
    reported_trait_name: Total Cholesterol
    standard_trait_name: Cholesterol
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002221
    neg_log_pval: 11.398
    otg_id: GCST002221
    pubmed_id: '24097068'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: ABCB11 encodes a transporter for taurocholate, a bile acid derived
        from cholesterol
      pubmed_id: 01862084
    gene_id: ENSG00000073734
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '2'
      position: 169830155
    locus_GRCh38:
      chromosome: '2'
      position: 168973645
    rsid: rs2287623
  trait_info:
    ontology:
    - HMDB0000067
    reported_trait_name: Cholesterol, total
    standard_trait_name: Cholesterol
- association_info:
    ancestry:
    - AFR
    - EAS
    - EUR
    - SAS
    gwas_catalog_id: GCST002221
    neg_log_pval: 16.075
    otg_id: GCST002221
    pubmed_id: '24097068'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: PPARG encodes a transcription factor that upreguates ABCA1 among
        other proteins involved in lipid metabolism.
      pubmed_id: '11135616'
    gene_id: ENSG00000132170
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '3'
      position: 12267648
    locus_GRCh38:
      chromosome: '3'
      position: 12226148
    rsid: rs7616006
  trait_info:
    ontology:
    - HMDB0000067
    reported_trait_name: Total Cholesterol
    standard_trait_name: Cholesterol
- association_info:
    ancestry:
    - AFR
    - EAS
    - EUR
    - SAS
    gwas_catalog_id: GCST002221
    neg_log_pval: 16.141
    otg_id: GCST002221
    pubmed_id: '24097068'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: LPA encodes the lipoprotein(a) protein, a constituent of the lipoprotein(a)
        particle, a carrier of cholesterol.
      pubmed_id: '24977982'
    gene_id: ENSG00000198670
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 161010118
    locus_GRCh38:
      chromosome: '6'
      position: 160589086
    rsid: rs10455872
  trait_info:
    ontology:
    - HMDB0000067
    reported_trait_name: Total Cholesterol
    standard_trait_name: Cholesterol
- association_info:
    ancestry:
    - AFR
    - EAS
    - EUR
    - SAS
    gwas_catalog_id: GCST002221
    neg_log_pval: 22.952
    otg_id: GCST002221
    pubmed_id: '24097068'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: CYP7A1 encodes a cytochrome P450 which is the rate limiting step
        in the conversion of cholesterol to bile acids.  CYP7A1 deficiency results
        in excess cholesterol.
      pubmed_id: 02993784
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: CYP7A1 encodes a cytochrome P450 which is the rate limiting step
        in the conversion of cholesterol to bile acids.  CYP7A1 deficiency results
        in excess cholesterol.
      pubmed_id: '12093894'
    gene_id: ENSG00000167910
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '8'
      position: 59393273
    locus_GRCh38:
      chromosome: '8'
      position: 58480714
    rsid: rs4738684
  trait_info:
    ontology:
    - HMDB0000067
    reported_trait_name: Total Cholesterol
    standard_trait_name: Cholesterol
- association_info:
    ancestry:
    - AFR
    - EAS
    - EUR
    - SAS
    gwas_catalog_id: GCST002221
    neg_log_pval: 9.176
    otg_id: GCST002221
    pubmed_id: '24097068'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: 'VLDLR encodes the very low density lipoprotein receptor '
      pubmed_id: 08294473
    gene_id: ENSG00000147852
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '9'
      position: 2640759
    locus_GRCh38:
      chromosome: '9'
      position: 2640759
    rsid: rs3780181
  trait_info:
    ontology:
    - HMDB0000067
    reported_trait_name: Total Cholesterol
    standard_trait_name: Cholesterol
- association_info:
    ancestry:
    - AFR
    - EAS
    - EUR
    - SAS
    gwas_catalog_id: GCST002221
    neg_log_pval: 8.006
    otg_id: GCST002221
    pubmed_id: '24097068'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: PPARA encodes a transcription factor which regulates expression
        of HDL apolipoproteins
      pubmed_id: 09808609
    gene_id: ENSG00000186951
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '22'
      position: 46627603
    locus_GRCh38:
      chromosome: '22'
      position: 46231706
    rsid: rs4253772
  trait_info:
    ontology:
    - HMDB0000067
    reported_trait_name: Total Cholesterol
    standard_trait_name: Cholesterol
- association_info:
    ancestry:
    - AFR
    - EAS
    - EUR
    - SAS
    gwas_catalog_id: GCST002223
    neg_log_pval: 7.744
    otg_id: GCST002223
    pubmed_id: '24097068'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: NAXE (formerly APOA1BP) encodes an APOA1 binding protein which
        promotes cholesterol efflux into high density lipoprotein (HDL) particles.
      pubmed_id: '23719382'
    gene_id: ENSG00000163382
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '1'
      position: 156700651
    locus_GRCh38:
      chromosome: '1'
      position: 156730859
    rsid: rs12145743
  trait_info:
    ontology:
    - EFO_0004612
    reported_trait_name: HDL Cholesterol
    standard_trait_name: high density lipoprotein cholesterol measurement
- association_info:
    ancestry:
    - AFR
    - EAS
    - EUR
    - SAS
    gwas_catalog_id: GCST002223
    neg_log_pval: 40.454
    otg_id: GCST002223
    pubmed_id: '24097068'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: GALNT2 encodes an acetylgalactosaminyltransferase which glycosylates
        the APOC3 protein, which in turn inhibits the lipoprotein lipase (LPL) enzyme
        which hydrolyzes triglycerides from triglyceride-containing lipoproteins,
        leading to the generation of HDL
      pubmed_id: '22152306'
    gene_id: ENSG00000143641
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '1'
      position: 230295691
    locus_GRCh38:
      chromosome: '1'
      position: 230159944
    rsid: rs4846914
  trait_info:
    ontology:
    - EFO_0004612
    reported_trait_name: HDL Cholesterol
    standard_trait_name: high density lipoprotein cholesterol measurement
- association_info:
    ancestry:
    - AFR
    - EAS
    - EUR
    - SAS
    gwas_catalog_id: GCST002223
    neg_log_pval: 8.663
    otg_id: GCST002223
    pubmed_id: '24097068'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: GPIHBP1 encodes the glycosylphosphatidylinositol-anchored high
        density lipoprotein-binding protein 1, a receptor for the HDL.
      pubmed_id: '12496272'
    gene_id: ENSG00000182851
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '8'
      position: 144303418
    locus_GRCh38:
      chromosome: '8'
      position: 143221248
    rsid: rs10087900
  trait_info:
    ontology:
    - EFO_0004612
    reported_trait_name: HDL Cholesterol
    standard_trait_name: high density lipoprotein cholesterol measurement
- association_info:
    ancestry:
    - AFR
    - EAS
    - EUR
    - SAS
    gwas_catalog_id: GCST002223
    neg_log_pval: 64.825
    otg_id: GCST002223
    pubmed_id: '24097068'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: ABCA1 encodes a cholesterol transporter.  Deficiency results in
        reduced HDL.
      pubmed_id: '10431237'
    gene_id: ENSG00000165029
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '9'
      position: 107664301
    locus_GRCh38:
      chromosome: '9'
      position: 104902020
    rsid: rs1883025
  trait_info:
    ontology:
    - EFO_0004612
    reported_trait_name: HDL Cholesterol
    standard_trait_name: high density lipoprotein cholesterol measurement
- association_info:
    ancestry:
    - AFR
    - EAS
    - EUR
    - SAS
    gwas_catalog_id: GCST002223
    neg_log_pval: 37.481
    otg_id: GCST002223
    pubmed_id: '24097068'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: NR1H3 encodes the LXR-alpha nuclear hormone receptor.  This transcription
        factor upreguates ABCA1, a cholesterol transporter with a direct impact on
        HDL levels.
      pubmed_id: '11090131'
    gene_id: ENSG00000025434
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 47333685
    locus_GRCh38:
      chromosome: '11'
      position: 47312134
    rsid: rs3847502
  trait_info:
    ontology:
    - EFO_0004612
    reported_trait_name: HDL Cholesterol
    standard_trait_name: high density lipoprotein cholesterol measurement
- association_info:
    ancestry:
    - AFR
    - EAS
    - EUR
    - SAS
    gwas_catalog_id: GCST002223
    neg_log_pval: 7.951
    otg_id: GCST002223
    pubmed_id: '24097068'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: DGAT2 encodes a diacylglycerol O-acyltransferase which produces
        triglycerides from diaglycerides.
      pubmed_id: '11481335'
    gene_id: ENSG00000062282
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 75455021
    locus_GRCh38:
      chromosome: '11'
      position: 75743976
    rsid: rs499974
  trait_info:
    ontology:
    - EFO_0004612
    reported_trait_name: HDL Cholesterol
    standard_trait_name: high density lipoprotein cholesterol measurement
- association_info:
    ancestry:
    - AFR
    - EAS
    - EUR
    - SAS
    gwas_catalog_id: GCST002223
    neg_log_pval: 19.604
    otg_id: GCST002223
    pubmed_id: '24097068'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: MVK encodes mevalonate kinase which synthesizes a precursor to
        cholesterol.
      pubmed_id: 02153681
    gene_id: ENSG00000110921
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '12'
      position: 109950144
    locus_GRCh38:
      chromosome: '12'
      position: 109512339
    rsid: rs2241210
  trait_info:
    ontology:
    - EFO_0004612
    reported_trait_name: HDL Cholesterol
    standard_trait_name: high density lipoprotein cholesterol measurement
- association_info:
    ancestry:
    - AFR
    - EAS
    - EUR
    - SAS
    gwas_catalog_id: GCST002223
    neg_log_pval: 32.135
    otg_id: GCST002223
    pubmed_id: '24097068'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: SCARB1 encodes a scavanger receptor which can act as an HDL receptor.
      pubmed_id: 08560269
    gene_id: ENSG00000073060
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '12'
      position: 125259888
    locus_GRCh38:
      chromosome: '12'
      position: 124775342
    rsid: rs838876
  trait_info:
    ontology:
    - EFO_0004612
    reported_trait_name: HDL Cholesterol
    standard_trait_name: high density lipoprotein cholesterol measurement
- association_info:
    ancestry:
    - AFR
    - EAS
    - EUR
    - SAS
    gwas_catalog_id: GCST002223
    neg_log_pval: 8.019
    otg_id: GCST002223
    pubmed_id: '24097068'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: AKT1 encodes a protein kinase which activates SREBP which induces
        transcription of enzymes involved in cholesterol biosynthesis.
      pubmed_id: '16007182'
    gene_id: ENSG00000142208
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '14'
      position: 105277209
    locus_GRCh38:
      chromosome: '14'
      position: 104810872
    rsid: rs4983559
  trait_info:
    ontology:
    - EFO_0004612
    reported_trait_name: HDL Cholesterol
    standard_trait_name: high density lipoprotein cholesterol measurement
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002223
    neg_log_pval: 188.0
    otg_id: GCST002223
    pubmed_id: '24097068'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: LIPC encodes hepatic triglyceride lipase which hydrolyses triglycerides.  The
        enzyme plays a key role in regulating levels of HDL.
      pubmed_id: '07417375'
    gene_id: ENSG00000166035
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '15'
      position: 58683366
    locus_GRCh38:
      chromosome: '15'
      position: 58391167
    rsid: rs1532085
  trait_info:
    ontology:
    - EFO_0004612
    reported_trait_name: HDL cholesterol
    standard_trait_name: high density lipoprotein cholesterol measurement
- association_info:
    ancestry:
    - AFR
    - EAS
    - EUR
    - SAS
    gwas_catalog_id: GCST002223
    neg_log_pval: 801.939
    otg_id: GCST002223
    pubmed_id: '24097068'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: 'CETP encodes the cholesterol ester transfer protein which acts
        on high density lipoprotein (HDL).  Deficiency of this enzyme results in increased
        HDL. '
      pubmed_id: 02586614
    gene_id: ENSG00000087237
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '16'
      position: 56989590
    locus_GRCh38:
      chromosome: '16'
      position: 56955678
    rsid: rs247616
  trait_info:
    ontology:
    - EFO_0004612
    reported_trait_name: HDL Cholesterol
    standard_trait_name: high density lipoprotein cholesterol measurement
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002223
    neg_log_pval: 53.097
    otg_id: GCST002223
    pubmed_id: '24097068'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: LCAT encodes lecithin-cholesterol acyltransferase which travels
        with HDL, esterifying cholesterol to cholesterol ester for incorporation into
        the HDL particles for transport back to the liver.
      pubmed_id: 04868699
    gene_id: ENSG00000213398
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '16'
      position: 67928042
    locus_GRCh38:
      chromosome: '16'
      position: 67894139
    rsid: rs16942887
  trait_info:
    ontology:
    - EFO_0004612
    reported_trait_name: HDL cholesterol
    standard_trait_name: high density lipoprotein cholesterol measurement
- association_info:
    ancestry:
    - AFR
    - EAS
    - EUR
    - SAS
    gwas_catalog_id: GCST002223
    neg_log_pval: 19.264
    otg_id: GCST002223
    pubmed_id: '24097068'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: STARD3 encodes the StAR-related lipid transfer protein 3 which
        promotes export of cholesterol to HDL
      pubmed_id: '25014273'
    gene_id: ENSG00000131748
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: GT
      reference: G
    locus_GRCh37:
      chromosome: '17'
      position: 37821435
    locus_GRCh38:
      chromosome: '17'
      position: 39665182
    rsid: rs113612868
  trait_info:
    ontology:
    - EFO_0004612
    reported_trait_name: HDL Cholesterol
    standard_trait_name: high density lipoprotein cholesterol measurement
- association_info:
    ancestry:
    - AFR
    - EAS
    - EUR
    - SAS
    gwas_catalog_id: GCST002223
    neg_log_pval: 65.746
    otg_id: GCST002223
    pubmed_id: '24097068'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: LIPG encodes endothelial lipase which acts on HDL.  Inhibition
        of endothelial lipase causes increased HDL cholesterol levels in vivo
      pubmed_id: '12569161'
    gene_id: ENSG00000101670
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '18'
      position: 47167214
    locus_GRCh38:
      chromosome: '18'
      position: 49640844
    rsid: rs4939883
  trait_info:
    ontology:
    - EFO_0004612
    reported_trait_name: HDL Cholesterol
    standard_trait_name: high density lipoprotein cholesterol measurement
- association_info:
    ancestry:
    - AFR
    - EAS
    - EUR
    - SAS
    gwas_catalog_id: GCST002223
    neg_log_pval: 33.785
    otg_id: GCST002223
    pubmed_id: '24097068'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: HNF4A drives expression of many cholesterol related genes including
        HMGCR
      pubmed_id: '21071704'
    gene_id: ENSG00000101076
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '20'
      position: 43042364
    locus_GRCh38:
      chromosome: '20'
      position: 44413724
    rsid: rs1800961
  trait_info:
    ontology:
    - EFO_0004612
    reported_trait_name: HDL Cholesterol
    standard_trait_name: high density lipoprotein cholesterol measurement
- association_info:
    ancestry:
    - AFR
    - EAS
    - EUR
    - SAS
    gwas_catalog_id: GCST002222
    neg_log_pval: 16.519
    otg_id: GCST002222
    pubmed_id: '24097068'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: LDLRAP1 encodes an adapter protein which binds to the LDL receptor.  Mutations
        in this gene cause a form of familial hypercholesterolemia.
      pubmed_id: '15166224'
    gene_id: ENSG00000157978
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '1'
      position: 25768937
    locus_GRCh38:
      chromosome: '1'
      position: 25442446
    rsid: rs10903129
  trait_info:
    ontology:
    - EFO_0004611
    reported_trait_name: LDL Cholesterol
    standard_trait_name: low density lipoprotein cholesterol measurement
- association_info:
    ancestry:
    - AFR
    - EAS
    - EUR
    - SAS
    gwas_catalog_id: GCST002222
    neg_log_pval: 142.067
    otg_id: GCST002222
    pubmed_id: '24097068'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: PCSK9 encodes a protein that binds to the LDLR receptor, promoting
        its degradation and thus influencing circulating LDL cholesterol levels.  Rare
        gain of function mutations result in greatly elevated LDL cholesterol levels.
      pubmed_id: '12730697'
    gene_id: ENSG00000169174
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '1'
      position: 55505647
    locus_GRCh38:
      chromosome: '1'
      position: 55039974
    rsid: rs11591147
  trait_info:
    ontology:
    - EFO_0004611
    reported_trait_name: LDL Cholesterol
    standard_trait_name: low density lipoprotein cholesterol measurement
- association_info:
    ancestry:
    - AFR
    - EAS
    - EUR
    - SAS
    gwas_catalog_id: GCST002222
    neg_log_pval: 271.788
    otg_id: GCST002222
    pubmed_id: '24097068'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: SORT1 encodes sortilin, a receptor with a role in VLDL secretion
        from the liver
      pubmed_id: '20686566'
    gene_id: ENSG00000134243
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '1'
      position: 109818530
    locus_GRCh38:
      chromosome: '1'
      position: 109275908
    rsid: rs646776
  trait_info:
    ontology:
    - EFO_0004611
    reported_trait_name: LDL Cholesterol
    standard_trait_name: low density lipoprotein cholesterol measurement
- association_info:
    ancestry:
    - AFR
    - EAS
    - EUR
    - SAS
    gwas_catalog_id: GCST002222
    neg_log_pval: 182.023
    otg_id: GCST002222
    pubmed_id: '24097068'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: APOB encodes apolipoprotein B, a major component of LDL particles.  Defects
        in APOB can lead to familial hypercholesterolemia.
      pubmed_id: '00052771'
    gene_id: ENSG00000084674
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '2'
      position: 21263900
    locus_GRCh38:
      chromosome: '2'
      position: 21041028
    rsid: rs1367117
  trait_info:
    ontology:
    - EFO_0004611
    reported_trait_name: LDL Cholesterol
    standard_trait_name: low density lipoprotein cholesterol measurement
- association_info:
    ancestry:
    - AFR
    - EAS
    - EUR
    - SAS
    gwas_catalog_id: GCST002222
    neg_log_pval: 11.77
    otg_id: GCST002222
    pubmed_id: '24097068'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: INSIG2 encodes a protein that plays a key role in regulating the
        SREBP cleavage-activating protein (SCAP), thus providing a means for feedback
        regulation of cholesterol synthesis over a wide range of sterol concentrations.
      pubmed_id: '12242332'
    gene_id: ENSG00000125629
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '2'
      position: 118835841
    locus_GRCh38:
      chromosome: '2'
      position: 118078265
    rsid: rs10490626
  trait_info:
    ontology:
    - EFO_0004611
    reported_trait_name: LDL Cholesterol
    standard_trait_name: low density lipoprotein cholesterol measurement
- association_info:
    ancestry:
    - AFR
    - EAS
    - EUR
    - SAS
    gwas_catalog_id: GCST002222
    neg_log_pval: 77.108
    otg_id: GCST002222
    pubmed_id: '24097068'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: HMGCR encodes HMG-CoA reductase, the rate-limiting enzyme for cholesterol
        biosynthesis
      pubmed_id: 01967820
    gene_id: ENSG00000113161
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 74656539
    locus_GRCh38:
      chromosome: '5'
      position: 75360714
    rsid: rs12916
  trait_info:
    ontology:
    - EFO_0004611
    reported_trait_name: LDL Cholesterol
    standard_trait_name: low density lipoprotein cholesterol measurement
- association_info:
    ancestry:
    - AFR
    - EAS
    - EUR
    - SAS
    gwas_catalog_id: GCST002222
    neg_log_pval: 16.68
    otg_id: GCST002222
    pubmed_id: '24097068'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: MYLIP encodes an E3 ubiquitin ligase which ubiquitinates the low
        density lipoprotein receptor (LDLR), which promotes the degradation of LDLR,
        influencing the circulating levels of LDL-cholesterol.
      pubmed_id: '19520913'
    gene_id: ENSG00000007944
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 16127407
    locus_GRCh38:
      chromosome: '6'
      position: 16127176
    rsid: rs3757354
  trait_info:
    ontology:
    - EFO_0004611
    reported_trait_name: LDL Cholesterol
    standard_trait_name: low density lipoprotein cholesterol measurement
- association_info:
    ancestry:
    - AFR
    - EAS
    - EUR
    - SAS
    gwas_catalog_id: GCST002222
    neg_log_pval: 20.716
    otg_id: GCST002222
    pubmed_id: '24097068'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: NPC1L1 encodes a transporter for cholesterol in the intestine.
      pubmed_id: '14976318'
    gene_id: ENSG00000015520
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '7'
      position: 44582331
    locus_GRCh38:
      chromosome: '7'
      position: 44542732
    rsid: rs2073547
  trait_info:
    ontology:
    - EFO_0004611
    reported_trait_name: LDL Cholesterol
    standard_trait_name: low density lipoprotein cholesterol measurement
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002222
    neg_log_pval: 40.398
    otg_id: GCST002222
    pubmed_id: '24097068'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: HP encodes haptoglobin which binds to ApoA-I, the primary protein
        component of HDL.
      pubmed_id: '23420675'
    gene_id: ENSG00000257017
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '16'
      position: 72108093
    locus_GRCh38:
      chromosome: '16'
      position: 72074194
    rsid: rs2000999
  trait_info:
    ontology:
    - EFO_0004611
    reported_trait_name: LDL cholesterol
    standard_trait_name: low density lipoprotein cholesterol measurement
- association_info:
    ancestry:
    - AFR
    - EAS
    - EUR
    - SAS
    gwas_catalog_id: GCST002222
    neg_log_pval: 11.008
    otg_id: GCST002222
    pubmed_id: '24097068'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: ApoH increases the enzymic activity of lipoprotein lipase (LPL)
        in the presence of apoC-II by 45.7 percent [ 7417307].  a small molecule inhibitor
        of PKC alpha, HBDDE, show minimal inhibition of cholesterol accumulation while
        a small molecule inhibitor of PKC beta, LY333513, could completely account
        for the inhibition of cholesterol accumulation by the classical group PKC
        isoenzyme [16930534]
      pubmed_id: '07417307'
    gene_id: ENSG00000091583
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '17'
      position: 64210580
    locus_GRCh38:
      chromosome: '17'
      position: 66214462
    rsid: rs1801689
  trait_info:
    ontology:
    - EFO_0004611
    reported_trait_name: LDL Cholesterol
    standard_trait_name: low density lipoprotein cholesterol measurement
- association_info:
    ancestry:
    - AFR
    - EAS
    - EUR
    - SAS
    gwas_catalog_id: GCST002222
    neg_log_pval: 261.415
    otg_id: GCST002222
    pubmed_id: '24097068'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: LDLR encodes the LDL receptor.
      pubmed_id: 00226968
    gene_id: ENSG00000130164
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '19'
      position: 11202306
    locus_GRCh38:
      chromosome: '19'
      position: 11091630
    rsid: rs6511720
  trait_info:
    ontology:
    - EFO_0004611
    reported_trait_name: LDL Cholesterol
    standard_trait_name: low density lipoprotein cholesterol measurement
- association_info:
    ancestry:
    - Caucasian
    gwas_catalog_id: GCST002219
    neg_log_pval: 81.456
    otg_id: GCST002219
    pubmed_id: '24097068'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: ANGPTL3 encodes a protein that regulates triglyceride clearance
        by reducing the activity of lipoprotein lipase (LPL).
      pubmed_id: '22063269'
    gene_id: ENSG00000132855
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '1'
      position: 63133930
    locus_GRCh38:
      chromosome: '1'
      position: 62668259
    rsid: rs4587594
  trait_info:
    ontology:
    - EFO_0004530
    reported_trait_name: Triglycerides
    standard_trait_name: triglyceride measurement
- association_info:
    ancestry:
    - Caucasian
    gwas_catalog_id: GCST002219
    neg_log_pval: 11.795
    otg_id: GCST002219
    pubmed_id: '24097068'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: LRPAP1 encodes a protein which binds the LDL-receptor-related protein
        and the VLDL receptor affecting distribution of lipoprotein particles.
      pubmed_id: 07538675
    gene_id: ENSG00000163956
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '4'
      position: 3473139
    locus_GRCh38:
      chromosome: '4'
      position: 3471412
    rsid: rs6831256
  trait_info:
    ontology:
    - EFO_0004530
    reported_trait_name: Triglycerides
    standard_trait_name: triglyceride measurement
- association_info:
    ancestry:
    - Caucasian
    gwas_catalog_id: GCST002219
    neg_log_pval: 7.676
    otg_id: GCST002219
    pubmed_id: '24097068'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: CAV1 encodes caveolin-1, a scaffolding protein.  Very rare CAV1
        frameshift mutations appear to be associated with atypical lipodystrophy and
        hypertriglyceridemia.
      pubmed_id: '18237401'
    gene_id: ENSG00000105974
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '7'
      position: 116358044
    locus_GRCh38:
      chromosome: '7'
      position: 116717990
    rsid: rs38855
  trait_info:
    ontology:
    - EFO_0004530
    reported_trait_name: Triglycerides
    standard_trait_name: triglyceride measurement
- association_info:
    ancestry:
    - Caucasian
    gwas_catalog_id: GCST002219
    neg_log_pval: 198.74
    otg_id: GCST002219
    pubmed_id: '24097068'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: LPL encodes the lipoprotein lipase which hydrolyzes triglycerides.  LPL
        deficiency results in accumulation of triglycerides.
      pubmed_id: '13712364'
    gene_id: ENSG00000175445
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '8'
      position: 19844222
    locus_GRCh38:
      chromosome: '8'
      position: 19986711
    rsid: rs12678919
  trait_info:
    ontology:
    - EFO_0004530
    reported_trait_name: Triglycerides
    standard_trait_name: triglyceride measurement
- association_info:
    ancestry:
    - Caucasian
    gwas_catalog_id: GCST002219
    neg_log_pval: 112.652
    otg_id: GCST002219
    pubmed_id: '24097068'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: TRIB1 regulates hepatic lipogenesis.
      pubmed_id: '26517927'
    gene_id: ENSG00000173334
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '8'
      position: 126482621
    locus_GRCh38:
      chromosome: '8'
      position: 125470379
    rsid: rs2954022
  trait_info:
    ontology:
    - EFO_0004530
    reported_trait_name: Triglycerides
    standard_trait_name: triglyceride measurement
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002242
    neg_log_pval: 40.0
    otg_id: GCST002242
    pubmed_id: '24159190'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: DDAH1 encodes dimethylarginine dimethylaminohydrolase which acts
        directly on dimethylarginine.
      pubmed_id: 07608105
    gene_id: ENSG00000153904
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '1'
      position: 85797110
    locus_GRCh38:
      chromosome: '1'
      position: 85331427
    rsid: rs28489187
  trait_info:
    ontology:
    - HMDB0001539
    reported_trait_name: Serum dimethylarginine levels (asymmetric)
    standard_trait_name: Asymmetric dimethylarginine
- association_info:
    ancestry:
    - EUR
    neg_log_pval: 36.538
    pubmed_id: '24507774'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: ANGPTL4 regulates TG clearance by reducing the activity of LPL
      pubmed_id: '16081640'
    gene_id: ENSG00000167772
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '19'
      position: 8429323
    locus_GRCh38:
      chromosome: '19'
      position: 8364439
    rsid: rs116843064
  trait_info:
    ontology:
    - EFO_0004530
    reported_trait_name: Triglycerides
    standard_trait_name: triglyceride measurement
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002549
    neg_log_pval: 15.699
    otg_id: GCST002549_7
    pubmed_id: '24528284'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: CYP2C19 encodes a cytochrome P450 which acts on xenobiotics including
        the selective serotonin reuptake inhibitor citalopram.
      pubmed_id: 08451774
    gene_id: ENSG00000165841
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '10'
      position: 96681846
    locus_GRCh38:
      chromosome: '10'
      position: 94922089
    rsid: rs1074145
  trait_info:
    ontology:
    - HMDB0060576
    - HMDB0005038
    reported_trait_name: Response to serotonin reuptake inhibitors in major depressive
      disorder (plasma drug and metabolite levels) (S-DCT/S-CT ratio)
    standard_trait_name: Desmethylcitalopram / Citalopram
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002549
    neg_log_pval: 15.699
    otg_id: GCST002549_8
    pubmed_id: '24528284'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: CYP2D6 encodes a cytochrome P450 which acts on many xenobiotics
        including the conversion of desmethylcitalopram to didesmethylcitalopram (DDCT)
      pubmed_id: 08451774
    gene_id: ENSG00000100197
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '22'
      position: 42526694
    locus_GRCh38:
      chromosome: '22'
      position: 42130692
    rsid: rs1065852
  trait_info:
    ontology:
    - HMDB0060472
    reported_trait_name: Response to serotonin reuptake inhibitors in major depressive
      disorder (plasma drug and metabolite levels) (S-DDCT concentration)
    standard_trait_name: Didemethylcitalopram
- association_info:
    ancestry:
    - AMR
    - EUR
    gwas_catalog_id: GCST002364
    neg_log_pval: 35.523
    otg_id: GCST002364_35
    pubmed_id: '24586186'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: FUT2 encodes a galactoside 2-alpha-L-fucosyltransferase, which
        adds fucose moeities to various proteins.
      pubmed_id: 07876235
    gene_id: ENSG00000176920
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '19'
      position: 49228272
    locus_GRCh38:
      chromosome: '19'
      position: 48725015
    rsid: rs2287921
  trait_info:
    ontology:
    - HMDB0000174
    reported_trait_name: Urinary metabolites (H-NMR features) (5.2125, Fucose)
    standard_trait_name: L-Fucose
- association_info:
    ancestry:
    - AMR
    - EUR
    gwas_catalog_id: GCST002364
    neg_log_pval: 33.0
    otg_id: GCST002364_9
    pubmed_id: '24586186'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: SLC7A9 encodes an amino acid transporter which can transport a
        range of amino acids including lysine
      pubmed_id: '24107421'
    gene_id: ENSG00000021488
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '19'
      position: 33364628
    locus_GRCh38:
      chromosome: '19'
      position: 32873722
    rsid: rs8101881
  trait_info:
    ontology:
    - HMDB0000182
    reported_trait_name: Urinary metabolites (H-NMR features) (1.7325, Lysine)
    standard_trait_name: L-Lysine
- association_info:
    ancestry:
    - ASW
    gwas_catalog_id: GCST002388
    neg_log_pval: 15.046
    otg_id: GCST002388_14
    pubmed_id: '24625756'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: ACY3 encodes an aminoacylase which preferentially deacetylates
        N-acetylaromatic amino acids including N-acetyl-L-phenylalanine.
      pubmed_id: '14656720'
    gene_id: ENSG00000132744
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '11'
      position: 67421341
    locus_GRCh38:
      chromosome: '11'
      position: 67653870
    rsid: rs12288023
  trait_info:
    ontology:
    - HMDB0000512
    reported_trait_name: Serum metabolite levels (N-acetylphenylalanine)
    standard_trait_name: N-Acetyl-L-phenylalanine
- association_info:
    ancestry:
    - ASW
    gwas_catalog_id: GCST002388
    neg_log_pval: 29.523
    otg_id: GCST002388_18
    pubmed_id: '24625756'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: TREH encodes trehalase which hydrolyses the disaccharide trehalose.
      pubmed_id: 09427547
    gene_id: ENSG00000118094
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 118549582
    locus_GRCh38:
      chromosome: '11'
      position: 118678873
    rsid: rs507080
  trait_info:
    ontology:
    - HMDB0000975
    reported_trait_name: Serum metabolite levels (Trehalose)
    standard_trait_name: Trehalose
- association_info:
    ancestry:
    - AFR
    - EUR
    gwas_catalog_id: GCST002391
    neg_log_pval: 12.155
    otg_id: GCST002391
    pubmed_id: '24651765'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: ALDH1L1 encodes a multifunctional enzyme which includes 10-formyltetrahydrofolate
        dehydrogenase activity.  The gene thus plays a key role in one carbon metabolism.
      pubmed_id: '07702556'
    gene_id: ENSG00000144908
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '3'
      position: 125906179
    locus_GRCh38:
      chromosome: '3'
      position: 126187336
    rsid: rs10934753
  trait_info:
    ontology:
    - HMDB0000742
    reported_trait_name: Plasma homocysteine levels (post-methionine load test)
    standard_trait_name: Homocysteine
- association_info:
    ancestry:
    - AFR
    - EUR
    gwas_catalog_id: GCST002391
    neg_log_pval: 62.699
    otg_id: GCST002391
    pubmed_id: '24651765'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: GNMT encodes an enzyme which produces S-adenosylhomocysteine.  S-adenosylhomocysteine
        can be converted to homocysteine by the enzyme S-adenosylhomocysteine hydrolase
      pubmed_id: '10843803'
    gene_id: ENSG00000124713
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 42925803
    locus_GRCh38:
      chromosome: '6'
      position: 42958065
    rsid: rs9296404
  trait_info:
    ontology:
    - HMDB0000742
    reported_trait_name: Plasma homocysteine levels (post-methionine load test)
    standard_trait_name: Homocysteine
- association_info:
    ancestry:
    - AFR
    - EUR
    gwas_catalog_id: GCST002391
    neg_log_pval: 25.523
    otg_id: GCST002391
    pubmed_id: '24651765'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: CBS encodes the cystathionine beta-synthase which acts on homocysteine
        to produce cystathionine
      pubmed_id: '16545978'
    gene_id: ENSG00000160200
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '21'
      position: 44488033
    locus_GRCh38:
      chromosome: '21'
      position: 43067923
    rsid: rs234714
  trait_info:
    ontology:
    - HMDB0000742
    reported_trait_name: Plasma homocysteine levels (post-methionine load test)
    standard_trait_name: Homocysteine
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 11.0
    otg_id: GCST002443_34
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: ADHFE1 encodes the hydroxyacid-oxoacid transhydrogenase which catalyzes
        the oxidation of 4-hydroxybutanoic acid to 4-oxobutanoic acid, while reducing
        2-oxoglutarate to 2-hydroxyglutarate.
      pubmed_id: '16616524'
    gene_id: ENSG00000147576
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '8'
      position: 67360725
    locus_GRCh38:
      chromosome: '8'
      position: 66448490
    rsid: rs1030420
  trait_info:
    ontology:
    - HMDB0000337
    reported_trait_name: Blood metabolite levels (X-04499--3,4-dihydroxybutyrate)
    standard_trait_name: (S)-3,4-Dihydroxybutyric acid
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 25.222
    otg_id: GCST002442_19
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: F12 encodes coagulation factor XII, a protease which activates
        kallikrein which releases bradykinin from kininogen.
      pubmed_id: '03521732'
    gene_id: ENSG00000131187
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 176842474
    locus_GRCh38:
      chromosome: '5'
      position: 177415473
    rsid: rs2731672
  trait_info:
    ontology:
    - HMDB0004246
    reported_trait_name: Blood metabolite ratios (X-12038/bradykinin, des-arg(9))
    standard_trait_name: / Bradykinin
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 60.0
    otg_id: GCST002443_9
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: NAT2 encodes an N-acetyltransferase which can produce methylxanthine
        as a downstream metabolite of caffeine.
      pubmed_id: '10744128'
    gene_id: ENSG00000156006
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '8'
      position: 18272438
    locus_GRCh38:
      chromosome: '8'
      position: 18414928
    rsid: rs4921914
  trait_info:
    ontology:
    - HMDB0010738
    reported_trait_name: Blood metabolite levels (1-methylxanthine)
    standard_trait_name: 1-methylxanthine
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 22.699
    otg_id: GCST002443_71
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: ALOX12 encodes arachidonate 12-lipoxygenase, which catalyzes the
        regio-selective addition of oxygen into arachidonic acid, generating 12R-hydroperoxyeicosatetraenoic
        acid (12R-HPETE).  12R-HPETE is rapidly reduced to the corresponding 12S-hydroxy
        compound, 12-HETE.
      pubmed_id: 04215079
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: ALOX12 encodes arachidonate 12-lipoxygenase, which catalyzes the
        regio-selective addition of oxygen into arachidonic acid, generating 12R-hydroperoxyeicosatetraenoic
        acid (12R-HPETE).  12R-HPETE is rapidly reduced to the corresponding 12S-hydroxy
        compound, 12-HETE.
      pubmed_id: '02377602'
    gene_id: ENSG00000108839
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '17'
      position: 6915401
    locus_GRCh38:
      chromosome: '17'
      position: 7012082
    rsid: rs2271316
  trait_info:
    ontology:
    - HMDB0006111
    reported_trait_name: Blood metabolite levels (X-12441--12-hydroxyeicosatetraenoate
      (12-HETE))
    standard_trait_name: 12-HETE
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 7.77
    otg_id: GCST002443_2
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: PEMT encodes the phosphatidylethanolamine N-methyltransferase which
        converts phosphatidylethanolamine to phosphatidylcholine.
      pubmed_id: 09370326
    gene_id: ENSG00000133027
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '17'
      position: 17422768
    locus_GRCh38:
      chromosome: '17'
      position: 17519454
    rsid: rs748196
  trait_info:
    ontology:
    - HMDB0061699
    reported_trait_name: 1-arachidonoylglycerophosphocholine - M33228
    standard_trait_name: 2-Arachidonoylglycerophosphocholine
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 11.751
    otg_id: GCST002443_99
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: HAO2 encodes a 2-hydroxyacid oxidase which catalyzes the oxidation
        of L-alpha-hydroxy acids; alpha-hydroxyisovalerate or a related metabolite
        may be a potential substrate
      pubmed_id: '10777549'
    gene_id: ENSG00000116882
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '1'
      position: 119952776
    locus_GRCh38:
      chromosome: '1'
      position: 119410153
    rsid: rs12141041
  trait_info:
    ontology:
    - HMDB0000407
    reported_trait_name: alpha-hydroxyisovalerate - M33937
    standard_trait_name: 2-Hydroxy-3-methylbutyric acid
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 30.0
    otg_id: GCST002443_99
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: LDHA encodes lactate dehydrogenase.  In addition to producing pyruvate
        from lactate, this enzyme can produce the observed metabolite from the keto
        acid 3-methyl-2-oxobutanoate
      pubmed_id: '26014429'
    gene_id: ENSG00000134333
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 18325146
    locus_GRCh38:
      chromosome: '11'
      position: 18303599
    rsid: rs2403254
  trait_info:
    ontology:
    - HMDB0000407
    reported_trait_name: Blood metabolite levels (alpha-hydroxyisovalerate)
    standard_trait_name: 2-Hydroxy-3-methylbutyric acid
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 10.155
    otg_id: GCST002443_69
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: IDO1 and IDO2 encode the two indoleamine 2,3-dioxygenase isozymes.  Both
        enzymes take tryptophan and tryptophan-related metabolites as substrates,
        but IDO1 is more active [18282734].  IDO1 has known activity against 5-hydroxy-tryptophan
        [10833386].  Common polymorphisms in IDO2 ablate activity but have no effect
        on this endpoint [17671174]
      pubmed_id: '10833386'
    gene_id: ENSG00000131203
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: T
      reference: A
    locus_GRCh37:
      chromosome: '8'
      position: 39823145
    locus_GRCh38:
      chromosome: '8'
      position: 39965626
    rsid: rs2160860
  trait_info:
    ontology:
    - HMDB0000472
    reported_trait_name: Blood metabolite levels (X-12100--hydroxytryptophan)
    standard_trait_name: 5-Hydroxy-L-tryptophan
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 10.699
    otg_id: GCST002443_49
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: UGT3A1 encodes a UDP glycosyltransferase.  This enzyme has demonstrated
        activity against the bile acid ursodeoxycholic acid.  The metabolite detected
        here is structurally related to the bile acids.
      pubmed_id: '18981171'
    gene_id: ENSG00000145626
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 35968000
    locus_GRCh38:
      chromosome: '5'
      position: 35967898
    rsid: rs10491431
  trait_info:
    ontology:
    - HMDB0094650
    reported_trait_name: Blood metabolite levels (X-11445--5-alpha-pregnan-3beta,20alpha-disulfate)
    standard_trait_name: 5alpha-pregnan-3beta,20alpha-diol disulfate
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 37.398
    otg_id: GCST002443_83
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: ECI2 encodes the enoyl-CoA delta isomerase 2, which is known to
        act on octenoyl-CoA and could possibly act on decenoyl-CoA as well.
      pubmed_id: '10419495'
    gene_id: ENSG00000198721
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 4146198
    locus_GRCh38:
      chromosome: '6'
      position: 4145964
    rsid: rs9392556
  trait_info:
    ontology:
    - HMDB0013205
    reported_trait_name: Blood metabolite levels (X-13435, a 10:1 acylcarnitine)
    standard_trait_name: 9-Decenoylcarnitine
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 20.097
    otg_id: GCST002443_70
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: GADL1 encodes the glutamate decarboxylase-like protein 1 which
        produces beta-alanine, a component of the dipeptide carnosine
      pubmed_id: '23038267'
    gene_id: ENSG00000144644
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '3'
      position: 30753573
    locus_GRCh38:
      chromosome: '3'
      position: 30712081
    rsid: rs6804368
  trait_info:
    ontology:
    - HMDB0012881
    reported_trait_name: Blood metabolite levels (X-12244--N-acetylcarnosine)
    standard_trait_name: Acetylcarnosine
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 37.523
    otg_id: GCST002443_100
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: 'AKR1C4 encodes a 3 alpha-hydroxysteroid dehydrogenase (HSD) isoform,
        which is expressed in the liver and acts on androsterone.   The nearby paralogous
        gene AKR1C3 is expressed in prostate and mammary gland and the encoded enzyme
        does not act on androsterone. '
      pubmed_id: '15026176'
    gene_id: ENSG00000198610
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '10'
      position: 5256272
    locus_GRCh38:
      chromosome: '10'
      position: 5214309
    rsid: rs17134585
  trait_info:
    ontology:
    - HMDB0002759
    - HMDB0062657
    reported_trait_name: Blood metabolite ratios (androsterone sulfate/epiandrosterone
      sulfate)
    standard_trait_name: Androsterone sulfate / Epiandrosterone Sulfate
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 360.699
    otg_id: GCST002442_26
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: FADS1 encodes a delta-5 desaturase, which converts dihomo-linolenate
        (20:3n6) to arachidonate (20:4n6).
      pubmed_id: '10601301'
    gene_id: ENSG00000149485
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 61571348
    locus_GRCh38:
      chromosome: '11'
      position: 61803876
    rsid: rs174548
  trait_info:
    ontology:
    - HMDB0060102
    - HMDB0002925
    reported_trait_name: Blood metabolite ratios (arachidonate (20:4n6)/dihomo-linolenate
      (20:3n3 or n6))
    standard_trait_name: Arachidonate / 8,11,14-Eicosatrienoic acid
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 28.699
    otg_id: GCST002442_26
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: MBOAT7 encodes a lysophosphatidylinositol acyltransferase that
        has specificity for arachidonoyl-CoA as an acyl donor. Arachidonate is readily
        converted to arachidonoyl-CoA. Thus the associated ratio is closely linked
        to the substrate/product pair for this enzyme. The associated ratio is closely
        linked to the substrate/product pair for this enzyme.
      pubmed_id: '18094042'
    gene_id: ENSG00000125505
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '19'
      position: 54676433
    locus_GRCh38:
      chromosome: '19'
      position: 54172738
    rsid: rs2576452
  trait_info:
    ontology:
    - HMDB0060102
    - HMDB0061690
    reported_trait_name: Blood metabolite ratios (arachidonate (20:4n6)/1-arachidonoylglycerophosphoinositol)
    standard_trait_name: Arachidonate|1-Arachidonoylglycerophosphoinositol
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 37.0
    otg_id: GCST002442_28
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: ACE encodes an angiotensin-converting enzyme.  This carboxypeptidase
        can generate aspartylphenylalanine from cholecystokinin-8.
      pubmed_id: 02554881
    gene_id: ENSG00000159640
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '17'
      position: 61566031
    locus_GRCh38:
      chromosome: '17'
      position: 63488670
    rsid: rs4343
  trait_info:
    ontology:
    - HMDB0000706
    reported_trait_name: Blood metabolite ratios (aspartylphenylalanine/X-14450--phenylalanylleucine)
    standard_trait_name: 'Aspartylphenylalanine / '
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 19.0
    otg_id: GCST002443_104
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: BHMT encodes a betaine-homocysteine methyltransferase which converts
        betaine to dimethylglycine.  Conversely, the homologous enzyme encoded by
        the nearby BHMT2 gene cannot use betaine.
      pubmed_id: 06746658
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: BHMT encodes a betaine-homocysteine methyltransferase which converts
        betaine to dimethylglycine.  Conversely, the homologous enzyme encoded by
        the nearby BHMT2 gene cannot use betaine.
      pubmed_id: '18230605'
    gene_id: ENSG00000145692
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 78346769
    locus_GRCh38:
      chromosome: '5'
      position: 79050946
    rsid: rs16876394
  trait_info:
    ontology:
    - HMDB0000043
    reported_trait_name: Blood metabolite levels (betaine)
    standard_trait_name: Betaine
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 12.097
    otg_id: GCST002443_104
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: SLC6A12 encodes a sodium- and chloride-dependent betaine transporter.
      pubmed_id: 08198549
    gene_id: ENSG00000111181
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: A
      reference: T
    locus_GRCh37:
      chromosome: '12'
      position: 320920
    locus_GRCh38:
      chromosome: '12'
      position: 211754
    rsid: rs499368
  trait_info:
    ontology:
    - HMDB0000043
    reported_trait_name: Blood metabolite levels (betaine)
    standard_trait_name: Betaine
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 12.222
    otg_id: GCST002443_109
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: KNG1 includes the coding sequence for the bradykinin peptide.
      pubmed_id: 02989293
    gene_id: ENSG00000113889
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '3'
      position: 186454180
    locus_GRCh38:
      chromosome: '3'
      position: 186736391
    rsid: rs5030062
  trait_info:
    ontology:
    - HMDB0004246
    reported_trait_name: Blood metabolite levels (bradykinin, des-arg(9))
    standard_trait_name: Bradykinin
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 47.398
    otg_id: GCST002443_109
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: KLKB1 encodes kallikrein, a serine protease which releases bradykinin
        from kininogen.
      pubmed_id: 08662673
    gene_id: ENSG00000164344
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '4'
      position: 187174683
    locus_GRCh38:
      chromosome: '4'
      position: 186253529
    rsid: rs4253311
  trait_info:
    ontology:
    - HMDB0004246
    reported_trait_name: Blood metabolite levels (bradykinin, des-arg(9))
    standard_trait_name: Bradykinin
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 629.523
    otg_id: GCST002443_110
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: 'ACADS encodes the short chain acyl-CoA dehydrogenase which takes
        butyrl-CoA as a substrate.   Butyryl-CoA and butyrylcarnitine readily interconvert.  '
      pubmed_id: 03597357
    gene_id: ENSG00000122971
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '12'
      position: 121160615
    locus_GRCh38:
      chromosome: '12'
      position: 120722812
    rsid: rs2066938
  trait_info:
    ontology:
    - HMDB0002013
    reported_trait_name: Blood metabolite levels (butyrylcarnitine)
    standard_trait_name: Butyrylcarnitine
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 7.657
    otg_id: GCST002443_25
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: CFH encodes complement factor H which binds complement factor 3.  The
        detected analyte is a peptide fragment of complement factor 3.
      pubmed_id: 06219696
    gene_id: ENSG00000000971
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '1'
      position: 196682346
    locus_GRCh38:
      chromosome: '1'
      position: 196713216
    rsid: rs7535263
  trait_info:
    ontology:
    - EFO_0004983
    reported_trait_name: HWESASXX - M32836
    standard_trait_name: C3f, complement C3 derived peptide
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 11.752
    otg_id: GCST002443_25
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: ANPEP encodes Aminopeptidase N, which is a broad specificity aminopeptidase.  HWESASXX,
        a peptide derived from C3 complement is a possible substrate.
      pubmed_id: 07957888
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: ANPEP encodes Aminopeptidase N, which is a broad specificity aminopeptidase.  HWESASXX,
        a peptide derived from C3 complement is a possible substrate.
      pubmed_id: 09647737
    gene_id: ENSG00000166825
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '15'
      position: 90345335
    locus_GRCh38:
      chromosome: '15'
      position: 89802104
    rsid: rs2007084
  trait_info:
    ontology:
    - EFO_0004983
    reported_trait_name: HWESASXX - M32836
    standard_trait_name: C3f, complement C3 derived peptide
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 10.097
    otg_id: GCST002443_115
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: ALDH18A1 encodes delta-1-pyrroline-5-carboxylate synthetase which
        catalyzes a step in the de novo production of ornithine which is subsequently
        converted to citrulline.  Mutations in ALDH18A1 cause hypocitrullinemia.
      pubmed_id: '11092761'
    gene_id: ENSG00000059573
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '10'
      position: 97395962
    locus_GRCh38:
      chromosome: '10'
      position: 95636205
    rsid: rs56322409
  trait_info:
    ontology:
    - HMDB0000904
    reported_trait_name: Blood metabolite levels (citrulline)
    standard_trait_name: Citrulline
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 44.0
    otg_id: GCST002442_17
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: SRD5A2 encodes the type II steroid 5 alpha-reductase enzyme best
        known for converting testosterone to dihydrotestosterone.  The metabolites
        represented by the ratio detected here are also steroid molecules differing
        in reduction at carbon 5.  The enzyme has known activity against corticosterone.
      pubmed_id: 07734398
    gene_id: ENSG00000049319
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: A
      reference: T
    locus_GRCh37:
      chromosome: '2'
      position: 31810974
    locus_GRCh38:
      chromosome: '2'
      position: 31585905
    rsid: rs559555
  trait_info:
    ontology:
    - HMDB0010320
    reported_trait_name: Blood metabolite ratios (X-11444/X-12844) (X-11444 is tentatively
      identified by Metabolon as urocortisol glucuronide or cortolone glucuronide
      and X-12844 is tentatively identified as tetrahydrocortisone glucuronide)
    standard_trait_name: cortolone glucuronide
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 12.699
    otg_id: GCST002443_117
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: 'GGT1 encodes gamma-glutamyltransferase 1 which catalyzes the transfer
        of the glutamyl moiety of glutathione to a number of different amino acids
        and can take the analyte reported here (the cysteine-glutathione mixed disulfide)
        as a substrate. '
      pubmed_id: '06130452'
    gene_id: ENSG00000100031
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '22'
      position: 25002081
    locus_GRCh38:
      chromosome: '22'
      position: 24606114
    rsid: rs2330809
  trait_info:
    ontology:
    - HMDB0000656
    reported_trait_name: Blood metabolite levels (cysteine-glutathione disulfide)
    standard_trait_name: Cysteineglutathione disulfide
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 37.061
    otg_id: GCST002443_118
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: ETFDH encodes a mitochondrial electron transfer flavoprotein dehydrogenase
        which is essential for electron transfer from the short-, medium- and long-chain
        acyl-CoA dehydrogenases.  Mutations in ETFDH lead to multiple acyl-CoA dehydrogenase
        deficiency, which is characterized by elevated short-, medium- and long-chain
        acyl carnitines.
      pubmed_id: '17412732'
    gene_id: ENSG00000171503
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '4'
      position: 159630817
    locus_GRCh38:
      chromosome: '4'
      position: 158709665
    rsid: rs8396
  trait_info:
    ontology:
    - HMDB0000651
    reported_trait_name: decanoylcarnitine - M33941
    standard_trait_name: Decanoylcarnitine
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 11.699
    otg_id: GCST002443_124
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: AKR1A1 encodes an aldehyde reductase which can catalyze the production
        of erythritol
      pubmed_id: 04402936
    gene_id: ENSG00000117448
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '1'
      position: 46990681
    locus_GRCh38:
      chromosome: '1'
      position: 46525009
    rsid: rs7542172
  trait_info:
    ontology:
    - HMDB0002994
    reported_trait_name: Blood metabolite levels (erythritol)
    standard_trait_name: erythritol
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 13.398
    otg_id: GCST002442
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: SLC27A2 encodes a very-long-chain acyl-CoA synthetase which activates
        fatty acids by forming their coenzyme A derivatives.
      pubmed_id: '10198260'
    gene_id: ENSG00000140284
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '15'
      position: 50477138
    locus_GRCh38:
      chromosome: '15'
      position: 50184941
    rsid: rs1365505
  trait_info:
    ontology:
    - HMDB0034286
    reported_trait_name: Blood metabolite ratios (10-undecenoate (11:1n1)/X-11438)
    standard_trait_name: 'Ethyl 10-undecenoate / '
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 36.046
    otg_id: GCST002442_4
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: ABO encodes a glycosyltransferase that determines the blood group.  ABO
        blood group contributes to von Willebrand Factor levels perhaps by protecting
        it from susceptibility to ADAMTS13-mediated proteolysis.  As part of the coagulation
        cascade, von Willebrand Factor effects rates of fibrinogen cleavage.
      pubmed_id: '17894864'
    gene_id: ENSG00000175164
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '9'
      position: 136154304
    locus_GRCh38:
      chromosome: '9'
      position: 133278860
    rsid: rs649129
  trait_info:
    ontology:
    - EFO_0004623
    reported_trait_name: Blood metabolite ratios (ADSGEGDFXAEGGGVR/ADpSGEGDFXAEGGGVR)
    standard_trait_name: Fibrinopeptide A
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 27.553
    otg_id: GCST002443_128
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: CPT2 encodes carnitine palmitoyltransferase II, which catalyzes
        the transfer of palmitate and related metabolites from carnitine to coenzyme
        A in the mitochondrial inner membrane.
      pubmed_id: 09654057
    gene_id: ENSG00000157184
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '1'
      position: 53695882
    locus_GRCh38:
      chromosome: '1'
      position: 53230210
    rsid: rs13375749
  trait_info:
    ontology:
    - HMDB13130
    reported_trait_name: Blood metabolite levels (glutaroyl carnitine)
    standard_trait_name: Glutarylcarnitine
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 44.222
    otg_id: GCST002443_128
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: GCDH encodes a glutaryl-CoA dehydrogenase which catalyzes the oxidative
        decarboxylation of glutaryl-CoA to crotonyl-CoA.
      pubmed_id: 03081514
    gene_id: ENSG00000105607
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '19'
      position: 13010520
    locus_GRCh38:
      chromosome: '19'
      position: 12899706
    rsid: rs8012
  trait_info:
    ontology:
    - HMDB13130
    reported_trait_name: Blood metabolite levels (glutaroyl carnitine)
    standard_trait_name: Glutarylcarnitine
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 16.0
    otg_id: GCST002443_135
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: MCCC1 encodes methylcrotonoyl-CoA carboxylase 1 which catalyzes
        the conversion of 3-methylcrotonyl-CoA to 3-methylglutaconyl-CoA in the breakdown
        of leucine.  An alternate fate of 3-methylcrotonyl-CoA is 3-hydroxyisovaleryl-CoA.  3-Methylcrotonyl-CoA
        carboxylase deficiency has been associated with elevated urinary 3-hydroxyisovalerylcarnitine
        levels.
      pubmed_id: '19339287'
    gene_id: ENSG00000078070
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '3'
      position: 182755209
    locus_GRCh38:
      chromosome: '3'
      position: 183037421
    rsid: rs2270968
  trait_info:
    ontology:
    - HMDB0062555
    reported_trait_name: Blood metabolite levels (hydroxyisovaleroyl carnitine)
    standard_trait_name: hydroxyisovaleroyl carnitine
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 15.699
    otg_id: GCST002443_136
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: GMPR encodes guanosine monophosphate reducatase which converts
        guanosine monophosphate to inosine monophosphate which can subsequently be
        converted to hypoxanthine by the enzyme purine-nucleoside phosphorylase.
      pubmed_id: 00218932
    gene_id: ENSG00000137198
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 16288192
    locus_GRCh38:
      chromosome: '6'
      position: 16287961
    rsid: rs6459467
  trait_info:
    ontology:
    - HMDB0000157
    reported_trait_name: Blood metabolite levels (hypoxanthine)
    standard_trait_name: Hypoxanthine
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 9.795
    otg_id: GCST002443_137
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: DDC encodes dopa decarboxylase which converts tryptophan to tryptamine,
        which can be further metabolized to indoleacetic acid.
      pubmed_id: '13610897'
    gene_id: ENSG00000132437
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: T
      reference: A
    locus_GRCh37:
      chromosome: '7'
      position: 50610379
    locus_GRCh38:
      chromosome: '7'
      position: 50542681
    rsid: rs7809234
  trait_info:
    ontology:
    - HMDB0000197
    reported_trait_name: indoleacetate - M27513
    standard_trait_name: Indoleacetic acid
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 12.0
    otg_id: GCST002443_137
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: 'CCBL1 encodes a kyneurenine aminotransferase, also known as hKAT-1,
        which can convert tryptophan to indolepyruvate.  Indolepyruvate is then converted
        to indolelactate. '
      pubmed_id: '15606768'
    gene_id: ENSG00000171097
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '9'
      position: 131572027
    locus_GRCh38:
      chromosome: '9'
      position: 128809748
    rsid: rs15676
  trait_info:
    ontology:
    - HMDB0000671
    reported_trait_name: Blood metabolite levels (indolelactate)
    standard_trait_name: Indolelactic acid
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 48.303
    otg_id: GCST002443_140
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: SLC22A1 encodes OCT1, an organic cation transporter with activity
        towards acylcarnitine.
      pubmed_id: '28942964'
    gene_id: ENSG00000175003
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 160564476
    locus_GRCh38:
      chromosome: '6'
      position: 160143444
    rsid: rs662138
  trait_info:
    ontology:
    - HMDB0062556
    reported_trait_name: isobutyrylcarnitine - M33441
    standard_trait_name: isobutyrylcarnitine
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 12.449
    otg_id: GCST002443_140
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: ETFA encodes a mitochondrial-specific electron transfer flavoprotein.  Enzyme
        deficiency results in urinary excretion of isobutyric acid and isobutyrylglycine;
        the urinary levels of these metabolites should reflect plasma levels of the
        analyte reported here, isobutyrylcarnitine.
      pubmed_id: '07360517'
    gene_id: ENSG00000140374
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '15'
      position: 77030792
    locus_GRCh38:
      chromosome: '15'
      position: 76738451
    rsid: rs2404602
  trait_info:
    ontology:
    - HMDB0062556
    reported_trait_name: isobutyrylcarnitine - M33441
    standard_trait_name: isobutyrylcarnitine
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 7.343
    otg_id: GCST002443_17
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: SUCLA2 encodes a subunit of succinyl-CoA synthetase a key enzyme
        in the Krebs cycle.  SUCLA2 deficiency results in elevated urinary excretion
        of leucine degradation products downstream of the analyte detected here (specifically
        3-hydroxyisovaleric acid and 3-methylglutaconic acid).
      pubmed_id: '19666145'
    gene_id: ENSG00000136143
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '13'
      position: 48459901
    locus_GRCh38:
      chromosome: '13'
      position: 47885766
    rsid: rs4941615
  trait_info:
    ontology:
    - HMDB0000695
    reported_trait_name: 4-methyl-2-oxopentanoate - M22116
    standard_trait_name: Ketoleucine
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 171.699
    otg_id: GCST002442_23
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: ACADM encodes an acyl-CoA dehydrogenase with a preference for medium
        chain length acyl-CoAs.  Acyl-CoAs are converted to acyl-carnitines for circulation
        which are then detected in the plasma.
      pubmed_id: 03597357
    gene_id: ENSG00000117054
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '1'
      position: 76161889
    locus_GRCh38:
      chromosome: '1'
      position: 75696204
    rsid: rs4949874
  trait_info:
    ontology:
    - HMDB0000201
    - HMDB0000705
    reported_trait_name: Blood metabolite ratios (acetylcarnitine/hexanoylcarnitine)
    standard_trait_name: L-Acetylcarnitine|Hexanoylcarnitine
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 8.831
    otg_id: GCST002443_102
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: ASRGL1 encodes an asparaginase which hydrolyzes asparagine to produce
        aspartate.
      pubmed_id: '24768817'
    gene_id: ENSG00000162174
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '11'
      position: 62176943
    locus_GRCh38:
      chromosome: '11'
      position: 62409471
    rsid: rs3017098
  trait_info:
    ontology:
    - HMDB0000168
    reported_trait_name: asparagine - M34283
    standard_trait_name: L-Asparagine
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 40.806
    otg_id: GCST002443_102
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: ASPG encodes an asparaginase homolog which which can hydrolyse
        asparagine to form aspartic acid
      pubmed_id: 09575212
    gene_id: ENSG00000166183
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '14'
      position: 104608068
    locus_GRCh38:
      chromosome: '14'
      position: 104141731
    rsid: rs2011069
  trait_info:
    ontology:
    - HMDB0000168
    reported_trait_name: asparagine - M34283
    standard_trait_name: L-Asparagine
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 25.046
    otg_id: GCST002443_142
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: SLC7A5 encodes LAT1 which mediates tryptophan/kynurenine exchange.
      pubmed_id: '17896864'
    gene_id: ENSG00000103257
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '16'
      position: 87878822
    locus_GRCh38:
      chromosome: '16'
      position: 87845216
    rsid: rs8051149
  trait_info:
    ontology:
    - HMDB0000684
    reported_trait_name: Blood metabolite levels (kynurenine)
    standard_trait_name: L-Kynurenine
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 26.155
    otg_id: GCST002443_161
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: PHGDH encodes a phosphoglycerate dehydrogenase which catalyses
        the first and rate-limiting step in serine biosynthesis.
      pubmed_id: '16589713'
    gene_id: ENSG00000092621
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '1'
      position: 120209755
    locus_GRCh38:
      chromosome: '1'
      position: 119667132
    rsid: rs1163251
  trait_info:
    ontology:
    - HMDB0000187
    reported_trait_name: Blood metabolite levels (serine)
    standard_trait_name: L-Serine
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 11.046
    otg_id: GCST002443_167
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: TDO2 encodes tryptophan 2,3-dioxygenase which acts on tryptophan.
      pubmed_id: 08666386
    gene_id: ENSG00000151790
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '4'
      position: 156808288
    locus_GRCh38:
      chromosome: '4'
      position: 155887136
    rsid: rs13122250
  trait_info:
    ontology:
    - HMDB0000929
    reported_trait_name: Blood metabolite levels (tryptophan)
    standard_trait_name: L-Tryptophan
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 50.523
    otg_id: GCST002442_46
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: SLC22A5 encodes the OCTN2 protein, which is the primary transporter
        reponsible for carnitine homeostasis.
      pubmed_id: '20648231'
    gene_id: ENSG00000197375
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 131665378
    locus_GRCh38:
      chromosome: '5'
      position: 132329685
    rsid: rs272889
  trait_info:
    ontology:
    - HMDB0000883
    - HMDB0000688
    reported_trait_name: Blood metabolite ratios (valine/isovalerylcarnitine)
    standard_trait_name: L-Valine / Isovalerylcarnitine
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 37.398
    otg_id: GCST002442_37
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: THEM4 is a broad range acyl-CoA thioesterase with a preference
        for medium and long chain acyl-CoAs. [19453107].  X-12442 has been identified
        as 5,8-tetradecadienoate.
      pubmed_id: '19453107'
    gene_id: ENSG00000159445
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '1'
      position: 151930645
    locus_GRCh38:
      chromosome: '1'
      position: 151958169
    rsid: rs6693388
  trait_info:
    ontology:
    - HMDB0000673
    - HMDB0000560
    reported_trait_name: Blood metabolite ratios (linoleate (18:2n6)/X-12442--5,8-tetradecadienoate)
    standard_trait_name: Linoleic acid / 5,8-Tetradecadienoic acid
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 13.097
    otg_id: GCST002443_59
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: FMO3 encodes a flavin containing monooxygenase which can act on
        S-allyl-cysteine and methionine. Methylcysteine is a plausible substrate.  This
        isozyme prefers smaller substrates and shows highest expression in liver.
      pubmed_id: '18775983'
    gene_id: ENSG00000007933
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '1'
      position: 171080615
    locus_GRCh38:
      chromosome: '1'
      position: 171111474
    rsid: rs7061710
  trait_info:
    ontology:
    - HMDB0002108
    reported_trait_name: Blood metabolite levels (X-11786--methylcysteine)
    standard_trait_name: Methylcysteine
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 13.301
    otg_id: GCST002443_148
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: ISYNA1 encodes an inositol-3-phosphate synthase, which converts
        d-glucose 6-phosphate to 1-d-myo-inositol 3-phosphate.
      pubmed_id: '15024000'
    gene_id: ENSG00000105655
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '19'
      position: 18618867
    locus_GRCh38:
      chromosome: '19'
      position: 18508057
    rsid: rs4808136
  trait_info:
    ontology:
    - HMDB0000211
    reported_trait_name: Blood metabolite levels (myo-inositol)
    standard_trait_name: myo-Inositol
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 115.0
    otg_id: GCST002442_40
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: SCD encodes a stearyl-CoA desaturase which acts on medium chain-length
        acyl-CoAs to bring about the delta 9 desaturation of various fatty acids,
        such as the conversion of myristate (14:0) to myristoleate (14:1n5).
      pubmed_id: 00008453
    gene_id: ENSG00000099194
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '10'
      position: 102075479
    locus_GRCh38:
      chromosome: '10'
      position: 100315722
    rsid: rs603424
  trait_info:
    ontology:
    - HMDB0000806
    - HMDB0002000
    reported_trait_name: Blood metabolite ratios (myristate (14:0)/myristoleate (14:1n5))
    standard_trait_name: Myristic acid / Myristoleic acid
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 13.523
    otg_id: GCST002443_31
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: 'AOC1 encodes an amine oxidase which deaminates N1-acetylspermidine
        to produce N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide (also known as acisoga).  '
      pubmed_id: '12072962'
    gene_id: ENSG00000002726
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '7'
      position: 150543721
    locus_GRCh38:
      chromosome: '7'
      position: 150846633
    rsid: rs1005390
  trait_info:
    ontology:
    - HMDB0061384
    reported_trait_name: Blood metabolite levels (X-03056--N-[3-(2-Oxopyrrolidin-1-yl)propyl]acetamide)
    standard_trait_name: N-(3-acetamidopropyl)pyrrolidin-2-one
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 12.523
    otg_id: GCST002443_32
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: 'PAOX encodes an N1-acetylspermidine oxidase.  The detected analyte
        is a downstream metabolite of N1-acetylspermidine.  '
      pubmed_id: '12660232'
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: 'PAOX encodes an N1-acetylspermidine oxidase.  The detected analyte
        is a downstream metabolite of N1-acetylspermidine.  '
      pubmed_id: 03558558
    gene_id: ENSG00000148832
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: T
      reference: A
    locus_GRCh37:
      chromosome: '10'
      position: 135197336
    locus_GRCh38:
      chromosome: '10'
      position: 133383832
    rsid: rs11101730
  trait_info:
    ontology:
    - HMDB0061384
    reported_trait_name: Blood metabolite levels (X-03056--N-[3-(2-Oxopyrrolidin-1-yl)propyl]acetamide)
    standard_trait_name: N-(3-acetamidopropyl)pyrrolidin-2-one
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 497.301
    otg_id: GCST002442_10
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: NAT8 shows sequence similarity to N-acetyltransferases.  N-acetylornithine
        may be a product or related to a product.  Ornithine itself is part of the
        urea cycle and myoinositol levels are altered in patients with urea cycle
        disorders.
      pubmed_id: '18662894'
    gene_id: ENSG00000144035
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '2'
      position: 73868328
    locus_GRCh38:
      chromosome: '2'
      position: 73641201
    rsid: rs13538
  trait_info:
    ontology:
    - HMDB0003357
    - HMDB0000211
    reported_trait_name: Blood metabolite ratios (N-acetylornithine/myo-inositol)
    standard_trait_name: N-Acetylornithine / myo-Inositol
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 11.222
    otg_id: GCST002443_68
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: ACMSD encodes alpha-Amino-beta-carboxymuconate-epsilon-semialdehyde
        decarboxylase, the key enzyme regulating de novo synthesis of nicitinamide
        adenine dinucleotide (NAD) from tryptophan.  The metabolite in question, N1-methyl-3-pyridone-4-carboxamide,
        is an endproduct of NAD degradation.
      pubmed_id: '16807375'
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: ACMSD encodes alpha-Amino-beta-carboxymuconate-epsilon-semialdehyde
        decarboxylase, the key enzyme regulating de novo synthesis of nicitinamide
        adenine dinucleotide (NAD) from tryptophan.  The metabolite in question, N1-methyl-3-pyridone-4-carboxamide,
        is an endproduct of NAD degradation.
      pubmed_id: '12694300'
    gene_id: ENSG00000153086
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '2'
      position: 135631400
    locus_GRCh38:
      chromosome: '2'
      position: 134873830
    rsid: rs6430553
  trait_info:
    ontology:
    - HMDB0004194
    reported_trait_name: Blood metabolite levels (X-12095--N1-methyl-3-pyridone-4-carboxamide)
    standard_trait_name: N1-Methyl-4-pyridone-3-carboxamide
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 134.0
    otg_id: GCST002443_82
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: ACADL encodes Long-chain acyl-CoA dehydrogenase which has activity
        against a variety of medium and long chain acyl-CoAs .  Intracellular acyl-CoAs
        are converted to acyl-carnitines for circulation.
      pubmed_id: '10832093'
    gene_id: ENSG00000115361
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '2'
      position: 210874246
    locus_GRCh38:
      chromosome: '2'
      position: 210009522
    rsid: rs3738934
  trait_info:
    ontology:
    - HMDB0013288
    reported_trait_name: Blood metabolite levels (X-13431--nonanoylcarnitine)
    standard_trait_name: Nonanoylcarnitine
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 177.301
    otg_id: GCST002443_58
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: COMT encodes the catechol-O-methyltransferase which can methylate
        ascorbate to produce O-methylascorbate.
      pubmed_id: 07129800
    gene_id: ENSG00000093010
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '22'
      position: 19951271
    locus_GRCh38:
      chromosome: '22'
      position: 19963748
    rsid: rs4680
  trait_info:
    ontology:
    - HMDB0000044
    reported_trait_name: Blood metabolite levels (X-11593--O-methylascorbate)
    standard_trait_name: O-methylascorbate
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 17.155
    otg_id: GCST002443_44
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: ARSA encodes the arylsulfatase A, which can act on L-tyrosine O-sulfate.
      pubmed_id: '00033715'
    gene_id: ENSG00000100299
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '22'
      position: 51063477
    locus_GRCh38:
      chromosome: '22'
      position: 50625049
    rsid: rs6151429
  trait_info:
    ontology:
    - HMDB0000158
    reported_trait_name: Blood metabolite levels (X-11423--O-sulfo-L-tyrosine)
    standard_trait_name: O-Sulfotyrosine
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 10.097
    otg_id: GCST002443_154
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: SLC5A6 encodes a solute transporter with demonstrated activity
        for pantothenate
      pubmed_id: 09516450
    gene_id: ENSG00000138074
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '2'
      position: 27424636
    locus_GRCh38:
      chromosome: '2'
      position: 27201768
    rsid: rs1395
  trait_info:
    ontology:
    - HMDB0000210
    reported_trait_name: Blood metabolite levels (pantothenate)
    standard_trait_name: Pantothenic acid
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 23.523
    otg_id: GCST002442_42
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: GOT2 encodes the enzyme aspartate aminotransferase which can take
        each of the aromatic amino acids as substrates. In particular, GOT2 catalyzes
        the conversion of phenylalanine to phenylpyruvate which is then converted
        to phenyllactate.
      pubmed_id: '04623131'
    gene_id: ENSG00000125166
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '16'
      position: 58829790
    locus_GRCh38:
      chromosome: '16'
      position: 58795886
    rsid: rs12709013
  trait_info:
    ontology:
    - HMDB0000779
    - HMDB0000159
    reported_trait_name: Blood metabolite ratios (phenyllactate (PLA)/phenylalanine)
    standard_trait_name: Phenyllactic acid / L-Phenylalanine
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 22.046
    otg_id: GCST002442_43
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: TKT encodes transkelolase, an enzyme with a prefererence for D-erythrose
        4-phosphate as a substrate.
      pubmed_id: 09924800
    gene_id: ENSG00000163931
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '3'
      position: 53282188
    locus_GRCh38:
      chromosome: '3'
      position: 53248172
    rsid: rs4687717
  trait_info:
    ontology:
    - HMDB0001429
    - HMDB0000613
    reported_trait_name: Blood metabolite ratios (phosphate/erythronate)
    standard_trait_name: Phosphate / Erythronic acid
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 42.046
    otg_id: GCST002442_44
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: IVD encodes isovaleryl-CoA dehydrogenase which acts on isovaleryl-CoA
        in the third step of leucine catabolism.  Isovaleryl-CoA is converted to isovalerylcarnitine
        for circulation.
      pubmed_id: 03597357
    gene_id: ENSG00000128928
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '15'
      position: 40703211
    locus_GRCh38:
      chromosome: '15'
      position: 40411012
    rsid: rs9635324
  trait_info:
    ontology:
    - HMDB0000824
    - HMDB0000688
    reported_trait_name: Blood metabolite ratios (propionylcarnitine/isovalerylcarnitine)
    standard_trait_name: Propionylcarnitine / Isovalerylcarnitine
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 109.222
    otg_id: GCST002443_22
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: OPLAH encodes 5-oxoprolinase which catalyzes the ATP-dependent
        hydrolysis of 5-oxoproline to glutamic acid
      pubmed_id: 09233839
    gene_id: ENSG00000178814
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '8'
      position: 145155408
    locus_GRCh38:
      chromosome: '8'
      position: 144100505
    rsid: rs12550729
  trait_info:
    ontology:
    - HMDB0000267
    reported_trait_name: Blood metabolite levels (5-oxoproline)
    standard_trait_name: Pyroglutamic acid
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 190.523
    otg_id: GCST002442_15
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: SULT2A1 encodes a bile salt sulfotransferase which can catalyze
        the sulfation of steroids and bile acids.
      pubmed_id: 08575776
    gene_id: ENSG00000105398
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '19'
      position: 48385057
    locus_GRCh38:
      chromosome: '19'
      position: 47881800
    rsid: rs2547231
  trait_info:
    ontology:
    - HMDB03818
    reported_trait_name: Blood metabolite ratios (X-11440/4-androsten-3beta,17beta-diol
      disulfate 2)
    standard_trait_name: similar to 5-Androstenediol
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 10.155
    otg_id: GCST002443_164
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: SUCLG2 encodes the beta subunit of succinate-CoA ligase which acts
        on succinate-CoA.  Acyl-CoAs and acyl-carnitines are readily interconverted.
      pubmed_id: '18392745'
    gene_id: ENSG00000172340
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '3'
      position: 67416322
    locus_GRCh38:
      chromosome: '3'
      position: 67365898
    rsid: rs17806888
  trait_info:
    ontology:
    - HMDB0061717
    reported_trait_name: Blood metabolite levels (succinylcarnitine)
    standard_trait_name: Succinylcarnitine
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 85.097
    otg_id: GCST002442
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: CYP4A11 encodes a fatty acid omega-hydroxylase.  X-11438 may be
        a hydroxylated tridecenoic acid (C13:1(OH)) so may represent a product.
      pubmed_id: '10860550'
    gene_id: ENSG00000187048
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '1'
      position: 47331966
    locus_GRCh38:
      chromosome: '1'
      position: 46866294
    rsid: rs6678639
  trait_info:
    ontology:
    - HMDB33724
    - HMDB0035881
    reported_trait_name: Blood metabolite ratios (10-undecenoate (11:1n1)/X-11438)
    standard_trait_name: Undecylenic acid / 11-Hydroxy-9-tridecenoic acid
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 7.467
    otg_id: GCST002443_170
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: CDA encodes cytidine deaminase which deaminates cytidine, producing
        uridine.
      pubmed_id: 08422236
    gene_id: ENSG00000158825
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '1'
      position: 20915172
    locus_GRCh38:
      chromosome: '1'
      position: 20588679
    rsid: rs532545
  trait_info:
    ontology:
    - HMDB0000296
    reported_trait_name: uridine - M00606
    standard_trait_name: Uridine
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 7.724
    otg_id: GCST002443_170
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: UPP1 encodes uridine phosphorylase which catalyzes the interconversion
        of uridine and uracil.
      pubmed_id: 07488099
    gene_id: ENSG00000183696
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '7'
      position: 48102911
    locus_GRCh38:
      chromosome: '7'
      position: 48063314
    rsid: rs2686796
  trait_info:
    ontology:
    - HMDB0000296
    reported_trait_name: uridine - M00606
    standard_trait_name: Uridine
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002443
    neg_log_pval: 15.398
    otg_id: GCST002443_170
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: TYMP encodes thymidine phosphorylase, which catalyzes the phosphorolysis
        of thymidine and deoxyuridine.   These pyrimidines are metabolically linked
        to uridine.
      pubmed_id: 07284378
    gene_id: ENSG00000025708
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '22'
      position: 50971752
    locus_GRCh38:
      chromosome: '22'
      position: 50533323
    rsid: rs131794
  trait_info:
    ontology:
    - HMDB0000296
    reported_trait_name: Blood metabolite levels (uridine)
    standard_trait_name: Uridine
- association_info:
    ancestry:
    - AFR
    - EUR
    gwas_catalog_id: GCST002559
    neg_log_pval: 12.699
    otg_id: GCST002559_2
    pubmed_id: '25147783'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: CUBN encodes cubilin, a protein involved in the uptake of vitamin
        B12 (cobalamin).  CUBN deficiency results in reduced levels of cobalamin.
      pubmed_id: 09478979
    gene_id: ENSG00000107611
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '10'
      position: 17156151
    locus_GRCh38:
      chromosome: '10'
      position: 17114152
    rsid: rs1801222
  trait_info:
    ontology:
    - HMDB0002174
    reported_trait_name: Vitamin B levels in ischemic stroke (Vitamin B12)
    standard_trait_name: Cobalamin
- association_info:
    ancestry:
    - EAS
    gwas_catalog_id: GCST002586
    neg_log_pval: 11.719
    otg_id: GCST002586
    pubmed_id: '25187374'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: FOXA2 encodes a transcription factor that impacts the expression
        of many genes (i.e., GCK, SLC2A2) previously related to the glucose levels.
      pubmed_id: '11875061'
    gene_id: ENSG00000125798
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '20'
      position: 22581268
    locus_GRCh38:
      chromosome: '20'
      position: 22600630
    rsid: rs6048216
  trait_info:
    ontology:
    - HMDB0000122
    reported_trait_name: Fasting plasma glucose (East Asian)
    standard_trait_name: D-Glucose
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002623
    neg_log_pval: 18.398
    otg_id: GCST002623
    pubmed_id: '25245031'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: ARG1 encodes an arginase which hydrolyzes arginine.  Enzyme deficiency
        causes argininemia.
      pubmed_id: 03540966
    gene_id: ENSG00000118520
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 131924689
    locus_GRCh38:
      chromosome: '6'
      position: 131603549
    rsid: rs2248551
  trait_info:
    ontology:
    - HMDB0000517
    reported_trait_name: L-arginine levels
    standard_trait_name: L-Arginine
- association_info:
    ancestry:
    - AMR
    - ASW
    - EUR
    - JPT
    - ZZ2
    gwas_catalog_id: GCST002652
    neg_log_pval: 154.699
    otg_id: GCST002652
    pubmed_id: '25293881'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: UGT2B10 encodes a UDP glucuronosyltransferase which glucuronidates
        cotinine to produce cotinine glucuronide
      pubmed_id: '17576790'
    gene_id: ENSG00000109181
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '4'
      position: 69673553
    locus_GRCh38:
      chromosome: '4'
      position: 68807835
    rsid: rs34100980
  trait_info:
    ontology:
    - HMDB0001013
    reported_trait_name: Cotinine glucuronidation
    standard_trait_name: Cotinine glucuronide
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002679
    neg_log_pval: 19.177
    otg_id: GCST002679
    pubmed_id: '25352340'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: TF encodes transferrin, a key transporter for iron.
      pubmed_id: 01809186
    gene_id: ENSG00000091513
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '3'
      position: 133477701
    locus_GRCh38:
      chromosome: '3'
      position: 133758857
    rsid: rs8177240
  trait_info:
    ontology:
    - HMDB0015531
    reported_trait_name: Iron|serum
    standard_trait_name: Iron
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002679
    neg_log_pval: 96.565
    otg_id: GCST002679
    pubmed_id: '25352340'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: HFE encodes the hereditary hemochromatosis protein which binds
        transferrin receptor which binds transferrin which binds iron
      pubmed_id: 09465039
    gene_id: ENSG00000010704
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 26093141
    locus_GRCh38:
      chromosome: '6'
      position: 26092913
    rsid: rs1800562
  trait_info:
    ontology:
    - HMDB0015531
    reported_trait_name: Iron|serum
    standard_trait_name: Iron
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002679
    neg_log_pval: 18.0
    otg_id: GCST002679
    pubmed_id: '25352340'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: TFR2 encodes a receptor for transferrin which binds iron
      pubmed_id: '10409623'
    gene_id: ENSG00000106327
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '7'
      position: 100235970
    locus_GRCh38:
      chromosome: '7'
      position: 100638347
    rsid: rs7385804
  trait_info:
    ontology:
    - HMDB0015531
    reported_trait_name: Iron status biomarkers (iron levels)
    standard_trait_name: Iron
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002679
    neg_log_pval: 139.0
    otg_id: GCST002679
    pubmed_id: '25352340'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: TMPRSS6 encodes a protease which regulates levels of hepcidin which
        regulates iron levels
      pubmed_id: '25588876'
    gene_id: ENSG00000187045
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '22'
      position: 37462936
    locus_GRCh38:
      chromosome: '22'
      position: 37066896
    rsid: rs855791
  trait_info:
    ontology:
    - HMDB0015531
    reported_trait_name: Iron status biomarkers (iron levels)
    standard_trait_name: Iron
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002690
    neg_log_pval: 39.577
    otg_id: GCST002690
    pubmed_id: '25378659'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: CERS4 encodes a ceramide synthase which produces ceramides from
        sphingosine and a long chain acyl CoA, derived from long chain free fatty
        acids.
      pubmed_id: '12912983'
    gene_id: ENSG00000090661
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '19'
      position: 8281635
    locus_GRCh38:
      chromosome: '19'
      position: 8216751
    rsid: rs2100944
  trait_info:
    ontology:
    - HMDB0002212
    reported_trait_name: FA 20:0|plasma
    standard_trait_name: Arachidic acid
- association_info:
    ancestry:
    - unknown
    gwas_catalog_id: GCST002712
    neg_log_pval: 48.523
    otg_id: GCST002712_9
    pubmed_id: '25500335'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: LPCAT3 encodes a lysophosphatidylcholine acyltransferase which
        takes the CoA version of oleic acid to convert lysophosphatidylcholine to
        phosphatidylcholine.
      pubmed_id: '18781350'
    gene_id: ENSG00000111684
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '12'
      position: 7075882
    locus_GRCh38:
      chromosome: '12'
      position: 6966719
    rsid: rs2110073
  trait_info:
    ontology:
    - HMDB0000207
    reported_trait_name: Red blood cell fatty acid levels (OA)
    standard_trait_name: Oleic Acid
- association_info:
    ancestry:
    - unknown
    gwas_catalog_id: GCST002831
    neg_log_pval: 13.398
    otg_id: GCST002831
    pubmed_id: '25820613'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: ALAD encodes aminolevulinate dehydratase, an enzyme which binds
        to lead.
      pubmed_id: '01713045'
    gene_id: ENSG00000148218
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '9'
      position: 116151191
    locus_GRCh38:
      chromosome: '9'
      position: 113388911
    rsid: rs1805313
  trait_info:
    ontology:
    - HMDB0004628
    reported_trait_name: Lead levels in blood
    standard_trait_name: Lead
- association_info:
    ancestry:
    - unknown
    gwas_catalog_id: GCST002932
    neg_log_pval: 13.658
    otg_id: GCST002932
    pubmed_id: '26025379'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: SLC30A10 encodes a transporter with specificity for manganese.
      pubmed_id: '25319704'
    gene_id: ENSG00000196660
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '1'
      position: 220080028
    locus_GRCh38:
      chromosome: '1'
      position: 219906686
    rsid: rs1776029
  trait_info:
    ontology:
    - HMDB0001333
    reported_trait_name: Manganese|plasma
    standard_trait_name: Manganese
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002964
    neg_log_pval: 31.699
    otg_id: GCST002964_2
    pubmed_id: '26068415'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: SPTLC3 encodes a subunit of serine palmitoyltransferase, which
        catalyzes the first step in de novo sphingolipid biosynthesis.
      pubmed_id: '17023427'
    gene_id: ENSG00000172296
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '20'
      position: 12959398
    locus_GRCh38:
      chromosome: '20'
      position: 12978750
    rsid: rs4814176
  trait_info:
    ontology:
    - HMDB0013469
    reported_trait_name: Sphingolipid levels (Hydroxysphingomyeline C24:1)
    standard_trait_name: Hydroxysphingomyeline C24:1
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002961
    neg_log_pval: 80.82
    otg_id: GCST002961_2
    pubmed_id: '26068415'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: SLC16A9 encodes a carnitine efflux transporter.
      pubmed_id: '21886157'
    gene_id: ENSG00000165449
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '10'
      position: 61469538
    locus_GRCh38:
      chromosome: '10'
      position: 59709780
    rsid: rs1171614
  trait_info:
    ontology:
    - HMDB0000062
    reported_trait_name: C0
    standard_trait_name: L-Carnitine
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002966
    neg_log_pval: 58.523
    otg_id: GCST002966_4
    pubmed_id: '26068415'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: PRODH encodes proline dehydrogenase which catalyzes the first step
        in proline degradation
      pubmed_id: '16874462'
    gene_id: ENSG00000100033
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '22'
      position: 18959684
    locus_GRCh38:
      chromosome: '22'
      position: 18972171
    rsid: rs2540641
  trait_info:
    ontology:
    - HMDB0000162
    reported_trait_name: Blood metabolite levels (proline)
    standard_trait_name: L-Proline
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002966
    neg_log_pval: 17.353
    otg_id: GCST002966_5
    pubmed_id: '26068415'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: PSPH encodes phosphoserine phosphatase which produces serine
      pubmed_id: '16589713'
    gene_id: ENSG00000146733
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '7'
      position: 56079094
    locus_GRCh38:
      chromosome: '7'
      position: 56011401
    rsid: rs4947534
  trait_info:
    ontology:
    - HMDB0000187
    reported_trait_name: Ser
    standard_trait_name: L-Serine
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002966
    neg_log_pval: 12.552
    otg_id: GCST002965_33
    pubmed_id: '26068415'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: MFSD2A encodes a lysophosphotidylcholine transporter.
      pubmed_id: '24828044'
    gene_id: ENSG00000168389
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '1'
      position: 40403370
    locus_GRCh38:
      chromosome: '1'
      position: 39937698
    rsid: rs7529794
  trait_info:
    ontology:
    - HMDB0010382
    reported_trait_name: lysoPC a C16:0
    standard_trait_name: LysoPC(16:0)
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002966
    neg_log_pval: 9.39
    otg_id: GCST002965_13
    pubmed_id: '26068415'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: AGPS encodes the alkylglycerone phosphate synthase which generates
        ether phospholipids such as the metabolite detected here.
      pubmed_id: '10215861'
    gene_id: ENSG00000018510
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '2'
      position: 178370631
    locus_GRCh38:
      chromosome: '2'
      position: 177505903
    rsid: rs7582179
  trait_info:
    ontology:
    - HMDB0013456
    reported_trait_name: PC ae C44:5
    standard_trait_name: PC(o-22:2(13Z,16Z)/22:3(10Z,13Z,16Z))
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002966
    neg_log_pval: 10.475
    otg_id: GCST002965_13
    pubmed_id: '26068415'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: ACSL1 encodes a long-chain fatty-acid-coenzyme A ligase which produces
        acyl-CoAs.  These in turn can be used in the synthesis of plasmalogens, e.g.,
        via LPCAT4
      pubmed_id: 08584017
    gene_id: ENSG00000151726
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '4'
      position: 185773811
    locus_GRCh38:
      chromosome: '4'
      position: 184852657
    rsid: rs7700133
  trait_info:
    ontology:
    - HMDB0013456
    reported_trait_name: PC ae C44:5
    standard_trait_name: PC(o-22:2(13Z,16Z)/22:3(10Z,13Z,16Z))
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST002966
    neg_log_pval: 10.419
    otg_id: GCST002965_2
    pubmed_id: '26068415'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: ABHD3 encodes a phospholipase with demonstrated activity against
        PC(32:2), specifically the PC(14:0/18:2) stereoisomer.
      pubmed_id: '21926997'
    gene_id: ENSG00000158201
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '18'
      position: 19263128
    locus_GRCh38:
      chromosome: '18'
      position: 21683167
    rsid: rs7343008
  trait_info:
    ontology:
    - HMDB0007874
    reported_trait_name: PC aa C32:2
    standard_trait_name: 'Phosphatidyl choline PC(14:0/18:2(9Z,12Z)) is a specific
      example  '
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST003119
    neg_log_pval: 251.625
    otg_id: GCST003119_11
    pubmed_id: '26352407'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: AGXT2 encodes an alanine-glyoxylate aminotransferase, an enzyme
        which can take 3-aminoisobutyrate as a substrate.
      pubmed_id: 08427875
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: AGXT2 encodes an alanine-glyoxylate aminotransferase, an enzyme
        which can take 3-aminoisobutyrate as a substrate.
      pubmed_id: 05773299
    gene_id: ENSG00000113492
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 35037115
    locus_GRCh38:
      chromosome: '5'
      position: 35037010
    rsid: rs37369
  trait_info:
    ontology:
    - HMDB0003911
    reported_trait_name: 3-aminoisobutyrate|urine
    standard_trait_name: 3-Aminoisobutanoic acid
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST003119
    neg_log_pval: 17.159
    pubmed_id: '26352407'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: AGXT encodes alanine-glyoxylate aminotransferase.  When acting
        on valine, rather than alanine, as a substrate, the enzyme will produce alpha-ketoisovaleric
        acid as a product (see EC code EC 2.6.1.66).  The mouse and rat orthologs
        have demonstrated activity on valine.
      pubmed_id: 00629740
    gene_id: ENSG00000172482
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '2'
      position: 241837452
    locus_GRCh38:
      chromosome: '2'
      position: 240898035
    rsid: rs6748734
  trait_info:
    ontology:
    - HMDB0000019
    reported_trait_name: alpha-ketoisovalerate|urine
    standard_trait_name: alpha-Ketoisovaleric acid
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST003119
    neg_log_pval: 59.074
    otg_id: GCST003119_14
    pubmed_id: '26352407'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: SLC6A20 encodes a transporter for N-methylglycine, proline and
        other specific amino acids.
      pubmed_id: '15632147'
    gene_id: ENSG00000163817
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '3'
      position: 45814094
    locus_GRCh38:
      chromosome: '3'
      position: 45772602
    rsid: rs17279437
  trait_info:
    ontology:
    - HMDB0000092
    - HMDB0000161
    reported_trait_name: N,N-dimethylglycine/alanine|urine
    standard_trait_name: Dimethylglycine / L-Alanine
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST003119
    neg_log_pval: 27.146
    pubmed_id: '26352407'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: ETNPPL encodes the ethanolamine-phosphate phospho-lyase which acts
        on the phosphorylated form of ethanolamine.  AGXT2L1 is a common synonym for
        this gene.
      pubmed_id: '22241472'
    gene_id: ENSG00000164089
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '4'
      position: 109705967
    locus_GRCh38:
      chromosome: '4'
      position: 108784811
    rsid: rs56043887
  trait_info:
    ontology:
    - HMDB0000149
    reported_trait_name: ethanolamine|urine
    standard_trait_name: Ethanolamine
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST003119
    neg_log_pval: 14.68
    otg_id: GCST003119_16
    pubmed_id: '26352407'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: SLC36A2 encodes the a proton-coupled amino acid transporter, which
        is specific for glycine and proline.
      pubmed_id: '19033659'
    gene_id: ENSG00000186335
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 150698806
    locus_GRCh38:
      chromosome: '5'
      position: 151319245
    rsid: rs3846710
  trait_info:
    ontology:
    - HMDB0000123
    - HMDB0000094
    reported_trait_name: glycine/citrate|urine
    standard_trait_name: Glycine / Citric acid
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST003119
    neg_log_pval: 13.53
    otg_id: GCST003119_17
    pubmed_id: '26352407'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: XYLB encodes a xylulokinase homolog which phosphorylates D-xylulose,
        a precursor of glycolate
      pubmed_id: 09783918
    gene_id: ENSG00000093217
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '3'
      position: 38395562
    locus_GRCh38:
      chromosome: '3'
      position: 38354071
    rsid: rs3132440
  trait_info:
    ontology:
    - HMDB0000115
    reported_trait_name: glycolate|urine
    standard_trait_name: Glycolic acid
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST003119
    neg_log_pval: 261.126
    otg_id: GCST002443_168
    pubmed_id: '26352407'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: SLC6A19 encodes a neutral amino acid transporter which can act
        on tyrosine.  The nearby paralog, SLC6A18, is specific for glycine.
      pubmed_id: '15044460'
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: SLC6A19 encodes a neutral amino acid transporter which can act
        on tyrosine.  The nearby paralog, SLC6A18, is specific for glycine.
      pubmed_id: '15804236'
    gene_id: ENSG00000174358
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 1183560
    locus_GRCh38:
      chromosome: '5'
      position: 1183445
    rsid: rs11750211
  trait_info:
    ontology:
    - HMDB0000158
    reported_trait_name: tyrosine|urine
    standard_trait_name: L-Tyrosine
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST003119
    neg_log_pval: 65.034
    otg_id: GCST002443_148
    pubmed_id: '26352407'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: SLC5A11 encodes a sodium/myo-inositol transporter (SMIT2) which
        can also transport scyllo-inostiol.
      pubmed_id: '21887366'
    gene_id: ENSG00000158865
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '16'
      position: 25002600
    locus_GRCh38:
      chromosome: '16'
      position: 24991279
    rsid: rs17702912
  trait_info:
    ontology:
    - HMDB0000211
    reported_trait_name: myo-inositol|urine
    standard_trait_name: myo-Inositol
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST003119
    neg_log_pval: 15.845
    otg_id: GCST003666_3
    pubmed_id: '26352407'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: SLC13A3 encodes a high affinity succinate transporter enriched
        in kidney tissue.
      pubmed_id: '10794676'
    gene_id: ENSG00000158296
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '20'
      position: 45261041
    locus_GRCh38:
      chromosome: '20'
      position: 46632402
    rsid: rs941206
  trait_info:
    ontology:
    - HMDB0000254
    - HMDB0000094
    reported_trait_name: sucinate/citrate|urine
    standard_trait_name: Succinic acid / Citric acid
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST006879
    neg_log_pval: 36.131
    otg_id: GCST006879_4
    pubmed_id: '26401656'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: SLC22A16 encodes transporter specific for carnitine
      pubmed_id: '12089149'
    gene_id: ENSG00000004809
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 110760008
    locus_GRCh38:
      chromosome: '6'
      position: 110438805
    rsid: rs12210538
  trait_info:
    ontology:
    - 'EFO_0005059 '
    reported_trait_name: total acylcarnitine
    standard_trait_name: acylcarnitine measurement
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST006879
    neg_log_pval: 11.622
    otg_id: GCST006879_5
    pubmed_id: '26401656'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: GPT encodes alanine aminotransferase which takes alanine as a substrate
        and produces glutamate which is one step removed from aspartate.
      pubmed_id: 09119391
    gene_id: ENSG00000167701
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '8'
      position: 145701453
    locus_GRCh38:
      chromosome: '8'
      position: 144476070
    rsid: rs750472
  trait_info:
    ontology:
    - HMDB0000161
    - HMDB0000168
    reported_trait_name: metabolite ratio (Ala/Asp)
    standard_trait_name: L-Alanine / L-Asparagine
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST006879
    neg_log_pval: 82.375
    otg_id: GCST006879_17
    pubmed_id: '26401656'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: 'CRAT encodes carnitine O-acetyltransferase, which catalyzes the
        interconversion of short chain acylcarnitines and acyl-coenzyme A derivatives. '
      pubmed_id: '02351134'
    gene_id: ENSG00000095321
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '9'
      position: 131865027
    locus_GRCh38:
      chromosome: '9'
      position: 129102748
    rsid: rs746872
  trait_info:
    ontology:
    - HMDB0013133
    reported_trait_name: Methylmalonylcarnitine
    standard_trait_name: Methylmalonylcarnitine
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST006879
    neg_log_pval: 7.269
    otg_id: GCST006879_2
    pubmed_id: '26401656'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: HLCS encodes a biotin apo-protein ligase which attaches biotin
        to four biotin-dependent enymes, including enzymes involved in branched chain
        amino acid catabolism.  Holocarboxylase synthetase deficiency results in increased
        levels of 3-Hydroxyisovalerylcarnitine.
      pubmed_id: '19201116'
    gene_id: ENSG00000159267
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '21'
      position: 38336834
    locus_GRCh38:
      chromosome: '21'
      position: 36964534
    rsid: rs1571700
  trait_info:
    ontology:
    - HMDB0061189
    reported_trait_name: 2-Hydroxyisovalerylcarnitine
    standard_trait_name: Similar to 3-Hydroxyisovalerylcarnitine
- association_info:
    ancestry:
    - FIN
    neg_log_pval: 85.239
    pubmed_id: '26407342'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: CYP2A6 encodes a cytochrome P450 which is the primary enzyme responsible
        for the conversion of nicotine to cotinine.
      pubmed_id: 08937855
    gene_id: ENSG00000255974
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '19'
      position: 41353107
    locus_GRCh38:
      chromosome: '19'
      position: 40847202
    rsid: rs56113850
  trait_info:
    ontology:
    - HMDB0001390
    - HMDB0001046
    reported_trait_name: Nicotine Metabolite Ratio
    standard_trait_name: ratio of Hydroxycotinine to Cotinine
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST003666
    neg_log_pval: 17.319
    otg_id: GCST003666_3
    pubmed_id: '27005778'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: SLC13A5 encodes NaCT, a sodium-coupled citrate transporter.
      pubmed_id: '16973915'
    gene_id: ENSG00000141485
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '17'
      position: 6595398
    locus_GRCh38:
      chromosome: '17'
      position: 6692079
    rsid: rs172642
  trait_info:
    ontology:
    - HMDB0000094
    reported_trait_name: Citrate
    standard_trait_name: Citric acid
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST003666
    neg_log_pval: 21.886
    otg_id: GCST003666_3
    pubmed_id: '27005778'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: SLC25A1 encodes the mitochondrial-localized tricarboxylate transporter
        of citrate.
      pubmed_id: 02804096
    gene_id: ENSG00000100075
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '22'
      position: 19161935
    locus_GRCh38:
      chromosome: '22'
      position: 19174422
    rsid: rs2040771
  trait_info:
    ontology:
    - HMDB0000094
    reported_trait_name: Citrate
    standard_trait_name: Citric acid
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST003666
    neg_log_pval: 300.0
    otg_id: GCST003666_7
    pubmed_id: '27005778'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: CPS1 encodes a mitochondrial carbamoyl phosphate synthetase which
        takes ammonia as a substrate.   Glycine and ammonia are interconverted via
        the glycine cleavage complex.
      pubmed_id: '18941301'
    gene_id: ENSG00000021826
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '2'
      position: 211540507
    locus_GRCh38:
      chromosome: '2'
      position: 210675783
    rsid: rs1047891
  trait_info:
    ontology:
    - HMDB0000123
    reported_trait_name: Glycine
    standard_trait_name: Glycine
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST003666
    neg_log_pval: 39.432
    otg_id: GCST003666_7
    pubmed_id: '27005778'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: GLDC encodes glycine dehydrogenase which takes glycine as a substrate.  GLDC
        deficiency causes excess of glycine.
      pubmed_id: 04585091
    gene_id: ENSG00000178445
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: TA
      reference: T
    locus_GRCh37:
      chromosome: '9'
      position: 5877295
    locus_GRCh38:
      chromosome: '9'
      position: 5877295
    rsid: rs140348140
  trait_info:
    ontology:
    - HMDB0000123
    reported_trait_name: Glycine
    standard_trait_name: Glycine
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST003666
    neg_log_pval: 12.523
    otg_id: GCST003666_7
    pubmed_id: '27005778'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: GCSH encodes the glycine cleavage system H protein which is involved
        in the degradation of glycine.  GCSH deficiency leads to excess plasma glycine.
      pubmed_id: '18941301'
    gene_id: ENSG00000140905
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '16'
      position: 81065282
    locus_GRCh38:
      chromosome: '16'
      position: 81031677
    rsid: rs10083777
  trait_info:
    ontology:
    - HMDB0000123
    reported_trait_name: Glycine
    standard_trait_name: Glycine
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST003665
    neg_log_pval: 10.495
    otg_id: GCST003665_10
    pubmed_id: '27005778'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: APOA2 encodes apolipoprotein A-II, a major component of HDL particles
      pubmed_id: '24089247'
    gene_id: ENSG00000158874
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '1'
      position: 161190250
    locus_GRCh38:
      chromosome: '1'
      position: 161220460
    rsid: rs4503368
  trait_info:
    ontology:
    - EFO_0004612
    reported_trait_name: XL.HDL.PL
    standard_trait_name: high density lipoprotein cholesterol measurement
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST003665
    neg_log_pval: 54.585
    otg_id: GCST003665
    pubmed_id: '27005778'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: PLTP encodes phospholipid transfer protein which acts directly
        on HDL particles.
      pubmed_id: 08664337
    gene_id: ENSG00000100979
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '20'
      position: 44551855
    locus_GRCh38:
      chromosome: '20'
      position: 45923216
    rsid: rs6073958
  trait_info:
    ontology:
    - EFO_0004612
    reported_trait_name: S.HDL.P
    standard_trait_name: high density lipoprotein cholesterol measurement
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST003666
    neg_log_pval: 12.215
    otg_id: GCST003666
    pubmed_id: '27005778'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: SLC38A4 encodes a liver-enriched amino acid transporter (ATA3)
        with affinity for most cationic and neutral amino acids including alanine.
      pubmed_id: '11342143'
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: SLC38A4 encodes a liver-enriched amino acid transporter (ATA3)
        with affinity for most cationic and neutral amino acids including alanine.
      pubmed_id: '11118514'
    gene_id: ENSG00000139209
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '12'
      position: 47201814
    locus_GRCh38:
      chromosome: '12'
      position: 46808031
    rsid: rs4554975
  trait_info:
    ontology:
    - HMDB0000161
    reported_trait_name: Alanine
    standard_trait_name: L-Alanine
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST003666
    neg_log_pval: 69.481
    otg_id: GCST003666_6
    pubmed_id: '27005778'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: GLS2 encodes the mitochondrial phosphate-activated glutaminase
        which catalyzes the hydrolysis of glutamine to glutamate and ammonia.
      pubmed_id: '10620514'
    gene_id: ENSG00000135423
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '12'
      position: 56865338
    locus_GRCh38:
      chromosome: '12'
      position: 56471554
    rsid: rs2657879
  trait_info:
    ontology:
    - HMDB0000641
    reported_trait_name: Glutamine
    standard_trait_name: L-Glutamine
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST003666
    neg_log_pval: 14.137
    otg_id: GCST003666_10
    pubmed_id: '27005778'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: HAL encodes histidine ammonia-lyase which catalyzes the first step
        in the degradation of histidine to glutamate.
      pubmed_id: '13018112'
    gene_id: ENSG00000084110
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '12'
      position: 96314795
    locus_GRCh38:
      chromosome: '12'
      position: 95921017
    rsid: rs7954638
  trait_info:
    ontology:
    - HMDB0000177
    reported_trait_name: Metabolite levels (small molecules and protein measures)
      (Histidine)
    standard_trait_name: L-Histidine
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST003666
    neg_log_pval: 14.602
    otg_id: GCST003666_11
    pubmed_id: '27005778'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: PAH encodes the enzyme phenylalanine hydroxylase which is the rate-limiting
        step in phenylalanine catabolism.
      pubmed_id: '04150152'
    gene_id: ENSG00000171759
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '12'
      position: 103242396
    locus_GRCh38:
      chromosome: '12'
      position: 102848618
    rsid: rs1718309
  trait_info:
    ontology:
    - HMDB0000159
    reported_trait_name: Phenylalanine
    standard_trait_name: L-Phenylalanine
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST003666
    neg_log_pval: 23.854
    otg_id: GCST003666_13
    pubmed_id: '27005778'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: SLC16A10 encodes the T?type amino acid transporter?1 (TAT1); this
        transporter transports tryptophan, tyrosine and phenylalanine
      pubmed_id: '11827462'
    gene_id: ENSG00000112394
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 111543944
    locus_GRCh38:
      chromosome: '6'
      position: 111222741
    rsid: rs14399
  trait_info:
    ontology:
    - HMDB0000158
    reported_trait_name: Tyrosine
    standard_trait_name: L-Tyrosine
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST003666
    neg_log_pval: 34.77
    otg_id: GCST003666_15
    pubmed_id: '27005778'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: PPM1K encodes a phosphatase called PP2Cm for the branched-chain
        keto acid dehydrogenase (BCKD) complex.  BCKD catalyzes an essential step
        in the catabolism of valine and the other branched chain amino acids.
      pubmed_id: '19411760'
    gene_id: ENSG00000163644
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '4'
      position: 89206230
    locus_GRCh38:
      chromosome: '4'
      position: 88285078
    rsid: rs9637599
  trait_info:
    ontology:
    - HMDB0000883
    reported_trait_name: Valine
    standard_trait_name: L-Valine
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST003666
    neg_log_pval: 10.678
    otg_id: GCST003666_12
    pubmed_id: '27005778'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: PDPR encodes a component of the pyruvate dehydrogenase complex
        (PDC) which converts pyruvate into acetyl-CoA.
      pubmed_id: 09395502
    gene_id: ENSG00000090857
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '16'
      position: 69979271
    locus_GRCh38:
      chromosome: '16'
      position: 69945368
    rsid: rs74249229
  trait_info:
    ontology:
    - HMDB0000243
    reported_trait_name: Pyruvate
    standard_trait_name: Pyruvic acid
- association_info:
    ancestry:
    - EUR
    gwas_catalog_id: GCST003665
    neg_log_pval: 99.866
    otg_id: GCST003217
    pubmed_id: '28334899'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: MLXIPL encodes the carbohydrate-responsive element-binding protein,
        a transcription factor for multiple lipogenic enzymes.
      pubmed_id: '16890538'
    gene_id: ENSG00000009950
    highest_confidence: High
  metadata:
    date_added: '2019-05-17'
    reviewed_by: Ed Mountjoy
    set_label: ProGeM
    submitted_by: Eric Fauman
    tags:
    - metabolite
    - mQTL
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '7'
      position: 72863249
    locus_GRCh38:
      chromosome: '7'
      position: 73448919
    rsid: rs17145738
  trait_info:
    ontology:
    - EFO_0004530
    reported_trait_name: Triglycerides
    standard_trait_name: triglyceride measurement
- association_info:
    ancestry:
    - European=341215
    gwas_catalog_id: GCST007798
    neg_log_pval: 10.221848749616356
    otg_id: GCST007798
    pubmed_id: '30929738'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: PI3-kinase p110-delta subunit inhibitor drug DUVELISIB is Phase
        II for the indiciation EFO_0000270 and targets the gene ENSG00000171608 at
        this locus (355116bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000171608
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '1'
      position: 9356676
    locus_GRCh38:
      chromosome: '1'
      position: 9296617
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European, Other=1157
    gwas_catalog_id: GCST001476
    neg_log_pval: 7.301029995663981
    otg_id: GCST001476_7
    pubmed_id: '22491018'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: PI3-kinase p110-delta subunit inhibitor drug DUVELISIB is Phase
        II for the indiciation EFO_0000685 and targets the gene ENSG00000171608 at
        this locus (302833bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000171608
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '1'
      position: 9408959
    locus_GRCh38:
      chromosome: '1'
      position: 9348900
  trait_info:
    ontology:
    - EFO_0000685
    reported_trait_name: Response to tocilizumab in rheumatoid arthritis [CSJC , EA,
      RF-]
    standard_trait_name: rheumatoid arthritis
- association_info:
    ancestry:
    - European=488
    - African American or Afro-Caribbean=111
    - Hispanic or Latin American=60
    - Other=56
    gwas_catalog_id: GCST004250
    neg_log_pval: 8.0
    otg_id: GCST004250_2
    pubmed_id: '28090653'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: CAMPATH-1 antigen inhibitor drug ALEMTUZUMAB is Phase II for the
        indiciation EFO_0000220 and targets the gene ENSG00000169442 at this locus
        (491379bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169442
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '1'
      position: 27138393
    locus_GRCh38:
      chromosome: '1'
      position: 26811902
  trait_info:
    ontology:
    - EFO_0000220
    reported_trait_name: Alanine aminotransferase (ALT) levels after remission induction
      therapy in actute lymphoblastic leukemia (ALL) [AA]
    standard_trait_name: acute lymphoblastic leukemia
- association_info:
    ancestry:
    - Other=1097
    - NR=150064
    gwas_catalog_id: GCST003048
    neg_log_pval: 8.522878745280337
    otg_id: GCST003048
    pubmed_id: '26198764'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Glycine transporter 1 inhibitor drug BITOPERTIN is Phase III for
        the indiciation EFO_0000692 and targets the gene ENSG00000196517 at this locus
        (419487bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000196517
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '1'
      position: 44037685
    locus_GRCh38:
      chromosome: '1'
      position: 43572014
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - East Asian=26026
    - European=82315
    gwas_catalog_id: GCST004946
    neg_log_pval: 12.0
    otg_id: GCST004946
    pubmed_id: '28991256'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Glycine transporter 1 inhibitor drug BITOPERTIN is Phase III for
        the indiciation EFO_0000692 and targets the gene ENSG00000196517 at this locus
        (359642bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000196517
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '1'
      position: 44097530
    locus_GRCh38:
      chromosome: '1'
      position: 43631859
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - East Asian=45528
    gwas_catalog_id: GCST007201
    neg_log_pval: 8.397940008672037
    otg_id: GCST007201_2
    pubmed_id: '30285260'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Glycine transporter 1 inhibitor drug BITOPERTIN is Phase III for
        the indiciation EFO_0000692 and targets the gene ENSG00000196517 at this locus
        (359642bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000196517
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '1'
      position: 44097530
    locus_GRCh38:
      chromosome: '1'
      position: 43631859
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia [EA]
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - European=105318
    gwas_catalog_id: GCST006803
    neg_log_pval: 11.0
    otg_id: GCST006803
    pubmed_id: '29483656'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Glycine transporter 1 inhibitor drug BITOPERTIN is Phase III for
        the indiciation EFO_0000692 and targets the gene ENSG00000196517 at this locus
        (359642bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000196517
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '1'
      position: 44097530
    locus_GRCh38:
      chromosome: '1'
      position: 43631859
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - East Asian=45528
    gwas_catalog_id: GCST007201
    neg_log_pval: 10.0
    otg_id: GCST007201
    pubmed_id: '30285260'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Glycine transporter 1 inhibitor drug BITOPERTIN is Phase III for
        the indiciation EFO_0000692 and targets the gene ENSG00000196517 at this locus
        (359642bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000196517
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '1'
      position: 44097530
    locus_GRCh38:
      chromosome: '1'
      position: 43631859
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - European=82315
    - East Asian=5219
    gwas_catalog_id: GCST002539
    neg_log_pval: 9.522878745280337
    otg_id: GCST002539
    pubmed_id: '25056061'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Glycine transporter 1 inhibitor drug BITOPERTIN is Phase III for
        the indiciation EFO_0000692 and targets the gene ENSG00000196517 at this locus
        (357087bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000196517
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '1'
      position: 44100084
    locus_GRCh38:
      chromosome: '1'
      position: 43634413
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - European=13574
    - NR=2380
    gwas_catalog_id: GCST004521
    neg_log_pval: 9.397940008672037
    otg_id: GCST004521
    pubmed_id: '28540026'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Glycine transporter 1 inhibitor drug BITOPERTIN is Phase III for
        the indiciation EFO_0000692 and targets the gene ENSG00000196517 at this locus
        (357087bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000196517
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '1'
      position: 44100084
    locus_GRCh38:
      chromosome: '1'
      position: 43634413
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Autism spectrum disorder or schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - European=139274
    gwas_catalog_id: GCST004988
    neg_log_pval: 7.530472520812986
    otg_id: GCST004988
    pubmed_id: '29059683'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Anandamide amidohydrolase inhibitor drug ACETAMINOPHEN is Phase
        II for the indiciation EFO_0000305 and targets the gene ENSG00000117480 at
        this locus (259073bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000117480
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '1'
      position: 46600917
    locus_GRCh38:
      chromosome: '1'
      position: 46135245
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 28.214189147749966
    otg_id: NEALE2_20002_1473
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Subtilisin/kexin type 9 inhibitor drug ALIROCUMAB is Phase IV for
        the indiciation HP_0003124 and targets the gene ENSG00000169174 at this locus
        (17875bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169174
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '1'
      position: 55487346
    locus_GRCh38:
      chromosome: '1'
      position: 55021673
  trait_info:
    ontology:
    - HP_0003124
    reported_trait_name: High cholesterol | non-cancer illness code, self-reported
    standard_trait_name: Hypercholesterolemia
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 28.214189147749966
    otg_id: NEALE2_20002_1473
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Subtilisin/kexin type 9 inhibitor drug EVOLOCUMAB is Phase III
        for the indiciation HP_0003124 and targets the gene ENSG00000169174 at this
        locus (17875bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169174
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '1'
      position: 55487346
    locus_GRCh38:
      chromosome: '1'
      position: 55021673
  trait_info:
    ontology:
    - HP_0003124
    reported_trait_name: High cholesterol | non-cancer illness code, self-reported
    standard_trait_name: Hypercholesterolemia
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 28.214189147749966
    otg_id: NEALE2_20002_1473
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Subtilisin/kexin type 9 inhibitor drug BOCOCIZUMAB is Phase II
        for the indiciation HP_0003124 and targets the gene ENSG00000169174 at this
        locus (17875bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169174
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '1'
      position: 55487346
    locus_GRCh38:
      chromosome: '1'
      position: 55021673
  trait_info:
    ontology:
    - HP_0003124
    reported_trait_name: High cholesterol | non-cancer illness code, self-reported
    standard_trait_name: Hypercholesterolemia
- association_info:
    ancestry:
    - European=406276
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 11.88941028970075
    otg_id: SAIGE_272_11
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Subtilisin/kexin type 9 inhibitor drug ALIROCUMAB is Phase IV for
        the indiciation HP_0003124 and targets the gene ENSG00000169174 at this locus
        (15680bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169174
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '1'
      position: 55489542
    locus_GRCh38:
      chromosome: '1'
      position: 55023869
  trait_info:
    ontology:
    - HP_0003124
    reported_trait_name: Hypercholesterolemia
    standard_trait_name: Hypercholesterolemia
- association_info:
    ancestry:
    - European=408961
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 12.71669877129645
    otg_id: SAIGE_272
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Subtilisin/kexin type 9 inhibitor drug ALIROCUMAB is Phase IV for
        the indiciation Orphanet_309005 and targets the gene ENSG00000169174 at this
        locus (15680bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169174
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '1'
      position: 55489542
    locus_GRCh38:
      chromosome: '1'
      position: 55023869
  trait_info:
    ontology:
    - Orphanet_309005
    reported_trait_name: Disorders of lipoid metabolism
    standard_trait_name: Disorder of lipid metabolism
- association_info:
    ancestry:
    - European=406276
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 11.88941028970075
    otg_id: SAIGE_272_11
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Subtilisin/kexin type 9 inhibitor drug BOCOCIZUMAB is Phase II
        for the indiciation HP_0003124 and targets the gene ENSG00000169174 at this
        locus (15680bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169174
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '1'
      position: 55489542
    locus_GRCh38:
      chromosome: '1'
      position: 55023869
  trait_info:
    ontology:
    - HP_0003124
    reported_trait_name: Hypercholesterolemia
    standard_trait_name: Hypercholesterolemia
- association_info:
    ancestry:
    - European=408961
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 12.71669877129645
    otg_id: SAIGE_272
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Subtilisin/kexin type 9 inhibitor drug EVOLOCUMAB is Phase III
        for the indiciation Orphanet_309005 and targets the gene ENSG00000169174 at
        this locus (15680bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169174
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '1'
      position: 55489542
    locus_GRCh38:
      chromosome: '1'
      position: 55023869
  trait_info:
    ontology:
    - Orphanet_309005
    reported_trait_name: Disorders of lipoid metabolism
    standard_trait_name: Disorder of lipid metabolism
- association_info:
    ancestry:
    - European=408878
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 12.79860287567955
    otg_id: SAIGE_272_1
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Subtilisin/kexin type 9 inhibitor drug EVOLOCUMAB is Phase III
        for the indiciation EFO_0003774 and targets the gene ENSG00000169174 at this
        locus (15680bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169174
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '1'
      position: 55489542
    locus_GRCh38:
      chromosome: '1'
      position: 55023869
  trait_info:
    ontology:
    - EFO_0003774
    reported_trait_name: Hyperlipidemia
    standard_trait_name: hyperlipidemia
- association_info:
    ancestry:
    - European=406276
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 11.88941028970075
    otg_id: SAIGE_272_11
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Subtilisin/kexin type 9 inhibitor drug EVOLOCUMAB is Phase III
        for the indiciation HP_0003124 and targets the gene ENSG00000169174 at this
        locus (15680bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169174
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '1'
      position: 55489542
    locus_GRCh38:
      chromosome: '1'
      position: 55023869
  trait_info:
    ontology:
    - HP_0003124
    reported_trait_name: Hypercholesterolemia
    standard_trait_name: Hypercholesterolemia
- association_info:
    ancestry:
    - European=141217
    - African American or Afro-Caribbean=3139
    - Hispanic or Latin American=4095
    - South Asian=25557
    - Greater Middle Eastern (Middle Eastern / North African / Persian)=2268
    - East Asian=11323
    gwas_catalog_id: GCST003116
    neg_log_pval: 7.698970004336019
    otg_id: GCST003116
    pubmed_id: '26343387'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Subtilisin/kexin type 9 inhibitor drug ALIROCUMAB is Phase IV for
        the indiciation EFO_0000378 and targets the gene ENSG00000169174 at this locus
        (9183bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169174
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '1'
      position: 55496039
    locus_GRCh38:
      chromosome: '1'
      position: 55030366
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - European=408878
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 23.57186520597121
    otg_id: SAIGE_272_1
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Subtilisin/kexin type 9 inhibitor drug BOCOCIZUMAB is Phase III
        for the indiciation EFO_0003774 and targets the gene ENSG00000169174 at this
        locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169174
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '1'
      position: 55505647
    locus_GRCh38:
      chromosome: '1'
      position: 55039974
  trait_info:
    ontology:
    - EFO_0003774
    reported_trait_name: Hyperlipidemia
    standard_trait_name: hyperlipidemia
- association_info:
    ancestry:
    - European=406276
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 20.25103713874384
    otg_id: SAIGE_272_11
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Subtilisin/kexin type 9 inhibitor drug EVOLOCUMAB is Phase III
        for the indiciation HP_0003124 and targets the gene ENSG00000169174 at this
        locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169174
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '1'
      position: 55505647
    locus_GRCh38:
      chromosome: '1'
      position: 55039974
  trait_info:
    ontology:
    - HP_0003124
    reported_trait_name: Hypercholesterolemia
    standard_trait_name: Hypercholesterolemia
- association_info:
    ancestry:
    - NR=250736
    gwas_catalog_id: GCST005196
    neg_log_pval: 24.69897000433602
    otg_id: GCST005196
    pubmed_id: '29212778'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Subtilisin/kexin type 9 inhibitor drug EVOLOCUMAB is Phase IV for
        the indiciation EFO_0000378 and targets the gene ENSG00000169174 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169174
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '1'
      position: 55505647
    locus_GRCh38:
      chromosome: '1'
      position: 55039974
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - European=408458
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 11.844663962534938
    otg_id: SAIGE_411
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Subtilisin/kexin type 9 inhibitor drug EVOLOCUMAB is Phase IV for
        the indiciation EFO_0000378 and targets the gene ENSG00000169174 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169174
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '1'
      position: 55505647
    locus_GRCh38:
      chromosome: '1'
      position: 55039974
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Ischemic heart disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - European=406276
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 20.25103713874384
    otg_id: SAIGE_272_11
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Subtilisin/kexin type 9 inhibitor drug ALIROCUMAB is Phase IV for
        the indiciation HP_0003124 and targets the gene ENSG00000169174 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169174
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '1'
      position: 55505647
    locus_GRCh38:
      chromosome: '1'
      position: 55039974
  trait_info:
    ontology:
    - HP_0003124
    reported_trait_name: Hypercholesterolemia
    standard_trait_name: Hypercholesterolemia
- association_info:
    ancestry:
    - European=406276
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 20.25103713874384
    otg_id: SAIGE_272_11
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Subtilisin/kexin type 9 inhibitor drug BOCOCIZUMAB is Phase II
        for the indiciation HP_0003124 and targets the gene ENSG00000169174 at this
        locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169174
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '1'
      position: 55505647
    locus_GRCh38:
      chromosome: '1'
      position: 55039974
  trait_info:
    ontology:
    - HP_0003124
    reported_trait_name: Hypercholesterolemia
    standard_trait_name: Hypercholesterolemia
- association_info:
    ancestry:
    - European=459000
    gwas_catalog_id: GCST007072
    neg_log_pval: 11.0
    otg_id: GCST007072
    pubmed_id: '30595370'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Subtilisin/kexin type 9 inhibitor drug EVOLOCUMAB is Phase IV for
        the indiciation EFO_0000319 and targets the gene ENSG00000169174 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169174
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '1'
      position: 55505647
    locus_GRCh38:
      chromosome: '1'
      position: 55039974
  trait_info:
    ontology:
    - EFO_0000319
    reported_trait_name: Cardiovascular disease
    standard_trait_name: cardiovascular system disease
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 64.89219328560758
    otg_id: NEALE2_20002_1473
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Subtilisin/kexin type 9 inhibitor drug EVOLOCUMAB is Phase III
        for the indiciation HP_0003124 and targets the gene ENSG00000169174 at this
        locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169174
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '1'
      position: 55505647
    locus_GRCh38:
      chromosome: '1'
      position: 55039974
  trait_info:
    ontology:
    - HP_0003124
    reported_trait_name: High cholesterol | non-cancer illness code, self-reported
    standard_trait_name: Hypercholesterolemia
- association_info:
    ancestry:
    - European, NR=63731
    gwas_catalog_id: GCST004787
    neg_log_pval: 9.522878745280337
    otg_id: GCST004787
    pubmed_id: '28714975'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Subtilisin/kexin type 9 inhibitor drug EVOLOCUMAB is Phase IV for
        the indiciation EFO_0000378 and targets the gene ENSG00000169174 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169174
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '1'
      position: 55505647
    locus_GRCh38:
      chromosome: '1'
      position: 55039974
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease (myocardial infarction, percutaneous
      transluminal coronary angioplasty, coronary artery bypass grafting, angina or
      chromic ischemic heart disease)
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 64.89219328560758
    otg_id: NEALE2_20002_1473
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Subtilisin/kexin type 9 inhibitor drug BOCOCIZUMAB is Phase II
        for the indiciation HP_0003124 and targets the gene ENSG00000169174 at this
        locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169174
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '1'
      position: 55505647
    locus_GRCh38:
      chromosome: '1'
      position: 55039974
  trait_info:
    ontology:
    - HP_0003124
    reported_trait_name: High cholesterol | non-cancer illness code, self-reported
    standard_trait_name: Hypercholesterolemia
- association_info:
    ancestry:
    - NR=296525
    gwas_catalog_id: GCST005194
    neg_log_pval: 21.731656086048936
    otg_id: GCST005194
    pubmed_id: '29212778'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Subtilisin/kexin type 9 inhibitor drug EVOLOCUMAB is Phase IV for
        the indiciation EFO_0000378 and targets the gene ENSG00000169174 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169174
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '1'
      position: 55505647
    locus_GRCh38:
      chromosome: '1'
      position: 55039974
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - NR=547261
    gwas_catalog_id: GCST005195
    neg_log_pval: 17.82390874094432
    otg_id: GCST005195
    pubmed_id: '29212778'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Subtilisin/kexin type 9 inhibitor drug EVOLOCUMAB is Phase IV for
        the indiciation EFO_0000378 and targets the gene ENSG00000169174 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169174
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '1'
      position: 55505647
    locus_GRCh38:
      chromosome: '1'
      position: 55039974
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - European=408961
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 23.614393726401687
    otg_id: SAIGE_272
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Subtilisin/kexin type 9 inhibitor drug ALIROCUMAB is Phase IV for
        the indiciation Orphanet_309005 and targets the gene ENSG00000169174 at this
        locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169174
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '1'
      position: 55505647
    locus_GRCh38:
      chromosome: '1'
      position: 55039974
  trait_info:
    ontology:
    - Orphanet_309005
    reported_trait_name: Disorders of lipoid metabolism
    standard_trait_name: Disorder of lipid metabolism
- association_info:
    ancestry:
    - European=408961
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 23.614393726401687
    otg_id: SAIGE_272
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Subtilisin/kexin type 9 inhibitor drug EVOLOCUMAB is Phase III
        for the indiciation Orphanet_309005 and targets the gene ENSG00000169174 at
        this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169174
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '1'
      position: 55505647
    locus_GRCh38:
      chromosome: '1'
      position: 55039974
  trait_info:
    ontology:
    - Orphanet_309005
    reported_trait_name: Disorders of lipoid metabolism
    standard_trait_name: Disorder of lipid metabolism
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 64.89219328560758
    otg_id: NEALE2_20002_1473
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Subtilisin/kexin type 9 inhibitor drug ALIROCUMAB is Phase IV for
        the indiciation HP_0003124 and targets the gene ENSG00000169174 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169174
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '1'
      position: 55505647
    locus_GRCh38:
      chromosome: '1'
      position: 55039974
  trait_info:
    ontology:
    - HP_0003124
    reported_trait_name: High cholesterol | non-cancer illness code, self-reported
    standard_trait_name: Hypercholesterolemia
- association_info:
    ancestry:
    - European=459000
    gwas_catalog_id: GCST007072
    neg_log_pval: 11.0
    otg_id: GCST007072
    pubmed_id: '30595370'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Subtilisin/kexin type 9 inhibitor drug BOCOCIZUMAB is Phase III
        for the indiciation EFO_0000319 and targets the gene ENSG00000169174 at this
        locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169174
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '1'
      position: 55505647
    locus_GRCh38:
      chromosome: '1'
      position: 55039974
  trait_info:
    ontology:
    - EFO_0000319
    reported_trait_name: Cardiovascular disease
    standard_trait_name: cardiovascular system disease
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 14.0
    otg_id: NEALE2_20002_1473
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Subtilisin/kexin type 9 inhibitor drug ALIROCUMAB is Phase IV for
        the indiciation HP_0003124 and targets the gene ENSG00000169174 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169174
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '1'
      position: 55521313
    locus_GRCh38:
      chromosome: '1'
      position: 55055640
  trait_info:
    ontology:
    - HP_0003124
    reported_trait_name: High cholesterol | non-cancer illness code, self-reported
    standard_trait_name: Hypercholesterolemia
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 14.0
    otg_id: NEALE2_20002_1473
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Subtilisin/kexin type 9 inhibitor drug BOCOCIZUMAB is Phase II
        for the indiciation HP_0003124 and targets the gene ENSG00000169174 at this
        locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169174
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '1'
      position: 55521313
    locus_GRCh38:
      chromosome: '1'
      position: 55055640
  trait_info:
    ontology:
    - HP_0003124
    reported_trait_name: High cholesterol | non-cancer illness code, self-reported
    standard_trait_name: Hypercholesterolemia
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 14.0
    otg_id: NEALE2_20002_1473
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Subtilisin/kexin type 9 inhibitor drug EVOLOCUMAB is Phase III
        for the indiciation HP_0003124 and targets the gene ENSG00000169174 at this
        locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169174
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '1'
      position: 55521313
    locus_GRCh38:
      chromosome: '1'
      position: 55055640
  trait_info:
    ontology:
    - HP_0003124
    reported_trait_name: High cholesterol | non-cancer illness code, self-reported
    standard_trait_name: Hypercholesterolemia
- association_info:
    ancestry:
    - European=406276
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 7.812479279163537
    otg_id: SAIGE_272_11
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Angiopoietin-related protein 3 inhibitor drug EVINACUMAB is Phase
        II for the indiciation HP_0003124 and targets the gene ENSG00000132855 at
        this locus (14882bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000132855
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '1'
      position: 63048277
    locus_GRCh38:
      chromosome: '1'
      position: 62582606
  trait_info:
    ontology:
    - HP_0003124
    reported_trait_name: Hypercholesterolemia
    standard_trait_name: Hypercholesterolemia
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 24.119709018294724
    otg_id: NEALE2_20002_1473
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Angiopoietin-related protein 3 inhibitor drug EVINACUMAB is Phase
        II for the indiciation HP_0003124 and targets the gene ENSG00000132855 at
        this locus (49271bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000132855
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: TC
      reference: T
    locus_GRCh37:
      chromosome: '1'
      position: 63121101
    locus_GRCh38:
      chromosome: '1'
      position: 62655430
  trait_info:
    ontology:
    - HP_0003124
    reported_trait_name: High cholesterol | non-cancer illness code, self-reported
    standard_trait_name: Hypercholesterolemia
- association_info:
    ancestry:
    - European=6889
    gwas_catalog_id: GCST001957
    neg_log_pval: 8.698970004336019
    otg_id: GCST001957
    pubmed_id: '23563609'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Leptin receptor agonist drug METRELEPTIN is Phase III for the indiciation
        EFO_0001073 and targets the gene ENSG00000116678 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000116678
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '1'
      position: 65979280
    locus_GRCh38:
      chromosome: '1'
      position: 65513597
  trait_info:
    ontology:
    - EFO_0001073
    reported_trait_name: Obesity (early onset extreme)
    standard_trait_name: obesity
- association_info:
    ancestry:
    - European=26621
    gwas_catalog_id: GCST001198
    neg_log_pval: 9.426548177964515
    otg_id: GCST001198
    pubmed_id: '21833088'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Sphingosine 1-phosphate receptor Edg-1 agonist drug SIPONIMOD is
        Phase III for the indiciation EFO_0003885 and targets the gene ENSG00000170989
        at this locus (294903bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000170989
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '1'
      position: 101407519
    locus_GRCh38:
      chromosome: '1'
      position: 100941963
  trait_info:
    ontology:
    - EFO_0003885
    reported_trait_name: Multiple sclerosis
    standard_trait_name: multiple sclerosis
- association_info:
    ancestry:
    - European=26621
    gwas_catalog_id: GCST001198
    neg_log_pval: 9.426548177964515
    otg_id: GCST001198
    pubmed_id: '21833088'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Sphingosine 1-phosphate receptor Edg-1 agonist drug PONESIMOD is
        Phase II for the indiciation EFO_0003885 and targets the gene ENSG00000170989
        at this locus (294903bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000170989
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '1'
      position: 101407519
    locus_GRCh38:
      chromosome: '1'
      position: 100941963
  trait_info:
    ontology:
    - EFO_0003885
    reported_trait_name: Multiple sclerosis
    standard_trait_name: multiple sclerosis
- association_info:
    ancestry:
    - European=33394
    gwas_catalog_id: GCST005527
    neg_log_pval: 14.221848749616356
    otg_id: GCST005527
    pubmed_id: '23143594'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: T-cell surface antigen CD2 inhibitor drug SIPLIZUMAB is Phase II
        for the indiciation EFO_0000676 and targets the gene ENSG00000116824 at this
        locus (9698bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000116824
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '1'
      position: 117287354
    locus_GRCh38:
      chromosome: '1'
      position: 116744732
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=33394
    gwas_catalog_id: GCST005527
    neg_log_pval: 14.221848749616356
    otg_id: GCST005527
    pubmed_id: '23143594'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: T-cell surface antigen CD2 inhibitor drug ALEFACEPT is Phase IV
        for the indiciation EFO_0000676 and targets the gene ENSG00000116824 at this
        locus (9698bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000116824
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '1'
      position: 117287354
    locus_GRCh38:
      chromosome: '1'
      position: 116744732
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - Other=1097
    - NR=150064
    gwas_catalog_id: GCST003048
    neg_log_pval: 9.397940008672037
    otg_id: GCST003048
    pubmed_id: '26198764'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Synaptic vesicle glycoprotein 2A modulator drug LEVETIRACETAM is
        Phase III for the indiciation EFO_0000692 and targets the gene ENSG00000159164
        at this locus (141651bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000159164
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: HG1287_PATCH
      position: 150745909
    locus_GRCh38:
      chromosome: '1'
      position: 150059494
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - European=105318
    gwas_catalog_id: GCST006803
    neg_log_pval: 9.154901959985743
    otg_id: GCST006803
    pubmed_id: '29483656'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Synaptic vesicle glycoprotein 2A modulator drug LEVETIRACETAM is
        Phase III for the indiciation EFO_0000692 and targets the gene ENSG00000159164
        at this locus (141651bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000159164
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: HG1287_PATCH
      position: 150745909
    locus_GRCh38:
      chromosome: '1'
      position: 150059494
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - European=82315
    - East Asian=5219
    gwas_catalog_id: GCST002539
    neg_log_pval: 9.397940008672037
    otg_id: GCST002539
    pubmed_id: '25056061'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Synaptic vesicle glycoprotein 2A modulator drug LEVETIRACETAM is
        Phase III for the indiciation EFO_0000692 and targets the gene ENSG00000159164
        at this locus (141651bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000159164
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: HG1287_PATCH
      position: 150745909
    locus_GRCh38:
      chromosome: '1'
      position: 150059494
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - NR=150064
    - European=70017
    gwas_catalog_id: GCST007257
    neg_log_pval: 10.301029995663981
    otg_id: GCST007257
    pubmed_id: '30626913'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Synaptic vesicle glycoprotein 2A modulator drug LEVETIRACETAM is
        Phase III for the indiciation EFO_0000692 and targets the gene ENSG00000159164
        at this locus (225954bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000159164
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '1'
      position: 150115974
    locus_GRCh38:
      chromosome: '1'
      position: 150143798
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Broad depression or schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - NR=150064
    - European=70017
    gwas_catalog_id: GCST007257
    neg_log_pval: 10.301029995663981
    otg_id: GCST007257
    pubmed_id: '30626913'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Synaptic vesicle glycoprotein 2A modulator drug LEVETIRACETAM is
        Phase III for the indiciation EFO_0003761 and targets the gene ENSG00000159164
        at this locus (225954bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000159164
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '1'
      position: 150115974
    locus_GRCh38:
      chromosome: '1'
      position: 150143798
  trait_info:
    ontology:
    - EFO_0003761
    reported_trait_name: Broad depression or schizophrenia
    standard_trait_name: unipolar depression
- association_info:
    ancestry:
    - European=140254
    gwas_catalog_id: GCST006085
    neg_log_pval: 11.0
    otg_id: GCST006085
    pubmed_id: '29892016'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Cathepsin K inhibitor drug ODANACATIB is Phase III for the indiciation
        EFO_0001663 and targets the gene ENSG00000143387 at this locus (110398bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000143387
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '1'
      position: 150658287
    locus_GRCh38:
      chromosome: '1'
      position: 150685811
  trait_info:
    ontology:
    - EFO_0001663
    reported_trait_name: Prostate cancer
    standard_trait_name: prostate carcinoma
- association_info:
    ancestry:
    - European=67543
    - Sub-Saharan African, African American or Afro-Caribbean=10463
    - East Asian=6954
    - Hispanic or Latin American=2080
    gwas_catalog_id: GCST002606
    neg_log_pval: 10.221848749616356
    otg_id: GCST002606_3
    pubmed_id: '25217961'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Cathepsin K inhibitor drug ODANACATIB is Phase III for the indiciation
        EFO_0001663 and targets the gene ENSG00000143387 at this locus (110398bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000143387
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '1'
      position: 150658287
    locus_GRCh38:
      chromosome: '1'
      position: 150685811
  trait_info:
    ontology:
    - EFO_0001663
    reported_trait_name: Prostate cancer [EA]
    standard_trait_name: prostate carcinoma
- association_info:
    ancestry:
    - European=67543
    - Sub-Saharan African, African American or Afro-Caribbean=10463
    - East Asian=6954
    - Hispanic or Latin American=2080
    gwas_catalog_id: GCST002606
    neg_log_pval: 8.522878745280337
    otg_id: GCST002606
    pubmed_id: '25217961'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Cathepsin K inhibitor drug ODANACATIB is Phase III for the indiciation
        EFO_0001663 and targets the gene ENSG00000143387 at this locus (110398bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000143387
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '1'
      position: 150658287
    locus_GRCh38:
      chromosome: '1'
      position: 150685811
  trait_info:
    ontology:
    - EFO_0001663
    reported_trait_name: Prostate cancer
    standard_trait_name: prostate carcinoma
- association_info:
    ancestry:
    - European=459000
    gwas_catalog_id: GCST007072
    neg_log_pval: 9.096910013008056
    otg_id: GCST007072
    pubmed_id: '30595370'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Atrial natriuretic peptide receptor A agonist drug NESIRITIDE is
        Phase IV for the indiciation EFO_0000319 and targets the gene ENSG00000169418
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169418
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '1'
      position: 153662423
    locus_GRCh38:
      chromosome: '1'
      position: 153689947
  trait_info:
    ontology:
    - EFO_0000319
    reported_trait_name: Cardiovascular disease
    standard_trait_name: cardiovascular system disease
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 10.209025579976215
    otg_id: NEALE2_20002_1065
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Atrial natriuretic peptide receptor A agonist drug NESIRITIDE is
        Phase IV for the indiciation EFO_0000537 and targets the gene ENSG00000169418
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169418
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '1'
      position: 153662423
    locus_GRCh38:
      chromosome: '1'
      position: 153689947
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Hypertension | non-cancer illness code, self-reported
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - European=22647
    - East Asian=3117
    gwas_catalog_id: GCST005529
    neg_log_pval: 14.698970004336019
    otg_id: GCST005529_3
    pubmed_id: '23749187'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-6 receptor alpha subunit inhibitor drug TOCILIZUMAB
        is Phase III for the indiciation EFO_0003898 and targets the gene ENSG00000160712
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000160712
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '1'
      position: 154426264
    locus_GRCh38:
      chromosome: '1'
      position: 154453788
  trait_info:
    ontology:
    - EFO_0003898
    reported_trait_name: Ankylosing spondylitis [EA]
    standard_trait_name: ankylosing spondylitis
- association_info:
    ancestry:
    - European=86475
    gwas_catalog_id: GCST005537
    neg_log_pval: 17.045757490560675
    otg_id: GCST005537
    pubmed_id: '26974007'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-6 receptor alpha subunit inhibitor drug TOCILIZUMAB
        is Phase III for the indiciation EFO_0003898 and targets the gene ENSG00000160712
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000160712
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '1'
      position: 154426264
    locus_GRCh38:
      chromosome: '1'
      position: 154453788
  trait_info:
    ontology:
    - EFO_0003898
    reported_trait_name: Chronic inflammatory diseases (ankylosing spondylitis, Crohn's
      disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
      [subset analysis]
    standard_trait_name: ankylosing spondylitis
- association_info:
    ancestry:
    - European=22647
    - East Asian=3117
    gwas_catalog_id: GCST005529
    neg_log_pval: 12.522878745280337
    otg_id: GCST005529
    pubmed_id: '23749187'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-6 receptor alpha subunit antagonist drug SARILUMAB
        is Phase II for the indiciation EFO_0003898 and targets the gene ENSG00000160712
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000160712
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '1'
      position: 154426264
    locus_GRCh38:
      chromosome: '1'
      position: 154453788
  trait_info:
    ontology:
    - EFO_0003898
    reported_trait_name: Ankylosing spondylitis
    standard_trait_name: ankylosing spondylitis
- association_info:
    ancestry:
    - European=22647
    - East Asian=3117
    gwas_catalog_id: GCST005529
    neg_log_pval: 14.698970004336019
    otg_id: GCST005529_3
    pubmed_id: '23749187'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-6 receptor alpha subunit antagonist drug SARILUMAB
        is Phase II for the indiciation EFO_0003898 and targets the gene ENSG00000160712
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000160712
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '1'
      position: 154426264
    locus_GRCh38:
      chromosome: '1'
      position: 154453788
  trait_info:
    ontology:
    - EFO_0003898
    reported_trait_name: Ankylosing spondylitis [EA]
    standard_trait_name: ankylosing spondylitis
- association_info:
    ancestry:
    - European=86475
    gwas_catalog_id: GCST005537
    neg_log_pval: 17.045757490560675
    otg_id: GCST005537
    pubmed_id: '26974007'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-6 receptor alpha subunit antagonist drug SARILUMAB
        is Phase II for the indiciation EFO_0003898 and targets the gene ENSG00000160712
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000160712
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '1'
      position: 154426264
    locus_GRCh38:
      chromosome: '1'
      position: 154453788
  trait_info:
    ontology:
    - EFO_0003898
    reported_trait_name: Chronic inflammatory diseases (ankylosing spondylitis, Crohn's
      disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
      [subset analysis]
    standard_trait_name: ankylosing spondylitis
- association_info:
    ancestry:
    - European=22647
    - East Asian=3117
    gwas_catalog_id: GCST005529
    neg_log_pval: 12.522878745280337
    otg_id: GCST005529
    pubmed_id: '23749187'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-6 receptor alpha subunit inhibitor drug TOCILIZUMAB
        is Phase III for the indiciation EFO_0003898 and targets the gene ENSG00000160712
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000160712
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '1'
      position: 154426264
    locus_GRCh38:
      chromosome: '1'
      position: 154453788
  trait_info:
    ontology:
    - EFO_0003898
    reported_trait_name: Ankylosing spondylitis
    standard_trait_name: ankylosing spondylitis
- association_info:
    ancestry:
    - European=58284
    - East Asian=22515
    gwas_catalog_id: GCST002318
    neg_log_pval: 8.397940008672037
    otg_id: GCST002318
    pubmed_id: '24390342'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Interleukin-6 receptor alpha subunit antagonist drug SARILUMAB
        is Phase IV for the indiciation EFO_0000685 and targets the gene ENSG00000160712
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000160712
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '1'
      position: 154426970
    locus_GRCh38:
      chromosome: '1'
      position: 154454494
  trait_info:
    ontology:
    - EFO_0000685
    reported_trait_name: Rheumatoid arthritis
    standard_trait_name: rheumatoid arthritis
- association_info:
    ancestry:
    - European=47580
    gwas_catalog_id: GCST005569
    neg_log_pval: 7.8807441107220635
    otg_id: GCST005569
    pubmed_id: '23143596'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Interleukin-6 receptor alpha subunit antagonist drug SARILUMAB
        is Phase IV for the indiciation EFO_0000685 and targets the gene ENSG00000160712
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000160712
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '1'
      position: 154426970
    locus_GRCh38:
      chromosome: '1'
      position: 154454494
  trait_info:
    ontology:
    - EFO_0000685
    reported_trait_name: Rheumatoid arthritis
    standard_trait_name: rheumatoid arthritis
- association_info:
    ancestry:
    - African American or Afro-Caribbean=2308
    gwas_catalog_id: GCST006959
    neg_log_pval: 8.522878745280337
    otg_id: GCST006959
    pubmed_id: '30423114'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Interleukin-6 receptor alpha subunit antagonist drug SARILUMAB
        is Phase IV for the indiciation EFO_0000685 and targets the gene ENSG00000160712
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000160712
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '1'
      position: 154426970
    locus_GRCh38:
      chromosome: '1'
      position: 154454494
  trait_info:
    ontology:
    - EFO_0000685
    reported_trait_name: Rheumatoid arthritis
    standard_trait_name: rheumatoid arthritis
- association_info:
    ancestry:
    - European=140254
    gwas_catalog_id: GCST006085
    neg_log_pval: 8.0
    otg_id: GCST006085
    pubmed_id: '29892016'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Farnesyl diphosphate synthase inhibitor drug ZOLEDRONIC ACID is
        Phase IV for the indiciation EFO_0001663 and targets the gene ENSG00000160752
        at this locus (447041bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000160752
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '1'
      position: 154834183
    locus_GRCh38:
      chromosome: '1'
      position: 154861707
  trait_info:
    ontology:
    - EFO_0001663
    reported_trait_name: Prostate cancer
    standard_trait_name: prostate carcinoma
- association_info:
    ancestry:
    - European=22548
    gwas_catalog_id: GCST001942
    neg_log_pval: 7.698970004336019
    otg_id: GCST001942
    pubmed_id: '23535732'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Farnesyl diphosphate synthase inhibitor drug ZOLEDRONIC ACID is
        Phase IV for the indiciation EFO_0001663 and targets the gene ENSG00000160752
        at this locus (447041bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000160752
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '1'
      position: 154834183
    locus_GRCh38:
      chromosome: '1'
      position: 154861707
  trait_info:
    ontology:
    - EFO_0001663
    reported_trait_name: Prostate cancer
    standard_trait_name: prostate carcinoma
- association_info:
    ancestry:
    - European=86475
    gwas_catalog_id: GCST005537
    neg_log_pval: 9.522878745280337
    otg_id: GCST005537
    pubmed_id: '26974007'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Farnesyl diphosphate synthase inhibitor drug PAMIDRONIC ACID is
        Phase IV for the indiciation EFO_0003898 and targets the gene ENSG00000160752
        at this locus (150834bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000160752
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '1'
      position: 155130391
    locus_GRCh38:
      chromosome: '1'
      position: 155157915
  trait_info:
    ontology:
    - EFO_0003898
    reported_trait_name: Chronic inflammatory diseases (ankylosing spondylitis, Crohn's
      disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
      [subset analysis]
    standard_trait_name: ankylosing spondylitis
- association_info:
    ancestry:
    - European=139274
    gwas_catalog_id: GCST004988
    neg_log_pval: 10.316502682320188
    otg_id: GCST004988
    pubmed_id: '29059683'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Farnesyl diphosphate synthase inhibitor drug ZOLEDRONIC ACID is
        Phase IV for the indiciation EFO_0000305 and targets the gene ENSG00000160752
        at this locus (132444bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000160752
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '1'
      position: 155148781
    locus_GRCh38:
      chromosome: '1'
      position: 155176305
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=139274
    gwas_catalog_id: GCST004988
    neg_log_pval: 10.316502682320188
    otg_id: GCST004988
    pubmed_id: '29059683'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Farnesyl diphosphate synthase inhibitor drug ALENDRONIC ACID is
        Phase III for the indiciation EFO_0000305 and targets the gene ENSG00000160752
        at this locus (132444bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000160752
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '1'
      position: 155148781
    locus_GRCh38:
      chromosome: '1'
      position: 155176305
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=139274
    gwas_catalog_id: GCST004988
    neg_log_pval: 10.316502682320188
    otg_id: GCST004988
    pubmed_id: '29059683'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Mucin-1 other drug HUHMFG1 is Phase II for the indiciation EFO_0000305
        and targets the gene ENSG00000185499 at this locus (9520bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000185499
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '1'
      position: 155148781
    locus_GRCh38:
      chromosome: '1'
      position: 155176305
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=360527
    neg_log_pval: 33.801755413771765
    otg_id: NEALE2_6152_7
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Coagulation factor V inhibitor drug DROTRECOGIN ALFA (ACTIVATED)
        is Phase II for the indiciation EFO_0003827 and targets the gene ENSG00000198734
        at this locus (15751bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000198734
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '1'
      position: 169467654
    locus_GRCh38:
      chromosome: '1'
      position: 169498416
  trait_info:
    ontology:
    - EFO_0003827
    reported_trait_name: Blood clot in the lung | blood clot, dvt, bronchitis, emphysema,
      asthma, rhinitis, eczema, allergy diagnosed by doctor
    standard_trait_name: pulmonary embolism
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 34.79160702064111
    otg_id: NEALE2_20002_1093
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Coagulation factor V inhibitor drug DROTRECOGIN ALFA (ACTIVATED)
        is Phase II for the indiciation EFO_0003827 and targets the gene ENSG00000198734
        at this locus (15751bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000198734
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '1'
      position: 169467654
    locus_GRCh38:
      chromosome: '1'
      position: 169498416
  trait_info:
    ontology:
    - EFO_0003827
    reported_trait_name: Pulmonary embolism +/- dvt | non-cancer illness code, self-reported
    standard_trait_name: pulmonary embolism
- association_info:
    ancestry:
    - European=258962
    gwas_catalog_id: GCST003390
    neg_log_pval: 136.39794000867204
    otg_id: GCST003390
    pubmed_id: '26908601'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Coagulation factor V inhibitor drug DROTRECOGIN ALFA (ACTIVATED)
        is Phase II for the indiciation EFO_0003827 and targets the gene ENSG00000198734
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000198734
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '1'
      position: 169519049
    locus_GRCh38:
      chromosome: '1'
      position: 169549811
  trait_info:
    ontology:
    - EFO_0003827
    reported_trait_name: Thrombosis
    standard_trait_name: pulmonary embolism
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 7.340779989063745
    otg_id: NEALE2_20002_1111
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tumor necrosis factor ligand superfamily member 4 inhibitor drug
        OXELUMAB is Phase II for the indiciation EFO_0000270 and targets the gene
        ENSG00000117586 at this locus (452003bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000117586
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '1'
      position: 172700868
    locus_GRCh38:
      chromosome: '1'
      position: 172731728
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma | non-cancer illness code, self-reported
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=341215
    gwas_catalog_id: GCST007798
    neg_log_pval: 11.154901959985743
    otg_id: GCST007798
    pubmed_id: '30929738'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tumor necrosis factor ligand superfamily member 4 inhibitor drug
        OXELUMAB is Phase II for the indiciation EFO_0000270 and targets the gene
        ENSG00000117586 at this locus (21377bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000117586
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '1'
      position: 173131493
    locus_GRCh38:
      chromosome: '1'
      position: 173162354
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=157242
    gwas_catalog_id: GCST003987
    neg_log_pval: 7.522878745280337
    otg_id: GCST003987
    pubmed_id: '27182965'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tumor necrosis factor ligand superfamily member 4 inhibitor drug
        OXELUMAB is Phase II for the indiciation EFO_0000270 and targets the gene
        ENSG00000117586 at this locus (834bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000117586
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '1'
      position: 173152036
    locus_GRCh38:
      chromosome: '1'
      position: 173182897
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 8.202546175019036
    otg_id: NEALE2_20002_1111
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tumor necrosis factor ligand superfamily member 4 inhibitor drug
        OXELUMAB is Phase II for the indiciation EFO_0000270 and targets the gene
        ENSG00000117586 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000117586
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '1'
      position: 173170618
    locus_GRCh38:
      chromosome: '1'
      position: 173201479
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma | non-cancer illness code, self-reported
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=360527
    neg_log_pval: 8.11264155329629
    otg_id: NEALE2_6152_8
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tumor necrosis factor ligand superfamily member 4 inhibitor drug
        OXELUMAB is Phase II for the indiciation EFO_0000270 and targets the gene
        ENSG00000117586 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000117586
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '1'
      position: 173170618
    locus_GRCh38:
      chromosome: '1'
      position: 173201479
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma | blood clot, dvt, bronchitis, emphysema, asthma,
      rhinitis, eczema, allergy diagnosed by doctor
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=455221
    gwas_catalog_id: GCST007093
    neg_log_pval: 8.0
    otg_id: GCST007093
    pubmed_id: '30664745'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Antithrombin-III activator drug HEPARIN SODIUM is Phase IV for
        the indiciation EFO_0002506 and targets the gene ENSG00000117601 at this locus
        (305887bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000117601
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: TAAAAAAAAAAAAAAAAA
    locus_GRCh37:
      chromosome: '1'
      position: 174192402
    locus_GRCh38:
      chromosome: '1'
      position: 174223264
  trait_info:
    ontology:
    - EFO_0002506
    reported_trait_name: Osteoarthritis
    standard_trait_name: osteoarthritis
- association_info:
    ancestry:
    - European=20883
    gwas_catalog_id: GCST003044
    neg_log_pval: 8.37190434327122
    otg_id: GCST003044
    pubmed_id: '26192919'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Cyclooxygenase-2 inhibitor drug CELECOXIB is Phase IV for the indiciation
        EFO_0000384 and targets the gene ENSG00000073756 at this locus (225905bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000073756
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '1'
      position: 186875459
    locus_GRCh38:
      chromosome: '1'
      position: 186906327
  trait_info:
    ontology:
    - EFO_0000384
    reported_trait_name: Crohn's disease [EA]
    standard_trait_name: Crohn's disease
- association_info:
    ancestry:
    - European=1030836
    gwas_catalog_id: GCST006414
    neg_log_pval: 19.006828394969236
    otg_id: GCST006414
    pubmed_id: '30061737'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Adenosine A1 receptor partial agonist drug CAPADENOSON is Phase
        II for the indiciation EFO_0000275 and targets the gene ENSG00000163485 at
        this locus (33568bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000163485
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '1'
      position: 203026214
    locus_GRCh38:
      chromosome: '1'
      position: 203057086
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=537409
    - East Asian=36792
    - African American or Afro-Caribbean=8967
    - Hispanic or Latin American=5022
    gwas_catalog_id: GCST006061
    neg_log_pval: 24.221848749616356
    otg_id: GCST006061
    pubmed_id: '29892015'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Adenosine A1 receptor partial agonist drug CAPADENOSON is Phase
        II for the indiciation EFO_0000275 and targets the gene ENSG00000163485 at
        this locus (33568bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000163485
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '1'
      position: 203026214
    locus_GRCh38:
      chromosome: '1'
      position: 203057086
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - East Asian=36792
    gwas_catalog_id: GCST004373
    neg_log_pval: 10.045757490560675
    otg_id: GCST004373
    pubmed_id: '28416822'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Adenosine A1 receptor agonist drug SELODENOSON is Phase II for
        the indiciation EFO_0000275 and targets the gene ENSG00000163485 at this locus
        (33191bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000163485
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '1'
      position: 203026591
    locus_GRCh38:
      chromosome: '1'
      position: 203057463
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=395739
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 9.97061622231479
    otg_id: SAIGE_427_2
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Adenosine A1 receptor agonist drug TECADENOSON is Phase II for
        the indiciation EFO_0000275 and targets the gene ENSG00000163485 at this locus
        (31072bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000163485
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '1'
      position: 203028711
    locus_GRCh38:
      chromosome: '1'
      position: 203059583
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation and flutter
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=537409
    - East Asian=36792
    - African American or Afro-Caribbean=8967
    - Hispanic or Latin American=5022
    gwas_catalog_id: GCST006061
    neg_log_pval: 18.0
    otg_id: GCST006061_3
    pubmed_id: '29892015'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Adenosine A1 receptor agonist drug TECADENOSON is Phase II for
        the indiciation EFO_0000275 and targets the gene ENSG00000163485 at this locus
        (31072bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000163485
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '1'
      position: 203028711
    locus_GRCh38:
      chromosome: '1'
      position: 203059583
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation [EA]
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - East Asian=4372
    gwas_catalog_id: GCST004352
    neg_log_pval: 8.698970004336019
    otg_id: GCST004352
    pubmed_id: '28460022'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Adenosine A1 receptor agonist drug SELODENOSON is Phase II for
        the indiciation EFO_0000275 and targets the gene ENSG00000163485 at this locus
        (24876bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000163485
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '1'
      position: 203034906
    locus_GRCh38:
      chromosome: '1'
      position: 203065778
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Early onset atrial fibrillation
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=360527
    neg_log_pval: 9.949848472659069
    otg_id: NEALE2_6152_8
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Adenosine A1 receptor antagonist drug PBF-680 is Phase II for the
        indiciation EFO_0000270 and targets the gene ENSG00000163485 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000163485
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '1'
      position: 203091274
    locus_GRCh38:
      chromosome: '1'
      position: 203122146
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma | blood clot, dvt, bronchitis, emphysema, asthma,
      rhinitis, eczema, allergy diagnosed by doctor
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=341215
    gwas_catalog_id: GCST007798
    neg_log_pval: 10.045757490560675
    otg_id: GCST007798
    pubmed_id: '30929738'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Adenosine A1 receptor antagonist drug PBF-680 is Phase II for the
        indiciation EFO_0000270 and targets the gene ENSG00000163485 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000163485
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '1'
      position: 203093201
    locus_GRCh38:
      chromosome: '1'
      position: 203124073
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=157242
    gwas_catalog_id: GCST003987
    neg_log_pval: 8.0
    otg_id: GCST003987
    pubmed_id: '27182965'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Adenosine A1 receptor antagonist drug PBF-680 is Phase II for the
        indiciation EFO_0000270 and targets the gene ENSG00000163485 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000163485
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: T
    locus_GRCh37:
      chromosome: '1'
      position: 203100504
    locus_GRCh38:
      chromosome: '1'
      position: 203131376
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 9.000392345087638
    otg_id: NEALE2_20002_1111
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Adenosine A1 receptor antagonist drug PBF-680 is Phase II for the
        indiciation EFO_0000270 and targets the gene ENSG00000163485 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000163485
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: TA
      reference: T
    locus_GRCh37:
      chromosome: '1'
      position: 203103205
    locus_GRCh38:
      chromosome: '1'
      position: 203134077
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma | non-cancer illness code, self-reported
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 8.172660456455034
    otg_id: NEALE2_20002_1065
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Potassium channel subfamily K member 2 opener drug SEVOFLURANE
        is Phase IV for the indiciation EFO_0000537 and targets the gene ENSG00000082482
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000082482
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: TATA
    locus_GRCh37:
      chromosome: '1'
      position: 215304685
    locus_GRCh38:
      chromosome: '1'
      position: 215131342
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Hypertension | non-cancer illness code, self-reported
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - European=139274
    gwas_catalog_id: GCST004988
    neg_log_pval: 8.408601448718752
    otg_id: GCST004988
    pubmed_id: '29059683'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Estrogen-related receptor gamma antagonist drug AFIMOXIFENE is
        Phase II for the indiciation EFO_0000305 and targets the gene ENSG00000196482
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000196482
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '1'
      position: 217220574
    locus_GRCh38:
      chromosome: '1'
      position: 217047232
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European, East Asian, African American or Afro-Caribbean, Hispanic or Latin
      American, NR=257811
    gwas_catalog_id: GCST007692
    neg_log_pval: 8.154901959985743
    otg_id: GCST007692
    pubmed_id: '30804561'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Muscarinic acetylcholine receptor M3 antagonist drug GLYCOPYRRONIUM
        is Phase IV for the indiciation EFO_0000341 and targets the gene ENSG00000133019
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000133019
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '1'
      position: 239901006
    locus_GRCh38:
      chromosome: '1'
      position: 239737706
  trait_info:
    ontology:
    - EFO_0000341
    reported_trait_name: Chronic obstructive pulmonary disease
    standard_trait_name: chronic obstructive pulmonary disease
- association_info:
    ancestry:
    - European, East Asian, African American or Afro-Caribbean, Hispanic or Latin
      American, NR=257811
    gwas_catalog_id: GCST007692
    neg_log_pval: 8.154901959985743
    otg_id: GCST007692
    pubmed_id: '30804561'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Muscarinic acetylcholine receptor M3 antagonist drug AZD8683 is
        Phase II for the indiciation EFO_0000341 and targets the gene ENSG00000133019
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000133019
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '1'
      position: 239901006
    locus_GRCh38:
      chromosome: '1'
      position: 239737706
  trait_info:
    ontology:
    - EFO_0000341
    reported_trait_name: Chronic obstructive pulmonary disease
    standard_trait_name: chronic obstructive pulmonary disease
- association_info:
    ancestry:
    - European=88583
    gwas_catalog_id: GCST007505
    neg_log_pval: 7.698970004336019
    otg_id: GCST007505
    pubmed_id: '30429480'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-2 receptor agonist drug ALDESLEUKIN is Phase III for
        the indiciation EFO_0000389 and targets the gene ENSG00000134460 at this locus
        (268502bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000134460
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '10'
      position: 5784151
    locus_GRCh38:
      chromosome: '10'
      position: 5742188
  trait_info:
    ontology:
    - EFO_0000389
    reported_trait_name: Nevus count or cutaneous melanoma
    standard_trait_name: skin melanoma
- association_info:
    ancestry:
    - European=20883
    gwas_catalog_id: GCST003044
    neg_log_pval: 12.095825631715837
    otg_id: GCST003044
    pubmed_id: '26192919'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-2 receptor agonist drug ALDESLEUKIN is Phase II for
        the indiciation EFO_0000384 and targets the gene ENSG00000134460 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000134460
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 6081230
    locus_GRCh38:
      chromosome: '10'
      position: 6039267
  trait_info:
    ontology:
    - EFO_0000384
    reported_trait_name: Crohn's disease [EA]
    standard_trait_name: Crohn's disease
- association_info:
    ancestry:
    - European=4421
    gwas_catalog_id: GCST004290
    neg_log_pval: 9.0
    otg_id: GCST004290
    pubmed_id: '28445677'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-2 receptor inhibitor drug DACLIZUMAB is Phase III for
        the indiciation EFO_0003885 and targets the gene ENSG00000134460 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000134460
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '10'
      position: 6092346
    locus_GRCh38:
      chromosome: '10'
      position: 6050383
  trait_info:
    ontology:
    - EFO_0003885
    reported_trait_name: Multiple sclerosis
    standard_trait_name: multiple sclerosis
- association_info:
    ancestry:
    - European=360527
    neg_log_pval: 14.096910013008056
    otg_id: NEALE2_6152_8
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-2 receptor inhibitor drug DACLIZUMAB is Phase II for
        the indiciation EFO_0000270 and targets the gene ENSG00000134460 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000134460
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 6093139
    locus_GRCh38:
      chromosome: '10'
      position: 6051176
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma | blood clot, dvt, bronchitis, emphysema, asthma,
      rhinitis, eczema, allergy diagnosed by doctor
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=341215
    gwas_catalog_id: GCST007798
    neg_log_pval: 17.69897000433602
    otg_id: GCST007798
    pubmed_id: '30929738'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-2 receptor inhibitor drug DACLIZUMAB is Phase II for
        the indiciation EFO_0000270 and targets the gene ENSG00000134460 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000134460
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 6093139
    locus_GRCh38:
      chromosome: '10'
      position: 6051176
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=401837
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 8.749579997691106
    otg_id: SAIGE_495
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-2 receptor inhibitor drug DACLIZUMAB is Phase II for
        the indiciation EFO_0000270 and targets the gene ENSG00000134460 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000134460
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 6093139
    locus_GRCh38:
      chromosome: '10'
      position: 6051176
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 13.823908740944319
    otg_id: NEALE2_20002_1111
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-2 receptor inhibitor drug DACLIZUMAB is Phase II for
        the indiciation EFO_0000270 and targets the gene ENSG00000134460 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000134460
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 6093139
    locus_GRCh38:
      chromosome: '10'
      position: 6051176
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma | non-cancer illness code, self-reported
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=86475
    gwas_catalog_id: GCST005537
    neg_log_pval: 15.0
    otg_id: GCST005537
    pubmed_id: '26974007'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-2 receptor inhibitor drug DACLIZUMAB is Phase II for
        the indiciation EFO_0000729 and targets the gene ENSG00000134460 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000134460
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 6094697
    locus_GRCh38:
      chromosome: '10'
      position: 6052734
  trait_info:
    ontology:
    - EFO_0000729
    reported_trait_name: Chronic inflammatory diseases (ankylosing spondylitis, Crohn's
      disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
      [subset analysis]
    standard_trait_name: ulcerative colitis
- association_info:
    ancestry:
    - European=16179
    gwas_catalog_id: GCST001394
    neg_log_pval: 8.301029995663981
    otg_id: GCST001394
    pubmed_id: '22293688'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-2 receptor inhibitor drug BASILIXIMAB is Phase III
        for the indiciation EFO_0001359 and targets the gene ENSG00000134460 at this
        locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000134460
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 6094697
    locus_GRCh38:
      chromosome: '10'
      position: 6052734
  trait_info:
    ontology:
    - EFO_0001359
    reported_trait_name: Type 1 diabetes
    standard_trait_name: insulin-dependent diabetes mellitus
- association_info:
    ancestry:
    - European, NR=40266
    gwas_catalog_id: GCST004132
    neg_log_pval: 7.702896349850744
    otg_id: GCST004132
    pubmed_id: '28067908'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-2 receptor agonist drug ALDESLEUKIN is Phase II for
        the indiciation EFO_0000384 and targets the gene ENSG00000134460 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000134460
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 6094697
    locus_GRCh38:
      chromosome: '10'
      position: 6052734
  trait_info:
    ontology:
    - EFO_0000384
    reported_trait_name: Crohn's disease
    standard_trait_name: Crohn's disease
- association_info:
    ancestry:
    - European=86475
    gwas_catalog_id: GCST005537
    neg_log_pval: 15.0
    otg_id: GCST005537
    pubmed_id: '26974007'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-2 receptor agonist drug ALDESLEUKIN is Phase II for
        the indiciation EFO_0000384 and targets the gene ENSG00000134460 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000134460
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 6094697
    locus_GRCh38:
      chromosome: '10'
      position: 6052734
  trait_info:
    ontology:
    - EFO_0000384
    reported_trait_name: Chronic inflammatory diseases (ankylosing spondylitis, Crohn's
      disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
      [subset analysis]
    standard_trait_name: Crohn's disease
- association_info:
    ancestry:
    - European=29652
    gwas_catalog_id: GCST005536
    neg_log_pval: 38.54606892809315
    otg_id: GCST005536
    pubmed_id: '25751624'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-2 receptor agonist drug ALDESLEUKIN is Phase II for
        the indiciation EFO_0001359 and targets the gene ENSG00000134460 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000134460
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 6094697
    locus_GRCh38:
      chromosome: '10'
      position: 6052734
  trait_info:
    ontology:
    - EFO_0001359
    reported_trait_name: Type 1 diabetes
    standard_trait_name: insulin-dependent diabetes mellitus
- association_info:
    ancestry:
    - European=16179
    gwas_catalog_id: GCST001394
    neg_log_pval: 8.301029995663981
    otg_id: GCST001394
    pubmed_id: '22293688'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-2 receptor agonist drug ALDESLEUKIN is Phase II for
        the indiciation EFO_0001359 and targets the gene ENSG00000134460 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000134460
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 6094697
    locus_GRCh38:
      chromosome: '10'
      position: 6052734
  trait_info:
    ontology:
    - EFO_0001359
    reported_trait_name: Type 1 diabetes
    standard_trait_name: insulin-dependent diabetes mellitus
- association_info:
    ancestry:
    - European=102453
    gwas_catalog_id: GCST007563
    neg_log_pval: 11.397940008672037
    otg_id: GCST007563
    pubmed_id: '29785011'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-2 receptor inhibitor drug DACLIZUMAB is Phase II for
        the indiciation EFO_0000270 and targets the gene ENSG00000134460 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000134460
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 6094697
    locus_GRCh38:
      chromosome: '10'
      position: 6052734
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Allergic disease (asthma, hay fever or eczema)
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=29652
    gwas_catalog_id: GCST005536
    neg_log_pval: 38.54606892809315
    otg_id: GCST005536
    pubmed_id: '25751624'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-2 receptor inhibitor drug BASILIXIMAB is Phase III
        for the indiciation EFO_0001359 and targets the gene ENSG00000134460 at this
        locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000134460
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 6094697
    locus_GRCh38:
      chromosome: '10'
      position: 6052734
  trait_info:
    ontology:
    - EFO_0001359
    reported_trait_name: Type 1 diabetes
    standard_trait_name: insulin-dependent diabetes mellitus
- association_info:
    ancestry:
    - European=20883
    gwas_catalog_id: GCST003044
    neg_log_pval: 12.496209316942819
    otg_id: GCST003044
    pubmed_id: '26192919'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-2 receptor agonist drug ALDESLEUKIN is Phase II for
        the indiciation EFO_0000384 and targets the gene ENSG00000134460 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000134460
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 6094697
    locus_GRCh38:
      chromosome: '10'
      position: 6052734
  trait_info:
    ontology:
    - EFO_0000384
    reported_trait_name: Crohn's disease [EA]
    standard_trait_name: Crohn's disease
- association_info:
    ancestry:
    - European=116538
    gwas_catalog_id: GCST007564
    neg_log_pval: 10.698970004336019
    otg_id: GCST007564
    pubmed_id: '29785011'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-2 receptor inhibitor drug DACLIZUMAB is Phase II for
        the indiciation EFO_0000270 and targets the gene ENSG00000134460 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000134460
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 6094697
    locus_GRCh38:
      chromosome: '10'
      position: 6052734
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma or allergic disease (pleiotropy)
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=19102
    gwas_catalog_id: GCST001191
    neg_log_pval: 38.0
    otg_id: GCST001191
    pubmed_id: '21829393'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-2 receptor agonist drug ALDESLEUKIN is Phase II for
        the indiciation EFO_0001359 and targets the gene ENSG00000134460 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000134460
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '10'
      position: 6097283
    locus_GRCh38:
      chromosome: '10'
      position: 6055320
  trait_info:
    ontology:
    - EFO_0001359
    reported_trait_name: Type 1 diabetes
    standard_trait_name: insulin-dependent diabetes mellitus
- association_info:
    ancestry:
    - European=19102
    gwas_catalog_id: GCST001191
    neg_log_pval: 38.0
    otg_id: GCST001191
    pubmed_id: '21829393'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-2 receptor inhibitor drug BASILIXIMAB is Phase III
        for the indiciation EFO_0001359 and targets the gene ENSG00000134460 at this
        locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000134460
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '10'
      position: 6097283
    locus_GRCh38:
      chromosome: '10'
      position: 6055320
  trait_info:
    ontology:
    - EFO_0001359
    reported_trait_name: Type 1 diabetes
    standard_trait_name: insulin-dependent diabetes mellitus
- association_info:
    ancestry:
    - European=16753
    gwas_catalog_id: GCST003097
    neg_log_pval: 8.221848749616356
    otg_id: GCST003097
    pubmed_id: '26301688'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-2 receptor agonist drug ALDESLEUKIN is Phase II for
        the indiciation EFO_0000384 and targets the gene ENSG00000134460 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000134460
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 6098949
    locus_GRCh38:
      chromosome: '10'
      position: 6056986
  trait_info:
    ontology:
    - EFO_0000384
    reported_trait_name: Pediatric autoimmune diseases
    standard_trait_name: Crohn's disease
- association_info:
    ancestry:
    - European=16753
    gwas_catalog_id: GCST003097
    neg_log_pval: 8.221848749616356
    otg_id: GCST003097
    pubmed_id: '26301688'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-2 receptor agonist drug ALDESLEUKIN is Phase II for
        the indiciation EFO_0001359 and targets the gene ENSG00000134460 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000134460
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 6098949
    locus_GRCh38:
      chromosome: '10'
      position: 6056986
  trait_info:
    ontology:
    - EFO_0001359
    reported_trait_name: Pediatric autoimmune diseases
    standard_trait_name: insulin-dependent diabetes mellitus
- association_info:
    ancestry:
    - European=16753
    gwas_catalog_id: GCST003097
    neg_log_pval: 8.221848749616356
    otg_id: GCST003097
    pubmed_id: '26301688'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-2 receptor inhibitor drug BASILIXIMAB is Phase III
        for the indiciation EFO_0001359 and targets the gene ENSG00000134460 at this
        locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000134460
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 6098949
    locus_GRCh38:
      chromosome: '10'
      position: 6056986
  trait_info:
    ontology:
    - EFO_0001359
    reported_trait_name: Pediatric autoimmune diseases
    standard_trait_name: insulin-dependent diabetes mellitus
- association_info:
    ancestry:
    - European=16753
    gwas_catalog_id: GCST003097
    neg_log_pval: 8.221848749616356
    otg_id: GCST003097
    pubmed_id: '26301688'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-2 receptor agonist drug ALDESLEUKIN is Phase II for
        the indiciation EFO_0002690 and targets the gene ENSG00000134460 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000134460
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 6098949
    locus_GRCh38:
      chromosome: '10'
      position: 6056986
  trait_info:
    ontology:
    - EFO_0002690
    reported_trait_name: Pediatric autoimmune diseases
    standard_trait_name: systemic lupus erythematosus
- association_info:
    ancestry:
    - European=16753
    gwas_catalog_id: GCST003097
    neg_log_pval: 8.221848749616356
    otg_id: GCST003097
    pubmed_id: '26301688'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-2 receptor inhibitor drug DACLIZUMAB is Phase II for
        the indiciation EFO_0000729 and targets the gene ENSG00000134460 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000134460
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 6098949
    locus_GRCh38:
      chromosome: '10'
      position: 6056986
  trait_info:
    ontology:
    - EFO_0000729
    reported_trait_name: Pediatric autoimmune diseases
    standard_trait_name: ulcerative colitis
- association_info:
    ancestry:
    - European=38582
    gwas_catalog_id: GCST005531
    neg_log_pval: 22.11861534322943
    otg_id: GCST005531
    pubmed_id: '24076602'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-2 receptor inhibitor drug DACLIZUMAB is Phase III for
        the indiciation EFO_0003885 and targets the gene ENSG00000134460 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000134460
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '10'
      position: 6099045
    locus_GRCh38:
      chromosome: '10'
      position: 6057082
  trait_info:
    ontology:
    - EFO_0003885
    reported_trait_name: Multiple sclerosis
    standard_trait_name: multiple sclerosis
- association_info:
    ancestry:
    - European=26621
    gwas_catalog_id: GCST001198
    neg_log_pval: 8.68909437062386
    otg_id: GCST001198
    pubmed_id: '21833088'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-2 receptor inhibitor drug DACLIZUMAB is Phase III for
        the indiciation EFO_0003885 and targets the gene ENSG00000134460 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000134460
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '10'
      position: 6101713
    locus_GRCh38:
      chromosome: '10'
      position: 6059750
  trait_info:
    ontology:
    - EFO_0003885
    reported_trait_name: Multiple sclerosis
    standard_trait_name: multiple sclerosis
- association_info:
    ancestry:
    - European=21389
    gwas_catalog_id: GCST000879
    neg_log_pval: 8.522878745280337
    otg_id: GCST000879
    pubmed_id: '21102463'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-2 receptor agonist drug ALDESLEUKIN is Phase II for
        the indiciation EFO_0000384 and targets the gene ENSG00000134460 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000134460
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 6102012
    locus_GRCh38:
      chromosome: '10'
      position: 6060049
  trait_info:
    ontology:
    - EFO_0000384
    reported_trait_name: Crohn's disease
    standard_trait_name: Crohn's disease
- association_info:
    ancestry:
    - European=5224
    gwas_catalog_id: GCST000062
    neg_log_pval: 7.522878745280337
    otg_id: GCST000062
    pubmed_id: '17660530'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-2 receptor inhibitor drug DACLIZUMAB is Phase III for
        the indiciation EFO_0003885 and targets the gene ENSG00000134460 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000134460
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 6102012
    locus_GRCh38:
      chromosome: '10'
      position: 6060049
  trait_info:
    ontology:
    - EFO_0003885
    reported_trait_name: Multiple sclerosis
    standard_trait_name: multiple sclerosis
- association_info:
    ancestry:
    - European=17698
    gwas_catalog_id: GCST001341
    neg_log_pval: 7.3979400086720375
    otg_id: GCST001341
    pubmed_id: '22190364'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-2 receptor inhibitor drug DACLIZUMAB is Phase III for
        the indiciation EFO_0003885 and targets the gene ENSG00000134460 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000134460
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 6102012
    locus_GRCh38:
      chromosome: '10'
      position: 6060049
  trait_info:
    ontology:
    - EFO_0003885
    reported_trait_name: Multiple sclerosis
    standard_trait_name: multiple sclerosis
- association_info:
    ancestry:
    - European=29652
    gwas_catalog_id: GCST005536
    neg_log_pval: 22.81702340982209
    otg_id: GCST005536
    pubmed_id: '25751624'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-2 receptor inhibitor drug BASILIXIMAB is Phase III
        for the indiciation EFO_0001359 and targets the gene ENSG00000134460 at this
        locus (2219bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000134460
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '10'
      position: 6106552
    locus_GRCh38:
      chromosome: '10'
      position: 6064589
  trait_info:
    ontology:
    - EFO_0001359
    reported_trait_name: Type 1 diabetes
    standard_trait_name: insulin-dependent diabetes mellitus
- association_info:
    ancestry:
    - European=29652
    gwas_catalog_id: GCST005536
    neg_log_pval: 22.81702340982209
    otg_id: GCST005536
    pubmed_id: '25751624'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-2 receptor agonist drug ALDESLEUKIN is Phase II for
        the indiciation EFO_0001359 and targets the gene ENSG00000134460 at this locus
        (2219bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000134460
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '10'
      position: 6106552
    locus_GRCh38:
      chromosome: '10'
      position: 6064589
  trait_info:
    ontology:
    - EFO_0001359
    reported_trait_name: Type 1 diabetes
    standard_trait_name: insulin-dependent diabetes mellitus
- association_info:
    ancestry:
    - European=38582
    gwas_catalog_id: GCST005531
    neg_log_pval: 20.443697499232712
    otg_id: GCST005531
    pubmed_id: '24076602'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-2 receptor inhibitor drug DACLIZUMAB is Phase III for
        the indiciation EFO_0003885 and targets the gene ENSG00000134460 at this locus
        (16953bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000134460
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '10'
      position: 6121286
    locus_GRCh38:
      chromosome: '10'
      position: 6079323
  trait_info:
    ontology:
    - EFO_0003885
    reported_trait_name: Multiple sclerosis
    standard_trait_name: multiple sclerosis
- association_info:
    ancestry:
    - European=15283
    gwas_catalog_id: GCST003566
    neg_log_pval: 8.397940008672037
    otg_id: GCST003566
    pubmed_id: '27386562'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-2 receptor inhibitor drug DACLIZUMAB is Phase III for
        the indiciation EFO_0003885 and targets the gene ENSG00000134460 at this locus
        (18336bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000134460
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '10'
      position: 6122669
    locus_GRCh38:
      chromosome: '10'
      position: 6080706
  trait_info:
    ontology:
    - EFO_0003885
    reported_trait_name: Multiple sclerosis
    standard_trait_name: multiple sclerosis
- association_info:
    ancestry:
    - European=16559
    gwas_catalog_id: GCST000392
    neg_log_pval: 13.0
    otg_id: GCST000392
    pubmed_id: '19430480'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-2 receptor inhibitor drug BASILIXIMAB is Phase III
        for the indiciation EFO_0001359 and targets the gene ENSG00000134460 at this
        locus (19162bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000134460
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 6123495
    locus_GRCh38:
      chromosome: '10'
      position: 6081532
  trait_info:
    ontology:
    - EFO_0001359
    reported_trait_name: Type 1 diabetes
    standard_trait_name: insulin-dependent diabetes mellitus
- association_info:
    ancestry:
    - European=16559
    gwas_catalog_id: GCST000392
    neg_log_pval: 13.0
    otg_id: GCST000392
    pubmed_id: '19430480'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-2 receptor agonist drug ALDESLEUKIN is Phase II for
        the indiciation EFO_0001359 and targets the gene ENSG00000134460 at this locus
        (19162bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000134460
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 6123495
    locus_GRCh38:
      chromosome: '10'
      position: 6081532
  trait_info:
    ontology:
    - EFO_0001359
    reported_trait_name: Type 1 diabetes
    standard_trait_name: insulin-dependent diabetes mellitus
- association_info:
    ancestry:
    - European=38582
    gwas_catalog_id: GCST005531
    neg_log_pval: 17.190440285364733
    otg_id: GCST005531
    pubmed_id: '24076602'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-2 receptor inhibitor drug DACLIZUMAB is Phase III for
        the indiciation EFO_0003885 and targets the gene ENSG00000134460 at this locus
        (19925bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000134460
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 6124257
    locus_GRCh38:
      chromosome: '10'
      position: 6082294
  trait_info:
    ontology:
    - EFO_0003885
    reported_trait_name: Multiple sclerosis
    standard_trait_name: multiple sclerosis
- association_info:
    ancestry:
    - European=29652
    gwas_catalog_id: GCST005536
    neg_log_pval: 8.257205214388867
    otg_id: GCST005536
    pubmed_id: '25751624'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-2 receptor agonist drug ALDESLEUKIN is Phase II for
        the indiciation EFO_0001359 and targets the gene ENSG00000134460 at this locus
        (25311bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000134460
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 6129643
    locus_GRCh38:
      chromosome: '10'
      position: 6087680
  trait_info:
    ontology:
    - EFO_0001359
    reported_trait_name: Type 1 diabetes
    standard_trait_name: insulin-dependent diabetes mellitus
- association_info:
    ancestry:
    - European=29652
    gwas_catalog_id: GCST005536
    neg_log_pval: 8.257205214388867
    otg_id: GCST005536
    pubmed_id: '25751624'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-2 receptor inhibitor drug DACLIZUMAB is Phase III for
        the indiciation EFO_0001359 and targets the gene ENSG00000134460 at this locus
        (25311bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000134460
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 6129643
    locus_GRCh38:
      chromosome: '10'
      position: 6087680
  trait_info:
    ontology:
    - EFO_0001359
    reported_trait_name: Type 1 diabetes
    standard_trait_name: insulin-dependent diabetes mellitus
- association_info:
    ancestry:
    - European=27432
    gwas_catalog_id: GCST003045
    neg_log_pval: 8.018482423811946
    otg_id: GCST003045
    pubmed_id: '26192919'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-2 receptor inhibitor drug BASILIXIMAB is Phase II for
        the indiciation EFO_0000729 and targets the gene ENSG00000134460 at this locus
        (71834bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000134460
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 6176166
    locus_GRCh38:
      chromosome: '10'
      position: 6134203
  trait_info:
    ontology:
    - EFO_0000729
    reported_trait_name: Ulcerative colitis [EA]
    standard_trait_name: ulcerative colitis
- association_info:
    ancestry:
    - European=8207
    gwas_catalog_id: GCST000258
    neg_log_pval: 8.397940008672037
    otg_id: GCST000258
    pubmed_id: '18978792'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-2 receptor inhibitor drug DACLIZUMAB is Phase III for
        the indiciation EFO_0001359 and targets the gene ENSG00000134460 at this locus
        (286119bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000134460
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '10'
      position: 6390450
    locus_GRCh38:
      chromosome: '10'
      position: 6348488
  trait_info:
    ontology:
    - EFO_0001359
    reported_trait_name: Type 1 diabetes
    standard_trait_name: insulin-dependent diabetes mellitus
- association_info:
    ancestry:
    - European=8207
    gwas_catalog_id: GCST000258
    neg_log_pval: 8.397940008672037
    otg_id: GCST000258
    pubmed_id: '18978792'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-2 receptor agonist drug ALDESLEUKIN is Phase II for
        the indiciation EFO_0001359 and targets the gene ENSG00000134460 at this locus
        (286119bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000134460
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '10'
      position: 6390450
    locus_GRCh38:
      chromosome: '10'
      position: 6348488
  trait_info:
    ontology:
    - EFO_0001359
    reported_trait_name: Type 1 diabetes
    standard_trait_name: insulin-dependent diabetes mellitus
- association_info:
    ancestry:
    - European=18264
    - African American or Afro-Caribbean=5422
    - Hispanic or Latin American=3888
    gwas_catalog_id: GCST005752
    neg_log_pval: 9.154901959985743
    otg_id: GCST005752
    pubmed_id: '28714469'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: c-Jun N-terminal kinase 1 inhibitor drug TANZISERTIB is Phase II
        for the indiciation EFO_0002690 and targets the gene ENSG00000107643 at this
        locus (327251bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000107643
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '10'
      position: 49974656
    locus_GRCh38:
      chromosome: '10'
      position: 48766611
  trait_info:
    ontology:
    - EFO_0002690
    reported_trait_name: Systemic lupus erythematosus
    standard_trait_name: systemic lupus erythematosus
- association_info:
    ancestry:
    - East Asian=5420
    gwas_catalog_id: GCST003599
    neg_log_pval: 8.698970004336019
    otg_id: GCST003599
    pubmed_id: '26663301'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: c-Jun N-terminal kinase 1 inhibitor drug TANZISERTIB is Phase II
        for the indiciation EFO_0002690 and targets the gene ENSG00000107643 at this
        locus (377992bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000107643
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '10'
      position: 50025396
    locus_GRCh38:
      chromosome: '10'
      position: 48817351
  trait_info:
    ontology:
    - EFO_0002690
    reported_trait_name: Systemic lupus erythematosus
    standard_trait_name: systemic lupus erythematosus
- association_info:
    ancestry:
    - European=14267
    gwas_catalog_id: GCST003155
    neg_log_pval: 10.065299598284575
    otg_id: GCST003155
    pubmed_id: '26502338'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: c-Jun N-terminal kinase 1 inhibitor drug TANZISERTIB is Phase II
        for the indiciation EFO_0002690 and targets the gene ENSG00000107643 at this
        locus (377992bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000107643
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '10'
      position: 50025396
    locus_GRCh38:
      chromosome: '10'
      position: 48817351
  trait_info:
    ontology:
    - EFO_0002690
    reported_trait_name: Systemic lupus erythematosus
    standard_trait_name: systemic lupus erythematosus
- association_info:
    ancestry:
    - East Asian=5057
    - European=10995
    gwas_catalog_id: GCST003622
    neg_log_pval: 10.045757490560675
    otg_id: GCST003622_3
    pubmed_id: '27399966'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: c-Jun N-terminal kinase 1 inhibitor drug TANZISERTIB is Phase II
        for the indiciation EFO_0002690 and targets the gene ENSG00000107643 at this
        locus (377992bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000107643
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '10'
      position: 50025396
    locus_GRCh38:
      chromosome: '10'
      position: 48817351
  trait_info:
    ontology:
    - EFO_0002690
    reported_trait_name: Systemic lupus erythematosus [EA]
    standard_trait_name: systemic lupus erythematosus
- association_info:
    ancestry:
    - European=14267
    gwas_catalog_id: GCST003156
    neg_log_pval: 10.065299598284575
    otg_id: GCST003156
    pubmed_id: '26502338'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: c-Jun N-terminal kinase 1 inhibitor drug TANZISERTIB is Phase II
        for the indiciation EFO_0002690 and targets the gene ENSG00000107643 at this
        locus (377992bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000107643
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '10'
      position: 50025396
    locus_GRCh38:
      chromosome: '10'
      position: 48817351
  trait_info:
    ontology:
    - EFO_0002690
    reported_trait_name: Systemic lupus erythematosus
    standard_trait_name: systemic lupus erythematosus
- association_info:
    ancestry:
    - East Asian=1798
    gwas_catalog_id: GCST000592
    neg_log_pval: 11.096910013008056
    otg_id: GCST000592
    pubmed_id: '20169177'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: c-Jun N-terminal kinase 1 inhibitor drug TANZISERTIB is Phase II
        for the indiciation EFO_0002690 and targets the gene ENSG00000107643 at this
        locus (377992bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000107643
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '10'
      position: 50025396
    locus_GRCh38:
      chromosome: '10'
      position: 48817351
  trait_info:
    ontology:
    - EFO_0002690
    reported_trait_name: Systemic lupus erythematosus
    standard_trait_name: systemic lupus erythematosus
- association_info:
    ancestry:
    - East Asian=5050
    gwas_catalog_id: GCST001795
    neg_log_pval: 8.096910013008056
    otg_id: GCST001795
    pubmed_id: '23273568'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: c-Jun N-terminal kinase 1 inhibitor drug TANZISERTIB is Phase II
        for the indiciation EFO_0002690 and targets the gene ENSG00000107643 at this
        locus (395547bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000107643
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '10'
      position: 50042951
    locus_GRCh38:
      chromosome: '10'
      position: 48834906
  trait_info:
    ontology:
    - EFO_0002690
    reported_trait_name: Systemic lupus erythematosus
    standard_trait_name: systemic lupus erythematosus
- association_info:
    ancestry:
    - European=18264
    gwas_catalog_id: GCST007400
    neg_log_pval: 8.0
    otg_id: GCST007400
    pubmed_id: '28714469'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: c-Jun N-terminal kinase 1 inhibitor drug TANZISERTIB is Phase II
        for the indiciation EFO_0002690 and targets the gene ENSG00000107643 at this
        locus (454572bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000107643
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '10'
      position: 50101977
    locus_GRCh38:
      chromosome: '10'
      position: 48893932
  trait_info:
    ontology:
    - EFO_0002690
    reported_trait_name: Systemic lupus erythematosus
    standard_trait_name: systemic lupus erythematosus
- association_info:
    ancestry:
    - East Asian=2252
    gwas_catalog_id: GCST000507
    neg_log_pval: 11.154901959985743
    otg_id: GCST000507
    pubmed_id: '19838193'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: c-Jun N-terminal kinase 1 inhibitor drug TANZISERTIB is Phase II
        for the indiciation EFO_0002690 and targets the gene ENSG00000107643 at this
        locus (471650bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000107643
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '10'
      position: 50119054
    locus_GRCh38:
      chromosome: '10'
      position: 48911009
  trait_info:
    ontology:
    - EFO_0002690
    reported_trait_name: Systemic lupus erythematosus
    standard_trait_name: systemic lupus erythematosus
- association_info:
    ancestry:
    - European=86475
    gwas_catalog_id: GCST005537
    neg_log_pval: 10.522878745280337
    otg_id: GCST005537
    pubmed_id: '26974007'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Cytochrome P450 26A1 inhibitor drug TALAROZOLE is Phase II for
        the indiciation EFO_0000676 and targets the gene ENSG00000095596 at this locus
        (401233bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000095596
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 94432000
    locus_GRCh38:
      chromosome: '10'
      position: 92672243
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Chronic inflammatory diseases (ankylosing spondylitis, Crohn's
      disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
      [subset analysis]
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=22548
    gwas_catalog_id: GCST001942
    neg_log_pval: 9.301029995663981
    otg_id: GCST001942
    pubmed_id: '23535732'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Cytochrome P450 17A1 inhibitor drug ABIRATERONE is Phase IV for
        the indiciation EFO_0001663 and targets the gene ENSG00000148795 at this locus
        (176068bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000148795
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '10'
      position: 104414221
    locus_GRCh38:
      chromosome: '10'
      position: 102654464
  trait_info:
    ontology:
    - EFO_0001663
    reported_trait_name: Prostate cancer
    standard_trait_name: prostate carcinoma
- association_info:
    ancestry:
    - European=22548
    gwas_catalog_id: GCST001942
    neg_log_pval: 9.301029995663981
    otg_id: GCST001942
    pubmed_id: '23535732'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Cytochrome P450 17A1 inhibitor drug ORTERONEL is Phase III for
        the indiciation EFO_0001663 and targets the gene ENSG00000148795 at this locus
        (176068bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000148795
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '10'
      position: 104414221
    locus_GRCh38:
      chromosome: '10'
      position: 102654464
  trait_info:
    ontology:
    - EFO_0001663
    reported_trait_name: Prostate cancer
    standard_trait_name: prostate carcinoma
- association_info:
    ancestry:
    - European=140254
    gwas_catalog_id: GCST006085
    neg_log_pval: 15.221848749616356
    otg_id: GCST006085
    pubmed_id: '29892016'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Cytochrome P450 17A1 inhibitor drug ABIRATERONE is Phase IV for
        the indiciation EFO_0001663 and targets the gene ENSG00000148795 at this locus
        (176068bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000148795
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '10'
      position: 104414221
    locus_GRCh38:
      chromosome: '10'
      position: 102654464
  trait_info:
    ontology:
    - EFO_0001663
    reported_trait_name: Prostate cancer
    standard_trait_name: prostate carcinoma
- association_info:
    ancestry:
    - European=140254
    gwas_catalog_id: GCST006085
    neg_log_pval: 15.221848749616356
    otg_id: GCST006085
    pubmed_id: '29892016'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Cytochrome P450 17A1 inhibitor drug ORTERONEL is Phase III for
        the indiciation EFO_0001663 and targets the gene ENSG00000148795 at this locus
        (176068bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000148795
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '10'
      position: 104414221
    locus_GRCh38:
      chromosome: '10'
      position: 102654464
  trait_info:
    ontology:
    - EFO_0001663
    reported_trait_name: Prostate cancer
    standard_trait_name: prostate carcinoma
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 8.399595651036623
    otg_id: NEALE2_20002_1065
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Beta-1 adrenergic receptor antagonist drug NADOLOL is Phase IV
        for the indiciation EFO_0000537 and targets the gene ENSG00000043591 at this
        locus (80138bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000043591
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 115723678
    locus_GRCh38:
      chromosome: '10'
      position: 113963919
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Hypertension | non-cancer illness code, self-reported
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - East Asian=50792
    gwas_catalog_id: GCST007707
    neg_log_pval: 8.698970004336019
    otg_id: GCST007707
    pubmed_id: '30487518'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Beta-1 adrenergic receptor antagonist drug ACEBUTOLOL is Phase
        IV for the indiciation EFO_0000537 and targets the gene ENSG00000043591 at
        this locus (61988bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000043591
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '10'
      position: 115741828
    locus_GRCh38:
      chromosome: '10'
      position: 113982069
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Hypertension [East Asian]
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - European=91102
    - African American or Afro-Caribbean=21417
    - Asian unspecified=12365
    - Hispanic or Latin American=8471
    gwas_catalog_id: GCST006434
    neg_log_pval: 19.69897000433602
    otg_id: GCST006434_9
    pubmed_id: '29912962'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Beta-1 adrenergic receptor antagonist drug PROPRANOLOL is Phase
        II for the indiciation EFO_0004329 and targets the gene ENSG00000043591 at
        this locus (11754bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000043591
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '10'
      position: 115792062
    locus_GRCh38:
      chromosome: '10'
      position: 114032303
  trait_info:
    ontology:
    - EFO_0004329
    reported_trait_name: Systolic blood pressure x alcohol consumption interaction
      (2df test) [EA]
    standard_trait_name: alcohol drinking
- association_info:
    ancestry:
    - European=91110
    - African American or Afro-Caribbean=21416
    - Asian unspecified=12365
    - Hispanic or Latin American=8470
    gwas_catalog_id: GCST006167
    neg_log_pval: 9.698970004336019
    otg_id: GCST006167_9
    pubmed_id: '29912962'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Beta-1 adrenergic receptor antagonist drug PROPRANOLOL is Phase
        II for the indiciation EFO_0004329 and targets the gene ENSG00000043591 at
        this locus (11029bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000043591
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '10'
      position: 115792787
    locus_GRCh38:
      chromosome: '10'
      position: 114033028
  trait_info:
    ontology:
    - EFO_0004329
    reported_trait_name: Mean arterial pressure x alcohol consumption interaction
      (2df test) [EA]
    standard_trait_name: alcohol drinking
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 21.73008330295326
    otg_id: NEALE2_20002_1065
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Beta-1 adrenergic receptor antagonist drug METOPROLOL is Phase
        IV for the indiciation EFO_0000537 and targets the gene ENSG00000043591 at
        this locus (11029bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000043591
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '10'
      position: 115792787
    locus_GRCh38:
      chromosome: '10'
      position: 114033028
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Hypertension | non-cancer illness code, self-reported
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - European=91099
    - African American or Afro-Caribbean=21416
    - Asian unspecified=12365
    - Hispanic or Latin American=8471
    gwas_catalog_id: GCST006166
    neg_log_pval: 22.096910013008056
    otg_id: GCST006166_8
    pubmed_id: '29912962'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Beta-1 adrenergic receptor antagonist drug PROPRANOLOL is Phase
        II for the indiciation EFO_0004329 and targets the gene ENSG00000043591 at
        this locus (11029bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000043591
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '10'
      position: 115792787
    locus_GRCh38:
      chromosome: '10'
      position: 114033028
  trait_info:
    ontology:
    - EFO_0004329
    reported_trait_name: Diastolic blood pressure x alcohol consumption interaction
      (2df test) [EA]
    standard_trait_name: alcohol drinking
- association_info:
    ancestry:
    - European=408089
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 14.522878745280337
    otg_id: SAIGE_401_1
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Beta-1 adrenergic receptor antagonist drug NEBIVOLOL is Phase IV
        for the indiciation EFO_0000537 and targets the gene ENSG00000043591 at this
        locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000043591
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '10'
      position: 115805056
    locus_GRCh38:
      chromosome: '10'
      position: 114045297
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Essential hypertension
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - European=408343
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 14.397940008672037
    otg_id: SAIGE_401
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Beta-1 adrenergic receptor antagonist drug NEBIVOLOL is Phase IV
        for the indiciation EFO_0000537 and targets the gene ENSG00000043591 at this
        locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000043591
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '10'
      position: 115805056
    locus_GRCh38:
      chromosome: '10'
      position: 114045297
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Hypertension
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - European=459000
    gwas_catalog_id: GCST007072
    neg_log_pval: 23.221848749616356
    otg_id: GCST007072
    pubmed_id: '30595370'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Beta-1 adrenergic receptor agonist drug DOPAMINE is Phase IV for
        the indiciation EFO_0000319 and targets the gene ENSG00000043591 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000043591
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '10'
      position: 115805056
    locus_GRCh38:
      chromosome: '10'
      position: 114045297
  trait_info:
    ontology:
    - EFO_0000319
    reported_trait_name: Cardiovascular disease
    standard_trait_name: cardiovascular system disease
- association_info:
    ancestry:
    - European=22627
    gwas_catalog_id: GCST001937
    neg_log_pval: 7.698970004336019
    otg_id: GCST001937
    pubmed_id: '23535729'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Fibroblast growth factor receptor 2 inhibitor drug LUCITANIB is
        Phase II for the indiciation EFO_0000305 and targets the gene ENSG00000066468
        at this locus (143947bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000066468
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 123093901
    locus_GRCh38:
      chromosome: '10'
      position: 121334387
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=33864
    gwas_catalog_id: GCST004950
    neg_log_pval: 8.096910013008056
    otg_id: GCST004950
    pubmed_id: '25751625'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Fibroblast growth factor receptor 2 inhibitor drug LUCITANIB is
        Phase II for the indiciation EFO_0000305 and targets the gene ENSG00000066468
        at this locus (143947bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000066468
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 123093901
    locus_GRCh38:
      chromosome: '10'
      position: 121334387
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=139274
    gwas_catalog_id: GCST004988
    neg_log_pval: 11.680685695909489
    otg_id: GCST004988
    pubmed_id: '29059683'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Fibroblast growth factor receptor 2 inhibitor drug LUCITANIB is
        Phase II for the indiciation EFO_0000305 and targets the gene ENSG00000066468
        at this locus (143858bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000066468
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: GT
      reference: G
    locus_GRCh37:
      chromosome: '10'
      position: 123093991
    locus_GRCh38:
      chromosome: '10'
      position: 121334477
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=139274
    gwas_catalog_id: GCST004988
    neg_log_pval: 43.678815972697684
    otg_id: GCST004988
    pubmed_id: '29059683'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Fibroblast growth factor receptor 2 inhibitor drug LUCITANIB is
        Phase II for the indiciation EFO_0000305 and targets the gene ENSG00000066468
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000066468
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: A
    locus_GRCh37:
      chromosome: '10'
      position: 123331467
    locus_GRCh38:
      chromosome: '10'
      position: 121571953
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=139274
    gwas_catalog_id: GCST004988
    neg_log_pval: 190.37059040089727
    otg_id: GCST004988
    pubmed_id: '29059683'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Fibroblast growth factor receptor 2 inhibitor drug LUCITANIB is
        Phase II for the indiciation EFO_0000305 and targets the gene ENSG00000066468
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000066468
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: A
    locus_GRCh37:
      chromosome: '10'
      position: 123331690
    locus_GRCh38:
      chromosome: '10'
      position: 121572176
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=123671
    gwas_catalog_id: GCST003588
    neg_log_pval: 34.096910013008056
    otg_id: GCST003588_2
    pubmed_id: '27197191'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Fibroblast growth factor receptor 2 inhibitor drug LUCITANIB is
        Phase II for the indiciation EFO_0000305 and targets the gene ENSG00000066468
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000066468
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '10'
      position: 123334930
    locus_GRCh38:
      chromosome: '10'
      position: 121575416
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Cancer (pleiotropy) [subset analysis]
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=123671
    gwas_catalog_id: GCST003588
    neg_log_pval: 34.096910013008056
    otg_id: GCST003588_2
    pubmed_id: '27197191'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Fibroblast growth factor receptor 2 inhibitor drug REGORAFENIB
        is Phase II for the indiciation EFO_0005842 and targets the gene ENSG00000066468
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000066468
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '10'
      position: 123334930
    locus_GRCh38:
      chromosome: '10'
      position: 121575416
  trait_info:
    ontology:
    - EFO_0005842
    reported_trait_name: Cancer (pleiotropy) [subset analysis]
    standard_trait_name: colorectal cancer
- association_info:
    ancestry:
    - European=123671
    gwas_catalog_id: GCST003588
    neg_log_pval: 34.096910013008056
    otg_id: GCST003588_2
    pubmed_id: '27197191'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Fibroblast growth factor receptor 2 inhibitor drug REGORAFENIB
        is Phase II for the indiciation EFO_0001075 and targets the gene ENSG00000066468
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000066468
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '10'
      position: 123334930
    locus_GRCh38:
      chromosome: '10'
      position: 121575416
  trait_info:
    ontology:
    - EFO_0001075
    reported_trait_name: Cancer (pleiotropy) [subset analysis]
    standard_trait_name: ovarian carcinoma
- association_info:
    ancestry:
    - European=8556
    gwas_catalog_id: GCST000678
    neg_log_pval: 30.397940008672037
    otg_id: GCST000678
    pubmed_id: '20453838'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Fibroblast growth factor receptor 2 inhibitor drug LUCITANIB is
        Phase II for the indiciation EFO_0000305 and targets the gene ENSG00000066468
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000066468
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '10'
      position: 123337335
    locus_GRCh38:
      chromosome: '10'
      position: 121577821
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=2287
    gwas_catalog_id: GCST000365
    neg_log_pval: 9.698970004336019
    otg_id: GCST000365
    pubmed_id: '19330030'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Fibroblast growth factor receptor 2 inhibitor drug LUCITANIB is
        Phase II for the indiciation EFO_0000305 and targets the gene ENSG00000066468
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000066468
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '10'
      position: 123337335
    locus_GRCh38:
      chromosome: '10'
      position: 121577821
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=22627
    gwas_catalog_id: GCST001937
    neg_log_pval: 169.69897000433602
    otg_id: GCST001937
    pubmed_id: '23535729'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Fibroblast growth factor receptor 2 inhibitor drug LUCITANIB is
        Phase II for the indiciation EFO_0000305 and targets the gene ENSG00000066468
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000066468
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '10'
      position: 123337335
    locus_GRCh38:
      chromosome: '10'
      position: 121577821
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - East Asian=13905
    gwas_catalog_id: GCST003520
    neg_log_pval: 10.522878745280337
    otg_id: GCST003520
    pubmed_id: '27354352'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Fibroblast growth factor receptor 2 inhibitor drug LUCITANIB is
        Phase II for the indiciation EFO_0000305 and targets the gene ENSG00000066468
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000066468
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '10'
      position: 123337335
    locus_GRCh38:
      chromosome: '10'
      position: 121577821
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=33864
    gwas_catalog_id: GCST004950
    neg_log_pval: 163.22184874961636
    otg_id: GCST004950
    pubmed_id: '25751625'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Fibroblast growth factor receptor 2 inhibitor drug LUCITANIB is
        Phase II for the indiciation EFO_0000305 and targets the gene ENSG00000066468
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000066468
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '10'
      position: 123337335
    locus_GRCh38:
      chromosome: '10'
      position: 121577821
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=330828
    neg_log_pval: 30.844827992822484
    otg_id: NEALE2_20110_5
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Fibroblast growth factor receptor 2 inhibitor drug LUCITANIB is
        Phase II for the indiciation EFO_0000305 and targets the gene ENSG00000066468
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000066468
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '10'
      position: 123338975
    locus_GRCh38:
      chromosome: '10'
      position: 121579461
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer | illnesses of mother
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - East Asian=4741
    gwas_catalog_id: GCST002234
    neg_log_pval: 12.0
    otg_id: GCST002234
    pubmed_id: '24143190'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Fibroblast growth factor receptor 2 inhibitor drug LUCITANIB is
        Phase II for the indiciation EFO_0000305 and targets the gene ENSG00000066468
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000066468
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 123340311
    locus_GRCh38:
      chromosome: '10'
      position: 121580797
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - East Asian=4741
    gwas_catalog_id: GCST002234
    neg_log_pval: 12.0
    otg_id: GCST002234
    pubmed_id: '24143190'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Fibroblast growth factor receptor 2 inhibitor drug LUCITANIB is
        Phase II for the indiciation EFO_0000305 and targets the gene ENSG00000066468
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000066468
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 123340311
    locus_GRCh38:
      chromosome: '10'
      position: 121580797
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=139274
    gwas_catalog_id: GCST004988
    neg_log_pval: 321.65300282934044
    otg_id: GCST004988
    pubmed_id: '29059683'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Fibroblast growth factor receptor 2 inhibitor drug LUCITANIB is
        Phase II for the indiciation EFO_0000305 and targets the gene ENSG00000066468
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000066468
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: GC
    locus_GRCh37:
      chromosome: '10'
      position: 123340431
    locus_GRCh38:
      chromosome: '10'
      position: 121580917
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=279478
    neg_log_pval: 14.096910013008056
    otg_id: NEALE2_20111_5
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Fibroblast growth factor receptor 2 inhibitor drug LUCITANIB is
        Phase II for the indiciation EFO_0000305 and targets the gene ENSG00000066468
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000066468
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '10'
      position: 123343909
    locus_GRCh38:
      chromosome: '10'
      position: 121584395
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer | illnesses of siblings
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=1703
    gwas_catalog_id: GCST000846
    neg_log_pval: 8.0
    otg_id: GCST000846
    pubmed_id: '21060860'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Fibroblast growth factor receptor 2 inhibitor drug LUCITANIB is
        Phase II for the indiciation EFO_0000305 and targets the gene ENSG00000066468
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000066468
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '10'
      position: 123346116
    locus_GRCh38:
      chromosome: '10'
      position: 121586602
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer in BRCA2 mutation carriers
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=401447
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 71.26440110030182
    otg_id: SAIGE_174
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Fibroblast growth factor receptor 2 inhibitor drug LUCITANIB is
        Phase II for the indiciation EFO_0000305 and targets the gene ENSG00000066468
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000066468
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '10'
      position: 123346116
    locus_GRCh38:
      chromosome: '10'
      position: 121586602
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=6346
    gwas_catalog_id: GCST000952
    neg_log_pval: 30.0
    otg_id: GCST000952
    pubmed_id: '21263130'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Fibroblast growth factor receptor 2 inhibitor drug LUCITANIB is
        Phase II for the indiciation EFO_0000305 and targets the gene ENSG00000066468
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000066468
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '10'
      position: 123346190
    locus_GRCh38:
      chromosome: '10'
      position: 121586676
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - East Asian=13905
    gwas_catalog_id: GCST003520
    neg_log_pval: 8.221848749616356
    otg_id: GCST003520
    pubmed_id: '27354352'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Fibroblast growth factor receptor 2 inhibitor drug LUCITANIB is
        Phase II for the indiciation EFO_0000305 and targets the gene ENSG00000066468
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000066468
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '10'
      position: 123346190
    locus_GRCh38:
      chromosome: '10'
      position: 121586676
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=8428
    gwas_catalog_id: GCST000811
    neg_log_pval: 12.698970004336019
    otg_id: GCST000811
    pubmed_id: '20872241'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Fibroblast growth factor receptor 2 inhibitor drug LUCITANIB is
        Phase II for the indiciation EFO_0000305 and targets the gene ENSG00000066468
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000066468
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '10'
      position: 123346190
    locus_GRCh38:
      chromosome: '10'
      position: 121586676
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=2287
    gwas_catalog_id: GCST000036
    neg_log_pval: 10.0
    otg_id: GCST000036
    pubmed_id: '17529973'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Fibroblast growth factor receptor 2 inhibitor drug LUCITANIB is
        Phase II for the indiciation EFO_0000305 and targets the gene ENSG00000066468
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000066468
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '10'
      position: 123346190
    locus_GRCh38:
      chromosome: '10'
      position: 121586676
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=6225
    gwas_catalog_id: GCST002346
    neg_log_pval: 26.522878745280337
    otg_id: GCST002346
    pubmed_id: '24493630'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Fibroblast growth factor receptor 2 inhibitor drug LUCITANIB is
        Phase II for the indiciation EFO_0000305 and targets the gene ENSG00000066468
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000066468
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: T
    locus_GRCh37:
      chromosome: '10'
      position: 123348662
    locus_GRCh38:
      chromosome: '10'
      position: 121589148
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer (early onset)
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=139274
    gwas_catalog_id: GCST004988
    neg_log_pval: 36.13804762507855
    otg_id: GCST004988
    pubmed_id: '29059683'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Fibroblast growth factor receptor 2 inhibitor drug LUCITANIB is
        Phase II for the indiciation EFO_0000305 and targets the gene ENSG00000066468
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000066468
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: A
    locus_GRCh37:
      chromosome: '10'
      position: 123349324
    locus_GRCh38:
      chromosome: '10'
      position: 121589810
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=359981
    neg_log_pval: 13.229147988357855
    otg_id: NEALE2_2453
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Fibroblast growth factor receptor 2 inhibitor drug REGORAFENIB
        is Phase II for the indiciation EFO_0000311 and targets the gene ENSG00000066468
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000066468
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '10'
      position: 123350216
    locus_GRCh38:
      chromosome: '10'
      position: 121590702
  trait_info:
    ontology:
    - EFO_0000311
    reported_trait_name: Cancer diagnosed by doctor
    standard_trait_name: cancer
- association_info:
    ancestry:
    - European=8211
    gwas_catalog_id: GCST007302
    neg_log_pval: 13.698970004336019
    otg_id: GCST007302
    pubmed_id: '23544012'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Fibroblast growth factor receptor 2 inhibitor drug LUCITANIB is
        Phase II for the indiciation EFO_0000305 and targets the gene ENSG00000066468
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000066468
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '10'
      position: 123351324
    locus_GRCh38:
      chromosome: '10'
      position: 121591810
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer in BRCA2 mutation carriers
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=5452
    gwas_catalog_id: GCST003823
    neg_log_pval: 10.301029995663981
    otg_id: GCST003823
    pubmed_id: '27764800'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Fibroblast growth factor receptor 2 inhibitor drug LUCITANIB is
        Phase II for the indiciation EFO_0000305 and targets the gene ENSG00000066468
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000066468
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 123352220
    locus_GRCh38:
      chromosome: '10'
      position: 121592706
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Estrogen receptor status in HER2 negative breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=754
    gwas_catalog_id: GCST000035
    neg_log_pval: 75.69897000433602
    otg_id: GCST000035
    pubmed_id: '17529967'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Fibroblast growth factor receptor 2 inhibitor drug LUCITANIB is
        Phase II for the indiciation EFO_0000305 and targets the gene ENSG00000066468
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000066468
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '10'
      position: 123352317
    locus_GRCh38:
      chromosome: '10'
      position: 121592803
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - East Asian=13905
    gwas_catalog_id: GCST003520
    neg_log_pval: 7.698970004336019
    otg_id: GCST003520
    pubmed_id: '27354352'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Fibroblast growth factor receptor 2 inhibitor drug LUCITANIB is
        Phase II for the indiciation EFO_0000305 and targets the gene ENSG00000066468
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000066468
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '10'
      position: 123352317
    locus_GRCh38:
      chromosome: '10'
      position: 121592803
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=8727
    gwas_catalog_id: GCST003821
    neg_log_pval: 11.221848749616356
    otg_id: GCST003821
    pubmed_id: '27764800'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Fibroblast growth factor receptor 2 inhibitor drug LUCITANIB is
        Phase II for the indiciation EFO_0000305 and targets the gene ENSG00000066468
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000066468
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 123353869
    locus_GRCh38:
      chromosome: '10'
      position: 121594355
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Estrogen receptor status in breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=139274
    gwas_catalog_id: GCST004988
    neg_log_pval: 13.173925197299173
    otg_id: GCST004988
    pubmed_id: '29059683'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Fibroblast growth factor receptor 2 inhibitor drug LUCITANIB is
        Phase II for the indiciation EFO_0000305 and targets the gene ENSG00000066468
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000066468
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 123357561
    locus_GRCh38:
      chromosome: '10'
      position: 121598047
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=408089
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 15.0
    otg_id: SAIGE_401_1
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tyrosine 3-hydroxylase inhibitor drug METYROSINE is Phase IV for
        the indiciation EFO_0000537 and targets the gene ENSG00000180176 at this locus
        (311928bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000180176
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: A
    locus_GRCh37:
      chromosome: '11'
      position: 1873232
    locus_GRCh38:
      chromosome: '11'
      position: 1852002
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Essential hypertension
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - European=408343
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 15.0
    otg_id: SAIGE_401
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tyrosine 3-hydroxylase inhibitor drug METYROSINE is Phase IV for
        the indiciation EFO_0000537 and targets the gene ENSG00000180176 at this locus
        (311928bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000180176
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: A
    locus_GRCh37:
      chromosome: '11'
      position: 1873232
    locus_GRCh38:
      chromosome: '11'
      position: 1852002
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Hypertension
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 16.29810490633703
    otg_id: NEALE2_20002_1065
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tyrosine 3-hydroxylase inhibitor drug METYROSINE is Phase IV for
        the indiciation EFO_0000537 and targets the gene ENSG00000180176 at this locus
        (308214bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000180176
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 1876945
    locus_GRCh38:
      chromosome: '11'
      position: 1855715
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Hypertension | non-cancer illness code, self-reported
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - East Asian=50792
    gwas_catalog_id: GCST007707
    neg_log_pval: 8.0
    otg_id: GCST007707_2
    pubmed_id: '30487518'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tyrosine 3-hydroxylase inhibitor drug METYROSINE is Phase IV for
        the indiciation EFO_0000537 and targets the gene ENSG00000180176 at this locus
        (298091bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000180176
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '11'
      position: 1887068
    locus_GRCh38:
      chromosome: '11'
      position: 1865838
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Hypertension [Japanese]
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 26.22452645095722
    otg_id: NEALE2_20002_1065
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tyrosine 3-hydroxylase inhibitor drug METYROSINE is Phase IV for
        the indiciation EFO_0000537 and targets the gene ENSG00000180176 at this locus
        (296545bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000180176
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 1888614
    locus_GRCh38:
      chromosome: '11'
      position: 1867384
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Hypertension | non-cancer illness code, self-reported
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - European=408089
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 19.518557371497696
    otg_id: SAIGE_401_1
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tyrosine 3-hydroxylase inhibitor drug METYROSINE is Phase IV for
        the indiciation EFO_0000537 and targets the gene ENSG00000180176 at this locus
        (296545bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000180176
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 1888614
    locus_GRCh38:
      chromosome: '11'
      position: 1867384
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Essential hypertension
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - European=408343
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 19.619788758288394
    otg_id: SAIGE_401
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tyrosine 3-hydroxylase inhibitor drug METYROSINE is Phase IV for
        the indiciation EFO_0000537 and targets the gene ENSG00000180176 at this locus
        (296545bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000180176
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 1888614
    locus_GRCh38:
      chromosome: '11'
      position: 1867384
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Hypertension
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - East Asian=50792
    gwas_catalog_id: GCST007707
    neg_log_pval: 15.397940008672037
    otg_id: GCST007707
    pubmed_id: '30487518'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tyrosine 3-hydroxylase inhibitor drug METYROSINE is Phase IV for
        the indiciation EFO_0000537 and targets the gene ENSG00000180176 at this locus
        (286496bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000180176
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '11'
      position: 1898664
    locus_GRCh38:
      chromosome: '11'
      position: 1877434
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Hypertension [East Asian]
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - European=139274
    gwas_catalog_id: GCST004988
    neg_log_pval: 37.01300446027562
    otg_id: GCST004988
    pubmed_id: '29059683'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Insulin-like growth factor II inhibitor drug DUSIGITUMAB is Phase
        II for the indiciation EFO_0000305 and targets the gene ENSG00000167244 at
        this locus (251679bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000167244
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '11'
      position: 1898664
    locus_GRCh38:
      chromosome: '11'
      position: 1877434
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=19291
    gwas_catalog_id: GCST003845
    neg_log_pval: 8.045757490560675
    otg_id: GCST003845
    pubmed_id: '27117709'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Insulin-like growth factor II inhibitor drug DUSIGITUMAB is Phase
        II for the indiciation EFO_0000305 and targets the gene ENSG00000167244 at
        this locus (248245bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000167244
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 1902097
    locus_GRCh38:
      chromosome: '11'
      position: 1880867
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=33864
    gwas_catalog_id: GCST004950
    neg_log_pval: 12.698970004336019
    otg_id: GCST004950
    pubmed_id: '25751625'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Insulin-like growth factor II inhibitor drug DUSIGITUMAB is Phase
        II for the indiciation EFO_0000305 and targets the gene ENSG00000167244 at
        this locus (241337bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000167244
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '11'
      position: 1909006
    locus_GRCh38:
      chromosome: '11'
      position: 1887776
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=22627
    gwas_catalog_id: GCST001937
    neg_log_pval: 10.698970004336019
    otg_id: GCST001937
    pubmed_id: '23535729'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Insulin-like growth factor II inhibitor drug DUSIGITUMAB is Phase
        II for the indiciation EFO_0000305 and targets the gene ENSG00000167244 at
        this locus (241337bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000167244
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '11'
      position: 1909006
    locus_GRCh38:
      chromosome: '11'
      position: 1887776
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=754
    gwas_catalog_id: GCST000035
    neg_log_pval: 8.522878745280337
    otg_id: GCST000035
    pubmed_id: '17529967'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Insulin-like growth factor II inhibitor drug DUSIGITUMAB is Phase
        II for the indiciation EFO_0000305 and targets the gene ENSG00000167244 at
        this locus (241337bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000167244
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '11'
      position: 1909006
    locus_GRCh38:
      chromosome: '11'
      position: 1887776
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=407701
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 9.896196279044043
    otg_id: SAIGE_250_2
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Potassium channel, inwardly rectifying, subfamily J, member 11
        opener drug DIAZOXIDE is Phase II for the indiciation EFO_0001360 and targets
        the gene ENSG00000187486 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000187486
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 17408404
    locus_GRCh38:
      chromosome: '11'
      position: 17386857
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=69033
    gwas_catalog_id: GCST005047
    neg_log_pval: 10.494850021680094
    otg_id: GCST005047
    pubmed_id: '22885922'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Potassium channel, inwardly rectifying, subfamily J, member 11
        opener drug DIAZOXIDE is Phase II for the indiciation EFO_0001360 and targets
        the gene ENSG00000187486 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000187486
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 17408630
    locus_GRCh38:
      chromosome: '11'
      position: 17387083
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=69033
    - East Asian=18817
    - South Asian=20019
    - Hispanic or Latin American=2583
    gwas_catalog_id: GCST002352
    neg_log_pval: 10.522878745280337
    otg_id: GCST002352
    pubmed_id: '24509480'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Potassium channel, inwardly rectifying, subfamily J, member 11
        opener drug DIAZOXIDE is Phase II for the indiciation EFO_0001360 and targets
        the gene ENSG00000187486 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000187486
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 17408630
    locus_GRCh38:
      chromosome: '11'
      position: 17387083
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=655666
    - South Asian=3650
    gwas_catalog_id: GCST006867
    neg_log_pval: 19.69897000433602
    otg_id: GCST006867
    pubmed_id: '30054458'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Potassium channel, inwardly rectifying, subfamily J, member 11
        opener drug DIAZOXIDE is Phase II for the indiciation EFO_0001360 and targets
        the gene ENSG00000187486 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000187486
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 17408630
    locus_GRCh38:
      chromosome: '11'
      position: 17387083
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - South Asian=13532
    - European=20298
    - NR=149821
    gwas_catalog_id: GCST004894
    neg_log_pval: 13.096910013008056
    otg_id: GCST004894_2
    pubmed_id: '28869590'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Potassium channel, inwardly rectifying, subfamily J, member 11
        opener drug DIAZOXIDE is Phase II for the indiciation EFO_0001360 and targets
        the gene ENSG00000187486 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000187486
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 17408630
    locus_GRCh38:
      chromosome: '11'
      position: 17387083
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes [EA]
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - South Asian=13532
    - European=20298
    - NR=149821
    gwas_catalog_id: GCST004894
    neg_log_pval: 20.0
    otg_id: GCST004894
    pubmed_id: '28869590'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Potassium channel, inwardly rectifying, subfamily J, member 11
        opener drug DIAZOXIDE is Phase II for the indiciation EFO_0001360 and targets
        the gene ENSG00000187486 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000187486
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 17408630
    locus_GRCh38:
      chromosome: '11'
      position: 17387083
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    gwas_catalog_id: GCST007518
    neg_log_pval: 21.30102999566398
    otg_id: GCST007518
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Potassium channel, inwardly rectifying, subfamily J, member 11
        opener drug DIAZOXIDE is Phase II for the indiciation EFO_0001360 and targets
        the gene ENSG00000187486 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000187486
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 17408630
    locus_GRCh38:
      chromosome: '11'
      position: 17387083
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes (adjusted for BMI)
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    gwas_catalog_id: GCST007517
    neg_log_pval: 16.397940008672037
    otg_id: GCST007517
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Potassium channel, inwardly rectifying, subfamily J, member 11
        opener drug DIAZOXIDE is Phase II for the indiciation EFO_0001360 and targets
        the gene ENSG00000187486 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000187486
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 17408630
    locus_GRCh38:
      chromosome: '11'
      position: 17387083
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=4862
    gwas_catalog_id: GCST000025
    neg_log_pval: 10.301029995663981
    otg_id: GCST000025_2
    pubmed_id: '17463249'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Potassium channel, inwardly rectifying, subfamily J, member 11
        opener drug DIAZOXIDE is Phase II for the indiciation EFO_0001360 and targets
        the gene ENSG00000187486 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000187486
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 17408630
    locus_GRCh38:
      chromosome: '11'
      position: 17387083
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes [DGI+FUSION+WTCCC]
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    - South Asian, East Asian, African American or Afro-Caribbean, Hispanic or Latin
      American=153287
    gwas_catalog_id: GCST007516
    neg_log_pval: 21.69897000433602
    otg_id: GCST007516
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Potassium channel, inwardly rectifying, subfamily J, member 11
        opener drug DIAZOXIDE is Phase II for the indiciation EFO_0001360 and targets
        the gene ENSG00000187486 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000187486
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '11'
      position: 17409572
    locus_GRCh38:
      chromosome: '11'
      position: 17388025
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes (adjusted for BMI)
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=2931
    gwas_catalog_id: GCST000028
    neg_log_pval: 10.154901959985743
    otg_id: GCST000028
    pubmed_id: '17463246'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Potassium channel, inwardly rectifying, subfamily J, member 11
        opener drug DIAZOXIDE is Phase II for the indiciation EFO_0001360 and targets
        the gene ENSG00000187486 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000187486
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '11'
      position: 17409572
    locus_GRCh38:
      chromosome: '11'
      position: 17388025
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=4862
    gwas_catalog_id: GCST000277
    neg_log_pval: 9.0
    otg_id: GCST000277
    pubmed_id: '19056611'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Potassium channel, inwardly rectifying, subfamily J, member 11
        opener drug DIAZOXIDE is Phase II for the indiciation EFO_0001360 and targets
        the gene ENSG00000187486 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000187486
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '11'
      position: 17409572
    locus_GRCh38:
      chromosome: '11'
      position: 17388025
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes [non-obese]
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=2335
    gwas_catalog_id: GCST000024
    neg_log_pval: 10.154901959985743
    otg_id: GCST000024_2
    pubmed_id: '17463248'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Potassium channel, inwardly rectifying, subfamily J, member 11
        opener drug DIAZOXIDE is Phase II for the indiciation EFO_0001360 and targets
        the gene ENSG00000187486 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000187486
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '11'
      position: 17409572
    locus_GRCh38:
      chromosome: '11'
      position: 17388025
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes [DGI+FUSION+WTCCC]
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    - South Asian, East Asian, African American or Afro-Caribbean, Hispanic or Latin
      American=153287
    gwas_catalog_id: GCST007515
    neg_log_pval: 21.221848749616356
    otg_id: GCST007515
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Potassium channel, inwardly rectifying, subfamily J, member 11
        opener drug DIAZOXIDE is Phase II for the indiciation EFO_0001360 and targets
        the gene ENSG00000187486 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000187486
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '11'
      position: 17409572
    locus_GRCh38:
      chromosome: '11'
      position: 17388025
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=459000
    gwas_catalog_id: GCST007077
    neg_log_pval: 11.698970004336019
    otg_id: GCST007077
    pubmed_id: '30595370'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Potassium channel, inwardly rectifying, subfamily J, member 11
        opener drug DIAZOXIDE is Phase II for the indiciation EFO_0001360 and targets
        the gene ENSG00000187486 at this locus (943bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000187486
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 17411821
    locus_GRCh38:
      chromosome: '11'
      position: 17390274
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 13.853871964321762
    otg_id: NEALE2_20002_1093
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Thrombin inhibitor drug DABIGATRAN ETEXILATE is Phase IV for the
        indiciation EFO_0003827 and targets the gene ENSG00000180210 at this locus
        (34991bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000180210
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 46705739
    locus_GRCh38:
      chromosome: '11'
      position: 46684189
  trait_info:
    ontology:
    - EFO_0003827
    reported_trait_name: Pulmonary embolism +/- dvt | non-cancer illness code, self-reported
    standard_trait_name: pulmonary embolism
- association_info:
    ancestry:
    - European=120158
    gwas_catalog_id: GCST004256
    neg_log_pval: 8.096910013008056
    otg_id: GCST004256_2
    pubmed_id: '28373160'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Thrombin inhibitor drug DABIGATRAN ETEXILATE is Phase III for the
        indiciation EFO_0004286 and targets the gene ENSG00000180210 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000180210
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 46760756
    locus_GRCh38:
      chromosome: '11'
      position: 46739206
  trait_info:
    ontology:
    - EFO_0004286
    reported_trait_name: Venous thromboembolism [Conditioned on rs1799963]
    standard_trait_name: venous thromboembolism
- association_info:
    ancestry:
    - European=120158
    gwas_catalog_id: GCST004256
    neg_log_pval: 8.096910013008056
    otg_id: GCST004256_2
    pubmed_id: '28373160'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Thrombin inhibitor drug DABIGATRAN is Phase IV for the indiciation
        EFO_0004286 and targets the gene ENSG00000180210 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000180210
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 46760756
    locus_GRCh38:
      chromosome: '11'
      position: 46739206
  trait_info:
    ontology:
    - EFO_0004286
    reported_trait_name: Venous thromboembolism [Conditioned on rs1799963]
    standard_trait_name: venous thromboembolism
- association_info:
    ancestry:
    - European=404271
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 12.829738284605043
    otg_id: SAIGE_459_9
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Thrombin inhibitor drug ARGATROBAN is Phase IV for the indiciation
        EFO_0000319 and targets the gene ENSG00000180210 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000180210
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 46761055
    locus_GRCh38:
      chromosome: '11'
      position: 46739505
  trait_info:
    ontology:
    - EFO_0000319
    reported_trait_name: Circulatory disease nec
    standard_trait_name: cardiovascular system disease
- association_info:
    ancestry:
    - European=258962
    gwas_catalog_id: GCST003390
    neg_log_pval: 24.0
    otg_id: GCST003390
    pubmed_id: '26908601'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Thrombin inhibitor drug DABIGATRAN ETEXILATE is Phase IV for the
        indiciation EFO_0000712 and targets the gene ENSG00000180210 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000180210
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 46761055
    locus_GRCh38:
      chromosome: '11'
      position: 46739505
  trait_info:
    ontology:
    - EFO_0000712
    reported_trait_name: Thrombosis
    standard_trait_name: cerebrovascular accident
- association_info:
    ancestry:
    - European=120158
    gwas_catalog_id: GCST004256
    neg_log_pval: 12.301029995663981
    otg_id: GCST004256
    pubmed_id: '28373160'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Thrombin inhibitor drug DABIGATRAN is Phase IV for the indiciation
        EFO_0004286 and targets the gene ENSG00000180210 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000180210
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 46761055
    locus_GRCh38:
      chromosome: '11'
      position: 46739505
  trait_info:
    ontology:
    - EFO_0004286
    reported_trait_name: Venous thromboembolism
    standard_trait_name: venous thromboembolism
- association_info:
    ancestry:
    - European=404449
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 12.882728704344236
    otg_id: SAIGE_459
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Thrombin inhibitor drug ARGATROBAN is Phase IV for the indiciation
        EFO_0000319 and targets the gene ENSG00000180210 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000180210
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 46761055
    locus_GRCh38:
      chromosome: '11'
      position: 46739505
  trait_info:
    ontology:
    - EFO_0000319
    reported_trait_name: Other disorders of circulatory system
    standard_trait_name: cardiovascular system disease
- association_info:
    ancestry:
    - European=404449
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 12.882728704344236
    otg_id: SAIGE_459
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Thrombin inhibitor drug BIVALIRUDIN is Phase III for the indiciation
        EFO_0000319 and targets the gene ENSG00000180210 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000180210
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 46761055
    locus_GRCh38:
      chromosome: '11'
      position: 46739505
  trait_info:
    ontology:
    - EFO_0000319
    reported_trait_name: Other disorders of circulatory system
    standard_trait_name: cardiovascular system disease
- association_info:
    ancestry:
    - European=258962
    gwas_catalog_id: GCST003390
    neg_log_pval: 24.0
    otg_id: GCST003390
    pubmed_id: '26908601'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Thrombin inhibitor drug ARGATROBAN is Phase III for the indiciation
        HP_0002140 and targets the gene ENSG00000180210 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000180210
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 46761055
    locus_GRCh38:
      chromosome: '11'
      position: 46739505
  trait_info:
    ontology:
    - HP_0002140
    reported_trait_name: Thrombosis
    standard_trait_name: Ischemic stroke
- association_info:
    ancestry:
    - European=360527
    neg_log_pval: 19.56919957537582
    otg_id: NEALE2_6152_5
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Thrombin inhibitor drug DESIRUDIN is Phase IV for the indiciation
        EFO_0003907 and targets the gene ENSG00000180210 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000180210
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 46761055
    locus_GRCh38:
      chromosome: '11'
      position: 46739505
  trait_info:
    ontology:
    - EFO_0003907
    reported_trait_name: Blood clot in the leg (dvt) | blood clot, dvt, bronchitis,
      emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor
    standard_trait_name: deep vein thrombosis
- association_info:
    ancestry:
    - European=60139
    gwas_catalog_id: GCST002808
    neg_log_pval: 8.698970004336019
    otg_id: GCST002808
    pubmed_id: '25772935'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Thrombin inhibitor drug DABIGATRAN is Phase IV for the indiciation
        EFO_0004286 and targets the gene ENSG00000180210 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000180210
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 46761055
    locus_GRCh38:
      chromosome: '11'
      position: 46739505
  trait_info:
    ontology:
    - EFO_0004286
    reported_trait_name: Venous thromboembolism
    standard_trait_name: venous thromboembolism
- association_info:
    ancestry:
    - European=258962
    gwas_catalog_id: GCST003390
    neg_log_pval: 24.0
    otg_id: GCST003390
    pubmed_id: '26908601'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Thrombin inhibitor drug DABIGATRAN is Phase IV for the indiciation
        EFO_0004286 and targets the gene ENSG00000180210 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000180210
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 46761055
    locus_GRCh38:
      chromosome: '11'
      position: 46739505
  trait_info:
    ontology:
    - EFO_0004286
    reported_trait_name: Thrombosis
    standard_trait_name: venous thromboembolism
- association_info:
    ancestry:
    - European=120158
    gwas_catalog_id: GCST004256
    neg_log_pval: 12.301029995663981
    otg_id: GCST004256
    pubmed_id: '28373160'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Thrombin inhibitor drug DABIGATRAN ETEXILATE is Phase III for the
        indiciation EFO_0004286 and targets the gene ENSG00000180210 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000180210
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 46761055
    locus_GRCh38:
      chromosome: '11'
      position: 46739505
  trait_info:
    ontology:
    - EFO_0004286
    reported_trait_name: Venous thromboembolism
    standard_trait_name: venous thromboembolism
- association_info:
    ancestry:
    - European=258962
    gwas_catalog_id: GCST003390
    neg_log_pval: 24.0
    otg_id: GCST003390
    pubmed_id: '26908601'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Thrombin inhibitor drug DESIRUDIN is Phase IV for the indiciation
        EFO_0003907 and targets the gene ENSG00000180210 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000180210
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 46761055
    locus_GRCh38:
      chromosome: '11'
      position: 46739505
  trait_info:
    ontology:
    - EFO_0003907
    reported_trait_name: Thrombosis
    standard_trait_name: deep vein thrombosis
- association_info:
    ancestry:
    - European=404271
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 12.829738284605043
    otg_id: SAIGE_459_9
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Thrombin inhibitor drug BIVALIRUDIN is Phase III for the indiciation
        EFO_0000319 and targets the gene ENSG00000180210 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000180210
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 46761055
    locus_GRCh38:
      chromosome: '11'
      position: 46739505
  trait_info:
    ontology:
    - EFO_0000319
    reported_trait_name: Circulatory disease nec
    standard_trait_name: cardiovascular system disease
- association_info:
    ancestry:
    - European=60139
    gwas_catalog_id: GCST002808
    neg_log_pval: 8.698970004336019
    otg_id: GCST002808
    pubmed_id: '25772935'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Thrombin inhibitor drug DABIGATRAN ETEXILATE is Phase III for the
        indiciation EFO_0004286 and targets the gene ENSG00000180210 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000180210
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 46761055
    locus_GRCh38:
      chromosome: '11'
      position: 46739505
  trait_info:
    ontology:
    - EFO_0004286
    reported_trait_name: Venous thromboembolism
    standard_trait_name: venous thromboembolism
- association_info:
    ancestry:
    - European=258962
    gwas_catalog_id: GCST003390
    neg_log_pval: 24.0
    otg_id: GCST003390
    pubmed_id: '26908601'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Thrombin inhibitor drug DABIGATRAN ETEXILATE is Phase IV for the
        indiciation EFO_0003827 and targets the gene ENSG00000180210 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000180210
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 46761055
    locus_GRCh38:
      chromosome: '11'
      position: 46739505
  trait_info:
    ontology:
    - EFO_0003827
    reported_trait_name: Thrombosis
    standard_trait_name: pulmonary embolism
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 20.081541349622885
    otg_id: NEALE2_20002_1094
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Thrombin inhibitor drug DESIRUDIN is Phase IV for the indiciation
        EFO_0003907 and targets the gene ENSG00000180210 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000180210
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 46761055
    locus_GRCh38:
      chromosome: '11'
      position: 46739505
  trait_info:
    ontology:
    - EFO_0003907
    reported_trait_name: Deep venous thrombosis (dvt) | non-cancer illness code, self-reported
    standard_trait_name: deep vein thrombosis
- association_info:
    ancestry:
    - European=360527
    neg_log_pval: 12.362510270487489
    otg_id: NEALE2_6152_7
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Thrombin inhibitor drug DABIGATRAN ETEXILATE is Phase IV for the
        indiciation EFO_0003827 and targets the gene ENSG00000180210 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000180210
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 46761055
    locus_GRCh38:
      chromosome: '11'
      position: 46739505
  trait_info:
    ontology:
    - EFO_0003827
    reported_trait_name: Blood clot in the lung | blood clot, dvt, bronchitis, emphysema,
      asthma, rhinitis, eczema, allergy diagnosed by doctor
    standard_trait_name: pulmonary embolism
- association_info:
    ancestry:
    - European=258962
    gwas_catalog_id: GCST003390
    neg_log_pval: 24.0
    otg_id: GCST003390
    pubmed_id: '26908601'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Thrombin inhibitor drug DABIGATRAN ETEXILATE is Phase III for the
        indiciation EFO_0004286 and targets the gene ENSG00000180210 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000180210
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 46761055
    locus_GRCh38:
      chromosome: '11'
      position: 46739505
  trait_info:
    ontology:
    - EFO_0004286
    reported_trait_name: Thrombosis
    standard_trait_name: venous thromboembolism
- association_info:
    ancestry:
    - European=360527
    neg_log_pval: 8.413929430513312
    otg_id: NEALE2_6152_9
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: G protein-coupled receptor 44 antagonist drug SETIPIPRANT is Phase
        III for the indiciation EFO_0003956 and targets the gene ENSG00000183134 at
        this locus (170226bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000183134
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 60793648
    locus_GRCh38:
      chromosome: '11'
      position: 61026176
  trait_info:
    ontology:
    - EFO_0003956
    reported_trait_name: Hayfever, allergic rhinitis or eczema | blood clot, dvt,
      bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor
    standard_trait_name: seasonal allergic rhinitis
- association_info:
    ancestry:
    - European=360527
    neg_log_pval: 8.413929430513312
    otg_id: NEALE2_6152_9
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: G protein-coupled receptor 44 antagonist drug QAV680 is Phase II
        for the indiciation EFO_0003956 and targets the gene ENSG00000183134 at this
        locus (170226bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000183134
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 60793648
    locus_GRCh38:
      chromosome: '11'
      position: 61026176
  trait_info:
    ontology:
    - EFO_0003956
    reported_trait_name: Hayfever, allergic rhinitis or eczema | blood clot, dvt,
      bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor
    standard_trait_name: seasonal allergic rhinitis
- association_info:
    ancestry:
    - European=1951
    gwas_catalog_id: GCST001737
    neg_log_pval: 26.0
    otg_id: GCST001737_2
    pubmed_id: '23144326'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Muscarinic acetylcholine receptor M1 antagonist drug GLYCOPYRRONIUM
        is Phase IV for the indiciation EFO_0000341 and targets the gene ENSG00000168539
        at this locus (489610bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000168539
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 62186542
    locus_GRCh38:
      chromosome: '11'
      position: 62419070
  trait_info:
    ontology:
    - EFO_0000341
    reported_trait_name: Chronic obstructive pulmonary disease-related biomarkers
      [CC16]
    standard_trait_name: chronic obstructive pulmonary disease
- association_info:
    ancestry:
    - European=1951
    gwas_catalog_id: GCST001737
    neg_log_pval: 26.0
    otg_id: GCST001737_2
    pubmed_id: '23144326'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Muscarinic acetylcholine receptor M1 antagonist drug ASM-024 is
        Phase II for the indiciation EFO_0000341 and targets the gene ENSG00000168539
        at this locus (489610bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000168539
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 62186542
    locus_GRCh38:
      chromosome: '11'
      position: 62419070
  trait_info:
    ontology:
    - EFO_0000341
    reported_trait_name: Chronic obstructive pulmonary disease-related biomarkers
      [CC16]
    standard_trait_name: chronic obstructive pulmonary disease
- association_info:
    ancestry:
    - European=1951
    gwas_catalog_id: GCST001737
    neg_log_pval: 13.698970004336019
    otg_id: GCST001737_2
    pubmed_id: '23144326'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Muscarinic acetylcholine receptor M1 antagonist drug ASM-024 is
        Phase II for the indiciation EFO_0000341 and targets the gene ENSG00000168539
        at this locus (478724bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000168539
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 62197427
    locus_GRCh38:
      chromosome: '11'
      position: 62429955
  trait_info:
    ontology:
    - EFO_0000341
    reported_trait_name: Chronic obstructive pulmonary disease-related biomarkers
      [CC16]
    standard_trait_name: chronic obstructive pulmonary disease
- association_info:
    ancestry:
    - European=1951
    gwas_catalog_id: GCST001737
    neg_log_pval: 13.698970004336019
    otg_id: GCST001737_2
    pubmed_id: '23144326'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Muscarinic acetylcholine receptor M1 antagonist drug GLYCOPYRRONIUM
        is Phase IV for the indiciation EFO_0000341 and targets the gene ENSG00000168539
        at this locus (478724bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000168539
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 62197427
    locus_GRCh38:
      chromosome: '11'
      position: 62429955
  trait_info:
    ontology:
    - EFO_0000341
    reported_trait_name: Chronic obstructive pulmonary disease-related biomarkers
      [CC16]
    standard_trait_name: chronic obstructive pulmonary disease
- association_info:
    ancestry:
    - European=1951
    gwas_catalog_id: GCST001737
    neg_log_pval: 9.0
    otg_id: GCST001737_2
    pubmed_id: '23144326'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Muscarinic acetylcholine receptor M1 antagonist drug ASM-024 is
        Phase II for the indiciation EFO_0000341 and targets the gene ENSG00000168539
        at this locus (476334bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000168539
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '11'
      position: 62199817
    locus_GRCh38:
      chromosome: '11'
      position: 62432345
  trait_info:
    ontology:
    - EFO_0000341
    reported_trait_name: Chronic obstructive pulmonary disease-related biomarkers
      [CC16]
    standard_trait_name: chronic obstructive pulmonary disease
- association_info:
    ancestry:
    - European=1951
    gwas_catalog_id: GCST001737
    neg_log_pval: 9.0
    otg_id: GCST001737_2
    pubmed_id: '23144326'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Muscarinic acetylcholine receptor M1 antagonist drug GLYCOPYRRONIUM
        is Phase IV for the indiciation EFO_0000341 and targets the gene ENSG00000168539
        at this locus (476334bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000168539
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '11'
      position: 62199817
    locus_GRCh38:
      chromosome: '11'
      position: 62432345
  trait_info:
    ontology:
    - EFO_0000341
    reported_trait_name: Chronic obstructive pulmonary disease-related biomarkers
      [CC16]
    standard_trait_name: chronic obstructive pulmonary disease
- association_info:
    ancestry:
    - European=408393
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 7.543633966870957
    otg_id: SAIGE_274_1
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Solute carrier family 22 member 12 inhibitor drug ARHALOFENATE
        is Phase II for the indiciation EFO_0004274 and targets the gene ENSG00000197891
        at this locus (23999bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000197891
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 64334114
    locus_GRCh38:
      chromosome: '11'
      position: 64566642
  trait_info:
    ontology:
    - EFO_0004274
    reported_trait_name: Gout
    standard_trait_name: gout
- association_info:
    ancestry:
    - European=408393
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 7.543633966870957
    otg_id: SAIGE_274_1
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Solute carrier family 22 member 12 inhibitor drug LESINURAD is
        Phase IV for the indiciation EFO_0004274 and targets the gene ENSG00000197891
        at this locus (23999bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000197891
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 64334114
    locus_GRCh38:
      chromosome: '11'
      position: 64566642
  trait_info:
    ontology:
    - EFO_0004274
    reported_trait_name: Gout
    standard_trait_name: gout
- association_info:
    ancestry:
    - European=408393
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 7.543633966870957
    otg_id: SAIGE_274_1
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Solute carrier family 22 member 11 inhibitor drug PROBENECID is
        Phase IV for the indiciation EFO_0004274 and targets the gene ENSG00000168065
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000168065
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 64334114
    locus_GRCh38:
      chromosome: '11'
      position: 64566642
  trait_info:
    ontology:
    - EFO_0004274
    reported_trait_name: Gout
    standard_trait_name: gout
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 15.066630665946775
    otg_id: NEALE2_20002_1466
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Solute carrier family 22 member 11 inhibitor drug PROBENECID is
        Phase IV for the indiciation EFO_0004274 and targets the gene ENSG00000168065
        at this locus (9456bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000168065
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 64349802
    locus_GRCh38:
      chromosome: '11'
      position: 64582330
  trait_info:
    ontology:
    - EFO_0004274
    reported_trait_name: Gout | non-cancer illness code, self-reported
    standard_trait_name: gout
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 15.066630665946775
    otg_id: NEALE2_20002_1466
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Solute carrier family 22 member 12 inhibitor drug ARHALOFENATE
        is Phase II for the indiciation EFO_0004274 and targets the gene ENSG00000197891
        at this locus (8311bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000197891
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 64349802
    locus_GRCh38:
      chromosome: '11'
      position: 64582330
  trait_info:
    ontology:
    - EFO_0004274
    reported_trait_name: Gout | non-cancer illness code, self-reported
    standard_trait_name: gout
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 15.066630665946775
    otg_id: NEALE2_20002_1466
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Solute carrier family 22 member 12 inhibitor drug SULFINPYRAZONE
        is Phase IV for the indiciation EFO_0004274 and targets the gene ENSG00000197891
        at this locus (8311bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000197891
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 64349802
    locus_GRCh38:
      chromosome: '11'
      position: 64582330
  trait_info:
    ontology:
    - EFO_0004274
    reported_trait_name: Gout | non-cancer illness code, self-reported
    standard_trait_name: gout
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 23.07433525192862
    otg_id: NEALE2_20002_1466
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Solute carrier family 22 member 12 inhibitor drug LESINURAD is
        Phase IV for the indiciation EFO_0004274 and targets the gene ENSG00000197891
        at this locus (6050bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000197891
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '11'
      position: 64352063
    locus_GRCh38:
      chromosome: '11'
      position: 64584591
  trait_info:
    ontology:
    - EFO_0004274
    reported_trait_name: Gout | non-cancer illness code, self-reported
    standard_trait_name: gout
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 23.07433525192862
    otg_id: NEALE2_20002_1466
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Solute carrier family 22 member 12 inhibitor drug ARHALOFENATE
        is Phase II for the indiciation EFO_0004274 and targets the gene ENSG00000197891
        at this locus (6050bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000197891
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '11'
      position: 64352063
    locus_GRCh38:
      chromosome: '11'
      position: 64584591
  trait_info:
    ontology:
    - EFO_0004274
    reported_trait_name: Gout | non-cancer illness code, self-reported
    standard_trait_name: gout
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 23.07433525192862
    otg_id: NEALE2_20002_1466
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Solute carrier family 22 member 11 inhibitor drug PROBENECID is
        Phase IV for the indiciation EFO_0004274 and targets the gene ENSG00000168065
        at this locus (11717bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000168065
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '11'
      position: 64352063
    locus_GRCh38:
      chromosome: '11'
      position: 64584591
  trait_info:
    ontology:
    - EFO_0004274
    reported_trait_name: Gout | non-cancer illness code, self-reported
    standard_trait_name: gout
- association_info:
    ancestry:
    - East Asian=2158
    gwas_catalog_id: GCST003925
    neg_log_pval: 10.301029995663981
    otg_id: GCST003925_2
    pubmed_id: '27899376'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Solute carrier family 22 member 11 inhibitor drug PROBENECID is
        Phase IV for the indiciation EFO_0004274 and targets the gene ENSG00000168065
        at this locus (95559bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000168065
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 64435906
    locus_GRCh38:
      chromosome: '11'
      position: 64668434
  trait_info:
    ontology:
    - EFO_0004274
    reported_trait_name: Gout [Japanese]
    standard_trait_name: gout
- association_info:
    ancestry:
    - East Asian=1832
    gwas_catalog_id: GCST003926
    neg_log_pval: 9.045757490560675
    otg_id: GCST003926
    pubmed_id: '27899376'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Solute carrier family 22 member 12 inhibitor drug ARHALOFENATE
        is Phase II for the indiciation EFO_0004274 and targets the gene ENSG00000197891
        at this locus (66081bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000197891
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 64435906
    locus_GRCh38:
      chromosome: '11'
      position: 64668434
  trait_info:
    ontology:
    - EFO_0004274
    reported_trait_name: Renal underexcretion gout
    standard_trait_name: gout
- association_info:
    ancestry:
    - East Asian=1832
    gwas_catalog_id: GCST003926
    neg_log_pval: 9.045757490560675
    otg_id: GCST003926
    pubmed_id: '27899376'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Solute carrier family 22 member 11 inhibitor drug PROBENECID is
        Phase IV for the indiciation EFO_0004274 and targets the gene ENSG00000168065
        at this locus (95559bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000168065
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 64435906
    locus_GRCh38:
      chromosome: '11'
      position: 64668434
  trait_info:
    ontology:
    - EFO_0004274
    reported_trait_name: Renal underexcretion gout
    standard_trait_name: gout
- association_info:
    ancestry:
    - East Asian=2158
    gwas_catalog_id: GCST003925
    neg_log_pval: 10.301029995663981
    otg_id: GCST003925_2
    pubmed_id: '27899376'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Solute carrier family 22 member 12 inhibitor drug ARHALOFENATE
        is Phase II for the indiciation EFO_0004274 and targets the gene ENSG00000197891
        at this locus (66081bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000197891
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 64435906
    locus_GRCh38:
      chromosome: '11'
      position: 64668434
  trait_info:
    ontology:
    - EFO_0004274
    reported_trait_name: Gout [Japanese]
    standard_trait_name: gout
- association_info:
    ancestry:
    - East Asian=1832
    gwas_catalog_id: GCST003926
    neg_log_pval: 9.045757490560675
    otg_id: GCST003926
    pubmed_id: '27899376'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Solute carrier family 22 member 12 inhibitor drug BENZBROMARONE
        is Phase IV for the indiciation EFO_0004274 and targets the gene ENSG00000197891
        at this locus (66081bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000197891
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 64435906
    locus_GRCh38:
      chromosome: '11'
      position: 64668434
  trait_info:
    ontology:
    - EFO_0004274
    reported_trait_name: Renal underexcretion gout
    standard_trait_name: gout
- association_info:
    ancestry:
    - East Asian=2158
    gwas_catalog_id: GCST003925
    neg_log_pval: 10.301029995663981
    otg_id: GCST003925_2
    pubmed_id: '27899376'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Solute carrier family 22 member 12 inhibitor drug BENZBROMARONE
        is Phase IV for the indiciation EFO_0004274 and targets the gene ENSG00000197891
        at this locus (66081bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000197891
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 64435906
    locus_GRCh38:
      chromosome: '11'
      position: 64668434
  trait_info:
    ontology:
    - EFO_0004274
    reported_trait_name: Gout [Japanese]
    standard_trait_name: gout
- association_info:
    ancestry:
    - European=688809
    gwas_catalog_id: GCST006477
    neg_log_pval: 9.0
    otg_id: GCST006477
    pubmed_id: '29942085'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Metabotropic glutamate receptor 5 modulator drug BASIMGLURANT is
        Phase II for the indiciation EFO_0003761 and targets the gene ENSG00000168959
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000168959
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '11'
      position: 88695846
    locus_GRCh38:
      chromosome: '11'
      position: 88962678
  trait_info:
    ontology:
    - EFO_0003761
    reported_trait_name: Depression
    standard_trait_name: unipolar depression
- association_info:
    ancestry:
    - NR=361315
    - European=446238
    gwas_catalog_id: GCST007342
    neg_log_pval: 24.522878745280337
    otg_id: GCST007342
    pubmed_id: '30718901'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Metabotropic glutamate receptor 5 modulator drug BASIMGLURANT is
        Phase II for the indiciation EFO_0003761 and targets the gene ENSG00000168959
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000168959
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '11'
      position: 88744425
    locus_GRCh38:
      chromosome: '11'
      position: 89011257
  trait_info:
    ontology:
    - EFO_0003761
    reported_trait_name: Depression
    standard_trait_name: unipolar depression
- association_info:
    ancestry:
    - European=322580
    gwas_catalog_id: GCST005902
    neg_log_pval: 10.171997842193115
    otg_id: GCST005902
    pubmed_id: '29662059'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Metabotropic glutamate receptor 5 modulator drug BASIMGLURANT is
        Phase II for the indiciation EFO_0003761 and targets the gene ENSG00000168959
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000168959
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '11'
      position: 88748162
    locus_GRCh38:
      chromosome: '11'
      position: 89014994
  trait_info:
    ontology:
    - EFO_0003761
    reported_trait_name: Depression (broad)
    standard_trait_name: unipolar depression
- association_info:
    ancestry:
    - East Asian=50792
    gwas_catalog_id: GCST007707
    neg_log_pval: 12.0
    otg_id: GCST007707
    pubmed_id: '30487518'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Progesterone receptor agonist drug DROSPIRENONE is Phase III for
        the indiciation EFO_0000537 and targets the gene ENSG00000082175 at this locus
        (318127bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000082175
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 100582228
    locus_GRCh38:
      chromosome: '11'
      position: 100711497
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Hypertension [East Asian]
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - East Asian=50792
    gwas_catalog_id: GCST007707
    neg_log_pval: 9.301029995663981
    otg_id: GCST007707_2
    pubmed_id: '30487518'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Progesterone receptor agonist drug DROSPIRENONE is Phase III for
        the indiciation EFO_0000537 and targets the gene ENSG00000082175 at this locus
        (306817bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000082175
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 100593538
    locus_GRCh38:
      chromosome: '11'
      position: 100722807
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Hypertension [Japanese]
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - European, NR=58918
    - European=458554
    gwas_catalog_id: GCST007611
    neg_log_pval: 46.69897000433602
    otg_id: GCST007611
    pubmed_id: '30940143'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Progesterone receptor agonist drug MEGESTROL ACETATE is Phase II
        for the indiciation EFO_0000341 and targets the gene ENSG00000082175 at this
        locus (306817bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000082175
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 100593538
    locus_GRCh38:
      chromosome: '11'
      position: 100722807
  trait_info:
    ontology:
    - EFO_0000341
    reported_trait_name: Chronic obstructive pulmonary disease or high blood pressure
      (pleiotropy)
    standard_trait_name: chronic obstructive pulmonary disease
- association_info:
    ancestry:
    - European=69395
    gwas_catalog_id: GCST001238
    neg_log_pval: 10.301029995663981
    otg_id: GCST001238
    pubmed_id: '21909115'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Progesterone receptor agonist drug DROSPIRENONE is Phase III for
        the indiciation EFO_0000537 and targets the gene ENSG00000082175 at this locus
        (306817bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000082175
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 100593538
    locus_GRCh38:
      chromosome: '11'
      position: 100722807
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Hypertension
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - European, NR=58918
    - European=458554
    gwas_catalog_id: GCST007611
    neg_log_pval: 46.69897000433602
    otg_id: GCST007611
    pubmed_id: '30940143'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Progesterone receptor agonist drug DROSPIRENONE is Phase III for
        the indiciation EFO_0000537 and targets the gene ENSG00000082175 at this locus
        (306817bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000082175
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 100593538
    locus_GRCh38:
      chromosome: '11'
      position: 100722807
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Chronic obstructive pulmonary disease or high blood pressure
      (pleiotropy)
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - European=408458
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 8.14206473528057
    otg_id: SAIGE_411
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Progesterone receptor agonist drug PROGESTERONE is Phase II for
        the indiciation EFO_0000378 and targets the gene ENSG00000082175 at this locus
        (306817bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000082175
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 100593538
    locus_GRCh38:
      chromosome: '11'
      position: 100722807
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Ischemic heart disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - European=459000
    gwas_catalog_id: GCST007072
    neg_log_pval: 39.096910013008056
    otg_id: GCST007072
    pubmed_id: '30595370'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Progesterone receptor agonist drug DROSPIRENONE is Phase IV for
        the indiciation EFO_0000319 and targets the gene ENSG00000082175 at this locus
        (289809bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000082175
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '11'
      position: 100610546
    locus_GRCh38:
      chromosome: '11'
      position: 100739815
  trait_info:
    ontology:
    - EFO_0000319
    reported_trait_name: Cardiovascular disease
    standard_trait_name: cardiovascular system disease
- association_info:
    ancestry:
    - NR=547261
    gwas_catalog_id: GCST005195
    neg_log_pval: 9.55284196865778
    otg_id: GCST005195
    pubmed_id: '29212778'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Progesterone receptor agonist drug PROGESTERONE is Phase II for
        the indiciation EFO_0000378 and targets the gene ENSG00000082175 at this locus
        (289809bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000082175
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '11'
      position: 100610546
    locus_GRCh38:
      chromosome: '11'
      position: 100739815
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - European=408089
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 20.34008379993015
    otg_id: SAIGE_401_1
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Progesterone receptor agonist drug DROSPIRENONE is Phase III for
        the indiciation EFO_0000537 and targets the gene ENSG00000082175 at this locus
        (289809bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000082175
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '11'
      position: 100610546
    locus_GRCh38:
      chromosome: '11'
      position: 100739815
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Essential hypertension
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - European=408343
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 20.27490547891853
    otg_id: SAIGE_401
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Progesterone receptor agonist drug DROSPIRENONE is Phase III for
        the indiciation EFO_0000537 and targets the gene ENSG00000082175 at this locus
        (289809bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000082175
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '11'
      position: 100610546
    locus_GRCh38:
      chromosome: '11'
      position: 100739815
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Hypertension
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 38.813874644838485
    otg_id: NEALE2_20002_1065
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Progesterone receptor agonist drug DROSPIRENONE is Phase III for
        the indiciation EFO_0000537 and targets the gene ENSG00000082175 at this locus
        (289809bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000082175
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '11'
      position: 100610546
    locus_GRCh38:
      chromosome: '11'
      position: 100739815
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Hypertension | non-cancer illness code, self-reported
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - NR=250736
    gwas_catalog_id: GCST005196
    neg_log_pval: 8.522878745280337
    otg_id: GCST005196
    pubmed_id: '29212778'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Progesterone receptor agonist drug PROGESTERONE is Phase II for
        the indiciation EFO_0000378 and targets the gene ENSG00000082175 at this locus
        (275756bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000082175
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '11'
      position: 100624599
    locus_GRCh38:
      chromosome: '11'
      position: 100753868
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - NR=296525
    gwas_catalog_id: GCST005194
    neg_log_pval: 10.168322150808534
    otg_id: GCST005194
    pubmed_id: '29212778'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Progesterone receptor agonist drug PROGESTERONE is Phase II for
        the indiciation EFO_0000378 and targets the gene ENSG00000082175 at this locus
        (268448bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000082175
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 100631908
    locus_GRCh38:
      chromosome: '11'
      position: 100761177
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - NR=574
    gwas_catalog_id: GCST002665
    neg_log_pval: 43.69897000433602
    otg_id: GCST002665_5
    pubmed_id: '25340798'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Matrix metalloproteinase 13 inhibitor drug DOXYCYCLINE is Phase
        III for the indiciation EFO_0000249 and targets the gene ENSG00000137745 at
        this locus (96747bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000137745
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '11'
      position: 102716980
    locus_GRCh38:
      chromosome: '11'
      position: 102846249
  trait_info:
    ontology:
    - EFO_0000249
    reported_trait_name: Cerebrospinal fluid levels of Alzheimer's disease-related
      proteins [Matrix metalloproteinase-3]
    standard_trait_name: Alzheimer's disease
- association_info:
    ancestry:
    - NR=574
    gwas_catalog_id: GCST002665
    neg_log_pval: 43.69897000433602
    otg_id: GCST002665_5
    pubmed_id: '25340798'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Matrix metalloproteinase 8 inhibitor drug DOXYCYCLINE is Phase
        III for the indiciation EFO_0000249 and targets the gene ENSG00000118113 at
        this locus (119199bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000118113
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '11'
      position: 102716980
    locus_GRCh38:
      chromosome: '11'
      position: 102846249
  trait_info:
    ontology:
    - EFO_0000249
    reported_trait_name: Cerebrospinal fluid levels of Alzheimer's disease-related
      proteins [Matrix metalloproteinase-3]
    standard_trait_name: Alzheimer's disease
- association_info:
    ancestry:
    - NR=574
    gwas_catalog_id: GCST002665
    neg_log_pval: 43.69897000433602
    otg_id: GCST002665_5
    pubmed_id: '25340798'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Matrix metalloproteinase-1 inhibitor drug DOXYCYCLINE is Phase
        III for the indiciation EFO_0000249 and targets the gene ENSG00000196611 at
        this locus (48090bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000196611
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '11'
      position: 102716980
    locus_GRCh38:
      chromosome: '11'
      position: 102846249
  trait_info:
    ontology:
    - EFO_0000249
    reported_trait_name: Cerebrospinal fluid levels of Alzheimer's disease-related
      proteins [Matrix metalloproteinase-3]
    standard_trait_name: Alzheimer's disease
- association_info:
    ancestry:
    - NR=574
    gwas_catalog_id: GCST002665
    neg_log_pval: 43.69897000433602
    otg_id: GCST002665_5
    pubmed_id: '25340798'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Matrix metalloproteinase 7 inhibitor drug DOXYCYCLINE is Phase
        III for the indiciation EFO_0000249 and targets the gene ENSG00000137673 at
        this locus (315500bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000137673
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '11'
      position: 102716980
    locus_GRCh38:
      chromosome: '11'
      position: 102846249
  trait_info:
    ontology:
    - EFO_0000249
    reported_trait_name: Cerebrospinal fluid levels of Alzheimer's disease-related
      proteins [Matrix metalloproteinase-3]
    standard_trait_name: Alzheimer's disease
- association_info:
    ancestry:
    - European=7100
    - African American or Afro-Caribbean=2570
    gwas_catalog_id: GCST002350
    neg_log_pval: 8.522878745280337
    otg_id: GCST002350
    pubmed_id: '24621683'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Matrix metalloproteinase 7 inhibitor drug DOXYCYCLINE is Phase
        IV for the indiciation EFO_0000341 and targets the gene ENSG00000137673 at
        this locus (319465bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000137673
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 102720945
    locus_GRCh38:
      chromosome: '11'
      position: 102850214
  trait_info:
    ontology:
    - EFO_0000341
    reported_trait_name: Chronic obstructive pulmonary disease (severe)
    standard_trait_name: chronic obstructive pulmonary disease
- association_info:
    ancestry:
    - European=7100
    - African American or Afro-Caribbean=2570
    gwas_catalog_id: GCST002350
    neg_log_pval: 8.522878745280337
    otg_id: GCST002350
    pubmed_id: '24621683'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Matrix metalloproteinase-1 inhibitor drug DOXYCYCLINE is Phase
        IV for the indiciation EFO_0000341 and targets the gene ENSG00000196611 at
        this locus (52055bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000196611
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 102720945
    locus_GRCh38:
      chromosome: '11'
      position: 102850214
  trait_info:
    ontology:
    - EFO_0000341
    reported_trait_name: Chronic obstructive pulmonary disease (severe)
    standard_trait_name: chronic obstructive pulmonary disease
- association_info:
    ancestry:
    - European=7100
    - African American or Afro-Caribbean=2570
    gwas_catalog_id: GCST002350
    neg_log_pval: 8.522878745280337
    otg_id: GCST002350
    pubmed_id: '24621683'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Matrix metalloproteinase 13 inhibitor drug DOXYCYCLINE is Phase
        IV for the indiciation EFO_0000341 and targets the gene ENSG00000137745 at
        this locus (92782bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000137745
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 102720945
    locus_GRCh38:
      chromosome: '11'
      position: 102850214
  trait_info:
    ontology:
    - EFO_0000341
    reported_trait_name: Chronic obstructive pulmonary disease (severe)
    standard_trait_name: chronic obstructive pulmonary disease
- association_info:
    ancestry:
    - European=7100
    - African American or Afro-Caribbean=2570
    gwas_catalog_id: GCST002350
    neg_log_pval: 8.522878745280337
    otg_id: GCST002350
    pubmed_id: '24621683'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Matrix metalloproteinase 8 inhibitor drug DOXYCYCLINE is Phase
        IV for the indiciation EFO_0000341 and targets the gene ENSG00000118113 at
        this locus (123164bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000118113
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 102720945
    locus_GRCh38:
      chromosome: '11'
      position: 102850214
  trait_info:
    ontology:
    - EFO_0000341
    reported_trait_name: Chronic obstructive pulmonary disease (severe)
    standard_trait_name: chronic obstructive pulmonary disease
- association_info:
    ancestry:
    - European=459000
    gwas_catalog_id: GCST007072
    neg_log_pval: 7.522878745280337
    otg_id: GCST007072
    pubmed_id: '30595370'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Matrix metalloproteinase-1 inhibitor drug DOXYCYCLINE is Phase
        IV for the indiciation EFO_0000319 and targets the gene ENSG00000196611 at
        this locus (284087bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000196611
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '11'
      position: 102952976
    locus_GRCh38:
      chromosome: '11'
      position: 103082247
  trait_info:
    ontology:
    - EFO_0000319
    reported_trait_name: Cardiovascular disease
    standard_trait_name: cardiovascular system disease
- association_info:
    ancestry:
    - European=459000
    gwas_catalog_id: GCST007072
    neg_log_pval: 7.522878745280337
    otg_id: GCST007072
    pubmed_id: '30595370'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Matrix metalloproteinase 8 inhibitor drug DOXYCYCLINE is Phase
        IV for the indiciation EFO_0000319 and targets the gene ENSG00000118113 at
        this locus (355197bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000118113
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '11'
      position: 102952976
    locus_GRCh38:
      chromosome: '11'
      position: 103082247
  trait_info:
    ontology:
    - EFO_0000319
    reported_trait_name: Cardiovascular disease
    standard_trait_name: cardiovascular system disease
- association_info:
    ancestry:
    - European=459000
    gwas_catalog_id: GCST007072
    neg_log_pval: 7.522878745280337
    otg_id: GCST007072
    pubmed_id: '30595370'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Matrix metalloproteinase 13 inhibitor drug DOXYCYCLINE is Phase
        IV for the indiciation EFO_0000319 and targets the gene ENSG00000137745 at
        this locus (126515bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000137745
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '11'
      position: 102952976
    locus_GRCh38:
      chromosome: '11'
      position: 103082247
  trait_info:
    ontology:
    - EFO_0000319
    reported_trait_name: Cardiovascular disease
    standard_trait_name: cardiovascular system disease
- association_info:
    ancestry:
    - European=348219
    gwas_catalog_id: GCST006478
    neg_log_pval: 9.0
    otg_id: GCST006478
    pubmed_id: '29942085'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dopamine D2 receptor antagonist drug PALIPERIDONE is Phase III
        for the indiciation EFO_0005230 and targets the gene ENSG00000149295 at this
        locus (452613bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000149295
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '11'
      position: 112827715
    locus_GRCh38:
      chromosome: '11'
      position: 112956992
  trait_info:
    ontology:
    - EFO_0005230
    reported_trait_name: Worry
    standard_trait_name: anxiety
- association_info:
    ancestry:
    - European=348219
    gwas_catalog_id: GCST006478
    neg_log_pval: 9.0
    otg_id: GCST006478
    pubmed_id: '29942085'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dopamine D2 receptor antagonist drug QUETIAPINE is Phase IV for
        the indiciation EFO_0005230 and targets the gene ENSG00000149295 at this locus
        (452613bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000149295
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '11'
      position: 112827715
    locus_GRCh38:
      chromosome: '11'
      position: 112956992
  trait_info:
    ontology:
    - EFO_0005230
    reported_trait_name: Worry
    standard_trait_name: anxiety
- association_info:
    ancestry:
    - European=357957
    gwas_catalog_id: GCST006475
    neg_log_pval: 8.487182241435127
    otg_id: GCST006475
    pubmed_id: '29942085'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dopamine D2 receptor antagonist drug CLOZAPINE is Phase III for
        the indiciation EFO_0003761 and targets the gene ENSG00000149295 at this locus
        (430609bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000149295
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: HG305_PATCH
      position: 112849719
    locus_GRCh38:
      chromosome: '11'
      position: 112978997
  trait_info:
    ontology:
    - EFO_0003761
    reported_trait_name: Depressed affect
    standard_trait_name: unipolar depression
- association_info:
    ancestry:
    - European=357957
    gwas_catalog_id: GCST006475
    neg_log_pval: 8.487182241435127
    otg_id: GCST006475
    pubmed_id: '29942085'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dopamine D2 receptor antagonist drug ILOPERIDONE is Phase IV for
        the indiciation EFO_0003761 and targets the gene ENSG00000149295 at this locus
        (430609bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000149295
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: HG305_PATCH
      position: 112849719
    locus_GRCh38:
      chromosome: '11'
      position: 112978997
  trait_info:
    ontology:
    - EFO_0003761
    reported_trait_name: Depressed affect
    standard_trait_name: unipolar depression
- association_info:
    ancestry:
    - European=357957
    gwas_catalog_id: GCST006475
    neg_log_pval: 8.487182241435127
    otg_id: GCST006475
    pubmed_id: '29942085'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dopamine D2 receptor antagonist drug QUETIAPINE is Phase III for
        the indiciation EFO_0004247 and targets the gene ENSG00000149295 at this locus
        (430609bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000149295
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: HG305_PATCH
      position: 112849719
    locus_GRCh38:
      chromosome: '11'
      position: 112978997
  trait_info:
    ontology:
    - EFO_0004247
    reported_trait_name: Depressed affect
    standard_trait_name: mood disorder
- association_info:
    ancestry:
    - European=357957
    gwas_catalog_id: GCST006475
    neg_log_pval: 8.487182241435127
    otg_id: GCST006475
    pubmed_id: '29942085'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dopamine D2 receptor antagonist drug ZIPRASIDONE is Phase IV for
        the indiciation EFO_0004247 and targets the gene ENSG00000149295 at this locus
        (430609bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000149295
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: HG305_PATCH
      position: 112849719
    locus_GRCh38:
      chromosome: '11'
      position: 112978997
  trait_info:
    ontology:
    - EFO_0004247
    reported_trait_name: Depressed affect
    standard_trait_name: mood disorder
- association_info:
    ancestry:
    - East Asian=45528
    gwas_catalog_id: GCST007201
    neg_log_pval: 7.698970004336019
    otg_id: GCST007201
    pubmed_id: '30285260'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dopamine D2 receptor antagonist drug SB-773812 is Phase II for
        the indiciation EFO_0000692 and targets the gene ENSG00000149295 at this locus
        (64405bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000149295
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: HG305_PATCH
      position: 113215923
    locus_GRCh38:
      chromosome: '11'
      position: 113345201
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - East Asian=45528
    gwas_catalog_id: GCST007201
    neg_log_pval: 7.698970004336019
    otg_id: GCST007201
    pubmed_id: '30285260'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Dopamine D2 receptor modulator drug CARIPRAZINE is Phase IV for
        the indiciation EFO_0000692 and targets the gene ENSG00000149295 at this locus
        (64405bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000149295
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: HG305_PATCH
      position: 113215923
    locus_GRCh38:
      chromosome: '11'
      position: 113345201
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - East Asian=45528
    gwas_catalog_id: GCST007201
    neg_log_pval: 7.698970004336019
    otg_id: GCST007201
    pubmed_id: '30285260'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Dopamine D2 receptor antagonist drug TRIMIPRAMINE is Phase III
        for the indiciation EFO_0000692 and targets the gene ENSG00000149295 at this
        locus (64405bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000149295
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: HG305_PATCH
      position: 113215923
    locus_GRCh38:
      chromosome: '11'
      position: 113345201
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - European=348219
    gwas_catalog_id: GCST006478
    neg_log_pval: 9.0
    otg_id: GCST006478
    pubmed_id: '29942085'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Dopamine D2 receptor partial agonist drug ARIPIPRAZOLE is Phase
        IV for the indiciation EFO_0005230 and targets the gene ENSG00000149295 at
        this locus (18235bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000149295
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 113364647
    locus_GRCh38:
      chromosome: '11'
      position: 113493925
  trait_info:
    ontology:
    - EFO_0005230
    reported_trait_name: Worry
    standard_trait_name: anxiety
- association_info:
    ancestry:
    - European=348219
    gwas_catalog_id: GCST006478
    neg_log_pval: 9.0
    otg_id: GCST006478
    pubmed_id: '29942085'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Dopamine D2 receptor antagonist drug BROMPERIDOL is Phase III for
        the indiciation EFO_0005230 and targets the gene ENSG00000149295 at this locus
        (18235bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000149295
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 113364647
    locus_GRCh38:
      chromosome: '11'
      position: 113493925
  trait_info:
    ontology:
    - EFO_0005230
    reported_trait_name: Worry
    standard_trait_name: anxiety
- association_info:
    ancestry:
    - NR=361315
    - European=446238
    gwas_catalog_id: GCST007342
    neg_log_pval: 38.39794000867204
    otg_id: GCST007342
    pubmed_id: '30718901'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Serotonin 3a (5-HT3a) receptor antagonist drug VORTIOXETINE is
        Phase IV for the indiciation EFO_0003761 and targets the gene ENSG00000166736
        at this locus (474846bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000166736
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 113370758
    locus_GRCh38:
      chromosome: '11'
      position: 113500036
  trait_info:
    ontology:
    - EFO_0003761
    reported_trait_name: Depression
    standard_trait_name: unipolar depression
- association_info:
    ancestry:
    - NR=361315
    - European=446238
    gwas_catalog_id: GCST007342
    neg_log_pval: 38.39794000867204
    otg_id: GCST007342
    pubmed_id: '30718901'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Dopamine D2 receptor partial agonist drug ARIPIPRAZOLE is Phase
        IV for the indiciation EFO_0003761 and targets the gene ENSG00000149295 at
        this locus (24346bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000149295
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 113370758
    locus_GRCh38:
      chromosome: '11'
      position: 113500036
  trait_info:
    ontology:
    - EFO_0003761
    reported_trait_name: Depression
    standard_trait_name: unipolar depression
- association_info:
    ancestry:
    - NR=361315
    - European=446238
    gwas_catalog_id: GCST007342
    neg_log_pval: 38.39794000867204
    otg_id: GCST007342
    pubmed_id: '30718901'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Dopamine D2 receptor modulator drug CARIPRAZINE is Phase III for
        the indiciation EFO_0003761 and targets the gene ENSG00000149295 at this locus
        (24346bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000149295
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 113370758
    locus_GRCh38:
      chromosome: '11'
      position: 113500036
  trait_info:
    ontology:
    - EFO_0003761
    reported_trait_name: Depression
    standard_trait_name: unipolar depression
- association_info:
    ancestry:
    - European=357957
    gwas_catalog_id: GCST006475
    neg_log_pval: 12.761953896871205
    otg_id: GCST006475
    pubmed_id: '29942085'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Serotonin 3a (5-HT3a) receptor antagonist drug VORTIOXETINE is
        Phase IV for the indiciation EFO_0003761 and targets the gene ENSG00000166736
        at this locus (459256bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000166736
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '11'
      position: 113386347
    locus_GRCh38:
      chromosome: '11'
      position: 113515625
  trait_info:
    ontology:
    - EFO_0003761
    reported_trait_name: Depressed affect
    standard_trait_name: unipolar depression
- association_info:
    ancestry:
    - European=357957
    gwas_catalog_id: GCST006475
    neg_log_pval: 12.761953896871205
    otg_id: GCST006475
    pubmed_id: '29942085'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Dopamine D2 receptor antagonist drug QUETIAPINE is Phase III for
        the indiciation EFO_0004247 and targets the gene ENSG00000149295 at this locus
        (39935bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000149295
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '11'
      position: 113386347
    locus_GRCh38:
      chromosome: '11'
      position: 113515625
  trait_info:
    ontology:
    - EFO_0004247
    reported_trait_name: Depressed affect
    standard_trait_name: mood disorder
- association_info:
    ancestry:
    - European=357957
    gwas_catalog_id: GCST006475
    neg_log_pval: 12.761953896871205
    otg_id: GCST006475
    pubmed_id: '29942085'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Dopamine D2 receptor antagonist drug PERPHENAZINE is Phase III
        for the indiciation EFO_0003761 and targets the gene ENSG00000149295 at this
        locus (39935bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000149295
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '11'
      position: 113386347
    locus_GRCh38:
      chromosome: '11'
      position: 113515625
  trait_info:
    ontology:
    - EFO_0003761
    reported_trait_name: Depressed affect
    standard_trait_name: unipolar depression
- association_info:
    ancestry:
    - European=357957
    gwas_catalog_id: GCST006475
    neg_log_pval: 12.761953896871205
    otg_id: GCST006475
    pubmed_id: '29942085'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Dopamine D2 receptor antagonist drug ZIPRASIDONE is Phase IV for
        the indiciation EFO_0004247 and targets the gene ENSG00000149295 at this locus
        (39935bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000149295
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '11'
      position: 113386347
    locus_GRCh38:
      chromosome: '11'
      position: 113515625
  trait_info:
    ontology:
    - EFO_0004247
    reported_trait_name: Depressed affect
    standard_trait_name: mood disorder
- association_info:
    ancestry:
    - European=357957
    gwas_catalog_id: GCST006475
    neg_log_pval: 12.761953896871205
    otg_id: GCST006475
    pubmed_id: '29942085'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Dopamine D2 receptor partial agonist drug ARIPIPRAZOLE is Phase
        IV for the indiciation EFO_0003761 and targets the gene ENSG00000149295 at
        this locus (39935bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000149295
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '11'
      position: 113386347
    locus_GRCh38:
      chromosome: '11'
      position: 113515625
  trait_info:
    ontology:
    - EFO_0003761
    reported_trait_name: Depressed affect
    standard_trait_name: unipolar depression
- association_info:
    ancestry:
    - East Asian=26026
    - European=82315
    gwas_catalog_id: GCST004946
    neg_log_pval: 10.301029995663981
    otg_id: GCST004946
    pubmed_id: '28991256'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Serotonin 3a (5-HT3a) receptor antagonist drug ONDANSETRON is Phase
        III for the indiciation EFO_0000692 and targets the gene ENSG00000166736 at
        this locus (452609bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000166736
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 113392994
    locus_GRCh38:
      chromosome: '11'
      position: 113522272
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - East Asian=26026
    - European=82315
    gwas_catalog_id: GCST004946
    neg_log_pval: 10.301029995663981
    otg_id: GCST004946
    pubmed_id: '28991256'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Dopamine D2 receptor antagonist drug CHLORPROTHIXENE is Phase III
        for the indiciation EFO_0000692 and targets the gene ENSG00000149295 at this
        locus (46582bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000149295
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 113392994
    locus_GRCh38:
      chromosome: '11'
      position: 113522272
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - European=82315
    - East Asian=5219
    gwas_catalog_id: GCST002539
    neg_log_pval: 10.522878745280337
    otg_id: GCST002539
    pubmed_id: '25056061'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Dopamine D2 receptor antagonist drug CHLORPROTHIXENE is Phase III
        for the indiciation EFO_0000692 and targets the gene ENSG00000149295 at this
        locus (46582bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000149295
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 113392994
    locus_GRCh38:
      chromosome: '11'
      position: 113522272
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - European=82315
    - East Asian=5219
    gwas_catalog_id: GCST002539
    neg_log_pval: 10.522878745280337
    otg_id: GCST002539
    pubmed_id: '25056061'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Serotonin 3a (5-HT3a) receptor antagonist drug ONDANSETRON is Phase
        III for the indiciation EFO_0000692 and targets the gene ENSG00000166736 at
        this locus (452609bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000166736
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 113392994
    locus_GRCh38:
      chromosome: '11'
      position: 113522272
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - East Asian=45528
    gwas_catalog_id: GCST007201
    neg_log_pval: 10.0
    otg_id: GCST007201
    pubmed_id: '30285260'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Serotonin 3a (5-HT3a) receptor antagonist drug VORTIOXETINE is
        Phase IV for the indiciation EFO_0000692 and targets the gene ENSG00000166736
        at this locus (452609bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000166736
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 113392994
    locus_GRCh38:
      chromosome: '11'
      position: 113522272
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - Other=1097
    - NR=150064
    gwas_catalog_id: GCST003048
    neg_log_pval: 9.698970004336019
    otg_id: GCST003048
    pubmed_id: '26198764'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Serotonin 3a (5-HT3a) receptor antagonist drug ONDANSETRON is Phase
        III for the indiciation EFO_0000692 and targets the gene ENSG00000166736 at
        this locus (452609bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000166736
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 113392994
    locus_GRCh38:
      chromosome: '11'
      position: 113522272
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - East Asian=26026
    - European=82315
    gwas_catalog_id: GCST004946
    neg_log_pval: 10.301029995663981
    otg_id: GCST004946
    pubmed_id: '28991256'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dopamine D2 receptor antagonist drug SB-773812 is Phase II for
        the indiciation EFO_0000692 and targets the gene ENSG00000149295 at this locus
        (46582bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000149295
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 113392994
    locus_GRCh38:
      chromosome: '11'
      position: 113522272
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - East Asian=45528
    gwas_catalog_id: GCST007201
    neg_log_pval: 9.301029995663981
    otg_id: GCST007201_2
    pubmed_id: '30285260'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dopamine D2 receptor antagonist drug SB-773812 is Phase II for
        the indiciation EFO_0000692 and targets the gene ENSG00000149295 at this locus
        (46582bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000149295
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 113392994
    locus_GRCh38:
      chromosome: '11'
      position: 113522272
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia [EA]
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - East Asian=45528
    gwas_catalog_id: GCST007201
    neg_log_pval: 9.301029995663981
    otg_id: GCST007201_2
    pubmed_id: '30285260'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Serotonin 3a (5-HT3a) receptor antagonist drug ONDANSETRON is Phase
        III for the indiciation EFO_0000692 and targets the gene ENSG00000166736 at
        this locus (452609bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000166736
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 113392994
    locus_GRCh38:
      chromosome: '11'
      position: 113522272
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia [EA]
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - East Asian=45528
    gwas_catalog_id: GCST007201
    neg_log_pval: 10.0
    otg_id: GCST007201
    pubmed_id: '30285260'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dopamine D2 receptor antagonist drug SB-773812 is Phase II for
        the indiciation EFO_0000692 and targets the gene ENSG00000149295 at this locus
        (46582bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000149295
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 113392994
    locus_GRCh38:
      chromosome: '11'
      position: 113522272
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - East Asian=45528
    gwas_catalog_id: GCST007201
    neg_log_pval: 10.0
    otg_id: GCST007201
    pubmed_id: '30285260'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Dopamine D2 receptor antagonist drug CHLORPROTHIXENE is Phase III
        for the indiciation EFO_0000692 and targets the gene ENSG00000149295 at this
        locus (46582bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000149295
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 113392994
    locus_GRCh38:
      chromosome: '11'
      position: 113522272
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - East Asian=26026
    - European=82315
    gwas_catalog_id: GCST004946
    neg_log_pval: 10.301029995663981
    otg_id: GCST004946
    pubmed_id: '28991256'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Dopamine D2 receptor antagonist drug FLUPHENAZINE DECANOATE is
        Phase IV for the indiciation EFO_0000692 and targets the gene ENSG00000149295
        at this locus (46582bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000149295
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 113392994
    locus_GRCh38:
      chromosome: '11'
      position: 113522272
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - European=82315
    - East Asian=5219
    gwas_catalog_id: GCST002539
    neg_log_pval: 10.522878745280337
    otg_id: GCST002539
    pubmed_id: '25056061'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Serotonin 3a (5-HT3a) receptor antagonist drug VORTIOXETINE is
        Phase IV for the indiciation EFO_0000692 and targets the gene ENSG00000166736
        at this locus (452609bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000166736
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 113392994
    locus_GRCh38:
      chromosome: '11'
      position: 113522272
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - European=105318
    gwas_catalog_id: GCST006803
    neg_log_pval: 11.698970004336019
    otg_id: GCST006803
    pubmed_id: '29483656'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Dopamine D2 receptor antagonist drug CHLORPROTHIXENE is Phase III
        for the indiciation EFO_0000692 and targets the gene ENSG00000149295 at this
        locus (46582bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000149295
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 113392994
    locus_GRCh38:
      chromosome: '11'
      position: 113522272
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - East Asian=45528
    gwas_catalog_id: GCST007201
    neg_log_pval: 9.301029995663981
    otg_id: GCST007201_2
    pubmed_id: '30285260'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Serotonin 3a (5-HT3a) receptor antagonist drug VORTIOXETINE is
        Phase IV for the indiciation EFO_0000692 and targets the gene ENSG00000166736
        at this locus (452609bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000166736
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 113392994
    locus_GRCh38:
      chromosome: '11'
      position: 113522272
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia [EA]
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - Other=1097
    - NR=150064
    gwas_catalog_id: GCST003048
    neg_log_pval: 9.698970004336019
    otg_id: GCST003048
    pubmed_id: '26198764'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Dopamine D2 receptor antagonist drug CHLORPROTHIXENE is Phase III
        for the indiciation EFO_0000692 and targets the gene ENSG00000149295 at this
        locus (46582bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000149295
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 113392994
    locus_GRCh38:
      chromosome: '11'
      position: 113522272
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - Other=1097
    - NR=150064
    gwas_catalog_id: GCST003048
    neg_log_pval: 9.698970004336019
    otg_id: GCST003048
    pubmed_id: '26198764'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Serotonin 3a (5-HT3a) receptor antagonist drug VORTIOXETINE is
        Phase IV for the indiciation EFO_0000692 and targets the gene ENSG00000166736
        at this locus (452609bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000166736
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 113392994
    locus_GRCh38:
      chromosome: '11'
      position: 113522272
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - East Asian=45528
    gwas_catalog_id: GCST007201
    neg_log_pval: 9.301029995663981
    otg_id: GCST007201_2
    pubmed_id: '30285260'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Dopamine D2 receptor antagonist drug FLUPHENAZINE DECANOATE is
        Phase IV for the indiciation EFO_0000692 and targets the gene ENSG00000149295
        at this locus (46582bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000149295
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 113392994
    locus_GRCh38:
      chromosome: '11'
      position: 113522272
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia [EA]
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - Other=1097
    - NR=150064
    gwas_catalog_id: GCST003048
    neg_log_pval: 9.698970004336019
    otg_id: GCST003048
    pubmed_id: '26198764'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dopamine D2 receptor antagonist drug SB-773812 is Phase II for
        the indiciation EFO_0000692 and targets the gene ENSG00000149295 at this locus
        (46582bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000149295
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 113392994
    locus_GRCh38:
      chromosome: '11'
      position: 113522272
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - European=105318
    gwas_catalog_id: GCST006803
    neg_log_pval: 11.698970004336019
    otg_id: GCST006803
    pubmed_id: '29483656'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Dopamine D2 receptor antagonist drug FLUPHENAZINE DECANOATE is
        Phase IV for the indiciation EFO_0000692 and targets the gene ENSG00000149295
        at this locus (46582bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000149295
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 113392994
    locus_GRCh38:
      chromosome: '11'
      position: 113522272
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - European=82315
    - East Asian=5219
    gwas_catalog_id: GCST002539
    neg_log_pval: 10.522878745280337
    otg_id: GCST002539
    pubmed_id: '25056061'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Dopamine D2 receptor antagonist drug FLUPHENAZINE DECANOATE is
        Phase IV for the indiciation EFO_0000692 and targets the gene ENSG00000149295
        at this locus (46582bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000149295
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 113392994
    locus_GRCh38:
      chromosome: '11'
      position: 113522272
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - European=82315
    - East Asian=5219
    gwas_catalog_id: GCST002539
    neg_log_pval: 10.522878745280337
    otg_id: GCST002539
    pubmed_id: '25056061'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dopamine D2 receptor antagonist drug SB-773812 is Phase II for
        the indiciation EFO_0000692 and targets the gene ENSG00000149295 at this locus
        (46582bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000149295
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 113392994
    locus_GRCh38:
      chromosome: '11'
      position: 113522272
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - East Asian=45528
    gwas_catalog_id: GCST007201
    neg_log_pval: 10.0
    otg_id: GCST007201
    pubmed_id: '30285260'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Serotonin 3a (5-HT3a) receptor antagonist drug ONDANSETRON is Phase
        III for the indiciation EFO_0000692 and targets the gene ENSG00000166736 at
        this locus (452609bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000166736
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 113392994
    locus_GRCh38:
      chromosome: '11'
      position: 113522272
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - European=105318
    gwas_catalog_id: GCST006803
    neg_log_pval: 11.698970004336019
    otg_id: GCST006803
    pubmed_id: '29483656'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Serotonin 3a (5-HT3a) receptor antagonist drug ONDANSETRON is Phase
        III for the indiciation EFO_0000692 and targets the gene ENSG00000166736 at
        this locus (452609bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000166736
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 113392994
    locus_GRCh38:
      chromosome: '11'
      position: 113522272
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - East Asian=26026
    - European=82315
    gwas_catalog_id: GCST004946
    neg_log_pval: 10.301029995663981
    otg_id: GCST004946
    pubmed_id: '28991256'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Serotonin 3a (5-HT3a) receptor antagonist drug VORTIOXETINE is
        Phase IV for the indiciation EFO_0000692 and targets the gene ENSG00000166736
        at this locus (452609bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000166736
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 113392994
    locus_GRCh38:
      chromosome: '11'
      position: 113522272
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - Other=1097
    - NR=150064
    gwas_catalog_id: GCST003048
    neg_log_pval: 9.698970004336019
    otg_id: GCST003048
    pubmed_id: '26198764'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Dopamine D2 receptor antagonist drug FLUPHENAZINE DECANOATE is
        Phase IV for the indiciation EFO_0000692 and targets the gene ENSG00000149295
        at this locus (46582bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000149295
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 113392994
    locus_GRCh38:
      chromosome: '11'
      position: 113522272
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - East Asian=45528
    gwas_catalog_id: GCST007201
    neg_log_pval: 9.301029995663981
    otg_id: GCST007201_2
    pubmed_id: '30285260'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Dopamine D2 receptor antagonist drug CHLORPROTHIXENE is Phase III
        for the indiciation EFO_0000692 and targets the gene ENSG00000149295 at this
        locus (46582bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000149295
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 113392994
    locus_GRCh38:
      chromosome: '11'
      position: 113522272
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia [EA]
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - European=105318
    gwas_catalog_id: GCST006803
    neg_log_pval: 11.698970004336019
    otg_id: GCST006803
    pubmed_id: '29483656'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Serotonin 3a (5-HT3a) receptor antagonist drug VORTIOXETINE is
        Phase IV for the indiciation EFO_0000692 and targets the gene ENSG00000166736
        at this locus (452609bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000166736
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 113392994
    locus_GRCh38:
      chromosome: '11'
      position: 113522272
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - East Asian=45528
    gwas_catalog_id: GCST007201
    neg_log_pval: 10.0
    otg_id: GCST007201
    pubmed_id: '30285260'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Dopamine D2 receptor antagonist drug FLUPHENAZINE DECANOATE is
        Phase IV for the indiciation EFO_0000692 and targets the gene ENSG00000149295
        at this locus (46582bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000149295
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 113392994
    locus_GRCh38:
      chromosome: '11'
      position: 113522272
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - European=105318
    gwas_catalog_id: GCST006803
    neg_log_pval: 11.698970004336019
    otg_id: GCST006803
    pubmed_id: '29483656'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dopamine D2 receptor antagonist drug SB-773812 is Phase II for
        the indiciation EFO_0000692 and targets the gene ENSG00000149295 at this locus
        (46582bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000149295
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 113392994
    locus_GRCh38:
      chromosome: '11'
      position: 113522272
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - European=13574
    - NR=2380
    gwas_catalog_id: GCST004521
    neg_log_pval: 8.301029995663981
    otg_id: GCST004521
    pubmed_id: '28540026'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dopamine D2 receptor antagonist drug SB-773812 is Phase II for
        the indiciation EFO_0000692 and targets the gene ENSG00000149295 at this locus
        (66031bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000149295
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '11'
      position: 113412443
    locus_GRCh38:
      chromosome: '11'
      position: 113541721
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Autism spectrum disorder or schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - European=13574
    - NR=2380
    gwas_catalog_id: GCST004521
    neg_log_pval: 8.301029995663981
    otg_id: GCST004521
    pubmed_id: '28540026'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Serotonin 3a (5-HT3a) receptor antagonist drug ONDANSETRON is Phase
        III for the indiciation EFO_0000692 and targets the gene ENSG00000166736 at
        this locus (433161bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000166736
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '11'
      position: 113412443
    locus_GRCh38:
      chromosome: '11'
      position: 113541721
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Autism spectrum disorder or schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - European=13574
    - NR=2380
    gwas_catalog_id: GCST004521
    neg_log_pval: 8.301029995663981
    otg_id: GCST004521
    pubmed_id: '28540026'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Dopamine D2 receptor partial agonist drug ARIPIPRAZOLE is Phase
        IV for the indiciation EFO_0003756 and targets the gene ENSG00000149295 at
        this locus (66031bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000149295
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '11'
      position: 113412443
    locus_GRCh38:
      chromosome: '11'
      position: 113541721
  trait_info:
    ontology:
    - EFO_0003756
    reported_trait_name: Autism spectrum disorder or schizophrenia
    standard_trait_name: autism spectrum disorder
- association_info:
    ancestry:
    - European=13574
    - NR=2380
    gwas_catalog_id: GCST004521
    neg_log_pval: 8.301029995663981
    otg_id: GCST004521
    pubmed_id: '28540026'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Dopamine D2 receptor antagonist drug ASENAPINE is Phase IV for
        the indiciation EFO_0000692 and targets the gene ENSG00000149295 at this locus
        (66031bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000149295
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '11'
      position: 113412443
    locus_GRCh38:
      chromosome: '11'
      position: 113541721
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Autism spectrum disorder or schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - European=13574
    - NR=2380
    gwas_catalog_id: GCST004521
    neg_log_pval: 8.301029995663981
    otg_id: GCST004521
    pubmed_id: '28540026'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Dopamine D2 receptor partial agonist drug BIFEPRUNOX is Phase III
        for the indiciation EFO_0000692 and targets the gene ENSG00000149295 at this
        locus (66031bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000149295
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '11'
      position: 113412443
    locus_GRCh38:
      chromosome: '11'
      position: 113541721
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Autism spectrum disorder or schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - European=13574
    - NR=2380
    gwas_catalog_id: GCST004521
    neg_log_pval: 8.301029995663981
    otg_id: GCST004521
    pubmed_id: '28540026'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Serotonin 3a (5-HT3a) receptor antagonist drug VORTIOXETINE is
        Phase IV for the indiciation EFO_0000692 and targets the gene ENSG00000166736
        at this locus (433161bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000166736
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '11'
      position: 113412443
    locus_GRCh38:
      chromosome: '11'
      position: 113541721
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Autism spectrum disorder or schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - European=67543
    - Sub-Saharan African, African American or Afro-Caribbean=10463
    - East Asian=6954
    - Hispanic or Latin American=2080
    gwas_catalog_id: GCST002606
    neg_log_pval: 7.522878745280337
    otg_id: GCST002606_3
    pubmed_id: '25217961'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dopamine D2 receptor antagonist drug METOCLOPRAMIDE is Phase IV
        for the indiciation EFO_0001663 and targets the gene ENSG00000149295 at this
        locus (460768bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000149295
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 113807181
    locus_GRCh38:
      chromosome: '11'
      position: 113936459
  trait_info:
    ontology:
    - EFO_0001663
    reported_trait_name: Prostate cancer [EA]
    standard_trait_name: prostate carcinoma
- association_info:
    ancestry:
    - European=67543
    - Sub-Saharan African, African American or Afro-Caribbean=10463
    - East Asian=6954
    - Hispanic or Latin American=2080
    gwas_catalog_id: GCST002606
    neg_log_pval: 7.301029995663981
    otg_id: GCST002606
    pubmed_id: '25217961'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dopamine D2 receptor antagonist drug METOCLOPRAMIDE is Phase IV
        for the indiciation EFO_0001663 and targets the gene ENSG00000149295 at this
        locus (460768bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000149295
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 113807181
    locus_GRCh38:
      chromosome: '11'
      position: 113936459
  trait_info:
    ontology:
    - EFO_0001663
    reported_trait_name: Prostate cancer
    standard_trait_name: prostate carcinoma
- association_info:
    ancestry:
    - European=140254
    gwas_catalog_id: GCST006085
    neg_log_pval: 14.397940008672037
    otg_id: GCST006085
    pubmed_id: '29892016'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dopamine D2 receptor antagonist drug METOCLOPRAMIDE is Phase IV
        for the indiciation EFO_0001663 and targets the gene ENSG00000149295 at this
        locus (460768bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000149295
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 113807181
    locus_GRCh38:
      chromosome: '11'
      position: 113936459
  trait_info:
    ontology:
    - EFO_0001663
    reported_trait_name: Prostate cancer
    standard_trait_name: prostate carcinoma
- association_info:
    ancestry:
    - European=67543
    - Sub-Saharan African, African American or Afro-Caribbean=10463
    - East Asian=6954
    - Hispanic or Latin American=2080
    gwas_catalog_id: GCST002606
    neg_log_pval: 7.522878745280337
    otg_id: GCST002606_3
    pubmed_id: '25217961'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Serotonin 3a (5-HT3a) receptor antagonist drug ONDANSETRON is Phase
        IV for the indiciation EFO_0001663 and targets the gene ENSG00000166736 at
        this locus (38422bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000166736
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 113807181
    locus_GRCh38:
      chromosome: '11'
      position: 113936459
  trait_info:
    ontology:
    - EFO_0001663
    reported_trait_name: Prostate cancer [EA]
    standard_trait_name: prostate carcinoma
- association_info:
    ancestry:
    - European=140254
    gwas_catalog_id: GCST006085
    neg_log_pval: 14.397940008672037
    otg_id: GCST006085
    pubmed_id: '29892016'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Serotonin 3a (5-HT3a) receptor antagonist drug ONDANSETRON is Phase
        IV for the indiciation EFO_0001663 and targets the gene ENSG00000166736 at
        this locus (38422bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000166736
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 113807181
    locus_GRCh38:
      chromosome: '11'
      position: 113936459
  trait_info:
    ontology:
    - EFO_0001663
    reported_trait_name: Prostate cancer
    standard_trait_name: prostate carcinoma
- association_info:
    ancestry:
    - European=67543
    - Sub-Saharan African, African American or Afro-Caribbean=10463
    - East Asian=6954
    - Hispanic or Latin American=2080
    gwas_catalog_id: GCST002606
    neg_log_pval: 7.301029995663981
    otg_id: GCST002606
    pubmed_id: '25217961'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Serotonin 3a (5-HT3a) receptor antagonist drug ONDANSETRON is Phase
        IV for the indiciation EFO_0001663 and targets the gene ENSG00000166736 at
        this locus (38422bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000166736
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 113807181
    locus_GRCh38:
      chromosome: '11'
      position: 113936459
  trait_info:
    ontology:
    - EFO_0001663
    reported_trait_name: Prostate cancer
    standard_trait_name: prostate carcinoma
- association_info:
    ancestry:
    - European=9799
    gwas_catalog_id: GCST003227
    neg_log_pval: 10.221848749616356
    otg_id: GCST003227
    pubmed_id: '26424050'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Serotonin 3a (5-HT3a) receptor antagonist drug GRANISETRON is Phase
        II for the indiciation EFO_0000326 and targets the gene ENSG00000166736 at
        this locus (169764bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000166736
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '11'
      position: 114030799
    locus_GRCh38:
      chromosome: '11'
      position: 114160077
  trait_info:
    ontology:
    - EFO_0000326
    reported_trait_name: Non-glioblastoma glioma
    standard_trait_name: central nervous system cancer
- association_info:
    ancestry:
    - European=24009
    gwas_catalog_id: GCST004348
    neg_log_pval: 11.301029995663981
    otg_id: GCST004348
    pubmed_id: '28346443'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Serotonin 3a (5-HT3a) receptor antagonist drug GRANISETRON is Phase
        II for the indiciation EFO_0000326 and targets the gene ENSG00000166736 at
        this locus (169764bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000166736
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '11'
      position: 114030799
    locus_GRCh38:
      chromosome: '11'
      position: 114160077
  trait_info:
    ontology:
    - EFO_0000326
    reported_trait_name: Non-glioblastoma glioma
    standard_trait_name: central nervous system cancer
- association_info:
    ancestry:
    - European=5548
    gwas_catalog_id: GCST000439
    neg_log_pval: 8.0
    otg_id: GCST000439
    pubmed_id: '19578367'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: T cell surface glycoprotein CD3 inhibitor drug MUROMONAB-CD3 is
        Phase II for the indiciation EFO_0000326 and targets the gene ENSG00000198851
        at this locus (290477bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000198851
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '11'
      position: 118477367
    locus_GRCh38:
      chromosome: '11'
      position: 118606652
  trait_info:
    ontology:
    - EFO_0000326
    reported_trait_name: Glioma
    standard_trait_name: central nervous system cancer
- association_info:
    ancestry:
    - European=11582
    gwas_catalog_id: GCST001058
    neg_log_pval: 10.301029995663981
    otg_id: GCST001058
    pubmed_id: '21531791'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: T cell surface glycoprotein CD3 inhibitor drug MUROMONAB-CD3 is
        Phase II for the indiciation EFO_0000326 and targets the gene ENSG00000198851
        at this locus (290477bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000198851
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '11'
      position: 118477367
    locus_GRCh38:
      chromosome: '11'
      position: 118606652
  trait_info:
    ontology:
    - EFO_0000326
    reported_trait_name: Glioma
    standard_trait_name: central nervous system cancer
- association_info:
    ancestry:
    - European=9799
    gwas_catalog_id: GCST003227
    neg_log_pval: 24.397940008672037
    otg_id: GCST003227
    pubmed_id: '26424050'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: T cell surface glycoprotein CD3 inhibitor drug MUROMONAB-CD3 is
        Phase II for the indiciation EFO_0000326 and targets the gene ENSG00000198851
        at this locus (293225bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000198851
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 118480115
    locus_GRCh38:
      chromosome: '11'
      position: 118609400
  trait_info:
    ontology:
    - EFO_0000326
    reported_trait_name: Non-glioblastoma glioma
    standard_trait_name: central nervous system cancer
- association_info:
    ancestry:
    - European=24009
    gwas_catalog_id: GCST004348
    neg_log_pval: 42.221848749616356
    otg_id: GCST004348
    pubmed_id: '28346443'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: T cell surface glycoprotein CD3 inhibitor drug MUROMONAB-CD3 is
        Phase II for the indiciation EFO_0000326 and targets the gene ENSG00000198851
        at this locus (293225bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000198851
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 118480115
    locus_GRCh38:
      chromosome: '11'
      position: 118609400
  trait_info:
    ontology:
    - EFO_0000326
    reported_trait_name: Non-glioblastoma glioma
    standard_trait_name: central nervous system cancer
- association_info:
    ancestry:
    - European=11582
    gwas_catalog_id: GCST003228
    neg_log_pval: 15.698970004336019
    otg_id: GCST003228
    pubmed_id: '26424050'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: T cell surface glycoprotein CD3 inhibitor drug MUROMONAB-CD3 is
        Phase II for the indiciation EFO_0000326 and targets the gene ENSG00000198851
        at this locus (293225bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000198851
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 118480115
    locus_GRCh38:
      chromosome: '11'
      position: 118609400
  trait_info:
    ontology:
    - EFO_0000326
    reported_trait_name: Glioma
    standard_trait_name: central nervous system cancer
- association_info:
    ancestry:
    - European=30659
    gwas_catalog_id: GCST004347
    neg_log_pval: 15.0
    otg_id: GCST004347
    pubmed_id: '28346443'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: T cell surface glycoprotein CD3 inhibitor drug MUROMONAB-CD3 is
        Phase II for the indiciation EFO_0000326 and targets the gene ENSG00000198851
        at this locus (293225bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000198851
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 118480115
    locus_GRCh38:
      chromosome: '11'
      position: 118609400
  trait_info:
    ontology:
    - EFO_0000326
    reported_trait_name: Glioma
    standard_trait_name: central nervous system cancer
- association_info:
    ancestry:
    - European=38053
    gwas_catalog_id: GCST000987
    neg_log_pval: 12.0
    otg_id: GCST000987
    pubmed_id: '21383967'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: T cell surface glycoprotein CD3 inhibitor drug MUROMONAB-CD3 is
        Phase IV for the indiciation EFO_0000540 and targets the gene ENSG00000198851
        at this locus (424897bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000198851
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 118611781
    locus_GRCh38:
      chromosome: '11'
      position: 118741072
  trait_info:
    ontology:
    - EFO_0000540
    reported_trait_name: Celiac disease or Rheumatoid arthritis
    standard_trait_name: immune system disease
- association_info:
    ancestry:
    - European=459000
    gwas_catalog_id: GCST007072
    neg_log_pval: 12.096910013008056
    otg_id: GCST007072
    pubmed_id: '30595370'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Phosphodiesterase 3A inhibitor drug MILRINONE is Phase IV for the
        indiciation EFO_0000319 and targets the gene ENSG00000172572 at this locus
        (361012bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000172572
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '12'
      position: 20161168
    locus_GRCh38:
      chromosome: '12'
      position: 20008234
  trait_info:
    ontology:
    - EFO_0000319
    reported_trait_name: Cardiovascular disease
    standard_trait_name: cardiovascular system disease
- association_info:
    ancestry:
    - NR=250736
    gwas_catalog_id: GCST005196
    neg_log_pval: 13.096910013008056
    otg_id: GCST005196
    pubmed_id: '29212778'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Phosphodiesterase 3A inhibitor drug CILOSTAZOL is Phase IV for
        the indiciation EFO_0000378 and targets the gene ENSG00000172572 at this locus
        (302146bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000172572
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '12'
      position: 20220033
    locus_GRCh38:
      chromosome: '12'
      position: 20067099
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - NR=547261
    gwas_catalog_id: GCST005195
    neg_log_pval: 8.2839966563652
    otg_id: GCST005195
    pubmed_id: '29212778'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Phosphodiesterase 3A inhibitor drug CILOSTAZOL is Phase IV for
        the indiciation EFO_0000378 and targets the gene ENSG00000172572 at this locus
        (302146bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000172572
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '12'
      position: 20220033
    locus_GRCh38:
      chromosome: '12'
      position: 20067099
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - NR=296525
    gwas_catalog_id: GCST005194
    neg_log_pval: 13.537602002101044
    otg_id: GCST005194
    pubmed_id: '29212778'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Phosphodiesterase 3A inhibitor drug CILOSTAZOL is Phase IV for
        the indiciation EFO_0000378 and targets the gene ENSG00000172572 at this locus
        (302146bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000172572
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '12'
      position: 20220033
    locus_GRCh38:
      chromosome: '12'
      position: 20067099
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - European=459000
    gwas_catalog_id: GCST007072
    neg_log_pval: 8.698970004336019
    otg_id: GCST007072
    pubmed_id: '30595370'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Phosphodiesterase 3A inhibitor drug CILOSTAZOL is Phase IV for
        the indiciation EFO_0000319 and targets the gene ENSG00000172572 at this locus
        (161851bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000172572
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '12'
      position: 20360328
    locus_GRCh38:
      chromosome: '12'
      position: 20207394
  trait_info:
    ontology:
    - EFO_0000319
    reported_trait_name: Cardiovascular disease
    standard_trait_name: cardiovascular system disease
- association_info:
    ancestry:
    - European=440328
    - East Asian=45564
    - South Asian=9144
    - African American or Afro-Caribbean=20687
    - Asian unspecified=555
    - Hispanic or Latin American=1247
    gwas_catalog_id: GCST005843
    neg_log_pval: 7.301029995663981
    otg_id: GCST005843
    pubmed_id: '29531354'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Phosphodiesterase 3A inhibitor drug CILOSTAZOL is Phase IV for
        the indiciation HP_0002140 and targets the gene ENSG00000172572 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000172572
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '12'
      position: 20577593
    locus_GRCh38:
      chromosome: '12'
      position: 20424659
  trait_info:
    ontology:
    - HP_0002140
    reported_trait_name: Ischemic stroke
    standard_trait_name: Ischemic stroke
- association_info:
    ancestry:
    - European=440328
    - East Asian=45564
    - South Asian=9144
    - African American or Afro-Caribbean=20687
    - Asian unspecified=555
    - Hispanic or Latin American=1247
    gwas_catalog_id: GCST005843
    neg_log_pval: 7.301029995663981
    otg_id: GCST005843
    pubmed_id: '29531354'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Phosphodiesterase 3A inhibitor drug CILOSTAZOL is Phase IV for
        the indiciation HP_0002140 and targets the gene ENSG00000172572 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000172572
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '12'
      position: 20577593
    locus_GRCh38:
      chromosome: '12'
      position: 20424659
  trait_info:
    ontology:
    - HP_0002140
    reported_trait_name: Ischemic stroke
    standard_trait_name: Ischemic stroke
- association_info:
    ancestry:
    - European=17565
    - African American or Afro-Caribbean=375
    - South Asian=4710
    gwas_catalog_id: GCST003322
    neg_log_pval: 7.522878745280337
    otg_id: GCST003322_2
    pubmed_id: '26732560'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Phosphodiesterase 3A inhibitor drug CILOSTAZOL is Phase IV for
        the indiciation HP_0002140 and targets the gene ENSG00000172572 at this locus
        (486296bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000172572
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '12'
      position: 21323611
    locus_GRCh38:
      chromosome: '12'
      position: 21170677
  trait_info:
    ontology:
    - HP_0002140
    reported_trait_name: Ischemic stroke (large artery atherosclerosis) [EA]
    standard_trait_name: Ischemic stroke
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 8.267891037697892
    otg_id: NEALE2_20002_1065
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Vitamin D receptor agonist drug CHOLECALCIFEROL is Phase IV for
        the indiciation EFO_0000537 and targets the gene ENSG00000111424 at this locus
        (48757bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000111424
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: T
    locus_GRCh37:
      chromosome: '12'
      position: 48186563
    locus_GRCh38:
      chromosome: '12'
      position: 47792780
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Hypertension | non-cancer illness code, self-reported
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 8.267891037697892
    otg_id: NEALE2_20002_1065
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Vitamin D receptor agonist drug CALCITRIOL is Phase II for the
        indiciation EFO_0000537 and targets the gene ENSG00000111424 at this locus
        (48757bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000111424
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: T
    locus_GRCh37:
      chromosome: '12'
      position: 48186563
    locus_GRCh38:
      chromosome: '12'
      position: 47792780
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Hypertension | non-cancer illness code, self-reported
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - European=360838
    gwas_catalog_id: GCST005038
    neg_log_pval: 10.941953769604718
    otg_id: GCST005038
    pubmed_id: '29083406'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Vitamin D receptor agonist drug CHOLECALCIFEROL is Phase II for
        the indiciation EFO_0003785 and targets the gene ENSG00000111424 at this locus
        (39448bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000111424
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '12'
      position: 48195873
    locus_GRCh38:
      chromosome: '12'
      position: 47802090
  trait_info:
    ontology:
    - EFO_0003785
    reported_trait_name: Allergic disease (asthma, hay fever or eczema)
    standard_trait_name: allergy
- association_info:
    ancestry:
    - European, NR=58918
    - European=458554
    gwas_catalog_id: GCST007611
    neg_log_pval: 10.154901959985743
    otg_id: GCST007611
    pubmed_id: '30940143'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Vitamin D receptor agonist drug CHOLECALCIFEROL is Phase IV for
        the indiciation EFO_0000537 and targets the gene ENSG00000111424 at this locus
        (30821bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000111424
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '12'
      position: 48204499
    locus_GRCh38:
      chromosome: '12'
      position: 47810716
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Chronic obstructive pulmonary disease or high blood pressure
      (pleiotropy)
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - European, NR=58918
    - European=458554
    gwas_catalog_id: GCST007611
    neg_log_pval: 10.154901959985743
    otg_id: GCST007611
    pubmed_id: '30940143'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Vitamin D receptor agonist drug CHOLECALCIFEROL is Phase IV for
        the indiciation EFO_0000341 and targets the gene ENSG00000111424 at this locus
        (30821bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000111424
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '12'
      position: 48204499
    locus_GRCh38:
      chromosome: '12'
      position: 47810716
  trait_info:
    ontology:
    - EFO_0000341
    reported_trait_name: Chronic obstructive pulmonary disease or high blood pressure
      (pleiotropy)
    standard_trait_name: chronic obstructive pulmonary disease
- association_info:
    ancestry:
    - European, NR=58918
    - European=458554
    gwas_catalog_id: GCST007611
    neg_log_pval: 10.154901959985743
    otg_id: GCST007611
    pubmed_id: '30940143'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Vitamin D receptor agonist drug CALCITRIOL is Phase II for the
        indiciation EFO_0000537 and targets the gene ENSG00000111424 at this locus
        (30821bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000111424
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '12'
      position: 48204499
    locus_GRCh38:
      chromosome: '12'
      position: 47810716
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Chronic obstructive pulmonary disease or high blood pressure
      (pleiotropy)
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - European=86475
    gwas_catalog_id: GCST005537
    neg_log_pval: 8.221848749616356
    otg_id: GCST005537
    pubmed_id: '26974007'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Vitamin D receptor agonist drug PEFCALCITOL is Phase III for the
        indiciation EFO_0000676 and targets the gene ENSG00000111424 at this locus
        (26953bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000111424
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '12'
      position: 48208368
    locus_GRCh38:
      chromosome: '12'
      position: 47814585
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Chronic inflammatory diseases (ankylosing spondylitis, Crohn's
      disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
      [subset analysis]
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=86475
    gwas_catalog_id: GCST005537
    neg_log_pval: 8.221848749616356
    otg_id: GCST005537
    pubmed_id: '26974007'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Vitamin D receptor agonist drug DOXERCALCIFEROL is Phase II for
        the indiciation EFO_0000676 and targets the gene ENSG00000111424 at this locus
        (26953bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000111424
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '12'
      position: 48208368
    locus_GRCh38:
      chromosome: '12'
      position: 47814585
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Chronic inflammatory diseases (ankylosing spondylitis, Crohn's
      disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
      [subset analysis]
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=86475
    gwas_catalog_id: GCST005537
    neg_log_pval: 8.221848749616356
    otg_id: GCST005537
    pubmed_id: '26974007'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Vitamin D receptor agonist drug CHOLECALCIFEROL is Phase III for
        the indiciation EFO_0000729 and targets the gene ENSG00000111424 at this locus
        (26953bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000111424
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '12'
      position: 48208368
    locus_GRCh38:
      chromosome: '12'
      position: 47814585
  trait_info:
    ontology:
    - EFO_0000729
    reported_trait_name: Chronic inflammatory diseases (ankylosing spondylitis, Crohn's
      disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
      [subset analysis]
    standard_trait_name: ulcerative colitis
- association_info:
    ancestry:
    - European=86475
    gwas_catalog_id: GCST005537
    neg_log_pval: 8.221848749616356
    otg_id: GCST005537
    pubmed_id: '26974007'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Vitamin D receptor agonist drug CALCITRIOL is Phase IV for the
        indiciation EFO_0000676 and targets the gene ENSG00000111424 at this locus
        (26953bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000111424
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '12'
      position: 48208368
    locus_GRCh38:
      chromosome: '12'
      position: 47814585
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Chronic inflammatory diseases (ankylosing spondylitis, Crohn's
      disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
      [subset analysis]
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=86475
    gwas_catalog_id: GCST005537
    neg_log_pval: 8.221848749616356
    otg_id: GCST005537
    pubmed_id: '26974007'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Vitamin D receptor agonist drug ERGOCALCIFEROL is Phase IV for
        the indiciation EFO_0000384 and targets the gene ENSG00000111424 at this locus
        (26953bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000111424
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '12'
      position: 48208368
    locus_GRCh38:
      chromosome: '12'
      position: 47814585
  trait_info:
    ontology:
    - EFO_0000384
    reported_trait_name: Chronic inflammatory diseases (ankylosing spondylitis, Crohn's
      disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
      [subset analysis]
    standard_trait_name: Crohn's disease
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 12.517126416391246
    otg_id: NEALE2_20002_1065
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Vitamin D receptor agonist drug CHOLECALCIFEROL is Phase IV for
        the indiciation EFO_0000537 and targets the gene ENSG00000111424 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000111424
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: T
    locus_GRCh37:
      chromosome: '12'
      position: 48254353
    locus_GRCh38:
      chromosome: '12'
      position: 47860570
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Hypertension | non-cancer illness code, self-reported
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - European=459000
    gwas_catalog_id: GCST007072
    neg_log_pval: 9.301029995663981
    otg_id: GCST007072
    pubmed_id: '30595370'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Vitamin D receptor agonist drug CHOLECALCIFEROL is Phase III for
        the indiciation EFO_0000319 and targets the gene ENSG00000111424 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000111424
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: T
    locus_GRCh37:
      chromosome: '12'
      position: 48254353
    locus_GRCh38:
      chromosome: '12'
      position: 47860570
  trait_info:
    ontology:
    - EFO_0000319
    reported_trait_name: Cardiovascular disease
    standard_trait_name: cardiovascular system disease
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 12.517126416391246
    otg_id: NEALE2_20002_1065
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Vitamin D receptor agonist drug CALCITRIOL is Phase II for the
        indiciation EFO_0000537 and targets the gene ENSG00000111424 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000111424
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: T
    locus_GRCh37:
      chromosome: '12'
      position: 48254353
    locus_GRCh38:
      chromosome: '12'
      position: 47860570
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Hypertension | non-cancer illness code, self-reported
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - European=2062
    gwas_catalog_id: GCST007843
    neg_log_pval: 11.522878745280337
    otg_id: GCST007843
    pubmed_id: '30891314'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Vitamin D receptor agonist drug ERGOCALCIFEROL is Phase IV for
        the indiciation EFO_0000685 and targets the gene ENSG00000111424 at this locus
        (78926bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000111424
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '12'
      position: 48415757
    locus_GRCh38:
      chromosome: '12'
      position: 48021974
  trait_info:
    ontology:
    - EFO_0000685
    reported_trait_name: Rheumatoid arthritis
    standard_trait_name: rheumatoid arthritis
- association_info:
    ancestry:
    - European=67543
    - Sub-Saharan African, African American or Afro-Caribbean=10463
    - East Asian=6954
    - Hispanic or Latin American=2080
    gwas_catalog_id: GCST002606
    neg_log_pval: 8.698970004336019
    otg_id: GCST002606
    pubmed_id: '25217961'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Vitamin D receptor agonist drug ERGOCALCIFEROL is Phase III for
        the indiciation EFO_0001663 and targets the gene ENSG00000111424 at this locus
        (82787bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000111424
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '12'
      position: 48419618
    locus_GRCh38:
      chromosome: '12'
      position: 48025835
  trait_info:
    ontology:
    - EFO_0001663
    reported_trait_name: Prostate cancer
    standard_trait_name: prostate carcinoma
- association_info:
    ancestry:
    - European=140254
    gwas_catalog_id: GCST006085
    neg_log_pval: 10.698970004336019
    otg_id: GCST006085
    pubmed_id: '29892016'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Vitamin D receptor agonist drug ERGOCALCIFEROL is Phase III for
        the indiciation EFO_0001663 and targets the gene ENSG00000111424 at this locus
        (82787bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000111424
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '12'
      position: 48419618
    locus_GRCh38:
      chromosome: '12'
      position: 48025835
  trait_info:
    ontology:
    - EFO_0001663
    reported_trait_name: Prostate cancer
    standard_trait_name: prostate carcinoma
- association_info:
    ancestry:
    - European=140254
    gwas_catalog_id: GCST006085
    neg_log_pval: 10.698970004336019
    otg_id: GCST006085
    pubmed_id: '29892016'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Vitamin D receptor agonist drug PARICALCITOL is Phase II for the
        indiciation EFO_0001663 and targets the gene ENSG00000111424 at this locus
        (82787bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000111424
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '12'
      position: 48419618
    locus_GRCh38:
      chromosome: '12'
      position: 48025835
  trait_info:
    ontology:
    - EFO_0001663
    reported_trait_name: Prostate cancer
    standard_trait_name: prostate carcinoma
- association_info:
    ancestry:
    - European=67543
    - Sub-Saharan African, African American or Afro-Caribbean=10463
    - East Asian=6954
    - Hispanic or Latin American=2080
    gwas_catalog_id: GCST002606
    neg_log_pval: 7.3979400086720375
    otg_id: GCST002606_3
    pubmed_id: '25217961'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Vitamin D receptor agonist drug PARICALCITOL is Phase II for the
        indiciation EFO_0001663 and targets the gene ENSG00000111424 at this locus
        (82787bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000111424
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '12'
      position: 48419618
    locus_GRCh38:
      chromosome: '12'
      position: 48025835
  trait_info:
    ontology:
    - EFO_0001663
    reported_trait_name: Prostate cancer [EA]
    standard_trait_name: prostate carcinoma
- association_info:
    ancestry:
    - European=67543
    - Sub-Saharan African, African American or Afro-Caribbean=10463
    - East Asian=6954
    - Hispanic or Latin American=2080
    gwas_catalog_id: GCST002606
    neg_log_pval: 8.698970004336019
    otg_id: GCST002606
    pubmed_id: '25217961'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Vitamin D receptor agonist drug PARICALCITOL is Phase II for the
        indiciation EFO_0001663 and targets the gene ENSG00000111424 at this locus
        (82787bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000111424
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '12'
      position: 48419618
    locus_GRCh38:
      chromosome: '12'
      position: 48025835
  trait_info:
    ontology:
    - EFO_0001663
    reported_trait_name: Prostate cancer
    standard_trait_name: prostate carcinoma
- association_info:
    ancestry:
    - European=67543
    - Sub-Saharan African, African American or Afro-Caribbean=10463
    - East Asian=6954
    - Hispanic or Latin American=2080
    gwas_catalog_id: GCST002606
    neg_log_pval: 7.3979400086720375
    otg_id: GCST002606_3
    pubmed_id: '25217961'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Vitamin D receptor agonist drug ERGOCALCIFEROL is Phase III for
        the indiciation EFO_0001663 and targets the gene ENSG00000111424 at this locus
        (82787bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000111424
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '12'
      position: 48419618
    locus_GRCh38:
      chromosome: '12'
      position: 48025835
  trait_info:
    ontology:
    - EFO_0001663
    reported_trait_name: Prostate cancer [EA]
    standard_trait_name: prostate carcinoma
- association_info:
    ancestry:
    - European=459000
    gwas_catalog_id: GCST007072
    neg_log_pval: 9.301029995663981
    otg_id: GCST007072
    pubmed_id: '30595370'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Vitamin D receptor agonist drug CHOLECALCIFEROL is Phase III for
        the indiciation EFO_0000319 and targets the gene ENSG00000111424 at this locus
        (260223bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000111424
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '12'
      position: 48597053
    locus_GRCh38:
      chromosome: '12'
      position: 48203270
  trait_info:
    ontology:
    - EFO_0000319
    reported_trait_name: Cardiovascular disease
    standard_trait_name: cardiovascular system disease
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 9.53863955699212
    otg_id: NEALE2_20002_1065
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Vitamin D receptor agonist drug CALCITRIOL is Phase II for the
        indiciation EFO_0000537 and targets the gene ENSG00000111424 at this locus
        (278452bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000111424
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: A
    locus_GRCh37:
      chromosome: '12'
      position: 48615283
    locus_GRCh38:
      chromosome: '12'
      position: 48221500
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Hypertension | non-cancer illness code, self-reported
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 9.53863955699212
    otg_id: NEALE2_20002_1065
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Vitamin D receptor agonist drug CHOLECALCIFEROL is Phase IV for
        the indiciation EFO_0000537 and targets the gene ENSG00000111424 at this locus
        (278452bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000111424
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: A
    locus_GRCh37:
      chromosome: '12'
      position: 48615283
    locus_GRCh38:
      chromosome: '12'
      position: 48221500
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Hypertension | non-cancer illness code, self-reported
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - European=58284
    - East Asian=22515
    gwas_catalog_id: GCST002318
    neg_log_pval: 10.0
    otg_id: GCST002318
    pubmed_id: '24390342'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-23 subunit alpha inhibitor drug GUSELKUMAB is Phase
        II for the indiciation EFO_0000685 and targets the gene ENSG00000110944 at
        this locus (333004bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000110944
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '12'
      position: 56394954
    locus_GRCh38:
      chromosome: '12'
      position: 56001170
  trait_info:
    ontology:
    - EFO_0000685
    reported_trait_name: Rheumatoid arthritis
    standard_trait_name: rheumatoid arthritis
- association_info:
    ancestry:
    - European=58284
    - East Asian=22515
    gwas_catalog_id: GCST002318
    neg_log_pval: 7.698970004336019
    otg_id: GCST002318_2
    pubmed_id: '24390342'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-23 subunit alpha inhibitor drug GUSELKUMAB is Phase
        II for the indiciation EFO_0000685 and targets the gene ENSG00000110944 at
        this locus (333004bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000110944
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '12'
      position: 56394954
    locus_GRCh38:
      chromosome: '12'
      position: 56001170
  trait_info:
    ontology:
    - EFO_0000685
    reported_trait_name: Rheumatoid arthritis [EA]
    standard_trait_name: rheumatoid arthritis
- association_info:
    ancestry:
    - African American or Afro-Caribbean=2308
    gwas_catalog_id: GCST006959
    neg_log_pval: 9.0
    otg_id: GCST006959
    pubmed_id: '30423114'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-23 subunit alpha inhibitor drug GUSELKUMAB is Phase
        II for the indiciation EFO_0000685 and targets the gene ENSG00000110944 at
        this locus (333004bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000110944
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '12'
      position: 56394954
    locus_GRCh38:
      chromosome: '12'
      position: 56001170
  trait_info:
    ontology:
    - EFO_0000685
    reported_trait_name: Rheumatoid arthritis
    standard_trait_name: rheumatoid arthritis
- association_info:
    ancestry:
    - European=16753
    gwas_catalog_id: GCST003097
    neg_log_pval: 8.397940008672037
    otg_id: GCST003097
    pubmed_id: '26301688'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-23 subunit alpha inhibitor drug GUSELKUMAB is Phase
        III for the indiciation EFO_0000384 and targets the gene ENSG00000110944 at
        this locus (331190bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000110944
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '12'
      position: 56396768
    locus_GRCh38:
      chromosome: '12'
      position: 56002984
  trait_info:
    ontology:
    - EFO_0000384
    reported_trait_name: Pediatric autoimmune diseases
    standard_trait_name: Crohn's disease
- association_info:
    ancestry:
    - European=16753
    gwas_catalog_id: GCST003097
    neg_log_pval: 8.397940008672037
    otg_id: GCST003097
    pubmed_id: '26301688'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-23 subunit alpha inhibitor drug GUSELKUMAB is Phase
        II for the indiciation EFO_0000729 and targets the gene ENSG00000110944 at
        this locus (331190bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000110944
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '12'
      position: 56396768
    locus_GRCh38:
      chromosome: '12'
      position: 56002984
  trait_info:
    ontology:
    - EFO_0000729
    reported_trait_name: Pediatric autoimmune diseases
    standard_trait_name: ulcerative colitis
- association_info:
    ancestry:
    - European=16753
    gwas_catalog_id: GCST003097
    neg_log_pval: 8.397940008672037
    otg_id: GCST003097
    pubmed_id: '26301688'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-23 subunit alpha inhibitor drug GUSELKUMAB is Phase
        IV for the indiciation EFO_0000676 and targets the gene ENSG00000110944 at
        this locus (331190bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000110944
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '12'
      position: 56396768
    locus_GRCh38:
      chromosome: '12'
      position: 56002984
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Pediatric autoimmune diseases
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=16753
    gwas_catalog_id: GCST003097
    neg_log_pval: 8.397940008672037
    otg_id: GCST003097
    pubmed_id: '26301688'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-23 subunit alpha inhibitor drug TILDRAKIZUMAB is Phase
        III for the indiciation EFO_0000676 and targets the gene ENSG00000110944 at
        this locus (331190bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000110944
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '12'
      position: 56396768
    locus_GRCh38:
      chromosome: '12'
      position: 56002984
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Pediatric autoimmune diseases
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=16753
    gwas_catalog_id: GCST003097
    neg_log_pval: 8.397940008672037
    otg_id: GCST003097
    pubmed_id: '26301688'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-23 subunit alpha inhibitor drug BRAZIKUMAB is Phase
        II for the indiciation EFO_0000384 and targets the gene ENSG00000110944 at
        this locus (331190bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000110944
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '12'
      position: 56396768
    locus_GRCh38:
      chromosome: '12'
      position: 56002984
  trait_info:
    ontology:
    - EFO_0000384
    reported_trait_name: Pediatric autoimmune diseases
    standard_trait_name: Crohn's disease
- association_info:
    ancestry:
    - European=2759
    gwas_catalog_id: GCST000322
    neg_log_pval: 9.0
    otg_id: GCST000322
    pubmed_id: '19169254'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Interleukin-23 subunit alpha inhibitor drug GUSELKUMAB is Phase
        IV for the indiciation EFO_0000676 and targets the gene ENSG00000110944 at
        this locus (3779bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000110944
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '12'
      position: 56737973
    locus_GRCh38:
      chromosome: '12'
      position: 56344189
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=12244
    gwas_catalog_id: GCST002738
    neg_log_pval: 9.221848749616356
    otg_id: GCST002738
    pubmed_id: '25574825'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-23 subunit alpha inhibitor drug TILDRAKIZUMAB is Phase
        III for the indiciation EFO_0000676 and targets the gene ENSG00000110944 at
        this locus (3779bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000110944
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '12'
      position: 56737973
    locus_GRCh38:
      chromosome: '12'
      position: 56344189
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=12244
    gwas_catalog_id: GCST002738
    neg_log_pval: 9.221848749616356
    otg_id: GCST002738
    pubmed_id: '25574825'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Interleukin-23 subunit alpha inhibitor drug GUSELKUMAB is Phase
        IV for the indiciation EFO_0000676 and targets the gene ENSG00000110944 at
        this locus (3779bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000110944
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '12'
      position: 56737973
    locus_GRCh38:
      chromosome: '12'
      position: 56344189
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=2759
    gwas_catalog_id: GCST000322
    neg_log_pval: 9.0
    otg_id: GCST000322
    pubmed_id: '19169254'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-23 subunit alpha inhibitor drug TILDRAKIZUMAB is Phase
        III for the indiciation EFO_0000676 and targets the gene ENSG00000110944 at
        this locus (3779bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000110944
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '12'
      position: 56737973
    locus_GRCh38:
      chromosome: '12'
      position: 56344189
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - East Asian=5134
    - European=8682
    gwas_catalog_id: GCST002874
    neg_log_pval: 11.301029995663981
    otg_id: GCST002874
    pubmed_id: '25903422'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-23 subunit alpha inhibitor drug TILDRAKIZUMAB is Phase
        III for the indiciation EFO_0000676 and targets the gene ENSG00000110944 at
        this locus (6489bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000110944
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '12'
      position: 56740682
    locus_GRCh38:
      chromosome: '12'
      position: 56346898
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - East Asian=5134
    - European=8682
    gwas_catalog_id: GCST002874
    neg_log_pval: 10.0
    otg_id: GCST002874_8
    pubmed_id: '25903422'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Interleukin-23 subunit alpha inhibitor drug GUSELKUMAB is Phase
        IV for the indiciation EFO_0000676 and targets the gene ENSG00000110944 at
        this locus (6489bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000110944
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '12'
      position: 56740682
    locus_GRCh38:
      chromosome: '12'
      position: 56346898
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis [EA]
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - East Asian=5134
    - European=8682
    gwas_catalog_id: GCST002874
    neg_log_pval: 11.301029995663981
    otg_id: GCST002874
    pubmed_id: '25903422'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Interleukin-23 subunit alpha inhibitor drug GUSELKUMAB is Phase
        IV for the indiciation EFO_0000676 and targets the gene ENSG00000110944 at
        this locus (6489bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000110944
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '12'
      position: 56740682
    locus_GRCh38:
      chromosome: '12'
      position: 56346898
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - East Asian=5134
    - European=8682
    gwas_catalog_id: GCST002874
    neg_log_pval: 10.0
    otg_id: GCST002874_8
    pubmed_id: '25903422'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-23 subunit alpha inhibitor drug TILDRAKIZUMAB is Phase
        III for the indiciation EFO_0000676 and targets the gene ENSG00000110944 at
        this locus (6489bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000110944
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '12'
      position: 56740682
    locus_GRCh38:
      chromosome: '12'
      position: 56346898
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis [EA]
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=287323
    gwas_catalog_id: GCST004346
    neg_log_pval: 24.397940008672037
    otg_id: GCST004346
    pubmed_id: '28537254'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Interleukin-23 subunit alpha inhibitor drug GUSELKUMAB is Phase
        IV for the indiciation EFO_0000676 and targets the gene ENSG00000110944 at
        this locus (7034bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000110944
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '12'
      position: 56741228
    locus_GRCh38:
      chromosome: '12'
      position: 56347444
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=287323
    gwas_catalog_id: GCST004346
    neg_log_pval: 24.397940008672037
    otg_id: GCST004346
    pubmed_id: '28537254'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-23 subunit alpha inhibitor drug TILDRAKIZUMAB is Phase
        III for the indiciation EFO_0000676 and targets the gene ENSG00000110944 at
        this locus (7034bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000110944
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '12'
      position: 56741228
    locus_GRCh38:
      chromosome: '12'
      position: 56347444
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=18190
    gwas_catalog_id: GCST002740
    neg_log_pval: 11.698970004336019
    otg_id: GCST002740_4
    pubmed_id: '25574825'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Interleukin-23 subunit alpha inhibitor drug GUSELKUMAB is Phase
        IV for the indiciation EFO_0000676 and targets the gene ENSG00000110944 at
        this locus (10082bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000110944
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '12'
      position: 56744276
    locus_GRCh38:
      chromosome: '12'
      position: 56350492
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Inflammatory skin disease [Psoriasis]
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=18190
    gwas_catalog_id: GCST002740
    neg_log_pval: 11.698970004336019
    otg_id: GCST002740_4
    pubmed_id: '25574825'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-23 subunit alpha inhibitor drug TILDRAKIZUMAB is Phase
        III for the indiciation EFO_0000676 and targets the gene ENSG00000110944 at
        this locus (10082bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000110944
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '12'
      position: 56744276
    locus_GRCh38:
      chromosome: '12'
      position: 56350492
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Inflammatory skin disease [Psoriasis]
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=8941
    gwas_catalog_id: GCST003268
    neg_log_pval: 14.397940008672037
    otg_id: GCST003268
    pubmed_id: '26626624'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Interleukin-23 subunit alpha inhibitor drug GUSELKUMAB is Phase
        IV for the indiciation EFO_1001494 and targets the gene ENSG00000110944 at
        this locus (16011bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000110944
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '12'
      position: 56750204
    locus_GRCh38:
      chromosome: '12'
      position: 56356420
  trait_info:
    ontology:
    - EFO_1001494
    reported_trait_name: Psoriasis vulgaris
    standard_trait_name: psoriasis vulgaris
- association_info:
    ancestry:
    - European=58284
    - East Asian=22515
    gwas_catalog_id: GCST002318
    neg_log_pval: 8.154901959985743
    otg_id: GCST002318_2
    pubmed_id: '24390342'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: MAP kinase-activated protein kinase 5 inhibitor drug GLPG-0259
        is Phase II for the indiciation EFO_0000685 and targets the gene ENSG00000089022
        at this locus (446244bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000089022
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '12'
      position: 111833788
    locus_GRCh38:
      chromosome: '12'
      position: 111395984
  trait_info:
    ontology:
    - EFO_0000685
    reported_trait_name: Rheumatoid arthritis [EA]
    standard_trait_name: rheumatoid arthritis
- association_info:
    ancestry:
    - East Asian=314
    gwas_catalog_id: GCST002293
    neg_log_pval: 7.301029995663981
    otg_id: GCST002293
    pubmed_id: '24277619'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Aldehyde dehydrogenase inhibitor drug DISULFIRAM is Phase IV for
        the indiciation EFO_0003829 and targets the gene ENSG00000111275 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000111275
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '12'
      position: 112241766
    locus_GRCh38:
      chromosome: '12'
      position: 111803962
  trait_info:
    ontology:
    - EFO_0003829
    reported_trait_name: Alcohol dependence
    standard_trait_name: alcohol dependence
- association_info:
    ancestry:
    - NR=7046
    - European=7320
    - NR, Hispanic or Latin American, African unspecified, Asian unspecified=636
    gwas_catalog_id: GCST002991
    neg_log_pval: 10.045757490560675
    otg_id: GCST002991
    pubmed_id: '26098869'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Tyrosine-protein kinase receptor FLT3 inhibitor drug SORAFENIB
        is Phase III for the indiciation EFO_0002618 and targets the gene ENSG00000122025
        at this locus (100433bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000122025
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '13'
      position: 28476978
    locus_GRCh38:
      chromosome: '13'
      position: 27902841
  trait_info:
    ontology:
    - EFO_0002618
    reported_trait_name: Pancreatic cancer
    standard_trait_name: pancreatic carcinoma
- association_info:
    ancestry:
    - NR=7046
    - European=7320
    - NR, Hispanic or Latin American, African unspecified, Asian unspecified=636
    gwas_catalog_id: GCST002991
    neg_log_pval: 10.045757490560675
    otg_id: GCST002991
    pubmed_id: '26098869'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tyrosine-protein kinase receptor FLT3 inhibitor drug ENMD-981693
        is Phase II for the indiciation EFO_0002618 and targets the gene ENSG00000122025
        at this locus (100433bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000122025
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '13'
      position: 28476978
    locus_GRCh38:
      chromosome: '13'
      position: 27902841
  trait_info:
    ontology:
    - EFO_0002618
    reported_trait_name: Pancreatic cancer
    standard_trait_name: pancreatic carcinoma
- association_info:
    ancestry:
    - European=21536
    gwas_catalog_id: GCST005434
    neg_log_pval: 13.301029995663981
    otg_id: GCST005434
    pubmed_id: '29422604'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Tyrosine-protein kinase receptor FLT3 inhibitor drug SORAFENIB
        is Phase III for the indiciation EFO_0002618 and targets the gene ENSG00000122025
        at this locus (83414bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000122025
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '13'
      position: 28493997
    locus_GRCh38:
      chromosome: '13'
      position: 27919860
  trait_info:
    ontology:
    - EFO_0002618
    reported_trait_name: Pancreatic cancer
    standard_trait_name: pancreatic carcinoma
- association_info:
    ancestry:
    - European=21536
    gwas_catalog_id: GCST005434
    neg_log_pval: 13.301029995663981
    otg_id: GCST005434
    pubmed_id: '29422604'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tyrosine-protein kinase receptor FLT3 inhibitor drug ENMD-981693
        is Phase II for the indiciation EFO_0002618 and targets the gene ENSG00000122025
        at this locus (83414bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000122025
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '13'
      position: 28493997
    locus_GRCh38:
      chromosome: '13'
      position: 27919860
  trait_info:
    ontology:
    - EFO_0002618
    reported_trait_name: Pancreatic cancer
    standard_trait_name: pancreatic carcinoma
- association_info:
    ancestry:
    - European=6785
    gwas_catalog_id: GCST002553
    neg_log_pval: 8.698970004336019
    otg_id: GCST002553
    pubmed_id: '25086665'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Tyrosine-protein kinase receptor FLT3 inhibitor drug SORAFENIB
        is Phase III for the indiciation EFO_0002618 and targets the gene ENSG00000122025
        at this locus (83414bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000122025
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '13'
      position: 28493997
    locus_GRCh38:
      chromosome: '13'
      position: 27919860
  trait_info:
    ontology:
    - EFO_0002618
    reported_trait_name: Pancreatic cancer
    standard_trait_name: pancreatic carcinoma
- association_info:
    ancestry:
    - European=6785
    gwas_catalog_id: GCST002553
    neg_log_pval: 8.698970004336019
    otg_id: GCST002553
    pubmed_id: '25086665'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tyrosine-protein kinase receptor FLT3 inhibitor drug ENMD-981693
        is Phase II for the indiciation EFO_0002618 and targets the gene ENSG00000122025
        at this locus (83414bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000122025
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '13'
      position: 28493997
    locus_GRCh38:
      chromosome: '13'
      position: 27919860
  trait_info:
    ontology:
    - EFO_0002618
    reported_trait_name: Pancreatic cancer
    standard_trait_name: pancreatic carcinoma
- association_info:
    ancestry:
    - European=459000
    gwas_catalog_id: GCST007072
    neg_log_pval: 11.698970004336019
    otg_id: GCST007072
    pubmed_id: '30595370'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Relaxin receptor 2 activator drug SERELAXIN is Phase IV for the
        indiciation EFO_0000319 and targets the gene ENSG00000133105 at this locus
        (67851bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000133105
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '13'
      position: 32245813
    locus_GRCh38:
      chromosome: '13'
      position: 31671676
  trait_info:
    ontology:
    - EFO_0000319
    reported_trait_name: Cardiovascular disease
    standard_trait_name: cardiovascular system disease
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 11.549904924128398
    otg_id: NEALE2_20002_1309
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Tumor necrosis factor ligand superfamily member 11 inhibitor drug
        DENOSUMAB is Phase IV for the indiciation EFO_0003882 and targets the gene
        ENSG00000120659 at this locus (184727bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000120659
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '13'
      position: 42952145
    locus_GRCh38:
      chromosome: '13'
      position: 42378009
  trait_info:
    ontology:
    - EFO_0003882
    reported_trait_name: Osteoporosis | non-cancer illness code, self-reported
    standard_trait_name: osteoporosis
- association_info:
    ancestry:
    - NR=250736
    gwas_catalog_id: GCST005196
    neg_log_pval: 11.096910013008056
    otg_id: GCST005196
    pubmed_id: '29212778'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Coagulation factor X inhibitor drug EDOXABAN is Phase IV for the
        indiciation EFO_0000378 and targets the gene ENSG00000126218 at this locus
        (145349bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000126218
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '13'
      position: 113631780
    locus_GRCh38:
      chromosome: '13'
      position: 112977466
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - NR=296525
    gwas_catalog_id: GCST005194
    neg_log_pval: 11.085445301482366
    otg_id: GCST005194
    pubmed_id: '29212778'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Coagulation factor X inhibitor drug EDOXABAN is Phase IV for the
        indiciation EFO_0000378 and targets the gene ENSG00000126218 at this locus
        (145349bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000126218
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '13'
      position: 113631780
    locus_GRCh38:
      chromosome: '13'
      position: 112977466
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - NR=250736
    gwas_catalog_id: GCST005196
    neg_log_pval: 11.096910013008056
    otg_id: GCST005196
    pubmed_id: '29212778'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Coagulation factor X inhibitor drug RIVAROXABAN is Phase III for
        the indiciation EFO_0000378 and targets the gene ENSG00000126218 at this locus
        (145349bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000126218
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '13'
      position: 113631780
    locus_GRCh38:
      chromosome: '13'
      position: 112977466
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - NR=296525
    gwas_catalog_id: GCST005194
    neg_log_pval: 11.085445301482366
    otg_id: GCST005194
    pubmed_id: '29212778'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Coagulation factor X inhibitor drug RIVAROXABAN is Phase III for
        the indiciation EFO_0000378 and targets the gene ENSG00000126218 at this locus
        (145349bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000126218
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '13'
      position: 113631780
    locus_GRCh38:
      chromosome: '13'
      position: 112977466
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - European=8071
    gwas_catalog_id: GCST001209
    neg_log_pval: 7.698970004336019
    otg_id: GCST001209
    pubmed_id: '21871595'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Coagulation factor X inhibitor drug RIVAROXABAN is Phase IV for
        the indiciation EFO_0002506 and targets the gene ENSG00000126218 at this locus
        (82619bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000126218
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '13'
      position: 113694509
    locus_GRCh38:
      chromosome: '13'
      position: 113040195
  trait_info:
    ontology:
    - EFO_0002506
    reported_trait_name: Osteoarthritis
    standard_trait_name: osteoarthritis
- association_info:
    ancestry:
    - European=1030836
    gwas_catalog_id: GCST006414
    neg_log_pval: 7.860750782428393
    otg_id: GCST006414
    pubmed_id: '30061737'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Coagulation factor X inhibitor drug BETRIXABAN is Phase II for
        the indiciation EFO_0000275 and targets the gene ENSG00000126218 at this locus
        (68870bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000126218
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '13'
      position: 113872712
    locus_GRCh38:
      chromosome: '13'
      position: 113218398
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=1030836
    gwas_catalog_id: GCST006414
    neg_log_pval: 7.860750782428393
    otg_id: GCST006414
    pubmed_id: '30061737'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Coagulation factor X inhibitor drug RIVAROXABAN is Phase IV for
        the indiciation EFO_0000275 and targets the gene ENSG00000126218 at this locus
        (68870bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000126218
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '13'
      position: 113872712
    locus_GRCh38:
      chromosome: '13'
      position: 113218398
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=1030836
    gwas_catalog_id: GCST006414
    neg_log_pval: 7.860750782428393
    otg_id: GCST006414
    pubmed_id: '30061737'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Coagulation factor X inhibitor drug IDRAPARINUX is Phase III for
        the indiciation EFO_0000275 and targets the gene ENSG00000126218 at this locus
        (68870bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000126218
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '13'
      position: 113872712
    locus_GRCh38:
      chromosome: '13'
      position: 113218398
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=140254
    gwas_catalog_id: GCST006085
    neg_log_pval: 7.698970004336019
    otg_id: GCST006085
    pubmed_id: '29892016'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: 26S proteosome inhibitor drug CARFILZOMIB is Phase II for the indiciation
        EFO_0001663 and targets the gene ENSG00000100804 at this locus (180104bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000100804
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '14'
      position: 23305649
    locus_GRCh38:
      chromosome: '14'
      position: 22836440
  trait_info:
    ontology:
    - EFO_0001663
    reported_trait_name: Prostate cancer
    standard_trait_name: prostate carcinoma
- association_info:
    ancestry:
    - European=140254
    gwas_catalog_id: GCST006085
    neg_log_pval: 7.698970004336019
    otg_id: GCST006085
    pubmed_id: '29892016'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Apoptosis regulator Bcl-W inhibitor drug NAVITOCLAX is Phase II
        for the indiciation EFO_0001663 and targets the gene ENSG00000258643 at this
        locus (470396bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000258643
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '14'
      position: 23305649
    locus_GRCh38:
      chromosome: '14'
      position: 22836440
  trait_info:
    ontology:
    - EFO_0001663
    reported_trait_name: Prostate cancer
    standard_trait_name: prostate carcinoma
- association_info:
    ancestry:
    - European=140254
    gwas_catalog_id: GCST006085
    neg_log_pval: 7.698970004336019
    otg_id: GCST006085
    pubmed_id: '29892016'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Apoptosis regulator Bcl-W inhibitor drug NAVITOCLAX is Phase II
        for the indiciation EFO_0001663 and targets the gene ENSG00000129473 at this
        locus (462350bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000129473
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '14'
      position: 23305649
    locus_GRCh38:
      chromosome: '14'
      position: 22836440
  trait_info:
    ontology:
    - EFO_0001663
    reported_trait_name: Prostate cancer
    standard_trait_name: prostate carcinoma
- association_info:
    ancestry:
    - African American or Afro-Caribbean=1452
    - European=2358
    - Hispanic or Latin American=1313
    gwas_catalog_id: GCST001912
    neg_log_pval: 11.045757490560675
    otg_id: GCST001912
    pubmed_id: '23512250'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: 26S proteosome inhibitor drug BORTEZOMIB is Phase III for the indiciation
        EFO_0000220 and targets the gene ENSG00000100804 at this locus (80894bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000100804
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '14'
      position: 23585333
    locus_GRCh38:
      chromosome: '14'
      position: 23116124
  trait_info:
    ontology:
    - EFO_0000220
    reported_trait_name: Acute lymphoblastic leukemia (childhood)
    standard_trait_name: acute lymphoblastic leukemia
- association_info:
    ancestry:
    - European=4735
    - Hispanic or Latin American=10533
    - African American or Afro-Caribbean=3972
    gwas_catalog_id: GCST005315
    neg_log_pval: 12.154901959985743
    otg_id: GCST005315
    pubmed_id: '29348612'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: 26S proteosome inhibitor drug BORTEZOMIB is Phase III for the indiciation
        EFO_0000220 and targets the gene ENSG00000100804 at this locus (84619bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000100804
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '14'
      position: 23589057
    locus_GRCh38:
      chromosome: '14'
      position: 23119848
  trait_info:
    ontology:
    - EFO_0000220
    reported_trait_name: Acute lymphoblastic leukemia (childhood)
    standard_trait_name: acute lymphoblastic leukemia
- association_info:
    ancestry:
    - European=893
    gwas_catalog_id: GCST001320
    neg_log_pval: 7.698970004336019
    otg_id: GCST001320_3
    pubmed_id: '22076464'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: 26S proteosome inhibitor drug BORTEZOMIB is Phase III for the indiciation
        EFO_0000220 and targets the gene ENSG00000100804 at this locus (84619bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000100804
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '14'
      position: 23589057
    locus_GRCh38:
      chromosome: '14'
      position: 23119848
  trait_info:
    ontology:
    - EFO_0000220
    reported_trait_name: Acute lymphoblastic leukemia (childhood) [ETV6-RUNX1 positive]
    standard_trait_name: acute lymphoblastic leukemia
- association_info:
    ancestry:
    - European=6381
    gwas_catalog_id: GCST002158
    neg_log_pval: 16.0
    otg_id: GCST002158
    pubmed_id: '23996088'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: 26S proteosome inhibitor drug BORTEZOMIB is Phase II for the indiciation
        EFO_0000094 and targets the gene ENSG00000100804 at this locus (84619bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000100804
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '14'
      position: 23589057
    locus_GRCh38:
      chromosome: '14'
      position: 23119848
  trait_info:
    ontology:
    - EFO_0000094
    reported_trait_name: Acute lymphoblastic leukemia (B-cell precursor)
    standard_trait_name: B-cell acute lymphoblastic leukemia
- association_info:
    ancestry:
    - European=893
    gwas_catalog_id: GCST001320
    neg_log_pval: 9.397940008672037
    otg_id: GCST001320
    pubmed_id: '22076464'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: 26S proteosome inhibitor drug BORTEZOMIB is Phase III for the indiciation
        EFO_0000220 and targets the gene ENSG00000100804 at this locus (84619bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000100804
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '14'
      position: 23589057
    locus_GRCh38:
      chromosome: '14'
      position: 23119848
  trait_info:
    ontology:
    - EFO_0000220
    reported_trait_name: Acute lymphoblastic leukemia (childhood)
    standard_trait_name: acute lymphoblastic leukemia
- association_info:
    ancestry:
    - European=17051
    gwas_catalog_id: GCST005832
    neg_log_pval: 13.301029995663981
    otg_id: GCST005832
    pubmed_id: '29632299'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: 26S proteosome inhibitor drug BORTEZOMIB is Phase II for the indiciation
        EFO_0000094 and targets the gene ENSG00000100804 at this locus (84619bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000100804
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '14'
      position: 23589057
    locus_GRCh38:
      chromosome: '14'
      position: 23119848
  trait_info:
    ontology:
    - EFO_0000094
    reported_trait_name: Acute lymphoblastic leukemia in childhood (B cell precursor)
    standard_trait_name: B-cell acute lymphoblastic leukemia
- association_info:
    ancestry:
    - European=480359
    gwas_catalog_id: GCST005839
    neg_log_pval: 9.096910013008056
    otg_id: GCST005839
    pubmed_id: '29700475'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Estrogen receptor beta modulator drug RALOXIFENE is Phase IV for
        the indiciation EFO_0003761 and targets the gene ENSG00000140009 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000140009
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '14'
      position: 64686207
    locus_GRCh38:
      chromosome: '14'
      position: 64219489
  trait_info:
    ontology:
    - EFO_0003761
    reported_trait_name: Depression
    standard_trait_name: unipolar depression
- association_info:
    ancestry:
    - East Asian=7394
    gwas_catalog_id: GCST003148
    neg_log_pval: 9.221848749616356
    otg_id: GCST003148
    pubmed_id: '26443449'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Estrogen receptor beta modulator drug ESTRAMUSTINE PHOSPHATE is
        Phase III for the indiciation EFO_0001663 and targets the gene ENSG00000140009
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000140009
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '14'
      position: 64693912
    locus_GRCh38:
      chromosome: '14'
      position: 64227194
  trait_info:
    ontology:
    - EFO_0001663
    reported_trait_name: Prostate cancer
    standard_trait_name: prostate carcinoma
- association_info:
    ancestry:
    - NR=361315
    - European=446238
    gwas_catalog_id: GCST007342
    neg_log_pval: 11.397940008672037
    otg_id: GCST007342
    pubmed_id: '30718901'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Estrogen receptor beta modulator drug RALOXIFENE is Phase IV for
        the indiciation EFO_0003761 and targets the gene ENSG00000140009 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000140009
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '14'
      position: 64697037
    locus_GRCh38:
      chromosome: '14'
      position: 64230319
  trait_info:
    ontology:
    - EFO_0003761
    reported_trait_name: Depression
    standard_trait_name: unipolar depression
- association_info:
    ancestry:
    - European=408961
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 9.172630726946174
    otg_id: SAIGE_366
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: GABA-A receptor; anion channel positive allosteric modulator drug
        MIDAZOLAM is Phase IV for the indiciation EFO_0001059 and targets the gene
        ENSG00000182256 at this locus (443188bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000182256
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '15'
      position: 28230318
    locus_GRCh38:
      chromosome: '15'
      position: 27985172
  trait_info:
    ontology:
    - EFO_0001059
    reported_trait_name: Cataract
    standard_trait_name: cataract
- association_info:
    ancestry:
    - European=11756
    gwas_catalog_id: GCST003524
    neg_log_pval: 12.301029995663981
    otg_id: GCST003524
    pubmed_id: '27135401'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Cytochrome P450 19A1 inhibitor drug LETROZOLE is Phase III for
        the indiciation EFO_1001512 and targets the gene ENSG00000137869 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000137869
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '15'
      position: 51537806
    locus_GRCh38:
      chromosome: '15'
      position: 51245609
  trait_info:
    ontology:
    - EFO_1001512
    reported_trait_name: Endometrial cancer
    standard_trait_name: endometrial carcinoma
- association_info:
    ancestry:
    - European=121885
    gwas_catalog_id: GCST006464
    neg_log_pval: 13.522878745280337
    otg_id: GCST006464
    pubmed_id: '30093612'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Cytochrome P450 19A1 inhibitor drug LETROZOLE is Phase III for
        the indiciation EFO_1001512 and targets the gene ENSG00000137869 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000137869
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '15'
      position: 51553909
    locus_GRCh38:
      chromosome: '15'
      position: 51261712
  trait_info:
    ontology:
    - EFO_1001512
    reported_trait_name: Endometrial cancer
    standard_trait_name: endometrial carcinoma
- association_info:
    ancestry:
    - European=54884
    gwas_catalog_id: GCST006465
    neg_log_pval: 9.698970004336019
    otg_id: GCST006465
    pubmed_id: '30093612'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Cytochrome P450 19A1 inhibitor drug LETROZOLE is Phase III for
        the indiciation EFO_1001512 and targets the gene ENSG00000137869 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000137869
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '15'
      position: 51553909
    locus_GRCh38:
      chromosome: '15'
      position: 51261712
  trait_info:
    ontology:
    - EFO_1001512
    reported_trait_name: Endometrial cancer (endometrioid histology)
    standard_trait_name: endometrial carcinoma
- association_info:
    ancestry:
    - European=20926
    - African American or Afro-Caribbean=2895
    gwas_catalog_id: GCST000675
    neg_log_pval: 8.0
    otg_id: GCST000675_2
    pubmed_id: '20445134'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Carbonic anhydrase XII inhibitor drug ACETAZOLAMIDE is Phase IV
        for the indiciation EFO_0003144 and targets the gene ENSG00000074410 at this
        locus (63881bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000074410
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '15'
      position: 63737925
    locus_GRCh38:
      chromosome: '15'
      position: 63445726
  trait_info:
    ontology:
    - EFO_0003144
    reported_trait_name: Heart failure [EA]
    standard_trait_name: heart failure
- association_info:
    ancestry:
    - European, NR=58918
    - European=458969
    gwas_catalog_id: GCST007656
    neg_log_pval: 12.0
    otg_id: GCST007656
    pubmed_id: '30940143'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Carbonic anhydrase XII inhibitor drug ACETAZOLAMIDE is Phase IV
        for the indiciation EFO_0000341 and targets the gene ENSG00000074410 at this
        locus (314720bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000074410
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: A
    locus_GRCh37:
      chromosome: '15'
      position: 63988765
    locus_GRCh38:
      chromosome: '15'
      position: 63696566
  trait_info:
    ontology:
    - EFO_0000341
    reported_trait_name: Chronic obstructive pulmonary disease or resting heart rate
      (pleiotropy)
    standard_trait_name: chronic obstructive pulmonary disease
- association_info:
    ancestry:
    - European=59133
    gwas_catalog_id: GCST001499
    neg_log_pval: 16.522878745280337
    otg_id: GCST001499
    pubmed_id: '22544366'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated
        channel 4 blocker drug DRONEDARONE is Phase IV for the indiciation EFO_0000275
        and targets the gene ENSG00000138622 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000138622
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '15'
      position: 73652174
    locus_GRCh38:
      chromosome: '15'
      position: 73359833
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=59133
    gwas_catalog_id: GCST001499
    neg_log_pval: 16.522878745280337
    otg_id: GCST001499
    pubmed_id: '22544366'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated
        channel 4 blocker drug IVABRADINE is Phase III for the indiciation EFO_0000275
        and targets the gene ENSG00000138622 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000138622
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '15'
      position: 73652174
    locus_GRCh38:
      chromosome: '15'
      position: 73359833
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=1030836
    gwas_catalog_id: GCST006414
    neg_log_pval: 35.32039042822024
    otg_id: GCST006414
    pubmed_id: '30061737'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated
        channel 4 blocker drug IVABRADINE is Phase III for the indiciation EFO_0000275
        and targets the gene ENSG00000138622 at this locus (5956bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000138622
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '15'
      position: 73667255
    locus_GRCh38:
      chromosome: '15'
      position: 73374914
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=1030836
    gwas_catalog_id: GCST006414
    neg_log_pval: 35.32039042822024
    otg_id: GCST006414
    pubmed_id: '30061737'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated
        channel 4 blocker drug DRONEDARONE is Phase IV for the indiciation EFO_0000275
        and targets the gene ENSG00000138622 at this locus (5956bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000138622
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '15'
      position: 73667255
    locus_GRCh38:
      chromosome: '15'
      position: 73374914
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=537409
    - East Asian=36792
    - African American or Afro-Caribbean=8967
    - Hispanic or Latin American=5022
    gwas_catalog_id: GCST006061
    neg_log_pval: 26.69897000433602
    otg_id: GCST006061_3
    pubmed_id: '29892015'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated
        channel 4 blocker drug IVABRADINE is Phase III for the indiciation EFO_0000275
        and targets the gene ENSG00000138622 at this locus (5956bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000138622
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '15'
      position: 73667255
    locus_GRCh38:
      chromosome: '15'
      position: 73374914
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation [EA]
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=537409
    - East Asian=36792
    - African American or Afro-Caribbean=8967
    - Hispanic or Latin American=5022
    gwas_catalog_id: GCST006061
    neg_log_pval: 26.69897000433602
    otg_id: GCST006061_3
    pubmed_id: '29892015'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated
        channel 4 blocker drug DRONEDARONE is Phase IV for the indiciation EFO_0000275
        and targets the gene ENSG00000138622 at this locus (5956bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000138622
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '15'
      position: 73667255
    locus_GRCh38:
      chromosome: '15'
      position: 73374914
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation [EA]
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=395739
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 14.522878745280337
    otg_id: SAIGE_427_2
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated
        channel 4 blocker drug IVABRADINE is Phase III for the indiciation EFO_0000275
        and targets the gene ENSG00000138622 at this locus (6748bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000138622
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '15'
      position: 73668046
    locus_GRCh38:
      chromosome: '15'
      position: 73375705
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation and flutter
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=395739
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 14.522878745280337
    otg_id: SAIGE_427_2
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated
        channel 4 blocker drug DRONEDARONE is Phase IV for the indiciation EFO_0000275
        and targets the gene ENSG00000138622 at this locus (6748bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000138622
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '15'
      position: 73668046
    locus_GRCh38:
      chromosome: '15'
      position: 73375705
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation and flutter
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=118755
    gwas_catalog_id: GCST004297
    neg_log_pval: 11.096910013008056
    otg_id: GCST004297
    pubmed_id: '28416818'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated
        channel 4 blocker drug IVABRADINE is Phase III for the indiciation EFO_0000275
        and targets the gene ENSG00000138622 at this locus (7708bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000138622
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '15'
      position: 73669006
    locus_GRCh38:
      chromosome: '15'
      position: 73376665
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=118755
    gwas_catalog_id: GCST004297
    neg_log_pval: 11.096910013008056
    otg_id: GCST004297
    pubmed_id: '28416818'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated
        channel 4 blocker drug DRONEDARONE is Phase IV for the indiciation EFO_0000275
        and targets the gene ENSG00000138622 at this locus (7708bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000138622
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '15'
      position: 73669006
    locus_GRCh38:
      chromosome: '15'
      position: 73376665
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=537409
    - East Asian=36792
    - African American or Afro-Caribbean=8967
    - Hispanic or Latin American=5022
    gwas_catalog_id: GCST006061
    neg_log_pval: 27.0
    otg_id: GCST006061
    pubmed_id: '29892015'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated
        channel 4 blocker drug IVABRADINE is Phase III for the indiciation EFO_0000275
        and targets the gene ENSG00000138622 at this locus (15966bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000138622
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '15'
      position: 73677264
    locus_GRCh38:
      chromosome: '15'
      position: 73384923
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=537409
    - East Asian=36792
    - African American or Afro-Caribbean=8967
    - Hispanic or Latin American=5022
    gwas_catalog_id: GCST006061
    neg_log_pval: 27.0
    otg_id: GCST006061
    pubmed_id: '29892015'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated
        channel 4 blocker drug DRONEDARONE is Phase IV for the indiciation EFO_0000275
        and targets the gene ENSG00000138622 at this locus (15966bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000138622
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '15'
      position: 73677264
    locus_GRCh38:
      chromosome: '15'
      position: 73384923
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=13574
    - NR=2380
    gwas_catalog_id: GCST004521
    neg_log_pval: 8.698970004336019
    otg_id: GCST004521
    pubmed_id: '28540026'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Glutamate [NMDA] receptor subunit epsilon 1 antagonist drug DEXTROMETHORPHAN
        is Phase II for the indiciation EFO_0000692 and targets the gene ENSG00000183454
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000183454
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '16'
      position: 9900057
    locus_GRCh38:
      chromosome: '16'
      position: 9806200
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Autism spectrum disorder or schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - European=13574
    - NR=2380
    gwas_catalog_id: GCST004521
    neg_log_pval: 8.698970004336019
    otg_id: GCST004521
    pubmed_id: '28540026'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Glutamate [NMDA] receptor subunit epsilon 1 antagonist drug DEXTROMETHORPHAN
        is Phase II for the indiciation EFO_0003756 and targets the gene ENSG00000183454
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000183454
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '16'
      position: 9900057
    locus_GRCh38:
      chromosome: '16'
      position: 9806200
  trait_info:
    ontology:
    - EFO_0003756
    reported_trait_name: Autism spectrum disorder or schizophrenia
    standard_trait_name: autism spectrum disorder
- association_info:
    ancestry:
    - European=105318
    gwas_catalog_id: GCST006803
    neg_log_pval: 8.221848749616356
    otg_id: GCST006803
    pubmed_id: '29483656'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Glutamate [NMDA] receptor subunit epsilon 1 antagonist drug DEXTROMETHORPHAN
        is Phase II for the indiciation EFO_0000692 and targets the gene ENSG00000183454
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000183454
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '16'
      position: 9900057
    locus_GRCh38:
      chromosome: '16'
      position: 9806200
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - East Asian=45528
    gwas_catalog_id: GCST007201
    neg_log_pval: 7.698970004336019
    otg_id: GCST007201
    pubmed_id: '30285260'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Glutamate [NMDA] receptor subunit epsilon 1 antagonist drug DEXTROMETHORPHAN
        is Phase II for the indiciation EFO_0000692 and targets the gene ENSG00000183454
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000183454
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '16'
      position: 9946319
    locus_GRCh38:
      chromosome: '16'
      position: 9852462
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - Other=1097
    - NR=150064
    gwas_catalog_id: GCST003048
    neg_log_pval: 8.698970004336019
    otg_id: GCST003048
    pubmed_id: '26198764'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Glutamate [NMDA] receptor subunit epsilon 1 antagonist drug DEXTROMETHORPHAN
        is Phase II for the indiciation EFO_0000692 and targets the gene ENSG00000183454
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000183454
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '16'
      position: 9946319
    locus_GRCh38:
      chromosome: '16'
      position: 9852462
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - East Asian=45528
    gwas_catalog_id: GCST007201
    neg_log_pval: 8.221848749616356
    otg_id: GCST007201_2
    pubmed_id: '30285260'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Glutamate [NMDA] receptor subunit epsilon 1 antagonist drug DEXTROMETHORPHAN
        is Phase II for the indiciation EFO_0000692 and targets the gene ENSG00000183454
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000183454
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '16'
      position: 9946319
    locus_GRCh38:
      chromosome: '16'
      position: 9852462
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia [EA]
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - European=82315
    - East Asian=5219
    gwas_catalog_id: GCST002539
    neg_log_pval: 8.0
    otg_id: GCST002539
    pubmed_id: '25056061'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Glutamate [NMDA] receptor subunit epsilon 1 antagonist drug DEXTROMETHORPHAN
        is Phase II for the indiciation EFO_0000692 and targets the gene ENSG00000183454
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000183454
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '16'
      position: 9946319
    locus_GRCh38:
      chromosome: '16'
      position: 9852462
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - East Asian=26026
    - European=82315
    gwas_catalog_id: GCST004946
    neg_log_pval: 8.522878745280337
    otg_id: GCST004946
    pubmed_id: '28991256'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Glutamate [NMDA] receptor subunit epsilon 1 antagonist drug DEXTROMETHORPHAN
        is Phase II for the indiciation EFO_0000692 and targets the gene ENSG00000183454
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000183454
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '16'
      position: 9946319
    locus_GRCh38:
      chromosome: '16'
      position: 9852462
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - European=28835
    gwas_catalog_id: GCST007797
    neg_log_pval: 8.301029995663981
    otg_id: GCST007797
    pubmed_id: '30929738'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-4 receptor subunit alpha antagonist drug DUPILUMAB
        is Phase III for the indiciation EFO_0000270 and targets the gene ENSG00000077238
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000077238
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '16'
      position: 27349168
    locus_GRCh38:
      chromosome: '16'
      position: 27337847
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma onset (childhood vs adult)
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 11.676747899828312
    otg_id: NEALE2_20002_1111
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-4 receptor subunit alpha antagonist drug DUPILUMAB
        is Phase III for the indiciation EFO_0000270 and targets the gene ENSG00000077238
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000077238
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '16'
      position: 27349168
    locus_GRCh38:
      chromosome: '16'
      position: 27337847
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma | non-cancer illness code, self-reported
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=459000
    gwas_catalog_id: GCST007076
    neg_log_pval: 15.301029995663981
    otg_id: GCST007076
    pubmed_id: '30595370'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-4 receptor subunit alpha antagonist drug DUPILUMAB
        is Phase II for the indiciation EFO_0000684 and targets the gene ENSG00000077238
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000077238
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '16'
      position: 27349168
    locus_GRCh38:
      chromosome: '16'
      position: 27337847
  trait_info:
    ontology:
    - EFO_0000684
    reported_trait_name: Respiratory diseases
    standard_trait_name: respiratory system disease
- association_info:
    ancestry:
    - European=360527
    neg_log_pval: 12.204815410317575
    otg_id: NEALE2_6152_8
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-4 receptor subunit alpha antagonist drug DUPILUMAB
        is Phase III for the indiciation EFO_0000270 and targets the gene ENSG00000077238
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000077238
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '16'
      position: 27349168
    locus_GRCh38:
      chromosome: '16'
      position: 27337847
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma | blood clot, dvt, bronchitis, emphysema, asthma,
      rhinitis, eczema, allergy diagnosed by doctor
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=401837
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 9.97061622231479
    otg_id: SAIGE_495
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-4 receptor subunit alpha antagonist drug DUPILUMAB
        is Phase III for the indiciation EFO_0000270 and targets the gene ENSG00000077238
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000077238
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '16'
      position: 27349438
    locus_GRCh38:
      chromosome: '16'
      position: 27338117
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=401837
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 8.866461091629782
    otg_id: SAIGE_495
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-4 receptor subunit alpha antagonist drug DUPILUMAB
        is Phase III for the indiciation EFO_0000270 and targets the gene ENSG00000077238
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000077238
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '16'
      position: 27355849
    locus_GRCh38:
      chromosome: '16'
      position: 27344528
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=341215
    gwas_catalog_id: GCST007798
    neg_log_pval: 19.397940008672037
    otg_id: GCST007798
    pubmed_id: '30929738'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-4 receptor subunit alpha antagonist drug DUPILUMAB
        is Phase III for the indiciation EFO_0000270 and targets the gene ENSG00000077238
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000077238
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '16'
      position: 27369502
    locus_GRCh38:
      chromosome: '16'
      position: 27358181
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 12.795880017344075
    otg_id: NEALE2_20002_1111
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-4 receptor subunit alpha antagonist drug DUPILUMAB
        is Phase III for the indiciation EFO_0000270 and targets the gene ENSG00000077238
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000077238
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '16'
      position: 27371424
    locus_GRCh38:
      chromosome: '16'
      position: 27360103
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma | non-cancer illness code, self-reported
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=360527
    neg_log_pval: 13.721246399047171
    otg_id: NEALE2_6152_8
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-4 receptor subunit alpha antagonist drug DUPILUMAB
        is Phase III for the indiciation EFO_0000270 and targets the gene ENSG00000077238
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000077238
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '16'
      position: 27371424
    locus_GRCh38:
      chromosome: '16'
      position: 27360103
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma | blood clot, dvt, bronchitis, emphysema, asthma,
      rhinitis, eczema, allergy diagnosed by doctor
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=459000
    gwas_catalog_id: GCST007075
    neg_log_pval: 8.096910013008056
    otg_id: GCST007075
    pubmed_id: '30595370'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Interleukin-4 receptor subunit alpha antagonist drug DUPILUMAB
        is Phase IV for the indiciation HP_0000964 and targets the gene ENSG00000077238
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000077238
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '16'
      position: 27371539
    locus_GRCh38:
      chromosome: '16'
      position: 27360218
  trait_info:
    ontology:
    - HP_0000964
    reported_trait_name: Eczema
    standard_trait_name: Eczema
- association_info:
    ancestry:
    - European=86475
    gwas_catalog_id: GCST005537
    neg_log_pval: 29.397940008672037
    otg_id: GCST005537
    pubmed_id: '26974007'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Integrin alpha-L/beta-2 (LFA-1) inhibitor drug EFALIZUMAB is Phase
        IV for the indiciation EFO_0000676 and targets the gene ENSG00000005844 at
        this locus (312964bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000005844
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: GT
    locus_GRCh37:
      chromosome: '16'
      position: 30171015
    locus_GRCh38:
      chromosome: '16'
      position: 30159694
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Chronic inflammatory diseases (ankylosing spondylitis, Crohn's
      disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
      [subset analysis]
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - East Asian=2252
    gwas_catalog_id: GCST000507
    neg_log_pval: 7.522878745280337
    otg_id: GCST000507
    pubmed_id: '19838193'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Integrin alpha-L/beta-2 (LFA-1) inhibitor drug EFALIZUMAB is Phase
        II for the indiciation EFO_0002690 and targets the gene ENSG00000005844 at
        this locus (108362bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000005844
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '16'
      position: 30642867
    locus_GRCh38:
      chromosome: '16'
      position: 30631546
  trait_info:
    ontology:
    - EFO_0002690
    reported_trait_name: Systemic lupus erythematosus
    standard_trait_name: systemic lupus erythematosus
- association_info:
    ancestry:
    - European=33394
    gwas_catalog_id: GCST005527
    neg_log_pval: 7.607581136972331
    otg_id: GCST005527
    pubmed_id: '23143594'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Integrin alpha-L/beta-2 (LFA-1) inhibitor drug EFALIZUMAB is Phase
        IV for the indiciation EFO_0000676 and targets the gene ENSG00000005844 at
        this locus (269751bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000005844
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '16'
      position: 30804257
    locus_GRCh38:
      chromosome: '16'
      position: 30792936
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - NR=4377
    gwas_catalog_id: GCST000834
    neg_log_pval: 9.045757490560675
    otg_id: GCST000834
    pubmed_id: '20953189'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Integrin alpha-L/beta-2 (LFA-1) inhibitor drug EFALIZUMAB is Phase
        IV for the indiciation EFO_0000676 and targets the gene ENSG00000005844 at
        this locus (408120bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000005844
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '16'
      position: 30942625
    locus_GRCh38:
      chromosome: '16'
      position: 30931304
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=86475
    gwas_catalog_id: GCST005537
    neg_log_pval: 10.0
    otg_id: GCST005537
    pubmed_id: '26974007'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Integrin alpha-L/beta-2 (LFA-1) inhibitor drug EFALIZUMAB is Phase
        IV for the indiciation EFO_0000676 and targets the gene ENSG00000005844 at
        this locus (436435bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000005844
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '16'
      position: 30970941
    locus_GRCh38:
      chromosome: '16'
      position: 30959620
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Chronic inflammatory diseases (ankylosing spondylitis, Crohn's
      disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
      [subset analysis]
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - East Asian=5134
    - European=8682
    gwas_catalog_id: GCST002874
    neg_log_pval: 7.698970004336019
    otg_id: GCST002874
    pubmed_id: '25903422'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Integrin alpha-L/beta-2 (LFA-1) inhibitor drug EFALIZUMAB is Phase
        IV for the indiciation EFO_0000676 and targets the gene ENSG00000005844 at
        this locus (466304bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000005844
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '16'
      position: 31000809
    locus_GRCh38:
      chromosome: '16'
      position: 30989488
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=287323
    gwas_catalog_id: GCST004346
    neg_log_pval: 15.0
    otg_id: GCST004346
    pubmed_id: '28537254'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Integrin alpha-L/beta-2 (LFA-1) inhibitor drug EFALIZUMAB is Phase
        IV for the indiciation EFO_0000676 and targets the gene ENSG00000005844 at
        this locus (486572bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000005844
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '16'
      position: 31021078
    locus_GRCh38:
      chromosome: '16'
      position: 31009757
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 9.289274371510311
    otg_id: NEALE2_20002_1065
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Sodium/glucose cotransporter 2 inhibitor drug DAPAGLIFLOZIN is
        Phase IV for the indiciation EFO_0000537 and targets the gene ENSG00000140675
        at this locus (345181bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000140675
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '16'
      position: 31149142
    locus_GRCh38:
      chromosome: '16'
      position: 31137821
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Hypertension | non-cancer illness code, self-reported
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - European=459000
    gwas_catalog_id: GCST007072
    neg_log_pval: 12.0
    otg_id: GCST007072
    pubmed_id: '30595370'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Sodium/glucose cotransporter 2 inhibitor drug EMPAGLIFLOZIN is
        Phase IV for the indiciation EFO_0000319 and targets the gene ENSG00000140675
        at this locus (345181bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000140675
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '16'
      position: 31149142
    locus_GRCh38:
      chromosome: '16'
      position: 31137821
  trait_info:
    ontology:
    - EFO_0000319
    reported_trait_name: Cardiovascular disease
    standard_trait_name: cardiovascular system disease
- association_info:
    ancestry:
    - European=22161
    gwas_catalog_id: GCST001003
    neg_log_pval: 8.045757490560675
    otg_id: GCST001003
    pubmed_id: '21386085'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Thiazide-sensitive sodium-chloride cotransporter inhibitor drug
        HYDROCHLOROTHIAZIDE is Phase IV for the indiciation EFO_0000195 and targets
        the gene ENSG00000070915 at this locus (38282bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000070915
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '16'
      position: 56988044
    locus_GRCh38:
      chromosome: '16'
      position: 56954132
  trait_info:
    ontology:
    - EFO_0000195
    reported_trait_name: Metabolic syndrome
    standard_trait_name: metabolic syndrome
- association_info:
    ancestry:
    - European=22161
    gwas_catalog_id: GCST001007
    neg_log_pval: 16.0
    otg_id: GCST001007_4
    pubmed_id: '21386085'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Thiazide-sensitive sodium-chloride cotransporter inhibitor drug
        HYDROCHLOROTHIAZIDE is Phase IV for the indiciation EFO_0000195 and targets
        the gene ENSG00000070915 at this locus (38282bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000070915
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '16'
      position: 56988044
    locus_GRCh38:
      chromosome: '16'
      position: 56954132
  trait_info:
    ontology:
    - EFO_0000195
    reported_trait_name: Metabolic syndrome (bivariate traits) [HDLC-WC]
    standard_trait_name: metabolic syndrome
- association_info:
    ancestry:
    - European=9618
    gwas_catalog_id: GCST004045
    neg_log_pval: 149.0
    otg_id: GCST004045
    pubmed_id: '27790247'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Cholesteryl ester transfer protein inhibitor drug ANACETRAPIB is
        Phase III for the indiciation EFO_0001645 and targets the gene ENSG00000087237
        at this locus (5120bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000087237
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '16'
      position: 56990716
    locus_GRCh38:
      chromosome: '16'
      position: 56956804
  trait_info:
    ontology:
    - EFO_0001645
    reported_trait_name: Age-related diseases, mortality and associated endophenotypes
    standard_trait_name: coronary heart disease
- association_info:
    ancestry:
    - European=9618
    gwas_catalog_id: GCST004045
    neg_log_pval: 149.0
    otg_id: GCST004045
    pubmed_id: '27790247'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Thiazide-sensitive sodium-chloride cotransporter inhibitor drug
        HYDROCHLOROTHIAZIDE is Phase IV for the indiciation EFO_0000400 and targets
        the gene ENSG00000070915 at this locus (40954bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000070915
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '16'
      position: 56990716
    locus_GRCh38:
      chromosome: '16'
      position: 56956804
  trait_info:
    ontology:
    - EFO_0000400
    reported_trait_name: Age-related diseases, mortality and associated endophenotypes
    standard_trait_name: diabetes mellitus
- association_info:
    ancestry:
    - European=9618
    gwas_catalog_id: GCST004045
    neg_log_pval: 149.0
    otg_id: GCST004045
    pubmed_id: '27790247'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Thiazide-sensitive sodium-chloride cotransporter inhibitor drug
        HYDROCHLOROTHIAZIDE is Phase IV for the indiciation EFO_0003144 and targets
        the gene ENSG00000070915 at this locus (40954bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000070915
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '16'
      position: 56990716
    locus_GRCh38:
      chromosome: '16'
      position: 56956804
  trait_info:
    ontology:
    - EFO_0003144
    reported_trait_name: Age-related diseases, mortality and associated endophenotypes
    standard_trait_name: heart failure
- association_info:
    ancestry:
    - European=10564
    gwas_catalog_id: GCST001436
    neg_log_pval: 59.045757490560675
    otg_id: GCST001436_2
    pubmed_id: '22399527'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Thiazide-sensitive sodium-chloride cotransporter inhibitor drug
        HYDROCHLOROTHIAZIDE is Phase IV for the indiciation EFO_0000195 and targets
        the gene ENSG00000070915 at this locus (40954bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000070915
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '16'
      position: 56990716
    locus_GRCh38:
      chromosome: '16'
      position: 56956804
  trait_info:
    ontology:
    - EFO_0000195
    reported_trait_name: Metabolic syndrome [HDL]
    standard_trait_name: metabolic syndrome
- association_info:
    ancestry:
    - European=22161
    gwas_catalog_id: GCST001007
    neg_log_pval: 12.522878745280337
    otg_id: GCST001007_2
    pubmed_id: '21386085'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Thiazide-sensitive sodium-chloride cotransporter inhibitor drug
        HYDROCHLOROTHIAZIDE is Phase IV for the indiciation EFO_0000195 and targets
        the gene ENSG00000070915 at this locus (43562bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000070915
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '16'
      position: 56993324
    locus_GRCh38:
      chromosome: '16'
      position: 56959412
  trait_info:
    ontology:
    - EFO_0000195
    reported_trait_name: Metabolic syndrome (bivariate traits) [BP-HDLC]
    standard_trait_name: metabolic syndrome
- association_info:
    ancestry:
    - South Asian=2554
    gwas_catalog_id: GCST000753
    neg_log_pval: 48.0
    otg_id: GCST000753_3
    pubmed_id: '20694148'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Thiazide-sensitive sodium-chloride cotransporter inhibitor drug
        HYDROCHLOROTHIAZIDE is Phase IV for the indiciation EFO_0000195 and targets
        the gene ENSG00000070915 at this locus (43562bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000070915
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '16'
      position: 56993324
    locus_GRCh38:
      chromosome: '16'
      position: 56959412
  trait_info:
    ontology:
    - EFO_0000195
    reported_trait_name: Metabolic syndrome [HDL]
    standard_trait_name: metabolic syndrome
- association_info:
    ancestry:
    - European=22161
    gwas_catalog_id: GCST001007
    neg_log_pval: 11.154901959985743
    otg_id: GCST001007_3
    pubmed_id: '21386085'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Thiazide-sensitive sodium-chloride cotransporter inhibitor drug
        HYDROCHLOROTHIAZIDE is Phase IV for the indiciation EFO_0000195 and targets
        the gene ENSG00000070915 at this locus (52971bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000070915
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '16'
      position: 57002732
    locus_GRCh38:
      chromosome: '16'
      position: 56968820
  trait_info:
    ontology:
    - EFO_0000195
    reported_trait_name: Metabolic syndrome (bivariate traits) [HDLC-GLUC]
    standard_trait_name: metabolic syndrome
- association_info:
    ancestry:
    - European=67543
    - Sub-Saharan African, African American or Afro-Caribbean=10463
    - East Asian=6954
    - Hispanic or Latin American=2080
    gwas_catalog_id: GCST002606
    neg_log_pval: 7.522878745280337
    otg_id: GCST002606
    pubmed_id: '25217961'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dihydroorotate dehydrogenase inhibitor drug LEFLUNOMIDE is Phase
        II for the indiciation EFO_0001663 and targets the gene ENSG00000102967 at
        this locus (351162bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000102967
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '16'
      position: 71691329
    locus_GRCh38:
      chromosome: '16'
      position: 71657426
  trait_info:
    ontology:
    - EFO_0001663
    reported_trait_name: Prostate cancer
    standard_trait_name: prostate carcinoma
- association_info:
    ancestry:
    - European=455221
    gwas_catalog_id: GCST007093
    neg_log_pval: 9.698970004336019
    otg_id: GCST007093
    pubmed_id: '30664745'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug COLCHICINE is Phase II for the indiciation
        EFO_0002506 and targets the gene ENSG00000258947 at this locus (283436bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000258947
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '16'
      position: 89704365
    locus_GRCh38:
      chromosome: '16'
      position: 89637957
  trait_info:
    ontology:
    - EFO_0002506
    reported_trait_name: Osteoarthritis
    standard_trait_name: osteoarthritis
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 33.803837637410474
    otg_id: NEALE2_20001_1059
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug DOCETAXEL is Phase II for the indiciation
        EFO_0000756 and targets the gene ENSG00000258947 at this locus (251643bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000258947
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '16'
      position: 89736157
    locus_GRCh38:
      chromosome: '16'
      position: 89669749
  trait_info:
    ontology:
    - EFO_0000756
    reported_trait_name: Malignant melanoma | cancer code, self-reported
    standard_trait_name: melanoma
- association_info:
    ancestry:
    - European=61457
    gwas_catalog_id: GCST003327
    neg_log_pval: 20.0
    otg_id: GCST003327_3
    pubmed_id: '26829030'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug DOCETAXEL is Phase IV for the indiciation
        EFO_0000707 and targets the gene ENSG00000258947 at this locus (251643bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000258947
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '16'
      position: 89736157
    locus_GRCh38:
      chromosome: '16'
      position: 89669749
  trait_info:
    ontology:
    - EFO_0000707
    reported_trait_name: Squamous cell carcinoma [adjusted for rs4268748]
    standard_trait_name: squamous cell carcinoma
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 33.803837637410474
    otg_id: NEALE2_20001_1059
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug PACLITAXEL is Phase III for the indiciation
        EFO_0000756 and targets the gene ENSG00000258947 at this locus (251643bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000258947
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '16'
      position: 89736157
    locus_GRCh38:
      chromosome: '16'
      position: 89669749
  trait_info:
    ontology:
    - EFO_0000756
    reported_trait_name: Malignant melanoma | cancer code, self-reported
    standard_trait_name: melanoma
- association_info:
    ancestry:
    - European=61457
    gwas_catalog_id: GCST003327
    neg_log_pval: 20.0
    otg_id: GCST003327_3
    pubmed_id: '26829030'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug PACLITAXEL is Phase III for the indiciation
        EFO_0000707 and targets the gene ENSG00000258947 at this locus (251643bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000258947
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '16'
      position: 89736157
    locus_GRCh38:
      chromosome: '16'
      position: 89669749
  trait_info:
    ontology:
    - EFO_0000707
    reported_trait_name: Squamous cell carcinoma [adjusted for rs4268748]
    standard_trait_name: squamous cell carcinoma
- association_info:
    ancestry:
    - European=10422
    gwas_catalog_id: GCST001267
    neg_log_pval: 26.522878745280337
    otg_id: GCST001267
    pubmed_id: '21983787'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug VINBLASTINE is Phase III for the indiciation
        EFO_0000756 and targets the gene ENSG00000258947 at this locus (231898bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000258947
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '16'
      position: 89755903
    locus_GRCh38:
      chromosome: '16'
      position: 89689495
  trait_info:
    ontology:
    - EFO_0000756
    reported_trait_name: Melanoma
    standard_trait_name: melanoma
- association_info:
    ancestry:
    - European=291407
    gwas_catalog_id: GCST004142
    neg_log_pval: 26.522878745280337
    otg_id: GCST004142
    pubmed_id: '28212542'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug VINBLASTINE is Phase III for the indiciation
        EFO_0000756 and targets the gene ENSG00000258947 at this locus (231898bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000258947
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '16'
      position: 89755903
    locus_GRCh38:
      chromosome: '16'
      position: 89689495
  trait_info:
    ontology:
    - EFO_0000756
    reported_trait_name: Melanoma
    standard_trait_name: melanoma
- association_info:
    ancestry:
    - European=291407
    gwas_catalog_id: GCST004142
    neg_log_pval: 26.522878745280337
    otg_id: GCST004142
    pubmed_id: '28212542'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug IXABEPILONE is Phase II for the indiciation
        EFO_0000756 and targets the gene ENSG00000258947 at this locus (231898bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000258947
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '16'
      position: 89755903
    locus_GRCh38:
      chromosome: '16'
      position: 89689495
  trait_info:
    ontology:
    - EFO_0000756
    reported_trait_name: Melanoma
    standard_trait_name: melanoma
- association_info:
    ancestry:
    - European=6122
    gwas_catalog_id: GCST002514
    neg_log_pval: 8.698970004336019
    otg_id: GCST002514
    pubmed_id: '24980573'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug IXABEPILONE is Phase II for the indiciation
        EFO_0000756 and targets the gene ENSG00000258947 at this locus (231898bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000258947
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '16'
      position: 89755903
    locus_GRCh38:
      chromosome: '16'
      position: 89689495
  trait_info:
    ontology:
    - EFO_0000756
    reported_trait_name: Melanoma
    standard_trait_name: melanoma
- association_info:
    ancestry:
    - European=5456
    gwas_catalog_id: GCST000437
    neg_log_pval: 26.522878745280337
    otg_id: GCST000437
    pubmed_id: '19578364'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug VINBLASTINE is Phase III for the indiciation
        EFO_0000756 and targets the gene ENSG00000258947 at this locus (231898bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000258947
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '16'
      position: 89755903
    locus_GRCh38:
      chromosome: '16'
      position: 89689495
  trait_info:
    ontology:
    - EFO_0000756
    reported_trait_name: Melanoma
    standard_trait_name: melanoma
- association_info:
    ancestry:
    - European=5456
    gwas_catalog_id: GCST000437
    neg_log_pval: 26.522878745280337
    otg_id: GCST000437
    pubmed_id: '19578364'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug IXABEPILONE is Phase II for the indiciation
        EFO_0000756 and targets the gene ENSG00000258947 at this locus (231898bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000258947
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '16'
      position: 89755903
    locus_GRCh38:
      chromosome: '16'
      position: 89689495
  trait_info:
    ontology:
    - EFO_0000756
    reported_trait_name: Melanoma
    standard_trait_name: melanoma
- association_info:
    ancestry:
    - European=10422
    gwas_catalog_id: GCST001267
    neg_log_pval: 26.522878745280337
    otg_id: GCST001267
    pubmed_id: '21983787'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug IXABEPILONE is Phase II for the indiciation
        EFO_0000756 and targets the gene ENSG00000258947 at this locus (231898bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000258947
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '16'
      position: 89755903
    locus_GRCh38:
      chromosome: '16'
      position: 89689495
  trait_info:
    ontology:
    - EFO_0000756
    reported_trait_name: Melanoma
    standard_trait_name: melanoma
- association_info:
    ancestry:
    - European=6122
    gwas_catalog_id: GCST002514
    neg_log_pval: 8.698970004336019
    otg_id: GCST002514
    pubmed_id: '24980573'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug VINBLASTINE is Phase III for the indiciation
        EFO_0000756 and targets the gene ENSG00000258947 at this locus (231898bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000258947
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '16'
      position: 89755903
    locus_GRCh38:
      chromosome: '16'
      position: 89689495
  trait_info:
    ontology:
    - EFO_0000756
    reported_trait_name: Melanoma
    standard_trait_name: melanoma
- association_info:
    ancestry:
    - European=58607
    neg_log_pval: 11.396639075651619
    otg_id: NEALE2_40009
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug DOCETAXEL is Phase III for the indiciation
        EFO_0000311 and targets the gene ENSG00000258947 at this locus (141123bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000258947
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '16'
      position: 89846677
    locus_GRCh38:
      chromosome: '16'
      position: 89780269
  trait_info:
    ontology:
    - EFO_0000311
    reported_trait_name: Reported occurrences of cancer
    standard_trait_name: cancer
- association_info:
    ancestry:
    - European=88583
    gwas_catalog_id: GCST007505
    neg_log_pval: 44.69897000433602
    otg_id: GCST007505
    pubmed_id: '30429480'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug VINORELBINE is Phase II for the indiciation
        EFO_0000389 and targets the gene ENSG00000258947 at this locus (141123bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000258947
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '16'
      position: 89846677
    locus_GRCh38:
      chromosome: '16'
      position: 89780269
  trait_info:
    ontology:
    - EFO_0000389
    reported_trait_name: Nevus count or cutaneous melanoma
    standard_trait_name: skin melanoma
- association_info:
    ancestry:
    - European=58607
    neg_log_pval: 11.396639075651619
    otg_id: NEALE2_40009
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug ERIBULIN is Phase II for the indiciation
        EFO_0000311 and targets the gene ENSG00000258947 at this locus (141123bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000258947
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '16'
      position: 89846677
    locus_GRCh38:
      chromosome: '16'
      position: 89780269
  trait_info:
    ontology:
    - EFO_0000311
    reported_trait_name: Reported occurrences of cancer
    standard_trait_name: cancer
- association_info:
    ancestry:
    - European=88583
    gwas_catalog_id: GCST007505
    neg_log_pval: 44.69897000433602
    otg_id: GCST007505
    pubmed_id: '30429480'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug PACLITAXEL is Phase III for the indiciation
        EFO_0000389 and targets the gene ENSG00000258947 at this locus (141123bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000258947
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '16'
      position: 89846677
    locus_GRCh38:
      chromosome: '16'
      position: 89780269
  trait_info:
    ontology:
    - EFO_0000389
    reported_trait_name: Nevus count or cutaneous melanoma
    standard_trait_name: skin melanoma
- association_info:
    ancestry:
    - European=58607
    neg_log_pval: 11.396639075651619
    otg_id: NEALE2_40009
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug PACLITAXEL is Phase IV for the indiciation
        EFO_0000311 and targets the gene ENSG00000258947 at this locus (141123bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000258947
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '16'
      position: 89846677
    locus_GRCh38:
      chromosome: '16'
      position: 89780269
  trait_info:
    ontology:
    - EFO_0000311
    reported_trait_name: Reported occurrences of cancer
    standard_trait_name: cancer
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 12.303643611266669
    otg_id: NEALE2_20001_1059
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug PACLITAXEL is Phase III for the indiciation
        EFO_0000756 and targets the gene ENSG00000258947 at this locus (36274bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000258947
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '16'
      position: 89951527
    locus_GRCh38:
      chromosome: '16'
      position: 89885119
  trait_info:
    ontology:
    - EFO_0000756
    reported_trait_name: Malignant melanoma | cancer code, self-reported
    standard_trait_name: melanoma
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 12.303643611266669
    otg_id: NEALE2_20001_1059
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug DOCETAXEL is Phase II for the indiciation
        EFO_0000756 and targets the gene ENSG00000258947 at this locus (36274bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000258947
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '16'
      position: 89951527
    locus_GRCh38:
      chromosome: '16'
      position: 89885119
  trait_info:
    ontology:
    - EFO_0000756
    reported_trait_name: Malignant melanoma | cancer code, self-reported
    standard_trait_name: melanoma
- association_info:
    ancestry:
    - European=406033
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 14.698970004336019
    otg_id: SAIGE_702_1
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug PACLITAXEL is Phase II for the indiciation
        EFO_0002496 and targets the gene ENSG00000258947 at this locus (1683bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000258947
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '16'
      position: 89986117
    locus_GRCh38:
      chromosome: '16'
      position: 89919709
  trait_info:
    ontology:
    - EFO_0002496
    reported_trait_name: Actinic keratosis
    standard_trait_name: actinic keratosis
- association_info:
    ancestry:
    - European=397762
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 28.661543506395397
    otg_id: SAIGE_172_11
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug VINORELBINE is Phase II for the indiciation
        EFO_0000389 and targets the gene ENSG00000258947 at this locus (1683bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000258947
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '16'
      position: 89986117
    locus_GRCh38:
      chromosome: '16'
      position: 89919709
  trait_info:
    ontology:
    - EFO_0000389
    reported_trait_name: Melanomas of skin
    standard_trait_name: skin melanoma
- association_info:
    ancestry:
    - European=291407
    gwas_catalog_id: GCST004142
    neg_log_pval: 36.39794000867204
    otg_id: GCST004142
    pubmed_id: '28212542'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug PACLITAXEL is Phase III for the indiciation
        EFO_0000756 and targets the gene ENSG00000258947 at this locus (1683bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000258947
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '16'
      position: 89986117
    locus_GRCh38:
      chromosome: '16'
      position: 89919709
  trait_info:
    ontology:
    - EFO_0000756
    reported_trait_name: Melanoma
    standard_trait_name: melanoma
- association_info:
    ancestry:
    - European=291407
    gwas_catalog_id: GCST004142
    neg_log_pval: 36.39794000867204
    otg_id: GCST004142
    pubmed_id: '28212542'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug IXABEPILONE is Phase II for the indiciation
        EFO_0000756 and targets the gene ENSG00000258947 at this locus (1683bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000258947
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '16'
      position: 89986117
    locus_GRCh38:
      chromosome: '16'
      position: 89919709
  trait_info:
    ontology:
    - EFO_0000756
    reported_trait_name: Melanoma
    standard_trait_name: melanoma
- association_info:
    ancestry:
    - European=287137
    gwas_catalog_id: GCST003655
    neg_log_pval: 38.045757490560675
    otg_id: GCST003655
    pubmed_id: '27424798'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug PACLITAXEL is Phase II for the indiciation
        EFO_1001927 and targets the gene ENSG00000258947 at this locus (1683bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000258947
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '16'
      position: 89986117
    locus_GRCh38:
      chromosome: '16'
      position: 89919709
  trait_info:
    ontology:
    - EFO_1001927
    reported_trait_name: Cutaneous squamous cell carcinoma
    standard_trait_name: cutaneous squamous cell carcinoma
- association_info:
    ancestry:
    - European=397762
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 28.661543506395397
    otg_id: SAIGE_172_11
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug PACLITAXEL is Phase III for the indiciation
        EFO_0000389 and targets the gene ENSG00000258947 at this locus (1683bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000258947
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '16'
      position: 89986117
    locus_GRCh38:
      chromosome: '16'
      position: 89919709
  trait_info:
    ontology:
    - EFO_0000389
    reported_trait_name: Melanomas of skin
    standard_trait_name: skin melanoma
- association_info:
    ancestry:
    - European=397762
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 28.661543506395397
    otg_id: SAIGE_172_1
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug PACLITAXEL is Phase III for the indiciation
        EFO_0000389 and targets the gene ENSG00000258947 at this locus (1683bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000258947
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '16'
      position: 89986117
    locus_GRCh38:
      chromosome: '16'
      position: 89919709
  trait_info:
    ontology:
    - EFO_0000389
    reported_trait_name: Melanomas of skin, dx or hx
    standard_trait_name: skin melanoma
- association_info:
    ancestry:
    - European=397762
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 28.661543506395397
    otg_id: SAIGE_172_1
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug VINORELBINE is Phase II for the indiciation
        EFO_0000389 and targets the gene ENSG00000258947 at this locus (1683bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000258947
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '16'
      position: 89986117
    locus_GRCh38:
      chromosome: '16'
      position: 89919709
  trait_info:
    ontology:
    - EFO_0000389
    reported_trait_name: Melanomas of skin, dx or hx
    standard_trait_name: skin melanoma
- association_info:
    ancestry:
    - European=397762
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 9.339134521996131
    otg_id: SAIGE_172_11
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug PACLITAXEL is Phase III for the indiciation
        EFO_0000389 and targets the gene ENSG00000258947 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000258947
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '16'
      position: 89990843
    locus_GRCh38:
      chromosome: '16'
      position: 89924435
  trait_info:
    ontology:
    - EFO_0000389
    reported_trait_name: Melanomas of skin
    standard_trait_name: skin melanoma
- association_info:
    ancestry:
    - European=397762
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 9.339134521996131
    otg_id: SAIGE_172_11
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug VINORELBINE is Phase II for the indiciation
        EFO_0000389 and targets the gene ENSG00000258947 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000258947
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '16'
      position: 89990843
    locus_GRCh38:
      chromosome: '16'
      position: 89924435
  trait_info:
    ontology:
    - EFO_0000389
    reported_trait_name: Melanomas of skin
    standard_trait_name: skin melanoma
- association_info:
    ancestry:
    - European=397762
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 9.339134521996131
    otg_id: SAIGE_172_1
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug VINORELBINE is Phase II for the indiciation
        EFO_0000389 and targets the gene ENSG00000258947 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000258947
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '16'
      position: 89990843
    locus_GRCh38:
      chromosome: '16'
      position: 89924435
  trait_info:
    ontology:
    - EFO_0000389
    reported_trait_name: Melanomas of skin, dx or hx
    standard_trait_name: skin melanoma
- association_info:
    ancestry:
    - European=397762
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 9.339134521996131
    otg_id: SAIGE_172_1
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug PACLITAXEL is Phase III for the indiciation
        EFO_0000389 and targets the gene ENSG00000258947 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000258947
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '16'
      position: 89990843
    locus_GRCh38:
      chromosome: '16'
      position: 89924435
  trait_info:
    ontology:
    - EFO_0000389
    reported_trait_name: Melanomas of skin, dx or hx
    standard_trait_name: skin melanoma
- association_info:
    ancestry:
    - European=359981
    neg_log_pval: 12.515700160653214
    otg_id: NEALE2_2453
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug DOCETAXEL is Phase III for the indiciation
        EFO_0000311 and targets the gene ENSG00000258947 at this locus (19038bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000258947
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '16'
      position: 90024206
    locus_GRCh38:
      chromosome: '16'
      position: 89957798
  trait_info:
    ontology:
    - EFO_0000311
    reported_trait_name: Cancer diagnosed by doctor
    standard_trait_name: cancer
- association_info:
    ancestry:
    - European=359981
    neg_log_pval: 12.515700160653214
    otg_id: NEALE2_2453
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug VINORELBINE is Phase II for the indiciation
        EFO_0000311 and targets the gene ENSG00000258947 at this locus (19038bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000258947
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '16'
      position: 90024206
    locus_GRCh38:
      chromosome: '16'
      position: 89957798
  trait_info:
    ontology:
    - EFO_0000311
    reported_trait_name: Cancer diagnosed by doctor
    standard_trait_name: cancer
- association_info:
    ancestry:
    - European=359981
    neg_log_pval: 12.515700160653214
    otg_id: NEALE2_2453
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug PACLITAXEL is Phase IV for the indiciation
        EFO_0000311 and targets the gene ENSG00000258947 at this locus (19038bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000258947
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '16'
      position: 90024206
    locus_GRCh38:
      chromosome: '16'
      position: 89957798
  trait_info:
    ontology:
    - EFO_0000311
    reported_trait_name: Cancer diagnosed by doctor
    standard_trait_name: cancer
- association_info:
    ancestry:
    - European=61457
    gwas_catalog_id: GCST003327
    neg_log_pval: 43.69897000433602
    otg_id: GCST003327
    pubmed_id: '26829030'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug PACLITAXEL is Phase III for the indiciation
        EFO_0000707 and targets the gene ENSG00000258947 at this locus (21343bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000258947
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '16'
      position: 90026512
    locus_GRCh38:
      chromosome: '16'
      position: 89960104
  trait_info:
    ontology:
    - EFO_0000707
    reported_trait_name: Squamous cell carcinoma
    standard_trait_name: squamous cell carcinoma
- association_info:
    ancestry:
    - European=61457
    gwas_catalog_id: GCST003327
    neg_log_pval: 43.69897000433602
    otg_id: GCST003327
    pubmed_id: '26829030'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug DOCETAXEL is Phase IV for the indiciation
        EFO_0000707 and targets the gene ENSG00000258947 at this locus (21343bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000258947
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '16'
      position: 90026512
    locus_GRCh38:
      chromosome: '16'
      position: 89960104
  trait_info:
    ontology:
    - EFO_0000707
    reported_trait_name: Squamous cell carcinoma
    standard_trait_name: squamous cell carcinoma
- association_info:
    ancestry:
    - European=13550
    gwas_catalog_id: GCST003422
    neg_log_pval: 8.698970004336019
    otg_id: GCST003422
    pubmed_id: '26908436'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug DOCETAXEL is Phase IV for the indiciation
        EFO_0000707 and targets the gene ENSG00000258947 at this locus (22458bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000258947
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: A
    locus_GRCh37:
      chromosome: '16'
      position: 90027626
    locus_GRCh38:
      chromosome: '16'
      position: 89961218
  trait_info:
    ontology:
    - EFO_0000707
    reported_trait_name: Squamous cell carcinoma
    standard_trait_name: squamous cell carcinoma
- association_info:
    ancestry:
    - European=13550
    gwas_catalog_id: GCST003422
    neg_log_pval: 8.698970004336019
    otg_id: GCST003422
    pubmed_id: '26908436'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug PACLITAXEL is Phase III for the indiciation
        EFO_0000707 and targets the gene ENSG00000258947 at this locus (22458bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000258947
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: A
    locus_GRCh37:
      chromosome: '16'
      position: 90027626
    locus_GRCh38:
      chromosome: '16'
      position: 89961218
  trait_info:
    ontology:
    - EFO_0000707
    reported_trait_name: Squamous cell carcinoma
    standard_trait_name: squamous cell carcinoma
- association_info:
    ancestry:
    - European=291407
    gwas_catalog_id: GCST004142
    neg_log_pval: 21.221848749616356
    otg_id: GCST004142
    pubmed_id: '28212542'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug PACLITAXEL is Phase III for the indiciation
        EFO_0000756 and targets the gene ENSG00000258947 at this locus (61767bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000258947
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '16'
      position: 90066936
    locus_GRCh38:
      chromosome: '16'
      position: 90000528
  trait_info:
    ontology:
    - EFO_0000756
    reported_trait_name: Melanoma
    standard_trait_name: melanoma
- association_info:
    ancestry:
    - European=5456
    gwas_catalog_id: GCST000437
    neg_log_pval: 21.221848749616356
    otg_id: GCST000437
    pubmed_id: '19578364'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug PACLITAXEL is Phase III for the indiciation
        EFO_0000756 and targets the gene ENSG00000258947 at this locus (61767bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000258947
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '16'
      position: 90066936
    locus_GRCh38:
      chromosome: '16'
      position: 90000528
  trait_info:
    ontology:
    - EFO_0000756
    reported_trait_name: Melanoma
    standard_trait_name: melanoma
- association_info:
    ancestry:
    - European=291407
    gwas_catalog_id: GCST004142
    neg_log_pval: 21.221848749616356
    otg_id: GCST004142
    pubmed_id: '28212542'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug IXABEPILONE is Phase II for the indiciation
        EFO_0000756 and targets the gene ENSG00000258947 at this locus (61767bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000258947
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '16'
      position: 90066936
    locus_GRCh38:
      chromosome: '16'
      position: 90000528
  trait_info:
    ontology:
    - EFO_0000756
    reported_trait_name: Melanoma
    standard_trait_name: melanoma
- association_info:
    ancestry:
    - European=5456
    gwas_catalog_id: GCST000437
    neg_log_pval: 21.221848749616356
    otg_id: GCST000437
    pubmed_id: '19578364'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug IXABEPILONE is Phase II for the indiciation
        EFO_0000756 and targets the gene ENSG00000258947 at this locus (61767bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000258947
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '16'
      position: 90066936
    locus_GRCh38:
      chromosome: '16'
      position: 90000528
  trait_info:
    ontology:
    - EFO_0000756
    reported_trait_name: Melanoma
    standard_trait_name: melanoma
- association_info:
    ancestry:
    - European=298957
    - South Asian, East Asian, African American or Afro-Caribbean, Hispanic or Latin
      American=153287
    gwas_catalog_id: GCST007515
    neg_log_pval: 10.096910013008056
    otg_id: GCST007515
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Vanilloid receptor opener drug ACETAMINOPHEN is Phase IV for the
        indiciation EFO_0001360 and targets the gene ENSG00000196689 at this locus
        (434940bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000196689
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '17'
      position: 3947644
    locus_GRCh38:
      chromosome: '17'
      position: 4044350
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    - South Asian, East Asian, African American or Afro-Caribbean, Hispanic or Latin
      American=153287
    gwas_catalog_id: GCST007515
    neg_log_pval: 10.096910013008056
    otg_id: GCST007515
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Vanilloid receptor antagonist drug XEN-D0501 is Phase II for the
        indiciation EFO_0001360 and targets the gene ENSG00000196689 at this locus
        (434940bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000196689
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '17'
      position: 3947644
    locus_GRCh38:
      chromosome: '17'
      position: 4044350
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    gwas_catalog_id: GCST007517
    neg_log_pval: 10.045757490560675
    otg_id: GCST007517
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Vanilloid receptor antagonist drug XEN-D0501 is Phase II for the
        indiciation EFO_0001360 and targets the gene ENSG00000196689 at this locus
        (440397bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000196689
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '17'
      position: 3953102
    locus_GRCh38:
      chromosome: '17'
      position: 4049808
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    gwas_catalog_id: GCST007518
    neg_log_pval: 8.096910013008056
    otg_id: GCST007518
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Vanilloid receptor antagonist drug XEN-D0501 is Phase II for the
        indiciation EFO_0001360 and targets the gene ENSG00000196689 at this locus
        (440397bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000196689
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '17'
      position: 3953102
    locus_GRCh38:
      chromosome: '17'
      position: 4049808
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes (adjusted for BMI)
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    gwas_catalog_id: GCST007518
    neg_log_pval: 8.096910013008056
    otg_id: GCST007518
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Vanilloid receptor opener drug ACETAMINOPHEN is Phase IV for the
        indiciation EFO_0001360 and targets the gene ENSG00000196689 at this locus
        (440397bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000196689
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '17'
      position: 3953102
    locus_GRCh38:
      chromosome: '17'
      position: 4049808
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes (adjusted for BMI)
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    gwas_catalog_id: GCST007517
    neg_log_pval: 10.045757490560675
    otg_id: GCST007517
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Vanilloid receptor opener drug ACETAMINOPHEN is Phase IV for the
        indiciation EFO_0001360 and targets the gene ENSG00000196689 at this locus
        (440397bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000196689
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '17'
      position: 3953102
    locus_GRCh38:
      chromosome: '17'
      position: 4049808
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 8.644381843915278
    otg_id: NEALE2_20002_1065
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Vanilloid receptor opener drug ACETAMINOPHEN is Phase IV for the
        indiciation EFO_0000537 and targets the gene ENSG00000196689 at this locus
        (467788bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000196689
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: T
    locus_GRCh37:
      chromosome: '17'
      position: 3980493
    locus_GRCh38:
      chromosome: '17'
      position: 4077199
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Hypertension | non-cancer illness code, self-reported
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - European=655666
    - South Asian=3650
    gwas_catalog_id: GCST006867
    neg_log_pval: 13.397940008672037
    otg_id: GCST006867
    pubmed_id: '30054458'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Vanilloid receptor opener drug ACETAMINOPHEN is Phase IV for the
        indiciation EFO_0001360 and targets the gene ENSG00000196689 at this locus
        (473159bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000196689
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '17'
      position: 3985864
    locus_GRCh38:
      chromosome: '17'
      position: 4082570
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=655666
    - South Asian=3650
    gwas_catalog_id: GCST006867
    neg_log_pval: 13.397940008672037
    otg_id: GCST006867
    pubmed_id: '30054458'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Vanilloid receptor antagonist drug XEN-D0501 is Phase II for the
        indiciation EFO_0001360 and targets the gene ENSG00000196689 at this locus
        (473159bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000196689
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '17'
      position: 3985864
    locus_GRCh38:
      chromosome: '17'
      position: 4082570
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - East Asian=5704
    gwas_catalog_id: GCST001364
    neg_log_pval: 10.045757490560675
    otg_id: GCST001364
    pubmed_id: '22197929'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tumor necrosis factor ligand superfamily member 13 inhibitor drug
        ATACICEPT is Phase II for the indiciation EFO_0004194 and targets the gene
        ENSG00000161955 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000161955
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '17'
      position: 7462969
    locus_GRCh38:
      chromosome: '17'
      position: 7559652
  trait_info:
    ontology:
    - EFO_0004194
    reported_trait_name: IgA nephropathy
    standard_trait_name: IGA glomerulonephritis
- association_info:
    ancestry:
    - East Asian=5704
    gwas_catalog_id: GCST001364
    neg_log_pval: 9.397940008672037
    otg_id: GCST001364
    pubmed_id: '22197929'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tumor necrosis factor ligand superfamily member 13 inhibitor drug
        ATACICEPT is Phase II for the indiciation EFO_0004194 and targets the gene
        ENSG00000161955 at this locus (26251bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000161955
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '17'
      position: 7491177
    locus_GRCh38:
      chromosome: '17'
      position: 7587859
  trait_info:
    ontology:
    - EFO_0004194
    reported_trait_name: IgA nephropathy
    standard_trait_name: IGA glomerulonephritis
- association_info:
    ancestry:
    - European=86475
    gwas_catalog_id: GCST005537
    neg_log_pval: 20.30102999566398
    otg_id: GCST005537
    pubmed_id: '26974007'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Eotaxin inhibitor drug BERTILIMUMAB is Phase II for the indiciation
        EFO_0000729 and targets the gene ENSG00000172156 at this locus (42141bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000172156
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '17'
      position: 32570547
    locus_GRCh38:
      chromosome: '17'
      position: 34243528
  trait_info:
    ontology:
    - EFO_0000729
    reported_trait_name: Chronic inflammatory diseases (ankylosing spondylitis, Crohn's
      disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
      [subset analysis]
    standard_trait_name: ulcerative colitis
- association_info:
    ancestry:
    - East Asian=4392
    gwas_catalog_id: GCST002082
    neg_log_pval: 9.045757490560675
    otg_id: GCST002082
    pubmed_id: '23817570'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: DNA topoisomerase II alpha inhibitor drug DOXORUBICIN is Phase
        II for the indiciation EFO_0001061 and targets the gene ENSG00000131747 at
        this locus (493430bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000131747
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '17'
      position: 38051348
    locus_GRCh38:
      chromosome: '17'
      position: 39895095
  trait_info:
    ontology:
    - EFO_0001061
    reported_trait_name: Cervical cancer [Matched]
    standard_trait_name: cervical carcinoma
- association_info:
    ancestry:
    - East Asian=4392
    gwas_catalog_id: GCST002082
    neg_log_pval: 9.045757490560675
    otg_id: GCST002082
    pubmed_id: '23817570'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Receptor protein-tyrosine kinase erbB-2 inhibitor drug LAPATINIB
        is Phase II for the indiciation EFO_0001061 and targets the gene ENSG00000141736
        at this locus (164669bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000141736
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '17'
      position: 38051348
    locus_GRCh38:
      chromosome: '17'
      position: 39895095
  trait_info:
    ontology:
    - EFO_0001061
    reported_trait_name: Cervical cancer [Matched]
    standard_trait_name: cervical carcinoma
- association_info:
    ancestry:
    - European=4735
    - Hispanic or Latin American=10533
    - African American or Afro-Caribbean=3972
    gwas_catalog_id: GCST005315
    neg_log_pval: 9.0
    otg_id: GCST005315
    pubmed_id: '29348612'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: DNA topoisomerase II alpha inhibitor drug ETOPOSIDE PHOSPHATE is
        Phase II for the indiciation EFO_0000220 and targets the gene ENSG00000131747
        at this locus (478539bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000131747
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '17'
      position: 38066240
    locus_GRCh38:
      chromosome: '17'
      position: 39909987
  trait_info:
    ontology:
    - EFO_0000220
    reported_trait_name: Acute lymphoblastic leukemia (childhood)
    standard_trait_name: acute lymphoblastic leukemia
- association_info:
    ancestry:
    - European=4735
    - Hispanic or Latin American=10533
    - African American or Afro-Caribbean=3972
    gwas_catalog_id: GCST005315
    neg_log_pval: 9.0
    otg_id: GCST005315
    pubmed_id: '29348612'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: DNA topoisomerase II alpha inhibitor drug DAUNORUBICIN is Phase
        IV for the indiciation EFO_0000220 and targets the gene ENSG00000131747 at
        this locus (478539bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000131747
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '17'
      position: 38066240
    locus_GRCh38:
      chromosome: '17'
      position: 39909987
  trait_info:
    ontology:
    - EFO_0000220
    reported_trait_name: Acute lymphoblastic leukemia (childhood)
    standard_trait_name: acute lymphoblastic leukemia
- association_info:
    ancestry:
    - European=359241
    neg_log_pval: 12.11747546204512
    otg_id: NEALE2_2463
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Sclerostin inhibitor drug ROMOSOZUMAB is Phase II for the indiciation
        EFO_0003931 and targets the gene ENSG00000167941 at this locus (37925bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000167941
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: CT
    locus_GRCh37:
      chromosome: '17'
      position: 41793182
    locus_GRCh38:
      chromosome: '17'
      position: 43715814
  trait_info:
    ontology:
    - EFO_0003931
    reported_trait_name: Fractured/broken bones in last 5 years
    standard_trait_name: bone fracture
- association_info:
    ancestry:
    - European=426795
    gwas_catalog_id: GCST006980
    neg_log_pval: 40.30102999566398
    otg_id: GCST006980
    pubmed_id: '30598549'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Sclerostin inhibitor drug ROMOSOZUMAB is Phase II for the indiciation
        EFO_0003931 and targets the gene ENSG00000167941 at this locus (32252bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000167941
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '17'
      position: 41798855
    locus_GRCh38:
      chromosome: '17'
      position: 43721487
  trait_info:
    ontology:
    - EFO_0003931
    reported_trait_name: Fractures
    standard_trait_name: bone fracture
- association_info:
    ancestry:
    - East Asian=800
    - European=264173
    gwas_catalog_id: GCST006423
    neg_log_pval: 24.522878745280337
    otg_id: GCST006423
    pubmed_id: '30158200'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Sclerostin inhibitor drug ROMOSOZUMAB is Phase II for the indiciation
        EFO_0003931 and targets the gene ENSG00000167941 at this locus (4268bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000167941
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '17'
      position: 41826839
    locus_GRCh38:
      chromosome: '17'
      position: 43749471
  trait_info:
    ontology:
    - EFO_0003931
    reported_trait_name: Fractures
    standard_trait_name: bone fracture
- association_info:
    ancestry:
    - NR=171776
    gwas_catalog_id: GCST005835
    neg_log_pval: 10.522878745280337
    otg_id: GCST005835
    pubmed_id: '29559929'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Corticotropin releasing factor receptor 1 antagonist drug VERUCERFONT
        is Phase II for the indiciation EFO_0003761 and targets the gene ENSG00000120088
        at this locus (297425bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000120088
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '17'
      position: 43564222
    locus_GRCh38:
      chromosome: '17'
      position: 45486856
  trait_info:
    ontology:
    - EFO_0003761
    reported_trait_name: Remission after SSRI treatment in MDD or neuroticism
    standard_trait_name: unipolar depression
- association_info:
    ancestry:
    - European=357957
    gwas_catalog_id: GCST006475
    neg_log_pval: 21.624885315307775
    otg_id: GCST006475
    pubmed_id: '29942085'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Corticotropin releasing factor receptor 1 antagonist drug VERUCERFONT
        is Phase II for the indiciation EFO_0003761 and targets the gene ENSG00000120088
        at this locus (5007bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000120088
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '17'
      position: 43856639
    locus_GRCh38:
      chromosome: '17'
      position: 45779273
  trait_info:
    ontology:
    - EFO_0003761
    reported_trait_name: Depressed affect
    standard_trait_name: unipolar depression
- association_info:
    ancestry:
    - European=38582
    gwas_catalog_id: GCST005531
    neg_log_pval: 15.265200170411154
    otg_id: GCST005531
    pubmed_id: '24076602'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Carbonic anhydrase IV inhibitor drug TOPIRAMATE is Phase II for
        the indiciation EFO_0003885 and targets the gene ENSG00000167434 at this locus
        (410546bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000167434
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '17'
      position: 57816757
    locus_GRCh38:
      chromosome: '17'
      position: 59739396
  trait_info:
    ontology:
    - EFO_0003885
    reported_trait_name: Multiple sclerosis
    standard_trait_name: multiple sclerosis
- association_info:
    ancestry:
    - European=459000
    gwas_catalog_id: GCST007072
    neg_log_pval: 24.154901959985743
    otg_id: GCST007072
    pubmed_id: '30595370'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Angiotensin-converting enzyme inhibitor drug FOSINOPRIL is Phase
        IV for the indiciation EFO_0000319 and targets the gene ENSG00000159640 at
        this locus (5504bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000159640
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '17'
      position: 61548918
    locus_GRCh38:
      chromosome: '17'
      position: 63471557
  trait_info:
    ontology:
    - EFO_0000319
    reported_trait_name: Cardiovascular disease
    standard_trait_name: cardiovascular system disease
- association_info:
    ancestry:
    - European=459000
    gwas_catalog_id: GCST007072
    neg_log_pval: 24.154901959985743
    otg_id: GCST007072
    pubmed_id: '30595370'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Sodium channel protein type IV alpha subunit blocker drug RANOLAZINE
        is Phase IV for the indiciation EFO_0000319 and targets the gene ENSG00000007314
        at this locus (466997bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000007314
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '17'
      position: 61548918
    locus_GRCh38:
      chromosome: '17'
      position: 63471557
  trait_info:
    ontology:
    - EFO_0000319
    reported_trait_name: Cardiovascular disease
    standard_trait_name: cardiovascular system disease
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 19.50811606596098
    otg_id: NEALE2_20002_1065
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Angiotensin-converting enzyme inhibitor drug CAPTOPRIL is Phase
        IV for the indiciation EFO_0000537 and targets the gene ENSG00000159640 at
        this locus (5474bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000159640
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '17'
      position: 61548948
    locus_GRCh38:
      chromosome: '17'
      position: 63471587
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Hypertension | non-cancer illness code, self-reported
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 19.50811606596098
    otg_id: NEALE2_20002_1065
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Angiotensin-converting enzyme inhibitor drug ENALAPRILAT is Phase
        III for the indiciation EFO_0000537 and targets the gene ENSG00000159640 at
        this locus (5474bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000159640
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '17'
      position: 61548948
    locus_GRCh38:
      chromosome: '17'
      position: 63471587
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Hypertension | non-cancer illness code, self-reported
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 19.50811606596098
    otg_id: NEALE2_20002_1065
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Sodium channel protein type IV alpha subunit blocker drug BUPIVACAINE
        is Phase IV for the indiciation EFO_0000537 and targets the gene ENSG00000007314
        at this locus (466967bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000007314
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '17'
      position: 61548948
    locus_GRCh38:
      chromosome: '17'
      position: 63471587
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Hypertension | non-cancer illness code, self-reported
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - European=408343
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 10.26440110030182
    otg_id: SAIGE_401
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Angiotensin-converting enzyme inhibitor drug LISINOPRIL is Phase
        IV for the indiciation EFO_0000537 and targets the gene ENSG00000159640 at
        this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000159640
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '17'
      position: 61556298
    locus_GRCh38:
      chromosome: '17'
      position: 63478937
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Hypertension
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - European=408343
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 10.26440110030182
    otg_id: SAIGE_401
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Angiotensin-converting enzyme inhibitor drug ENALAPRILAT is Phase
        III for the indiciation EFO_0000537 and targets the gene ENSG00000159640 at
        this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000159640
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '17'
      position: 61556298
    locus_GRCh38:
      chromosome: '17'
      position: 63478937
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Hypertension
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - European=408343
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 10.26440110030182
    otg_id: SAIGE_401
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Sodium channel protein type IV alpha subunit blocker drug LEVOBUPIVACAINE
        is Phase IV for the indiciation EFO_0000537 and targets the gene ENSG00000007314
        at this locus (459618bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000007314
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '17'
      position: 61556298
    locus_GRCh38:
      chromosome: '17'
      position: 63478937
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Hypertension
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - European=408089
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 10.172630726946174
    otg_id: SAIGE_401_1
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Angiotensin-converting enzyme inhibitor drug ENALAPRILAT is Phase
        III for the indiciation EFO_0000537 and targets the gene ENSG00000159640 at
        this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000159640
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '17'
      position: 61556298
    locus_GRCh38:
      chromosome: '17'
      position: 63478937
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Essential hypertension
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - European=408089
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 10.172630726946174
    otg_id: SAIGE_401_1
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Angiotensin-converting enzyme inhibitor drug LISINOPRIL is Phase
        IV for the indiciation EFO_0000537 and targets the gene ENSG00000159640 at
        this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000159640
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '17'
      position: 61556298
    locus_GRCh38:
      chromosome: '17'
      position: 63478937
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Essential hypertension
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - European=408089
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 10.172630726946174
    otg_id: SAIGE_401_1
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Sodium channel protein type IV alpha subunit blocker drug LEVOBUPIVACAINE
        is Phase IV for the indiciation EFO_0000537 and targets the gene ENSG00000007314
        at this locus (459618bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000007314
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '17'
      position: 61556298
    locus_GRCh38:
      chromosome: '17'
      position: 63478937
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Essential hypertension
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - European=655666
    - South Asian=3650
    gwas_catalog_id: GCST006867
    neg_log_pval: 7.3979400086720375
    otg_id: GCST006867
    pubmed_id: '30054458'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Angiotensin-converting enzyme inhibitor drug ENALAPRILAT is Phase
        IV for the indiciation EFO_0001360 and targets the gene ENSG00000159640 at
        this locus (111860bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000159640
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '17'
      position: 61687600
    locus_GRCh38:
      chromosome: '17'
      position: 63610240
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=655666
    - South Asian=3650
    gwas_catalog_id: GCST006867
    neg_log_pval: 7.3979400086720375
    otg_id: GCST006867
    pubmed_id: '30054458'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Angiotensin-converting enzyme inhibitor drug PERINDOPRIL is Phase
        III for the indiciation EFO_0001360 and targets the gene ENSG00000159640 at
        this locus (111860bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000159640
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '17'
      position: 61687600
    locus_GRCh38:
      chromosome: '17'
      position: 63610240
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=655666
    - South Asian=3650
    gwas_catalog_id: GCST006867
    neg_log_pval: 7.3979400086720375
    otg_id: GCST006867
    pubmed_id: '30054458'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Sodium channel protein type IV alpha subunit blocker drug RANOLAZINE
        is Phase III for the indiciation EFO_0001360 and targets the gene ENSG00000007314
        at this locus (328315bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000007314
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '17'
      position: 61687600
    locus_GRCh38:
      chromosome: '17'
      position: 63610240
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - NR=250736
    gwas_catalog_id: GCST005196
    neg_log_pval: 10.096910013008056
    otg_id: GCST005196
    pubmed_id: '29212778'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Sodium channel protein type IV alpha subunit blocker drug RANOLAZINE
        is Phase IV for the indiciation EFO_0000378 and targets the gene ENSG00000007314
        at this locus (336814bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000007314
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '17'
      position: 62387091
    locus_GRCh38:
      chromosome: '17'
      position: 64309731
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - NR=296525
    gwas_catalog_id: GCST005194
    neg_log_pval: 10.20210951694165
    otg_id: GCST005194
    pubmed_id: '29212778'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Sodium channel protein type IV alpha subunit blocker drug RANOLAZINE
        is Phase IV for the indiciation EFO_0000378 and targets the gene ENSG00000007314
        at this locus (351688bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000007314
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '17'
      position: 62401965
    locus_GRCh38:
      chromosome: '17'
      position: 64324605
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - European=537409
    - East Asian=36792
    - African American or Afro-Caribbean=8967
    - Hispanic or Latin American=5022
    gwas_catalog_id: GCST006061
    neg_log_pval: 10.0
    otg_id: GCST006061
    pubmed_id: '29892015'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Inward rectifier potassium channel 2 blocker drug DRONEDARONE is
        Phase IV for the indiciation EFO_0000275 and targets the gene ENSG00000123700
        at this locus (160996bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000123700
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '17'
      position: 68337185
    locus_GRCh38:
      chromosome: '17'
      position: 70341044
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=537409
    - East Asian=36792
    - African American or Afro-Caribbean=8967
    - Hispanic or Latin American=5022
    gwas_catalog_id: GCST006061
    neg_log_pval: 8.522878745280337
    otg_id: GCST006061_3
    pubmed_id: '29892015'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Inward rectifier potassium channel 2 blocker drug DRONEDARONE is
        Phase IV for the indiciation EFO_0000275 and targets the gene ENSG00000123700
        at this locus (171150bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000123700
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '17'
      position: 68347338
    locus_GRCh38:
      chromosome: '17'
      position: 70351197
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation [EA]
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=537409
    - East Asian=36792
    - African American or Afro-Caribbean=8967
    - Hispanic or Latin American=5022
    gwas_catalog_id: GCST006061
    neg_log_pval: 8.522878745280337
    otg_id: GCST006061_3
    pubmed_id: '29892015'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Inward rectifier potassium channel 2 blocker drug DRONEDARONE is
        Phase IV for the indiciation EFO_0000275 and targets the gene ENSG00000123700
        at this locus (171150bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000123700
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '17'
      position: 68347338
    locus_GRCh38:
      chromosome: '17'
      position: 70351197
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation [EA]
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - East Asian=9299
    - European=45790
    gwas_catalog_id: GCST006048
    neg_log_pval: 7.522878745280337
    otg_id: GCST006048
    pubmed_id: '24532676'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug PACLITAXEL is Phase II for the indiciation
        EFO_0000685 and targets the gene ENSG00000176014 at this locus (453375bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000176014
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '18'
      position: 12797694
    locus_GRCh38:
      chromosome: '18'
      position: 12797695
  trait_info:
    ontology:
    - EFO_0000685
    reported_trait_name: Rheumatoid arthritis (ACPA-positive)
    standard_trait_name: rheumatoid arthritis
- association_info:
    ancestry:
    - East Asian=20965
    gwas_catalog_id: GCST001454
    neg_log_pval: 7.698970004336019
    otg_id: GCST001454
    pubmed_id: '22446963'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug PACLITAXEL is Phase II for the indiciation
        EFO_0000685 and targets the gene ENSG00000176014 at this locus (453375bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000176014
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '18'
      position: 12797694
    locus_GRCh38:
      chromosome: '18'
      position: 12797695
  trait_info:
    ontology:
    - EFO_0000685
    reported_trait_name: Rheumatoid arthritis
    standard_trait_name: rheumatoid arthritis
- association_info:
    ancestry:
    - East Asian=4075
    gwas_catalog_id: GCST001674
    neg_log_pval: 10.698970004336019
    otg_id: GCST001674
    pubmed_id: '22960999'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug PACLITAXEL is Phase III for the indiciation
        EFO_0000707 and targets the gene ENSG00000176014 at this locus (477275bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000176014
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '18'
      position: 12821593
    locus_GRCh38:
      chromosome: '18'
      position: 12821594
  trait_info:
    ontology:
    - EFO_0000707
    reported_trait_name: Esophageal cancer (squamous cell)
    standard_trait_name: squamous cell carcinoma
- association_info:
    ancestry:
    - East Asian=4075
    gwas_catalog_id: GCST001674
    neg_log_pval: 10.698970004336019
    otg_id: GCST001674
    pubmed_id: '22960999'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug DOCETAXEL is Phase IV for the indiciation
        EFO_0000707 and targets the gene ENSG00000176014 at this locus (477275bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000176014
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '18'
      position: 12821593
    locus_GRCh38:
      chromosome: '18'
      position: 12821594
  trait_info:
    ontology:
    - EFO_0000707
    reported_trait_name: Esophageal cancer (squamous cell)
    standard_trait_name: squamous cell carcinoma
- association_info:
    ancestry:
    - East Asian=4075
    gwas_catalog_id: GCST001674
    neg_log_pval: 10.698970004336019
    otg_id: GCST001674
    pubmed_id: '22960999'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug PACLITAXEL is Phase III for the indiciation
        EFO_0002916 and targets the gene ENSG00000176014 at this locus (477275bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000176014
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '18'
      position: 12821593
    locus_GRCh38:
      chromosome: '18'
      position: 12821594
  trait_info:
    ontology:
    - EFO_0002916
    reported_trait_name: Esophageal cancer (squamous cell)
    standard_trait_name: esophageal carcinoma
- association_info:
    ancestry:
    - European=2258
    gwas_catalog_id: GCST000663
    neg_log_pval: 10.221848749616356
    otg_id: GCST000663
    pubmed_id: '20421936'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Melanocortin receptor 4 agonist drug SETMELANOTIDE is Phase III
        for the indiciation EFO_0001073 and targets the gene ENSG00000166603 at this
        locus (226313bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000166603
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '18'
      position: 57811982
    locus_GRCh38:
      chromosome: '18'
      position: 60144750
  trait_info:
    ontology:
    - EFO_0001073
    reported_trait_name: Obesity (early onset extreme)
    standard_trait_name: obesity
- association_info:
    ancestry:
    - European=204498
    gwas_catalog_id: GCST001953
    neg_log_pval: 35.69897000433602
    otg_id: GCST001953_4
    pubmed_id: '23563607'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Melanocortin receptor 4 agonist drug SETMELANOTIDE is Phase III
        for the indiciation EFO_0001073 and targets the gene ENSG00000166603 at this
        locus (187873bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000166603
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '18'
      position: 57850422
    locus_GRCh38:
      chromosome: '18'
      position: 60183189
  trait_info:
    ontology:
    - EFO_0001073
    reported_trait_name: Obesity [Obesity class I]
    standard_trait_name: obesity
- association_info:
    ancestry:
    - European=2796
    gwas_catalog_id: GCST000317
    neg_log_pval: 7.698970004336019
    otg_id: GCST000317_3
    pubmed_id: '19151714'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Melanocortin receptor 4 agonist drug SETMELANOTIDE is Phase III
        for the indiciation EFO_0001073 and targets the gene ENSG00000166603 at this
        locus (187199bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000166603
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '18'
      position: 57851097
    locus_GRCh38:
      chromosome: '18'
      position: 60183864
  trait_info:
    ontology:
    - EFO_0001073
    reported_trait_name: Obesity [children]
    standard_trait_name: obesity
- association_info:
    ancestry:
    - European=2796
    gwas_catalog_id: GCST000317
    neg_log_pval: 14.301029995663981
    otg_id: GCST000317
    pubmed_id: '19151714'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Melanocortin receptor 4 agonist drug SETMELANOTIDE is Phase III
        for the indiciation EFO_0001073 and targets the gene ENSG00000166603 at this
        locus (187199bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000166603
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '18'
      position: 57851097
    locus_GRCh38:
      chromosome: '18'
      position: 60183864
  trait_info:
    ontology:
    - EFO_0001073
    reported_trait_name: Obesity
    standard_trait_name: obesity
- association_info:
    ancestry:
    - European=2796
    gwas_catalog_id: GCST000317
    neg_log_pval: 8.397940008672037
    otg_id: GCST000317_2
    pubmed_id: '19151714'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Melanocortin receptor 4 agonist drug SETMELANOTIDE is Phase III
        for the indiciation EFO_0001073 and targets the gene ENSG00000166603 at this
        locus (187199bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000166603
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '18'
      position: 57851097
    locus_GRCh38:
      chromosome: '18'
      position: 60183864
  trait_info:
    ontology:
    - EFO_0001073
    reported_trait_name: Obesity [adults]
    standard_trait_name: obesity
- association_info:
    ancestry:
    - European=204498
    gwas_catalog_id: GCST001953
    neg_log_pval: 26.69897000433602
    otg_id: GCST001953_5
    pubmed_id: '23563607'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Melanocortin receptor 4 agonist drug SETMELANOTIDE is Phase III
        for the indiciation EFO_0001073 and targets the gene ENSG00000166603 at this
        locus (186533bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000166603
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '18'
      position: 57851763
    locus_GRCh38:
      chromosome: '18'
      position: 60184530
  trait_info:
    ontology:
    - EFO_0001073
    reported_trait_name: Obesity [Overweight]
    standard_trait_name: obesity
- association_info:
    ancestry:
    - European=408792
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 11.251037138743838
    otg_id: SAIGE_278_1
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Melanocortin receptor 4 agonist drug SETMELANOTIDE is Phase III
        for the indiciation EFO_0001073 and targets the gene ENSG00000166603 at this
        locus (185708bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000166603
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '18'
      position: 57852587
    locus_GRCh38:
      chromosome: '18'
      position: 60185354
  trait_info:
    ontology:
    - EFO_0001073
    reported_trait_name: Obesity
    standard_trait_name: obesity
- association_info:
    ancestry:
    - European=6889
    gwas_catalog_id: GCST001957
    neg_log_pval: 13.045757490560675
    otg_id: GCST001957
    pubmed_id: '23563609'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Melanocortin receptor 4 agonist drug SETMELANOTIDE is Phase III
        for the indiciation EFO_0001073 and targets the gene ENSG00000166603 at this
        locus (185708bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000166603
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '18'
      position: 57852587
    locus_GRCh38:
      chromosome: '18'
      position: 60185354
  trait_info:
    ontology:
    - EFO_0001073
    reported_trait_name: Obesity (early onset extreme)
    standard_trait_name: obesity
- association_info:
    ancestry:
    - European=408961
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 11.126098402135538
    otg_id: SAIGE_278
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Melanocortin receptor 4 agonist drug SETMELANOTIDE is Phase III
        for the indiciation EFO_0001073 and targets the gene ENSG00000166603 at this
        locus (185708bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000166603
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '18'
      position: 57852587
    locus_GRCh38:
      chromosome: '18'
      position: 60185354
  trait_info:
    ontology:
    - EFO_0001073
    reported_trait_name: Overweight, obesity and other hyperalimentation
    standard_trait_name: obesity
- association_info:
    ancestry:
    - European=204498
    gwas_catalog_id: GCST001953
    neg_log_pval: 21.522878745280337
    otg_id: GCST001953_3
    pubmed_id: '23563607'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Melanocortin receptor 4 agonist drug SETMELANOTIDE is Phase III
        for the indiciation EFO_0001073 and targets the gene ENSG00000166603 at this
        locus (185347bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000166603
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '18'
      position: 57852948
    locus_GRCh38:
      chromosome: '18'
      position: 60185715
  trait_info:
    ontology:
    - EFO_0001073
    reported_trait_name: Obesity [Obesity class II]
    standard_trait_name: obesity
- association_info:
    ancestry:
    - European=10486
    gwas_catalog_id: GCST002643
    neg_log_pval: 9.096910013008056
    otg_id: GCST002643
    pubmed_id: '25279986'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Apoptosis regulator Bcl-2 inhibitor drug VENETOCLAX is Phase II
        for the indiciation EFO_0000096 and targets the gene ENSG00000171791 at this
        locus (7369bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000171791
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '18'
      position: 60783211
    locus_GRCh38:
      chromosome: '18'
      position: 63115978
  trait_info:
    ontology:
    - EFO_0000096
    reported_trait_name: Follicular lymphoma
    standard_trait_name: neoplasm of mature B-cells
- association_info:
    ancestry:
    - European=17691
    gwas_catalog_id: GCST004146
    neg_log_pval: 10.698970004336019
    otg_id: GCST004146
    pubmed_id: '28165464'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Apoptosis regulator Bcl-2 inhibitor drug NAVITOCLAX is Phase II
        for the indiciation EFO_0000095 and targets the gene ENSG00000171791 at this
        locus (1834bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000171791
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '18'
      position: 60788745
    locus_GRCh38:
      chromosome: '18'
      position: 63121512
  trait_info:
    ontology:
    - EFO_0000095
    reported_trait_name: Chronic lymphocytic leukemia
    standard_trait_name: chronic lymphocytic leukemia
- association_info:
    ancestry:
    - European=17691
    gwas_catalog_id: GCST004146
    neg_log_pval: 10.698970004336019
    otg_id: GCST004146
    pubmed_id: '28165464'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Apoptosis regulator Bcl-2 inhibitor drug VENETOCLAX is Phase IV
        for the indiciation EFO_0000095 and targets the gene ENSG00000171791 at this
        locus (1834bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000171791
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '18'
      position: 60788745
    locus_GRCh38:
      chromosome: '18'
      position: 63121512
  trait_info:
    ontology:
    - EFO_0000095
    reported_trait_name: Chronic lymphocytic leukemia
    standard_trait_name: chronic lymphocytic leukemia
- association_info:
    ancestry:
    - European=10767
    gwas_catalog_id: GCST003468
    neg_log_pval: 10.397940008672037
    otg_id: GCST003468
    pubmed_id: '26956414'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Apoptosis regulator Bcl-2 inhibitor drug NAVITOCLAX is Phase II
        for the indiciation EFO_0000095 and targets the gene ENSG00000171791 at this
        locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000171791
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '18'
      position: 60793494
    locus_GRCh38:
      chromosome: '18'
      position: 63126261
  trait_info:
    ontology:
    - EFO_0000095
    reported_trait_name: Chronic lymphocytic leukemia
    standard_trait_name: chronic lymphocytic leukemia
- association_info:
    ancestry:
    - European=10767
    gwas_catalog_id: GCST003468
    neg_log_pval: 10.397940008672037
    otg_id: GCST003468
    pubmed_id: '26956414'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Apoptosis regulator Bcl-2 inhibitor drug VENETOCLAX is Phase IV
        for the indiciation EFO_0000095 and targets the gene ENSG00000171791 at this
        locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000171791
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '18'
      position: 60793494
    locus_GRCh38:
      chromosome: '18'
      position: 63126261
  trait_info:
    ontology:
    - EFO_0000095
    reported_trait_name: Chronic lymphocytic leukemia
    standard_trait_name: chronic lymphocytic leukemia
- association_info:
    ancestry:
    - European=8400
    gwas_catalog_id: GCST002073
    neg_log_pval: 11.522878745280337
    otg_id: GCST002073
    pubmed_id: '23770605'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Apoptosis regulator Bcl-2 inhibitor drug NAVITOCLAX is Phase II
        for the indiciation EFO_0000095 and targets the gene ENSG00000171791 at this
        locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000171791
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '18'
      position: 60793549
    locus_GRCh38:
      chromosome: '18'
      position: 63126316
  trait_info:
    ontology:
    - EFO_0000095
    reported_trait_name: Chronic lymphocytic leukemia
    standard_trait_name: chronic lymphocytic leukemia
- association_info:
    ancestry:
    - European=8400
    gwas_catalog_id: GCST002073
    neg_log_pval: 11.522878745280337
    otg_id: GCST002073
    pubmed_id: '23770605'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Apoptosis regulator Bcl-2 inhibitor drug VENETOCLAX is Phase IV
        for the indiciation EFO_0000095 and targets the gene ENSG00000171791 at this
        locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000171791
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '18'
      position: 60793549
    locus_GRCh38:
      chromosome: '18'
      position: 63126316
  trait_info:
    ontology:
    - EFO_0000095
    reported_trait_name: Chronic lymphocytic leukemia
    standard_trait_name: chronic lymphocytic leukemia
- association_info:
    ancestry:
    - European=8400
    gwas_catalog_id: GCST002073
    neg_log_pval: 10.096910013008056
    otg_id: GCST002073
    pubmed_id: '23770605'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Apoptosis regulator Bcl-2 inhibitor drug NAVITOCLAX is Phase II
        for the indiciation EFO_0000095 and targets the gene ENSG00000171791 at this
        locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000171791
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '18'
      position: 60793921
    locus_GRCh38:
      chromosome: '18'
      position: 63126688
  trait_info:
    ontology:
    - EFO_0000095
    reported_trait_name: Chronic lymphocytic leukemia
    standard_trait_name: chronic lymphocytic leukemia
- association_info:
    ancestry:
    - European=8400
    gwas_catalog_id: GCST002073
    neg_log_pval: 10.096910013008056
    otg_id: GCST002073
    pubmed_id: '23770605'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Apoptosis regulator Bcl-2 inhibitor drug VENETOCLAX is Phase IV
        for the indiciation EFO_0000095 and targets the gene ENSG00000171791 at this
        locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000171791
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '18'
      position: 60793921
    locus_GRCh38:
      chromosome: '18'
      position: 63126688
  trait_info:
    ontology:
    - EFO_0000095
    reported_trait_name: Chronic lymphocytic leukemia
    standard_trait_name: chronic lymphocytic leukemia
- association_info:
    ancestry:
    - European=140254
    gwas_catalog_id: GCST006085
    neg_log_pval: 8.0
    otg_id: GCST006085
    pubmed_id: '29892016'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Apoptosis regulator Bcl-2 inhibitor drug NAVITOCLAX is Phase II
        for the indiciation EFO_0001663 and targets the gene ENSG00000171791 at this
        locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000171791
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: CT
      reference: C
    locus_GRCh37:
      chromosome: '18'
      position: 60961193
    locus_GRCh38:
      chromosome: '18'
      position: 63293960
  trait_info:
    ontology:
    - EFO_0001663
    reported_trait_name: Prostate cancer
    standard_trait_name: prostate carcinoma
- association_info:
    ancestry:
    - European=140254
    gwas_catalog_id: GCST006085
    neg_log_pval: 8.0
    otg_id: GCST006085
    pubmed_id: '29892016'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Apoptosis regulator Bcl-2 inhibitor drug NAVITOCLAX is Phase II
        for the indiciation EFO_0001663 and targets the gene ENSG00000171791 at this
        locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000171791
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: CT
    locus_GRCh37:
      chromosome: '18'
      position: 60961193
    locus_GRCh38:
      chromosome: '18'
      position: 63293960
  trait_info:
    ontology:
    - EFO_0001663
    reported_trait_name: Prostate cancer
    standard_trait_name: prostate carcinoma
- association_info:
    ancestry:
    - European=33976
    gwas_catalog_id: GCST003219
    neg_log_pval: 7.522878745280337
    otg_id: GCST003219_2
    pubmed_id: '26691988'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Complement factor D inhibitor drug LAMPALIZUMAB is Phase III for
        the indiciation EFO_0001365 and targets the gene ENSG00000197766 at this locus
        (167810bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000197766
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '19'
      position: 1031438
    locus_GRCh38:
      chromosome: '19'
      position: 1031439
  trait_info:
    ontology:
    - EFO_0001365
    reported_trait_name: Advanced age-related macular degeneration [EA]
    standard_trait_name: age-related macular degeneration
- association_info:
    ancestry:
    - European=17691
    gwas_catalog_id: GCST004146
    neg_log_pval: 7.301029995663981
    otg_id: GCST004146
    pubmed_id: '28165464'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Elongation factor 2 inhibitor drug DENILEUKIN DIFTITOX is Phase
        II for the indiciation EFO_0000095 and targets the gene ENSG00000167658 at
        this locus (83658bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000167658
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '19'
      position: 4069119
    locus_GRCh38:
      chromosome: '19'
      position: 4069121
  trait_info:
    ontology:
    - EFO_0000095
    reported_trait_name: Chronic lymphocytic leukemia
    standard_trait_name: chronic lymphocytic leukemia
- association_info:
    ancestry:
    - European=1043
    gwas_catalog_id: GCST005934
    neg_log_pval: 8.522878745280337
    otg_id: GCST005934
    pubmed_id: '29884837'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Insulin receptor inhibitor drug LINSITINIB is Phase II for the
        indiciation EFO_0006859 and targets the gene ENSG00000171105 at this locus
        (340047bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000171105
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '19'
      position: 7699347
    locus_GRCh38:
      chromosome: '19'
      position: 7634461
  trait_info:
    ontology:
    - EFO_0006859
    reported_trait_name: Neuropathic pain in head and neck cancer
    standard_trait_name: head and neck malignant neoplasia
- association_info:
    ancestry:
    - European=86475
    gwas_catalog_id: GCST005537
    neg_log_pval: 21.69897000433602
    otg_id: GCST005537
    pubmed_id: '26974007'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Kelch-like ECH-associated protein 1 inhibitor drug DIMETHYL FUMARATE
        is Phase III for the indiciation EFO_0000676 and targets the gene ENSG00000079999
        at this locus (169080bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000079999
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: T
    locus_GRCh37:
      chromosome: '19'
      position: 10427721
    locus_GRCh38:
      chromosome: '19'
      position: 10317045
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Chronic inflammatory diseases (ankylosing spondylitis, Crohn's
      disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
      [subset analysis]
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=287323
    gwas_catalog_id: GCST004346
    neg_log_pval: 42.52287874528034
    otg_id: GCST004346
    pubmed_id: '28537254'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Kelch-like ECH-associated protein 1 inhibitor drug DIMETHYL FUMARATE
        is Phase III for the indiciation EFO_0000676 and targets the gene ENSG00000079999
        at this locus (133684bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000079999
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '19'
      position: 10463118
    locus_GRCh38:
      chromosome: '19'
      position: 10352442
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 11.517984423549288
    otg_id: NEALE2_20002_1453
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Kelch-like ECH-associated protein 1 inhibitor drug DIMETHYL FUMARATE
        is Phase III for the indiciation EFO_0000676 and targets the gene ENSG00000079999
        at this locus (133684bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000079999
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '19'
      position: 10463118
    locus_GRCh38:
      chromosome: '19'
      position: 10352442
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis | non-cancer illness code, self-reported
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=33394
    gwas_catalog_id: GCST005527
    neg_log_pval: 13.045757490560675
    otg_id: GCST005527
    pubmed_id: '23143594'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Kelch-like ECH-associated protein 1 inhibitor drug DIMETHYL FUMARATE
        is Phase III for the indiciation EFO_0000676 and targets the gene ENSG00000079999
        at this locus (133684bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000079999
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '19'
      position: 10463118
    locus_GRCh38:
      chromosome: '19'
      position: 10352442
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=7353
    gwas_catalog_id: GCST000833
    neg_log_pval: 10.397940008672037
    otg_id: GCST000833
    pubmed_id: '20953190'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Kelch-like ECH-associated protein 1 inhibitor drug DIMETHYL FUMARATE
        is Phase III for the indiciation EFO_0000676 and targets the gene ENSG00000079999
        at this locus (126826bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000079999
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '19'
      position: 10469975
    locus_GRCh38:
      chromosome: '19'
      position: 10359299
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=7353
    gwas_catalog_id: GCST000833
    neg_log_pval: 8.397940008672037
    otg_id: GCST000833
    pubmed_id: '20953190'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Kelch-like ECH-associated protein 1 inhibitor drug DIMETHYL FUMARATE
        is Phase III for the indiciation EFO_0000676 and targets the gene ENSG00000079999
        at this locus (123868bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000079999
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '19'
      position: 10472933
    locus_GRCh38:
      chromosome: '19'
      position: 10362257
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=18190
    gwas_catalog_id: GCST002740
    neg_log_pval: 13.522878745280337
    otg_id: GCST002740_4
    pubmed_id: '25574825'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Kelch-like ECH-associated protein 1 inhibitor drug DIMETHYL FUMARATE
        is Phase III for the indiciation EFO_0000676 and targets the gene ENSG00000079999
        at this locus (18959bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000079999
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '19'
      position: 10577843
    locus_GRCh38:
      chromosome: '19'
      position: 10467167
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Inflammatory skin disease [Psoriasis]
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=38582
    gwas_catalog_id: GCST005531
    neg_log_pval: 9.019088062223156
    otg_id: GCST005531
    pubmed_id: '24076602'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Kelch-like ECH-associated protein 1 inhibitor drug DIMETHYL FUMARATE
        is Phase IV for the indiciation EFO_0003885 and targets the gene ENSG00000079999
        at this locus (127936bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000079999
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '19'
      position: 10742170
    locus_GRCh38:
      chromosome: '19'
      position: 10631494
  trait_info:
    ontology:
    - EFO_0003885
    reported_trait_name: Multiple sclerosis
    standard_trait_name: multiple sclerosis
- association_info:
    ancestry:
    - European=38582
    gwas_catalog_id: GCST005531
    neg_log_pval: 9.019088062223156
    otg_id: GCST005531
    pubmed_id: '24076602'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Sphingosine 1-phosphate receptor Edg-8 agonist drug SIPONIMOD is
        Phase III for the indiciation EFO_0003885 and targets the gene ENSG00000180739
        at this locus (113564bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000180739
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '19'
      position: 10742170
    locus_GRCh38:
      chromosome: '19'
      position: 10631494
  trait_info:
    ontology:
    - EFO_0003885
    reported_trait_name: Multiple sclerosis
    standard_trait_name: multiple sclerosis
- association_info:
    ancestry:
    - European=33394
    gwas_catalog_id: GCST005527
    neg_log_pval: 9.378437388797577
    otg_id: GCST005527
    pubmed_id: '23143594'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Kelch-like ECH-associated protein 1 inhibitor drug DIMETHYL FUMARATE
        is Phase III for the indiciation EFO_0000676 and targets the gene ENSG00000079999
        at this locus (203859bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000079999
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '19'
      position: 10818092
    locus_GRCh38:
      chromosome: '19'
      position: 10707416
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=287323
    gwas_catalog_id: GCST004346
    neg_log_pval: 9.698970004336019
    otg_id: GCST004346
    pubmed_id: '28537254'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Kelch-like ECH-associated protein 1 inhibitor drug DIMETHYL FUMARATE
        is Phase III for the indiciation EFO_0000676 and targets the gene ENSG00000079999
        at this locus (271972bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000079999
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '19'
      position: 10886206
    locus_GRCh38:
      chromosome: '19'
      position: 10775530
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=6042
    gwas_catalog_id: GCST000340
    neg_log_pval: 8.698970004336019
    otg_id: GCST000340
    pubmed_id: '19198609'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Erythropoietin receptor agonist drug EPOETIN ALFA is Phase II for
        the indiciation EFO_0000612 and targets the gene ENSG00000187266 at this locus
        (324283bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000187266
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '19'
      position: 11163601
    locus_GRCh38:
      chromosome: '19'
      position: 11052925
  trait_info:
    ontology:
    - EFO_0000612
    reported_trait_name: Myocardial infarction (early onset)
    standard_trait_name: myocardial infarction
- association_info:
    ancestry:
    - NR=123388
    gwas_catalog_id: GCST002287
    neg_log_pval: 11.522878745280337
    otg_id: GCST002287
    pubmed_id: '24262325'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Erythropoietin receptor agonist drug EPOETIN ALFA is Phase II for
        the indiciation EFO_0000712 and targets the gene ENSG00000187266 at this locus
        (324283bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000187266
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '19'
      position: 11163601
    locus_GRCh38:
      chromosome: '19'
      position: 11052925
  trait_info:
    ontology:
    - EFO_0000712
    reported_trait_name: Coronary artery disease or ischemic stroke
    standard_trait_name: cerebrovascular accident
- association_info:
    ancestry:
    - European=6042
    gwas_catalog_id: GCST000340
    neg_log_pval: 8.698970004336019
    otg_id: GCST000340
    pubmed_id: '19198609'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Erythropoietin receptor agonist drug DARBEPOETIN ALFA is Phase
        III for the indiciation EFO_0000612 and targets the gene ENSG00000187266 at
        this locus (324283bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000187266
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '19'
      position: 11163601
    locus_GRCh38:
      chromosome: '19'
      position: 11052925
  trait_info:
    ontology:
    - EFO_0000612
    reported_trait_name: Myocardial infarction (early onset)
    standard_trait_name: myocardial infarction
- association_info:
    ancestry:
    - European=446696
    - East Asian=45564
    - South Asian=9144
    - African American or Afro-Caribbean=20695
    - Asian unspecified=698
    - Hispanic or Latin American=1557
    gwas_catalog_id: GCST005838
    neg_log_pval: 7.522878745280337
    otg_id: GCST005838
    pubmed_id: '29531354'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Erythropoietin receptor agonist drug EPOETIN ALFA is Phase II for
        the indiciation EFO_0000712 and targets the gene ENSG00000187266 at this locus
        (312949bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000187266
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '19'
      position: 11174935
    locus_GRCh38:
      chromosome: '19'
      position: 11064259
  trait_info:
    ontology:
    - EFO_0000712
    reported_trait_name: Stroke
    standard_trait_name: cerebrovascular accident
- association_info:
    ancestry:
    - African American or Afro-Caribbean=2908
    - Hispanic or Latin American=3615
    - South Asian=23156
    - Greater Middle Eastern (Middle Eastern / North African / Persian)=754
    - East Asian=9396
    - European=126630
    gwas_catalog_id: GCST003117
    neg_log_pval: 7.522878745280337
    otg_id: GCST003117
    pubmed_id: '26343387'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Erythropoietin receptor agonist drug EPOETIN ALFA is Phase II for
        the indiciation EFO_0000612 and targets the gene ENSG00000187266 at this locus
        (299730bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000187266
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '19'
      position: 11188153
    locus_GRCh38:
      chromosome: '19'
      position: 11077477
  trait_info:
    ontology:
    - EFO_0000612
    reported_trait_name: Myocardial infarction
    standard_trait_name: myocardial infarction
- association_info:
    ancestry:
    - African American or Afro-Caribbean=2908
    - Hispanic or Latin American=3615
    - South Asian=23156
    - Greater Middle Eastern (Middle Eastern / North African / Persian)=754
    - East Asian=9396
    - European=126630
    gwas_catalog_id: GCST003117
    neg_log_pval: 7.522878745280337
    otg_id: GCST003117
    pubmed_id: '26343387'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Erythropoietin receptor agonist drug DARBEPOETIN ALFA is Phase
        III for the indiciation EFO_0000612 and targets the gene ENSG00000187266 at
        this locus (299730bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000187266
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '19'
      position: 11188153
    locus_GRCh38:
      chromosome: '19'
      position: 11077477
  trait_info:
    ontology:
    - EFO_0000612
    reported_trait_name: Myocardial infarction
    standard_trait_name: myocardial infarction
- association_info:
    ancestry:
    - European=388806
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 8.777283528852417
    otg_id: SAIGE_411_2
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Erythropoietin receptor agonist drug DARBEPOETIN ALFA is Phase
        III for the indiciation EFO_0000612 and targets the gene ENSG00000187266 at
        this locus (299720bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000187266
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '19'
      position: 11188164
    locus_GRCh38:
      chromosome: '19'
      position: 11077488
  trait_info:
    ontology:
    - EFO_0000612
    reported_trait_name: Myocardial infarction
    standard_trait_name: myocardial infarction
- association_info:
    ancestry:
    - European=388806
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 8.777283528852417
    otg_id: SAIGE_411_2
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Erythropoietin receptor agonist drug EPOETIN ALFA is Phase II for
        the indiciation EFO_0000612 and targets the gene ENSG00000187266 at this locus
        (299720bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000187266
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '19'
      position: 11188164
    locus_GRCh38:
      chromosome: '19'
      position: 11077488
  trait_info:
    ontology:
    - EFO_0000612
    reported_trait_name: Myocardial infarction
    standard_trait_name: myocardial infarction
- association_info:
    ancestry:
    - NR=296525
    gwas_catalog_id: GCST005194
    neg_log_pval: 35.71175077442801
    otg_id: GCST005194
    pubmed_id: '29212778'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Erythropoietin receptor agonist drug EPOETIN ALFA is Phase II for
        the indiciation EFO_0000378 and targets the gene ENSG00000187266 at this locus
        (299637bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000187266
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '19'
      position: 11188247
    locus_GRCh38:
      chromosome: '19'
      position: 11077571
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - European=408458
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 12.602059991327963
    otg_id: SAIGE_411
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Erythropoietin receptor agonist drug EPOETIN ALFA is Phase II for
        the indiciation EFO_0000378 and targets the gene ENSG00000187266 at this locus
        (299637bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000187266
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '19'
      position: 11188247
    locus_GRCh38:
      chromosome: '19'
      position: 11077571
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Ischemic heart disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - European=141217
    - African American or Afro-Caribbean=3139
    - Hispanic or Latin American=4095
    - South Asian=25557
    - Greater Middle Eastern (Middle Eastern / North African / Persian)=2268
    - East Asian=11323
    gwas_catalog_id: GCST003116
    neg_log_pval: 14.397940008672037
    otg_id: GCST003116
    pubmed_id: '26343387'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Erythropoietin receptor agonist drug EPOETIN ALFA is Phase II for
        the indiciation EFO_0000378 and targets the gene ENSG00000187266 at this locus
        (299637bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000187266
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '19'
      position: 11188247
    locus_GRCh38:
      chromosome: '19'
      position: 11077571
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - NR=250736
    gwas_catalog_id: GCST005196
    neg_log_pval: 40.30102999566398
    otg_id: GCST005196
    pubmed_id: '29212778'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Erythropoietin receptor agonist drug EPOETIN ALFA is Phase II for
        the indiciation EFO_0000378 and targets the gene ENSG00000187266 at this locus
        (285577bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000187266
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '19'
      position: 11202306
    locus_GRCh38:
      chromosome: '19'
      position: 11091630
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - European, NR=63731
    gwas_catalog_id: GCST004787
    neg_log_pval: 21.096910013008056
    otg_id: GCST004787
    pubmed_id: '28714975'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Erythropoietin receptor agonist drug EPOETIN ALFA is Phase II for
        the indiciation EFO_0000378 and targets the gene ENSG00000187266 at this locus
        (285577bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000187266
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '19'
      position: 11202306
    locus_GRCh38:
      chromosome: '19'
      position: 11091630
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease (myocardial infarction, percutaneous
      transluminal coronary angioplasty, coronary artery bypass grafting, angina or
      chromic ischemic heart disease)
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - NR=547261
    gwas_catalog_id: GCST005195
    neg_log_pval: 23.4089353929735
    otg_id: GCST005195
    pubmed_id: '29212778'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Erythropoietin receptor agonist drug EPOETIN ALFA is Phase II for
        the indiciation EFO_0000378 and targets the gene ENSG00000187266 at this locus
        (285577bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000187266
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '19'
      position: 11202306
    locus_GRCh38:
      chromosome: '19'
      position: 11091630
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - NR=296525
    gwas_catalog_id: GCST005194
    neg_log_pval: 7.705313375720557
    otg_id: GCST005194
    pubmed_id: '29212778'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Erythropoietin receptor agonist drug EPOETIN ALFA is Phase II for
        the indiciation EFO_0000378 and targets the gene ENSG00000187266 at this locus
        (263618bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000187266
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '19'
      position: 11224265
    locus_GRCh38:
      chromosome: '19'
      position: 11113589
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - NR=250736
    gwas_catalog_id: GCST005196
    neg_log_pval: 7.698970004336019
    otg_id: GCST005196
    pubmed_id: '29212778'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Erythropoietin receptor agonist drug EPOETIN ALFA is Phase II for
        the indiciation EFO_0000378 and targets the gene ENSG00000187266 at this locus
        (184329bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000187266
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '19'
      position: 11303554
    locus_GRCh38:
      chromosome: '19'
      position: 11192878
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - European=87827
    gwas_catalog_id: GCST005077
    neg_log_pval: 8.154901959985743
    otg_id: GCST005077
    pubmed_id: '29058716'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Erythropoietin receptor agonist drug EPOETIN ALFA is Phase III
        for the indiciation EFO_0000305 and targets the gene ENSG00000187266 at this
        locus (64180bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000187266
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '19'
      position: 11423703
    locus_GRCh38:
      chromosome: '19'
      position: 11313027
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - NR=547261
    gwas_catalog_id: GCST005195
    neg_log_pval: 8.2518119729938
    otg_id: GCST005195
    pubmed_id: '29212778'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Erythropoietin receptor agonist drug EPOETIN ALFA is Phase II for
        the indiciation EFO_0000378 and targets the gene ENSG00000187266 at this locus
        (1963bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000187266
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '19'
      position: 11496981
    locus_GRCh38:
      chromosome: '19'
      position: 11386305
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - European=66756
    gwas_catalog_id: GCST004744
    neg_log_pval: 9.045757490560675
    otg_id: GCST004744
    pubmed_id: '28604730'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tyrosine-protein kinase receptor UFO inhibitor drug R428 is Phase
        II for the indiciation EFO_0000571 and targets the gene ENSG00000167601 at
        this locus (372022bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000167601
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '19'
      position: 41353107
    locus_GRCh38:
      chromosome: '19'
      position: 40847202
  trait_info:
    ontology:
    - EFO_0000571
    reported_trait_name: Lung adenocarcinoma
    standard_trait_name: lung adenocarcinoma
- association_info:
    ancestry:
    - European=140254
    gwas_catalog_id: GCST006085
    neg_log_pval: 8.045757490560675
    otg_id: GCST006085
    pubmed_id: '29892016'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Sodium/potassium-transporting ATPase inhibitor drug DIGOXIN is
        Phase II for the indiciation EFO_0001663 and targets the gene ENSG00000105409
        at this locus (199298bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000105409
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '19'
      position: 42700947
    locus_GRCh38:
      chromosome: '19'
      position: 42196795
  trait_info:
    ontology:
    - EFO_0001663
    reported_trait_name: Prostate cancer
    standard_trait_name: prostate carcinoma
- association_info:
    ancestry:
    - European=22548
    gwas_catalog_id: GCST001942
    neg_log_pval: 7.522878745280337
    otg_id: GCST001942
    pubmed_id: '23535732'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Ornithine decarboxylase inhibitor drug EFLORNITHINE is Phase II
        for the indiciation EFO_0001663 and targets the gene ENSG00000115758 at this
        locus (462229bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000115758
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '2'
      position: 10117868
    locus_GRCh38:
      chromosome: '2'
      position: 9977740
  trait_info:
    ontology:
    - EFO_0001663
    reported_trait_name: Prostate cancer
    standard_trait_name: prostate carcinoma
- association_info:
    ancestry:
    - European=67543
    - Sub-Saharan African, African American or Afro-Caribbean=10463
    - East Asian=6954
    - Hispanic or Latin American=2080
    gwas_catalog_id: GCST002606
    neg_log_pval: 7.698970004336019
    otg_id: GCST002606_3
    pubmed_id: '25217961'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Ornithine decarboxylase inhibitor drug EFLORNITHINE is Phase II
        for the indiciation EFO_0001663 and targets the gene ENSG00000115758 at this
        locus (122277bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000115758
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '2'
      position: 10710730
    locus_GRCh38:
      chromosome: '2'
      position: 10570604
  trait_info:
    ontology:
    - EFO_0001663
    reported_trait_name: Prostate cancer [EA]
    standard_trait_name: prostate carcinoma
- association_info:
    ancestry:
    - European=140254
    gwas_catalog_id: GCST006085
    neg_log_pval: 16.221848749616356
    otg_id: GCST006085
    pubmed_id: '29892016'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Ornithine decarboxylase inhibitor drug EFLORNITHINE is Phase II
        for the indiciation EFO_0001663 and targets the gene ENSG00000115758 at this
        locus (122277bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000115758
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '2'
      position: 10710730
    locus_GRCh38:
      chromosome: '2'
      position: 10570604
  trait_info:
    ontology:
    - EFO_0001663
    reported_trait_name: Prostate cancer
    standard_trait_name: prostate carcinoma
- association_info:
    ancestry:
    - European=67543
    - Sub-Saharan African, African American or Afro-Caribbean=10463
    - East Asian=6954
    - Hispanic or Latin American=2080
    gwas_catalog_id: GCST002606
    neg_log_pval: 7.522878745280337
    otg_id: GCST002606
    pubmed_id: '25217961'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Ornithine decarboxylase inhibitor drug EFLORNITHINE is Phase II
        for the indiciation EFO_0001663 and targets the gene ENSG00000115758 at this
        locus (122277bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000115758
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '2'
      position: 10710730
    locus_GRCh38:
      chromosome: '2'
      position: 10570604
  trait_info:
    ontology:
    - EFO_0001663
    reported_trait_name: Prostate cancer
    standard_trait_name: prostate carcinoma
- association_info:
    ancestry:
    - European=241704
    gwas_catalog_id: GCST004483
    neg_log_pval: 16.0
    otg_id: GCST004483
    pubmed_id: '27363682'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: DNA (cytosine-5)-methyltransferase 3A inhibitor drug AZACITIDINE
        is Phase II for the indiciation EFO_0001378 and targets the gene ENSG00000119772
        at this locus (47687bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000119772
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '2'
      position: 25613146
    locus_GRCh38:
      chromosome: '2'
      position: 25390277
  trait_info:
    ontology:
    - EFO_0001378
    reported_trait_name: Multiple myeloma
    standard_trait_name: multiple myeloma
- association_info:
    ancestry:
    - European=14421
    gwas_catalog_id: GCST004099
    neg_log_pval: 9.221848749616356
    otg_id: GCST004099
    pubmed_id: '28112199'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: DNA (cytosine-5)-methyltransferase 3A inhibitor drug AZACITIDINE
        is Phase II for the indiciation EFO_0001378 and targets the gene ENSG00000119772
        at this locus (63979bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000119772
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '2'
      position: 25629438
    locus_GRCh38:
      chromosome: '2'
      position: 25406569
  trait_info:
    ontology:
    - EFO_0001378
    reported_trait_name: B-cell malignancies (chronic lymphocytic leukemia, Hodgkin
      lymphoma or multiple myeloma) (pleiotropy)
    standard_trait_name: multiple myeloma
- association_info:
    ancestry:
    - European=14421
    gwas_catalog_id: GCST004099
    neg_log_pval: 9.221848749616356
    otg_id: GCST004099
    pubmed_id: '28112199'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: DNA (cytosine-5)-methyltransferase 3A inhibitor drug AZACITIDINE
        is Phase II for the indiciation EFO_0000095 and targets the gene ENSG00000119772
        at this locus (63979bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000119772
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '2'
      position: 25629438
    locus_GRCh38:
      chromosome: '2'
      position: 25406569
  trait_info:
    ontology:
    - EFO_0000095
    reported_trait_name: B-cell malignancies (chronic lymphocytic leukemia, Hodgkin
      lymphoma or multiple myeloma) (pleiotropy)
    standard_trait_name: chronic lymphocytic leukemia
- association_info:
    ancestry:
    - European=408089
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 35.59516628338006
    otg_id: SAIGE_401_1
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Potassium channel subfamily K member 3 opener drug SEVOFLURANE
        is Phase IV for the indiciation EFO_0000537 and targets the gene ENSG00000171303
        at this locus (1194bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000171303
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '2'
      position: 26914364
    locus_GRCh38:
      chromosome: '2'
      position: 26691496
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Essential hypertension
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 39.522019692388156
    otg_id: NEALE2_20002_1065
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Potassium channel subfamily K member 3 opener drug SEVOFLURANE
        is Phase IV for the indiciation EFO_0000537 and targets the gene ENSG00000171303
        at this locus (1194bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000171303
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '2'
      position: 26914364
    locus_GRCh38:
      chromosome: '2'
      position: 26691496
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Hypertension | non-cancer illness code, self-reported
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - East Asian=50792
    gwas_catalog_id: GCST007707
    neg_log_pval: 13.301029995663981
    otg_id: GCST007707_2
    pubmed_id: '30487518'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Potassium channel subfamily K member 3 opener drug SEVOFLURANE
        is Phase IV for the indiciation EFO_0000537 and targets the gene ENSG00000171303
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000171303
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: T
    locus_GRCh37:
      chromosome: '2'
      position: 26920025
    locus_GRCh38:
      chromosome: '2'
      position: 26697157
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Hypertension [Japanese]
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - European=408343
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 35.37263414340727
    otg_id: SAIGE_401
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Potassium channel subfamily K member 3 opener drug SEVOFLURANE
        is Phase IV for the indiciation EFO_0000537 and targets the gene ENSG00000171303
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000171303
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '2'
      position: 26923568
    locus_GRCh38:
      chromosome: '2'
      position: 26700700
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Hypertension
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - East Asian=50792
    gwas_catalog_id: GCST007707
    neg_log_pval: 17.69897000433602
    otg_id: GCST007707
    pubmed_id: '30487518'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Potassium channel subfamily K member 3 opener drug SEVOFLURANE
        is Phase IV for the indiciation EFO_0000537 and targets the gene ENSG00000171303
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000171303
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '2'
      position: 26930411
    locus_GRCh38:
      chromosome: '2'
      position: 26707543
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Hypertension [East Asian]
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - European=17500
    gwas_catalog_id: GCST003983
    neg_log_pval: 14.698970004336019
    otg_id: GCST003983
    pubmed_id: '27182965'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Steroid 5-alpha-reductase 2 inhibitor drug FINASTERIDE is Phase
        IV for the indiciation EFO_0004191 and targets the gene ENSG00000277893 at
        this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000277893
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '2'
      position: 31805826
    locus_GRCh38:
      chromosome: '2'
      position: 31580756
  trait_info:
    ontology:
    - EFO_0004191
    reported_trait_name: Male-pattern baldness
    standard_trait_name: androgenetic alopecia
- association_info:
    ancestry:
    - European=43590
    gwas_catalog_id: GCST005116
    neg_log_pval: 25.69897000433602
    otg_id: GCST005116
    pubmed_id: '29146897'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Steroid 5-alpha-reductase 2 inhibitor drug FINASTERIDE is Phase
        IV for the indiciation EFO_0004191 and targets the gene ENSG00000277893 at
        this locus (375418bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000277893
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '2'
      position: 32181424
    locus_GRCh38:
      chromosome: '2'
      position: 31956355
  trait_info:
    ontology:
    - EFO_0004191
    reported_trait_name: Male-pattern baldness
    standard_trait_name: androgenetic alopecia
- association_info:
    ancestry:
    - East Asian=5255
    gwas_catalog_id: GCST001634
    neg_log_pval: 8.397940008672037
    otg_id: GCST001634
    pubmed_id: '22885925'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Luteinizing hormone/Choriogonadotropin receptor agonist drug CHORIOGONADOTROPIN
        ALFA is Phase II for the indiciation EFO_0000660 and targets the gene ENSG00000138039
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000138039
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '2'
      position: 48978159
    locus_GRCh38:
      chromosome: '2'
      position: 48751020
  trait_info:
    ontology:
    - EFO_0000660
    reported_trait_name: Polycystic ovary syndrome
    standard_trait_name: polycystic ovary syndrome
- association_info:
    ancestry:
    - East Asian=1639
    gwas_catalog_id: GCST000914
    neg_log_pval: 20.096910013008056
    otg_id: GCST000914
    pubmed_id: '21151128'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Luteinizing hormone/Choriogonadotropin receptor agonist drug GONADOTROPIN,
        CHORIONIC is Phase IV for the indiciation EFO_0000660 and targets the gene
        ENSG00000138039 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000138039
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '2'
      position: 48978159
    locus_GRCh38:
      chromosome: '2'
      position: 48751020
  trait_info:
    ontology:
    - EFO_0000660
    reported_trait_name: Polycystic ovary syndrome
    standard_trait_name: polycystic ovary syndrome
- association_info:
    ancestry:
    - East Asian=5255
    gwas_catalog_id: GCST001634
    neg_log_pval: 8.397940008672037
    otg_id: GCST001634
    pubmed_id: '22885925'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Follicle stimulating hormone receptor agonist drug MENOTROPINS
        is Phase IV for the indiciation EFO_0000660 and targets the gene ENSG00000170820
        at this locus (211138bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000170820
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '2'
      position: 48978159
    locus_GRCh38:
      chromosome: '2'
      position: 48751020
  trait_info:
    ontology:
    - EFO_0000660
    reported_trait_name: Polycystic ovary syndrome
    standard_trait_name: polycystic ovary syndrome
- association_info:
    ancestry:
    - East Asian=5255
    gwas_catalog_id: GCST001634
    neg_log_pval: 8.397940008672037
    otg_id: GCST001634
    pubmed_id: '22885925'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Luteinizing hormone/Choriogonadotropin receptor agonist drug GONADOTROPIN,
        CHORIONIC is Phase IV for the indiciation EFO_0000660 and targets the gene
        ENSG00000138039 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000138039
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '2'
      position: 48978159
    locus_GRCh38:
      chromosome: '2'
      position: 48751020
  trait_info:
    ontology:
    - EFO_0000660
    reported_trait_name: Polycystic ovary syndrome
    standard_trait_name: polycystic ovary syndrome
- association_info:
    ancestry:
    - East Asian=1639
    gwas_catalog_id: GCST000914
    neg_log_pval: 20.096910013008056
    otg_id: GCST000914
    pubmed_id: '21151128'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Luteinizing hormone/Choriogonadotropin receptor agonist drug CHORIOGONADOTROPIN
        ALFA is Phase II for the indiciation EFO_0000660 and targets the gene ENSG00000138039
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000138039
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '2'
      position: 48978159
    locus_GRCh38:
      chromosome: '2'
      position: 48751020
  trait_info:
    ontology:
    - EFO_0000660
    reported_trait_name: Polycystic ovary syndrome
    standard_trait_name: polycystic ovary syndrome
- association_info:
    ancestry:
    - East Asian=1639
    gwas_catalog_id: GCST000914
    neg_log_pval: 20.096910013008056
    otg_id: GCST000914
    pubmed_id: '21151128'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Follicle stimulating hormone receptor agonist drug MENOTROPINS
        is Phase IV for the indiciation EFO_0000660 and targets the gene ENSG00000170820
        at this locus (211138bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000170820
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '2'
      position: 48978159
    locus_GRCh38:
      chromosome: '2'
      position: 48751020
  trait_info:
    ontology:
    - EFO_0000660
    reported_trait_name: Polycystic ovary syndrome
    standard_trait_name: polycystic ovary syndrome
- association_info:
    ancestry:
    - East Asian=5255
    gwas_catalog_id: GCST001634
    neg_log_pval: 12.0
    otg_id: GCST001634
    pubmed_id: '22885925'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Luteinizing hormone/Choriogonadotropin receptor agonist drug LH
        (MENOTROPINS) is Phase IV for the indiciation EFO_0000660 and targets the
        gene ENSG00000138039 at this locus (218743bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000138039
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '2'
      position: 49201612
    locus_GRCh38:
      chromosome: '2'
      position: 48974473
  trait_info:
    ontology:
    - EFO_0000660
    reported_trait_name: Polycystic ovary syndrome
    standard_trait_name: polycystic ovary syndrome
- association_info:
    ancestry:
    - East Asian=5255
    gwas_catalog_id: GCST001634
    neg_log_pval: 12.0
    otg_id: GCST001634
    pubmed_id: '22885925'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Luteinizing hormone/Choriogonadotropin receptor agonist drug CHORIOGONADOTROPIN
        ALFA is Phase II for the indiciation EFO_0000660 and targets the gene ENSG00000138039
        at this locus (218743bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000138039
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '2'
      position: 49201612
    locus_GRCh38:
      chromosome: '2'
      position: 48974473
  trait_info:
    ontology:
    - EFO_0000660
    reported_trait_name: Polycystic ovary syndrome
    standard_trait_name: polycystic ovary syndrome
- association_info:
    ancestry:
    - East Asian=5255
    gwas_catalog_id: GCST001634
    neg_log_pval: 12.0
    otg_id: GCST001634
    pubmed_id: '22885925'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Follicle stimulating hormone receptor agonist drug HUMAN FSH is
        Phase IV for the indiciation EFO_0000660 and targets the gene ENSG00000170820
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000170820
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '2'
      position: 49201612
    locus_GRCh38:
      chromosome: '2'
      position: 48974473
  trait_info:
    ontology:
    - EFO_0000660
    reported_trait_name: Polycystic ovary syndrome
    standard_trait_name: polycystic ovary syndrome
- association_info:
    ancestry:
    - European=407052
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 7.52432881167557
    otg_id: SAIGE_420_2
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-1 beta inhibitor drug RILONACEPT is Phase III for the
        indiciation EFO_0007427 and targets the gene ENSG00000125538 at this locus
        (15088bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000125538
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '2'
      position: 113609568
    locus_GRCh38:
      chromosome: '2'
      position: 112851991
  trait_info:
    ontology:
    - EFO_0007427
    reported_trait_name: Pericarditis
    standard_trait_name: pericarditis
- association_info:
    ancestry:
    - European, East Asian, African American or Afro-Caribbean, Hispanic or Latin
      American, NR=257811
    gwas_catalog_id: GCST007692
    neg_log_pval: 7.698970004336019
    otg_id: GCST007692
    pubmed_id: '30804561'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Mitochondrial glycerol-3-phosphate dehydrogenase inhibitor drug
        METFORMIN is Phase IV for the indiciation EFO_0000341 and targets the gene
        ENSG00000115159 at this locus (278767bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000115159
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '2'
      position: 157013035
    locus_GRCh38:
      chromosome: '2'
      position: 156156523
  trait_info:
    ontology:
    - EFO_0000341
    reported_trait_name: Chronic obstructive pulmonary disease
    standard_trait_name: chronic obstructive pulmonary disease
- association_info:
    ancestry:
    - NR=361315
    - European=446238
    gwas_catalog_id: GCST007342
    neg_log_pval: 17.522878745280337
    otg_id: GCST007342
    pubmed_id: '30718901'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Mitochondrial glycerol-3-phosphate dehydrogenase inhibitor drug
        METFORMIN is Phase IV for the indiciation EFO_0003761 and targets the gene
        ENSG00000115159 at this locus (180489bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000115159
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '2'
      position: 157111313
    locus_GRCh38:
      chromosome: '2'
      position: 156254801
  trait_info:
    ontology:
    - EFO_0003761
    reported_trait_name: Depression
    standard_trait_name: unipolar depression
- association_info:
    ancestry:
    - European=480359
    gwas_catalog_id: GCST005839
    neg_log_pval: 7.698970004336019
    otg_id: GCST005839
    pubmed_id: '29700475'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Mitochondrial glycerol-3-phosphate dehydrogenase inhibitor drug
        METFORMIN is Phase IV for the indiciation EFO_0003761 and targets the gene
        ENSG00000115159 at this locus (180489bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000115159
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '2'
      position: 157111313
    locus_GRCh38:
      chromosome: '2'
      position: 156254801
  trait_info:
    ontology:
    - EFO_0003761
    reported_trait_name: Depression
    standard_trait_name: unipolar depression
- association_info:
    ancestry:
    - European=357957
    gwas_catalog_id: GCST006475
    neg_log_pval: 7.4889191544608815
    otg_id: GCST006475
    pubmed_id: '29942085'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Mitochondrial glycerol-3-phosphate dehydrogenase inhibitor drug
        METFORMIN is Phase IV for the indiciation EFO_0003761 and targets the gene
        ENSG00000115159 at this locus (134654bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000115159
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '2'
      position: 157157148
    locus_GRCh38:
      chromosome: '2'
      position: 156300636
  trait_info:
    ontology:
    - EFO_0003761
    reported_trait_name: Depressed affect
    standard_trait_name: unipolar depression
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 8.54284051026846
    otg_id: NEALE2_20002_1065
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dipeptidyl peptidase IV inhibitor drug SITAGLIPTIN is Phase IV
        for the indiciation EFO_0000537 and targets the gene ENSG00000197635 at this
        locus (367302bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000197635
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '2'
      position: 162481453
    locus_GRCh38:
      chromosome: '2'
      position: 161624943
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Hypertension | non-cancer illness code, self-reported
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - European=408343
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 7.732828271596986
    otg_id: SAIGE_401
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dipeptidyl peptidase IV inhibitor drug SITAGLIPTIN is Phase IV
        for the indiciation EFO_0000537 and targets the gene ENSG00000197635 at this
        locus (265252bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000197635
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '2'
      position: 162583504
    locus_GRCh38:
      chromosome: '2'
      position: 161726994
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Hypertension
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - European=408089
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 7.580044251510242
    otg_id: SAIGE_401_1
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dipeptidyl peptidase IV inhibitor drug SITAGLIPTIN is Phase IV
        for the indiciation EFO_0000537 and targets the gene ENSG00000197635 at this
        locus (265252bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000197635
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '2'
      position: 162583504
    locus_GRCh38:
      chromosome: '2'
      position: 161726994
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Essential hypertension
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - European=82315
    - East Asian=5219
    gwas_catalog_id: GCST002539
    neg_log_pval: 7.301029995663981
    otg_id: GCST002539
    pubmed_id: '25056061'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Dipeptidyl peptidase IV inhibitor drug LINAGLIPTIN is Phase IV
        for the indiciation EFO_0000692 and targets the gene ENSG00000197635 at this
        locus (2901bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000197635
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '2'
      position: 162845855
    locus_GRCh38:
      chromosome: '2'
      position: 161989345
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - European=86475
    gwas_catalog_id: GCST005537
    neg_log_pval: 12.522878745280337
    otg_id: GCST005537
    pubmed_id: '26974007'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dipeptidyl peptidase IV inhibitor drug SITAGLIPTIN is Phase II
        for the indiciation EFO_0000676 and targets the gene ENSG00000197635 at this
        locus (179811bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000197635
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '2'
      position: 163110536
    locus_GRCh38:
      chromosome: '2'
      position: 162254026
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Chronic inflammatory diseases (ankylosing spondylitis, Crohn's
      disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
      [subset analysis]
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=18190
    gwas_catalog_id: GCST002740
    neg_log_pval: 11.698970004336019
    otg_id: GCST002740_4
    pubmed_id: '25574825'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dipeptidyl peptidase IV inhibitor drug SITAGLIPTIN is Phase II
        for the indiciation EFO_0000676 and targets the gene ENSG00000197635 at this
        locus (179811bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000197635
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '2'
      position: 163110536
    locus_GRCh38:
      chromosome: '2'
      position: 162254026
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Inflammatory skin disease [Psoriasis]
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=29652
    gwas_catalog_id: GCST005536
    neg_log_pval: 17.418639958543828
    otg_id: GCST005536
    pubmed_id: '25751624'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Dipeptidyl peptidase IV inhibitor drug SITAGLIPTIN is Phase IV
        for the indiciation EFO_0001359 and targets the gene ENSG00000197635 at this
        locus (179811bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000197635
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '2'
      position: 163110536
    locus_GRCh38:
      chromosome: '2'
      position: 162254026
  trait_info:
    ontology:
    - EFO_0001359
    reported_trait_name: Type 1 diabetes
    standard_trait_name: insulin-dependent diabetes mellitus
- association_info:
    ancestry:
    - European=29652
    gwas_catalog_id: GCST005536
    neg_log_pval: 17.418639958543828
    otg_id: GCST005536
    pubmed_id: '25751624'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Dipeptidyl peptidase IV inhibitor drug VILDAGLIPTIN is Phase III
        for the indiciation EFO_0001359 and targets the gene ENSG00000197635 at this
        locus (179811bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000197635
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '2'
      position: 163110536
    locus_GRCh38:
      chromosome: '2'
      position: 162254026
  trait_info:
    ontology:
    - EFO_0001359
    reported_trait_name: Type 1 diabetes
    standard_trait_name: insulin-dependent diabetes mellitus
- association_info:
    ancestry:
    - European=33394
    gwas_catalog_id: GCST005527
    neg_log_pval: 7.709543459425466
    otg_id: GCST005527
    pubmed_id: '23143594'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dipeptidyl peptidase IV inhibitor drug SITAGLIPTIN is Phase II
        for the indiciation EFO_0000676 and targets the gene ENSG00000197635 at this
        locus (193326bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000197635
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '2'
      position: 163124051
    locus_GRCh38:
      chromosome: '2'
      position: 162267541
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=19102
    gwas_catalog_id: GCST001191
    neg_log_pval: 13.698970004336019
    otg_id: GCST001191
    pubmed_id: '21829393'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Dipeptidyl peptidase IV inhibitor drug SAXAGLIPTIN is Phase IV
        for the indiciation EFO_0001359 and targets the gene ENSG00000197635 at this
        locus (193326bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000197635
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '2'
      position: 163124051
    locus_GRCh38:
      chromosome: '2'
      position: 162267541
  trait_info:
    ontology:
    - EFO_0001359
    reported_trait_name: Type 1 diabetes
    standard_trait_name: insulin-dependent diabetes mellitus
- association_info:
    ancestry:
    - East Asian=5134
    - European=8682
    gwas_catalog_id: GCST002874
    neg_log_pval: 8.0
    otg_id: GCST002874
    pubmed_id: '25903422'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dipeptidyl peptidase IV inhibitor drug SITAGLIPTIN is Phase II
        for the indiciation EFO_0000676 and targets the gene ENSG00000197635 at this
        locus (193326bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000197635
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '2'
      position: 163124051
    locus_GRCh38:
      chromosome: '2'
      position: 162267541
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=5000
    gwas_catalog_id: GCST000038
    neg_log_pval: 10.698970004336019
    otg_id: GCST000038
    pubmed_id: '17554260'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Dipeptidyl peptidase IV inhibitor drug SAXAGLIPTIN is Phase IV
        for the indiciation EFO_0001359 and targets the gene ENSG00000197635 at this
        locus (193326bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000197635
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '2'
      position: 163124051
    locus_GRCh38:
      chromosome: '2'
      position: 162267541
  trait_info:
    ontology:
    - EFO_0001359
    reported_trait_name: Type 1 diabetes
    standard_trait_name: insulin-dependent diabetes mellitus
- association_info:
    ancestry:
    - European=16559
    gwas_catalog_id: GCST000392
    neg_log_pval: 8.154901959985743
    otg_id: GCST000392
    pubmed_id: '19430480'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Dipeptidyl peptidase IV inhibitor drug SAXAGLIPTIN is Phase IV
        for the indiciation EFO_0001359 and targets the gene ENSG00000197635 at this
        locus (193326bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000197635
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '2'
      position: 163124051
    locus_GRCh38:
      chromosome: '2'
      position: 162267541
  trait_info:
    ontology:
    - EFO_0001359
    reported_trait_name: Type 1 diabetes
    standard_trait_name: insulin-dependent diabetes mellitus
- association_info:
    ancestry:
    - European=16559
    gwas_catalog_id: GCST000392
    neg_log_pval: 8.154901959985743
    otg_id: GCST000392
    pubmed_id: '19430480'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Dipeptidyl peptidase IV inhibitor drug VILDAGLIPTIN is Phase III
        for the indiciation EFO_0001359 and targets the gene ENSG00000197635 at this
        locus (193326bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000197635
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '2'
      position: 163124051
    locus_GRCh38:
      chromosome: '2'
      position: 162267541
  trait_info:
    ontology:
    - EFO_0001359
    reported_trait_name: Type 1 diabetes
    standard_trait_name: insulin-dependent diabetes mellitus
- association_info:
    ancestry:
    - European=5000
    gwas_catalog_id: GCST000038
    neg_log_pval: 10.698970004336019
    otg_id: GCST000038
    pubmed_id: '17554260'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Dipeptidyl peptidase IV inhibitor drug VILDAGLIPTIN is Phase III
        for the indiciation EFO_0001359 and targets the gene ENSG00000197635 at this
        locus (193326bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000197635
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '2'
      position: 163124051
    locus_GRCh38:
      chromosome: '2'
      position: 162267541
  trait_info:
    ontology:
    - EFO_0001359
    reported_trait_name: Type 1 diabetes
    standard_trait_name: insulin-dependent diabetes mellitus
- association_info:
    ancestry:
    - European=19102
    gwas_catalog_id: GCST001191
    neg_log_pval: 13.698970004336019
    otg_id: GCST001191
    pubmed_id: '21829393'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Dipeptidyl peptidase IV inhibitor drug VILDAGLIPTIN is Phase III
        for the indiciation EFO_0001359 and targets the gene ENSG00000197635 at this
        locus (193326bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000197635
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '2'
      position: 163124051
    locus_GRCh38:
      chromosome: '2'
      position: 162267541
  trait_info:
    ontology:
    - EFO_0001359
    reported_trait_name: Type 1 diabetes
    standard_trait_name: insulin-dependent diabetes mellitus
- association_info:
    ancestry:
    - East Asian=5134
    - European=8682
    gwas_catalog_id: GCST002874
    neg_log_pval: 10.522878745280337
    otg_id: GCST002874_5
    pubmed_id: '25903422'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dipeptidyl peptidase IV inhibitor drug SITAGLIPTIN is Phase II
        for the indiciation EFO_0000676 and targets the gene ENSG00000197635 at this
        locus (198100bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000197635
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '2'
      position: 163128824
    locus_GRCh38:
      chromosome: '2'
      position: 162272314
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis [EA, conditional on rs1990760]
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - East Asian=5134
    - European=8682
    gwas_catalog_id: GCST002874
    neg_log_pval: 18.0
    otg_id: GCST002874_9
    pubmed_id: '25903422'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dipeptidyl peptidase IV inhibitor drug SITAGLIPTIN is Phase II
        for the indiciation EFO_0000676 and targets the gene ENSG00000197635 at this
        locus (198100bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000197635
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '2'
      position: 163128824
    locus_GRCh38:
      chromosome: '2'
      position: 162272314
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis [conditional on rs1990760]
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=287323
    gwas_catalog_id: GCST004346
    neg_log_pval: 24.0
    otg_id: GCST004346
    pubmed_id: '28537254'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dipeptidyl peptidase IV inhibitor drug SITAGLIPTIN is Phase II
        for the indiciation EFO_0000676 and targets the gene ENSG00000197635 at this
        locus (237021bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000197635
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '2'
      position: 163167746
    locus_GRCh38:
      chromosome: '2'
      position: 162311236
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=12244
    gwas_catalog_id: GCST002738
    neg_log_pval: 8.522878745280337
    otg_id: GCST002738
    pubmed_id: '25574825'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dipeptidyl peptidase IV inhibitor drug SITAGLIPTIN is Phase II
        for the indiciation EFO_0000676 and targets the gene ENSG00000197635 at this
        locus (329966bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000197635
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '2'
      position: 163260691
    locus_GRCh38:
      chromosome: '2'
      position: 162404181
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=7353
    gwas_catalog_id: GCST000833
    neg_log_pval: 13.0
    otg_id: GCST000833
    pubmed_id: '20953190'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dipeptidyl peptidase IV inhibitor drug SITAGLIPTIN is Phase II
        for the indiciation EFO_0000676 and targets the gene ENSG00000197635 at this
        locus (329966bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000197635
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '2'
      position: 163260691
    locus_GRCh38:
      chromosome: '2'
      position: 162404181
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European, NR=40266
    gwas_catalog_id: GCST004132
    neg_log_pval: 10.012333735073724
    otg_id: GCST004132
    pubmed_id: '28067908'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Integrin alpha-4/beta-1 inhibitor drug NATALIZUMAB is Phase IV
        for the indiciation EFO_0000384 and targets the gene ENSG00000115232 at this
        locus (13578bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000115232
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '2'
      position: 182308352
    locus_GRCh38:
      chromosome: '2'
      position: 181443625
  trait_info:
    ontology:
    - EFO_0000384
    reported_trait_name: Crohn's disease
    standard_trait_name: Crohn's disease
- association_info:
    ancestry:
    - East Asian=4325
    gwas_catalog_id: GCST001457
    neg_log_pval: 13.045757490560675
    otg_id: GCST001457
    pubmed_id: '22452962'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Receptor protein-tyrosine kinase erbB-4 inhibitor drug BMS-690514
        is Phase II for the indiciation EFO_0000305 and targets the gene ENSG00000178568
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000178568
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '2'
      position: 213296863
    locus_GRCh38:
      chromosome: '2'
      position: 212432139
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European, NR=58918
    - European=458969
    gwas_catalog_id: GCST007656
    neg_log_pval: 8.698970004336019
    otg_id: GCST007656
    pubmed_id: '30940143'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-8 receptor A antagonist drug NAVARIXIN is Phase II
        for the indiciation EFO_0000341 and targets the gene ENSG00000163464 at this
        locus (360196bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000163464
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '2'
      position: 218667372
    locus_GRCh38:
      chromosome: '2'
      position: 217802649
  trait_info:
    ontology:
    - EFO_0000341
    reported_trait_name: Chronic obstructive pulmonary disease or resting heart rate
      (pleiotropy)
    standard_trait_name: chronic obstructive pulmonary disease
- association_info:
    ancestry:
    - European, NR=58918
    - European=458969
    gwas_catalog_id: GCST007656
    neg_log_pval: 8.698970004336019
    otg_id: GCST007656
    pubmed_id: '30940143'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-8 receptor B antagonist drug NAVARIXIN is Phase II
        for the indiciation EFO_0000341 and targets the gene ENSG00000180871 at this
        locus (322641bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000180871
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '2'
      position: 218667372
    locus_GRCh38:
      chromosome: '2'
      position: 217802649
  trait_info:
    ontology:
    - EFO_0000341
    reported_trait_name: Chronic obstructive pulmonary disease or resting heart rate
      (pleiotropy)
    standard_trait_name: chronic obstructive pulmonary disease
- association_info:
    ancestry:
    - European, East Asian, African American or Afro-Caribbean, Hispanic or Latin
      American, NR=257811
    gwas_catalog_id: GCST007692
    neg_log_pval: 11.522878745280337
    otg_id: GCST007692
    pubmed_id: '30804561'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-8 receptor A antagonist drug NAVARIXIN is Phase II
        for the indiciation EFO_0000341 and targets the gene ENSG00000163464 at this
        locus (344415bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000163464
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '2'
      position: 218683154
    locus_GRCh38:
      chromosome: '2'
      position: 217818431
  trait_info:
    ontology:
    - EFO_0000341
    reported_trait_name: Chronic obstructive pulmonary disease
    standard_trait_name: chronic obstructive pulmonary disease
- association_info:
    ancestry:
    - European, East Asian, African American or Afro-Caribbean, Hispanic or Latin
      American, NR=257811
    gwas_catalog_id: GCST007692
    neg_log_pval: 11.522878745280337
    otg_id: GCST007692
    pubmed_id: '30804561'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-8 receptor B antagonist drug DANIRIXIN is Phase II
        for the indiciation EFO_0000341 and targets the gene ENSG00000180871 at this
        locus (306858bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000180871
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '2'
      position: 218683154
    locus_GRCh38:
      chromosome: '2'
      position: 217818431
  trait_info:
    ontology:
    - EFO_0000341
    reported_trait_name: Chronic obstructive pulmonary disease
    standard_trait_name: chronic obstructive pulmonary disease
- association_info:
    ancestry:
    - European=139274
    gwas_catalog_id: GCST004988
    neg_log_pval: 9.466355021201236
    otg_id: GCST004988
    pubmed_id: '29059683'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-8 receptor A modulator drug REPARIXIN is Phase II for
        the indiciation EFO_0000305 and targets the gene ENSG00000163464 at this locus
        (304113bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000163464
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '2'
      position: 218723455
    locus_GRCh38:
      chromosome: '2'
      position: 217858732
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=139274
    gwas_catalog_id: GCST004988
    neg_log_pval: 9.466355021201236
    otg_id: GCST004988
    pubmed_id: '29059683'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-8 receptor B modulator drug REPARIXIN is Phase II for
        the indiciation EFO_0000305 and targets the gene ENSG00000180871 at this locus
        (266557bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000180871
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '2'
      position: 218723455
    locus_GRCh38:
      chromosome: '2'
      position: 217858732
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=27432
    gwas_catalog_id: GCST003045
    neg_log_pval: 8.682610761959468
    otg_id: GCST003045
    pubmed_id: '26192919'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-8 receptor B antagonist drug ELUBRIXIN is Phase II
        for the indiciation EFO_0000729 and targets the gene ENSG00000180871 at this
        locus (8173bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000180871
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '2'
      position: 219010146
    locus_GRCh38:
      chromosome: '2'
      position: 218145423
  trait_info:
    ontology:
    - EFO_0000729
    reported_trait_name: Ulcerative colitis [EA]
    standard_trait_name: ulcerative colitis
- association_info:
    ancestry:
    - European=86475
    gwas_catalog_id: GCST005537
    neg_log_pval: 10.698970004336019
    otg_id: GCST005537
    pubmed_id: '26974007'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-8 receptor B antagonist drug ELUBRIXIN is Phase II
        for the indiciation EFO_0000729 and targets the gene ENSG00000180871 at this
        locus (8173bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000180871
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '2'
      position: 219010146
    locus_GRCh38:
      chromosome: '2'
      position: 218145423
  trait_info:
    ontology:
    - EFO_0000729
    reported_trait_name: Chronic inflammatory diseases (ankylosing spondylitis, Crohn's
      disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
      [subset analysis]
    standard_trait_name: ulcerative colitis
- association_info:
    ancestry:
    - European=26405
    gwas_catalog_id: GCST000964
    neg_log_pval: 8.056505484093897
    otg_id: GCST000964
    pubmed_id: '21297633'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-8 receptor B antagonist drug ELUBRIXIN is Phase II
        for the indiciation EFO_0000729 and targets the gene ENSG00000180871 at this
        locus (8173bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000180871
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '2'
      position: 219010146
    locus_GRCh38:
      chromosome: '2'
      position: 218145423
  trait_info:
    ontology:
    - EFO_0000729
    reported_trait_name: Ulcerative colitis
    standard_trait_name: ulcerative colitis
- association_info:
    ancestry:
    - European=86475
    gwas_catalog_id: GCST005537
    neg_log_pval: 10.698970004336019
    otg_id: GCST005537
    pubmed_id: '26974007'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-8 receptor B antagonist drug NAVARIXIN is Phase II
        for the indiciation EFO_0000676 and targets the gene ENSG00000180871 at this
        locus (8173bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000180871
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '2'
      position: 219010146
    locus_GRCh38:
      chromosome: '2'
      position: 218145423
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Chronic inflammatory diseases (ankylosing spondylitis, Crohn's
      disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
      [subset analysis]
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=86475
    gwas_catalog_id: GCST005537
    neg_log_pval: 10.698970004336019
    otg_id: GCST005537
    pubmed_id: '26974007'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-8 receptor A antagonist drug NAVARIXIN is Phase II
        for the indiciation EFO_0000676 and targets the gene ENSG00000163464 at this
        locus (17422bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000163464
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '2'
      position: 219010146
    locus_GRCh38:
      chromosome: '2'
      position: 218145423
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Chronic inflammatory diseases (ankylosing spondylitis, Crohn's
      disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
      [subset analysis]
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=17691
    gwas_catalog_id: GCST004146
    neg_log_pval: 11.045757490560675
    otg_id: GCST004146
    pubmed_id: '28165464'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Programmed cell death protein 1 inhibitor drug NIVOLUMAB is Phase
        II for the indiciation EFO_0000095 and targets the gene ENSG00000188389 at
        this locus (494386bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000188389
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '2'
      position: 242294913
    locus_GRCh38:
      chromosome: '2'
      position: 241355498
  trait_info:
    ontology:
    - EFO_0000095
    reported_trait_name: Chronic lymphocytic leukemia
    standard_trait_name: chronic lymphocytic leukemia
- association_info:
    ancestry:
    - European=140254
    gwas_catalog_id: GCST006085
    neg_log_pval: 14.0
    otg_id: GCST006085
    pubmed_id: '29892016'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Programmed cell death protein 1 inhibitor drug PEMBROLIZUMAB is
        Phase II for the indiciation EFO_0001663 and targets the gene ENSG00000188389
        at this locus (406436bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000188389
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '2'
      position: 242382864
    locus_GRCh38:
      chromosome: '2'
      position: 241443449
  trait_info:
    ontology:
    - EFO_0001663
    reported_trait_name: Prostate cancer
    standard_trait_name: prostate carcinoma
- association_info:
    ancestry:
    - European=22548
    gwas_catalog_id: GCST001942
    neg_log_pval: 8.301029995663981
    otg_id: GCST001942
    pubmed_id: '23535732'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Programmed cell death protein 1 inhibitor drug PEMBROLIZUMAB is
        Phase II for the indiciation EFO_0001663 and targets the gene ENSG00000188389
        at this locus (406436bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000188389
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '2'
      position: 242382864
    locus_GRCh38:
      chromosome: '2'
      position: 241443449
  trait_info:
    ontology:
    - EFO_0001663
    reported_trait_name: Prostate cancer
    standard_trait_name: prostate carcinoma
- association_info:
    ancestry:
    - European=16559
    gwas_catalog_id: GCST000392
    neg_log_pval: 11.0
    otg_id: GCST000392
    pubmed_id: '19430480'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: FK506-binding protein 1A inhibitor drug SIROLIMUS is Phase IV for
        the indiciation EFO_0001359 and targets the gene ENSG00000088832 at this locus
        (236734bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000088832
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '20'
      position: 1610551
    locus_GRCh38:
      chromosome: '20'
      position: 1629905
  trait_info:
    ontology:
    - EFO_0001359
    reported_trait_name: Type 1 diabetes
    standard_trait_name: insulin-dependent diabetes mellitus
- association_info:
    ancestry:
    - European=16559
    gwas_catalog_id: GCST000392
    neg_log_pval: 11.0
    otg_id: GCST000392
    pubmed_id: '19430480'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: FK506-binding protein 1A inhibitor drug TACROLIMUS is Phase III
        for the indiciation EFO_0001359 and targets the gene ENSG00000088832 at this
        locus (236734bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000088832
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '20'
      position: 1610551
    locus_GRCh38:
      chromosome: '20'
      position: 1629905
  trait_info:
    ontology:
    - EFO_0001359
    reported_trait_name: Type 1 diabetes
    standard_trait_name: insulin-dependent diabetes mellitus
- association_info:
    ancestry:
    - European=29652
    gwas_catalog_id: GCST005536
    neg_log_pval: 9.526299949462304
    otg_id: GCST005536
    pubmed_id: '25751624'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: FK506-binding protein 1A inhibitor drug SIROLIMUS is Phase IV for
        the indiciation EFO_0001359 and targets the gene ENSG00000088832 at this locus
        (242388bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000088832
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '20'
      position: 1616206
    locus_GRCh38:
      chromosome: '20'
      position: 1635560
  trait_info:
    ontology:
    - EFO_0001359
    reported_trait_name: Type 1 diabetes
    standard_trait_name: insulin-dependent diabetes mellitus
- association_info:
    ancestry:
    - European=29652
    gwas_catalog_id: GCST005536
    neg_log_pval: 9.526299949462304
    otg_id: GCST005536
    pubmed_id: '25751624'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: FK506-binding protein 1A inhibitor drug TACROLIMUS is Phase III
        for the indiciation EFO_0001359 and targets the gene ENSG00000088832 at this
        locus (242388bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000088832
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '20'
      position: 1616206
    locus_GRCh38:
      chromosome: '20'
      position: 1635560
  trait_info:
    ontology:
    - EFO_0001359
    reported_trait_name: Type 1 diabetes
    standard_trait_name: insulin-dependent diabetes mellitus
- association_info:
    ancestry:
    - European=20883
    gwas_catalog_id: GCST003044
    neg_log_pval: 54.01739783478714
    otg_id: GCST003044
    pubmed_id: '26192919'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: FK506-binding protein 1A inhibitor drug SIROLIMUS is Phase IV for
        the indiciation EFO_0000384 and targets the gene ENSG00000088832 at this locus
        (308219bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000088832
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '20'
      position: 1682037
    locus_GRCh38:
      chromosome: '20'
      position: 1701391
  trait_info:
    ontology:
    - EFO_0000384
    reported_trait_name: Crohn's disease [EA]
    standard_trait_name: Crohn's disease
- association_info:
    ancestry:
    - European=27432
    gwas_catalog_id: GCST003045
    neg_log_pval: 41.87573133737034
    otg_id: GCST003045
    pubmed_id: '26192919'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: FK506-binding protein 1A inhibitor drug TACROLIMUS is Phase IV
        for the indiciation EFO_0000729 and targets the gene ENSG00000088832 at this
        locus (308219bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000088832
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '20'
      position: 1682037
    locus_GRCh38:
      chromosome: '20'
      position: 1701391
  trait_info:
    ontology:
    - EFO_0000729
    reported_trait_name: Ulcerative colitis [EA]
    standard_trait_name: ulcerative colitis
- association_info:
    ancestry:
    - European=20883
    gwas_catalog_id: GCST003044
    neg_log_pval: 54.01739783478714
    otg_id: GCST003044
    pubmed_id: '26192919'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: FK506-binding protein 1A inhibitor drug TACROLIMUS is Phase II
        for the indiciation EFO_0000384 and targets the gene ENSG00000088832 at this
        locus (308219bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000088832
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '20'
      position: 1682037
    locus_GRCh38:
      chromosome: '20'
      position: 1701391
  trait_info:
    ontology:
    - EFO_0000384
    reported_trait_name: Crohn's disease [EA]
    standard_trait_name: Crohn's disease
- association_info:
    ancestry:
    - European=89677
    gwas_catalog_id: GCST007236
    neg_log_pval: 7.4634655452861525
    otg_id: GCST007236
    pubmed_id: '25751625'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Matrix metalloproteinase 9 inhibitor drug MARIMASTAT is Phase III
        for the indiciation EFO_0000305 and targets the gene ENSG00000100985 at this
        locus (408100bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000100985
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '20'
      position: 44229447
    locus_GRCh38:
      chromosome: '20'
      position: 45600808
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European, NR=40266
    gwas_catalog_id: GCST004132
    neg_log_pval: 10.576918041702768
    otg_id: GCST004132
    pubmed_id: '28067908'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Matrix metalloproteinase 9 inhibitor drug ANDECALIXIMAB is Phase
        II for the indiciation EFO_0000384 and targets the gene ENSG00000100985 at
        this locus (2636bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000100985
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '20'
      position: 44634912
    locus_GRCh38:
      chromosome: '20'
      position: 46006273
  trait_info:
    ontology:
    - EFO_0000384
    reported_trait_name: Crohn's disease
    standard_trait_name: Crohn's disease
- association_info:
    ancestry:
    - European=89677
    gwas_catalog_id: GCST007236
    neg_log_pval: 7.402641632544848
    otg_id: GCST007236
    pubmed_id: '25751625'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Matrix metalloproteinase 9 inhibitor drug MARIMASTAT is Phase III
        for the indiciation EFO_0000305 and targets the gene ENSG00000100985 at this
        locus (48698bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000100985
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '20'
      position: 44693897
    locus_GRCh38:
      chromosome: '20'
      position: 46065258
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=43327
    gwas_catalog_id: GCST005568
    neg_log_pval: 9.0
    otg_id: GCST005568
    pubmed_id: '23143596'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Matrix metalloproteinase 9 inhibitor drug ANDECALIXIMAB is Phase
        II for the indiciation EFO_0000685 and targets the gene ENSG00000100985 at
        this locus (89110bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000100985
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '20'
      position: 44734310
    locus_GRCh38:
      chromosome: '20'
      position: 46105671
  trait_info:
    ontology:
    - EFO_0000685
    reported_trait_name: Rheumatoid arthritis (ACPA-positive)
    standard_trait_name: rheumatoid arthritis
- association_info:
    ancestry:
    - European=20883
    gwas_catalog_id: GCST003044
    neg_log_pval: 11.569280112136719
    otg_id: GCST003044
    pubmed_id: '26192919'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Matrix metalloproteinase 9 inhibitor drug ANDECALIXIMAB is Phase
        II for the indiciation EFO_0000384 and targets the gene ENSG00000100985 at
        this locus (94996bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000100985
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '20'
      position: 44740196
    locus_GRCh38:
      chromosome: '20'
      position: 46111557
  trait_info:
    ontology:
    - EFO_0000384
    reported_trait_name: Crohn's disease [EA]
    standard_trait_name: Crohn's disease
- association_info:
    ancestry:
    - European=86475
    gwas_catalog_id: GCST005537
    neg_log_pval: 11.397940008672037
    otg_id: GCST005537
    pubmed_id: '26974007'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Matrix metalloproteinase 9 inhibitor drug ANDECALIXIMAB is Phase
        II for the indiciation EFO_0000729 and targets the gene ENSG00000100985 at
        this locus (101782bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000100985
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '20'
      position: 44746982
    locus_GRCh38:
      chromosome: '20'
      position: 46118343
  trait_info:
    ontology:
    - EFO_0000729
    reported_trait_name: Chronic inflammatory diseases (ankylosing spondylitis, Crohn's
      disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
      [subset analysis]
    standard_trait_name: ulcerative colitis
- association_info:
    ancestry:
    - European=86475
    gwas_catalog_id: GCST005537
    neg_log_pval: 11.397940008672037
    otg_id: GCST005537
    pubmed_id: '26974007'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Matrix metalloproteinase 9 inhibitor drug ANDECALIXIMAB is Phase
        II for the indiciation EFO_0000384 and targets the gene ENSG00000100985 at
        this locus (101782bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000100985
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '20'
      position: 44746982
    locus_GRCh38:
      chromosome: '20'
      position: 46118343
  trait_info:
    ontology:
    - EFO_0000384
    reported_trait_name: Chronic inflammatory diseases (ankylosing spondylitis, Crohn's
      disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
      [subset analysis]
    standard_trait_name: Crohn's disease
- association_info:
    ancestry:
    - East Asian=9299
    - European=45790
    gwas_catalog_id: GCST006048
    neg_log_pval: 12.698970004336019
    otg_id: GCST006048
    pubmed_id: '24532676'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Matrix metalloproteinase 9 inhibitor drug ANDECALIXIMAB is Phase
        II for the indiciation EFO_0000685 and targets the gene ENSG00000100985 at
        this locus (101782bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000100985
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '20'
      position: 44746982
    locus_GRCh38:
      chromosome: '20'
      position: 46118343
  trait_info:
    ontology:
    - EFO_0000685
    reported_trait_name: Rheumatoid arthritis (ACPA-positive)
    standard_trait_name: rheumatoid arthritis
- association_info:
    ancestry:
    - European=25708
    gwas_catalog_id: GCST000679
    neg_log_pval: 8.244874758392445
    otg_id: GCST000679
    pubmed_id: '20453842'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Matrix metalloproteinase 9 inhibitor drug ANDECALIXIMAB is Phase
        II for the indiciation EFO_0000685 and targets the gene ENSG00000100985 at
        this locus (102748bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000100985
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '20'
      position: 44747947
    locus_GRCh38:
      chromosome: '20'
      position: 46119308
  trait_info:
    ontology:
    - EFO_0000685
    reported_trait_name: Rheumatoid arthritis
    standard_trait_name: rheumatoid arthritis
- association_info:
    ancestry:
    - European=15853
    gwas_catalog_id: GCST000232
    neg_log_pval: 8.096910013008056
    otg_id: GCST000232
    pubmed_id: '18794853'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Matrix metalloproteinase 9 inhibitor drug ANDECALIXIMAB is Phase
        II for the indiciation EFO_0000685 and targets the gene ENSG00000100985 at
        this locus (102748bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000100985
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '20'
      position: 44747947
    locus_GRCh38:
      chromosome: '20'
      position: 46119308
  trait_info:
    ontology:
    - EFO_0000685
    reported_trait_name: Rheumatoid arthritis
    standard_trait_name: rheumatoid arthritis
- association_info:
    ancestry:
    - European=43327
    gwas_catalog_id: GCST005568
    neg_log_pval: 10.045757490560675
    otg_id: GCST005568
    pubmed_id: '23143596'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Matrix metalloproteinase 9 inhibitor drug ANDECALIXIMAB is Phase
        II for the indiciation EFO_0000685 and targets the gene ENSG00000100985 at
        this locus (102748bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000100985
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '20'
      position: 44747947
    locus_GRCh38:
      chromosome: '20'
      position: 46119308
  trait_info:
    ontology:
    - EFO_0000685
    reported_trait_name: Rheumatoid arthritis (ACPA-positive)
    standard_trait_name: rheumatoid arthritis
- association_info:
    ancestry:
    - African American or Afro-Caribbean=2308
    gwas_catalog_id: GCST006959
    neg_log_pval: 13.522878745280337
    otg_id: GCST006959
    pubmed_id: '30423114'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Matrix metalloproteinase 9 inhibitor drug ANDECALIXIMAB is Phase
        II for the indiciation EFO_0000685 and targets the gene ENSG00000100985 at
        this locus (104051bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000100985
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '20'
      position: 44749251
    locus_GRCh38:
      chromosome: '20'
      position: 46120612
  trait_info:
    ontology:
    - EFO_0000685
    reported_trait_name: Rheumatoid arthritis
    standard_trait_name: rheumatoid arthritis
- association_info:
    ancestry:
    - European=58284
    - East Asian=22515
    gwas_catalog_id: GCST002318
    neg_log_pval: 17.397940008672037
    otg_id: GCST002318
    pubmed_id: '24390342'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Matrix metalloproteinase 9 inhibitor drug ANDECALIXIMAB is Phase
        II for the indiciation EFO_0000685 and targets the gene ENSG00000100985 at
        this locus (104051bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000100985
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '20'
      position: 44749251
    locus_GRCh38:
      chromosome: '20'
      position: 46120612
  trait_info:
    ontology:
    - EFO_0000685
    reported_trait_name: Rheumatoid arthritis
    standard_trait_name: rheumatoid arthritis
- association_info:
    ancestry:
    - African American or Afro-Caribbean=2308
    gwas_catalog_id: GCST006959
    neg_log_pval: 13.397940008672037
    otg_id: GCST006959_3
    pubmed_id: '30423114'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Matrix metalloproteinase 9 inhibitor drug ANDECALIXIMAB is Phase
        II for the indiciation EFO_0000685 and targets the gene ENSG00000100985 at
        this locus (104051bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000100985
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '20'
      position: 44749251
    locus_GRCh38:
      chromosome: '20'
      position: 46120612
  trait_info:
    ontology:
    - EFO_0000685
    reported_trait_name: Rheumatoid arthritis [EA]
    standard_trait_name: rheumatoid arthritis
- association_info:
    ancestry:
    - European=58284
    - East Asian=22515
    gwas_catalog_id: GCST002318
    neg_log_pval: 16.0
    otg_id: GCST002318_2
    pubmed_id: '24390342'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Matrix metalloproteinase 9 inhibitor drug ANDECALIXIMAB is Phase
        II for the indiciation EFO_0000685 and targets the gene ENSG00000100985 at
        this locus (104051bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000100985
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '20'
      position: 44749251
    locus_GRCh38:
      chromosome: '20'
      position: 46120612
  trait_info:
    ontology:
    - EFO_0000685
    reported_trait_name: Rheumatoid arthritis [EA]
    standard_trait_name: rheumatoid arthritis
- association_info:
    ancestry:
    - European=89677
    gwas_catalog_id: GCST007236
    neg_log_pval: 7.61253898367965
    otg_id: GCST007236
    pubmed_id: '25751625'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Matrix metalloproteinase 9 inhibitor drug MARIMASTAT is Phase III
        for the indiciation EFO_0000305 and targets the gene ENSG00000100985 at this
        locus (229958bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000100985
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '20'
      position: 44875157
    locus_GRCh38:
      chromosome: '20'
      position: 46246518
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=89677
    gwas_catalog_id: GCST007236
    neg_log_pval: 7.818633826857316
    otg_id: GCST007236
    pubmed_id: '25751625'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Matrix metalloproteinase 9 inhibitor drug MARIMASTAT is Phase III
        for the indiciation EFO_0000305 and targets the gene ENSG00000100985 at this
        locus (391013bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000100985
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '20'
      position: 45036213
    locus_GRCh38:
      chromosome: '20'
      position: 46407574
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=89677
    gwas_catalog_id: GCST007236
    neg_log_pval: 8.34338536184194
    otg_id: GCST007236
    pubmed_id: '25751625'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug TRASTUZUMAB EMTANSINE is Phase IV for the
        indiciation EFO_0000305 and targets the gene ENSG00000101162 at this locus
        (226411bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000101162
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '20'
      position: 57367899
    locus_GRCh38:
      chromosome: '20'
      position: 58792844
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=89677
    gwas_catalog_id: GCST007236
    neg_log_pval: 8.34338536184194
    otg_id: GCST007236
    pubmed_id: '25751625'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug CABAZITAXEL is Phase II for the indiciation
        EFO_0000305 and targets the gene ENSG00000101162 at this locus (226411bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000101162
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '20'
      position: 57367899
    locus_GRCh38:
      chromosome: '20'
      position: 58792844
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - East Asian=70506
    gwas_catalog_id: GCST007552
    neg_log_pval: 7.698970004336019
    otg_id: GCST007552
    pubmed_id: '30529582'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug DOCETAXEL is Phase II for the indiciation
        EFO_0005842 and targets the gene ENSG00000101162 at this locus (119118bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000101162
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '20'
      position: 57475191
    locus_GRCh38:
      chromosome: '20'
      position: 58900136
  trait_info:
    ontology:
    - EFO_0005842
    reported_trait_name: Colorectal cancer
    standard_trait_name: colorectal cancer
- association_info:
    ancestry:
    - European=89677
    gwas_catalog_id: GCST007236
    neg_log_pval: 7.5130894413060085
    otg_id: GCST007236
    pubmed_id: '25751625'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug CABAZITAXEL is Phase II for the indiciation
        EFO_0000305 and targets the gene ENSG00000101162 at this locus (57416bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000101162
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '20'
      position: 57659124
    locus_GRCh38:
      chromosome: '20'
      position: 59084069
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=89677
    gwas_catalog_id: GCST007236
    neg_log_pval: 7.5130894413060085
    otg_id: GCST007236
    pubmed_id: '25751625'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug IXABEPILONE is Phase IV for the indiciation
        EFO_0000305 and targets the gene ENSG00000101162 at this locus (57416bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000101162
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '20'
      position: 57659124
    locus_GRCh38:
      chromosome: '20'
      position: 59084069
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - NR=296525
    gwas_catalog_id: GCST005194
    neg_log_pval: 9.099086932262331
    otg_id: GCST005194
    pubmed_id: '29212778'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug PACLITAXEL is Phase IV for the indiciation
        EFO_0000378 and targets the gene ENSG00000101162 at this locus (112317bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000101162
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '20'
      position: 57714025
    locus_GRCh38:
      chromosome: '20'
      position: 59138970
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - European=86475
    gwas_catalog_id: GCST005537
    neg_log_pval: 11.397940008672037
    otg_id: GCST005537
    pubmed_id: '26974007'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug PACLITAXEL is Phase II for the indiciation
        EFO_0000676 and targets the gene ENSG00000101162 at this locus (222600bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000101162
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '20'
      position: 57824309
    locus_GRCh38:
      chromosome: '20'
      position: 59249254
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Chronic inflammatory diseases (ankylosing spondylitis, Crohn's
      disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
      [subset analysis]
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=89677
    gwas_catalog_id: GCST007236
    neg_log_pval: 7.339507340775082
    otg_id: GCST007236
    pubmed_id: '25751625'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug IXABEPILONE is Phase IV for the indiciation
        EFO_0000305 and targets the gene ENSG00000101162 at this locus (369395bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000101162
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '20'
      position: 57971104
    locus_GRCh38:
      chromosome: '20'
      position: 59396049
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=89677
    gwas_catalog_id: GCST007236
    neg_log_pval: 7.339507340775082
    otg_id: GCST007236
    pubmed_id: '25751625'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug CABAZITAXEL is Phase II for the indiciation
        EFO_0000305 and targets the gene ENSG00000101162 at this locus (369395bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000101162
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '20'
      position: 57971104
    locus_GRCh38:
      chromosome: '20'
      position: 59396049
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=140254
    gwas_catalog_id: GCST006085
    neg_log_pval: 17.522878745280337
    otg_id: GCST006085
    pubmed_id: '29892016'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tyrosine-protein kinase BRK inhibitor drug VANDETANIB is Phase
        II for the indiciation EFO_0001663 and targets the gene ENSG00000101213 at
        this locus (193836bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000101213
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '20'
      position: 62362563
    locus_GRCh38:
      chromosome: '20'
      position: 63731211
  trait_info:
    ontology:
    - EFO_0001663
    reported_trait_name: Prostate cancer
    standard_trait_name: prostate carcinoma
- association_info:
    ancestry:
    - European=22548
    gwas_catalog_id: GCST001942
    neg_log_pval: 15.397940008672037
    otg_id: GCST001942
    pubmed_id: '23535732'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tyrosine-protein kinase BRK inhibitor drug VANDETANIB is Phase
        II for the indiciation EFO_0001663 and targets the gene ENSG00000101213 at
        this locus (193836bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000101213
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '20'
      position: 62362563
    locus_GRCh38:
      chromosome: '20'
      position: 63731211
  trait_info:
    ontology:
    - EFO_0001663
    reported_trait_name: Prostate cancer
    standard_trait_name: prostate carcinoma
- association_info:
    ancestry:
    - European=58284
    - East Asian=22515
    gwas_catalog_id: GCST002318
    neg_log_pval: 7.522878745280337
    otg_id: GCST002318_2
    pubmed_id: '24390342'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interferon-alpha/beta receptor alpha chain antagonist drug ANIFROLUMAB
        is Phase II for the indiciation EFO_0000685 and targets the gene ENSG00000142166
        at this locus (32118bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000142166
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '21'
      position: 34764288
    locus_GRCh38:
      chromosome: '21'
      position: 33391982
  trait_info:
    ontology:
    - EFO_0000685
    reported_trait_name: Rheumatoid arthritis [EA]
    standard_trait_name: rheumatoid arthritis
- association_info:
    ancestry:
    - European, NR=63731
    gwas_catalog_id: GCST004787
    neg_log_pval: 9.154901959985743
    otg_id: GCST004787
    pubmed_id: '28714975'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Adenosine A2a receptor agonist drug REGADENOSON is Phase III for
        the indiciation EFO_0000378 and targets the gene ENSG00000128271 at this locus
        (154989bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000128271
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '22'
      position: 24658858
    locus_GRCh38:
      chromosome: '22'
      position: 24262890
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease (myocardial infarction, percutaneous
      transluminal coronary angioplasty, coronary artery bypass grafting, angina or
      chromic ischemic heart disease)
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - European=141217
    - African American or Afro-Caribbean=3139
    - Hispanic or Latin American=4095
    - South Asian=25557
    - Greater Middle Eastern (Middle Eastern / North African / Persian)=2268
    - East Asian=11323
    gwas_catalog_id: GCST003116
    neg_log_pval: 9.698970004336019
    otg_id: GCST003116_2
    pubmed_id: '26343387'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Adenosine A2a receptor agonist drug REGADENOSON is Phase III for
        the indiciation EFO_0000378 and targets the gene ENSG00000128271 at this locus
        (154989bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000128271
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '22'
      position: 24658858
    locus_GRCh38:
      chromosome: '22'
      position: 24262890
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease [additive model]
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - NR=250736
    gwas_catalog_id: GCST005196
    neg_log_pval: 9.045757490560675
    otg_id: GCST005196
    pubmed_id: '29212778'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Adenosine A2a receptor agonist drug REGADENOSON is Phase III for
        the indiciation EFO_0000378 and targets the gene ENSG00000128271 at this locus
        (151677bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000128271
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '22'
      position: 24662171
    locus_GRCh38:
      chromosome: '22'
      position: 24266203
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - NR=296525
    gwas_catalog_id: GCST005194
    neg_log_pval: 8.428291168191313
    otg_id: GCST005194
    pubmed_id: '29212778'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Adenosine A2a receptor agonist drug REGADENOSON is Phase III for
        the indiciation EFO_0000378 and targets the gene ENSG00000128271 at this locus
        (141129bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000128271
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '22'
      position: 24672718
    locus_GRCh38:
      chromosome: '22'
      position: 24276750
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - European, NR=40266
    gwas_catalog_id: GCST004132
    neg_log_pval: 7.7544873321858505
    otg_id: GCST004132
    pubmed_id: '28067908'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-2 receptor agonist drug ALDESLEUKIN is Phase II for
        the indiciation EFO_0000384 and targets the gene ENSG00000100385 at this locus
        (263382bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000100385
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '22'
      position: 37258503
    locus_GRCh38:
      chromosome: '22'
      position: 36862461
  trait_info:
    ontology:
    - EFO_0000384
    reported_trait_name: Crohn's disease
    standard_trait_name: Crohn's disease
- association_info:
    ancestry:
    - European=29652
    gwas_catalog_id: GCST005536
    neg_log_pval: 7.748198311221298
    otg_id: GCST005536
    pubmed_id: '25751624'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-2 receptor agonist drug ALDESLEUKIN is Phase II for
        the indiciation EFO_0001359 and targets the gene ENSG00000100385 at this locus
        (16018bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000100385
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '22'
      position: 37587111
    locus_GRCh38:
      chromosome: '22'
      position: 37191071
  trait_info:
    ontology:
    - EFO_0001359
    reported_trait_name: Type 1 diabetes
    standard_trait_name: insulin-dependent diabetes mellitus
- association_info:
    ancestry:
    - European=8207
    gwas_catalog_id: GCST000258
    neg_log_pval: 7.698970004336019
    otg_id: GCST000258
    pubmed_id: '18978792'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-2 receptor agonist drug ALDESLEUKIN is Phase II for
        the indiciation EFO_0001359 and targets the gene ENSG00000100385 at this locus
        (20224bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000100385
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '22'
      position: 37591318
    locus_GRCh38:
      chromosome: '22'
      position: 37195278
  trait_info:
    ontology:
    - EFO_0001359
    reported_trait_name: Type 1 diabetes
    standard_trait_name: insulin-dependent diabetes mellitus
- association_info:
    ancestry:
    - NR=237
    gwas_catalog_id: GCST004105
    neg_log_pval: 7.3979400086720375
    otg_id: GCST004105
    pubmed_id: '28044437'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-5 receptor subunit alpha inhibitor drug BENRALIZUMAB
        is Phase III for the indiciation EFO_0000341 and targets the gene ENSG00000091181
        at this locus (122868bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091181
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '3'
      position: 2985142
    locus_GRCh38:
      chromosome: '3'
      position: 2943458
  trait_info:
    ontology:
    - EFO_0000341
    reported_trait_name: Body mass index (change over time) in chronic obstructive
      pulmonary disease
    standard_trait_name: chronic obstructive pulmonary disease
- association_info:
    ancestry:
    - European=459000
    gwas_catalog_id: GCST007072
    neg_log_pval: 10.0
    otg_id: GCST007072
    pubmed_id: '30595370'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Histamine H1 receptor agonist drug TOLAZOLINE is Phase IV for the
        indiciation EFO_0000319 and targets the gene ENSG00000196639 at this locus
        (203935bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000196639
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 11508965
    locus_GRCh38:
      chromosome: '3'
      position: 11467491
  trait_info:
    ontology:
    - EFO_0000319
    reported_trait_name: Cardiovascular disease
    standard_trait_name: cardiovascular system disease
- association_info:
    ancestry:
    - European=688809
    gwas_catalog_id: GCST006477
    neg_log_pval: 7.301029995663981
    otg_id: GCST006477
    pubmed_id: '29942085'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Histamine H1 receptor antagonist drug HYDROXYZINE is Phase III
        for the indiciation EFO_0003761 and targets the gene ENSG00000196639 at this
        locus (285721bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000196639
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '3'
      position: 11590751
    locus_GRCh38:
      chromosome: '3'
      position: 11549277
  trait_info:
    ontology:
    - EFO_0003761
    reported_trait_name: Depression
    standard_trait_name: unipolar depression
- association_info:
    ancestry:
    - European=688809
    gwas_catalog_id: GCST006477
    neg_log_pval: 7.301029995663981
    otg_id: GCST006477
    pubmed_id: '29942085'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Histamine H1 receptor agonist drug BETAHISTINE is Phase II for
        the indiciation EFO_0003761 and targets the gene ENSG00000196639 at this locus
        (285721bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000196639
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '3'
      position: 11590751
    locus_GRCh38:
      chromosome: '3'
      position: 11549277
  trait_info:
    ontology:
    - EFO_0003761
    reported_trait_name: Depression
    standard_trait_name: unipolar depression
- association_info:
    ancestry:
    - European=688809
    gwas_catalog_id: GCST006477
    neg_log_pval: 7.301029995663981
    otg_id: GCST006477
    pubmed_id: '29942085'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Histamine H1 receptor antagonist drug DIBENZEPIN is Phase IV for
        the indiciation EFO_0003761 and targets the gene ENSG00000196639 at this locus
        (285721bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000196639
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '3'
      position: 11590751
    locus_GRCh38:
      chromosome: '3'
      position: 11549277
  trait_info:
    ontology:
    - EFO_0003761
    reported_trait_name: Depression
    standard_trait_name: unipolar depression
- association_info:
    ancestry:
    - European=459000
    gwas_catalog_id: GCST007077
    neg_log_pval: 11.0
    otg_id: GCST007077
    pubmed_id: '30595370'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Peroxisome proliferator-activated receptor gamma agonist drug MURAGLITAZAR
        is Phase III for the indiciation EFO_0001360 and targets the gene ENSG00000132170
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000132170
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 12329783
    locus_GRCh38:
      chromosome: '3'
      position: 12288284
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=360192
    neg_log_pval: 7.5486127463375
    otg_id: NEALE2_2443
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Peroxisome proliferator-activated receptor gamma agonist drug PIOGLITAZONE
        is Phase IV for the indiciation EFO_0000400 and targets the gene ENSG00000132170
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000132170
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 12329783
    locus_GRCh38:
      chromosome: '3'
      position: 12288284
  trait_info:
    ontology:
    - EFO_0000400
    reported_trait_name: Diabetes diagnosed by doctor
    standard_trait_name: diabetes mellitus
- association_info:
    ancestry:
    - European=459000
    gwas_catalog_id: GCST007077
    neg_log_pval: 11.0
    otg_id: GCST007077
    pubmed_id: '30595370'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Peroxisome proliferator-activated receptor gamma modulator drug
        ARHALOFENATE is Phase II for the indiciation EFO_0001360 and targets the gene
        ENSG00000132170 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000132170
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 12329783
    locus_GRCh38:
      chromosome: '3'
      position: 12288284
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=459000
    gwas_catalog_id: GCST007077
    neg_log_pval: 11.0
    otg_id: GCST007077
    pubmed_id: '30595370'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Peroxisome proliferator-activated receptor gamma agonist drug ROSIGLITAZONE
        is Phase IV for the indiciation EFO_0001360 and targets the gene ENSG00000132170
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000132170
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 12329783
    locus_GRCh38:
      chromosome: '3'
      position: 12288284
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=360192
    neg_log_pval: 7.5486127463375
    otg_id: NEALE2_2443
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Peroxisome proliferator-activated receptor gamma agonist drug MURAGLITAZAR
        is Phase III for the indiciation EFO_0000400 and targets the gene ENSG00000132170
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000132170
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 12329783
    locus_GRCh38:
      chromosome: '3'
      position: 12288284
  trait_info:
    ontology:
    - EFO_0000400
    reported_trait_name: Diabetes diagnosed by doctor
    standard_trait_name: diabetes mellitus
- association_info:
    ancestry:
    - European=69033
    gwas_catalog_id: GCST005047
    neg_log_pval: 8.795880017344075
    otg_id: GCST005047
    pubmed_id: '22885922'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Peroxisome proliferator-activated receptor gamma modulator drug
        ARHALOFENATE is Phase II for the indiciation EFO_0001360 and targets the gene
        ENSG00000132170 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000132170
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 12392272
    locus_GRCh38:
      chromosome: '3'
      position: 12350773
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=69033
    gwas_catalog_id: GCST005047
    neg_log_pval: 8.795880017344075
    otg_id: GCST005047
    pubmed_id: '22885922'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Peroxisome proliferator-activated receptor gamma agonist drug MURAGLITAZAR
        is Phase III for the indiciation EFO_0001360 and targets the gene ENSG00000132170
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000132170
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 12392272
    locus_GRCh38:
      chromosome: '3'
      position: 12350773
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=69033
    gwas_catalog_id: GCST005047
    neg_log_pval: 8.795880017344075
    otg_id: GCST005047
    pubmed_id: '22885922'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Peroxisome proliferator-activated receptor gamma agonist drug ROSIGLITAZONE
        is Phase IV for the indiciation EFO_0001360 and targets the gene ENSG00000132170
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000132170
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 12392272
    locus_GRCh38:
      chromosome: '3'
      position: 12350773
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    gwas_catalog_id: GCST007517
    neg_log_pval: 11.301029995663981
    otg_id: GCST007517
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Peroxisome proliferator-activated receptor gamma modulator drug
        ARHALOFENATE is Phase II for the indiciation EFO_0001360 and targets the gene
        ENSG00000132170 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000132170
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 12393125
    locus_GRCh38:
      chromosome: '3'
      position: 12351626
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - South Asian=13532
    - European=20298
    - NR=149821
    gwas_catalog_id: GCST004894
    neg_log_pval: 13.698970004336019
    otg_id: GCST004894_2
    pubmed_id: '28869590'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Peroxisome proliferator-activated receptor gamma agonist drug ROSIGLITAZONE
        is Phase IV for the indiciation EFO_0001360 and targets the gene ENSG00000132170
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000132170
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 12393125
    locus_GRCh38:
      chromosome: '3'
      position: 12351626
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes [EA]
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    - South Asian, East Asian, African American or Afro-Caribbean, Hispanic or Latin
      American=153287
    gwas_catalog_id: GCST007516
    neg_log_pval: 18.522878745280337
    otg_id: GCST007516
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Peroxisome proliferator-activated receptor gamma modulator drug
        ARHALOFENATE is Phase II for the indiciation EFO_0001360 and targets the gene
        ENSG00000132170 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000132170
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 12393125
    locus_GRCh38:
      chromosome: '3'
      position: 12351626
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes (adjusted for BMI)
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    gwas_catalog_id: GCST007518
    neg_log_pval: 16.0
    otg_id: GCST007518
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Peroxisome proliferator-activated receptor gamma agonist drug MURAGLITAZAR
        is Phase III for the indiciation EFO_0001360 and targets the gene ENSG00000132170
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000132170
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 12393125
    locus_GRCh38:
      chromosome: '3'
      position: 12351626
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes (adjusted for BMI)
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=69033
    - East Asian=18817
    - South Asian=20019
    - Hispanic or Latin American=2583
    gwas_catalog_id: GCST002352
    neg_log_pval: 9.221848749616356
    otg_id: GCST002352
    pubmed_id: '24509480'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Peroxisome proliferator-activated receptor gamma agonist drug ROSIGLITAZONE
        is Phase IV for the indiciation EFO_0001360 and targets the gene ENSG00000132170
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000132170
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 12393125
    locus_GRCh38:
      chromosome: '3'
      position: 12351626
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - South Asian=13532
    - European=20298
    - NR=149821
    gwas_catalog_id: GCST004894
    neg_log_pval: 13.698970004336019
    otg_id: GCST004894_2
    pubmed_id: '28869590'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Peroxisome proliferator-activated receptor gamma agonist drug MURAGLITAZAR
        is Phase III for the indiciation EFO_0001360 and targets the gene ENSG00000132170
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000132170
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 12393125
    locus_GRCh38:
      chromosome: '3'
      position: 12351626
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes [EA]
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    - South Asian, East Asian, African American or Afro-Caribbean, Hispanic or Latin
      American=153287
    gwas_catalog_id: GCST007516
    neg_log_pval: 18.522878745280337
    otg_id: GCST007516
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Peroxisome proliferator-activated receptor gamma agonist drug MURAGLITAZAR
        is Phase III for the indiciation EFO_0001360 and targets the gene ENSG00000132170
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000132170
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 12393125
    locus_GRCh38:
      chromosome: '3'
      position: 12351626
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes (adjusted for BMI)
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - South Asian=13532
    - European=20298
    - NR=149821
    gwas_catalog_id: GCST004894
    neg_log_pval: 18.69897000433602
    otg_id: GCST004894
    pubmed_id: '28869590'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Peroxisome proliferator-activated receptor gamma agonist drug ROSIGLITAZONE
        is Phase IV for the indiciation EFO_0001360 and targets the gene ENSG00000132170
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000132170
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 12393125
    locus_GRCh38:
      chromosome: '3'
      position: 12351626
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=69033
    - East Asian=18817
    - South Asian=20019
    - Hispanic or Latin American=2583
    gwas_catalog_id: GCST002352
    neg_log_pval: 9.221848749616356
    otg_id: GCST002352
    pubmed_id: '24509480'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Peroxisome proliferator-activated receptor gamma agonist drug MURAGLITAZAR
        is Phase III for the indiciation EFO_0001360 and targets the gene ENSG00000132170
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000132170
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 12393125
    locus_GRCh38:
      chromosome: '3'
      position: 12351626
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=69033
    - East Asian=18817
    - South Asian=20019
    - Hispanic or Latin American=2583
    gwas_catalog_id: GCST002352
    neg_log_pval: 9.221848749616356
    otg_id: GCST002352
    pubmed_id: '24509480'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Peroxisome proliferator-activated receptor gamma modulator drug
        ARHALOFENATE is Phase II for the indiciation EFO_0001360 and targets the gene
        ENSG00000132170 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000132170
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 12393125
    locus_GRCh38:
      chromosome: '3'
      position: 12351626
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    - South Asian, East Asian, African American or Afro-Caribbean, Hispanic or Latin
      American=153287
    gwas_catalog_id: GCST007515
    neg_log_pval: 17.0
    otg_id: GCST007515
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Peroxisome proliferator-activated receptor gamma modulator drug
        ARHALOFENATE is Phase II for the indiciation EFO_0001360 and targets the gene
        ENSG00000132170 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000132170
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 12393125
    locus_GRCh38:
      chromosome: '3'
      position: 12351626
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    gwas_catalog_id: GCST007517
    neg_log_pval: 11.301029995663981
    otg_id: GCST007517
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Peroxisome proliferator-activated receptor gamma agonist drug ROSIGLITAZONE
        is Phase IV for the indiciation EFO_0001360 and targets the gene ENSG00000132170
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000132170
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 12393125
    locus_GRCh38:
      chromosome: '3'
      position: 12351626
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    - South Asian, East Asian, African American or Afro-Caribbean, Hispanic or Latin
      American=153287
    gwas_catalog_id: GCST007516
    neg_log_pval: 18.522878745280337
    otg_id: GCST007516
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Peroxisome proliferator-activated receptor gamma agonist drug ROSIGLITAZONE
        is Phase IV for the indiciation EFO_0001360 and targets the gene ENSG00000132170
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000132170
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 12393125
    locus_GRCh38:
      chromosome: '3'
      position: 12351626
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes (adjusted for BMI)
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    - South Asian, East Asian, African American or Afro-Caribbean, Hispanic or Latin
      American=153287
    gwas_catalog_id: GCST007515
    neg_log_pval: 17.0
    otg_id: GCST007515
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Peroxisome proliferator-activated receptor gamma agonist drug MURAGLITAZAR
        is Phase III for the indiciation EFO_0001360 and targets the gene ENSG00000132170
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000132170
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 12393125
    locus_GRCh38:
      chromosome: '3'
      position: 12351626
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - South Asian=13532
    - European=20298
    - NR=149821
    gwas_catalog_id: GCST004894
    neg_log_pval: 18.69897000433602
    otg_id: GCST004894
    pubmed_id: '28869590'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Peroxisome proliferator-activated receptor gamma modulator drug
        ARHALOFENATE is Phase II for the indiciation EFO_0001360 and targets the gene
        ENSG00000132170 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000132170
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 12393125
    locus_GRCh38:
      chromosome: '3'
      position: 12351626
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    gwas_catalog_id: GCST007518
    neg_log_pval: 16.0
    otg_id: GCST007518
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Peroxisome proliferator-activated receptor gamma modulator drug
        ARHALOFENATE is Phase II for the indiciation EFO_0001360 and targets the gene
        ENSG00000132170 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000132170
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 12393125
    locus_GRCh38:
      chromosome: '3'
      position: 12351626
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes (adjusted for BMI)
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    gwas_catalog_id: GCST007517
    neg_log_pval: 11.301029995663981
    otg_id: GCST007517
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Peroxisome proliferator-activated receptor gamma agonist drug MURAGLITAZAR
        is Phase III for the indiciation EFO_0001360 and targets the gene ENSG00000132170
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000132170
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 12393125
    locus_GRCh38:
      chromosome: '3'
      position: 12351626
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - South Asian=13532
    - European=20298
    - NR=149821
    gwas_catalog_id: GCST004894
    neg_log_pval: 18.69897000433602
    otg_id: GCST004894
    pubmed_id: '28869590'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Peroxisome proliferator-activated receptor gamma agonist drug MURAGLITAZAR
        is Phase III for the indiciation EFO_0001360 and targets the gene ENSG00000132170
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000132170
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 12393125
    locus_GRCh38:
      chromosome: '3'
      position: 12351626
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - South Asian=13532
    - European=20298
    - NR=149821
    gwas_catalog_id: GCST004894
    neg_log_pval: 13.698970004336019
    otg_id: GCST004894_2
    pubmed_id: '28869590'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Peroxisome proliferator-activated receptor gamma modulator drug
        ARHALOFENATE is Phase II for the indiciation EFO_0001360 and targets the gene
        ENSG00000132170 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000132170
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 12393125
    locus_GRCh38:
      chromosome: '3'
      position: 12351626
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes [EA]
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    gwas_catalog_id: GCST007518
    neg_log_pval: 16.0
    otg_id: GCST007518
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Peroxisome proliferator-activated receptor gamma agonist drug ROSIGLITAZONE
        is Phase IV for the indiciation EFO_0001360 and targets the gene ENSG00000132170
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000132170
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 12393125
    locus_GRCh38:
      chromosome: '3'
      position: 12351626
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes (adjusted for BMI)
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    - South Asian, East Asian, African American or Afro-Caribbean, Hispanic or Latin
      American=153287
    gwas_catalog_id: GCST007515
    neg_log_pval: 17.0
    otg_id: GCST007515
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Peroxisome proliferator-activated receptor gamma agonist drug ROSIGLITAZONE
        is Phase IV for the indiciation EFO_0001360 and targets the gene ENSG00000132170
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000132170
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 12393125
    locus_GRCh38:
      chromosome: '3'
      position: 12351626
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=655666
    - South Asian=3650
    gwas_catalog_id: GCST006867
    neg_log_pval: 23.69897000433602
    otg_id: GCST006867
    pubmed_id: '30054458'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Peroxisome proliferator-activated receptor gamma agonist drug MURAGLITAZAR
        is Phase III for the indiciation EFO_0001360 and targets the gene ENSG00000132170
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000132170
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 12394840
    locus_GRCh38:
      chromosome: '3'
      position: 12353341
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=655666
    - South Asian=3650
    gwas_catalog_id: GCST006867
    neg_log_pval: 23.69897000433602
    otg_id: GCST006867
    pubmed_id: '30054458'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Peroxisome proliferator-activated receptor gamma agonist drug ROSIGLITAZONE
        is Phase IV for the indiciation EFO_0001360 and targets the gene ENSG00000132170
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000132170
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 12394840
    locus_GRCh38:
      chromosome: '3'
      position: 12353341
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=655666
    - South Asian=3650
    gwas_catalog_id: GCST006867
    neg_log_pval: 23.69897000433602
    otg_id: GCST006867
    pubmed_id: '30054458'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Peroxisome proliferator-activated receptor gamma modulator drug
        ARHALOFENATE is Phase II for the indiciation EFO_0001360 and targets the gene
        ENSG00000132170 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000132170
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 12394840
    locus_GRCh38:
      chromosome: '3'
      position: 12353341
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=70127
    gwas_catalog_id: GCST005413
    neg_log_pval: 15.357832365595055
    otg_id: GCST005413
    pubmed_id: '29358691'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Peroxisome proliferator-activated receptor gamma modulator drug
        ARHALOFENATE is Phase II for the indiciation EFO_0001360 and targets the gene
        ENSG00000132170 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000132170
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '3'
      position: 12396913
    locus_GRCh38:
      chromosome: '3'
      position: 12355414
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=70127
    gwas_catalog_id: GCST005413
    neg_log_pval: 15.357832365595055
    otg_id: GCST005413
    pubmed_id: '29358691'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Peroxisome proliferator-activated receptor gamma agonist drug ROSIGLITAZONE
        is Phase IV for the indiciation EFO_0001360 and targets the gene ENSG00000132170
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000132170
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '3'
      position: 12396913
    locus_GRCh38:
      chromosome: '3'
      position: 12355414
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=70127
    gwas_catalog_id: GCST005413
    neg_log_pval: 15.357832365595055
    otg_id: GCST005413
    pubmed_id: '29358691'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Peroxisome proliferator-activated receptor gamma agonist drug MURAGLITAZAR
        is Phase III for the indiciation EFO_0001360 and targets the gene ENSG00000132170
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000132170
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '3'
      position: 12396913
    locus_GRCh38:
      chromosome: '3'
      position: 12355414
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=537409
    - East Asian=36792
    - African American or Afro-Caribbean=8967
    - Hispanic or Latin American=5022
    gwas_catalog_id: GCST006061
    neg_log_pval: 7.698970004336019
    otg_id: GCST006061_3
    pubmed_id: '29892015'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Sodium channel protein type V alpha subunit blocker drug RANOLAZINE
        is Phase III for the indiciation EFO_0000275 and targets the gene ENSG00000183873
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000183873
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 38634142
    locus_GRCh38:
      chromosome: '3'
      position: 38592651
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation [EA]
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=537409
    - East Asian=36792
    - African American or Afro-Caribbean=8967
    - Hispanic or Latin American=5022
    gwas_catalog_id: GCST006061
    neg_log_pval: 7.698970004336019
    otg_id: GCST006061_3
    pubmed_id: '29892015'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Sodium channel protein type V alpha subunit blocker drug AZD1305
        is Phase II for the indiciation EFO_0000275 and targets the gene ENSG00000183873
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000183873
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 38634142
    locus_GRCh38:
      chromosome: '3'
      position: 38592651
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation [EA]
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=537409
    - East Asian=36792
    - African American or Afro-Caribbean=8967
    - Hispanic or Latin American=5022
    gwas_catalog_id: GCST006061
    neg_log_pval: 7.698970004336019
    otg_id: GCST006061_3
    pubmed_id: '29892015'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Sodium channel protein type V alpha subunit blocker drug FLECAINIDE
        is Phase IV for the indiciation EFO_0000275 and targets the gene ENSG00000183873
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000183873
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 38634142
    locus_GRCh38:
      chromosome: '3'
      position: 38592651
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation [EA]
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=1030836
    gwas_catalog_id: GCST006414
    neg_log_pval: 15.12010167566999
    otg_id: GCST006414
    pubmed_id: '30061737'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Sodium channel protein type V alpha subunit blocker drug FLECAINIDE
        is Phase IV for the indiciation EFO_0000275 and targets the gene ENSG00000183873
        at this locus (19151bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000183873
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '3'
      position: 38710315
    locus_GRCh38:
      chromosome: '3'
      position: 38668824
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=1030836
    gwas_catalog_id: GCST006414
    neg_log_pval: 15.12010167566999
    otg_id: GCST006414
    pubmed_id: '30061737'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Sodium channel protein type V alpha subunit blocker drug RANOLAZINE
        is Phase III for the indiciation EFO_0000275 and targets the gene ENSG00000183873
        at this locus (19151bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000183873
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '3'
      position: 38710315
    locus_GRCh38:
      chromosome: '3'
      position: 38668824
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=537409
    - East Asian=36792
    - African American or Afro-Caribbean=8967
    - Hispanic or Latin American=5022
    gwas_catalog_id: GCST006061
    neg_log_pval: 13.154901959985743
    otg_id: GCST006061_3
    pubmed_id: '29892015'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Sodium channel protein type V alpha subunit blocker drug AZD7009
        is Phase II for the indiciation EFO_0000275 and targets the gene ENSG00000183873
        at this locus (19151bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000183873
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '3'
      position: 38710315
    locus_GRCh38:
      chromosome: '3'
      position: 38668824
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation [EA]
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=537409
    - East Asian=36792
    - African American or Afro-Caribbean=8967
    - Hispanic or Latin American=5022
    gwas_catalog_id: GCST006061
    neg_log_pval: 13.154901959985743
    otg_id: GCST006061_3
    pubmed_id: '29892015'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Sodium channel protein type V alpha subunit blocker drug FLECAINIDE
        is Phase IV for the indiciation EFO_0000275 and targets the gene ENSG00000183873
        at this locus (19151bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000183873
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '3'
      position: 38710315
    locus_GRCh38:
      chromosome: '3'
      position: 38668824
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation [EA]
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=537409
    - East Asian=36792
    - African American or Afro-Caribbean=8967
    - Hispanic or Latin American=5022
    gwas_catalog_id: GCST006061
    neg_log_pval: 13.154901959985743
    otg_id: GCST006061_3
    pubmed_id: '29892015'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Sodium channel protein type V alpha subunit blocker drug RANOLAZINE
        is Phase III for the indiciation EFO_0000275 and targets the gene ENSG00000183873
        at this locus (19151bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000183873
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '3'
      position: 38710315
    locus_GRCh38:
      chromosome: '3'
      position: 38668824
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation [EA]
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=1030836
    gwas_catalog_id: GCST006414
    neg_log_pval: 15.12010167566999
    otg_id: GCST006414
    pubmed_id: '30061737'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Sodium channel protein type V alpha subunit blocker drug AZD7009
        is Phase II for the indiciation EFO_0000275 and targets the gene ENSG00000183873
        at this locus (19151bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000183873
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '3'
      position: 38710315
    locus_GRCh38:
      chromosome: '3'
      position: 38668824
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=395739
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 7.87942606879415
    otg_id: SAIGE_427_2
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Sodium channel protein type V alpha subunit blocker drug RANOLAZINE
        is Phase III for the indiciation EFO_0000275 and targets the gene ENSG00000183873
        at this locus (75512bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000183873
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '3'
      position: 38766675
    locus_GRCh38:
      chromosome: '3'
      position: 38725184
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation and flutter
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=395739
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 7.87942606879415
    otg_id: SAIGE_427_2
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Sodium channel protein type V alpha subunit blocker drug FLECAINIDE
        is Phase IV for the indiciation EFO_0000275 and targets the gene ENSG00000183873
        at this locus (75512bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000183873
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '3'
      position: 38766675
    locus_GRCh38:
      chromosome: '3'
      position: 38725184
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation and flutter
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=395739
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 7.87942606879415
    otg_id: SAIGE_427_2
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Sodium channel protein type V alpha subunit blocker drug AZD1305
        is Phase II for the indiciation EFO_0000275 and targets the gene ENSG00000183873
        at this locus (75512bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000183873
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '3'
      position: 38766675
    locus_GRCh38:
      chromosome: '3'
      position: 38725184
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation and flutter
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=537409
    - East Asian=36792
    - African American or Afro-Caribbean=8967
    - Hispanic or Latin American=5022
    gwas_catalog_id: GCST006061
    neg_log_pval: 17.397940008672037
    otg_id: GCST006061
    pubmed_id: '29892015'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Sodium channel protein type V alpha subunit blocker drug RANOLAZINE
        is Phase III for the indiciation EFO_0000275 and targets the gene ENSG00000183873
        at this locus (80761bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000183873
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 38771925
    locus_GRCh38:
      chromosome: '3'
      position: 38730434
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=537409
    - East Asian=36792
    - African American or Afro-Caribbean=8967
    - Hispanic or Latin American=5022
    gwas_catalog_id: GCST006061
    neg_log_pval: 14.221848749616356
    otg_id: GCST006061_3
    pubmed_id: '29892015'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Sodium channel protein type V alpha subunit blocker drug RANOLAZINE
        is Phase III for the indiciation EFO_0000275 and targets the gene ENSG00000183873
        at this locus (80761bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000183873
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 38771925
    locus_GRCh38:
      chromosome: '3'
      position: 38730434
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation [EA]
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=1030836
    gwas_catalog_id: GCST006414
    neg_log_pval: 19.619607839942972
    otg_id: GCST006414
    pubmed_id: '30061737'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Sodium channel protein type V alpha subunit blocker drug AZD1305
        is Phase II for the indiciation EFO_0000275 and targets the gene ENSG00000183873
        at this locus (80761bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000183873
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 38771925
    locus_GRCh38:
      chromosome: '3'
      position: 38730434
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=1030836
    gwas_catalog_id: GCST006414
    neg_log_pval: 19.619607839942972
    otg_id: GCST006414
    pubmed_id: '30061737'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Sodium channel protein type V alpha subunit blocker drug RANOLAZINE
        is Phase III for the indiciation EFO_0000275 and targets the gene ENSG00000183873
        at this locus (80761bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000183873
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 38771925
    locus_GRCh38:
      chromosome: '3'
      position: 38730434
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=537409
    - East Asian=36792
    - African American or Afro-Caribbean=8967
    - Hispanic or Latin American=5022
    gwas_catalog_id: GCST006061
    neg_log_pval: 14.221848749616356
    otg_id: GCST006061_3
    pubmed_id: '29892015'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Sodium channel protein type V alpha subunit blocker drug AZD1305
        is Phase II for the indiciation EFO_0000275 and targets the gene ENSG00000183873
        at this locus (80761bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000183873
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 38771925
    locus_GRCh38:
      chromosome: '3'
      position: 38730434
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation [EA]
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=537409
    - East Asian=36792
    - African American or Afro-Caribbean=8967
    - Hispanic or Latin American=5022
    gwas_catalog_id: GCST006061
    neg_log_pval: 17.397940008672037
    otg_id: GCST006061
    pubmed_id: '29892015'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Sodium channel protein type V alpha subunit blocker drug AZD1305
        is Phase II for the indiciation EFO_0000275 and targets the gene ENSG00000183873
        at this locus (80761bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000183873
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 38771925
    locus_GRCh38:
      chromosome: '3'
      position: 38730434
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=537409
    - East Asian=36792
    - African American or Afro-Caribbean=8967
    - Hispanic or Latin American=5022
    gwas_catalog_id: GCST006061
    neg_log_pval: 14.221848749616356
    otg_id: GCST006061_3
    pubmed_id: '29892015'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Sodium channel protein type V alpha subunit blocker drug FLECAINIDE
        is Phase IV for the indiciation EFO_0000275 and targets the gene ENSG00000183873
        at this locus (80761bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000183873
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 38771925
    locus_GRCh38:
      chromosome: '3'
      position: 38730434
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation [EA]
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=1030836
    gwas_catalog_id: GCST006414
    neg_log_pval: 19.619607839942972
    otg_id: GCST006414
    pubmed_id: '30061737'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Sodium channel protein type V alpha subunit blocker drug FLECAINIDE
        is Phase IV for the indiciation EFO_0000275 and targets the gene ENSG00000183873
        at this locus (80761bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000183873
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 38771925
    locus_GRCh38:
      chromosome: '3'
      position: 38730434
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=537409
    - East Asian=36792
    - African American or Afro-Caribbean=8967
    - Hispanic or Latin American=5022
    gwas_catalog_id: GCST006061
    neg_log_pval: 17.397940008672037
    otg_id: GCST006061
    pubmed_id: '29892015'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Sodium channel protein type V alpha subunit blocker drug FLECAINIDE
        is Phase IV for the indiciation EFO_0000275 and targets the gene ENSG00000183873
        at this locus (80761bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000183873
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 38771925
    locus_GRCh38:
      chromosome: '3'
      position: 38730434
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 10.553695886048077
    otg_id: NEALE2_20002_1456
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: C-C chemokine receptor type 9 antagonist drug VERCIRNON is Phase
        II for the indiciation EFO_0001060 and targets the gene ENSG00000173585 at
        this locus (247604bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000173585
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '3'
      position: 46192270
    locus_GRCh38:
      chromosome: '3'
      position: 46150778
  trait_info:
    ontology:
    - EFO_0001060
    reported_trait_name: Malabsorption/coeliac disease | non-cancer illness code,
      self-reported
    standard_trait_name: celiac disease
- association_info:
    ancestry:
    - European=23649
    - South Asian=620
    gwas_catalog_id: GCST005523
    neg_log_pval: 8.045757490560675
    otg_id: GCST005523_7
    pubmed_id: '22057235'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: C-C chemokine receptor type 9 antagonist drug VERCIRNON is Phase
        II for the indiciation EFO_0001060 and targets the gene ENSG00000173585 at
        this locus (261019bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000173585
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 46205686
    locus_GRCh38:
      chromosome: '3'
      position: 46164194
  trait_info:
    ontology:
    - EFO_0001060
    reported_trait_name: Celiac disease [conditioned on rs2097282]
    standard_trait_name: celiac disease
- association_info:
    ancestry:
    - European=15283
    gwas_catalog_id: GCST000612
    neg_log_pval: 10.597222930389652
    otg_id: GCST000612
    pubmed_id: '20190752'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: C-C chemokine receptor type 9 antagonist drug VERCIRNON is Phase
        II for the indiciation EFO_0001060 and targets the gene ENSG00000173585 at
        this locus (290535bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000173585
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 46235201
    locus_GRCh38:
      chromosome: '3'
      position: 46193709
  trait_info:
    ontology:
    - EFO_0001060
    reported_trait_name: Celiac disease
    standard_trait_name: celiac disease
- association_info:
    ancestry:
    - European=4634
    gwas_catalog_id: GCST002520
    neg_log_pval: 7.3979400086720375
    otg_id: GCST002520
    pubmed_id: '24999842'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: C-C chemokine receptor type 9 antagonist drug VERCIRNON is Phase
        II for the indiciation EFO_0001060 and targets the gene ENSG00000173585 at
        this locus (337078bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000173585
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 46281744
    locus_GRCh38:
      chromosome: '3'
      position: 46240253
  trait_info:
    ontology:
    - EFO_0001060
    reported_trait_name: Celiac disease
    standard_trait_name: celiac disease
- association_info:
    ancestry:
    - European=23649
    - South Asian=620
    gwas_catalog_id: GCST005523
    neg_log_pval: 20.0
    otg_id: GCST005523
    pubmed_id: '22057235'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: C-C chemokine receptor type 9 antagonist drug VERCIRNON is Phase
        II for the indiciation EFO_0001060 and targets the gene ENSG00000173585 at
        this locus (433359bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000173585
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 46378025
    locus_GRCh38:
      chromosome: '3'
      position: 46336534
  trait_info:
    ontology:
    - EFO_0001060
    reported_trait_name: Celiac disease
    standard_trait_name: celiac disease
- association_info:
    ancestry:
    - European=86475
    gwas_catalog_id: GCST005537
    neg_log_pval: 7.698970004336019
    otg_id: GCST005537
    pubmed_id: '26974007'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: C-C chemokine receptor type 2 antagonist drug CENICRIVIROC is Phase
        II for the indiciation EFO_0004268 and targets the gene ENSG00000121807 at
        this locus (26239bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000121807
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '3'
      position: 46428658
    locus_GRCh38:
      chromosome: '3'
      position: 46387167
  trait_info:
    ontology:
    - EFO_0004268
    reported_trait_name: Chronic inflammatory diseases (ankylosing spondylitis, Crohn's
      disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
      [subset analysis]
    standard_trait_name: sclerosing cholangitis
- association_info:
    ancestry:
    - European=86475
    gwas_catalog_id: GCST005537
    neg_log_pval: 7.698970004336019
    otg_id: GCST005537
    pubmed_id: '26974007'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: C-C chemokine receptor type 5 antagonist drug CENICRIVIROC is Phase
        II for the indiciation EFO_0004268 and targets the gene ENSG00000160791 at
        this locus (10962bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000160791
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '3'
      position: 46428658
    locus_GRCh38:
      chromosome: '3'
      position: 46387167
  trait_info:
    ontology:
    - EFO_0004268
    reported_trait_name: Chronic inflammatory diseases (ankylosing spondylitis, Crohn's
      disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
      [subset analysis]
    standard_trait_name: sclerosing cholangitis
- association_info:
    ancestry:
    - European=86475
    gwas_catalog_id: GCST005537
    neg_log_pval: 7.698970004336019
    otg_id: GCST005537
    pubmed_id: '26974007'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: C-C chemokine receptor type 9 antagonist drug VERCIRNON is Phase
        III for the indiciation EFO_0000384 and targets the gene ENSG00000173585 at
        this locus (483992bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000173585
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '3'
      position: 46428658
    locus_GRCh38:
      chromosome: '3'
      position: 46387167
  trait_info:
    ontology:
    - EFO_0000384
    reported_trait_name: Chronic inflammatory diseases (ankylosing spondylitis, Crohn's
      disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
      [subset analysis]
    standard_trait_name: Crohn's disease
- association_info:
    ancestry:
    - European=86475
    gwas_catalog_id: GCST005537
    neg_log_pval: 7.698970004336019
    otg_id: GCST005537
    pubmed_id: '26974007'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: C-C chemokine receptor type 9 antagonist drug VERCIRNON is Phase
        II for the indiciation EFO_0000729 and targets the gene ENSG00000173585 at
        this locus (483992bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000173585
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '3'
      position: 46428658
    locus_GRCh38:
      chromosome: '3'
      position: 46387167
  trait_info:
    ontology:
    - EFO_0000729
    reported_trait_name: Chronic inflammatory diseases (ankylosing spondylitis, Crohn's
      disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
      [subset analysis]
    standard_trait_name: ulcerative colitis
- association_info:
    ancestry:
    - European=6315
    gwas_catalog_id: GCST003183
    neg_log_pval: 18.69897000433602
    otg_id: GCST003183
    pubmed_id: '26553974'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: C-C chemokine receptor type 2 antagonist drug CENICRIVIROC is Phase
        II for the indiciation EFO_0000180 and targets the gene ENSG00000121807 at
        this locus (49262bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000121807
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '3'
      position: 46451680
    locus_GRCh38:
      chromosome: '3'
      position: 46410189
  trait_info:
    ontology:
    - EFO_0000180
    reported_trait_name: Setpoint viral load in HIV-1 infection
    standard_trait_name: HIV-1 infection
- association_info:
    ancestry:
    - European=6315
    gwas_catalog_id: GCST003183
    neg_log_pval: 18.69897000433602
    otg_id: GCST003183
    pubmed_id: '26553974'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: C-C chemokine receptor type 5 antagonist drug CENICRIVIROC is Phase
        II for the indiciation EFO_0000180 and targets the gene ENSG00000160791 at
        this locus (33984bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000160791
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '3'
      position: 46451680
    locus_GRCh38:
      chromosome: '3'
      position: 46410189
  trait_info:
    ontology:
    - EFO_0000180
    reported_trait_name: Setpoint viral load in HIV-1 infection
    standard_trait_name: HIV-1 infection
- association_info:
    ancestry:
    - European=6315
    gwas_catalog_id: GCST003183
    neg_log_pval: 18.69897000433602
    otg_id: GCST003183
    pubmed_id: '26553974'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: C-C chemokine receptor type 5 antagonist drug MARAVIROC is Phase
        IV for the indiciation EFO_0000180 and targets the gene ENSG00000160791 at
        this locus (33984bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000160791
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '3'
      position: 46451680
    locus_GRCh38:
      chromosome: '3'
      position: 46410189
  trait_info:
    ontology:
    - EFO_0000180
    reported_trait_name: Setpoint viral load in HIV-1 infection
    standard_trait_name: HIV-1 infection
- association_info:
    ancestry:
    - European=13574
    - NR=2380
    gwas_catalog_id: GCST004521
    neg_log_pval: 7.3979400086720375
    otg_id: GCST004521
    pubmed_id: '28540026'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Nischarin agonist drug MOXONIDINE is Phase IV for the indiciation
        EFO_0000692 and targets the gene ENSG00000010322 at this locus (220268bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000010322
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '3'
      position: 52268866
    locus_GRCh38:
      chromosome: '3'
      position: 52234850
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Autism spectrum disorder or schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - Other=1097
    - NR=150064
    gwas_catalog_id: GCST003048
    neg_log_pval: 8.522878745280337
    otg_id: GCST003048
    pubmed_id: '26198764'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Nischarin agonist drug MOXONIDINE is Phase IV for the indiciation
        EFO_0000692 and targets the gene ENSG00000010322 at this locus (201667bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000010322
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '3'
      position: 52287468
    locus_GRCh38:
      chromosome: '3'
      position: 52253452
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - European=398213
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 7.847711655616943
    otg_id: SAIGE_740_1
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Toll-like receptor 9 antagonist drug HYDROXYCHLOROQUINE is Phase
        III for the indiciation EFO_0002506 and targets the gene ENSG00000239732 at
        this locus (196795bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000239732
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '3'
      position: 52456973
    locus_GRCh38:
      chromosome: '3'
      position: 52422957
  trait_info:
    ontology:
    - EFO_0002506
    reported_trait_name: Osteoarthritis; localized
    standard_trait_name: osteoarthritis
- association_info:
    ancestry:
    - East Asian=45528
    gwas_catalog_id: GCST007201
    neg_log_pval: 12.698970004336019
    otg_id: GCST007201
    pubmed_id: '30285260'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Nischarin agonist drug MOXONIDINE is Phase IV for the indiciation
        EFO_0000692 and targets the gene ENSG00000010322 at this locus (100972bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000010322
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 52628056
    locus_GRCh38:
      chromosome: '3'
      position: 52594040
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - East Asian=26026
    - European=82315
    gwas_catalog_id: GCST004946
    neg_log_pval: 12.301029995663981
    otg_id: GCST004946
    pubmed_id: '28991256'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Nischarin agonist drug MOXONIDINE is Phase IV for the indiciation
        EFO_0000692 and targets the gene ENSG00000010322 at this locus (100972bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000010322
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 52628056
    locus_GRCh38:
      chromosome: '3'
      position: 52594040
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - European=18419
    gwas_catalog_id: GCST001592
    neg_log_pval: 8.301029995663981
    otg_id: GCST001592
    pubmed_id: '22763110'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Toll-like receptor 9 antagonist drug HYDROXYCHLOROQUINE is Phase
        III for the indiciation EFO_0002506 and targets the gene ENSG00000239732 at
        this locus (461126bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000239732
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '3'
      position: 52721305
    locus_GRCh38:
      chromosome: '3'
      position: 52687289
  trait_info:
    ontology:
    - EFO_0002506
    reported_trait_name: Osteoarthritis
    standard_trait_name: osteoarthritis
- association_info:
    ancestry:
    - European=417596
    gwas_catalog_id: GCST007092
    neg_log_pval: 9.698970004336019
    otg_id: GCST007092
    pubmed_id: '30664745'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Toll-like receptor 9 antagonist drug HYDROXYCHLOROQUINE is Phase
        II for the indiciation EFO_0004616 and targets the gene ENSG00000239732 at
        this locus (468625bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000239732
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 52728804
    locus_GRCh38:
      chromosome: '3'
      position: 52694788
  trait_info:
    ontology:
    - EFO_0004616
    reported_trait_name: Osteoarthritis of the hip or knee
    standard_trait_name: osteoarthritis, knee
- association_info:
    ancestry:
    - NR, African American or Afro-Caribbean, European, African unspecified, Asian
      unspecified, Other=48070
    gwas_catalog_id: GCST002254
    neg_log_pval: 7.522878745280337
    otg_id: GCST002254
    pubmed_id: '24166486'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Nischarin agonist drug MOXONIDINE is Phase IV for the indiciation
        EFO_0000692 and targets the gene ENSG00000010322 at this locus (288821bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000010322
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '3'
      position: 52815905
    locus_GRCh38:
      chromosome: '3'
      position: 52781889
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia, schizoaffective disorder or bipolar disorder
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - European=61220
    gwas_catalog_id: GCST001877
    neg_log_pval: 11.522878745280337
    otg_id: GCST001877
    pubmed_id: '23453885'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Nischarin agonist drug MOXONIDINE is Phase IV for the indiciation
        EFO_0000692 and targets the gene ENSG00000010322 at this locus (306136bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000010322
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '3'
      position: 52833219
    locus_GRCh38:
      chromosome: '3'
      position: 52799203
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Autism spectrum disorder, attention deficit-hyperactivity
      disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - NR=150064
    - European=70017
    gwas_catalog_id: GCST007257
    neg_log_pval: 10.698970004336019
    otg_id: GCST007257
    pubmed_id: '30626913'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Nischarin agonist drug MOXONIDINE is Phase IV for the indiciation
        EFO_0000692 and targets the gene ENSG00000010322 at this locus (306136bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000010322
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '3'
      position: 52833219
    locus_GRCh38:
      chromosome: '3'
      position: 52799203
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Broad depression or schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - European=105318
    gwas_catalog_id: GCST006803
    neg_log_pval: 11.0
    otg_id: GCST006803
    pubmed_id: '29483656'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Nischarin agonist drug MOXONIDINE is Phase IV for the indiciation
        EFO_0000692 and targets the gene ENSG00000010322 at this locus (306721bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000010322
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 52833805
    locus_GRCh38:
      chromosome: '3'
      position: 52799789
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - European=13574
    - NR=2380
    gwas_catalog_id: GCST004521
    neg_log_pval: 11.522878745280337
    otg_id: GCST004521
    pubmed_id: '28540026'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Nischarin agonist drug MOXONIDINE is Phase IV for the indiciation
        EFO_0000692 and targets the gene ENSG00000010322 at this locus (306721bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000010322
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 52833805
    locus_GRCh38:
      chromosome: '3'
      position: 52799789
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Autism spectrum disorder or schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - East Asian=45528
    gwas_catalog_id: GCST007201
    neg_log_pval: 10.0
    otg_id: GCST007201_2
    pubmed_id: '30285260'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Nischarin agonist drug MOXONIDINE is Phase IV for the indiciation
        EFO_0000692 and targets the gene ENSG00000010322 at this locus (306721bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000010322
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 52833805
    locus_GRCh38:
      chromosome: '3'
      position: 52799789
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia [EA]
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - European=11244
    - NR=20899
    gwas_catalog_id: GCST002149
    neg_log_pval: 8.0
    otg_id: GCST002149
    pubmed_id: '23974872'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Nischarin agonist drug MOXONIDINE is Phase IV for the indiciation
        EFO_0000692 and targets the gene ENSG00000010322 at this locus (311318bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000010322
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '3'
      position: 52838402
    locus_GRCh38:
      chromosome: '3'
      position: 52804386
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - European=82315
    - East Asian=5219
    gwas_catalog_id: GCST002539
    neg_log_pval: 10.397940008672037
    otg_id: GCST002539
    pubmed_id: '25056061'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Nischarin agonist drug MOXONIDINE is Phase IV for the indiciation
        EFO_0000692 and targets the gene ENSG00000010322 at this locus (318021bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000010322
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '3'
      position: 52845105
    locus_GRCh38:
      chromosome: '3'
      position: 52811089
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - Other=1097
    - NR=150064
    gwas_catalog_id: GCST003048
    neg_log_pval: 10.698970004336019
    otg_id: GCST003048
    pubmed_id: '26198764'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Nischarin agonist drug MOXONIDINE is Phase IV for the indiciation
        EFO_0000692 and targets the gene ENSG00000010322 at this locus (318021bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000010322
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '3'
      position: 52845105
    locus_GRCh38:
      chromosome: '3'
      position: 52811089
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - East Asian=5158
    gwas_catalog_id: GCST004302
    neg_log_pval: 12.522878745280337
    otg_id: GCST004302
    pubmed_id: '28425483'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: T-lymphocyte activation antigen CD80 inhibitor drug ABATACEPT is
        Phase IV for the indiciation EFO_1001486 and targets the gene ENSG00000121594
        at this locus (93052bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000121594
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '3'
      position: 119150089
    locus_GRCh38:
      chromosome: '3'
      position: 119431242
  trait_info:
    ontology:
    - EFO_1001486
    reported_trait_name: Primary biliary cholangitis
    standard_trait_name: primary biliary cirrhosis
- association_info:
    ancestry:
    - European=18264
    - African American or Afro-Caribbean=5422
    - Hispanic or Latin American=3888
    gwas_catalog_id: GCST005752
    neg_log_pval: 11.0
    otg_id: GCST005752
    pubmed_id: '28714469'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: T-lymphocyte activation antigen CD80 inhibitor drug ABATACEPT is
        Phase II for the indiciation EFO_0002690 and targets the gene ENSG00000121594
        at this locus (68758bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000121594
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '3'
      position: 119174383
    locus_GRCh38:
      chromosome: '3'
      position: 119455536
  trait_info:
    ontology:
    - EFO_0002690
    reported_trait_name: Systemic lupus erythematosus
    standard_trait_name: systemic lupus erythematosus
- association_info:
    ancestry:
    - European=13239
    gwas_catalog_id: GCST003129
    neg_log_pval: 14.397940008672037
    otg_id: GCST003129
    pubmed_id: '26394269'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: T-lymphocyte activation antigen CD80 inhibitor drug ABATACEPT is
        Phase IV for the indiciation EFO_1001486 and targets the gene ENSG00000121594
        at this locus (23206bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000121594
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '3'
      position: 119219934
    locus_GRCh38:
      chromosome: '3'
      position: 119501087
  trait_info:
    ontology:
    - EFO_1001486
    reported_trait_name: Primary biliary cholangitis
    standard_trait_name: primary biliary cirrhosis
- association_info:
    ancestry:
    - European=26621
    gwas_catalog_id: GCST001198
    neg_log_pval: 8.96738123914928
    otg_id: GCST001198
    pubmed_id: '21833088'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: T-lymphocyte activation antigen CD80 inhibitor drug ABATACEPT is
        Phase II for the indiciation EFO_0003885 and targets the gene ENSG00000121594
        at this locus (23206bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000121594
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '3'
      position: 119219934
    locus_GRCh38:
      chromosome: '3'
      position: 119501087
  trait_info:
    ontology:
    - EFO_0003885
    reported_trait_name: Multiple sclerosis
    standard_trait_name: multiple sclerosis
- association_info:
    ancestry:
    - European=11375
    gwas_catalog_id: GCST005581
    neg_log_pval: 15.16526148109616
    otg_id: GCST005581
    pubmed_id: '22961000'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: T-lymphocyte activation antigen CD80 inhibitor drug ABATACEPT is
        Phase IV for the indiciation EFO_1001486 and targets the gene ENSG00000121594
        at this locus (23206bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000121594
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '3'
      position: 119219934
    locus_GRCh38:
      chromosome: '3'
      position: 119501087
  trait_info:
    ontology:
    - EFO_1001486
    reported_trait_name: Primary biliary cirrhosis
    standard_trait_name: primary biliary cirrhosis
- association_info:
    ancestry:
    - East Asian=3574
    gwas_catalog_id: GCST007036
    neg_log_pval: 8.221848749616356
    otg_id: GCST007036
    pubmed_id: '30643196'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: T-lymphocyte activation antigen CD80 inhibitor drug ABATACEPT is
        Phase IV for the indiciation EFO_1001486 and targets the gene ENSG00000121594
        at this locus (23206bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000121594
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '3'
      position: 119219934
    locus_GRCh38:
      chromosome: '3'
      position: 119501087
  trait_info:
    ontology:
    - EFO_1001486
    reported_trait_name: Primary biliary cholangitis
    standard_trait_name: primary biliary cirrhosis
- association_info:
    ancestry:
    - European=18264
    gwas_catalog_id: GCST007400
    neg_log_pval: 9.0
    otg_id: GCST007400
    pubmed_id: '28714469'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: T-lymphocyte activation antigen CD80 inhibitor drug ABATACEPT is
        Phase II for the indiciation EFO_0002690 and targets the gene ENSG00000121594
        at this locus (20684bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000121594
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '3'
      position: 119222456
    locus_GRCh38:
      chromosome: '3'
      position: 119503609
  trait_info:
    ontology:
    - EFO_0002690
    reported_trait_name: Systemic lupus erythematosus
    standard_trait_name: systemic lupus erythematosus
- association_info:
    ancestry:
    - European=38582
    gwas_catalog_id: GCST005531
    neg_log_pval: 14.397940008672037
    otg_id: GCST005531
    pubmed_id: '24076602'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: T-lymphocyte activation antigen CD80 inhibitor drug ABATACEPT is
        Phase II for the indiciation EFO_0003885 and targets the gene ENSG00000121594
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000121594
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '3'
      position: 119244593
    locus_GRCh38:
      chromosome: '3'
      position: 119525746
  trait_info:
    ontology:
    - EFO_0003885
    reported_trait_name: Multiple sclerosis
    standard_trait_name: multiple sclerosis
- association_info:
    ancestry:
    - East Asian=5050
    gwas_catalog_id: GCST001795
    neg_log_pval: 15.522878745280337
    otg_id: GCST001795
    pubmed_id: '23273568'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: T-lymphocyte activation antigen CD80 inhibitor drug ABATACEPT is
        Phase II for the indiciation EFO_0002690 and targets the gene ENSG00000121594
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000121594
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '3'
      position: 119260944
    locus_GRCh38:
      chromosome: '3'
      position: 119542097
  trait_info:
    ontology:
    - EFO_0002690
    reported_trait_name: Systemic lupus erythematosus
    standard_trait_name: systemic lupus erythematosus
- association_info:
    ancestry:
    - East Asian=5050
    gwas_catalog_id: GCST002845
    neg_log_pval: 7.301029995663981
    otg_id: GCST002845
    pubmed_id: '25862617'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: T-lymphocyte activation antigen CD80 inhibitor drug ABATACEPT is
        Phase II for the indiciation EFO_0002690 and targets the gene ENSG00000121594
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000121594
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '3'
      position: 119272391
    locus_GRCh38:
      chromosome: '3'
      position: 119553544
  trait_info:
    ontology:
    - EFO_0002690
    reported_trait_name: Systemic lupus erythematosus
    standard_trait_name: systemic lupus erythematosus
- association_info:
    ancestry:
    - European=38582
    gwas_catalog_id: GCST005531
    neg_log_pval: 14.154901959985743
    otg_id: GCST005531
    pubmed_id: '24076602'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: T-lymphocyte activation antigen CD86 inhibitor drug ABATACEPT is
        Phase II for the indiciation EFO_0003885 and targets the gene ENSG00000114013
        at this locus (230632bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000114013
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '3'
      position: 121543577
    locus_GRCh38:
      chromosome: '3'
      position: 121824730
  trait_info:
    ontology:
    - EFO_0003885
    reported_trait_name: Multiple sclerosis
    standard_trait_name: multiple sclerosis
- association_info:
    ancestry:
    - NR=215725
    gwas_catalog_id: GCST007124
    neg_log_pval: 7.3979400086720375
    otg_id: GCST007124
    pubmed_id: '26920376'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: T-lymphocyte activation antigen CD86 inhibitor drug ABATACEPT is
        Phase II for the indiciation EFO_0003885 and targets the gene ENSG00000114013
        at this locus (113546bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000114013
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '3'
      position: 121660664
    locus_GRCh38:
      chromosome: '3'
      position: 121941817
  trait_info:
    ontology:
    - EFO_0003885
    reported_trait_name: Multiple sclerosis and HDL levels (pleiotropy)
    standard_trait_name: multiple sclerosis
- association_info:
    ancestry:
    - European=341215
    gwas_catalog_id: GCST007798
    neg_log_pval: 8.154901959985743
    otg_id: GCST007798
    pubmed_id: '30929738'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: T-lymphocyte activation antigen CD86 inhibitor drug ABATACEPT is
        Phase II for the indiciation EFO_0000270 and targets the gene ENSG00000114013
        at this locus (58039bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000114013
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 121716171
    locus_GRCh38:
      chromosome: '3'
      position: 121997324
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=15283
    gwas_catalog_id: GCST003566
    neg_log_pval: 9.0
    otg_id: GCST003566
    pubmed_id: '27386562'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: T-lymphocyte activation antigen CD86 inhibitor drug ABATACEPT is
        Phase II for the indiciation EFO_0003885 and targets the gene ENSG00000114013
        at this locus (4687bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000114013
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '3'
      position: 121769522
    locus_GRCh38:
      chromosome: '3'
      position: 122050675
  trait_info:
    ontology:
    - EFO_0003885
    reported_trait_name: Multiple sclerosis
    standard_trait_name: multiple sclerosis
- association_info:
    ancestry:
    - NR=3599
    - Hispanic or Latin American=1956
    - European=17698
    gwas_catalog_id: GCST003340
    neg_log_pval: 7.301029995663981
    otg_id: GCST003340
    pubmed_id: '26819262'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: T-lymphocyte activation antigen CD86 inhibitor drug ABATACEPT is
        Phase II for the indiciation EFO_0003885 and targets the gene ENSG00000114013
        at this locus (3670bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000114013
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '3'
      position: 121770539
    locus_GRCh38:
      chromosome: '3'
      position: 122051692
  trait_info:
    ontology:
    - EFO_0003885
    reported_trait_name: Epstein Barr virus nuclear antigen 1 IgG levels or multiple
      sclerosis
    standard_trait_name: multiple sclerosis
- association_info:
    ancestry:
    - European=38582
    gwas_catalog_id: GCST005531
    neg_log_pval: 12.273272790973428
    otg_id: GCST005531
    pubmed_id: '24076602'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: T-lymphocyte activation antigen CD86 inhibitor drug ABATACEPT is
        Phase II for the indiciation EFO_0003885 and targets the gene ENSG00000114013
        at this locus (3670bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000114013
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '3'
      position: 121770539
    locus_GRCh38:
      chromosome: '3'
      position: 122051692
  trait_info:
    ontology:
    - EFO_0003885
    reported_trait_name: Multiple sclerosis
    standard_trait_name: multiple sclerosis
- association_info:
    ancestry:
    - European=26621
    gwas_catalog_id: GCST001198
    neg_log_pval: 8.811915626285062
    otg_id: GCST001198
    pubmed_id: '21833088'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: T-lymphocyte activation antigen CD86 inhibitor drug ABATACEPT is
        Phase II for the indiciation EFO_0003885 and targets the gene ENSG00000114013
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000114013
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '3'
      position: 121796768
    locus_GRCh38:
      chromosome: '3'
      position: 122077921
  trait_info:
    ontology:
    - EFO_0003885
    reported_trait_name: Multiple sclerosis
    standard_trait_name: multiple sclerosis
- association_info:
    ancestry:
    - European=41199
    gwas_catalog_id: GCST000639
    neg_log_pval: 11.0
    otg_id: GCST000639
    pubmed_id: '20348956'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Fibroblast growth factor receptor 3 inhibitor drug DOVITINIB is
        Phase II for the indiciation EFO_0000292 and targets the gene ENSG00000068078
        at this locus (60781bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000068078
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '4'
      position: 1734239
    locus_GRCh38:
      chromosome: '4'
      position: 1732512
  trait_info:
    ontology:
    - EFO_0000292
    reported_trait_name: Urinary bladder cancer
    standard_trait_name: bladder carcinoma
- association_info:
    ancestry:
    - European=6206
    gwas_catalog_id: GCST002240
    neg_log_pval: 24.154901959985743
    otg_id: GCST002240
    pubmed_id: '24163127'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Fibroblast growth factor receptor 3 inhibitor drug DOVITINIB is
        Phase II for the indiciation EFO_0000292 and targets the gene ENSG00000068078
        at this locus (60781bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000068078
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '4'
      position: 1734239
    locus_GRCh38:
      chromosome: '4'
      position: 1732512
  trait_info:
    ontology:
    - EFO_0000292
    reported_trait_name: Bladder cancer
    standard_trait_name: bladder carcinoma
- association_info:
    ancestry:
    - European=8652
    gwas_catalog_id: GCST000842
    neg_log_pval: 12.397940008672037
    otg_id: GCST000842
    pubmed_id: '20972438'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Fibroblast growth factor receptor 3 inhibitor drug DOVITINIB is
        Phase II for the indiciation EFO_0000292 and targets the gene ENSG00000068078
        at this locus (60781bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000068078
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '4'
      position: 1734239
    locus_GRCh38:
      chromosome: '4'
      position: 1732512
  trait_info:
    ontology:
    - EFO_0000292
    reported_trait_name: Bladder cancer
    standard_trait_name: bladder carcinoma
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 7.692944898477948
    otg_id: NEALE2_20001_1035
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Fibroblast growth factor receptor 3 inhibitor drug DOVITINIB is
        Phase II for the indiciation EFO_0000292 and targets the gene ENSG00000068078
        at this locus (25584bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000068078
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '4'
      position: 1769436
    locus_GRCh38:
      chromosome: '4'
      position: 1767709
  trait_info:
    ontology:
    - EFO_0000292
    reported_trait_name: Bladder cancer | cancer code, self-reported
    standard_trait_name: bladder carcinoma
- association_info:
    ancestry:
    - African American or Afro-Caribbean=1541
    - European=1436
    gwas_catalog_id: GCST004955
    neg_log_pval: 7.522878745280337
    otg_id: GCST004955
    pubmed_id: '28990359'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: GABA-A receptor; anion channel positive allosteric modulator drug
        LORAZEPAM is Phase IV for the indiciation EFO_0003829 and targets the gene
        ENSG00000163285 at this locus (490719bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000163285
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '4'
      position: 45547068
    locus_GRCh38:
      chromosome: '4'
      position: 45545051
  trait_info:
    ontology:
    - EFO_0003829
    reported_trait_name: Risky sexual behaviors in alcohol dependence [AA]
    standard_trait_name: alcohol dependence
- association_info:
    ancestry:
    - African American or Afro-Caribbean=1541
    - European=1436
    gwas_catalog_id: GCST004955
    neg_log_pval: 7.522878745280337
    otg_id: GCST004955
    pubmed_id: '28990359'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: GABA-A receptor; anion channel allosteric antagonist drug FLUMAZENIL
        is Phase II for the indiciation EFO_0003829 and targets the gene ENSG00000163285
        at this locus (490719bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000163285
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '4'
      position: 45547068
    locus_GRCh38:
      chromosome: '4'
      position: 45545051
  trait_info:
    ontology:
    - EFO_0003829
    reported_trait_name: Risky sexual behaviors in alcohol dependence [AA]
    standard_trait_name: alcohol dependence
- association_info:
    ancestry:
    - African American or Afro-Caribbean=1541
    - European=1436
    gwas_catalog_id: GCST004955
    neg_log_pval: 7.522878745280337
    otg_id: GCST004955
    pubmed_id: '28990359'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: GABA-A receptor; anion channel positive allosteric modulator drug
        CHLORDIAZEPOXIDE is Phase III for the indiciation EFO_0003829 and targets
        the gene ENSG00000163285 at this locus (490719bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000163285
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '4'
      position: 45547068
    locus_GRCh38:
      chromosome: '4'
      position: 45545051
  trait_info:
    ontology:
    - EFO_0003829
    reported_trait_name: Risky sexual behaviors in alcohol dependence [AA]
    standard_trait_name: alcohol dependence
- association_info:
    ancestry:
    - European=3524
    gwas_catalog_id: GCST003427
    neg_log_pval: 9.0
    otg_id: GCST003427
    pubmed_id: '26830138'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: GABA-A receptor; anion channel inverse agonist drug RESEQUINIL
        is Phase II for the indiciation EFO_0000249 and targets the gene ENSG00000163285
        at this locus (288042bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000163285
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '4'
      position: 46414112
    locus_GRCh38:
      chromosome: '4'
      position: 46412095
  trait_info:
    ontology:
    - EFO_0000249
    reported_trait_name: Alzheimer disease and age of onset [between families]
    standard_trait_name: Alzheimer's disease
- association_info:
    ancestry:
    - European=3524
    gwas_catalog_id: GCST003427
    neg_log_pval: 9.0
    otg_id: GCST003427
    pubmed_id: '26830138'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: GABA-A receptor; anion channel inverse agonist drug RESEQUINIL
        is Phase II for the indiciation EFO_0000249 and targets the gene ENSG00000151834
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000151834
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '4'
      position: 46414112
    locus_GRCh38:
      chromosome: '4'
      position: 46412095
  trait_info:
    ontology:
    - EFO_0000249
    reported_trait_name: Alzheimer disease and age of onset [between families]
    standard_trait_name: Alzheimer's disease
- association_info:
    ancestry:
    - European=26405
    gwas_catalog_id: GCST000964
    neg_log_pval: 8.872895201635192
    otg_id: GCST000964
    pubmed_id: '21297633'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: GABA-A receptor; anion channel positive allosteric modulator drug
        MIDAZOLAM is Phase IV for the indiciation EFO_0000729 and targets the gene
        ENSG00000151834 at this locus (66059bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000151834
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '4'
      position: 46543306
    locus_GRCh38:
      chromosome: '4'
      position: 46541289
  trait_info:
    ontology:
    - EFO_0000729
    reported_trait_name: Ulcerative colitis
    standard_trait_name: ulcerative colitis
- association_info:
    ancestry:
    - European=26405
    gwas_catalog_id: GCST000964
    neg_log_pval: 8.872895201635192
    otg_id: GCST000964
    pubmed_id: '21297633'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: GABA-A receptor; anion channel positive allosteric modulator drug
        MIDAZOLAM is Phase IV for the indiciation EFO_0000729 and targets the gene
        ENSG00000163285 at this locus (417235bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000163285
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '4'
      position: 46543306
    locus_GRCh38:
      chromosome: '4'
      position: 46541289
  trait_info:
    ontology:
    - EFO_0000729
    reported_trait_name: Ulcerative colitis
    standard_trait_name: ulcerative colitis
- association_info:
    ancestry:
    - European=3524
    gwas_catalog_id: GCST003427
    neg_log_pval: 9.0
    otg_id: GCST003427
    pubmed_id: '26830138'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: GABA-A receptor; anion channel inverse agonist drug RESEQUINIL
        is Phase II for the indiciation EFO_0000249 and targets the gene ENSG00000151834
        at this locus (213998bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000151834
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '4'
      position: 46691244
    locus_GRCh38:
      chromosome: '4'
      position: 46689227
  trait_info:
    ontology:
    - EFO_0000249
    reported_trait_name: Alzheimer disease and age of onset [between families]
    standard_trait_name: Alzheimer's disease
- association_info:
    ancestry:
    - East Asian=4275
    gwas_catalog_id: GCST001384
    neg_log_pval: 8.096910013008056
    otg_id: GCST001384
    pubmed_id: '22291604'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: c-Jun N-terminal kinase 3 inhibitor drug TANZISERTIB is Phase II
        for the indiciation EFO_0002690 and targets the gene ENSG00000109339 at this
        locus (442619bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000109339
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '4'
      position: 87958395
    locus_GRCh38:
      chromosome: '4'
      position: 87037243
  trait_info:
    ontology:
    - EFO_0002690
    reported_trait_name: Systemic lupus erythematosus
    standard_trait_name: systemic lupus erythematosus
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 9.056494107508188
    otg_id: NEALE2_20002_1262
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Alpha-synuclein inhibitor drug BIIB054 is Phase II for the indiciation
        EFO_0002508 and targets the gene ENSG00000145335 at this locus (25518bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145335
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: TA
      reference: T
    locus_GRCh37:
      chromosome: '4'
      position: 90619732
    locus_GRCh38:
      chromosome: '4'
      position: 89698581
  trait_info:
    ontology:
    - EFO_0002508
    reported_trait_name: Parkinsons disease | non-cancer illness code, self-reported
    standard_trait_name: Parkinson's disease
- association_info:
    ancestry:
    - European=334141
    gwas_catalog_id: GCST003984
    neg_log_pval: 56.0
    otg_id: GCST003984
    pubmed_id: '27182965'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Alpha-synuclein inhibitor drug BIIB054 is Phase II for the indiciation
        EFO_0002508 and targets the gene ENSG00000145335 at this locus (19139bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145335
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '4'
      position: 90626111
    locus_GRCh38:
      chromosome: '4'
      position: 89704960
  trait_info:
    ontology:
    - EFO_0002508
    reported_trait_name: Parkinson's disease
    standard_trait_name: Parkinson's disease
- association_info:
    ancestry:
    - European=108990
    gwas_catalog_id: GCST002544
    neg_log_pval: 72.39794000867204
    otg_id: GCST002544
    pubmed_id: '25064009'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Alpha-synuclein inhibitor drug BIIB054 is Phase II for the indiciation
        EFO_0002508 and targets the gene ENSG00000145335 at this locus (19139bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145335
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '4'
      position: 90626111
    locus_GRCh38:
      chromosome: '4'
      position: 89704960
  trait_info:
    ontology:
    - EFO_0002508
    reported_trait_name: Parkinson's disease
    standard_trait_name: Parkinson's disease
- association_info:
    ancestry:
    - European=417508
    gwas_catalog_id: GCST004902
    neg_log_pval: 122.30102999566398
    otg_id: GCST004902
    pubmed_id: '28892059'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Alpha-synuclein inhibitor drug BIIB054 is Phase II for the indiciation
        EFO_0002508 and targets the gene ENSG00000145335 at this locus (19139bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145335
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '4'
      position: 90626111
    locus_GRCh38:
      chromosome: '4'
      position: 89704960
  trait_info:
    ontology:
    - EFO_0002508
    reported_trait_name: Parkinson's disease
    standard_trait_name: Parkinson's disease
- association_info:
    ancestry:
    - NR=4258
    gwas_catalog_id: GCST001445
    neg_log_pval: 64.22184874961636
    otg_id: GCST001445_2
    pubmed_id: '22438815'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Alpha-synuclein inhibitor drug BIIB054 is Phase II for the indiciation
        EFO_0002508 and targets the gene ENSG00000145335 at this locus (7650bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145335
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '4'
      position: 90637601
    locus_GRCh38:
      chromosome: '4'
      position: 89716450
  trait_info:
    ontology:
    - EFO_0002508
    reported_trait_name: Parkinson's disease [EA]
    standard_trait_name: Parkinson's disease
- association_info:
    ancestry:
    - European=17352
    gwas_catalog_id: GCST000959
    neg_log_pval: 46.69897000433602
    otg_id: GCST000959
    pubmed_id: '21292315'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Alpha-synuclein inhibitor drug BIIB054 is Phase II for the indiciation
        EFO_0002508 and targets the gene ENSG00000145335 at this locus (7650bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145335
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '4'
      position: 90637601
    locus_GRCh38:
      chromosome: '4'
      position: 89716450
  trait_info:
    ontology:
    - EFO_0002508
    reported_trait_name: Parkinson's disease
    standard_trait_name: Parkinson's disease
- association_info:
    ancestry:
    - East Asian=3509
    gwas_catalog_id: GCST000530
    neg_log_pval: 16.154901959985743
    otg_id: GCST000530
    pubmed_id: '19915576'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Alpha-synuclein inhibitor drug BIIB054 is Phase II for the indiciation
        EFO_0002508 and targets the gene ENSG00000145335 at this locus (5735bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145335
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '4'
      position: 90639515
    locus_GRCh38:
      chromosome: '4'
      position: 89718364
  trait_info:
    ontology:
    - EFO_0002508
    reported_trait_name: Parkinson's disease
    standard_trait_name: Parkinson's disease
- association_info:
    ancestry:
    - European=33050
    gwas_catalog_id: GCST001126
    neg_log_pval: 18.69897000433602
    otg_id: GCST001126
    pubmed_id: '21738487'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Alpha-synuclein inhibitor drug BIIB054 is Phase II for the indiciation
        EFO_0002508 and targets the gene ENSG00000145335 at this locus (3911bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145335
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '4'
      position: 90641340
    locus_GRCh38:
      chromosome: '4'
      position: 89720189
  trait_info:
    ontology:
    - EFO_0002508
    reported_trait_name: Parkinson's disease
    standard_trait_name: Parkinson's disease
- association_info:
    ancestry:
    - European=3986
    gwas_catalog_id: GCST002353
    neg_log_pval: 9.0
    otg_id: GCST002353_3
    pubmed_id: '24511991'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Alpha-synuclein inhibitor drug BIIB054 is Phase II for the indiciation
        EFO_0002508 and targets the gene ENSG00000145335 at this locus (3911bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145335
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '4'
      position: 90641340
    locus_GRCh38:
      chromosome: '4'
      position: 89720189
  trait_info:
    ontology:
    - EFO_0002508
    reported_trait_name: Parkinson's disease [Sporadic]
    standard_trait_name: Parkinson's disease
- association_info:
    ancestry:
    - European=8477
    gwas_catalog_id: GCST001430
    neg_log_pval: 34.096910013008056
    otg_id: GCST001430
    pubmed_id: '22451204'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Alpha-synuclein inhibitor drug BIIB054 is Phase II for the indiciation
        EFO_0002508 and targets the gene ENSG00000145335 at this locus (3911bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145335
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '4'
      position: 90641340
    locus_GRCh38:
      chromosome: '4'
      position: 89720189
  trait_info:
    ontology:
    - EFO_0002508
    reported_trait_name: Parkinson's disease
    standard_trait_name: Parkinson's disease
- association_info:
    ancestry:
    - European=3986
    gwas_catalog_id: GCST000772
    neg_log_pval: 10.522878745280337
    otg_id: GCST000772
    pubmed_id: '20711177'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Alpha-synuclein inhibitor drug BIIB054 is Phase II for the indiciation
        EFO_0002508 and targets the gene ENSG00000145335 at this locus (3911bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145335
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '4'
      position: 90641340
    locus_GRCh38:
      chromosome: '4'
      position: 89720189
  trait_info:
    ontology:
    - EFO_0002508
    reported_trait_name: Parkinson's disease
    standard_trait_name: Parkinson's disease
- association_info:
    ancestry:
    - European=6880
    gwas_catalog_id: GCST000855
    neg_log_pval: 15.045757490560675
    otg_id: GCST000855
    pubmed_id: '21044948'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Alpha-synuclein inhibitor drug BIIB054 is Phase II for the indiciation
        EFO_0002508 and targets the gene ENSG00000145335 at this locus (3911bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145335
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '4'
      position: 90641340
    locus_GRCh38:
      chromosome: '4'
      position: 89720189
  trait_info:
    ontology:
    - EFO_0002508
    reported_trait_name: Parkinson's disease
    standard_trait_name: Parkinson's disease
- association_info:
    ancestry:
    - European=3023
    gwas_catalog_id: GCST000874
    neg_log_pval: 7.522878745280337
    otg_id: GCST000874
    pubmed_id: '21084426'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Alpha-synuclein inhibitor drug BIIB054 is Phase II for the indiciation
        EFO_0002508 and targets the gene ENSG00000145335 at this locus (3911bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145335
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '4'
      position: 90641340
    locus_GRCh38:
      chromosome: '4'
      position: 89720189
  trait_info:
    ontology:
    - EFO_0002508
    reported_trait_name: Parkinson's disease
    standard_trait_name: Parkinson's disease
- association_info:
    ancestry:
    - European=3986
    gwas_catalog_id: GCST002353
    neg_log_pval: 10.522878745280337
    otg_id: GCST002353
    pubmed_id: '24511991'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Alpha-synuclein inhibitor drug BIIB054 is Phase II for the indiciation
        EFO_0002508 and targets the gene ENSG00000145335 at this locus (3911bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145335
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '4'
      position: 90641340
    locus_GRCh38:
      chromosome: '4'
      position: 89720189
  trait_info:
    ontology:
    - EFO_0002508
    reported_trait_name: Parkinson's disease
    standard_trait_name: Parkinson's disease
- association_info:
    ancestry:
    - East Asian=14006
    gwas_catalog_id: GCST003922
    neg_log_pval: 32.0
    otg_id: GCST003922
    pubmed_id: '28011712'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Alpha-synuclein inhibitor drug BIIB054 is Phase II for the indiciation
        EFO_0002508 and targets the gene ENSG00000145335 at this locus (797bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145335
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '4'
      position: 90644454
    locus_GRCh38:
      chromosome: '4'
      position: 89723303
  trait_info:
    ontology:
    - EFO_0002508
    reported_trait_name: Parkinson's disease
    standard_trait_name: Parkinson's disease
- association_info:
    ancestry:
    - NR=17996
    gwas_catalog_id: GCST007780
    neg_log_pval: 11.698970004336019
    otg_id: GCST007780
    pubmed_id: '30957308'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Alpha-synuclein inhibitor drug BIIB054 is Phase II for the indiciation
        EFO_0002508 and targets the gene ENSG00000145335 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145335
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '4'
      position: 90666041
    locus_GRCh38:
      chromosome: '4'
      position: 89744890
  trait_info:
    ontology:
    - EFO_0002508
    reported_trait_name: Parkinson's disease (age of onset)
    standard_trait_name: Parkinson's disease
- association_info:
    ancestry:
    - European=5691
    gwas_catalog_id: GCST000528
    neg_log_pval: 15.698970004336019
    otg_id: GCST000528
    pubmed_id: '19915575'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Alpha-synuclein inhibitor drug BIIB054 is Phase II for the indiciation
        EFO_0002508 and targets the gene ENSG00000145335 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145335
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '4'
      position: 90678541
    locus_GRCh38:
      chromosome: '4'
      position: 89757390
  trait_info:
    ontology:
    - EFO_0002508
    reported_trait_name: Parkinson's disease
    standard_trait_name: Parkinson's disease
- association_info:
    ancestry:
    - NR=4258
    gwas_catalog_id: GCST001445
    neg_log_pval: 10.301029995663981
    otg_id: GCST001445
    pubmed_id: '22438815'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Alpha-synuclein inhibitor drug BIIB054 is Phase II for the indiciation
        EFO_0002508 and targets the gene ENSG00000145335 at this locus (21437bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145335
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '4'
      position: 90780902
    locus_GRCh38:
      chromosome: '4'
      position: 89859751
  trait_info:
    ontology:
    - EFO_0002508
    reported_trait_name: Parkinson's disease [Asian]
    standard_trait_name: Parkinson's disease
- association_info:
    ancestry:
    - European=459000
    gwas_catalog_id: GCST007072
    neg_log_pval: 14.096910013008056
    otg_id: GCST007072
    pubmed_id: '30595370'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Microsomal triglyceride transfer protein inhibitor drug LOMITAPIDE
        is Phase IV for the indiciation EFO_0000319 and targets the gene ENSG00000138823
        at this locus (245600bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000138823
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '4'
      position: 100239319
    locus_GRCh38:
      chromosome: '4'
      position: 99318162
  trait_info:
    ontology:
    - EFO_0000319
    reported_trait_name: Cardiovascular disease
    standard_trait_name: cardiovascular system disease
- association_info:
    ancestry:
    - East Asian=4168
    gwas_catalog_id: GCST003154
    neg_log_pval: 8.301029995663981
    otg_id: GCST003154
    pubmed_id: '26488411'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Endothelin receptor ET-A antagonist drug ZIBOTENTAN is Phase II
        for the indiciation EFO_0004265 and targets the gene ENSG00000151617 at this
        locus (1251bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000151617
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '4'
      position: 148400819
    locus_GRCh38:
      chromosome: '4'
      position: 147479667
  trait_info:
    ontology:
    - EFO_0004265
    reported_trait_name: Peripheral artery disease
    standard_trait_name: peripheral arterial disease
- association_info:
    ancestry:
    - European=1030836
    gwas_catalog_id: GCST006414
    neg_log_pval: 10.878440155812498
    otg_id: GCST006414
    pubmed_id: '30061737'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Mineralocorticoid receptor antagonist drug SPIRONOLACTONE is Phase
        IV for the indiciation EFO_0000275 and targets the gene ENSG00000151623 at
        this locus (62377bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000151623
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '4'
      position: 148937537
    locus_GRCh38:
      chromosome: '4'
      position: 148016386
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=537409
    - East Asian=36792
    - African American or Afro-Caribbean=8967
    - Hispanic or Latin American=5022
    gwas_catalog_id: GCST006061
    neg_log_pval: 13.221848749616356
    otg_id: GCST006061
    pubmed_id: '29892015'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Mineralocorticoid receptor antagonist drug SPIRONOLACTONE is Phase
        IV for the indiciation EFO_0000275 and targets the gene ENSG00000151623 at
        this locus (62377bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000151623
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '4'
      position: 148937537
    locus_GRCh38:
      chromosome: '4'
      position: 148016386
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=1030836
    gwas_catalog_id: GCST006414
    neg_log_pval: 10.878440155812498
    otg_id: GCST006414
    pubmed_id: '30061737'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Mineralocorticoid receptor antagonist drug EPLERENONE is Phase
        II for the indiciation EFO_0000275 and targets the gene ENSG00000151623 at
        this locus (62377bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000151623
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '4'
      position: 148937537
    locus_GRCh38:
      chromosome: '4'
      position: 148016386
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=537409
    - East Asian=36792
    - African American or Afro-Caribbean=8967
    - Hispanic or Latin American=5022
    gwas_catalog_id: GCST006061
    neg_log_pval: 13.221848749616356
    otg_id: GCST006061
    pubmed_id: '29892015'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Mineralocorticoid receptor antagonist drug EPLERENONE is Phase
        II for the indiciation EFO_0000275 and targets the gene ENSG00000151623 at
        this locus (62377bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000151623
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '4'
      position: 148937537
    locus_GRCh38:
      chromosome: '4'
      position: 148016386
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=537409
    - East Asian=36792
    - African American or Afro-Caribbean=8967
    - Hispanic or Latin American=5022
    gwas_catalog_id: GCST006061
    neg_log_pval: 12.154901959985743
    otg_id: GCST006061_3
    pubmed_id: '29892015'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Mineralocorticoid receptor antagonist drug CANRENONE is Phase IV
        for the indiciation EFO_0000275 and targets the gene ENSG00000151623 at this
        locus (53224bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000151623
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '4'
      position: 148946690
    locus_GRCh38:
      chromosome: '4'
      position: 148025539
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation [EA]
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=537409
    - East Asian=36792
    - African American or Afro-Caribbean=8967
    - Hispanic or Latin American=5022
    gwas_catalog_id: GCST006061
    neg_log_pval: 12.154901959985743
    otg_id: GCST006061_3
    pubmed_id: '29892015'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Mineralocorticoid receptor antagonist drug EPLERENONE is Phase
        II for the indiciation EFO_0000275 and targets the gene ENSG00000151623 at
        this locus (53224bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000151623
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '4'
      position: 148946690
    locus_GRCh38:
      chromosome: '4'
      position: 148025539
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation [EA]
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=459000
    gwas_catalog_id: GCST007072
    neg_log_pval: 10.698970004336019
    otg_id: GCST007072
    pubmed_id: '30595370'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Soluble guanylate cyclase activator drug NITROGLYCERIN is Phase
        IV for the indiciation EFO_0000319 and targets the gene ENSG00000061918 at
        this locus (259540bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000061918
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: A
    locus_GRCh37:
      chromosome: '4'
      position: 156420605
    locus_GRCh38:
      chromosome: '4'
      position: 155499453
  trait_info:
    ontology:
    - EFO_0000319
    reported_trait_name: Cardiovascular disease
    standard_trait_name: cardiovascular system disease
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 8.636910992288339
    otg_id: NEALE2_20002_1065
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Soluble guanylate cyclase activator drug ISOSORBIDE MONONITRATE
        is Phase II for the indiciation EFO_0000537 and targets the gene ENSG00000061918
        at this locus (246836bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000061918
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '4'
      position: 156433308
    locus_GRCh38:
      chromosome: '4'
      position: 155512156
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Hypertension | non-cancer illness code, self-reported
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 8.636910992288339
    otg_id: NEALE2_20002_1065
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Soluble guanylate cyclase activator drug SODIUM NITROPRUSSIDE is
        Phase IV for the indiciation EFO_0000537 and targets the gene ENSG00000061918
        at this locus (246836bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000061918
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '4'
      position: 156433308
    locus_GRCh38:
      chromosome: '4'
      position: 155512156
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Hypertension | non-cancer illness code, self-reported
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - NR=296525
    gwas_catalog_id: GCST005194
    neg_log_pval: 9.962972120244226
    otg_id: GCST005194
    pubmed_id: '29212778'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Soluble guanylate cyclase activator drug NITRIC OXIDE is Phase
        II for the indiciation EFO_0000378 and targets the gene ENSG00000061918 at
        this locus (243638bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000061918
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '4'
      position: 156436507
    locus_GRCh38:
      chromosome: '4'
      position: 155515355
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - NR=296525
    gwas_catalog_id: GCST005194
    neg_log_pval: 9.962972120244226
    otg_id: GCST005194
    pubmed_id: '29212778'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Soluble guanylate cyclase activator drug NITROGLYCERIN is Phase
        IV for the indiciation EFO_0000378 and targets the gene ENSG00000061918 at
        this locus (243638bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000061918
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '4'
      position: 156436507
    locus_GRCh38:
      chromosome: '4'
      position: 155515355
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - NR=296525
    gwas_catalog_id: GCST005194
    neg_log_pval: 9.962972120244226
    otg_id: GCST005194
    pubmed_id: '29212778'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Soluble guanylate cyclase activator drug ISOSORBIDE DINITRATE is
        Phase III for the indiciation EFO_0000378 and targets the gene ENSG00000061918
        at this locus (243638bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000061918
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '4'
      position: 156436507
    locus_GRCh38:
      chromosome: '4'
      position: 155515355
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - NR=250736
    gwas_catalog_id: GCST005196
    neg_log_pval: 10.0
    otg_id: GCST005196
    pubmed_id: '29212778'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Soluble guanylate cyclase activator drug ISOSORBIDE DINITRATE is
        Phase III for the indiciation EFO_0000378 and targets the gene ENSG00000061918
        at this locus (243628bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000061918
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '4'
      position: 156436517
    locus_GRCh38:
      chromosome: '4'
      position: 155515365
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - NR=250736
    gwas_catalog_id: GCST005196
    neg_log_pval: 10.0
    otg_id: GCST005196
    pubmed_id: '29212778'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Soluble guanylate cyclase activator drug NITRIC OXIDE is Phase
        II for the indiciation EFO_0000378 and targets the gene ENSG00000061918 at
        this locus (243628bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000061918
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '4'
      position: 156436517
    locus_GRCh38:
      chromosome: '4'
      position: 155515365
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - NR=250736
    gwas_catalog_id: GCST005196
    neg_log_pval: 10.0
    otg_id: GCST005196
    pubmed_id: '29212778'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Soluble guanylate cyclase activator drug NITROGLYCERIN is Phase
        IV for the indiciation EFO_0000378 and targets the gene ENSG00000061918 at
        this locus (243628bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000061918
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '4'
      position: 156436517
    locus_GRCh38:
      chromosome: '4'
      position: 155515365
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - NR=547261
    gwas_catalog_id: GCST005195
    neg_log_pval: 14.0
    otg_id: GCST005195
    pubmed_id: '29212778'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Soluble guanylate cyclase activator drug NITRIC OXIDE is Phase
        II for the indiciation EFO_0000378 and targets the gene ENSG00000061918 at
        this locus (65960bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000061918
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '4'
      position: 156614184
    locus_GRCh38:
      chromosome: '4'
      position: 155693032
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - NR=547261
    gwas_catalog_id: GCST005195
    neg_log_pval: 14.0
    otg_id: GCST005195
    pubmed_id: '29212778'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Soluble guanylate cyclase activator drug NITROGLYCERIN is Phase
        IV for the indiciation EFO_0000378 and targets the gene ENSG00000061918 at
        this locus (65960bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000061918
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '4'
      position: 156614184
    locus_GRCh38:
      chromosome: '4'
      position: 155693032
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - NR=547261
    gwas_catalog_id: GCST005195
    neg_log_pval: 14.0
    otg_id: GCST005195
    pubmed_id: '29212778'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Soluble guanylate cyclase activator drug ISOSORBIDE DINITRATE is
        Phase III for the indiciation EFO_0000378 and targets the gene ENSG00000061918
        at this locus (65960bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000061918
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '4'
      position: 156614184
    locus_GRCh38:
      chromosome: '4'
      position: 155693032
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - NR=296525
    gwas_catalog_id: GCST005194
    neg_log_pval: 22.476643793345207
    otg_id: GCST005194
    pubmed_id: '29212778'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Soluble guanylate cyclase activator drug NITRIC OXIDE is Phase
        II for the indiciation EFO_0000378 and targets the gene ENSG00000061918 at
        this locus (44835bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000061918
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '4'
      position: 156635309
    locus_GRCh38:
      chromosome: '4'
      position: 155714157
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - NR=250736
    gwas_catalog_id: GCST005196
    neg_log_pval: 21.397940008672037
    otg_id: GCST005196
    pubmed_id: '29212778'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Soluble guanylate cyclase activator drug NITRIC OXIDE is Phase
        II for the indiciation EFO_0000378 and targets the gene ENSG00000061918 at
        this locus (44835bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000061918
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '4'
      position: 156635309
    locus_GRCh38:
      chromosome: '4'
      position: 155714157
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - NR=250736
    gwas_catalog_id: GCST005196
    neg_log_pval: 21.397940008672037
    otg_id: GCST005196
    pubmed_id: '29212778'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Soluble guanylate cyclase activator drug ISOSORBIDE DINITRATE is
        Phase III for the indiciation EFO_0000378 and targets the gene ENSG00000061918
        at this locus (44835bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000061918
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '4'
      position: 156635309
    locus_GRCh38:
      chromosome: '4'
      position: 155714157
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - NR=250736
    gwas_catalog_id: GCST005196
    neg_log_pval: 21.397940008672037
    otg_id: GCST005196
    pubmed_id: '29212778'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Soluble guanylate cyclase activator drug ISOSORBIDE MONONITRATE
        is Phase IV for the indiciation EFO_0000378 and targets the gene ENSG00000061918
        at this locus (44835bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000061918
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '4'
      position: 156635309
    locus_GRCh38:
      chromosome: '4'
      position: 155714157
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - NR=296525
    gwas_catalog_id: GCST005194
    neg_log_pval: 22.476643793345207
    otg_id: GCST005194
    pubmed_id: '29212778'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Soluble guanylate cyclase activator drug ISOSORBIDE DINITRATE is
        Phase III for the indiciation EFO_0000378 and targets the gene ENSG00000061918
        at this locus (44835bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000061918
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '4'
      position: 156635309
    locus_GRCh38:
      chromosome: '4'
      position: 155714157
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - NR=296525
    gwas_catalog_id: GCST005194
    neg_log_pval: 22.476643793345207
    otg_id: GCST005194
    pubmed_id: '29212778'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Soluble guanylate cyclase activator drug ISOSORBIDE MONONITRATE
        is Phase IV for the indiciation EFO_0000378 and targets the gene ENSG00000061918
        at this locus (44835bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000061918
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '4'
      position: 156635309
    locus_GRCh38:
      chromosome: '4'
      position: 155714157
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - European, NR=63731
    gwas_catalog_id: GCST004787
    neg_log_pval: 9.0
    otg_id: GCST004787
    pubmed_id: '28714975'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Soluble guanylate cyclase activator drug NITRIC OXIDE is Phase
        II for the indiciation EFO_0000378 and targets the gene ENSG00000061918 at
        this locus (41572bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000061918
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '4'
      position: 156638573
    locus_GRCh38:
      chromosome: '4'
      position: 155717421
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease (myocardial infarction, percutaneous
      transluminal coronary angioplasty, coronary artery bypass grafting, angina or
      chromic ischemic heart disease)
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - European, NR=63731
    gwas_catalog_id: GCST004787
    neg_log_pval: 9.0
    otg_id: GCST004787
    pubmed_id: '28714975'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Soluble guanylate cyclase activator drug NITROGLYCERIN is Phase
        IV for the indiciation EFO_0000378 and targets the gene ENSG00000061918 at
        this locus (41572bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000061918
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '4'
      position: 156638573
    locus_GRCh38:
      chromosome: '4'
      position: 155717421
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease (myocardial infarction, percutaneous
      transluminal coronary angioplasty, coronary artery bypass grafting, angina or
      chromic ischemic heart disease)
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - European, NR=63731
    gwas_catalog_id: GCST004787
    neg_log_pval: 9.0
    otg_id: GCST004787
    pubmed_id: '28714975'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Soluble guanylate cyclase activator drug ISOSORBIDE DINITRATE is
        Phase III for the indiciation EFO_0000378 and targets the gene ENSG00000061918
        at this locus (41572bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000061918
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '4'
      position: 156638573
    locus_GRCh38:
      chromosome: '4'
      position: 155717421
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease (myocardial infarction, percutaneous
      transluminal coronary angioplasty, coronary artery bypass grafting, angina or
      chromic ischemic heart disease)
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - European=141217
    - African American or Afro-Caribbean=3139
    - Hispanic or Latin American=4095
    - South Asian=25557
    - Greater Middle Eastern (Middle Eastern / North African / Persian)=2268
    - East Asian=11323
    gwas_catalog_id: GCST003116
    neg_log_pval: 8.221848749616356
    otg_id: GCST003116
    pubmed_id: '26343387'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Soluble guanylate cyclase activator drug ISOSORBIDE DINITRATE is
        Phase III for the indiciation EFO_0000378 and targets the gene ENSG00000061918
        at this locus (40257bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000061918
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '4'
      position: 156639888
    locus_GRCh38:
      chromosome: '4'
      position: 155718736
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - European=141217
    - African American or Afro-Caribbean=3139
    - Hispanic or Latin American=4095
    - South Asian=25557
    - Greater Middle Eastern (Middle Eastern / North African / Persian)=2268
    - East Asian=11323
    gwas_catalog_id: GCST003116
    neg_log_pval: 8.221848749616356
    otg_id: GCST003116
    pubmed_id: '26343387'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Soluble guanylate cyclase activator drug NITROGLYCERIN is Phase
        IV for the indiciation EFO_0000378 and targets the gene ENSG00000061918 at
        this locus (40257bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000061918
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '4'
      position: 156639888
    locus_GRCh38:
      chromosome: '4'
      position: 155718736
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - European=141217
    - African American or Afro-Caribbean=3139
    - Hispanic or Latin American=4095
    - South Asian=25557
    - Greater Middle Eastern (Middle Eastern / North African / Persian)=2268
    - East Asian=11323
    gwas_catalog_id: GCST003116
    neg_log_pval: 8.221848749616356
    otg_id: GCST003116
    pubmed_id: '26343387'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Soluble guanylate cyclase activator drug NITRIC OXIDE is Phase
        II for the indiciation EFO_0000378 and targets the gene ENSG00000061918 at
        this locus (40257bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000061918
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '4'
      position: 156639888
    locus_GRCh38:
      chromosome: '4'
      position: 155718736
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - African American or Afro-Caribbean=2908
    - Hispanic or Latin American=3615
    - South Asian=23156
    - Greater Middle Eastern (Middle Eastern / North African / Persian)=754
    - East Asian=9396
    - European=126630
    gwas_catalog_id: GCST003117
    neg_log_pval: 7.698970004336019
    otg_id: GCST003117
    pubmed_id: '26343387'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Soluble guanylate cyclase activator drug NITROGLYCERIN is Phase
        IV for the indiciation EFO_0000612 and targets the gene ENSG00000061918 at
        this locus (40257bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000061918
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '4'
      position: 156639888
    locus_GRCh38:
      chromosome: '4'
      position: 155718736
  trait_info:
    ontology:
    - EFO_0000612
    reported_trait_name: Myocardial infarction
    standard_trait_name: myocardial infarction
- association_info:
    ancestry:
    - European=408343
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 16.378823718224965
    otg_id: SAIGE_401
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Soluble guanylate cyclase activator drug NITROGLYCERIN is Phase
        IV for the indiciation EFO_0000537 and targets the gene ENSG00000061918 at
        this locus (37260bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000061918
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '4'
      position: 156642884
    locus_GRCh38:
      chromosome: '4'
      position: 155721732
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Hypertension
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - European=408089
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 16.32513885926219
    otg_id: SAIGE_401_1
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Soluble guanylate cyclase activator drug NITROGLYCERIN is Phase
        IV for the indiciation EFO_0000537 and targets the gene ENSG00000061918 at
        this locus (37260bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000061918
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '4'
      position: 156642884
    locus_GRCh38:
      chromosome: '4'
      position: 155721732
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Essential hypertension
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - European=408343
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 16.378823718224965
    otg_id: SAIGE_401
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Soluble guanylate cyclase activator drug ISOSORBIDE MONONITRATE
        is Phase II for the indiciation EFO_0000537 and targets the gene ENSG00000061918
        at this locus (37260bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000061918
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '4'
      position: 156642884
    locus_GRCh38:
      chromosome: '4'
      position: 155721732
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Hypertension
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - European=408089
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 16.32513885926219
    otg_id: SAIGE_401_1
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Soluble guanylate cyclase activator drug ISOSORBIDE MONONITRATE
        is Phase II for the indiciation EFO_0000537 and targets the gene ENSG00000061918
        at this locus (37260bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000061918
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '4'
      position: 156642884
    locus_GRCh38:
      chromosome: '4'
      position: 155721732
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Essential hypertension
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - European=408458
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 9.669586226650809
    otg_id: SAIGE_411
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Soluble guanylate cyclase activator drug ISOSORBIDE MONONITRATE
        is Phase IV for the indiciation EFO_0000378 and targets the gene ENSG00000061918
        at this locus (34631bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000061918
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '4'
      position: 156645513
    locus_GRCh38:
      chromosome: '4'
      position: 155724361
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Ischemic heart disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - European=408458
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 9.669586226650809
    otg_id: SAIGE_411
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Soluble guanylate cyclase activator drug ISOSORBIDE DINITRATE is
        Phase III for the indiciation EFO_0000378 and targets the gene ENSG00000061918
        at this locus (34631bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000061918
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '4'
      position: 156645513
    locus_GRCh38:
      chromosome: '4'
      position: 155724361
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Ischemic heart disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - European=408458
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 9.669586226650809
    otg_id: SAIGE_411
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Soluble guanylate cyclase activator drug NITRIC OXIDE is Phase
        II for the indiciation EFO_0000378 and targets the gene ENSG00000061918 at
        this locus (34631bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000061918
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '4'
      position: 156645513
    locus_GRCh38:
      chromosome: '4'
      position: 155724361
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Ischemic heart disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - European=459000
    gwas_catalog_id: GCST007072
    neg_log_pval: 19.69897000433602
    otg_id: GCST007072
    pubmed_id: '30595370'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Soluble guanylate cyclase activator drug ISOSORBIDE DINITRATE is
        Phase IV for the indiciation EFO_0000319 and targets the gene ENSG00000061918
        at this locus (33805bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000061918
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: T
    locus_GRCh37:
      chromosome: '4'
      position: 156646340
    locus_GRCh38:
      chromosome: '4'
      position: 155725188
  trait_info:
    ontology:
    - EFO_0000319
    reported_trait_name: Cardiovascular disease
    standard_trait_name: cardiovascular system disease
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 15.293624498063002
    otg_id: NEALE2_20002_1065
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Soluble guanylate cyclase activator drug NITROGLYCERIN is Phase
        IV for the indiciation EFO_0000537 and targets the gene ENSG00000061918 at
        this locus (33805bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000061918
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: T
    locus_GRCh37:
      chromosome: '4'
      position: 156646340
    locus_GRCh38:
      chromosome: '4'
      position: 155725188
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Hypertension | non-cancer illness code, self-reported
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 15.293624498063002
    otg_id: NEALE2_20002_1065
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Soluble guanylate cyclase activator drug ISOSORBIDE MONONITRATE
        is Phase II for the indiciation EFO_0000537 and targets the gene ENSG00000061918
        at this locus (33805bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000061918
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: T
    locus_GRCh37:
      chromosome: '4'
      position: 156646340
    locus_GRCh38:
      chromosome: '4'
      position: 155725188
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Hypertension | non-cancer illness code, self-reported
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - East Asian=50792
    gwas_catalog_id: GCST007707
    neg_log_pval: 8.698970004336019
    otg_id: GCST007707
    pubmed_id: '30487518'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Soluble guanylate cyclase activator drug ISOSORBIDE MONONITRATE
        is Phase II for the indiciation EFO_0000537 and targets the gene ENSG00000061918
        at this locus (13153bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000061918
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: A
    locus_GRCh37:
      chromosome: '4'
      position: 156666991
    locus_GRCh38:
      chromosome: '4'
      position: 155745839
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Hypertension [East Asian]
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - East Asian=50792
    gwas_catalog_id: GCST007707
    neg_log_pval: 8.698970004336019
    otg_id: GCST007707
    pubmed_id: '30487518'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Soluble guanylate cyclase activator drug SODIUM NITROPRUSSIDE is
        Phase IV for the indiciation EFO_0000537 and targets the gene ENSG00000061918
        at this locus (13153bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000061918
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: A
    locus_GRCh37:
      chromosome: '4'
      position: 156666991
    locus_GRCh38:
      chromosome: '4'
      position: 155745839
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Hypertension [East Asian]
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - European=30659
    gwas_catalog_id: GCST004347
    neg_log_pval: 65.52287874528034
    otg_id: GCST004347
    pubmed_id: '28346443'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Dopamine transporter releasing agent drug DEXTROAMPHETAMINE is
        Phase III for the indiciation EFO_0000326 and targets the gene ENSG00000142319
        at this locus (113119bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000142319
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 1279790
    locus_GRCh38:
      chromosome: '5'
      position: 1279675
  trait_info:
    ontology:
    - EFO_0000326
    reported_trait_name: Glioma
    standard_trait_name: central nervous system cancer
- association_info:
    ancestry:
    - African American or Afro-Caribbean=3749
    - European=5388
    gwas_catalog_id: GCST001298
    neg_log_pval: 10.0
    otg_id: GCST001298
    pubmed_id: '22037553'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Telomerase reverse transcriptase inhibitor drug IMETELSTAT SODIUM
        is Phase II for the indiciation EFO_0000305 and targets the gene ENSG00000164362
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000164362
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 1279790
    locus_GRCh38:
      chromosome: '5'
      position: 1279675
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=33864
    gwas_catalog_id: GCST004950
    neg_log_pval: 8.0
    otg_id: GCST004950
    pubmed_id: '25751625'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dopamine transporter inhibitor drug METHYLPHENIDATE is Phase II
        for the indiciation EFO_0000305 and targets the gene ENSG00000142319 at this
        locus (113119bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000142319
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 1279790
    locus_GRCh38:
      chromosome: '5'
      position: 1279675
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=24381
    gwas_catalog_id: GCST004349
    neg_log_pval: 73.09691001300806
    otg_id: GCST004349
    pubmed_id: '28346443'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Dopamine transporter releasing agent drug DEXTROAMPHETAMINE is
        Phase III for the indiciation EFO_0000326 and targets the gene ENSG00000142319
        at this locus (113119bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000142319
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 1279790
    locus_GRCh38:
      chromosome: '5'
      position: 1279675
  trait_info:
    ontology:
    - EFO_0000326
    reported_trait_name: Glioblastoma
    standard_trait_name: central nervous system cancer
- association_info:
    ancestry:
    - European=24381
    gwas_catalog_id: GCST004349
    neg_log_pval: 73.09691001300806
    otg_id: GCST004349
    pubmed_id: '28346443'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dopamine transporter inhibitor drug ARMODAFINIL is Phase II for
        the indiciation EFO_0000326 and targets the gene ENSG00000142319 at this locus
        (113119bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000142319
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 1279790
    locus_GRCh38:
      chromosome: '5'
      position: 1279675
  trait_info:
    ontology:
    - EFO_0000326
    reported_trait_name: Glioblastoma
    standard_trait_name: central nervous system cancer
- association_info:
    ancestry:
    - European=24009
    gwas_catalog_id: GCST004348
    neg_log_pval: 16.0
    otg_id: GCST004348
    pubmed_id: '28346443'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dopamine transporter inhibitor drug ARMODAFINIL is Phase II for
        the indiciation EFO_0000326 and targets the gene ENSG00000142319 at this locus
        (113119bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000142319
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 1279790
    locus_GRCh38:
      chromosome: '5'
      position: 1279675
  trait_info:
    ontology:
    - EFO_0000326
    reported_trait_name: Non-glioblastoma glioma
    standard_trait_name: central nervous system cancer
- association_info:
    ancestry:
    - European=22627
    gwas_catalog_id: GCST001937
    neg_log_pval: 8.154901959985743
    otg_id: GCST001937
    pubmed_id: '23535729'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dopamine transporter inhibitor drug METHYLPHENIDATE is Phase II
        for the indiciation EFO_0000305 and targets the gene ENSG00000142319 at this
        locus (113119bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000142319
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 1279790
    locus_GRCh38:
      chromosome: '5'
      position: 1279675
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=15566
    gwas_catalog_id: GCST005075
    neg_log_pval: 15.397940008672037
    otg_id: GCST005075
    pubmed_id: '29058716'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Telomerase reverse transcriptase inhibitor drug IMETELSTAT SODIUM
        is Phase II for the indiciation EFO_0000305 and targets the gene ENSG00000164362
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000164362
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 1279790
    locus_GRCh38:
      chromosome: '5'
      position: 1279675
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast Cancer in BRCA1 mutation carriers
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=24009
    gwas_catalog_id: GCST004348
    neg_log_pval: 16.0
    otg_id: GCST004348
    pubmed_id: '28346443'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Dopamine transporter releasing agent drug DEXTROAMPHETAMINE is
        Phase III for the indiciation EFO_0000326 and targets the gene ENSG00000142319
        at this locus (113119bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000142319
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 1279790
    locus_GRCh38:
      chromosome: '5'
      position: 1279675
  trait_info:
    ontology:
    - EFO_0000326
    reported_trait_name: Non-glioblastoma glioma
    standard_trait_name: central nervous system cancer
- association_info:
    ancestry:
    - European=30659
    gwas_catalog_id: GCST004347
    neg_log_pval: 65.52287874528034
    otg_id: GCST004347
    pubmed_id: '28346443'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dopamine transporter inhibitor drug ARMODAFINIL is Phase II for
        the indiciation EFO_0000326 and targets the gene ENSG00000142319 at this locus
        (113119bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000142319
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 1279790
    locus_GRCh38:
      chromosome: '5'
      position: 1279675
  trait_info:
    ontology:
    - EFO_0000326
    reported_trait_name: Glioma
    standard_trait_name: central nervous system cancer
- association_info:
    ancestry:
    - European=139274
    gwas_catalog_id: GCST004988
    neg_log_pval: 16.10874138309586
    otg_id: GCST004988
    pubmed_id: '29059683'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dopamine transporter inhibitor drug METHYLPHENIDATE is Phase II
        for the indiciation EFO_0000305 and targets the gene ENSG00000142319 at this
        locus (113119bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000142319
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 1279790
    locus_GRCh38:
      chromosome: '5'
      position: 1279675
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=11582
    gwas_catalog_id: GCST003228
    neg_log_pval: 19.397940008672037
    otg_id: GCST003228
    pubmed_id: '26424050'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dopamine transporter inhibitor drug ARMODAFINIL is Phase II for
        the indiciation EFO_0000326 and targets the gene ENSG00000142319 at this locus
        (113119bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000142319
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 1279790
    locus_GRCh38:
      chromosome: '5'
      position: 1279675
  trait_info:
    ontology:
    - EFO_0000326
    reported_trait_name: Glioma
    standard_trait_name: central nervous system cancer
- association_info:
    ancestry:
    - European=22627
    gwas_catalog_id: GCST001937
    neg_log_pval: 8.154901959985743
    otg_id: GCST001937
    pubmed_id: '23535729'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Telomerase reverse transcriptase inhibitor drug IMETELSTAT SODIUM
        is Phase II for the indiciation EFO_0000305 and targets the gene ENSG00000164362
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000164362
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 1279790
    locus_GRCh38:
      chromosome: '5'
      position: 1279675
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=63347
    gwas_catalog_id: GCST004415
    neg_log_pval: 7.522878745280337
    otg_id: GCST004415
    pubmed_id: '28346442'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dopamine transporter inhibitor drug MODAFINIL is Phase II for the
        indiciation EFO_0001075 and targets the gene ENSG00000142319 at this locus
        (113119bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000142319
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 1279790
    locus_GRCh38:
      chromosome: '5'
      position: 1279675
  trait_info:
    ontology:
    - EFO_0001075
    reported_trait_name: Invasive epithelial ovarian cancer
    standard_trait_name: ovarian carcinoma
- association_info:
    ancestry:
    - European=39387
    gwas_catalog_id: GCST001930
    neg_log_pval: 11.301029995663981
    otg_id: GCST001930
    pubmed_id: '23535733'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Telomerase reverse transcriptase inhibitor drug IMETELSTAT SODIUM
        is Phase II for the indiciation EFO_0000305 and targets the gene ENSG00000164362
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000164362
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 1279790
    locus_GRCh38:
      chromosome: '5'
      position: 1279675
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=39387
    gwas_catalog_id: GCST001930
    neg_log_pval: 11.301029995663981
    otg_id: GCST001930
    pubmed_id: '23535733'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dopamine transporter inhibitor drug METHYLPHENIDATE is Phase II
        for the indiciation EFO_0000305 and targets the gene ENSG00000142319 at this
        locus (113119bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000142319
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 1279790
    locus_GRCh38:
      chromosome: '5'
      position: 1279675
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=139274
    gwas_catalog_id: GCST004988
    neg_log_pval: 16.10874138309586
    otg_id: GCST004988
    pubmed_id: '29059683'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Telomerase reverse transcriptase inhibitor drug IMETELSTAT SODIUM
        is Phase II for the indiciation EFO_0000305 and targets the gene ENSG00000164362
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000164362
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 1279790
    locus_GRCh38:
      chromosome: '5'
      position: 1279675
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=15566
    gwas_catalog_id: GCST005075
    neg_log_pval: 15.397940008672037
    otg_id: GCST005075
    pubmed_id: '29058716'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dopamine transporter inhibitor drug METHYLPHENIDATE is Phase II
        for the indiciation EFO_0000305 and targets the gene ENSG00000142319 at this
        locus (113119bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000142319
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 1279790
    locus_GRCh38:
      chromosome: '5'
      position: 1279675
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast Cancer in BRCA1 mutation carriers
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=11582
    gwas_catalog_id: GCST003228
    neg_log_pval: 19.397940008672037
    otg_id: GCST003228
    pubmed_id: '26424050'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Dopamine transporter releasing agent drug DEXTROAMPHETAMINE is
        Phase III for the indiciation EFO_0000326 and targets the gene ENSG00000142319
        at this locus (113119bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000142319
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 1279790
    locus_GRCh38:
      chromosome: '5'
      position: 1279675
  trait_info:
    ontology:
    - EFO_0000326
    reported_trait_name: Glioma
    standard_trait_name: central nervous system cancer
- association_info:
    ancestry:
    - European=33864
    gwas_catalog_id: GCST004950
    neg_log_pval: 8.0
    otg_id: GCST004950
    pubmed_id: '25751625'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Telomerase reverse transcriptase inhibitor drug IMETELSTAT SODIUM
        is Phase II for the indiciation EFO_0000305 and targets the gene ENSG00000164362
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000164362
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 1279790
    locus_GRCh38:
      chromosome: '5'
      position: 1279675
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - African American or Afro-Caribbean=3749
    - European=5388
    gwas_catalog_id: GCST001298
    neg_log_pval: 10.0
    otg_id: GCST001298
    pubmed_id: '22037553'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dopamine transporter inhibitor drug METHYLPHENIDATE is Phase II
        for the indiciation EFO_0000305 and targets the gene ENSG00000142319 at this
        locus (113119bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000142319
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 1279790
    locus_GRCh38:
      chromosome: '5'
      position: 1279675
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=140254
    gwas_catalog_id: GCST006085
    neg_log_pval: 51.39794000867204
    otg_id: GCST006085
    pubmed_id: '29892016'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dopamine transporter inhibitor drug METHYLPHENIDATE is Phase II
        for the indiciation EFO_0001663 and targets the gene ENSG00000142319 at this
        locus (112882bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000142319
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 1280028
    locus_GRCh38:
      chromosome: '5'
      position: 1279913
  trait_info:
    ontology:
    - EFO_0001663
    reported_trait_name: Prostate cancer
    standard_trait_name: prostate carcinoma
- association_info:
    ancestry:
    - European=19291
    gwas_catalog_id: GCST003845
    neg_log_pval: 27.096910013008056
    otg_id: GCST003845
    pubmed_id: '27117709'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dopamine transporter inhibitor drug METHYLPHENIDATE is Phase II
        for the indiciation EFO_0000305 and targets the gene ENSG00000142319 at this
        locus (112882bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000142319
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 1280028
    locus_GRCh38:
      chromosome: '5'
      position: 1279913
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=19291
    gwas_catalog_id: GCST003845
    neg_log_pval: 27.096910013008056
    otg_id: GCST003845
    pubmed_id: '27117709'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Telomerase reverse transcriptase inhibitor drug IMETELSTAT SODIUM
        is Phase II for the indiciation EFO_0000305 and targets the gene ENSG00000164362
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000164362
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 1280028
    locus_GRCh38:
      chromosome: '5'
      position: 1279913
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=13560
    gwas_catalog_id: GCST001148
    neg_log_pval: 23.522878745280337
    otg_id: GCST001148
    pubmed_id: '21743467'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dopamine transporter inhibitor drug METHYLPHENIDATE is Phase II
        for the indiciation EFO_0001663 and targets the gene ENSG00000142319 at this
        locus (112882bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000142319
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 1280028
    locus_GRCh38:
      chromosome: '5'
      position: 1279913
  trait_info:
    ontology:
    - EFO_0001663
    reported_trait_name: Prostate cancer
    standard_trait_name: prostate carcinoma
- association_info:
    ancestry:
    - European=407770
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 8.411168274405792
    otg_id: SAIGE_191_1
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dopamine transporter inhibitor drug ARMODAFINIL is Phase II for
        the indiciation EFO_0000326 and targets the gene ENSG00000142319 at this locus
        (112079bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000142319
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 1280830
    locus_GRCh38:
      chromosome: '5'
      position: 1280715
  trait_info:
    ontology:
    - EFO_0000326
    reported_trait_name: Cancer of brain and nervous system
    standard_trait_name: central nervous system cancer
- association_info:
    ancestry:
    - European=407770
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 8.411168274405792
    otg_id: SAIGE_191_1
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Dopamine transporter releasing agent drug DEXTROAMPHETAMINE is
        Phase III for the indiciation EFO_0000326 and targets the gene ENSG00000142319
        at this locus (112079bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000142319
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 1280830
    locus_GRCh38:
      chromosome: '5'
      position: 1280715
  trait_info:
    ontology:
    - EFO_0000326
    reported_trait_name: Cancer of brain and nervous system
    standard_trait_name: central nervous system cancer
- association_info:
    ancestry:
    - European=19291
    gwas_catalog_id: GCST003845
    neg_log_pval: 7.522878745280337
    otg_id: GCST003845
    pubmed_id: '27117709'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dopamine transporter inhibitor drug METHYLPHENIDATE is Phase II
        for the indiciation EFO_0000305 and targets the gene ENSG00000142319 at this
        locus (110590bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000142319
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 1282319
    locus_GRCh38:
      chromosome: '5'
      position: 1282204
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=19291
    gwas_catalog_id: GCST003845
    neg_log_pval: 7.522878745280337
    otg_id: GCST003845
    pubmed_id: '27117709'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Telomerase reverse transcriptase inhibitor drug IMETELSTAT SODIUM
        is Phase II for the indiciation EFO_0000305 and targets the gene ENSG00000164362
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000164362
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 1282319
    locus_GRCh38:
      chromosome: '5'
      position: 1282204
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=123671
    gwas_catalog_id: GCST003588
    neg_log_pval: 9.698970004336019
    otg_id: GCST003588_2
    pubmed_id: '27197191'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dopamine transporter inhibitor drug MODAFINIL is Phase II for the
        indiciation EFO_0001075 and targets the gene ENSG00000142319 at this locus
        (110495bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000142319
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 1282414
    locus_GRCh38:
      chromosome: '5'
      position: 1282299
  trait_info:
    ontology:
    - EFO_0001075
    reported_trait_name: Cancer (pleiotropy) [subset analysis]
    standard_trait_name: ovarian carcinoma
- association_info:
    ancestry:
    - European=123671
    gwas_catalog_id: GCST003588
    neg_log_pval: 9.698970004336019
    otg_id: GCST003588_2
    pubmed_id: '27197191'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dopamine transporter inhibitor drug METHYLPHENIDATE is Phase II
        for the indiciation EFO_0001663 and targets the gene ENSG00000142319 at this
        locus (110495bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000142319
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 1282414
    locus_GRCh38:
      chromosome: '5'
      position: 1282299
  trait_info:
    ontology:
    - EFO_0001663
    reported_trait_name: Cancer (pleiotropy) [subset analysis]
    standard_trait_name: prostate carcinoma
- association_info:
    ancestry:
    - European=123671
    gwas_catalog_id: GCST003588
    neg_log_pval: 9.698970004336019
    otg_id: GCST003588_2
    pubmed_id: '27197191'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dopamine transporter inhibitor drug METHYLPHENIDATE is Phase II
        for the indiciation EFO_0000305 and targets the gene ENSG00000142319 at this
        locus (110495bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000142319
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 1282414
    locus_GRCh38:
      chromosome: '5'
      position: 1282299
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Cancer (pleiotropy) [subset analysis]
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=123671
    gwas_catalog_id: GCST003588
    neg_log_pval: 9.698970004336019
    otg_id: GCST003588_2
    pubmed_id: '27197191'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Dopamine transporter inhibitor drug BUPROPION is Phase III for
        the indiciation EFO_0001071 and targets the gene ENSG00000142319 at this locus
        (110495bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000142319
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 1282414
    locus_GRCh38:
      chromosome: '5'
      position: 1282299
  trait_info:
    ontology:
    - EFO_0001071
    reported_trait_name: Cancer (pleiotropy) [subset analysis]
    standard_trait_name: lung carcinoma
- association_info:
    ancestry:
    - European=123671
    gwas_catalog_id: GCST003588
    neg_log_pval: 9.698970004336019
    otg_id: GCST003588_2
    pubmed_id: '27197191'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Telomerase reverse transcriptase inhibitor drug IMETELSTAT SODIUM
        is Phase II for the indiciation EFO_0000305 and targets the gene ENSG00000164362
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000164362
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 1282414
    locus_GRCh38:
      chromosome: '5'
      position: 1282299
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Cancer (pleiotropy) [subset analysis]
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=7541
    gwas_catalog_id: GCST002890
    neg_log_pval: 10.522878745280337
    otg_id: GCST002890
    pubmed_id: '25939597'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dopamine transporter inhibitor drug METHYLPHENIDATE is Phase II
        for the indiciation EFO_0001663 and targets the gene ENSG00000142319 at this
        locus (110495bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000142319
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 1282414
    locus_GRCh38:
      chromosome: '5'
      position: 1282299
  trait_info:
    ontology:
    - EFO_0001663
    reported_trait_name: Prostate cancer
    standard_trait_name: prostate carcinoma
- association_info:
    ancestry:
    - European=291407
    gwas_catalog_id: GCST004142
    neg_log_pval: 11.154901959985743
    otg_id: GCST004142
    pubmed_id: '28212542'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dopamine transporter inhibitor drug MODAFINIL is Phase II for the
        indiciation EFO_0000756 and targets the gene ENSG00000142319 at this locus
        (108257bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000142319
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 1284653
    locus_GRCh38:
      chromosome: '5'
      position: 1284538
  trait_info:
    ontology:
    - EFO_0000756
    reported_trait_name: Melanoma
    standard_trait_name: melanoma
- association_info:
    ancestry:
    - European=63347
    gwas_catalog_id: GCST004415
    neg_log_pval: 9.154901959985743
    otg_id: GCST004415
    pubmed_id: '28346442'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dopamine transporter inhibitor drug MODAFINIL is Phase II for the
        indiciation EFO_0001075 and targets the gene ENSG00000142319 at this locus
        (106936bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000142319
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 1285974
    locus_GRCh38:
      chromosome: '5'
      position: 1285859
  trait_info:
    ontology:
    - EFO_0001075
    reported_trait_name: Invasive epithelial ovarian cancer
    standard_trait_name: ovarian carcinoma
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 7.383947958952672
    otg_id: NEALE2_20002_1438
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Telomerase reverse transcriptase inhibitor drug IMETELSTAT is Phase
        II for the indiciation EFO_0002429 and targets the gene ENSG00000164362 at
        this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000164362
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 1285974
    locus_GRCh38:
      chromosome: '5'
      position: 1285859
  trait_info:
    ontology:
    - EFO_0002429
    reported_trait_name: Polycythaemia vera | non-cancer illness code, self-reported
    standard_trait_name: polycythemia vera
- association_info:
    ancestry:
    - East Asian=5408
    gwas_catalog_id: GCST001140
    neg_log_pval: 27.0
    otg_id: GCST001140
    pubmed_id: '21725308'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Dopamine transporter inhibitor drug BUPROPION is Phase III for
        the indiciation EFO_0001071 and targets the gene ENSG00000142319 at this locus
        (106394bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000142319
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 1286516
    locus_GRCh38:
      chromosome: '5'
      position: 1286401
  trait_info:
    ontology:
    - EFO_0001071
    reported_trait_name: Lung cancer
    standard_trait_name: lung carcinoma
- association_info:
    ancestry:
    - European=4773
    gwas_catalog_id: GCST001194
    neg_log_pval: 8.154901959985743
    otg_id: GCST001194
    pubmed_id: '21827660'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Dopamine transporter releasing agent drug DEXTROAMPHETAMINE is
        Phase III for the indiciation EFO_0000326 and targets the gene ENSG00000142319
        at this locus (106394bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000142319
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 1286516
    locus_GRCh38:
      chromosome: '5'
      position: 1286401
  trait_info:
    ontology:
    - EFO_0000326
    reported_trait_name: Glioma
    standard_trait_name: central nervous system cancer
- association_info:
    ancestry:
    - European=11582
    gwas_catalog_id: GCST001058
    neg_log_pval: 14.0
    otg_id: GCST001058
    pubmed_id: '21531791'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dopamine transporter inhibitor drug ARMODAFINIL is Phase II for
        the indiciation EFO_0000326 and targets the gene ENSG00000142319 at this locus
        (106394bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000142319
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 1286516
    locus_GRCh38:
      chromosome: '5'
      position: 1286401
  trait_info:
    ontology:
    - EFO_0000326
    reported_trait_name: Glioma
    standard_trait_name: central nervous system cancer
- association_info:
    ancestry:
    - European=7608
    gwas_catalog_id: GCST002474
    neg_log_pval: 15.0
    otg_id: GCST002474
    pubmed_id: '24908248'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dopamine transporter inhibitor drug ARMODAFINIL is Phase II for
        the indiciation EFO_0000326 and targets the gene ENSG00000142319 at this locus
        (106394bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000142319
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 1286516
    locus_GRCh38:
      chromosome: '5'
      position: 1286401
  trait_info:
    ontology:
    - EFO_0000326
    reported_trait_name: Glioma (high-grade)
    standard_trait_name: central nervous system cancer
- association_info:
    ancestry:
    - European=5548
    gwas_catalog_id: GCST000439
    neg_log_pval: 16.69897000433602
    otg_id: GCST000439
    pubmed_id: '19578367'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Dopamine transporter releasing agent drug DEXTROAMPHETAMINE is
        Phase III for the indiciation EFO_0000326 and targets the gene ENSG00000142319
        at this locus (106394bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000142319
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 1286516
    locus_GRCh38:
      chromosome: '5'
      position: 1286401
  trait_info:
    ontology:
    - EFO_0000326
    reported_trait_name: Glioma
    standard_trait_name: central nervous system cancer
- association_info:
    ancestry:
    - East Asian=10054
    gwas_catalog_id: GCST001740
    neg_log_pval: 26.397940008672037
    otg_id: GCST001740
    pubmed_id: '23143601'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Dopamine transporter inhibitor drug BUPROPION is Phase III for
        the indiciation EFO_0001071 and targets the gene ENSG00000142319 at this locus
        (106394bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000142319
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 1286516
    locus_GRCh38:
      chromosome: '5'
      position: 1286401
  trait_info:
    ontology:
    - EFO_0001071
    reported_trait_name: Lung cancer
    standard_trait_name: lung carcinoma
- association_info:
    ancestry:
    - European=4773
    gwas_catalog_id: GCST001194
    neg_log_pval: 8.154901959985743
    otg_id: GCST001194
    pubmed_id: '21827660'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dopamine transporter inhibitor drug ARMODAFINIL is Phase II for
        the indiciation EFO_0000326 and targets the gene ENSG00000142319 at this locus
        (106394bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000142319
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 1286516
    locus_GRCh38:
      chromosome: '5'
      position: 1286401
  trait_info:
    ontology:
    - EFO_0000326
    reported_trait_name: Glioma
    standard_trait_name: central nervous system cancer
- association_info:
    ancestry:
    - European=6811
    gwas_catalog_id: GCST001633
    neg_log_pval: 8.397940008672037
    otg_id: GCST001633
    pubmed_id: '22886559'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dopamine transporter inhibitor drug ARMODAFINIL is Phase II for
        the indiciation EFO_0000326 and targets the gene ENSG00000142319 at this locus
        (106394bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000142319
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 1286516
    locus_GRCh38:
      chromosome: '5'
      position: 1286401
  trait_info:
    ontology:
    - EFO_0000326
    reported_trait_name: Glioma
    standard_trait_name: central nervous system cancer
- association_info:
    ancestry:
    - European=7608
    gwas_catalog_id: GCST002474
    neg_log_pval: 15.0
    otg_id: GCST002474
    pubmed_id: '24908248'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Dopamine transporter releasing agent drug DEXTROAMPHETAMINE is
        Phase III for the indiciation EFO_0000326 and targets the gene ENSG00000142319
        at this locus (106394bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000142319
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 1286516
    locus_GRCh38:
      chromosome: '5'
      position: 1286401
  trait_info:
    ontology:
    - EFO_0000326
    reported_trait_name: Glioma (high-grade)
    standard_trait_name: central nervous system cancer
- association_info:
    ancestry:
    - European=5548
    gwas_catalog_id: GCST000439
    neg_log_pval: 16.69897000433602
    otg_id: GCST000439
    pubmed_id: '19578367'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dopamine transporter inhibitor drug ARMODAFINIL is Phase II for
        the indiciation EFO_0000326 and targets the gene ENSG00000142319 at this locus
        (106394bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000142319
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 1286516
    locus_GRCh38:
      chromosome: '5'
      position: 1286401
  trait_info:
    ontology:
    - EFO_0000326
    reported_trait_name: Glioma
    standard_trait_name: central nervous system cancer
- association_info:
    ancestry:
    - European=11582
    gwas_catalog_id: GCST001058
    neg_log_pval: 14.0
    otg_id: GCST001058
    pubmed_id: '21531791'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Dopamine transporter releasing agent drug DEXTROAMPHETAMINE is
        Phase III for the indiciation EFO_0000326 and targets the gene ENSG00000142319
        at this locus (106394bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000142319
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 1286516
    locus_GRCh38:
      chromosome: '5'
      position: 1286401
  trait_info:
    ontology:
    - EFO_0000326
    reported_trait_name: Glioma
    standard_trait_name: central nervous system cancer
- association_info:
    ancestry:
    - European=6811
    gwas_catalog_id: GCST001633
    neg_log_pval: 8.397940008672037
    otg_id: GCST001633
    pubmed_id: '22886559'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Dopamine transporter releasing agent drug DEXTROAMPHETAMINE is
        Phase III for the indiciation EFO_0000326 and targets the gene ENSG00000142319
        at this locus (106394bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000142319
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 1286516
    locus_GRCh38:
      chromosome: '5'
      position: 1286401
  trait_info:
    ontology:
    - EFO_0000326
    reported_trait_name: Glioma
    standard_trait_name: central nervous system cancer
- association_info:
    ancestry:
    - African American or Afro-Caribbean=5339
    gwas_catalog_id: GCST003775
    neg_log_pval: 8.522878745280337
    otg_id: GCST003775
    pubmed_id: '27393504'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Dopamine transporter inhibitor drug BUPROPION is Phase III for
        the indiciation EFO_0001071 and targets the gene ENSG00000142319 at this locus
        (105715bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000142319
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 1287194
    locus_GRCh38:
      chromosome: '5'
      position: 1287079
  trait_info:
    ontology:
    - EFO_0001071
    reported_trait_name: Lung cancer
    standard_trait_name: lung carcinoma
- association_info:
    ancestry:
    - European=5548
    gwas_catalog_id: GCST000439
    neg_log_pval: 13.397940008672037
    otg_id: GCST000439
    pubmed_id: '19578367'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Dopamine transporter releasing agent drug DEXTROAMPHETAMINE is
        Phase III for the indiciation EFO_0000326 and targets the gene ENSG00000142319
        at this locus (104363bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000142319
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 1288547
    locus_GRCh38:
      chromosome: '5'
      position: 1288432
  trait_info:
    ontology:
    - EFO_0000326
    reported_trait_name: Glioma
    standard_trait_name: central nervous system cancer
- association_info:
    ancestry:
    - European=5548
    gwas_catalog_id: GCST000439
    neg_log_pval: 13.397940008672037
    otg_id: GCST000439
    pubmed_id: '19578367'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dopamine transporter inhibitor drug ARMODAFINIL is Phase II for
        the indiciation EFO_0000326 and targets the gene ENSG00000142319 at this locus
        (104363bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000142319
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 1288547
    locus_GRCh38:
      chromosome: '5'
      position: 1288432
  trait_info:
    ontology:
    - EFO_0000326
    reported_trait_name: Glioma
    standard_trait_name: central nervous system cancer
- association_info:
    ancestry:
    - European=139274
    gwas_catalog_id: GCST004988
    neg_log_pval: 20.392866795608434
    otg_id: GCST004988
    pubmed_id: '29059683'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Telomerase reverse transcriptase inhibitor drug IMETELSTAT SODIUM
        is Phase II for the indiciation EFO_0000305 and targets the gene ENSG00000164362
        at this locus (166bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000164362
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 1295349
    locus_GRCh38:
      chromosome: '5'
      position: 1295234
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=139274
    gwas_catalog_id: GCST004988
    neg_log_pval: 20.392866795608434
    otg_id: GCST004988
    pubmed_id: '29059683'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dopamine transporter inhibitor drug METHYLPHENIDATE is Phase II
        for the indiciation EFO_0000305 and targets the gene ENSG00000142319 at this
        locus (97561bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000142319
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 1295349
    locus_GRCh38:
      chromosome: '5'
      position: 1295234
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=19291
    gwas_catalog_id: GCST003845
    neg_log_pval: 13.522878745280337
    otg_id: GCST003845
    pubmed_id: '27117709'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dopamine transporter inhibitor drug METHYLPHENIDATE is Phase II
        for the indiciation EFO_0000305 and targets the gene ENSG00000142319 at this
        locus (95422bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000142319
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 1297488
    locus_GRCh38:
      chromosome: '5'
      position: 1297373
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=33864
    gwas_catalog_id: GCST004950
    neg_log_pval: 8.698970004336019
    otg_id: GCST004950
    pubmed_id: '25751625'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Telomerase reverse transcriptase inhibitor drug IMETELSTAT SODIUM
        is Phase II for the indiciation EFO_0000305 and targets the gene ENSG00000164362
        at this locus (2305bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000164362
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 1297488
    locus_GRCh38:
      chromosome: '5'
      position: 1297373
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=33864
    gwas_catalog_id: GCST004950
    neg_log_pval: 8.698970004336019
    otg_id: GCST004950
    pubmed_id: '25751625'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dopamine transporter inhibitor drug METHYLPHENIDATE is Phase II
        for the indiciation EFO_0000305 and targets the gene ENSG00000142319 at this
        locus (95422bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000142319
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 1297488
    locus_GRCh38:
      chromosome: '5'
      position: 1297373
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=19291
    gwas_catalog_id: GCST003845
    neg_log_pval: 13.522878745280337
    otg_id: GCST003845
    pubmed_id: '27117709'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Telomerase reverse transcriptase inhibitor drug IMETELSTAT SODIUM
        is Phase II for the indiciation EFO_0000305 and targets the gene ENSG00000164362
        at this locus (2305bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000164362
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 1297488
    locus_GRCh38:
      chromosome: '5'
      position: 1297373
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=3390
    gwas_catalog_id: GCST000459
    neg_log_pval: 8.522878745280337
    otg_id: GCST000459
    pubmed_id: '19654303'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Dopamine transporter inhibitor drug BUPROPION is Phase III for
        the indiciation EFO_0001071 and targets the gene ENSG00000142319 at this locus
        (77250bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000142319
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 1315660
    locus_GRCh38:
      chromosome: '5'
      position: 1315545
  trait_info:
    ontology:
    - EFO_0001071
    reported_trait_name: Lung cancer
    standard_trait_name: lung carcinoma
- association_info:
    ancestry:
    - European=40187
    gwas_catalog_id: GCST004749
    neg_log_pval: 16.522878745280337
    otg_id: GCST004749
    pubmed_id: '28604730'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Dopamine transporter inhibitor drug BUPROPION is Phase III for
        the indiciation EFO_0001071 and targets the gene ENSG00000142319 at this locus
        (72773bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000142319
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 1320136
    locus_GRCh38:
      chromosome: '5'
      position: 1320021
  trait_info:
    ontology:
    - EFO_0001071
    reported_trait_name: Lung cancer in ever smokers
    standard_trait_name: lung carcinoma
- association_info:
    ancestry:
    - European=85716
    gwas_catalog_id: GCST004748
    neg_log_pval: 31.69897000433602
    otg_id: GCST004748
    pubmed_id: '28604730'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Dopamine transporter inhibitor drug BUPROPION is Phase III for
        the indiciation EFO_0001071 and targets the gene ENSG00000142319 at this locus
        (72663bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000142319
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 1320247
    locus_GRCh38:
      chromosome: '5'
      position: 1320132
  trait_info:
    ontology:
    - EFO_0001071
    reported_trait_name: Lung cancer
    standard_trait_name: lung carcinoma
- association_info:
    ancestry:
    - European=10422
    gwas_catalog_id: GCST001267
    neg_log_pval: 7.522878745280337
    otg_id: GCST001267
    pubmed_id: '21983787'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dopamine transporter inhibitor drug MODAFINIL is Phase II for the
        indiciation EFO_0000756 and targets the gene ENSG00000142319 at this locus
        (70822bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000142319
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 1322087
    locus_GRCh38:
      chromosome: '5'
      position: 1321972
  trait_info:
    ontology:
    - EFO_0000756
    reported_trait_name: Melanoma
    standard_trait_name: melanoma
- association_info:
    ancestry:
    - European=10295
    gwas_catalog_id: GCST000257
    neg_log_pval: 8.096910013008056
    otg_id: GCST000257
    pubmed_id: '18978787'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Dopamine transporter inhibitor drug BUPROPION is Phase III for
        the indiciation EFO_0001071 and targets the gene ENSG00000142319 at this locus
        (70822bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000142319
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 1322087
    locus_GRCh38:
      chromosome: '5'
      position: 1321972
  trait_info:
    ontology:
    - EFO_0001071
    reported_trait_name: Lung cancer
    standard_trait_name: lung carcinoma
- association_info:
    ancestry:
    - European=314072
    neg_log_pval: 10.406891232219362
    otg_id: NEALE2_20107_3
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Dopamine transporter inhibitor drug BUPROPION is Phase III for
        the indiciation EFO_0001071 and targets the gene ENSG00000142319 at this locus
        (53019bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000142319
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 1339890
    locus_GRCh38:
      chromosome: '5'
      position: 1339775
  trait_info:
    ontology:
    - EFO_0001071
    reported_trait_name: Lung cancer | illnesses of father
    standard_trait_name: lung carcinoma
- association_info:
    ancestry:
    - European=360738
    neg_log_pval: 7.9587810673873625
    otg_id: NEALE2_1200
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Dopamine transporter inhibitor drug MODAFINIL is Phase IV for the
        indiciation EFO_0004698 and targets the gene ENSG00000142319 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000142319
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 1442979
    locus_GRCh38:
      chromosome: '5'
      position: 1442864
  trait_info:
    ontology:
    - EFO_0004698
    reported_trait_name: Sleeplessness / insomnia
    standard_trait_name: insomnia
- association_info:
    ancestry:
    - European=360738
    neg_log_pval: 7.9587810673873625
    otg_id: NEALE2_1200
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dopamine transporter inhibitor drug ARMODAFINIL is Phase II for
        the indiciation EFO_0004698 and targets the gene ENSG00000142319 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000142319
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 1442979
    locus_GRCh38:
      chromosome: '5'
      position: 1442864
  trait_info:
    ontology:
    - EFO_0004698
    reported_trait_name: Sleeplessness / insomnia
    standard_trait_name: insomnia
- association_info:
    ancestry:
    - East Asian=4969
    gwas_catalog_id: GCST000750
    neg_log_pval: 17.397940008672037
    otg_id: GCST000750
    pubmed_id: '20676098'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dopamine transporter inhibitor drug METHYLPHENIDATE is Phase II
        for the indiciation EFO_0001663 and targets the gene ENSG00000142319 at this
        locus (450275bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000142319
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 1895829
    locus_GRCh38:
      chromosome: '5'
      position: 1895715
  trait_info:
    ontology:
    - EFO_0001663
    reported_trait_name: Prostate cancer
    standard_trait_name: prostate carcinoma
- association_info:
    ancestry:
    - East Asian=7394
    gwas_catalog_id: GCST003148
    neg_log_pval: 11.698970004336019
    otg_id: GCST003148
    pubmed_id: '26443449'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Dopamine transporter inhibitor drug METHYLPHENIDATE is Phase II
        for the indiciation EFO_0001663 and targets the gene ENSG00000142319 at this
        locus (450275bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000142319
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 1895829
    locus_GRCh38:
      chromosome: '5'
      position: 1895715
  trait_info:
    ontology:
    - EFO_0001663
    reported_trait_name: Prostate cancer
    standard_trait_name: prostate carcinoma
- association_info:
    ancestry:
    - European, NR=45975
    gwas_catalog_id: GCST004133
    neg_log_pval: 8.104080454689985
    otg_id: GCST004133
    pubmed_id: '28067908'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Prostanoid EP4 receptor agonist drug RIVENPROST is Phase II for
        the indiciation EFO_0000729 and targets the gene ENSG00000171522 at this locus
        (332548bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000171522
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 40347469
    locus_GRCh38:
      chromosome: '5'
      position: 40347367
  trait_info:
    ontology:
    - EFO_0000729
    reported_trait_name: Ulcerative colitis
    standard_trait_name: ulcerative colitis
- association_info:
    ancestry:
    - European=27432
    gwas_catalog_id: GCST003045
    neg_log_pval: 11.43486084803021
    otg_id: GCST003045
    pubmed_id: '26192919'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Prostanoid EP4 receptor agonist drug RIVENPROST is Phase II for
        the indiciation EFO_0000729 and targets the gene ENSG00000171522 at this locus
        (265131bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000171522
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 40414886
    locus_GRCh38:
      chromosome: '5'
      position: 40414784
  trait_info:
    ontology:
    - EFO_0000729
    reported_trait_name: Ulcerative colitis [EA]
    standard_trait_name: ulcerative colitis
- association_info:
    ancestry:
    - European=86475
    gwas_catalog_id: GCST005537
    neg_log_pval: 74.0
    otg_id: GCST005537
    pubmed_id: '26974007'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Prostanoid EP4 receptor agonist drug RIVENPROST is Phase II for
        the indiciation EFO_0000729 and targets the gene ENSG00000171522 at this locus
        (265029bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000171522
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 40414989
    locus_GRCh38:
      chromosome: '5'
      position: 40414887
  trait_info:
    ontology:
    - EFO_0000729
    reported_trait_name: Chronic inflammatory diseases (ankylosing spondylitis, Crohn's
      disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
      [subset analysis]
    standard_trait_name: ulcerative colitis
- association_info:
    ancestry:
    - European=16753
    gwas_catalog_id: GCST003097
    neg_log_pval: 10.096910013008056
    otg_id: GCST003097
    pubmed_id: '26301688'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Prostanoid EP4 receptor agonist drug RIVENPROST is Phase II for
        the indiciation EFO_0000729 and targets the gene ENSG00000171522 at this locus
        (192747bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000171522
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 40487270
    locus_GRCh38:
      chromosome: '5'
      position: 40487168
  trait_info:
    ontology:
    - EFO_0000729
    reported_trait_name: Pediatric autoimmune diseases
    standard_trait_name: ulcerative colitis
- association_info:
    ancestry:
    - European=83129
    gwas_catalog_id: GCST006983
    neg_log_pval: 7.522878745280337
    otg_id: GCST006983
    pubmed_id: '30610198'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Growth hormone receptor agonist drug SOMATROPIN is Phase IV for
        the indiciation EFO_0003888 and targets the gene ENSG00000112964 at this locus
        (332768bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000112964
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 43054747
    locus_GRCh38:
      chromosome: '5'
      position: 43054645
  trait_info:
    ontology:
    - EFO_0003888
    reported_trait_name: Attention deficit hyperactivity disorder or cannabis use
    standard_trait_name: attention deficit hyperactivity disorder
- association_info:
    ancestry:
    - European=459000
    gwas_catalog_id: GCST007072
    neg_log_pval: 7.3979400086720375
    otg_id: GCST007072
    pubmed_id: '30595370'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Serotonin 1a (5-HT1a) receptor agonist drug ERGOLOID is Phase IV
        for the indiciation EFO_0000319 and targets the gene ENSG00000178394 at this
        locus (478140bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000178394
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 63736474
    locus_GRCh38:
      chromosome: '5'
      position: 64440647
  trait_info:
    ontology:
    - EFO_0000319
    reported_trait_name: Cardiovascular disease
    standard_trait_name: cardiovascular system disease
- association_info:
    ancestry:
    - European=408878
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 15.436518914605589
    otg_id: SAIGE_272_1
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: HMG-CoA reductase inhibitor drug ATORVASTATIN is Phase IV for the
        indiciation EFO_0003774 and targets the gene ENSG00000113161 at this locus
        (26934bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113161
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 74605220
    locus_GRCh38:
      chromosome: '5'
      position: 75309395
  trait_info:
    ontology:
    - EFO_0003774
    reported_trait_name: Hyperlipidemia
    standard_trait_name: hyperlipidemia
- association_info:
    ancestry:
    - European=406276
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 14.154901959985743
    otg_id: SAIGE_272_11
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: HMG-CoA reductase inhibitor drug PRAVASTATIN is Phase IV for the
        indiciation HP_0003124 and targets the gene ENSG00000113161 at this locus
        (26934bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113161
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 74605220
    locus_GRCh38:
      chromosome: '5'
      position: 75309395
  trait_info:
    ontology:
    - HP_0003124
    reported_trait_name: Hypercholesterolemia
    standard_trait_name: Hypercholesterolemia
- association_info:
    ancestry:
    - European=408961
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 15.410050398674292
    otg_id: SAIGE_272
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: HMG-CoA reductase inhibitor drug ATORVASTATIN is Phase IV for the
        indiciation Orphanet_309005 and targets the gene ENSG00000113161 at this locus
        (26934bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113161
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 74605220
    locus_GRCh38:
      chromosome: '5'
      position: 75309395
  trait_info:
    ontology:
    - Orphanet_309005
    reported_trait_name: Disorders of lipoid metabolism
    standard_trait_name: Disorder of lipid metabolism
- association_info:
    ancestry:
    - European=408961
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 15.410050398674292
    otg_id: SAIGE_272
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: HMG-CoA reductase inhibitor drug LOVASTATIN is Phase III for the
        indiciation Orphanet_309005 and targets the gene ENSG00000113161 at this locus
        (26934bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113161
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 74605220
    locus_GRCh38:
      chromosome: '5'
      position: 75309395
  trait_info:
    ontology:
    - Orphanet_309005
    reported_trait_name: Disorders of lipoid metabolism
    standard_trait_name: Disorder of lipid metabolism
- association_info:
    ancestry:
    - European=9618
    gwas_catalog_id: GCST004045
    neg_log_pval: 11.045757490560675
    otg_id: GCST004045
    pubmed_id: '27790247'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: HMG-CoA reductase inhibitor drug SIMVASTATIN is Phase II for the
        indiciation EFO_0000275 and targets the gene ENSG00000113161 at this locus
        (6667bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113161
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 74625487
    locus_GRCh38:
      chromosome: '5'
      position: 75329662
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Age-related diseases, mortality and associated endophenotypes
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=9618
    gwas_catalog_id: GCST004045
    neg_log_pval: 11.045757490560675
    otg_id: GCST004045
    pubmed_id: '27790247'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: HMG-CoA reductase inhibitor drug ATORVASTATIN is Phase IV for the
        indiciation EFO_0000712 and targets the gene ENSG00000113161 at this locus
        (6667bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113161
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 74625487
    locus_GRCh38:
      chromosome: '5'
      position: 75329662
  trait_info:
    ontology:
    - EFO_0000712
    reported_trait_name: Age-related diseases, mortality and associated endophenotypes
    standard_trait_name: cerebrovascular accident
- association_info:
    ancestry:
    - European=9618
    gwas_catalog_id: GCST004045
    neg_log_pval: 11.045757490560675
    otg_id: GCST004045
    pubmed_id: '27790247'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: HMG-CoA reductase inhibitor drug ATORVASTATIN is Phase IV for the
        indiciation EFO_0000275 and targets the gene ENSG00000113161 at this locus
        (6667bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113161
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 74625487
    locus_GRCh38:
      chromosome: '5'
      position: 75329662
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Age-related diseases, mortality and associated endophenotypes
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=9618
    gwas_catalog_id: GCST004045
    neg_log_pval: 11.045757490560675
    otg_id: GCST004045
    pubmed_id: '27790247'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: HMG-CoA reductase inhibitor drug ATORVASTATIN is Phase II for the
        indiciation EFO_0000311 and targets the gene ENSG00000113161 at this locus
        (6667bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113161
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 74625487
    locus_GRCh38:
      chromosome: '5'
      position: 75329662
  trait_info:
    ontology:
    - EFO_0000311
    reported_trait_name: Age-related diseases, mortality and associated endophenotypes
    standard_trait_name: cancer
- association_info:
    ancestry:
    - European=9618
    gwas_catalog_id: GCST004045
    neg_log_pval: 11.045757490560675
    otg_id: GCST004045
    pubmed_id: '27790247'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: HMG-CoA reductase inhibitor drug PRAVASTATIN is Phase IV for the
        indiciation EFO_0003144 and targets the gene ENSG00000113161 at this locus
        (6667bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113161
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 74625487
    locus_GRCh38:
      chromosome: '5'
      position: 75329662
  trait_info:
    ontology:
    - EFO_0003144
    reported_trait_name: Age-related diseases, mortality and associated endophenotypes
    standard_trait_name: heart failure
- association_info:
    ancestry:
    - European=9618
    gwas_catalog_id: GCST004045
    neg_log_pval: 11.045757490560675
    otg_id: GCST004045
    pubmed_id: '27790247'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: HMG-CoA reductase inhibitor drug ROSUVASTATIN is Phase IV for the
        indiciation EFO_0000400 and targets the gene ENSG00000113161 at this locus
        (6667bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113161
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 74625487
    locus_GRCh38:
      chromosome: '5'
      position: 75329662
  trait_info:
    ontology:
    - EFO_0000400
    reported_trait_name: Age-related diseases, mortality and associated endophenotypes
    standard_trait_name: diabetes mellitus
- association_info:
    ancestry:
    - European=9618
    gwas_catalog_id: GCST004045
    neg_log_pval: 11.045757490560675
    otg_id: GCST004045
    pubmed_id: '27790247'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: HMG-CoA reductase inhibitor drug ROSUVASTATIN is Phase IV for the
        indiciation EFO_0001645 and targets the gene ENSG00000113161 at this locus
        (6667bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113161
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 74625487
    locus_GRCh38:
      chromosome: '5'
      position: 75329662
  trait_info:
    ontology:
    - EFO_0001645
    reported_trait_name: Age-related diseases, mortality and associated endophenotypes
    standard_trait_name: coronary heart disease
- association_info:
    ancestry:
    - European=459000
    gwas_catalog_id: GCST007072
    neg_log_pval: 8.301029995663981
    otg_id: GCST007072
    pubmed_id: '30595370'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: HMG-CoA reductase inhibitor drug PRAVASTATIN is Phase IV for the
        indiciation EFO_0000319 and targets the gene ENSG00000113161 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113161
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 74656539
    locus_GRCh38:
      chromosome: '5'
      position: 75360714
  trait_info:
    ontology:
    - EFO_0000319
    reported_trait_name: Cardiovascular disease
    standard_trait_name: cardiovascular system disease
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 42.19124767849288
    otg_id: NEALE2_20002_1473
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: HMG-CoA reductase inhibitor drug ROSUVASTATIN is Phase IV for the
        indiciation HP_0003124 and targets the gene ENSG00000113161 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113161
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 74656539
    locus_GRCh38:
      chromosome: '5'
      position: 75360714
  trait_info:
    ontology:
    - HP_0003124
    reported_trait_name: High cholesterol | non-cancer illness code, self-reported
    standard_trait_name: Hypercholesterolemia
- association_info:
    ancestry:
    - European=9618
    gwas_catalog_id: GCST004045
    neg_log_pval: 7.698970004336019
    otg_id: GCST004045
    pubmed_id: '27790247'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: HMG-CoA reductase inhibitor drug SIMVASTATIN is Phase II for the
        indiciation EFO_0000275 and targets the gene ENSG00000113161 at this locus
        (101258bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113161
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 74759183
    locus_GRCh38:
      chromosome: '5'
      position: 75463358
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Age-related diseases, mortality and associated endophenotypes
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=9618
    gwas_catalog_id: GCST004045
    neg_log_pval: 7.698970004336019
    otg_id: GCST004045
    pubmed_id: '27790247'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: HMG-CoA reductase inhibitor drug ATORVASTATIN is Phase IV for the
        indiciation EFO_0001645 and targets the gene ENSG00000113161 at this locus
        (101258bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113161
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 74759183
    locus_GRCh38:
      chromosome: '5'
      position: 75463358
  trait_info:
    ontology:
    - EFO_0001645
    reported_trait_name: Age-related diseases, mortality and associated endophenotypes
    standard_trait_name: coronary heart disease
- association_info:
    ancestry:
    - European=9618
    gwas_catalog_id: GCST004045
    neg_log_pval: 7.698970004336019
    otg_id: GCST004045
    pubmed_id: '27790247'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: HMG-CoA reductase inhibitor drug ATORVASTATIN is Phase IV for the
        indiciation EFO_0000275 and targets the gene ENSG00000113161 at this locus
        (101258bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113161
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 74759183
    locus_GRCh38:
      chromosome: '5'
      position: 75463358
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Age-related diseases, mortality and associated endophenotypes
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=9618
    gwas_catalog_id: GCST004045
    neg_log_pval: 7.698970004336019
    otg_id: GCST004045
    pubmed_id: '27790247'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: HMG-CoA reductase inhibitor drug ATORVASTATIN is Phase IV for the
        indiciation EFO_0000400 and targets the gene ENSG00000113161 at this locus
        (101258bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113161
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 74759183
    locus_GRCh38:
      chromosome: '5'
      position: 75463358
  trait_info:
    ontology:
    - EFO_0000400
    reported_trait_name: Age-related diseases, mortality and associated endophenotypes
    standard_trait_name: diabetes mellitus
- association_info:
    ancestry:
    - European=9618
    gwas_catalog_id: GCST004045
    neg_log_pval: 7.698970004336019
    otg_id: GCST004045
    pubmed_id: '27790247'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: HMG-CoA reductase inhibitor drug SIMVASTATIN is Phase IV for the
        indiciation EFO_0000712 and targets the gene ENSG00000113161 at this locus
        (101258bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113161
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 74759183
    locus_GRCh38:
      chromosome: '5'
      position: 75463358
  trait_info:
    ontology:
    - EFO_0000712
    reported_trait_name: Age-related diseases, mortality and associated endophenotypes
    standard_trait_name: cerebrovascular accident
- association_info:
    ancestry:
    - European=9618
    gwas_catalog_id: GCST004045
    neg_log_pval: 7.698970004336019
    otg_id: GCST004045
    pubmed_id: '27790247'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: HMG-CoA reductase inhibitor drug ATORVASTATIN is Phase IV for the
        indiciation EFO_0003144 and targets the gene ENSG00000113161 at this locus
        (101258bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113161
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 74759183
    locus_GRCh38:
      chromosome: '5'
      position: 75463358
  trait_info:
    ontology:
    - EFO_0003144
    reported_trait_name: Age-related diseases, mortality and associated endophenotypes
    standard_trait_name: heart failure
- association_info:
    ancestry:
    - European=9618
    gwas_catalog_id: GCST004045
    neg_log_pval: 7.698970004336019
    otg_id: GCST004045
    pubmed_id: '27790247'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: HMG-CoA reductase inhibitor drug ATORVASTATIN is Phase II for the
        indiciation EFO_0000311 and targets the gene ENSG00000113161 at this locus
        (101258bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113161
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 74759183
    locus_GRCh38:
      chromosome: '5'
      position: 75463358
  trait_info:
    ontology:
    - EFO_0000311
    reported_trait_name: Age-related diseases, mortality and associated endophenotypes
    standard_trait_name: cancer
- association_info:
    ancestry:
    - European=9618
    gwas_catalog_id: GCST004045
    neg_log_pval: 7.522878745280337
    otg_id: GCST004045
    pubmed_id: '27790247'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: HMG-CoA reductase inhibitor drug ATORVASTATIN is Phase IV for the
        indiciation EFO_0001645 and targets the gene ENSG00000113161 at this locus
        (221964bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113161
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 74879890
    locus_GRCh38:
      chromosome: '5'
      position: 75584065
  trait_info:
    ontology:
    - EFO_0001645
    reported_trait_name: Age-related diseases, mortality and associated endophenotypes
    standard_trait_name: coronary heart disease
- association_info:
    ancestry:
    - European=9618
    gwas_catalog_id: GCST004045
    neg_log_pval: 7.522878745280337
    otg_id: GCST004045
    pubmed_id: '27790247'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: HMG-CoA reductase inhibitor drug ROSUVASTATIN is Phase IV for the
        indiciation EFO_0000275 and targets the gene ENSG00000113161 at this locus
        (221964bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113161
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 74879890
    locus_GRCh38:
      chromosome: '5'
      position: 75584065
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Age-related diseases, mortality and associated endophenotypes
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=9618
    gwas_catalog_id: GCST004045
    neg_log_pval: 7.522878745280337
    otg_id: GCST004045
    pubmed_id: '27790247'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: HMG-CoA reductase inhibitor drug ATORVASTATIN is Phase IV for the
        indiciation EFO_0000712 and targets the gene ENSG00000113161 at this locus
        (221964bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113161
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 74879890
    locus_GRCh38:
      chromosome: '5'
      position: 75584065
  trait_info:
    ontology:
    - EFO_0000712
    reported_trait_name: Age-related diseases, mortality and associated endophenotypes
    standard_trait_name: cerebrovascular accident
- association_info:
    ancestry:
    - European=9618
    gwas_catalog_id: GCST004045
    neg_log_pval: 7.522878745280337
    otg_id: GCST004045
    pubmed_id: '27790247'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: HMG-CoA reductase inhibitor drug SIMVASTATIN is Phase II for the
        indiciation EFO_0000275 and targets the gene ENSG00000113161 at this locus
        (221964bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113161
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 74879890
    locus_GRCh38:
      chromosome: '5'
      position: 75584065
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Age-related diseases, mortality and associated endophenotypes
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=9618
    gwas_catalog_id: GCST004045
    neg_log_pval: 7.522878745280337
    otg_id: GCST004045
    pubmed_id: '27790247'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: HMG-CoA reductase inhibitor drug PRAVASTATIN is Phase IV for the
        indiciation EFO_0003144 and targets the gene ENSG00000113161 at this locus
        (221964bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113161
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 74879890
    locus_GRCh38:
      chromosome: '5'
      position: 75584065
  trait_info:
    ontology:
    - EFO_0003144
    reported_trait_name: Age-related diseases, mortality and associated endophenotypes
    standard_trait_name: heart failure
- association_info:
    ancestry:
    - European=9618
    gwas_catalog_id: GCST004045
    neg_log_pval: 7.522878745280337
    otg_id: GCST004045
    pubmed_id: '27790247'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: HMG-CoA reductase inhibitor drug ATORVASTATIN is Phase II for the
        indiciation EFO_0000311 and targets the gene ENSG00000113161 at this locus
        (221964bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113161
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 74879890
    locus_GRCh38:
      chromosome: '5'
      position: 75584065
  trait_info:
    ontology:
    - EFO_0000311
    reported_trait_name: Age-related diseases, mortality and associated endophenotypes
    standard_trait_name: cancer
- association_info:
    ancestry:
    - European=9618
    gwas_catalog_id: GCST004045
    neg_log_pval: 7.522878745280337
    otg_id: GCST004045
    pubmed_id: '27790247'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: HMG-CoA reductase inhibitor drug ATORVASTATIN is Phase IV for the
        indiciation EFO_0000400 and targets the gene ENSG00000113161 at this locus
        (221964bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113161
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 74879890
    locus_GRCh38:
      chromosome: '5'
      position: 75584065
  trait_info:
    ontology:
    - EFO_0000400
    reported_trait_name: Age-related diseases, mortality and associated endophenotypes
    standard_trait_name: diabetes mellitus
- association_info:
    ancestry:
    - European=655666
    - South Asian=3650
    gwas_catalog_id: GCST006867
    neg_log_pval: 7.522878745280337
    otg_id: GCST006867
    pubmed_id: '30054458'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: HMG-CoA reductase inhibitor drug ROSUVASTATIN is Phase IV for the
        indiciation EFO_0001360 and targets the gene ENSG00000113161 at this locus
        (345752bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113161
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 75003678
    locus_GRCh38:
      chromosome: '5'
      position: 75707853
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    - South Asian, East Asian, African American or Afro-Caribbean, Hispanic or Latin
      American=153287
    gwas_catalog_id: GCST007515
    neg_log_pval: 14.698970004336019
    otg_id: GCST007515
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: HMG-CoA reductase inhibitor drug ROSUVASTATIN is Phase IV for the
        indiciation EFO_0001360 and targets the gene ENSG00000113161 at this locus
        (345752bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113161
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 75003678
    locus_GRCh38:
      chromosome: '5'
      position: 75707853
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    gwas_catalog_id: GCST007517
    neg_log_pval: 11.301029995663981
    otg_id: GCST007517
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: HMG-CoA reductase inhibitor drug ROSUVASTATIN is Phase IV for the
        indiciation EFO_0001360 and targets the gene ENSG00000113161 at this locus
        (345752bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113161
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 75003678
    locus_GRCh38:
      chromosome: '5'
      position: 75707853
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=204498
    gwas_catalog_id: GCST001953
    neg_log_pval: 11.522878745280337
    otg_id: GCST001953_4
    pubmed_id: '23563607'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: HMG-CoA reductase inhibitor drug ROSUVASTATIN is Phase III for
        the indiciation EFO_0001073 and targets the gene ENSG00000113161 at this locus
        (345752bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113161
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 75003678
    locus_GRCh38:
      chromosome: '5'
      position: 75707853
  trait_info:
    ontology:
    - EFO_0001073
    reported_trait_name: Obesity [Obesity class I]
    standard_trait_name: obesity
- association_info:
    ancestry:
    - European=204498
    gwas_catalog_id: GCST001953
    neg_log_pval: 8.397940008672037
    otg_id: GCST001953_3
    pubmed_id: '23563607'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: HMG-CoA reductase inhibitor drug ROSUVASTATIN is Phase III for
        the indiciation EFO_0001073 and targets the gene ENSG00000113161 at this locus
        (357316bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113161
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 75015242
    locus_GRCh38:
      chromosome: '5'
      position: 75719417
  trait_info:
    ontology:
    - EFO_0001073
    reported_trait_name: Obesity [Obesity class II]
    standard_trait_name: obesity
- association_info:
    ancestry:
    - European=204498
    gwas_catalog_id: GCST001953
    neg_log_pval: 8.0
    otg_id: GCST001953_5
    pubmed_id: '23563607'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: HMG-CoA reductase inhibitor drug ROSUVASTATIN is Phase III for
        the indiciation EFO_0001073 and targets the gene ENSG00000113161 at this locus
        (357316bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113161
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 75015242
    locus_GRCh38:
      chromosome: '5'
      position: 75719417
  trait_info:
    ontology:
    - EFO_0001073
    reported_trait_name: Obesity [Overweight]
    standard_trait_name: obesity
- association_info:
    ancestry:
    - European=116538
    gwas_catalog_id: GCST007564
    neg_log_pval: 19.0
    otg_id: GCST007564
    pubmed_id: '29785011'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug TEZEPELUMAB is Phase
        III for the indiciation EFO_0000270 and targets the gene ENSG00000145777 at
        this locus (262947bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 110142816
    locus_GRCh38:
      chromosome: '5'
      position: 110807116
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma or allergic disease (pleiotropy)
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=116538
    gwas_catalog_id: GCST007564
    neg_log_pval: 19.0
    otg_id: GCST007564
    pubmed_id: '29785011'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug AMG-157 is Phase II
        for the indiciation EFO_0000270 and targets the gene ENSG00000145777 at this
        locus (262947bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 110142816
    locus_GRCh38:
      chromosome: '5'
      position: 110807116
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma or allergic disease (pleiotropy)
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=102453
    gwas_catalog_id: GCST007563
    neg_log_pval: 19.69897000433602
    otg_id: GCST007563
    pubmed_id: '29785011'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug TEZEPELUMAB is Phase
        III for the indiciation EFO_0000270 and targets the gene ENSG00000145777 at
        this locus (262947bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 110142816
    locus_GRCh38:
      chromosome: '5'
      position: 110807116
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Allergic disease (asthma, hay fever or eczema)
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=102453
    gwas_catalog_id: GCST007563
    neg_log_pval: 19.69897000433602
    otg_id: GCST007563
    pubmed_id: '29785011'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug AMG-157 is Phase II
        for the indiciation EFO_0000270 and targets the gene ENSG00000145777 at this
        locus (262947bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 110142816
    locus_GRCh38:
      chromosome: '5'
      position: 110807116
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Allergic disease (asthma, hay fever or eczema)
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=401837
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 7.835647144215563
    otg_id: SAIGE_495
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug TEZEPELUMAB is Phase
        III for the indiciation EFO_0000270 and targets the gene ENSG00000145777 at
        this locus (246917bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 110158844
    locus_GRCh38:
      chromosome: '5'
      position: 110823145
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=401837
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 7.835647144215563
    otg_id: SAIGE_495
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug AMG-157 is Phase II
        for the indiciation EFO_0000270 and targets the gene ENSG00000145777 at this
        locus (246917bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 110158844
    locus_GRCh38:
      chromosome: '5'
      position: 110823145
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=91787
    neg_log_pval: 7.755663492560309
    otg_id: NEALE2_22127
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug AMG-157 is Phase II
        for the indiciation EFO_0000270 and targets the gene ENSG00000145777 at this
        locus (244289bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: CA
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 110161473
    locus_GRCh38:
      chromosome: '5'
      position: 110825774
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Doctor diagnosed asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=91787
    neg_log_pval: 7.755663492560309
    otg_id: NEALE2_22127
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug TEZEPELUMAB is Phase
        III for the indiciation EFO_0000270 and targets the gene ENSG00000145777 at
        this locus (244289bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: CA
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 110161473
    locus_GRCh38:
      chromosome: '5'
      position: 110825774
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Doctor diagnosed asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 17.72690377259096
    otg_id: NEALE2_20002_1111
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug AMG-157 is Phase II
        for the indiciation EFO_0000270 and targets the gene ENSG00000145777 at this
        locus (244289bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: CA
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 110161473
    locus_GRCh38:
      chromosome: '5'
      position: 110825774
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma | non-cancer illness code, self-reported
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 17.72690377259096
    otg_id: NEALE2_20002_1111
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug TEZEPELUMAB is Phase
        III for the indiciation EFO_0000270 and targets the gene ENSG00000145777 at
        this locus (244289bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: CA
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 110161473
    locus_GRCh38:
      chromosome: '5'
      position: 110825774
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma | non-cancer illness code, self-reported
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=360527
    neg_log_pval: 19.160999247384563
    otg_id: NEALE2_6152_8
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug AMG-157 is Phase II
        for the indiciation EFO_0000270 and targets the gene ENSG00000145777 at this
        locus (244289bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: CA
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 110161473
    locus_GRCh38:
      chromosome: '5'
      position: 110825774
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma | blood clot, dvt, bronchitis, emphysema, asthma,
      rhinitis, eczema, allergy diagnosed by doctor
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=72232
    neg_log_pval: 8.280520382028882
    otg_id: NEALE2_3761_raw
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug TEZEPELUMAB is Phase
        II for the indiciation EFO_0000274 and targets the gene ENSG00000145777 at
        this locus (244289bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: CA
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 110161473
    locus_GRCh38:
      chromosome: '5'
      position: 110825774
  trait_info:
    ontology:
    - EFO_0000274
    reported_trait_name: Age hay fever, rhinitis or eczema diagnosed
    standard_trait_name: atopic eczema
- association_info:
    ancestry:
    - European=360527
    neg_log_pval: 19.160999247384563
    otg_id: NEALE2_6152_8
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug TEZEPELUMAB is Phase
        III for the indiciation EFO_0000270 and targets the gene ENSG00000145777 at
        this locus (244289bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: CA
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 110161473
    locus_GRCh38:
      chromosome: '5'
      position: 110825774
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma | blood clot, dvt, bronchitis, emphysema, asthma,
      rhinitis, eczema, allergy diagnosed by doctor
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=127669
    gwas_catalog_id: GCST006862
    neg_log_pval: 10.097453220686008
    otg_id: GCST006862
    pubmed_id: '29273806'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug TEZEPELUMAB is Phase
        III for the indiciation EFO_0000270 and targets the gene ENSG00000145777 at
        this locus (207647bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 110198114
    locus_GRCh38:
      chromosome: '5'
      position: 110862415
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=127669
    gwas_catalog_id: GCST006862
    neg_log_pval: 10.097453220686008
    otg_id: GCST006862
    pubmed_id: '29273806'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug AMG-157 is Phase II
        for the indiciation EFO_0000270 and targets the gene ENSG00000145777 at this
        locus (207647bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 110198114
    locus_GRCh38:
      chromosome: '5'
      position: 110862415
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=36955
    neg_log_pval: 7.8621333944441085
    otg_id: NEALE2_3786_raw
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug AMG-157 is Phase II
        for the indiciation EFO_0000270 and targets the gene ENSG00000145777 at this
        locus (3888bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 110401872
    locus_GRCh38:
      chromosome: '5'
      position: 111066174
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Age asthma diagnosed
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=127669
    gwas_catalog_id: GCST006862
    neg_log_pval: 20.97469413473523
    otg_id: GCST006862
    pubmed_id: '29273806'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug TEZEPELUMAB is Phase
        III for the indiciation EFO_0000270 and targets the gene ENSG00000145777 at
        this locus (3888bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 110401872
    locus_GRCh38:
      chromosome: '5'
      position: 111066174
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=360527
    neg_log_pval: 36.21098861481695
    otg_id: NEALE2_6152_8
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug TEZEPELUMAB is Phase
        III for the indiciation EFO_0000270 and targets the gene ENSG00000145777 at
        this locus (3888bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 110401872
    locus_GRCh38:
      chromosome: '5'
      position: 111066174
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma | blood clot, dvt, bronchitis, emphysema, asthma,
      rhinitis, eczema, allergy diagnosed by doctor
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=157242
    gwas_catalog_id: GCST003987
    neg_log_pval: 30.522878745280337
    otg_id: GCST003987
    pubmed_id: '27182965'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug TEZEPELUMAB is Phase
        III for the indiciation EFO_0000270 and targets the gene ENSG00000145777 at
        this locus (3888bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 110401872
    locus_GRCh38:
      chromosome: '5'
      position: 111066174
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=90853
    gwas_catalog_id: GCST007562
    neg_log_pval: 19.69897000433602
    otg_id: GCST007562
    pubmed_id: '29785011'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug TEZEPELUMAB is Phase
        III for the indiciation EFO_0000270 and targets the gene ENSG00000145777 at
        this locus (3888bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 110401872
    locus_GRCh38:
      chromosome: '5'
      position: 111066174
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=36955
    neg_log_pval: 7.8621333944441085
    otg_id: NEALE2_3786_raw
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug TEZEPELUMAB is Phase
        III for the indiciation EFO_0000270 and targets the gene ENSG00000145777 at
        this locus (3888bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 110401872
    locus_GRCh38:
      chromosome: '5'
      position: 111066174
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Age asthma diagnosed
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=90853
    gwas_catalog_id: GCST007562
    neg_log_pval: 19.69897000433602
    otg_id: GCST007562
    pubmed_id: '29785011'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug AMG-157 is Phase II
        for the indiciation EFO_0000270 and targets the gene ENSG00000145777 at this
        locus (3888bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 110401872
    locus_GRCh38:
      chromosome: '5'
      position: 111066174
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=157242
    gwas_catalog_id: GCST003987
    neg_log_pval: 30.522878745280337
    otg_id: GCST003987
    pubmed_id: '27182965'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug AMG-157 is Phase II
        for the indiciation EFO_0000270 and targets the gene ENSG00000145777 at this
        locus (3888bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 110401872
    locus_GRCh38:
      chromosome: '5'
      position: 111066174
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - African American or Afro-Caribbean=1612
    - European=2088
    - Hispanic or Latin American=1688
    gwas_catalog_id: GCST001182
    neg_log_pval: 14.0
    otg_id: GCST001182
    pubmed_id: '21804549'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug AMG-157 is Phase II
        for the indiciation EFO_0000270 and targets the gene ENSG00000145777 at this
        locus (3888bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 110401872
    locus_GRCh38:
      chromosome: '5'
      position: 111066174
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 37.65559397059892
    otg_id: NEALE2_20002_1111
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug AMG-157 is Phase II
        for the indiciation EFO_0000270 and targets the gene ENSG00000145777 at this
        locus (3888bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 110401872
    locus_GRCh38:
      chromosome: '5'
      position: 111066174
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma | non-cancer illness code, self-reported
    standard_trait_name: asthma
- association_info:
    ancestry:
    - African American or Afro-Caribbean=1612
    - European=2088
    - Hispanic or Latin American=1688
    gwas_catalog_id: GCST001182
    neg_log_pval: 14.0
    otg_id: GCST001182
    pubmed_id: '21804549'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug TEZEPELUMAB is Phase
        III for the indiciation EFO_0000270 and targets the gene ENSG00000145777 at
        this locus (3888bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 110401872
    locus_GRCh38:
      chromosome: '5'
      position: 111066174
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=91787
    neg_log_pval: 21.00267741002066
    otg_id: NEALE2_22127
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug TEZEPELUMAB is Phase
        III for the indiciation EFO_0000270 and targets the gene ENSG00000145777 at
        this locus (3888bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 110401872
    locus_GRCh38:
      chromosome: '5'
      position: 111066174
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Doctor diagnosed asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=116538
    gwas_catalog_id: GCST007564
    neg_log_pval: 20.397940008672037
    otg_id: GCST007564
    pubmed_id: '29785011'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug TEZEPELUMAB is Phase
        III for the indiciation EFO_0000270 and targets the gene ENSG00000145777 at
        this locus (3888bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 110401872
    locus_GRCh38:
      chromosome: '5'
      position: 111066174
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma or allergic disease (pleiotropy)
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=401837
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 26.016373712875467
    otg_id: SAIGE_495
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug TEZEPELUMAB is Phase
        III for the indiciation EFO_0000270 and targets the gene ENSG00000145777 at
        this locus (3888bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 110401872
    locus_GRCh38:
      chromosome: '5'
      position: 111066174
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=127669
    gwas_catalog_id: GCST006862
    neg_log_pval: 20.97469413473523
    otg_id: GCST006862
    pubmed_id: '29273806'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug AMG-157 is Phase II
        for the indiciation EFO_0000270 and targets the gene ENSG00000145777 at this
        locus (3888bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 110401872
    locus_GRCh38:
      chromosome: '5'
      position: 111066174
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=116538
    gwas_catalog_id: GCST007564
    neg_log_pval: 20.397940008672037
    otg_id: GCST007564
    pubmed_id: '29785011'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug AMG-157 is Phase II
        for the indiciation EFO_0000270 and targets the gene ENSG00000145777 at this
        locus (3888bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 110401872
    locus_GRCh38:
      chromosome: '5'
      position: 111066174
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma or allergic disease (pleiotropy)
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=341215
    gwas_catalog_id: GCST007798
    neg_log_pval: 41.0
    otg_id: GCST007798
    pubmed_id: '30929738'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug TEZEPELUMAB is Phase
        III for the indiciation EFO_0000270 and targets the gene ENSG00000145777 at
        this locus (3888bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 110401872
    locus_GRCh38:
      chromosome: '5'
      position: 111066174
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=20776
    gwas_catalog_id: GCST002322
    neg_log_pval: 9.0
    otg_id: GCST002322
    pubmed_id: '24388013'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug TEZEPELUMAB is Phase
        III for the indiciation EFO_0000270 and targets the gene ENSG00000145777 at
        this locus (3888bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 110401872
    locus_GRCh38:
      chromosome: '5'
      position: 111066174
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma and hay fever
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 37.65559397059892
    otg_id: NEALE2_20002_1111
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug TEZEPELUMAB is Phase
        III for the indiciation EFO_0000270 and targets the gene ENSG00000145777 at
        this locus (3888bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 110401872
    locus_GRCh38:
      chromosome: '5'
      position: 111066174
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma | non-cancer illness code, self-reported
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=341215
    gwas_catalog_id: GCST007798
    neg_log_pval: 41.0
    otg_id: GCST007798
    pubmed_id: '30929738'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug AMG-157 is Phase II
        for the indiciation EFO_0000270 and targets the gene ENSG00000145777 at this
        locus (3888bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 110401872
    locus_GRCh38:
      chromosome: '5'
      position: 111066174
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=30810
    gwas_catalog_id: GCST006911
    neg_log_pval: 21.69897000433602
    otg_id: GCST006911
    pubmed_id: '30552067'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug TEZEPELUMAB is Phase
        III for the indiciation EFO_0000270 and targets the gene ENSG00000145777 at
        this locus (3888bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 110401872
    locus_GRCh38:
      chromosome: '5'
      position: 111066174
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma (moderate or severe)
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=20776
    gwas_catalog_id: GCST002322
    neg_log_pval: 9.0
    otg_id: GCST002322
    pubmed_id: '24388013'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug AMG-157 is Phase II
        for the indiciation EFO_0000270 and targets the gene ENSG00000145777 at this
        locus (3888bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 110401872
    locus_GRCh38:
      chromosome: '5'
      position: 111066174
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma and hay fever
    standard_trait_name: asthma
- association_info:
    ancestry:
    - East Asian=4836
    gwas_catalog_id: GCST001183
    neg_log_pval: 16.0
    otg_id: GCST001183
    pubmed_id: '21804548'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug AMG-157 is Phase II
        for the indiciation EFO_0000270 and targets the gene ENSG00000145777 at this
        locus (3888bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 110401872
    locus_GRCh38:
      chromosome: '5'
      position: 111066174
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=28835
    gwas_catalog_id: GCST007797
    neg_log_pval: 14.301029995663981
    otg_id: GCST007797
    pubmed_id: '30929738'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug AMG-157 is Phase II
        for the indiciation EFO_0000270 and targets the gene ENSG00000145777 at this
        locus (3888bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 110401872
    locus_GRCh38:
      chromosome: '5'
      position: 111066174
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma onset (childhood vs adult)
    standard_trait_name: asthma
- association_info:
    ancestry:
    - East Asian=4836
    gwas_catalog_id: GCST001183
    neg_log_pval: 16.0
    otg_id: GCST001183
    pubmed_id: '21804548'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug TEZEPELUMAB is Phase
        III for the indiciation EFO_0000270 and targets the gene ENSG00000145777 at
        this locus (3888bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 110401872
    locus_GRCh38:
      chromosome: '5'
      position: 111066174
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=401837
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 26.016373712875467
    otg_id: SAIGE_495
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug AMG-157 is Phase II
        for the indiciation EFO_0000270 and targets the gene ENSG00000145777 at this
        locus (3888bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 110401872
    locus_GRCh38:
      chromosome: '5'
      position: 111066174
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=30810
    gwas_catalog_id: GCST006911
    neg_log_pval: 21.69897000433602
    otg_id: GCST006911
    pubmed_id: '30552067'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug AMG-157 is Phase II
        for the indiciation EFO_0000270 and targets the gene ENSG00000145777 at this
        locus (3888bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 110401872
    locus_GRCh38:
      chromosome: '5'
      position: 111066174
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma (moderate or severe)
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=91787
    neg_log_pval: 21.00267741002066
    otg_id: NEALE2_22127
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug AMG-157 is Phase II
        for the indiciation EFO_0000270 and targets the gene ENSG00000145777 at this
        locus (3888bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 110401872
    locus_GRCh38:
      chromosome: '5'
      position: 111066174
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Doctor diagnosed asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=360527
    neg_log_pval: 36.21098861481695
    otg_id: NEALE2_6152_8
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug AMG-157 is Phase II
        for the indiciation EFO_0000270 and targets the gene ENSG00000145777 at this
        locus (3888bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 110401872
    locus_GRCh38:
      chromosome: '5'
      position: 111066174
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma | blood clot, dvt, bronchitis, emphysema, asthma,
      rhinitis, eczema, allergy diagnosed by doctor
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=28835
    gwas_catalog_id: GCST007797
    neg_log_pval: 14.301029995663981
    otg_id: GCST007797
    pubmed_id: '30929738'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug TEZEPELUMAB is Phase
        III for the indiciation EFO_0000270 and targets the gene ENSG00000145777 at
        this locus (3888bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 110401872
    locus_GRCh38:
      chromosome: '5'
      position: 111066174
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma onset (childhood vs adult)
    standard_trait_name: asthma
- association_info:
    ancestry:
    - African unspecified, African American or Afro-Caribbean=8204
    - European=127669
    - East Asian=5215
    - Hispanic or Latin American=1398
    gwas_catalog_id: GCST005212
    neg_log_pval: 25.045757490560675
    otg_id: GCST005212
    pubmed_id: '29273806'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug AMG-157 is Phase II
        for the indiciation EFO_0000270 and targets the gene ENSG00000145777 at this
        locus (762bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 110404999
    locus_GRCh38:
      chromosome: '5'
      position: 111069301
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - African unspecified, African American or Afro-Caribbean=8204
    - European=127669
    - East Asian=5215
    - Hispanic or Latin American=1398
    gwas_catalog_id: GCST005212
    neg_log_pval: 25.045757490560675
    otg_id: GCST005212
    pubmed_id: '29273806'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug TEZEPELUMAB is Phase
        III for the indiciation EFO_0000270 and targets the gene ENSG00000145777 at
        this locus (762bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 110404999
    locus_GRCh38:
      chromosome: '5'
      position: 111069301
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=127669
    gwas_catalog_id: GCST006862
    neg_log_pval: 24.692503962086786
    otg_id: GCST006862
    pubmed_id: '29273806'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug AMG-157 is Phase II
        for the indiciation EFO_0000270 and targets the gene ENSG00000145777 at this
        locus (762bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 110404999
    locus_GRCh38:
      chromosome: '5'
      position: 111069301
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=127669
    gwas_catalog_id: GCST006862
    neg_log_pval: 24.692503962086786
    otg_id: GCST006862
    pubmed_id: '29273806'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug TEZEPELUMAB is Phase
        III for the indiciation EFO_0000270 and targets the gene ENSG00000145777 at
        this locus (762bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 110404999
    locus_GRCh38:
      chromosome: '5'
      position: 111069301
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 18.959010211096686
    otg_id: NEALE2_20002_1111
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug TEZEPELUMAB is Phase
        III for the indiciation EFO_0000270 and targets the gene ENSG00000145777 at
        this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 110406742
    locus_GRCh38:
      chromosome: '5'
      position: 111071044
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma | non-cancer illness code, self-reported
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 18.959010211096686
    otg_id: NEALE2_20002_1111
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug AMG-157 is Phase II
        for the indiciation EFO_0000270 and targets the gene ENSG00000145777 at this
        locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 110406742
    locus_GRCh38:
      chromosome: '5'
      position: 111071044
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma | non-cancer illness code, self-reported
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=360527
    neg_log_pval: 20.137288556960716
    otg_id: NEALE2_6152_8
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug AMG-157 is Phase II
        for the indiciation EFO_0000270 and targets the gene ENSG00000145777 at this
        locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 110406742
    locus_GRCh38:
      chromosome: '5'
      position: 111071044
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma | blood clot, dvt, bronchitis, emphysema, asthma,
      rhinitis, eczema, allergy diagnosed by doctor
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=360527
    neg_log_pval: 20.137288556960716
    otg_id: NEALE2_6152_8
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug TEZEPELUMAB is Phase
        III for the indiciation EFO_0000270 and targets the gene ENSG00000145777 at
        this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 110406742
    locus_GRCh38:
      chromosome: '5'
      position: 111071044
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma | blood clot, dvt, bronchitis, emphysema, asthma,
      rhinitis, eczema, allergy diagnosed by doctor
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=20776
    gwas_catalog_id: GCST002322
    neg_log_pval: 10.522878745280337
    otg_id: GCST002322
    pubmed_id: '24388013'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug TEZEPELUMAB is Phase
        III for the indiciation EFO_0000270 and targets the gene ENSG00000145777 at
        this locus (53775bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 110467499
    locus_GRCh38:
      chromosome: '5'
      position: 111131801
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma and hay fever
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=30810
    gwas_catalog_id: GCST006911
    neg_log_pval: 12.522878745280337
    otg_id: GCST006911
    pubmed_id: '30552067'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug AMG-157 is Phase II
        for the indiciation EFO_0000270 and targets the gene ENSG00000145777 at this
        locus (53775bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 110467499
    locus_GRCh38:
      chromosome: '5'
      position: 111131801
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma (moderate or severe)
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=30810
    gwas_catalog_id: GCST006911
    neg_log_pval: 12.522878745280337
    otg_id: GCST006911
    pubmed_id: '30552067'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug TEZEPELUMAB is Phase
        III for the indiciation EFO_0000270 and targets the gene ENSG00000145777 at
        this locus (53775bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 110467499
    locus_GRCh38:
      chromosome: '5'
      position: 111131801
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma (moderate or severe)
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=102453
    gwas_catalog_id: GCST007563
    neg_log_pval: 19.30102999566398
    otg_id: GCST007563
    pubmed_id: '29785011'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug AMG-157 is Phase II
        for the indiciation EFO_0000270 and targets the gene ENSG00000145777 at this
        locus (53775bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 110467499
    locus_GRCh38:
      chromosome: '5'
      position: 111131801
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Allergic disease (asthma, hay fever or eczema)
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=102453
    gwas_catalog_id: GCST007563
    neg_log_pval: 19.30102999566398
    otg_id: GCST007563
    pubmed_id: '29785011'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug TEZEPELUMAB is Phase
        III for the indiciation EFO_0000270 and targets the gene ENSG00000145777 at
        this locus (53775bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 110467499
    locus_GRCh38:
      chromosome: '5'
      position: 111131801
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Allergic disease (asthma, hay fever or eczema)
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=20776
    gwas_catalog_id: GCST002322
    neg_log_pval: 10.522878745280337
    otg_id: GCST002322
    pubmed_id: '24388013'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug AMG-157 is Phase II
        for the indiciation EFO_0000270 and targets the gene ENSG00000145777 at this
        locus (53775bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 110467499
    locus_GRCh38:
      chromosome: '5'
      position: 111131801
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma and hay fever
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=401837
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 18.149353764816933
    otg_id: SAIGE_495
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug AMG-157 is Phase II
        for the indiciation EFO_0000270 and targets the gene ENSG00000145777 at this
        locus (56414bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 110470137
    locus_GRCh38:
      chromosome: '5'
      position: 111134439
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=401837
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 18.149353764816933
    otg_id: SAIGE_495
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug TEZEPELUMAB is Phase
        III for the indiciation EFO_0000270 and targets the gene ENSG00000145777 at
        this locus (56414bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 110470137
    locus_GRCh38:
      chromosome: '5'
      position: 111134439
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=72232
    neg_log_pval: 8.814540009081632
    otg_id: NEALE2_3761_raw
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Thymic stromal lymphopoietin inhibitor drug TEZEPELUMAB is Phase
        II for the indiciation EFO_0000274 and targets the gene ENSG00000145777 at
        this locus (57494bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145777
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 110471218
    locus_GRCh38:
      chromosome: '5'
      position: 111135520
  trait_info:
    ontology:
    - EFO_0000274
    reported_trait_name: Age hay fever, rhinitis or eczema diagnosed
    standard_trait_name: atopic eczema
- association_info:
    ancestry:
    - East Asian=20965
    gwas_catalog_id: GCST001454
    neg_log_pval: 9.522878745280337
    otg_id: GCST001454
    pubmed_id: '22446963'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Granulocyte-macrophage colony-stimulating factor inhibitor drug
        NAMILUMAB is Phase II for the indiciation EFO_0000685 and targets the gene
        ENSG00000164400 at this locus (18255bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000164400
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 131430118
    locus_GRCh38:
      chromosome: '5'
      position: 132094425
  trait_info:
    ontology:
    - EFO_0000685
    reported_trait_name: Rheumatoid arthritis
    standard_trait_name: rheumatoid arthritis
- association_info:
    ancestry:
    - European=27432
    gwas_catalog_id: GCST003045
    neg_log_pval: 25.175982286576183
    otg_id: GCST003045
    pubmed_id: '26192919'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug ANRUKINZUMAB is Phase II for the
        indiciation EFO_0000729 and targets the gene ENSG00000169194 at this locus
        (322795bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 131669161
    locus_GRCh38:
      chromosome: '5'
      position: 132333468
  trait_info:
    ontology:
    - EFO_0000729
    reported_trait_name: Ulcerative colitis [EA]
    standard_trait_name: ulcerative colitis
- association_info:
    ancestry:
    - European=20883
    gwas_catalog_id: GCST003044
    neg_log_pval: 46.705144404319334
    otg_id: GCST003044
    pubmed_id: '26192919'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug QAX-576 is Phase II for the indiciation
        EFO_0000384 and targets the gene ENSG00000169194 at this locus (322795bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 131669161
    locus_GRCh38:
      chromosome: '5'
      position: 132333468
  trait_info:
    ontology:
    - EFO_0000384
    reported_trait_name: Crohn's disease [EA]
    standard_trait_name: Crohn's disease
- association_info:
    ancestry:
    - European=719047
    gwas_catalog_id: GCST007443
    neg_log_pval: 8.0
    otg_id: GCST007443
    pubmed_id: '30643255'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-5 inhibitor drug MEPOLIZUMAB is Phase II for the indiciation
        EFO_1000391 and targets the gene ENSG00000113525 at this locus (200819bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113525
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 131676320
    locus_GRCh38:
      chromosome: '5'
      position: 132340627
  trait_info:
    ontology:
    - EFO_1000391
    reported_trait_name: Nasal polyps
    standard_trait_name: Nasal Cavity Polyp
- association_info:
    ancestry:
    - European=393356
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 9.707743928643524
    otg_id: SAIGE_471
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-5 inhibitor drug MEPOLIZUMAB is Phase II for the indiciation
        EFO_1000391 and targets the gene ENSG00000113525 at this locus (166739bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113525
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 131710399
    locus_GRCh38:
      chromosome: '5'
      position: 132374707
  trait_info:
    ontology:
    - EFO_1000391
    reported_trait_name: Nasal polyps
    standard_trait_name: Nasal Cavity Polyp
- association_info:
    ancestry:
    - European=20883
    gwas_catalog_id: GCST003044
    neg_log_pval: 25.162379159732975
    otg_id: GCST003044
    pubmed_id: '26192919'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug QAX-576 is Phase II for the indiciation
        EFO_0000384 and targets the gene ENSG00000169194 at this locus (259500bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 131732456
    locus_GRCh38:
      chromosome: '5'
      position: 132396764
  trait_info:
    ontology:
    - EFO_0000384
    reported_trait_name: Crohn's disease [EA]
    standard_trait_name: Crohn's disease
- association_info:
    ancestry:
    - European, NR=40266
    gwas_catalog_id: GCST004132
    neg_log_pval: 35.25274360255786
    otg_id: GCST004132
    pubmed_id: '28067908'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug QAX-576 is Phase II for the indiciation
        EFO_0000384 and targets the gene ENSG00000169194 at this locus (221151bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 131770805
    locus_GRCh38:
      chromosome: '5'
      position: 132435113
  trait_info:
    ontology:
    - EFO_0000384
    reported_trait_name: Crohn's disease
    standard_trait_name: Crohn's disease
- association_info:
    ancestry:
    - European=9541
    gwas_catalog_id: GCST000207
    neg_log_pval: 17.69897000433602
    otg_id: GCST000207
    pubmed_id: '18587394'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug QAX-576 is Phase II for the indiciation
        EFO_0000384 and targets the gene ENSG00000169194 at this locus (221151bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 131770805
    locus_GRCh38:
      chromosome: '5'
      position: 132435113
  trait_info:
    ontology:
    - EFO_0000384
    reported_trait_name: Crohn's disease
    standard_trait_name: Crohn's disease
- association_info:
    ancestry:
    - European=86475
    gwas_catalog_id: GCST005537
    neg_log_pval: 54.69897000433602
    otg_id: GCST005537
    pubmed_id: '26974007'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug ANRUKINZUMAB is Phase II for the
        indiciation EFO_0000729 and targets the gene ENSG00000169194 at this locus
        (213503bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 131778452
    locus_GRCh38:
      chromosome: '5'
      position: 132442760
  trait_info:
    ontology:
    - EFO_0000729
    reported_trait_name: Chronic inflammatory diseases (ankylosing spondylitis, Crohn's
      disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
      [subset analysis]
    standard_trait_name: ulcerative colitis
- association_info:
    ancestry:
    - European=86475
    gwas_catalog_id: GCST005537
    neg_log_pval: 54.69897000433602
    otg_id: GCST005537
    pubmed_id: '26974007'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug QAX-576 is Phase II for the indiciation
        EFO_0000384 and targets the gene ENSG00000169194 at this locus (213503bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 131778452
    locus_GRCh38:
      chromosome: '5'
      position: 132442760
  trait_info:
    ontology:
    - EFO_0000384
    reported_trait_name: Chronic inflammatory diseases (ankylosing spondylitis, Crohn's
      disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
      [subset analysis]
    standard_trait_name: Crohn's disease
- association_info:
    ancestry:
    - European=86475
    gwas_catalog_id: GCST005537
    neg_log_pval: 54.69897000433602
    otg_id: GCST005537
    pubmed_id: '26974007'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Granulocyte-macrophage colony-stimulating factor inhibitor drug
        NAMILUMAB is Phase II for the indiciation EFO_0003898 and targets the gene
        ENSG00000164400 at this locus (366590bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000164400
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 131778452
    locus_GRCh38:
      chromosome: '5'
      position: 132442760
  trait_info:
    ontology:
    - EFO_0003898
    reported_trait_name: Chronic inflammatory diseases (ankylosing spondylitis, Crohn's
      disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
      [subset analysis]
    standard_trait_name: ankylosing spondylitis
- association_info:
    ancestry:
    - European=86475
    gwas_catalog_id: GCST005537
    neg_log_pval: 54.69897000433602
    otg_id: GCST005537
    pubmed_id: '26974007'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Granulocyte-macrophage colony-stimulating factor inhibitor drug
        NAMILUMAB is Phase II for the indiciation EFO_0000676 and targets the gene
        ENSG00000164400 at this locus (366590bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000164400
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 131778452
    locus_GRCh38:
      chromosome: '5'
      position: 132442760
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Chronic inflammatory diseases (ankylosing spondylitis, Crohn's
      disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
      [subset analysis]
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=21389
    gwas_catalog_id: GCST000879
    neg_log_pval: 20.0
    otg_id: GCST000879
    pubmed_id: '21102463'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug QAX-576 is Phase II for the indiciation
        EFO_0000384 and targets the gene ENSG00000169194 at this locus (207562bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 131784393
    locus_GRCh38:
      chromosome: '5'
      position: 132448701
  trait_info:
    ontology:
    - EFO_0000384
    reported_trait_name: Crohn's disease
    standard_trait_name: Crohn's disease
- association_info:
    ancestry:
    - European=34366
    gwas_catalog_id: GCST001729
    neg_log_pval: 19.496209316942817
    otg_id: GCST001729
    pubmed_id: '23128233'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug QAX-576 is Phase II for the indiciation
        EFO_0000384 and targets the gene ENSG00000169194 at this locus (207562bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 131784393
    locus_GRCh38:
      chromosome: '5'
      position: 132448701
  trait_info:
    ontology:
    - EFO_0000384
    reported_trait_name: Crohn's disease
    standard_trait_name: Crohn's disease
- association_info:
    ancestry:
    - European=27432
    gwas_catalog_id: GCST003045
    neg_log_pval: 10.237794241945119
    otg_id: GCST003045
    pubmed_id: '26192919'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug ANRUKINZUMAB is Phase II for the
        indiciation EFO_0000729 and targets the gene ENSG00000169194 at this locus
        (195033bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 131796922
    locus_GRCh38:
      chromosome: '5'
      position: 132461230
  trait_info:
    ontology:
    - EFO_0000729
    reported_trait_name: Ulcerative colitis [EA]
    standard_trait_name: ulcerative colitis
- association_info:
    ancestry:
    - European=127669
    gwas_catalog_id: GCST006862
    neg_log_pval: 10.667561540084394
    otg_id: GCST006862
    pubmed_id: '29273806'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Interleukin-5 inhibitor drug RESLIZUMAB is Phase IV for the indiciation
        EFO_0000270 and targets the gene ENSG00000113525 at this locus (79591bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113525
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 131797547
    locus_GRCh38:
      chromosome: '5'
      position: 132461855
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=127669
    gwas_catalog_id: GCST006862
    neg_log_pval: 10.667561540084394
    otg_id: GCST006862
    pubmed_id: '29273806'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug ANRUKINZUMAB is Phase II for the
        indiciation EFO_0000270 and targets the gene ENSG00000169194 at this locus
        (194409bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 131797547
    locus_GRCh38:
      chromosome: '5'
      position: 132461855
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=127669
    gwas_catalog_id: GCST006862
    neg_log_pval: 10.667561540084394
    otg_id: GCST006862
    pubmed_id: '29273806'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug TRALOKINUMAB is Phase III for the
        indiciation EFO_0000270 and targets the gene ENSG00000169194 at this locus
        (194409bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 131797547
    locus_GRCh38:
      chromosome: '5'
      position: 132461855
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=127669
    gwas_catalog_id: GCST006862
    neg_log_pval: 10.667561540084394
    otg_id: GCST006862
    pubmed_id: '29273806'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-4 inhibitor drug PASCOLIZUMAB is Phase II for the indiciation
        EFO_0000270 and targets the gene ENSG00000113520 at this locus (212132bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113520
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 131797547
    locus_GRCh38:
      chromosome: '5'
      position: 132461855
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=33394
    gwas_catalog_id: GCST005527
    neg_log_pval: 7.620391669707774
    otg_id: GCST005527
    pubmed_id: '23143594'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Granulocyte-macrophage colony-stimulating factor inhibitor drug
        NAMILUMAB is Phase II for the indiciation EFO_0000676 and targets the gene
        ENSG00000164400 at this locus (387511bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000164400
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 131799373
    locus_GRCh38:
      chromosome: '5'
      position: 132463681
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=30810
    gwas_catalog_id: GCST006911
    neg_log_pval: 13.221848749616356
    otg_id: GCST006911
    pubmed_id: '30552067'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug QAX-576 is Phase II for the indiciation
        EFO_0000270 and targets the gene ENSG00000169194 at this locus (192330bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 131799626
    locus_GRCh38:
      chromosome: '5'
      position: 132463934
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma (moderate or severe)
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=360527
    neg_log_pval: 26.061318695302564
    otg_id: NEALE2_6152_8
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug TRALOKINUMAB is Phase III for the
        indiciation EFO_0000270 and targets the gene ENSG00000169194 at this locus
        (192330bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 131799626
    locus_GRCh38:
      chromosome: '5'
      position: 132463934
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma | blood clot, dvt, bronchitis, emphysema, asthma,
      rhinitis, eczema, allergy diagnosed by doctor
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=401837
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 9.563837352959244
    otg_id: SAIGE_495
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-4 inhibitor drug PASCOLIZUMAB is Phase II for the indiciation
        EFO_0000270 and targets the gene ENSG00000113520 at this locus (210052bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113520
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 131799626
    locus_GRCh38:
      chromosome: '5'
      position: 132463934
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=360527
    neg_log_pval: 26.061318695302564
    otg_id: NEALE2_6152_8
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-4 inhibitor drug PASCOLIZUMAB is Phase II for the indiciation
        EFO_0000270 and targets the gene ENSG00000113520 at this locus (210052bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113520
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 131799626
    locus_GRCh38:
      chromosome: '5'
      position: 132463934
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma | blood clot, dvt, bronchitis, emphysema, asthma,
      rhinitis, eczema, allergy diagnosed by doctor
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=30810
    gwas_catalog_id: GCST006911
    neg_log_pval: 13.221848749616356
    otg_id: GCST006911
    pubmed_id: '30552067'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-4 inhibitor drug PASCOLIZUMAB is Phase II for the indiciation
        EFO_0000270 and targets the gene ENSG00000113520 at this locus (210052bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113520
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 131799626
    locus_GRCh38:
      chromosome: '5'
      position: 132463934
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma (moderate or severe)
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=360527
    neg_log_pval: 26.061318695302564
    otg_id: NEALE2_6152_8
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug QAX-576 is Phase II for the indiciation
        EFO_0000270 and targets the gene ENSG00000169194 at this locus (192330bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 131799626
    locus_GRCh38:
      chromosome: '5'
      position: 132463934
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma | blood clot, dvt, bronchitis, emphysema, asthma,
      rhinitis, eczema, allergy diagnosed by doctor
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=30810
    gwas_catalog_id: GCST006911
    neg_log_pval: 13.221848749616356
    otg_id: GCST006911
    pubmed_id: '30552067'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug TRALOKINUMAB is Phase III for the
        indiciation EFO_0000270 and targets the gene ENSG00000169194 at this locus
        (192330bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 131799626
    locus_GRCh38:
      chromosome: '5'
      position: 132463934
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma (moderate or severe)
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=401837
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 9.563837352959244
    otg_id: SAIGE_495
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug TRALOKINUMAB is Phase III for the
        indiciation EFO_0000270 and targets the gene ENSG00000169194 at this locus
        (192330bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 131799626
    locus_GRCh38:
      chromosome: '5'
      position: 132463934
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=401837
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 9.563837352959244
    otg_id: SAIGE_495
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Interleukin-5 inhibitor drug MEPOLIZUMAB is Phase IV for the indiciation
        EFO_0000270 and targets the gene ENSG00000113525 at this locus (77511bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113525
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 131799626
    locus_GRCh38:
      chromosome: '5'
      position: 132463934
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 27.398007329534234
    otg_id: NEALE2_20002_1111
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Interleukin-5 inhibitor drug MEPOLIZUMAB is Phase IV for the indiciation
        EFO_0000270 and targets the gene ENSG00000113525 at this locus (77511bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113525
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 131799626
    locus_GRCh38:
      chromosome: '5'
      position: 132463934
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma | non-cancer illness code, self-reported
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 27.398007329534234
    otg_id: NEALE2_20002_1111
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug TRALOKINUMAB is Phase III for the
        indiciation EFO_0000270 and targets the gene ENSG00000169194 at this locus
        (192330bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 131799626
    locus_GRCh38:
      chromosome: '5'
      position: 132463934
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma | non-cancer illness code, self-reported
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 27.398007329534234
    otg_id: NEALE2_20002_1111
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-4 inhibitor drug PASCOLIZUMAB is Phase II for the indiciation
        EFO_0000270 and targets the gene ENSG00000113520 at this locus (210052bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113520
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 131799626
    locus_GRCh38:
      chromosome: '5'
      position: 132463934
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma | non-cancer illness code, self-reported
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=30810
    gwas_catalog_id: GCST006911
    neg_log_pval: 13.221848749616356
    otg_id: GCST006911
    pubmed_id: '30552067'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Interleukin-5 inhibitor drug MEPOLIZUMAB is Phase IV for the indiciation
        EFO_0000270 and targets the gene ENSG00000113525 at this locus (77511bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113525
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 131799626
    locus_GRCh38:
      chromosome: '5'
      position: 132463934
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma (moderate or severe)
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 27.398007329534234
    otg_id: NEALE2_20002_1111
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug QAX-576 is Phase II for the indiciation
        EFO_0000270 and targets the gene ENSG00000169194 at this locus (192330bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 131799626
    locus_GRCh38:
      chromosome: '5'
      position: 132463934
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma | non-cancer illness code, self-reported
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=401837
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 9.563837352959244
    otg_id: SAIGE_495
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug QAX-576 is Phase II for the indiciation
        EFO_0000270 and targets the gene ENSG00000169194 at this locus (192330bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 131799626
    locus_GRCh38:
      chromosome: '5'
      position: 132463934
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=360527
    neg_log_pval: 26.061318695302564
    otg_id: NEALE2_6152_8
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Interleukin-5 inhibitor drug MEPOLIZUMAB is Phase IV for the indiciation
        EFO_0000270 and targets the gene ENSG00000113525 at this locus (77511bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113525
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 131799626
    locus_GRCh38:
      chromosome: '5'
      position: 132463934
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma | blood clot, dvt, bronchitis, emphysema, asthma,
      rhinitis, eczema, allergy diagnosed by doctor
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=116538
    gwas_catalog_id: GCST007564
    neg_log_pval: 9.301029995663981
    otg_id: GCST007564
    pubmed_id: '29785011'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Interleukin-5 inhibitor drug MEPOLIZUMAB is Phase IV for the indiciation
        EFO_0000270 and targets the gene ENSG00000113525 at this locus (68469bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113525
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 131808668
    locus_GRCh38:
      chromosome: '5'
      position: 132472976
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma or allergic disease (pleiotropy)
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=116538
    gwas_catalog_id: GCST007564
    neg_log_pval: 9.301029995663981
    otg_id: GCST007564
    pubmed_id: '29785011'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-4 inhibitor drug PASCOLIZUMAB is Phase II for the indiciation
        EFO_0000270 and targets the gene ENSG00000113520 at this locus (201010bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113520
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 131808668
    locus_GRCh38:
      chromosome: '5'
      position: 132472976
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma or allergic disease (pleiotropy)
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=116538
    gwas_catalog_id: GCST007564
    neg_log_pval: 9.301029995663981
    otg_id: GCST007564
    pubmed_id: '29785011'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug LEBRIKIZUMAB is Phase III for the
        indiciation EFO_0000270 and targets the gene ENSG00000169194 at this locus
        (183287bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 131808668
    locus_GRCh38:
      chromosome: '5'
      position: 132472976
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma or allergic disease (pleiotropy)
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=116538
    gwas_catalog_id: GCST007564
    neg_log_pval: 9.301029995663981
    otg_id: GCST007564
    pubmed_id: '29785011'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug QAX-576 is Phase II for the indiciation
        EFO_0000270 and targets the gene ENSG00000169194 at this locus (183287bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 131808668
    locus_GRCh38:
      chromosome: '5'
      position: 132472976
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma or allergic disease (pleiotropy)
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=16753
    gwas_catalog_id: GCST003097
    neg_log_pval: 8.698970004336019
    otg_id: GCST003097
    pubmed_id: '26301688'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug QAX-576 is Phase II for the indiciation
        EFO_0000384 and targets the gene ENSG00000169194 at this locus (180773bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 131811182
    locus_GRCh38:
      chromosome: '5'
      position: 132475490
  trait_info:
    ontology:
    - EFO_0000384
    reported_trait_name: Pediatric autoimmune diseases
    standard_trait_name: Crohn's disease
- association_info:
    ancestry:
    - European=16753
    gwas_catalog_id: GCST003097
    neg_log_pval: 8.698970004336019
    otg_id: GCST003097
    pubmed_id: '26301688'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug ANRUKINZUMAB is Phase II for the
        indiciation EFO_0000729 and targets the gene ENSG00000169194 at this locus
        (180773bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 131811182
    locus_GRCh38:
      chromosome: '5'
      position: 132475490
  trait_info:
    ontology:
    - EFO_0000729
    reported_trait_name: Pediatric autoimmune diseases
    standard_trait_name: ulcerative colitis
- association_info:
    ancestry:
    - European=16753
    gwas_catalog_id: GCST003097
    neg_log_pval: 8.698970004336019
    otg_id: GCST003097
    pubmed_id: '26301688'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Granulocyte-macrophage colony-stimulating factor inhibitor drug
        NAMILUMAB is Phase II for the indiciation EFO_0003898 and targets the gene
        ENSG00000164400 at this locus (399320bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000164400
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 131811182
    locus_GRCh38:
      chromosome: '5'
      position: 132475490
  trait_info:
    ontology:
    - EFO_0003898
    reported_trait_name: Pediatric autoimmune diseases
    standard_trait_name: ankylosing spondylitis
- association_info:
    ancestry:
    - European=16753
    gwas_catalog_id: GCST003097
    neg_log_pval: 8.698970004336019
    otg_id: GCST003097
    pubmed_id: '26301688'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Granulocyte-macrophage colony-stimulating factor inhibitor drug
        NAMILUMAB is Phase II for the indiciation EFO_0000676 and targets the gene
        ENSG00000164400 at this locus (399320bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000164400
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 131811182
    locus_GRCh38:
      chromosome: '5'
      position: 132475490
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Pediatric autoimmune diseases
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=91787
    neg_log_pval: 11.05858795962645
    otg_id: NEALE2_22127
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Interleukin-5 inhibitor drug RESLIZUMAB is Phase IV for the indiciation
        EFO_0000270 and targets the gene ENSG00000113525 at this locus (50815bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113525
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 131826322
    locus_GRCh38:
      chromosome: '5'
      position: 132490630
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Doctor diagnosed asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=91787
    neg_log_pval: 11.05858795962645
    otg_id: NEALE2_22127
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug TRALOKINUMAB is Phase III for the
        indiciation EFO_0000270 and targets the gene ENSG00000169194 at this locus
        (165633bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 131826322
    locus_GRCh38:
      chromosome: '5'
      position: 132490630
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Doctor diagnosed asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=91787
    neg_log_pval: 11.05858795962645
    otg_id: NEALE2_22127
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-4 inhibitor drug PASCOLIZUMAB is Phase II for the indiciation
        EFO_0000270 and targets the gene ENSG00000113520 at this locus (183357bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113520
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 131826322
    locus_GRCh38:
      chromosome: '5'
      position: 132490630
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Doctor diagnosed asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=91787
    neg_log_pval: 11.05858795962645
    otg_id: NEALE2_22127
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug ANRUKINZUMAB is Phase II for the
        indiciation EFO_0000270 and targets the gene ENSG00000169194 at this locus
        (165633bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 131826322
    locus_GRCh38:
      chromosome: '5'
      position: 132490630
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Doctor diagnosed asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=30810
    gwas_catalog_id: GCST006911
    neg_log_pval: 14.698970004336019
    otg_id: GCST006911
    pubmed_id: '30552067'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug TRALOKINUMAB is Phase III for the
        indiciation EFO_0000270 and targets the gene ENSG00000169194 at this locus
        (103970bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 131887986
    locus_GRCh38:
      chromosome: '5'
      position: 132552294
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma (moderate or severe)
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=30810
    gwas_catalog_id: GCST006911
    neg_log_pval: 14.698970004336019
    otg_id: GCST006911
    pubmed_id: '30552067'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug ANRUKINZUMAB is Phase II for the
        indiciation EFO_0000270 and targets the gene ENSG00000169194 at this locus
        (103970bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 131887986
    locus_GRCh38:
      chromosome: '5'
      position: 132552294
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma (moderate or severe)
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=30810
    gwas_catalog_id: GCST006911
    neg_log_pval: 14.698970004336019
    otg_id: GCST006911
    pubmed_id: '30552067'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Interleukin-5 inhibitor drug MEPOLIZUMAB is Phase IV for the indiciation
        EFO_0000270 and targets the gene ENSG00000113525 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113525
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 131887986
    locus_GRCh38:
      chromosome: '5'
      position: 132552294
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma (moderate or severe)
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=30810
    gwas_catalog_id: GCST006911
    neg_log_pval: 14.698970004336019
    otg_id: GCST006911
    pubmed_id: '30552067'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-4 inhibitor drug PASCOLIZUMAB is Phase II for the indiciation
        EFO_0000270 and targets the gene ENSG00000113520 at this locus (121692bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113520
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 131887986
    locus_GRCh38:
      chromosome: '5'
      position: 132552294
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma (moderate or severe)
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=157242
    gwas_catalog_id: GCST003987
    neg_log_pval: 15.698970004336019
    otg_id: GCST003987
    pubmed_id: '27182965'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug LEBRIKIZUMAB is Phase III for the
        indiciation EFO_0000270 and targets the gene ENSG00000169194 at this locus
        (90730bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 131901225
    locus_GRCh38:
      chromosome: '5'
      position: 132565533
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=157242
    gwas_catalog_id: GCST003987
    neg_log_pval: 15.698970004336019
    otg_id: GCST003987
    pubmed_id: '27182965'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Interleukin-5 inhibitor drug MEPOLIZUMAB is Phase IV for the indiciation
        EFO_0000270 and targets the gene ENSG00000113525 at this locus (8696bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113525
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 131901225
    locus_GRCh38:
      chromosome: '5'
      position: 132565533
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=157242
    gwas_catalog_id: GCST003987
    neg_log_pval: 15.698970004336019
    otg_id: GCST003987
    pubmed_id: '27182965'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug ANRUKINZUMAB is Phase II for the
        indiciation EFO_0000270 and targets the gene ENSG00000169194 at this locus
        (90730bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 131901225
    locus_GRCh38:
      chromosome: '5'
      position: 132565533
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=157242
    gwas_catalog_id: GCST003987
    neg_log_pval: 15.698970004336019
    otg_id: GCST003987
    pubmed_id: '27182965'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-4 inhibitor drug PASCOLIZUMAB is Phase II for the indiciation
        EFO_0000270 and targets the gene ENSG00000113520 at this locus (108454bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113520
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 131901225
    locus_GRCh38:
      chromosome: '5'
      position: 132565533
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=341215
    gwas_catalog_id: GCST007798
    neg_log_pval: 31.154901959985743
    otg_id: GCST007798
    pubmed_id: '30929738'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug TRALOKINUMAB is Phase III for the
        indiciation EFO_0000270 and targets the gene ENSG00000169194 at this locus
        (75015bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 131916940
    locus_GRCh38:
      chromosome: '5'
      position: 132581248
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 26.939774475605834
    otg_id: NEALE2_20002_1111
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug QAX-576 is Phase II for the indiciation
        EFO_0000270 and targets the gene ENSG00000169194 at this locus (75015bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 131916940
    locus_GRCh38:
      chromosome: '5'
      position: 132581248
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma | non-cancer illness code, self-reported
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=360527
    neg_log_pval: 28.044273294785736
    otg_id: NEALE2_6152_8
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Interleukin-5 inhibitor drug MEPOLIZUMAB is Phase IV for the indiciation
        EFO_0000270 and targets the gene ENSG00000113525 at this locus (24411bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113525
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 131916940
    locus_GRCh38:
      chromosome: '5'
      position: 132581248
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma | blood clot, dvt, bronchitis, emphysema, asthma,
      rhinitis, eczema, allergy diagnosed by doctor
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=341215
    gwas_catalog_id: GCST007798
    neg_log_pval: 31.154901959985743
    otg_id: GCST007798
    pubmed_id: '30929738'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug QAX-576 is Phase II for the indiciation
        EFO_0000270 and targets the gene ENSG00000169194 at this locus (75015bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 131916940
    locus_GRCh38:
      chromosome: '5'
      position: 132581248
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=360527
    neg_log_pval: 28.044273294785736
    otg_id: NEALE2_6152_8
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug QAX-576 is Phase II for the indiciation
        EFO_0000270 and targets the gene ENSG00000169194 at this locus (75015bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 131916940
    locus_GRCh38:
      chromosome: '5'
      position: 132581248
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma | blood clot, dvt, bronchitis, emphysema, asthma,
      rhinitis, eczema, allergy diagnosed by doctor
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=341215
    gwas_catalog_id: GCST007798
    neg_log_pval: 31.154901959985743
    otg_id: GCST007798
    pubmed_id: '30929738'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Interleukin-5 inhibitor drug MEPOLIZUMAB is Phase IV for the indiciation
        EFO_0000270 and targets the gene ENSG00000113525 at this locus (24411bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113525
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 131916940
    locus_GRCh38:
      chromosome: '5'
      position: 132581248
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 26.939774475605834
    otg_id: NEALE2_20002_1111
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-4 inhibitor drug PASCOLIZUMAB is Phase II for the indiciation
        EFO_0000270 and targets the gene ENSG00000113520 at this locus (92738bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113520
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 131916940
    locus_GRCh38:
      chromosome: '5'
      position: 132581248
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma | non-cancer illness code, self-reported
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=28835
    gwas_catalog_id: GCST007797
    neg_log_pval: 8.154901959985743
    otg_id: GCST007797
    pubmed_id: '30929738'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-4 inhibitor drug PASCOLIZUMAB is Phase II for the indiciation
        EFO_0000270 and targets the gene ENSG00000113520 at this locus (92738bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113520
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 131916940
    locus_GRCh38:
      chromosome: '5'
      position: 132581248
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma onset (childhood vs adult)
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=360527
    neg_log_pval: 28.044273294785736
    otg_id: NEALE2_6152_8
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug TRALOKINUMAB is Phase III for the
        indiciation EFO_0000270 and targets the gene ENSG00000169194 at this locus
        (75015bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 131916940
    locus_GRCh38:
      chromosome: '5'
      position: 132581248
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma | blood clot, dvt, bronchitis, emphysema, asthma,
      rhinitis, eczema, allergy diagnosed by doctor
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 26.939774475605834
    otg_id: NEALE2_20002_1111
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Interleukin-5 inhibitor drug MEPOLIZUMAB is Phase IV for the indiciation
        EFO_0000270 and targets the gene ENSG00000113525 at this locus (24411bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113525
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 131916940
    locus_GRCh38:
      chromosome: '5'
      position: 132581248
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma | non-cancer illness code, self-reported
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=28835
    gwas_catalog_id: GCST007797
    neg_log_pval: 8.154901959985743
    otg_id: GCST007797
    pubmed_id: '30929738'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug TRALOKINUMAB is Phase III for the
        indiciation EFO_0000270 and targets the gene ENSG00000169194 at this locus
        (75015bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 131916940
    locus_GRCh38:
      chromosome: '5'
      position: 132581248
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma onset (childhood vs adult)
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=28835
    gwas_catalog_id: GCST007797
    neg_log_pval: 8.154901959985743
    otg_id: GCST007797
    pubmed_id: '30929738'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug QAX-576 is Phase II for the indiciation
        EFO_0000270 and targets the gene ENSG00000169194 at this locus (75015bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 131916940
    locus_GRCh38:
      chromosome: '5'
      position: 132581248
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma onset (childhood vs adult)
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=28835
    gwas_catalog_id: GCST007797
    neg_log_pval: 8.154901959985743
    otg_id: GCST007797
    pubmed_id: '30929738'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Interleukin-5 inhibitor drug MEPOLIZUMAB is Phase IV for the indiciation
        EFO_0000270 and targets the gene ENSG00000113525 at this locus (24411bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113525
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 131916940
    locus_GRCh38:
      chromosome: '5'
      position: 132581248
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma onset (childhood vs adult)
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=360527
    neg_log_pval: 28.044273294785736
    otg_id: NEALE2_6152_8
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-4 inhibitor drug PASCOLIZUMAB is Phase II for the indiciation
        EFO_0000270 and targets the gene ENSG00000113520 at this locus (92738bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113520
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 131916940
    locus_GRCh38:
      chromosome: '5'
      position: 132581248
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma | blood clot, dvt, bronchitis, emphysema, asthma,
      rhinitis, eczema, allergy diagnosed by doctor
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 26.939774475605834
    otg_id: NEALE2_20002_1111
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug TRALOKINUMAB is Phase III for the
        indiciation EFO_0000270 and targets the gene ENSG00000169194 at this locus
        (75015bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 131916940
    locus_GRCh38:
      chromosome: '5'
      position: 132581248
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma | non-cancer illness code, self-reported
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=341215
    gwas_catalog_id: GCST007798
    neg_log_pval: 31.154901959985743
    otg_id: GCST007798
    pubmed_id: '30929738'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-4 inhibitor drug PASCOLIZUMAB is Phase II for the indiciation
        EFO_0000270 and targets the gene ENSG00000113520 at this locus (92738bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113520
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 131916940
    locus_GRCh38:
      chromosome: '5'
      position: 132581248
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=90853
    gwas_catalog_id: GCST007562
    neg_log_pval: 11.0
    otg_id: GCST007562
    pubmed_id: '29785011'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-4 inhibitor drug PASCOLIZUMAB is Phase II for the indiciation
        EFO_0000270 and targets the gene ENSG00000113520 at this locus (84491bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113520
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 131925187
    locus_GRCh38:
      chromosome: '5'
      position: 132589495
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=90853
    gwas_catalog_id: GCST007562
    neg_log_pval: 11.0
    otg_id: GCST007562
    pubmed_id: '29785011'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug ANRUKINZUMAB is Phase II for the
        indiciation EFO_0000270 and targets the gene ENSG00000169194 at this locus
        (66768bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 131925187
    locus_GRCh38:
      chromosome: '5'
      position: 132589495
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=90853
    gwas_catalog_id: GCST007562
    neg_log_pval: 11.0
    otg_id: GCST007562
    pubmed_id: '29785011'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Interleukin-5 inhibitor drug MEPOLIZUMAB is Phase IV for the indiciation
        EFO_0000270 and targets the gene ENSG00000113525 at this locus (32657bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113525
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 131925187
    locus_GRCh38:
      chromosome: '5'
      position: 132589495
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=90853
    gwas_catalog_id: GCST007562
    neg_log_pval: 11.0
    otg_id: GCST007562
    pubmed_id: '29785011'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug TRALOKINUMAB is Phase III for the
        indiciation EFO_0000270 and targets the gene ENSG00000169194 at this locus
        (66768bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 131925187
    locus_GRCh38:
      chromosome: '5'
      position: 132589495
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=18190
    gwas_catalog_id: GCST002740
    neg_log_pval: 17.69897000433602
    otg_id: GCST002740_3
    pubmed_id: '25574825'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug TRALOKINUMAB is Phase III for the
        indiciation EFO_0000274 and targets the gene ENSG00000169194 at this locus
        (39733bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 131952222
    locus_GRCh38:
      chromosome: '5'
      position: 132616530
  trait_info:
    ontology:
    - EFO_0000274
    reported_trait_name: Inflammatory skin disease [Opposed]
    standard_trait_name: atopic eczema
- association_info:
    ancestry:
    - European=18190
    gwas_catalog_id: GCST002740
    neg_log_pval: 17.69897000433602
    otg_id: GCST002740_3
    pubmed_id: '25574825'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug LEBRIKIZUMAB is Phase II for the
        indiciation EFO_0000274 and targets the gene ENSG00000169194 at this locus
        (39733bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 131952222
    locus_GRCh38:
      chromosome: '5'
      position: 132616530
  trait_info:
    ontology:
    - EFO_0000274
    reported_trait_name: Inflammatory skin disease [Opposed]
    standard_trait_name: atopic eczema
- association_info:
    ancestry:
    - NR, European=212120
    gwas_catalog_id: GCST006409
    neg_log_pval: 8.698970004336019
    otg_id: GCST006409
    pubmed_id: '30013184'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug QAX-576 is Phase II for the indiciation
        EFO_0005854 and targets the gene ENSG00000169194 at this locus (36379bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 131955577
    locus_GRCh38:
      chromosome: '5'
      position: 132619885
  trait_info:
    ontology:
    - EFO_0005854
    reported_trait_name: Allergic rhinitis
    standard_trait_name: allergic rhinitis
- association_info:
    ancestry:
    - NR, European=212120
    gwas_catalog_id: GCST006409
    neg_log_pval: 8.698970004336019
    otg_id: GCST006409
    pubmed_id: '30013184'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug QAX-576 is Phase II for the indiciation
        EFO_0005854 and targets the gene ENSG00000169194 at this locus (36379bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: TATATATATATAG
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 131955577
    locus_GRCh38:
      chromosome: '5'
      position: 132619885
  trait_info:
    ontology:
    - EFO_0005854
    reported_trait_name: Allergic rhinitis
    standard_trait_name: allergic rhinitis
- association_info:
    ancestry:
    - NR, European=212120
    gwas_catalog_id: GCST006409
    neg_log_pval: 8.698970004336019
    otg_id: GCST006409
    pubmed_id: '30013184'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug QAX-576 is Phase II for the indiciation
        EFO_0005854 and targets the gene ENSG00000169194 at this locus (36379bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: TAGAG
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 131955577
    locus_GRCh38:
      chromosome: '5'
      position: 132619885
  trait_info:
    ontology:
    - EFO_0005854
    reported_trait_name: Allergic rhinitis
    standard_trait_name: allergic rhinitis
- association_info:
    ancestry:
    - NR, European=212120
    gwas_catalog_id: GCST006409
    neg_log_pval: 8.698970004336019
    otg_id: GCST006409
    pubmed_id: '30013184'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug QAX-576 is Phase II for the indiciation
        EFO_0005854 and targets the gene ENSG00000169194 at this locus (36379bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: TAG
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 131955577
    locus_GRCh38:
      chromosome: '5'
      position: 132619885
  trait_info:
    ontology:
    - EFO_0005854
    reported_trait_name: Allergic rhinitis
    standard_trait_name: allergic rhinitis
- association_info:
    ancestry:
    - NR, European=212120
    gwas_catalog_id: GCST006409
    neg_log_pval: 8.698970004336019
    otg_id: GCST006409
    pubmed_id: '30013184'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug QAX-576 is Phase II for the indiciation
        EFO_0005854 and targets the gene ENSG00000169194 at this locus (36379bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: TAA
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 131955577
    locus_GRCh38:
      chromosome: '5'
      position: 132619885
  trait_info:
    ontology:
    - EFO_0005854
    reported_trait_name: Allergic rhinitis
    standard_trait_name: allergic rhinitis
- association_info:
    ancestry:
    - European=103066
    - Hispanic or Latin American=1892
    - African American or Afro-Caribbean=1266
    - East Asian=9438
    - NR=1201
    gwas_catalog_id: GCST003184
    neg_log_pval: 16.397940008672037
    otg_id: GCST003184
    pubmed_id: '26482879'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug TRALOKINUMAB is Phase III for the
        indiciation EFO_0000274 and targets the gene ENSG00000169194 at this locus
        (871bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 131991085
    locus_GRCh38:
      chromosome: '5'
      position: 132655393
  trait_info:
    ontology:
    - EFO_0000274
    reported_trait_name: Atopic dermatitis [EA, fixed effects]
    standard_trait_name: atopic eczema
- association_info:
    ancestry:
    - European=103066
    - Hispanic or Latin American=1892
    - African American or Afro-Caribbean=1266
    - East Asian=9438
    - NR=1201
    gwas_catalog_id: GCST003184
    neg_log_pval: 16.397940008672037
    otg_id: GCST003184
    pubmed_id: '26482879'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug LEBRIKIZUMAB is Phase II for the
        indiciation EFO_0000274 and targets the gene ENSG00000169194 at this locus
        (871bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 131991085
    locus_GRCh38:
      chromosome: '5'
      position: 132655393
  trait_info:
    ontology:
    - EFO_0000274
    reported_trait_name: Atopic dermatitis [EA, fixed effects]
    standard_trait_name: atopic eczema
- association_info:
    ancestry:
    - European=401837
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 15.5654310959658
    otg_id: SAIGE_495
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug QAX-576 is Phase II for the indiciation
        EFO_0000270 and targets the gene ENSG00000169194 at this locus (74bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 131991881
    locus_GRCh38:
      chromosome: '5'
      position: 132656189
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=401837
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 15.5654310959658
    otg_id: SAIGE_495
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Interleukin-5 inhibitor drug MEPOLIZUMAB is Phase IV for the indiciation
        EFO_0000270 and targets the gene ENSG00000113525 at this locus (99351bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113525
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 131991881
    locus_GRCh38:
      chromosome: '5'
      position: 132656189
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=401837
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 15.5654310959658
    otg_id: SAIGE_495
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug LEBRIKIZUMAB is Phase III for the
        indiciation EFO_0000270 and targets the gene ENSG00000169194 at this locus
        (74bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 131991881
    locus_GRCh38:
      chromosome: '5'
      position: 132656189
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=401837
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 15.5654310959658
    otg_id: SAIGE_495
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-4 inhibitor drug PASCOLIZUMAB is Phase II for the indiciation
        EFO_0000270 and targets the gene ENSG00000113520 at this locus (17797bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113520
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 131991881
    locus_GRCh38:
      chromosome: '5'
      position: 132656189
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=5617
    gwas_catalog_id: GCST002100
    neg_log_pval: 16.69897000433602
    otg_id: GCST002100
    pubmed_id: '23886662'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug TRALOKINUMAB is Phase III for the
        indiciation EFO_0000274 and targets the gene ENSG00000169194 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 131995843
    locus_GRCh38:
      chromosome: '5'
      position: 132660151
  trait_info:
    ontology:
    - EFO_0000274
    reported_trait_name: Atopic dermatitis
    standard_trait_name: atopic eczema
- association_info:
    ancestry:
    - European=5946
    gwas_catalog_id: GCST002737
    neg_log_pval: 8.301029995663981
    otg_id: GCST002737
    pubmed_id: '25574825'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug TRALOKINUMAB is Phase III for the
        indiciation EFO_0000274 and targets the gene ENSG00000169194 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 131995843
    locus_GRCh38:
      chromosome: '5'
      position: 132660151
  trait_info:
    ontology:
    - EFO_0000274
    reported_trait_name: Atopic dermatitis
    standard_trait_name: atopic eczema
- association_info:
    ancestry:
    - European=5617
    gwas_catalog_id: GCST002100
    neg_log_pval: 16.69897000433602
    otg_id: GCST002100
    pubmed_id: '23886662'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug LEBRIKIZUMAB is Phase II for the
        indiciation EFO_0000274 and targets the gene ENSG00000169194 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 131995843
    locus_GRCh38:
      chromosome: '5'
      position: 132660151
  trait_info:
    ontology:
    - EFO_0000274
    reported_trait_name: Atopic dermatitis
    standard_trait_name: atopic eczema
- association_info:
    ancestry:
    - European=5946
    gwas_catalog_id: GCST002737
    neg_log_pval: 8.301029995663981
    otg_id: GCST002737
    pubmed_id: '25574825'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug LEBRIKIZUMAB is Phase II for the
        indiciation EFO_0000274 and targets the gene ENSG00000169194 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 131995843
    locus_GRCh38:
      chromosome: '5'
      position: 132660151
  trait_info:
    ontology:
    - EFO_0000274
    reported_trait_name: Atopic dermatitis
    standard_trait_name: atopic eczema
- association_info:
    ancestry:
    - African unspecified, African American or Afro-Caribbean=8204
    - European=127669
    - East Asian=5215
    - Hispanic or Latin American=1398
    gwas_catalog_id: GCST005212
    neg_log_pval: 15.301029995663981
    otg_id: GCST005212
    pubmed_id: '29273806'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug QAX-576 is Phase II for the indiciation
        EFO_0000270 and targets the gene ENSG00000169194 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 131995964
    locus_GRCh38:
      chromosome: '5'
      position: 132660272
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - African unspecified, African American or Afro-Caribbean=8204
    - European=127669
    - East Asian=5215
    - Hispanic or Latin American=1398
    gwas_catalog_id: GCST005212
    neg_log_pval: 15.301029995663981
    otg_id: GCST005212
    pubmed_id: '29273806'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug TRALOKINUMAB is Phase III for the
        indiciation EFO_0000270 and targets the gene ENSG00000169194 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 131995964
    locus_GRCh38:
      chromosome: '5'
      position: 132660272
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=127669
    gwas_catalog_id: GCST006862
    neg_log_pval: 13.853871964321762
    otg_id: GCST006862
    pubmed_id: '29273806'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug TRALOKINUMAB is Phase III for the
        indiciation EFO_0000270 and targets the gene ENSG00000169194 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 131995964
    locus_GRCh38:
      chromosome: '5'
      position: 132660272
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=127669
    gwas_catalog_id: GCST006862
    neg_log_pval: 13.853871964321762
    otg_id: GCST006862
    pubmed_id: '29273806'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-4 inhibitor drug PASCOLIZUMAB is Phase II for the indiciation
        EFO_0000270 and targets the gene ENSG00000113520 at this locus (13714bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113520
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 131995964
    locus_GRCh38:
      chromosome: '5'
      position: 132660272
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - African unspecified, African American or Afro-Caribbean=8204
    - European=127669
    - East Asian=5215
    - Hispanic or Latin American=1398
    gwas_catalog_id: GCST005212
    neg_log_pval: 15.301029995663981
    otg_id: GCST005212
    pubmed_id: '29273806'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-5 inhibitor drug RESLIZUMAB is Phase IV for the indiciation
        EFO_0000270 and targets the gene ENSG00000113525 at this locus (103434bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113525
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 131995964
    locus_GRCh38:
      chromosome: '5'
      position: 132660272
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=127669
    gwas_catalog_id: GCST006862
    neg_log_pval: 13.853871964321762
    otg_id: GCST006862
    pubmed_id: '29273806'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug QAX-576 is Phase II for the indiciation
        EFO_0000270 and targets the gene ENSG00000169194 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 131995964
    locus_GRCh38:
      chromosome: '5'
      position: 132660272
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - African unspecified, African American or Afro-Caribbean=8204
    - European=127669
    - East Asian=5215
    - Hispanic or Latin American=1398
    gwas_catalog_id: GCST005212
    neg_log_pval: 15.301029995663981
    otg_id: GCST005212
    pubmed_id: '29273806'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-4 inhibitor drug PASCOLIZUMAB is Phase II for the indiciation
        EFO_0000270 and targets the gene ENSG00000113520 at this locus (13714bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113520
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 131995964
    locus_GRCh38:
      chromosome: '5'
      position: 132660272
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=127669
    gwas_catalog_id: GCST006862
    neg_log_pval: 13.853871964321762
    otg_id: GCST006862
    pubmed_id: '29273806'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-5 inhibitor drug RESLIZUMAB is Phase IV for the indiciation
        EFO_0000270 and targets the gene ENSG00000113525 at this locus (103434bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113525
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 131995964
    locus_GRCh38:
      chromosome: '5'
      position: 132660272
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=7565
    gwas_catalog_id: GCST004866
    neg_log_pval: 8.301029995663981
    otg_id: GCST004866
    pubmed_id: '25608926'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug TRALOKINUMAB is Phase II for the
        indiciation EFO_0004192 and targets the gene ENSG00000169194 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 131996500
    locus_GRCh38:
      chromosome: '5'
      position: 132660808
  trait_info:
    ontology:
    - EFO_0004192
    reported_trait_name: Alopecia areata
    standard_trait_name: alopecia areata
- association_info:
    ancestry:
    - European=103066
    - Hispanic or Latin American=1892
    - African American or Afro-Caribbean=1266
    - East Asian=9438
    - NR=1201
    gwas_catalog_id: GCST003184
    neg_log_pval: 11.154901959985743
    otg_id: GCST003184_2
    pubmed_id: '26482879'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug LEBRIKIZUMAB is Phase II for the
        indiciation EFO_0000274 and targets the gene ENSG00000169194 at this locus
        (32057bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 132028858
    locus_GRCh38:
      chromosome: '5'
      position: 132693166
  trait_info:
    ontology:
    - EFO_0000274
    reported_trait_name: Atopic dermatitis [conditional on rs6419573]
    standard_trait_name: atopic eczema
- association_info:
    ancestry:
    - European=103066
    - Hispanic or Latin American=1892
    - African American or Afro-Caribbean=1266
    - East Asian=9438
    - NR=1201
    gwas_catalog_id: GCST003184
    neg_log_pval: 11.154901959985743
    otg_id: GCST003184_2
    pubmed_id: '26482879'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug TRALOKINUMAB is Phase III for the
        indiciation EFO_0000274 and targets the gene ENSG00000169194 at this locus
        (32057bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 132028858
    locus_GRCh38:
      chromosome: '5'
      position: 132693166
  trait_info:
    ontology:
    - EFO_0000274
    reported_trait_name: Atopic dermatitis [conditional on rs6419573]
    standard_trait_name: atopic eczema
- association_info:
    ancestry:
    - European=11181
    gwas_catalog_id: GCST003180
    neg_log_pval: 7.301029995663981
    otg_id: GCST003180
    pubmed_id: '26542096'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug LEBRIKIZUMAB is Phase II for the
        indiciation EFO_0000274 and targets the gene ENSG00000169194 at this locus
        (33866bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 132030667
    locus_GRCh38:
      chromosome: '5'
      position: 132694975
  trait_info:
    ontology:
    - EFO_0000274
    reported_trait_name: Atopic march
    standard_trait_name: atopic eczema
- association_info:
    ancestry:
    - European=11181
    gwas_catalog_id: GCST003180
    neg_log_pval: 7.301029995663981
    otg_id: GCST003180
    pubmed_id: '26542096'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug TRALOKINUMAB is Phase III for the
        indiciation EFO_0000274 and targets the gene ENSG00000169194 at this locus
        (33866bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 132030667
    locus_GRCh38:
      chromosome: '5'
      position: 132694975
  trait_info:
    ontology:
    - EFO_0000274
    reported_trait_name: Atopic march
    standard_trait_name: atopic eczema
- association_info:
    ancestry:
    - European=103066
    - Hispanic or Latin American=1892
    - African American or Afro-Caribbean=1266
    - East Asian=9438
    - NR=1201
    gwas_catalog_id: GCST003184
    neg_log_pval: 10.0
    otg_id: GCST003184
    pubmed_id: '26482879'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug TRALOKINUMAB is Phase III for the
        indiciation EFO_0000274 and targets the gene ENSG00000169194 at this locus
        (52225bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 132049027
    locus_GRCh38:
      chromosome: '5'
      position: 132713335
  trait_info:
    ontology:
    - EFO_0000274
    reported_trait_name: Atopic dermatitis [EA, fixed effects]
    standard_trait_name: atopic eczema
- association_info:
    ancestry:
    - European=26171
    gwas_catalog_id: GCST001363
    neg_log_pval: 7.3979400086720375
    otg_id: GCST001363
    pubmed_id: '22197932'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug TRALOKINUMAB is Phase III for the
        indiciation EFO_0000274 and targets the gene ENSG00000169194 at this locus
        (52225bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 132049027
    locus_GRCh38:
      chromosome: '5'
      position: 132713335
  trait_info:
    ontology:
    - EFO_0000274
    reported_trait_name: Atopic dermatitis
    standard_trait_name: atopic eczema
- association_info:
    ancestry:
    - European=103066
    - Hispanic or Latin American=1892
    - African American or Afro-Caribbean=1266
    - East Asian=9438
    - NR=1201
    gwas_catalog_id: GCST003184
    neg_log_pval: 10.0
    otg_id: GCST003184
    pubmed_id: '26482879'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug LEBRIKIZUMAB is Phase II for the
        indiciation EFO_0000274 and targets the gene ENSG00000169194 at this locus
        (52225bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 132049027
    locus_GRCh38:
      chromosome: '5'
      position: 132713335
  trait_info:
    ontology:
    - EFO_0000274
    reported_trait_name: Atopic dermatitis [EA, fixed effects]
    standard_trait_name: atopic eczema
- association_info:
    ancestry:
    - European=26171
    gwas_catalog_id: GCST001363
    neg_log_pval: 7.3979400086720375
    otg_id: GCST001363
    pubmed_id: '22197932'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug LEBRIKIZUMAB is Phase II for the
        indiciation EFO_0000274 and targets the gene ENSG00000169194 at this locus
        (52225bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 132049027
    locus_GRCh38:
      chromosome: '5'
      position: 132713335
  trait_info:
    ontology:
    - EFO_0000274
    reported_trait_name: Atopic dermatitis
    standard_trait_name: atopic eczema
- association_info:
    ancestry:
    - European=36955
    neg_log_pval: 8.737359096244738
    otg_id: NEALE2_3786_raw
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug TRALOKINUMAB is Phase III for the
        indiciation EFO_0000270 and targets the gene ENSG00000169194 at this locus
        (60072bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 132056874
    locus_GRCh38:
      chromosome: '5'
      position: 132721182
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Age asthma diagnosed
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=36955
    neg_log_pval: 8.737359096244738
    otg_id: NEALE2_3786_raw
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug ANRUKINZUMAB is Phase II for the
        indiciation EFO_0000270 and targets the gene ENSG00000169194 at this locus
        (60072bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 132056874
    locus_GRCh38:
      chromosome: '5'
      position: 132721182
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Age asthma diagnosed
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=36955
    neg_log_pval: 8.737359096244738
    otg_id: NEALE2_3786_raw
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-4 inhibitor drug PASCOLIZUMAB is Phase II for the indiciation
        EFO_0000270 and targets the gene ENSG00000113520 at this locus (38505bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113520
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 132056874
    locus_GRCh38:
      chromosome: '5'
      position: 132721182
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Age asthma diagnosed
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=36955
    neg_log_pval: 8.737359096244738
    otg_id: NEALE2_3786_raw
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-5 inhibitor drug MEPOLIZUMAB is Phase IV for the indiciation
        EFO_0000270 and targets the gene ENSG00000113525 at this locus (164345bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113525
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 132056874
    locus_GRCh38:
      chromosome: '5'
      position: 132721182
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Age asthma diagnosed
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=116538
    gwas_catalog_id: GCST007564
    neg_log_pval: 9.698970004336019
    otg_id: GCST007564
    pubmed_id: '29785011'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-5 inhibitor drug RESLIZUMAB is Phase IV for the indiciation
        EFO_0000270 and targets the gene ENSG00000113525 at this locus (168054bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113525
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 132060583
    locus_GRCh38:
      chromosome: '5'
      position: 132724891
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma or allergic disease (pleiotropy)
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=116538
    gwas_catalog_id: GCST007564
    neg_log_pval: 9.698970004336019
    otg_id: GCST007564
    pubmed_id: '29785011'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-4 inhibitor drug PASCOLIZUMAB is Phase II for the indiciation
        EFO_0000270 and targets the gene ENSG00000113520 at this locus (42213bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113520
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 132060583
    locus_GRCh38:
      chromosome: '5'
      position: 132724891
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma or allergic disease (pleiotropy)
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=116538
    gwas_catalog_id: GCST007564
    neg_log_pval: 9.698970004336019
    otg_id: GCST007564
    pubmed_id: '29785011'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug ANRUKINZUMAB is Phase II for the
        indiciation EFO_0000270 and targets the gene ENSG00000169194 at this locus
        (63781bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 132060583
    locus_GRCh38:
      chromosome: '5'
      position: 132724891
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma or allergic disease (pleiotropy)
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=116538
    gwas_catalog_id: GCST007564
    neg_log_pval: 9.698970004336019
    otg_id: GCST007564
    pubmed_id: '29785011'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug LEBRIKIZUMAB is Phase III for the
        indiciation EFO_0000270 and targets the gene ENSG00000169194 at this locus
        (63781bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 132060583
    locus_GRCh38:
      chromosome: '5'
      position: 132724891
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma or allergic disease (pleiotropy)
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European, East Asian, African American or Afro-Caribbean, Hispanic or Latin
      American, NR=257811
    gwas_catalog_id: GCST007692
    neg_log_pval: 7.698970004336019
    otg_id: GCST007692
    pubmed_id: '30804561'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug LEBRIKIZUMAB is Phase II for the
        indiciation EFO_0000341 and targets the gene ENSG00000169194 at this locus
        (442208bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 132439010
    locus_GRCh38:
      chromosome: '5'
      position: 133103318
  trait_info:
    ontology:
    - EFO_0000341
    reported_trait_name: Chronic obstructive pulmonary disease
    standard_trait_name: chronic obstructive pulmonary disease
- association_info:
    ancestry:
    - European, East Asian, African American or Afro-Caribbean, Hispanic or Latin
      American, NR=257811
    gwas_catalog_id: GCST007692
    neg_log_pval: 7.698970004336019
    otg_id: GCST007692
    pubmed_id: '30804561'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-13 inhibitor drug LEBRIKIZUMAB is Phase II for the
        indiciation EFO_0000341 and targets the gene ENSG00000169194 at this locus
        (442208bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169194
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 132439010
    locus_GRCh38:
      chromosome: '5'
      position: 133103318
  trait_info:
    ontology:
    - EFO_0000341
    reported_trait_name: Chronic obstructive pulmonary disease
    standard_trait_name: chronic obstructive pulmonary disease
- association_info:
    ancestry:
    - European=537409
    - East Asian=36792
    - African American or Afro-Caribbean=8967
    - Hispanic or Latin American=5022
    gwas_catalog_id: GCST006061
    neg_log_pval: 10.221848749616356
    otg_id: GCST006061_3
    pubmed_id: '29892015'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Glucocorticoid receptor agonist drug HYDROCORTISONE is Phase II
        for the indiciation EFO_0000275 and targets the gene ENSG00000113580 at this
        locus (7093bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113580
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 142650404
    locus_GRCh38:
      chromosome: '5'
      position: 143270839
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation [EA]
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=537409
    - East Asian=36792
    - African American or Afro-Caribbean=8967
    - Hispanic or Latin American=5022
    gwas_catalog_id: GCST006061
    neg_log_pval: 11.0
    otg_id: GCST006061
    pubmed_id: '29892015'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Glucocorticoid receptor agonist drug HYDROCORTISONE is Phase II
        for the indiciation EFO_0000275 and targets the gene ENSG00000113580 at this
        locus (7093bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113580
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 142650404
    locus_GRCh38:
      chromosome: '5'
      position: 143270839
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=537409
    - East Asian=36792
    - African American or Afro-Caribbean=8967
    - Hispanic or Latin American=5022
    gwas_catalog_id: GCST006061
    neg_log_pval: 11.0
    otg_id: GCST006061
    pubmed_id: '29892015'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Glucocorticoid receptor agonist drug PREDNISONE is Phase IV for
        the indiciation EFO_0000275 and targets the gene ENSG00000113580 at this locus
        (7093bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113580
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 142650404
    locus_GRCh38:
      chromosome: '5'
      position: 143270839
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=537409
    - East Asian=36792
    - African American or Afro-Caribbean=8967
    - Hispanic or Latin American=5022
    gwas_catalog_id: GCST006061
    neg_log_pval: 10.221848749616356
    otg_id: GCST006061_3
    pubmed_id: '29892015'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Glucocorticoid receptor agonist drug PREDNISONE is Phase IV for
        the indiciation EFO_0000275 and targets the gene ENSG00000113580 at this locus
        (7093bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113580
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 142650404
    locus_GRCh38:
      chromosome: '5'
      position: 143270839
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation [EA]
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=1030836
    gwas_catalog_id: GCST006414
    neg_log_pval: 16.716472635138306
    otg_id: GCST006414
    pubmed_id: '30061737'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Glucocorticoid receptor agonist drug METHYLPREDNISOLONE HEMISUCCINATE
        is Phase IV for the indiciation EFO_0000275 and targets the gene ENSG00000113580
        at this locus (65455bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113580
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 142880532
    locus_GRCh38:
      chromosome: '5'
      position: 143500967
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=1030836
    gwas_catalog_id: GCST006414
    neg_log_pval: 16.716472635138306
    otg_id: GCST006414
    pubmed_id: '30061737'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Glucocorticoid receptor agonist drug HYDROCORTISONE is Phase II
        for the indiciation EFO_0000275 and targets the gene ENSG00000113580 at this
        locus (65455bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113580
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 142880532
    locus_GRCh38:
      chromosome: '5'
      position: 143500967
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European, East Asian, African American or Afro-Caribbean, Hispanic or Latin
      American, NR=257811
    gwas_catalog_id: GCST007692
    neg_log_pval: 32.52287874528034
    otg_id: GCST007692
    pubmed_id: '30804561'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Beta-2 adrenergic receptor agonist drug FENOTEROL is Phase III
        for the indiciation EFO_0000341 and targets the gene ENSG00000169252 at this
        locus (349839bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169252
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 147854970
    locus_GRCh38:
      chromosome: '5'
      position: 148475407
  trait_info:
    ontology:
    - EFO_0000341
    reported_trait_name: Chronic obstructive pulmonary disease
    standard_trait_name: chronic obstructive pulmonary disease
- association_info:
    ancestry:
    - European, East Asian, African American or Afro-Caribbean, Hispanic or Latin
      American, NR=257811
    gwas_catalog_id: GCST007692
    neg_log_pval: 32.52287874528034
    otg_id: GCST007692
    pubmed_id: '30804561'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Beta-2 adrenergic receptor partial agonist drug CELIPROLOL is Phase
        IV for the indiciation EFO_0000341 and targets the gene ENSG00000169252 at
        this locus (349839bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169252
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 147854970
    locus_GRCh38:
      chromosome: '5'
      position: 148475407
  trait_info:
    ontology:
    - EFO_0000341
    reported_trait_name: Chronic obstructive pulmonary disease
    standard_trait_name: chronic obstructive pulmonary disease
- association_info:
    ancestry:
    - European, East Asian, African American or Afro-Caribbean, Hispanic or Latin
      American, NR=257811
    gwas_catalog_id: GCST007692
    neg_log_pval: 32.52287874528034
    otg_id: GCST007692
    pubmed_id: '30804561'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Beta-2 adrenergic receptor agonist drug CARMOTEROL is Phase II
        for the indiciation EFO_0000341 and targets the gene ENSG00000169252 at this
        locus (349839bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169252
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 147854970
    locus_GRCh38:
      chromosome: '5'
      position: 148475407
  trait_info:
    ontology:
    - EFO_0000341
    reported_trait_name: Chronic obstructive pulmonary disease
    standard_trait_name: chronic obstructive pulmonary disease
- association_info:
    ancestry:
    - European, NR=58918
    - European=458554
    gwas_catalog_id: GCST007611
    neg_log_pval: 13.0
    otg_id: GCST007611
    pubmed_id: '30940143'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Beta-2 adrenergic receptor agonist drug SALMETEROL is Phase IV
        for the indiciation EFO_0000341 and targets the gene ENSG00000169252 at this
        locus (348475bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169252
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 147856333
    locus_GRCh38:
      chromosome: '5'
      position: 148476770
  trait_info:
    ontology:
    - EFO_0000341
    reported_trait_name: Chronic obstructive pulmonary disease or high blood pressure
      (pleiotropy)
    standard_trait_name: chronic obstructive pulmonary disease
- association_info:
    ancestry:
    - European, NR=58918
    - European=458554
    gwas_catalog_id: GCST007611
    neg_log_pval: 13.0
    otg_id: GCST007611
    pubmed_id: '30940143'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Beta-2 adrenergic receptor agonist drug FENOTEROL is Phase III
        for the indiciation EFO_0000341 and targets the gene ENSG00000169252 at this
        locus (348475bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169252
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 147856333
    locus_GRCh38:
      chromosome: '5'
      position: 148476770
  trait_info:
    ontology:
    - EFO_0000341
    reported_trait_name: Chronic obstructive pulmonary disease or high blood pressure
      (pleiotropy)
    standard_trait_name: chronic obstructive pulmonary disease
- association_info:
    ancestry:
    - European, NR=58918
    - European=458554
    gwas_catalog_id: GCST007611
    neg_log_pval: 13.0
    otg_id: GCST007611
    pubmed_id: '30940143'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Beta-2 adrenergic receptor agonist drug CARMOTEROL is Phase II
        for the indiciation EFO_0000341 and targets the gene ENSG00000169252 at this
        locus (348475bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169252
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 147856333
    locus_GRCh38:
      chromosome: '5'
      position: 148476770
  trait_info:
    ontology:
    - EFO_0000341
    reported_trait_name: Chronic obstructive pulmonary disease or high blood pressure
      (pleiotropy)
    standard_trait_name: chronic obstructive pulmonary disease
- association_info:
    ancestry:
    - African American or Afro-Caribbean=3522
    - Hispanic or Latin American=600
    - European=47856
    - East Asian=6940
    gwas_catalog_id: GCST004147
    neg_log_pval: 25.30102999566398
    otg_id: GCST004147
    pubmed_id: '28166215'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Beta-2 adrenergic receptor agonist drug FENOTEROL is Phase III
        for the indiciation EFO_0000341 and targets the gene ENSG00000169252 at this
        locus (348475bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169252
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 147856333
    locus_GRCh38:
      chromosome: '5'
      position: 148476770
  trait_info:
    ontology:
    - EFO_0000341
    reported_trait_name: Chronic obstructive pulmonary disease
    standard_trait_name: chronic obstructive pulmonary disease
- association_info:
    ancestry:
    - African American or Afro-Caribbean=3522
    - Hispanic or Latin American=600
    - European=47856
    - East Asian=6940
    gwas_catalog_id: GCST004147
    neg_log_pval: 25.30102999566398
    otg_id: GCST004147
    pubmed_id: '28166215'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Beta-2 adrenergic receptor agonist drug CARMOTEROL is Phase II
        for the indiciation EFO_0000341 and targets the gene ENSG00000169252 at this
        locus (348475bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169252
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 147856333
    locus_GRCh38:
      chromosome: '5'
      position: 148476770
  trait_info:
    ontology:
    - EFO_0000341
    reported_trait_name: Chronic obstructive pulmonary disease
    standard_trait_name: chronic obstructive pulmonary disease
- association_info:
    ancestry:
    - European, NR=58918
    - European=458554
    gwas_catalog_id: GCST007611
    neg_log_pval: 13.0
    otg_id: GCST007611
    pubmed_id: '30940143'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Beta-2 adrenergic receptor antagonist drug PROPRANOLOL is Phase
        IV for the indiciation EFO_0000537 and targets the gene ENSG00000169252 at
        this locus (348475bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169252
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 147856333
    locus_GRCh38:
      chromosome: '5'
      position: 148476770
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Chronic obstructive pulmonary disease or high blood pressure
      (pleiotropy)
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - African American or Afro-Caribbean=3522
    - Hispanic or Latin American=600
    - European=47856
    - East Asian=6940
    gwas_catalog_id: GCST004147
    neg_log_pval: 25.30102999566398
    otg_id: GCST004147
    pubmed_id: '28166215'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Beta-2 adrenergic receptor agonist drug SALMETEROL is Phase IV
        for the indiciation EFO_0000341 and targets the gene ENSG00000169252 at this
        locus (348475bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169252
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 147856333
    locus_GRCh38:
      chromosome: '5'
      position: 148476770
  trait_info:
    ontology:
    - EFO_0000341
    reported_trait_name: Chronic obstructive pulmonary disease
    standard_trait_name: chronic obstructive pulmonary disease
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 8.715497077748008
    otg_id: NEALE2_20002_1065
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Beta-2 adrenergic receptor antagonist drug NEBIVOLOL is Phase IV
        for the indiciation EFO_0000537 and targets the gene ENSG00000169252 at this
        locus (139293bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169252
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 148347543
    locus_GRCh38:
      chromosome: '5'
      position: 148967980
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Hypertension | non-cancer illness code, self-reported
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - European=88583
    gwas_catalog_id: GCST007505
    neg_log_pval: 8.698970004336019
    otg_id: GCST007505
    pubmed_id: '30429480'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Macrophage colony stimulating factor receptor inhibitor drug VATALANIB
        is Phase II for the indiciation EFO_0000389 and targets the gene ENSG00000182578
        at this locus (236621bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000182578
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 149196234
    locus_GRCh38:
      chromosome: '5'
      position: 149816671
  trait_info:
    ontology:
    - EFO_0000389
    reported_trait_name: Nevus count or cutaneous melanoma
    standard_trait_name: skin melanoma
- association_info:
    ancestry:
    - European=88583
    gwas_catalog_id: GCST007505
    neg_log_pval: 8.698970004336019
    otg_id: GCST007505
    pubmed_id: '30429480'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Platelet-derived growth factor receptor beta inhibitor drug DASATINIB
        is Phase II for the indiciation EFO_0000389 and targets the gene ENSG00000113721
        at this locus (297168bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113721
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 149196234
    locus_GRCh38:
      chromosome: '5'
      position: 149816671
  trait_info:
    ontology:
    - EFO_0000389
    reported_trait_name: Nevus count or cutaneous melanoma
    standard_trait_name: skin melanoma
- association_info:
    ancestry:
    - European=88583
    gwas_catalog_id: GCST007505
    neg_log_pval: 8.698970004336019
    otg_id: GCST007505
    pubmed_id: '30429480'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Platelet-derived growth factor receptor beta inhibitor drug SORAFENIB
        is Phase III for the indiciation EFO_0000389 and targets the gene ENSG00000113721
        at this locus (297168bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113721
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 149196234
    locus_GRCh38:
      chromosome: '5'
      position: 149816671
  trait_info:
    ontology:
    - EFO_0000389
    reported_trait_name: Nevus count or cutaneous melanoma
    standard_trait_name: skin melanoma
- association_info:
    ancestry:
    - European=33394
    gwas_catalog_id: GCST005527
    neg_log_pval: 10.388393510619363
    otg_id: GCST005527
    pubmed_id: '23143594'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-12 subunit beta inhibitor drug BRIAKINUMAB is Phase
        III for the indiciation EFO_0000676 and targets the gene ENSG00000113302 at
        this locus (71878bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 158669913
    locus_GRCh38:
      chromosome: '5'
      position: 159242905
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=33394
    gwas_catalog_id: GCST005527
    neg_log_pval: 10.388393510619363
    otg_id: GCST005527
    pubmed_id: '23143594'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Interleukin-12 inhibitor drug USTEKINUMAB is Phase IV for the indiciation
        EFO_0000676 and targets the gene ENSG00000113302 at this locus (71878bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 158669913
    locus_GRCh38:
      chromosome: '5'
      position: 159242905
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=2759
    gwas_catalog_id: GCST000322
    neg_log_pval: 27.69897000433602
    otg_id: GCST000322
    pubmed_id: '19169254'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Interleukin-12 inhibitor drug USTEKINUMAB is Phase IV for the indiciation
        EFO_0000676 and targets the gene ENSG00000113302 at this locus (24003bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 158717789
    locus_GRCh38:
      chromosome: '5'
      position: 159290781
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=6297
    gwas_catalog_id: GCST003269
    neg_log_pval: 13.0
    otg_id: GCST003269
    pubmed_id: '26626624'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-12 subunit beta inhibitor drug BRIAKINUMAB is Phase
        III for the indiciation EFO_0000676 and targets the gene ENSG00000113302 at
        this locus (24003bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 158717789
    locus_GRCh38:
      chromosome: '5'
      position: 159290781
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Cutaneous psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=2759
    gwas_catalog_id: GCST000322
    neg_log_pval: 27.69897000433602
    otg_id: GCST000322
    pubmed_id: '19169254'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-12 subunit beta inhibitor drug BRIAKINUMAB is Phase
        III for the indiciation EFO_0000676 and targets the gene ENSG00000113302 at
        this locus (24003bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 158717789
    locus_GRCh38:
      chromosome: '5'
      position: 159290781
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=6297
    gwas_catalog_id: GCST003269
    neg_log_pval: 13.0
    otg_id: GCST003269
    pubmed_id: '26626624'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Interleukin-12 inhibitor drug USTEKINUMAB is Phase IV for the indiciation
        EFO_0000676 and targets the gene ENSG00000113302 at this locus (24003bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 158717789
    locus_GRCh38:
      chromosome: '5'
      position: 159290781
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Cutaneous psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - East Asian=5134
    - European=8682
    gwas_catalog_id: GCST002874
    neg_log_pval: 9.301029995663981
    otg_id: GCST002874_10
    pubmed_id: '25903422'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Interleukin-12 inhibitor drug USTEKINUMAB is Phase IV for the indiciation
        EFO_0000676 and targets the gene ENSG00000113302 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 158749088
    locus_GRCh38:
      chromosome: '5'
      position: 159322080
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis [conditional on rs7709212, rs4921493]
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - East Asian=5134
    - European=8682
    gwas_catalog_id: GCST002874
    neg_log_pval: 9.301029995663981
    otg_id: GCST002874_10
    pubmed_id: '25903422'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-12 subunit beta inhibitor drug BRIAKINUMAB is Phase
        III for the indiciation EFO_0000676 and targets the gene ENSG00000113302 at
        this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 158749088
    locus_GRCh38:
      chromosome: '5'
      position: 159322080
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis [conditional on rs7709212, rs4921493]
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - East Asian=5134
    - European=8682
    gwas_catalog_id: GCST002874
    neg_log_pval: 7.698970004336019
    otg_id: GCST002874_6
    pubmed_id: '25903422'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Interleukin-12 inhibitor drug USTEKINUMAB is Phase IV for the indiciation
        EFO_0000676 and targets the gene ENSG00000113302 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 158749088
    locus_GRCh38:
      chromosome: '5'
      position: 159322080
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis [EA, conditional on rs7709212, rs4921493]
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - East Asian=5134
    - European=8682
    gwas_catalog_id: GCST002874
    neg_log_pval: 7.698970004336019
    otg_id: GCST002874_6
    pubmed_id: '25903422'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-12 subunit beta inhibitor drug BRIAKINUMAB is Phase
        III for the indiciation EFO_0000676 and targets the gene ENSG00000113302 at
        this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 158749088
    locus_GRCh38:
      chromosome: '5'
      position: 159322080
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis [EA, conditional on rs7709212, rs4921493]
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=7353
    gwas_catalog_id: GCST000833
    neg_log_pval: 10.301029995663981
    otg_id: GCST000833
    pubmed_id: '20953190'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Interleukin-12 inhibitor drug USTEKINUMAB is Phase IV for the indiciation
        EFO_0000676 and targets the gene ENSG00000113302 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 158750769
    locus_GRCh38:
      chromosome: '5'
      position: 159323761
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - East Asian=2271
    gwas_catalog_id: GCST000321
    neg_log_pval: 25.522878745280337
    otg_id: GCST000321
    pubmed_id: '19169255'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Interleukin-12 inhibitor drug USTEKINUMAB is Phase IV for the indiciation
        EFO_0000676 and targets the gene ENSG00000113302 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 158750769
    locus_GRCh38:
      chromosome: '5'
      position: 159323761
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=7353
    gwas_catalog_id: GCST000833
    neg_log_pval: 10.301029995663981
    otg_id: GCST000833
    pubmed_id: '20953190'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-12 subunit beta inhibitor drug BRIAKINUMAB is Phase
        III for the indiciation EFO_0000676 and targets the gene ENSG00000113302 at
        this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 158750769
    locus_GRCh38:
      chromosome: '5'
      position: 159323761
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - East Asian=2271
    gwas_catalog_id: GCST000321
    neg_log_pval: 25.522878745280337
    otg_id: GCST000321
    pubmed_id: '19169255'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-12 subunit beta inhibitor drug BRIAKINUMAB is Phase
        III for the indiciation EFO_0000676 and targets the gene ENSG00000113302 at
        this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 158750769
    locus_GRCh38:
      chromosome: '5'
      position: 159323761
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=398907
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 8.0268721464003
    otg_id: SAIGE_696_42
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Interleukin-12 inhibitor drug USTEKINUMAB is Phase IV for the indiciation
        EFO_0003778 and targets the gene ENSG00000113302 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 158755845
    locus_GRCh38:
      chromosome: '5'
      position: 159328837
  trait_info:
    ontology:
    - EFO_0003778
    reported_trait_name: Psoriatic arthropathy
    standard_trait_name: psoriatic arthritis
- association_info:
    ancestry:
    - European=18190
    gwas_catalog_id: GCST002740
    neg_log_pval: 34.52287874528034
    otg_id: GCST002740_4
    pubmed_id: '25574825'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Interleukin-12 inhibitor drug USTEKINUMAB is Phase IV for the indiciation
        EFO_0000676 and targets the gene ENSG00000113302 at this locus (2006bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 158759900
    locus_GRCh38:
      chromosome: '5'
      position: 159332892
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Inflammatory skin disease [Psoriasis]
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=1618
    gwas_catalog_id: GCST000836
    neg_log_pval: 20.0
    otg_id: GCST000836
    pubmed_id: '20953188'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Interleukin-12 inhibitor drug USTEKINUMAB is Phase IV for the indiciation
        EFO_0000676 and targets the gene ENSG00000113302 at this locus (2006bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 158759900
    locus_GRCh38:
      chromosome: '5'
      position: 159332892
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=1618
    gwas_catalog_id: GCST000836
    neg_log_pval: 20.0
    otg_id: GCST000836
    pubmed_id: '20953188'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-12 subunit beta inhibitor drug BRIAKINUMAB is Phase
        III for the indiciation EFO_0000676 and targets the gene ENSG00000113302 at
        this locus (2006bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 158759900
    locus_GRCh38:
      chromosome: '5'
      position: 159332892
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=18190
    gwas_catalog_id: GCST002740
    neg_log_pval: 34.52287874528034
    otg_id: GCST002740_4
    pubmed_id: '25574825'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-12 subunit beta inhibitor drug BRIAKINUMAB is Phase
        III for the indiciation EFO_0000676 and targets the gene ENSG00000113302 at
        this locus (2006bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 158759900
    locus_GRCh38:
      chromosome: '5'
      position: 159332892
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Inflammatory skin disease [Psoriasis]
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - East Asian=5134
    - European=8682
    gwas_catalog_id: GCST002874
    neg_log_pval: 19.522878745280337
    otg_id: GCST002874_8
    pubmed_id: '25903422'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-12 subunit beta inhibitor drug BRIAKINUMAB is Phase
        III for the indiciation EFO_0000676 and targets the gene ENSG00000113302 at
        this locus (6282bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 158764177
    locus_GRCh38:
      chromosome: '5'
      position: 159337169
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis [EA]
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - East Asian=5134
    - European=8682
    gwas_catalog_id: GCST002874
    neg_log_pval: 11.0
    otg_id: GCST002874_3
    pubmed_id: '25903422'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Interleukin-12 inhibitor drug USTEKINUMAB is Phase IV for the indiciation
        EFO_0000676 and targets the gene ENSG00000113302 at this locus (6282bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 158764177
    locus_GRCh38:
      chromosome: '5'
      position: 159337169
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis [Chinese]
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - East Asian=5134
    - European=8682
    gwas_catalog_id: GCST002874
    neg_log_pval: 8.301029995663981
    otg_id: GCST002874_2
    pubmed_id: '25903422'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Interleukin-12 inhibitor drug USTEKINUMAB is Phase IV for the indiciation
        EFO_0000676 and targets the gene ENSG00000113302 at this locus (6282bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 158764177
    locus_GRCh38:
      chromosome: '5'
      position: 159337169
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis [Chinese, conditional on rs1990760]
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - East Asian=5134
    - European=8682
    gwas_catalog_id: GCST002874
    neg_log_pval: 11.0
    otg_id: GCST002874_3
    pubmed_id: '25903422'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-12 subunit beta inhibitor drug BRIAKINUMAB is Phase
        III for the indiciation EFO_0000676 and targets the gene ENSG00000113302 at
        this locus (6282bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 158764177
    locus_GRCh38:
      chromosome: '5'
      position: 159337169
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis [Chinese]
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - East Asian=5134
    - European=8682
    gwas_catalog_id: GCST002874
    neg_log_pval: 19.522878745280337
    otg_id: GCST002874_8
    pubmed_id: '25903422'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Interleukin-12 inhibitor drug USTEKINUMAB is Phase IV for the indiciation
        EFO_0000676 and targets the gene ENSG00000113302 at this locus (6282bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 158764177
    locus_GRCh38:
      chromosome: '5'
      position: 159337169
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis [EA]
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - East Asian=5134
    - European=8682
    gwas_catalog_id: GCST002874
    neg_log_pval: 29.69897000433602
    otg_id: GCST002874
    pubmed_id: '25903422'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Interleukin-12 inhibitor drug USTEKINUMAB is Phase IV for the indiciation
        EFO_0000676 and targets the gene ENSG00000113302 at this locus (6282bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 158764177
    locus_GRCh38:
      chromosome: '5'
      position: 159337169
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - East Asian=5134
    - European=8682
    gwas_catalog_id: GCST002874
    neg_log_pval: 8.301029995663981
    otg_id: GCST002874_2
    pubmed_id: '25903422'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-12 subunit beta inhibitor drug BRIAKINUMAB is Phase
        III for the indiciation EFO_0000676 and targets the gene ENSG00000113302 at
        this locus (6282bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 158764177
    locus_GRCh38:
      chromosome: '5'
      position: 159337169
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis [Chinese, conditional on rs1990760]
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - East Asian=5134
    - European=8682
    gwas_catalog_id: GCST002874
    neg_log_pval: 29.69897000433602
    otg_id: GCST002874
    pubmed_id: '25903422'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-12 subunit beta inhibitor drug BRIAKINUMAB is Phase
        III for the indiciation EFO_0000676 and targets the gene ENSG00000113302 at
        this locus (6282bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 158764177
    locus_GRCh38:
      chromosome: '5'
      position: 159337169
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=6880
    gwas_catalog_id: GCST003270
    neg_log_pval: 24.0
    otg_id: GCST003270
    pubmed_id: '26626624'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Interleukin-12 inhibitor drug USTEKINUMAB is Phase IV for the indiciation
        EFO_0003778 and targets the gene ENSG00000113302 at this locus (6584bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 158764478
    locus_GRCh38:
      chromosome: '5'
      position: 159337470
  trait_info:
    ontology:
    - EFO_0003778
    reported_trait_name: Psoriatic arthritis
    standard_trait_name: psoriatic arthritis
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 22.400348322298537
    otg_id: NEALE2_20002_1453
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Interleukin-12 inhibitor drug USTEKINUMAB is Phase IV for the indiciation
        EFO_0000676 and targets the gene ENSG00000113302 at this locus (8128bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 158766022
    locus_GRCh38:
      chromosome: '5'
      position: 159339014
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis | non-cancer illness code, self-reported
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 22.400348322298537
    otg_id: NEALE2_20002_1453
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-12 subunit beta inhibitor drug BRIAKINUMAB is Phase
        III for the indiciation EFO_0000676 and targets the gene ENSG00000113302 at
        this locus (8128bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 158766022
    locus_GRCh38:
      chromosome: '5'
      position: 159339014
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis | non-cancer illness code, self-reported
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=2198
    gwas_catalog_id: GCST007043
    neg_log_pval: 9.045757490560675
    otg_id: GCST007043
    pubmed_id: '30552173'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Interleukin-12 inhibitor drug USTEKINUMAB is Phase IV for the indiciation
        EFO_0003778 and targets the gene ENSG00000113302 at this locus (10470bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 158768365
    locus_GRCh38:
      chromosome: '5'
      position: 159341357
  trait_info:
    ontology:
    - EFO_0003778
    reported_trait_name: Psoriatic arthritis
    standard_trait_name: psoriatic arthritis
- association_info:
    ancestry:
    - European=20883
    gwas_catalog_id: GCST003044
    neg_log_pval: 33.5271134750456
    otg_id: GCST003044
    pubmed_id: '26192919'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-23 inhibitor drug USTEKINUMAB is Phase III for the
        indiciation EFO_0000384 and targets the gene ENSG00000113302 at this locus
        (13443bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 158771337
    locus_GRCh38:
      chromosome: '5'
      position: 159344329
  trait_info:
    ontology:
    - EFO_0000384
    reported_trait_name: Crohn's disease [EA]
    standard_trait_name: Crohn's disease
- association_info:
    ancestry:
    - European=20883
    gwas_catalog_id: GCST003044
    neg_log_pval: 33.5271134750456
    otg_id: GCST003044
    pubmed_id: '26192919'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-12 subunit beta inhibitor drug BRIAKINUMAB is Phase
        II for the indiciation EFO_0000384 and targets the gene ENSG00000113302 at
        this locus (13443bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 158771337
    locus_GRCh38:
      chromosome: '5'
      position: 159344329
  trait_info:
    ontology:
    - EFO_0000384
    reported_trait_name: Crohn's disease [EA]
    standard_trait_name: Crohn's disease
- association_info:
    ancestry:
    - European=27432
    gwas_catalog_id: GCST003045
    neg_log_pval: 16.91802094893202
    otg_id: GCST003045
    pubmed_id: '26192919'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-23 inhibitor drug USTEKINUMAB is Phase III for the
        indiciation EFO_0000729 and targets the gene ENSG00000113302 at this locus
        (17070bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 158774965
    locus_GRCh38:
      chromosome: '5'
      position: 159347957
  trait_info:
    ontology:
    - EFO_0000729
    reported_trait_name: Ulcerative colitis [EA]
    standard_trait_name: ulcerative colitis
- association_info:
    ancestry:
    - European, NR=45975
    gwas_catalog_id: GCST004133
    neg_log_pval: 19.67571754470231
    otg_id: GCST004133
    pubmed_id: '28067908'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-23 inhibitor drug USTEKINUMAB is Phase III for the
        indiciation EFO_0000729 and targets the gene ENSG00000113302 at this locus
        (17070bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 158774965
    locus_GRCh38:
      chromosome: '5'
      position: 159347957
  trait_info:
    ontology:
    - EFO_0000729
    reported_trait_name: Ulcerative colitis
    standard_trait_name: ulcerative colitis
- association_info:
    ancestry:
    - European=21389
    gwas_catalog_id: GCST000879
    neg_log_pval: 13.301029995663981
    otg_id: GCST000879
    pubmed_id: '21102463'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-12 subunit beta inhibitor drug BRIAKINUMAB is Phase
        II for the indiciation EFO_0000384 and targets the gene ENSG00000113302 at
        this locus (29491bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 158787385
    locus_GRCh38:
      chromosome: '5'
      position: 159360377
  trait_info:
    ontology:
    - EFO_0000384
    reported_trait_name: Crohn's disease
    standard_trait_name: Crohn's disease
- association_info:
    ancestry:
    - European=21389
    gwas_catalog_id: GCST000879
    neg_log_pval: 13.301029995663981
    otg_id: GCST000879
    pubmed_id: '21102463'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-23 inhibitor drug USTEKINUMAB is Phase III for the
        indiciation EFO_0000384 and targets the gene ENSG00000113302 at this locus
        (29491bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 158787385
    locus_GRCh38:
      chromosome: '5'
      position: 159360377
  trait_info:
    ontology:
    - EFO_0000384
    reported_trait_name: Crohn's disease
    standard_trait_name: Crohn's disease
- association_info:
    ancestry:
    - European, NR=40266
    gwas_catalog_id: GCST004132
    neg_log_pval: 19.061080187755227
    otg_id: GCST004132
    pubmed_id: '28067908'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-23 inhibitor drug USTEKINUMAB is Phase III for the
        indiciation EFO_0000384 and targets the gene ENSG00000113302 at this locus
        (40181bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 158798075
    locus_GRCh38:
      chromosome: '5'
      position: 159371067
  trait_info:
    ontology:
    - EFO_0000384
    reported_trait_name: Crohn's disease
    standard_trait_name: Crohn's disease
- association_info:
    ancestry:
    - European, NR=40266
    gwas_catalog_id: GCST004132
    neg_log_pval: 19.061080187755227
    otg_id: GCST004132
    pubmed_id: '28067908'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-12 subunit beta inhibitor drug BRIAKINUMAB is Phase
        II for the indiciation EFO_0000384 and targets the gene ENSG00000113302 at
        this locus (40181bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 158798075
    locus_GRCh38:
      chromosome: '5'
      position: 159371067
  trait_info:
    ontology:
    - EFO_0000384
    reported_trait_name: Crohn's disease
    standard_trait_name: Crohn's disease
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 20.03839715731701
    otg_id: NEALE2_20002_1453
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-12 subunit beta inhibitor drug BRIAKINUMAB is Phase
        III for the indiciation EFO_0000676 and targets the gene ENSG00000113302 at
        this locus (52898bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 158810793
    locus_GRCh38:
      chromosome: '5'
      position: 159383785
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis | non-cancer illness code, self-reported
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 20.03839715731701
    otg_id: NEALE2_20002_1453
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Interleukin-12 inhibitor drug USTEKINUMAB is Phase IV for the indiciation
        EFO_0000676 and targets the gene ENSG00000113302 at this locus (52898bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 158810793
    locus_GRCh38:
      chromosome: '5'
      position: 159383785
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis | non-cancer illness code, self-reported
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=9541
    gwas_catalog_id: GCST000207
    neg_log_pval: 12.397940008672037
    otg_id: GCST000207
    pubmed_id: '18587394'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-12 subunit beta inhibitor drug BRIAKINUMAB is Phase
        II for the indiciation EFO_0000384 and targets the gene ENSG00000113302 at
        this locus (56638bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 158814533
    locus_GRCh38:
      chromosome: '5'
      position: 159387525
  trait_info:
    ontology:
    - EFO_0000384
    reported_trait_name: Crohn's disease
    standard_trait_name: Crohn's disease
- association_info:
    ancestry:
    - European=9541
    gwas_catalog_id: GCST000207
    neg_log_pval: 12.397940008672037
    otg_id: GCST000207
    pubmed_id: '18587394'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-23 inhibitor drug USTEKINUMAB is Phase III for the
        indiciation EFO_0000384 and targets the gene ENSG00000113302 at this locus
        (56638bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 158814533
    locus_GRCh38:
      chromosome: '5'
      position: 159387525
  trait_info:
    ontology:
    - EFO_0000384
    reported_trait_name: Crohn's disease
    standard_trait_name: Crohn's disease
- association_info:
    ancestry:
    - European=11802
    gwas_catalog_id: GCST001149
    neg_log_pval: 7.698970004336019
    otg_id: GCST001149
    pubmed_id: '21743469'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-23 inhibitor drug USTEKINUMAB is Phase III for the
        indiciation EFO_0003898 and targets the gene ENSG00000113302 at this locus
        (60850bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 158818745
    locus_GRCh38:
      chromosome: '5'
      position: 159391737
  trait_info:
    ontology:
    - EFO_0003898
    reported_trait_name: Ankylosing spondylitis
    standard_trait_name: ankylosing spondylitis
- association_info:
    ancestry:
    - European=400436
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 13.292429823902063
    otg_id: SAIGE_696_4
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-12 subunit beta inhibitor drug BRIAKINUMAB is Phase
        III for the indiciation EFO_0000676 and targets the gene ENSG00000113302 at
        this locus (62166bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 158820061
    locus_GRCh38:
      chromosome: '5'
      position: 159393053
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=400436
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 13.292429823902063
    otg_id: SAIGE_696_4
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Interleukin-12 inhibitor drug USTEKINUMAB is Phase IV for the indiciation
        EFO_0000676 and targets the gene ENSG00000113302 at this locus (62166bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 158820061
    locus_GRCh38:
      chromosome: '5'
      position: 159393053
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=33394
    gwas_catalog_id: GCST005527
    neg_log_pval: 13.017728766960431
    otg_id: GCST005527
    pubmed_id: '23143594'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Interleukin-12 inhibitor drug USTEKINUMAB is Phase IV for the indiciation
        EFO_0000676 and targets the gene ENSG00000113302 at this locus (64023bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 158821917
    locus_GRCh38:
      chromosome: '5'
      position: 159394909
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=33394
    gwas_catalog_id: GCST005527
    neg_log_pval: 13.017728766960431
    otg_id: GCST005527
    pubmed_id: '23143594'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-12 subunit beta inhibitor drug BRIAKINUMAB is Phase
        III for the indiciation EFO_0000676 and targets the gene ENSG00000113302 at
        this locus (64023bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 158821917
    locus_GRCh38:
      chromosome: '5'
      position: 159394909
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=400492
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 20.714442690992225
    otg_id: SAIGE_696
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Interleukin-12 inhibitor drug USTEKINUMAB is Phase IV for the indiciation
        EFO_0000676 and targets the gene ENSG00000113302 at this locus (68416bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 158826310
    locus_GRCh38:
      chromosome: '5'
      position: 159399302
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis and related disorders
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=400492
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 20.714442690992225
    otg_id: SAIGE_696
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-12 subunit beta inhibitor drug BRIAKINUMAB is Phase
        III for the indiciation EFO_0000676 and targets the gene ENSG00000113302 at
        this locus (68416bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 158826310
    locus_GRCh38:
      chromosome: '5'
      position: 159399302
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis and related disorders
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=22647
    - East Asian=3117
    gwas_catalog_id: GCST005529
    neg_log_pval: 7.522878745280337
    otg_id: GCST005529
    pubmed_id: '23749187'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-23 inhibitor drug USTEKINUMAB is Phase III for the
        indiciation EFO_0003898 and targets the gene ENSG00000113302 at this locus
        (68897bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 158826792
    locus_GRCh38:
      chromosome: '5'
      position: 159399784
  trait_info:
    ontology:
    - EFO_0003898
    reported_trait_name: Ankylosing spondylitis
    standard_trait_name: ankylosing spondylitis
- association_info:
    ancestry:
    - European, NR=45975
    gwas_catalog_id: GCST004133
    neg_log_pval: 23.22951619056889
    otg_id: GCST004133
    pubmed_id: '28067908'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-23 inhibitor drug USTEKINUMAB is Phase III for the
        indiciation EFO_0000729 and targets the gene ENSG00000113302 at this locus
        (68897bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 158826792
    locus_GRCh38:
      chromosome: '5'
      position: 159399784
  trait_info:
    ontology:
    - EFO_0000729
    reported_trait_name: Ulcerative colitis
    standard_trait_name: ulcerative colitis
- association_info:
    ancestry:
    - European=26405
    gwas_catalog_id: GCST000964
    neg_log_pval: 7.991399828238082
    otg_id: GCST000964
    pubmed_id: '21297633'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-23 inhibitor drug USTEKINUMAB is Phase III for the
        indiciation EFO_0000729 and targets the gene ENSG00000113302 at this locus
        (68897bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 158826792
    locus_GRCh38:
      chromosome: '5'
      position: 159399784
  trait_info:
    ontology:
    - EFO_0000729
    reported_trait_name: Ulcerative colitis
    standard_trait_name: ulcerative colitis
- association_info:
    ancestry:
    - European=27432
    gwas_catalog_id: GCST003045
    neg_log_pval: 26.13838459401752
    otg_id: GCST003045
    pubmed_id: '26192919'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-23 inhibitor drug USTEKINUMAB is Phase III for the
        indiciation EFO_0000729 and targets the gene ENSG00000113302 at this locus
        (69875bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 158827769
    locus_GRCh38:
      chromosome: '5'
      position: 159400761
  trait_info:
    ontology:
    - EFO_0000729
    reported_trait_name: Ulcerative colitis [EA]
    standard_trait_name: ulcerative colitis
- association_info:
    ancestry:
    - European=86475
    gwas_catalog_id: GCST005537
    neg_log_pval: 42.52287874528034
    otg_id: GCST005537
    pubmed_id: '26974007'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-23 inhibitor drug USTEKINUMAB is Phase III for the
        indiciation EFO_0000729 and targets the gene ENSG00000113302 at this locus
        (69875bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 158827769
    locus_GRCh38:
      chromosome: '5'
      position: 159400761
  trait_info:
    ontology:
    - EFO_0000729
    reported_trait_name: Chronic inflammatory diseases (ankylosing spondylitis, Crohn's
      disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
      [subset analysis]
    standard_trait_name: ulcerative colitis
- association_info:
    ancestry:
    - European=20883
    gwas_catalog_id: GCST003044
    neg_log_pval: 40.64029045008325
    otg_id: GCST003044
    pubmed_id: '26192919'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-23 inhibitor drug USTEKINUMAB is Phase III for the
        indiciation EFO_0000384 and targets the gene ENSG00000113302 at this locus
        (69875bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 158827769
    locus_GRCh38:
      chromosome: '5'
      position: 159400761
  trait_info:
    ontology:
    - EFO_0000384
    reported_trait_name: Crohn's disease [EA]
    standard_trait_name: Crohn's disease
- association_info:
    ancestry:
    - European=20883
    gwas_catalog_id: GCST003044
    neg_log_pval: 40.64029045008325
    otg_id: GCST003044
    pubmed_id: '26192919'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-12 subunit beta inhibitor drug BRIAKINUMAB is Phase
        II for the indiciation EFO_0000384 and targets the gene ENSG00000113302 at
        this locus (69875bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 158827769
    locus_GRCh38:
      chromosome: '5'
      position: 159400761
  trait_info:
    ontology:
    - EFO_0000384
    reported_trait_name: Crohn's disease [EA]
    standard_trait_name: Crohn's disease
- association_info:
    ancestry:
    - European=86475
    gwas_catalog_id: GCST005537
    neg_log_pval: 42.52287874528034
    otg_id: GCST005537
    pubmed_id: '26974007'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Interleukin-12 inhibitor drug USTEKINUMAB is Phase IV for the indiciation
        EFO_0000676 and targets the gene ENSG00000113302 at this locus (69875bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 158827769
    locus_GRCh38:
      chromosome: '5'
      position: 159400761
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Chronic inflammatory diseases (ankylosing spondylitis, Crohn's
      disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
      [subset analysis]
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=86475
    gwas_catalog_id: GCST005537
    neg_log_pval: 42.52287874528034
    otg_id: GCST005537
    pubmed_id: '26974007'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-23 inhibitor drug USTEKINUMAB is Phase III for the
        indiciation EFO_0000384 and targets the gene ENSG00000113302 at this locus
        (69875bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 158827769
    locus_GRCh38:
      chromosome: '5'
      position: 159400761
  trait_info:
    ontology:
    - EFO_0000384
    reported_trait_name: Chronic inflammatory diseases (ankylosing spondylitis, Crohn's
      disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
      [subset analysis]
    standard_trait_name: Crohn's disease
- association_info:
    ancestry:
    - European=86475
    gwas_catalog_id: GCST005537
    neg_log_pval: 42.52287874528034
    otg_id: GCST005537
    pubmed_id: '26974007'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-23 inhibitor drug USTEKINUMAB is Phase III for the
        indiciation EFO_0003898 and targets the gene ENSG00000113302 at this locus
        (69875bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 158827769
    locus_GRCh38:
      chromosome: '5'
      position: 159400761
  trait_info:
    ontology:
    - EFO_0003898
    reported_trait_name: Chronic inflammatory diseases (ankylosing spondylitis, Crohn's
      disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
      [subset analysis]
    standard_trait_name: ankylosing spondylitis
- association_info:
    ancestry:
    - European=86475
    gwas_catalog_id: GCST005537
    neg_log_pval: 42.52287874528034
    otg_id: GCST005537
    pubmed_id: '26974007'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-12 subunit beta inhibitor drug BRIAKINUMAB is Phase
        II for the indiciation EFO_0000384 and targets the gene ENSG00000113302 at
        this locus (69875bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 158827769
    locus_GRCh38:
      chromosome: '5'
      position: 159400761
  trait_info:
    ontology:
    - EFO_0000384
    reported_trait_name: Chronic inflammatory diseases (ankylosing spondylitis, Crohn's
      disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
      [subset analysis]
    standard_trait_name: Crohn's disease
- association_info:
    ancestry:
    - European=86475
    gwas_catalog_id: GCST005537
    neg_log_pval: 42.52287874528034
    otg_id: GCST005537
    pubmed_id: '26974007'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-12 subunit beta inhibitor drug BRIAKINUMAB is Phase
        III for the indiciation EFO_0000676 and targets the gene ENSG00000113302 at
        this locus (69875bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 158827769
    locus_GRCh38:
      chromosome: '5'
      position: 159400761
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Chronic inflammatory diseases (ankylosing spondylitis, Crohn's
      disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
      [subset analysis]
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=400436
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 19.950781977329818
    otg_id: SAIGE_696_4
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Interleukin-12 inhibitor drug USTEKINUMAB is Phase IV for the indiciation
        EFO_0000676 and targets the gene ENSG00000113302 at this locus (71395bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 158829289
    locus_GRCh38:
      chromosome: '5'
      position: 159402281
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=400436
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 19.950781977329818
    otg_id: SAIGE_696_4
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-12 subunit beta inhibitor drug BRIAKINUMAB is Phase
        III for the indiciation EFO_0000676 and targets the gene ENSG00000113302 at
        this locus (71395bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 158829289
    locus_GRCh38:
      chromosome: '5'
      position: 159402281
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=16753
    gwas_catalog_id: GCST003097
    neg_log_pval: 9.698970004336019
    otg_id: GCST003097
    pubmed_id: '26301688'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-23 inhibitor drug USTEKINUMAB is Phase III for the
        indiciation EFO_0000729 and targets the gene ENSG00000113302 at this locus
        (71399bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 158829294
    locus_GRCh38:
      chromosome: '5'
      position: 159402286
  trait_info:
    ontology:
    - EFO_0000729
    reported_trait_name: Pediatric autoimmune diseases
    standard_trait_name: ulcerative colitis
- association_info:
    ancestry:
    - European=16753
    gwas_catalog_id: GCST003097
    neg_log_pval: 9.698970004336019
    otg_id: GCST003097
    pubmed_id: '26301688'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-12 subunit beta inhibitor drug BRIAKINUMAB is Phase
        II for the indiciation EFO_0000384 and targets the gene ENSG00000113302 at
        this locus (71399bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 158829294
    locus_GRCh38:
      chromosome: '5'
      position: 159402286
  trait_info:
    ontology:
    - EFO_0000384
    reported_trait_name: Pediatric autoimmune diseases
    standard_trait_name: Crohn's disease
- association_info:
    ancestry:
    - European=16753
    gwas_catalog_id: GCST003097
    neg_log_pval: 9.698970004336019
    otg_id: GCST003097
    pubmed_id: '26301688'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-23 inhibitor drug USTEKINUMAB is Phase III for the
        indiciation EFO_0000384 and targets the gene ENSG00000113302 at this locus
        (71399bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 158829294
    locus_GRCh38:
      chromosome: '5'
      position: 159402286
  trait_info:
    ontology:
    - EFO_0000384
    reported_trait_name: Pediatric autoimmune diseases
    standard_trait_name: Crohn's disease
- association_info:
    ancestry:
    - European=16753
    gwas_catalog_id: GCST003097
    neg_log_pval: 9.698970004336019
    otg_id: GCST003097
    pubmed_id: '26301688'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-23 inhibitor drug USTEKINUMAB is Phase III for the
        indiciation EFO_0003898 and targets the gene ENSG00000113302 at this locus
        (71399bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 158829294
    locus_GRCh38:
      chromosome: '5'
      position: 159402286
  trait_info:
    ontology:
    - EFO_0003898
    reported_trait_name: Pediatric autoimmune diseases
    standard_trait_name: ankylosing spondylitis
- association_info:
    ancestry:
    - European=16753
    gwas_catalog_id: GCST003097
    neg_log_pval: 9.698970004336019
    otg_id: GCST003097
    pubmed_id: '26301688'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Interleukin-12 inhibitor drug USTEKINUMAB is Phase IV for the indiciation
        EFO_0000676 and targets the gene ENSG00000113302 at this locus (71399bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 158829294
    locus_GRCh38:
      chromosome: '5'
      position: 159402286
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Pediatric autoimmune diseases
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=16753
    gwas_catalog_id: GCST003097
    neg_log_pval: 9.698970004336019
    otg_id: GCST003097
    pubmed_id: '26301688'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-12 subunit beta inhibitor drug BRIAKINUMAB is Phase
        III for the indiciation EFO_0000676 and targets the gene ENSG00000113302 at
        this locus (71399bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 158829294
    locus_GRCh38:
      chromosome: '5'
      position: 159402286
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Pediatric autoimmune diseases
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European, NR=40266
    gwas_catalog_id: GCST004132
    neg_log_pval: 28.860120913598763
    otg_id: GCST004132
    pubmed_id: '28067908'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-12 subunit beta inhibitor drug BRIAKINUMAB is Phase
        II for the indiciation EFO_0000384 and targets the gene ENSG00000113302 at
        this locus (71399bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 158829294
    locus_GRCh38:
      chromosome: '5'
      position: 159402286
  trait_info:
    ontology:
    - EFO_0000384
    reported_trait_name: Crohn's disease
    standard_trait_name: Crohn's disease
- association_info:
    ancestry:
    - European=16753
    gwas_catalog_id: GCST003097
    neg_log_pval: 9.698970004336019
    otg_id: GCST003097
    pubmed_id: '26301688'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-12 inhibitor drug USTEKINUMAB is Phase II for the indiciation
        EFO_0001359 and targets the gene ENSG00000113302 at this locus (71399bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 158829294
    locus_GRCh38:
      chromosome: '5'
      position: 159402286
  trait_info:
    ontology:
    - EFO_0001359
    reported_trait_name: Pediatric autoimmune diseases
    standard_trait_name: insulin-dependent diabetes mellitus
- association_info:
    ancestry:
    - European=16753
    gwas_catalog_id: GCST003097
    neg_log_pval: 9.698970004336019
    otg_id: GCST003097
    pubmed_id: '26301688'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-23 inhibitor drug USTEKINUMAB is Phase III for the
        indiciation EFO_0002690 and targets the gene ENSG00000113302 at this locus
        (71399bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 158829294
    locus_GRCh38:
      chromosome: '5'
      position: 159402286
  trait_info:
    ontology:
    - EFO_0002690
    reported_trait_name: Pediatric autoimmune diseases
    standard_trait_name: systemic lupus erythematosus
- association_info:
    ancestry:
    - European, NR=40266
    gwas_catalog_id: GCST004132
    neg_log_pval: 28.860120913598763
    otg_id: GCST004132
    pubmed_id: '28067908'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-23 inhibitor drug USTEKINUMAB is Phase III for the
        indiciation EFO_0000384 and targets the gene ENSG00000113302 at this locus
        (71399bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 158829294
    locus_GRCh38:
      chromosome: '5'
      position: 159402286
  trait_info:
    ontology:
    - EFO_0000384
    reported_trait_name: Crohn's disease
    standard_trait_name: Crohn's disease
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 32.77779353908738
    otg_id: NEALE2_20002_1453
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-12 subunit beta inhibitor drug BRIAKINUMAB is Phase
        III for the indiciation EFO_0000676 and targets the gene ENSG00000113302 at
        this locus (71632bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 158829527
    locus_GRCh38:
      chromosome: '5'
      position: 159402519
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis | non-cancer illness code, self-reported
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=1460
    gwas_catalog_id: GCST000835
    neg_log_pval: 16.154901959985743
    otg_id: GCST000835
    pubmed_id: '20953186'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Interleukin-12 inhibitor drug USTEKINUMAB is Phase IV for the indiciation
        EFO_0003778 and targets the gene ENSG00000113302 at this locus (71632bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 158829527
    locus_GRCh38:
      chromosome: '5'
      position: 159402519
  trait_info:
    ontology:
    - EFO_0003778
    reported_trait_name: Psoriatic arthritis
    standard_trait_name: psoriatic arthritis
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 32.77779353908738
    otg_id: NEALE2_20002_1453
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Interleukin-12 inhibitor drug USTEKINUMAB is Phase IV for the indiciation
        EFO_0000676 and targets the gene ENSG00000113302 at this locus (71632bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 158829527
    locus_GRCh38:
      chromosome: '5'
      position: 159402519
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis | non-cancer illness code, self-reported
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=287323
    gwas_catalog_id: GCST004346
    neg_log_pval: 83.52287874528034
    otg_id: GCST004346
    pubmed_id: '28537254'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Interleukin-12 inhibitor drug USTEKINUMAB is Phase IV for the indiciation
        EFO_0000676 and targets the gene ENSG00000113302 at this locus (71632bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 158829527
    locus_GRCh38:
      chromosome: '5'
      position: 159402519
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=33394
    gwas_catalog_id: GCST005527
    neg_log_pval: 12.669586226650809
    otg_id: GCST005527
    pubmed_id: '23143594'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-12 subunit beta inhibitor drug BRIAKINUMAB is Phase
        III for the indiciation EFO_0000676 and targets the gene ENSG00000113302 at
        this locus (71632bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 158829527
    locus_GRCh38:
      chromosome: '5'
      position: 159402519
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=33394
    gwas_catalog_id: GCST005527
    neg_log_pval: 12.669586226650809
    otg_id: GCST005527
    pubmed_id: '23143594'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Interleukin-12 inhibitor drug USTEKINUMAB is Phase IV for the indiciation
        EFO_0000676 and targets the gene ENSG00000113302 at this locus (71632bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 158829527
    locus_GRCh38:
      chromosome: '5'
      position: 159402519
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 11.735654492949907
    otg_id: NEALE2_20002_1477
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Interleukin-12 inhibitor drug USTEKINUMAB is Phase IV for the indiciation
        EFO_0003778 and targets the gene ENSG00000113302 at this locus (71632bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 158829527
    locus_GRCh38:
      chromosome: '5'
      position: 159402519
  trait_info:
    ontology:
    - EFO_0003778
    reported_trait_name: Psoriatic arthropathy | non-cancer illness code, self-reported
    standard_trait_name: psoriatic arthritis
- association_info:
    ancestry:
    - European=287323
    gwas_catalog_id: GCST004346
    neg_log_pval: 83.52287874528034
    otg_id: GCST004346
    pubmed_id: '28537254'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-12 subunit beta inhibitor drug BRIAKINUMAB is Phase
        III for the indiciation EFO_0000676 and targets the gene ENSG00000113302 at
        this locus (71632bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 158829527
    locus_GRCh38:
      chromosome: '5'
      position: 159402519
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=398907
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 10.665546248849068
    otg_id: SAIGE_696_42
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Interleukin-12 inhibitor drug USTEKINUMAB is Phase IV for the indiciation
        EFO_0003778 and targets the gene ENSG00000113302 at this locus (71632bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 158829527
    locus_GRCh38:
      chromosome: '5'
      position: 159402519
  trait_info:
    ontology:
    - EFO_0003778
    reported_trait_name: Psoriatic arthropathy
    standard_trait_name: psoriatic arthritis
- association_info:
    ancestry:
    - European=7208
    gwas_catalog_id: GCST005538
    neg_log_pval: 8.698970004336019
    otg_id: GCST005538
    pubmed_id: '26051272'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-12 inhibitor drug USTEKINUMAB is Phase II for the indiciation
        Orphanet_797 and targets the gene ENSG00000113302 at this locus (74382bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 158832277
    locus_GRCh38:
      chromosome: '5'
      position: 159405269
  trait_info:
    ontology:
    - Orphanet_797
    reported_trait_name: Sarcoidosis [EA]
    standard_trait_name: Sarcoidosis
- association_info:
    ancestry:
    - East Asian=5134
    - European=8682
    gwas_catalog_id: GCST002874
    neg_log_pval: 12.154901959985743
    otg_id: GCST002874_11
    pubmed_id: '25903422'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Interleukin-12 inhibitor drug USTEKINUMAB is Phase IV for the indiciation
        EFO_0000676 and targets the gene ENSG00000113302 at this locus (78212bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 158836107
    locus_GRCh38:
      chromosome: '5'
      position: 159409099
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis [conditional on rs7709212]
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - East Asian=5134
    - European=8682
    gwas_catalog_id: GCST002874
    neg_log_pval: 10.522878745280337
    otg_id: GCST002874_7
    pubmed_id: '25903422'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Interleukin-12 inhibitor drug USTEKINUMAB is Phase IV for the indiciation
        EFO_0000676 and targets the gene ENSG00000113302 at this locus (78212bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 158836107
    locus_GRCh38:
      chromosome: '5'
      position: 159409099
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis [EA, conditional on rs7709212]
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - East Asian=5134
    - European=8682
    gwas_catalog_id: GCST002874
    neg_log_pval: 12.154901959985743
    otg_id: GCST002874_11
    pubmed_id: '25903422'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-12 subunit beta inhibitor drug BRIAKINUMAB is Phase
        III for the indiciation EFO_0000676 and targets the gene ENSG00000113302 at
        this locus (78212bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 158836107
    locus_GRCh38:
      chromosome: '5'
      position: 159409099
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis [conditional on rs7709212]
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - East Asian=5134
    - European=8682
    gwas_catalog_id: GCST002874
    neg_log_pval: 10.522878745280337
    otg_id: GCST002874_7
    pubmed_id: '25903422'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Interleukin-12 subunit beta inhibitor drug BRIAKINUMAB is Phase
        III for the indiciation EFO_0000676 and targets the gene ENSG00000113302 at
        this locus (78212bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113302
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 158836107
    locus_GRCh38:
      chromosome: '5'
      position: 159409099
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis [EA, conditional on rs7709212]
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=351833
    neg_log_pval: 8.322648589788734
    otg_id: NEALE2_1980
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: GABA-A receptor; anion channel agonist drug MEPROBAMATE is Phase
        IV for the indiciation EFO_0005230 and targets the gene ENSG00000145863 at
        this locus (281691bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145863
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: CA
    locus_GRCh37:
      chromosome: '5'
      position: 161411289
    locus_GRCh38:
      chromosome: '5'
      position: 161984283
  trait_info:
    ontology:
    - EFO_0005230
    reported_trait_name: Worrier / anxious feelings
    standard_trait_name: anxiety
- association_info:
    ancestry:
    - European=351833
    neg_log_pval: 8.322648589788734
    otg_id: NEALE2_1980
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: GABA-A receptor; anion channel positive allosteric modulator drug
        ALPRAZOLAM is Phase IV for the indiciation EFO_0005230 and targets the gene
        ENSG00000022355 at this locus (84303bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000022355
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: CA
    locus_GRCh37:
      chromosome: '5'
      position: 161411289
    locus_GRCh38:
      chromosome: '5'
      position: 161984283
  trait_info:
    ontology:
    - EFO_0005230
    reported_trait_name: Worrier / anxious feelings
    standard_trait_name: anxiety
- association_info:
    ancestry:
    - European=351833
    neg_log_pval: 8.322648589788734
    otg_id: NEALE2_1980
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: GABA-A receptor; anion channel agonist drug MEPROBAMATE is Phase
        IV for the indiciation EFO_0005230 and targets the gene ENSG00000145864 at
        this locus (435239bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145864
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: CA
    locus_GRCh37:
      chromosome: '5'
      position: 161411289
    locus_GRCh38:
      chromosome: '5'
      position: 161984283
  trait_info:
    ontology:
    - EFO_0005230
    reported_trait_name: Worrier / anxious feelings
    standard_trait_name: anxiety
- association_info:
    ancestry:
    - European=351833
    neg_log_pval: 8.322648589788734
    otg_id: NEALE2_1980
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: GABA-A receptor; anion channel positive allosteric modulator drug
        TRIAZOLAM is Phase III for the indiciation EFO_0005230 and targets the gene
        ENSG00000022355 at this locus (84303bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000022355
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: CA
    locus_GRCh37:
      chromosome: '5'
      position: 161411289
    locus_GRCh38:
      chromosome: '5'
      position: 161984283
  trait_info:
    ontology:
    - EFO_0005230
    reported_trait_name: Worrier / anxious feelings
    standard_trait_name: anxiety
- association_info:
    ancestry:
    - European=351833
    neg_log_pval: 8.322648589788734
    otg_id: NEALE2_1980
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: GABA-A receptor; anion channel positive allosteric modulator drug
        TRIAZOLAM is Phase III for the indiciation EFO_0005230 and targets the gene
        ENSG00000113327 at this locus (15775bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113327
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: CA
    locus_GRCh37:
      chromosome: '5'
      position: 161411289
    locus_GRCh38:
      chromosome: '5'
      position: 161984283
  trait_info:
    ontology:
    - EFO_0005230
    reported_trait_name: Worrier / anxious feelings
    standard_trait_name: anxiety
- association_info:
    ancestry:
    - European=351833
    neg_log_pval: 8.322648589788734
    otg_id: NEALE2_1980
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: GABA-A receptor; anion channel positive allosteric modulator drug
        CLORAZEPIC ACID is Phase IV for the indiciation EFO_0005230 and targets the
        gene ENSG00000113327 at this locus (15775bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000113327
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: CA
    locus_GRCh37:
      chromosome: '5'
      position: 161411289
    locus_GRCh38:
      chromosome: '5'
      position: 161984283
  trait_info:
    ontology:
    - EFO_0005230
    reported_trait_name: Worrier / anxious feelings
    standard_trait_name: anxiety
- association_info:
    ancestry:
    - European=351833
    neg_log_pval: 8.322648589788734
    otg_id: NEALE2_1980
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: GABA-A receptor; anion channel positive allosteric modulator drug
        CLOMETHIAZOLE is Phase III for the indiciation EFO_0005230 and targets the
        gene ENSG00000145864 at this locus (435239bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000145864
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: CA
    locus_GRCh37:
      chromosome: '5'
      position: 161411289
    locus_GRCh38:
      chromosome: '5'
      position: 161984283
  trait_info:
    ontology:
    - EFO_0005230
    reported_trait_name: Worrier / anxious feelings
    standard_trait_name: anxiety
- association_info:
    ancestry:
    - European=10767
    gwas_catalog_id: GCST003468
    neg_log_pval: 7.698970004336019
    otg_id: GCST003468
    pubmed_id: '26956414'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug VINCRISTINE is Phase III for the indiciation
        EFO_0000095 and targets the gene ENSG00000137285 at this locus (255233bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000137285
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 2969278
    locus_GRCh38:
      chromosome: '6'
      position: 2969044
  trait_info:
    ontology:
    - EFO_0000095
    reported_trait_name: Chronic lymphocytic leukemia
    standard_trait_name: chronic lymphocytic leukemia
- association_info:
    ancestry:
    - European=10767
    gwas_catalog_id: GCST003468
    neg_log_pval: 7.698970004336019
    otg_id: GCST003468
    pubmed_id: '26956414'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug VINCRISTINE is Phase III for the indiciation
        EFO_0000095 and targets the gene ENSG00000137267 at this locus (184622bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000137267
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 2969278
    locus_GRCh38:
      chromosome: '6'
      position: 2969044
  trait_info:
    ontology:
    - EFO_0000095
    reported_trait_name: Chronic lymphocytic leukemia
    standard_trait_name: chronic lymphocytic leukemia
- association_info:
    ancestry:
    - East Asian=7321
    gwas_catalog_id: GCST007728
    neg_log_pval: 8.045757490560675
    otg_id: GCST007728_9
    pubmed_id: '30898391'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug DOCETAXEL is Phase III for the indiciation
        EFO_0001075 and targets the gene ENSG00000137285 at this locus (349126bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000137285
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 3581089
    locus_GRCh38:
      chromosome: '6'
      position: 3580855
  trait_info:
    ontology:
    - EFO_0001075
    reported_trait_name: Epithelial ovarian cancer [serous]
    standard_trait_name: ovarian carcinoma
- association_info:
    ancestry:
    - East Asian=7321
    gwas_catalog_id: GCST007728
    neg_log_pval: 8.045757490560675
    otg_id: GCST007728_9
    pubmed_id: '30898391'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug PACLITAXEL is Phase IV for the indiciation
        EFO_0001075 and targets the gene ENSG00000137285 at this locus (349126bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000137285
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 3581089
    locus_GRCh38:
      chromosome: '6'
      position: 3580855
  trait_info:
    ontology:
    - EFO_0001075
    reported_trait_name: Epithelial ovarian cancer [serous]
    standard_trait_name: ovarian carcinoma
- association_info:
    ancestry:
    - East Asian=7321
    gwas_catalog_id: GCST007728
    neg_log_pval: 8.045757490560675
    otg_id: GCST007728_9
    pubmed_id: '30898391'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug DOCETAXEL is Phase III for the indiciation
        EFO_0001075 and targets the gene ENSG00000137267 at this locus (423311bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000137267
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 3581089
    locus_GRCh38:
      chromosome: '6'
      position: 3580855
  trait_info:
    ontology:
    - EFO_0001075
    reported_trait_name: Epithelial ovarian cancer [serous]
    standard_trait_name: ovarian carcinoma
- association_info:
    ancestry:
    - East Asian=7321
    gwas_catalog_id: GCST007728
    neg_log_pval: 8.045757490560675
    otg_id: GCST007728_9
    pubmed_id: '30898391'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug PACLITAXEL is Phase IV for the indiciation
        EFO_0001075 and targets the gene ENSG00000137267 at this locus (423311bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000137267
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 3581089
    locus_GRCh38:
      chromosome: '6'
      position: 3580855
  trait_info:
    ontology:
    - EFO_0001075
    reported_trait_name: Epithelial ovarian cancer [serous]
    standard_trait_name: ovarian carcinoma
- association_info:
    ancestry:
    - East Asian=7321
    gwas_catalog_id: GCST007728
    neg_log_pval: 7.3979400086720375
    otg_id: GCST007728_2
    pubmed_id: '30898391'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug PACLITAXEL is Phase IV for the indiciation
        EFO_0001075 and targets the gene ENSG00000137285 at this locus (349126bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000137285
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 3581089
    locus_GRCh38:
      chromosome: '6'
      position: 3580855
  trait_info:
    ontology:
    - EFO_0001075
    reported_trait_name: Epithelial ovarian cancer [HGSOC]
    standard_trait_name: ovarian carcinoma
- association_info:
    ancestry:
    - East Asian=7321
    gwas_catalog_id: GCST007728
    neg_log_pval: 7.3979400086720375
    otg_id: GCST007728_2
    pubmed_id: '30898391'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug IXABEPILONE is Phase II for the indiciation
        EFO_0001075 and targets the gene ENSG00000137285 at this locus (349126bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000137285
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 3581089
    locus_GRCh38:
      chromosome: '6'
      position: 3580855
  trait_info:
    ontology:
    - EFO_0001075
    reported_trait_name: Epithelial ovarian cancer [HGSOC]
    standard_trait_name: ovarian carcinoma
- association_info:
    ancestry:
    - East Asian=7321
    gwas_catalog_id: GCST007728
    neg_log_pval: 8.045757490560675
    otg_id: GCST007728_9
    pubmed_id: '30898391'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug IXABEPILONE is Phase II for the indiciation
        EFO_0001075 and targets the gene ENSG00000137285 at this locus (349126bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000137285
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 3581089
    locus_GRCh38:
      chromosome: '6'
      position: 3580855
  trait_info:
    ontology:
    - EFO_0001075
    reported_trait_name: Epithelial ovarian cancer [serous]
    standard_trait_name: ovarian carcinoma
- association_info:
    ancestry:
    - East Asian=7321
    gwas_catalog_id: GCST007728
    neg_log_pval: 8.045757490560675
    otg_id: GCST007728_9
    pubmed_id: '30898391'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug CABAZITAXEL is Phase II for the indiciation
        EFO_0001075 and targets the gene ENSG00000137267 at this locus (423311bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000137267
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 3581089
    locus_GRCh38:
      chromosome: '6'
      position: 3580855
  trait_info:
    ontology:
    - EFO_0001075
    reported_trait_name: Epithelial ovarian cancer [serous]
    standard_trait_name: ovarian carcinoma
- association_info:
    ancestry:
    - East Asian=7321
    gwas_catalog_id: GCST007728
    neg_log_pval: 7.3979400086720375
    otg_id: GCST007728_2
    pubmed_id: '30898391'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug CABAZITAXEL is Phase II for the indiciation
        EFO_0001075 and targets the gene ENSG00000137267 at this locus (423311bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000137267
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 3581089
    locus_GRCh38:
      chromosome: '6'
      position: 3580855
  trait_info:
    ontology:
    - EFO_0001075
    reported_trait_name: Epithelial ovarian cancer [HGSOC]
    standard_trait_name: ovarian carcinoma
- association_info:
    ancestry:
    - East Asian=7321
    gwas_catalog_id: GCST007728
    neg_log_pval: 7.3979400086720375
    otg_id: GCST007728_2
    pubmed_id: '30898391'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug PACLITAXEL is Phase IV for the indiciation
        EFO_0001075 and targets the gene ENSG00000137267 at this locus (423311bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000137267
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 3581089
    locus_GRCh38:
      chromosome: '6'
      position: 3580855
  trait_info:
    ontology:
    - EFO_0001075
    reported_trait_name: Epithelial ovarian cancer [HGSOC]
    standard_trait_name: ovarian carcinoma
- association_info:
    ancestry:
    - East Asian=7321
    gwas_catalog_id: GCST007728
    neg_log_pval: 7.3979400086720375
    otg_id: GCST007728_2
    pubmed_id: '30898391'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug DOCETAXEL is Phase III for the indiciation
        EFO_0001075 and targets the gene ENSG00000137267 at this locus (423311bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000137267
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 3581089
    locus_GRCh38:
      chromosome: '6'
      position: 3580855
  trait_info:
    ontology:
    - EFO_0001075
    reported_trait_name: Epithelial ovarian cancer [HGSOC]
    standard_trait_name: ovarian carcinoma
- association_info:
    ancestry:
    - East Asian=7321
    gwas_catalog_id: GCST007728
    neg_log_pval: 7.3979400086720375
    otg_id: GCST007728_2
    pubmed_id: '30898391'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug DOCETAXEL is Phase III for the indiciation
        EFO_0001075 and targets the gene ENSG00000137285 at this locus (349126bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000137285
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 3581089
    locus_GRCh38:
      chromosome: '6'
      position: 3580855
  trait_info:
    ontology:
    - EFO_0001075
    reported_trait_name: Epithelial ovarian cancer [HGSOC]
    standard_trait_name: ovarian carcinoma
- association_info:
    ancestry:
    - European=40187
    gwas_catalog_id: GCST004749
    neg_log_pval: 12.154901959985743
    otg_id: GCST004749
    pubmed_id: '28604730'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug VINCRISTINE is Phase III for the indiciation
        EFO_0001071 and targets the gene ENSG00000196230 at this locus (345376bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000196230
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 30342753
    locus_GRCh38:
      chromosome: '6'
      position: 30374976
  trait_info:
    ontology:
    - EFO_0001071
    reported_trait_name: Lung cancer in ever smokers
    standard_trait_name: lung carcinoma
- association_info:
    ancestry:
    - European=40187
    gwas_catalog_id: GCST004749
    neg_log_pval: 12.154901959985743
    otg_id: GCST004749
    pubmed_id: '28604730'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug IXABEPILONE is Phase II for the indiciation
        EFO_0001071 and targets the gene ENSG00000196230 at this locus (345376bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000196230
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 30342753
    locus_GRCh38:
      chromosome: '6'
      position: 30374976
  trait_info:
    ontology:
    - EFO_0001071
    reported_trait_name: Lung cancer in ever smokers
    standard_trait_name: lung carcinoma
- association_info:
    ancestry:
    - European=63053
    gwas_catalog_id: GCST004750
    neg_log_pval: 13.522878745280337
    otg_id: GCST004750
    pubmed_id: '28604730'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug VINORELBINE is Phase III for the indiciation
        EFO_0000708 and targets the gene ENSG00000196230 at this locus (336782bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000196230
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 30351348
    locus_GRCh38:
      chromosome: '6'
      position: 30383571
  trait_info:
    ontology:
    - EFO_0000708
    reported_trait_name: Squamous cell lung carcinoma
    standard_trait_name: squamous cell lung carcinoma
- association_info:
    ancestry:
    - European=63053
    gwas_catalog_id: GCST004750
    neg_log_pval: 13.522878745280337
    otg_id: GCST004750
    pubmed_id: '28604730'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug PACLITAXEL is Phase IV for the indiciation
        EFO_0000708 and targets the gene ENSG00000196230 at this locus (336782bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000196230
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 30351348
    locus_GRCh38:
      chromosome: '6'
      position: 30383571
  trait_info:
    ontology:
    - EFO_0000708
    reported_trait_name: Squamous cell lung carcinoma
    standard_trait_name: squamous cell lung carcinoma
- association_info:
    ancestry:
    - European=85716
    gwas_catalog_id: GCST004748
    neg_log_pval: 17.397940008672037
    otg_id: GCST004748
    pubmed_id: '28604730'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug VINORELBINE is Phase III for the indiciation
        EFO_0001071 and targets the gene ENSG00000196230 at this locus (330836bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000196230
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 30357294
    locus_GRCh38:
      chromosome: '6'
      position: 30389517
  trait_info:
    ontology:
    - EFO_0001071
    reported_trait_name: Lung cancer
    standard_trait_name: lung carcinoma
- association_info:
    ancestry:
    - European=85716
    gwas_catalog_id: GCST004748
    neg_log_pval: 17.397940008672037
    otg_id: GCST004748
    pubmed_id: '28604730'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug IXABEPILONE is Phase II for the indiciation
        EFO_0001071 and targets the gene ENSG00000196230 at this locus (330836bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000196230
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 30357294
    locus_GRCh38:
      chromosome: '6'
      position: 30389517
  trait_info:
    ontology:
    - EFO_0001071
    reported_trait_name: Lung cancer
    standard_trait_name: lung carcinoma
- association_info:
    ancestry:
    - European=140254
    gwas_catalog_id: GCST006085
    neg_log_pval: 8.221848749616356
    otg_id: GCST006085
    pubmed_id: '29892016'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug VINBLASTINE is Phase III for the indiciation
        EFO_0001663 and targets the gene ENSG00000196230 at this locus (86897bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000196230
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 30601232
    locus_GRCh38:
      chromosome: '6'
      position: 30633455
  trait_info:
    ontology:
    - EFO_0001663
    reported_trait_name: Prostate cancer
    standard_trait_name: prostate carcinoma
- association_info:
    ancestry:
    - European=140254
    gwas_catalog_id: GCST006085
    neg_log_pval: 8.221848749616356
    otg_id: GCST006085
    pubmed_id: '29892016'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug CABAZITAXEL is Phase IV for the indiciation
        EFO_0001663 and targets the gene ENSG00000196230 at this locus (86897bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000196230
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 30601232
    locus_GRCh38:
      chromosome: '6'
      position: 30633455
  trait_info:
    ontology:
    - EFO_0001663
    reported_trait_name: Prostate cancer
    standard_trait_name: prostate carcinoma
- association_info:
    ancestry:
    - European=140254
    gwas_catalog_id: GCST006085
    neg_log_pval: 8.221848749616356
    otg_id: GCST006085
    pubmed_id: '29892016'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug ERIBULIN is Phase II for the indiciation
        EFO_0001663 and targets the gene ENSG00000196230 at this locus (86897bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000196230
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 30601232
    locus_GRCh38:
      chromosome: '6'
      position: 30633455
  trait_info:
    ontology:
    - EFO_0001663
    reported_trait_name: Prostate cancer
    standard_trait_name: prostate carcinoma
- association_info:
    ancestry:
    - European=85716
    gwas_catalog_id: GCST004748
    neg_log_pval: 18.154901959985743
    otg_id: GCST004748
    pubmed_id: '28604730'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug DOCETAXEL is Phase III for the indiciation
        EFO_0001071 and targets the gene ENSG00000196230 at this locus (171076bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000196230
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 30864279
    locus_GRCh38:
      chromosome: '6'
      position: 30896502
  trait_info:
    ontology:
    - EFO_0001071
    reported_trait_name: Lung cancer
    standard_trait_name: lung carcinoma
- association_info:
    ancestry:
    - European=85716
    gwas_catalog_id: GCST004748
    neg_log_pval: 18.154901959985743
    otg_id: GCST004748
    pubmed_id: '28604730'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug IXABEPILONE is Phase II for the indiciation
        EFO_0001071 and targets the gene ENSG00000196230 at this locus (171076bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000196230
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 30864279
    locus_GRCh38:
      chromosome: '6'
      position: 30896502
  trait_info:
    ontology:
    - EFO_0001071
    reported_trait_name: Lung cancer
    standard_trait_name: lung carcinoma
- association_info:
    ancestry:
    - European=63053
    gwas_catalog_id: GCST004750
    neg_log_pval: 15.522878745280337
    otg_id: GCST004750
    pubmed_id: '28604730'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug DOCETAXEL is Phase IV for the indiciation
        EFO_0000708 and targets the gene ENSG00000196230 at this locus (189213bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000196230
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 30882415
    locus_GRCh38:
      chromosome: '6'
      position: 30914638
  trait_info:
    ontology:
    - EFO_0000708
    reported_trait_name: Squamous cell lung carcinoma
    standard_trait_name: squamous cell lung carcinoma
- association_info:
    ancestry:
    - European=63053
    gwas_catalog_id: GCST004750
    neg_log_pval: 15.522878745280337
    otg_id: GCST004750
    pubmed_id: '28604730'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug VINORELBINE is Phase III for the indiciation
        EFO_0000708 and targets the gene ENSG00000196230 at this locus (189213bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000196230
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 30882415
    locus_GRCh38:
      chromosome: '6'
      position: 30914638
  trait_info:
    ontology:
    - EFO_0000708
    reported_trait_name: Squamous cell lung carcinoma
    standard_trait_name: squamous cell lung carcinoma
- association_info:
    ancestry:
    - European=287323
    gwas_catalog_id: GCST004346
    neg_log_pval: 324.22184874961636
    otg_id: GCST004346
    pubmed_id: '28537254'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug PACLITAXEL is Phase II for the indiciation
        EFO_0000676 and targets the gene ENSG00000196230 at this locus (223056bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000196230
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 30916259
    locus_GRCh38:
      chromosome: '6'
      position: 30948482
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=120184
    - East Asian=5294
    gwas_catalog_id: GCST007856
    neg_log_pval: 8.045757490560675
    otg_id: GCST007856
    pubmed_id: '30510241'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug DOCETAXEL is Phase II for the indiciation
        EFO_0005842 and targets the gene ENSG00000196230 at this locus (316982bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000196230
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 31010185
    locus_GRCh38:
      chromosome: '6'
      position: 31042408
  trait_info:
    ontology:
    - EFO_0005842
    reported_trait_name: Colorectal cancer or advanced adenoma
    standard_trait_name: colorectal cancer
- association_info:
    ancestry:
    - European=1712
    - African American or Afro-Caribbean=1233
    - Hispanic or Latin American=677
    gwas_catalog_id: GCST000863
    neg_log_pval: 8.0
    otg_id: GCST000863
    pubmed_id: '21051598'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug PACLITAXEL is Phase III for the indiciation
        EFO_0000180 and targets the gene ENSG00000196230 at this locus (331606bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000196230
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 31024808
    locus_GRCh38:
      chromosome: '6'
      position: 31057031
  trait_info:
    ontology:
    - EFO_0000180
    reported_trait_name: HIV-1 control [AA]
    standard_trait_name: HIV-1 infection
- association_info:
    ancestry:
    - East Asian=1098
    gwas_catalog_id: GCST001768
    neg_log_pval: 11.0
    otg_id: GCST001768
    pubmed_id: '23001997'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug COLCHICINE is Phase II for the indiciation
        EFO_0003780 and targets the gene ENSG00000196230 at this locus (364975bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000196230
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 31058178
    locus_GRCh38:
      chromosome: '6'
      position: 31090401
  trait_info:
    ontology:
    - EFO_0003780
    reported_trait_name: Behcet's disease
    standard_trait_name: Behcet's syndrome
- association_info:
    ancestry:
    - East Asian=1098
    gwas_catalog_id: GCST001768
    neg_log_pval: 11.0
    otg_id: GCST001768
    pubmed_id: '23001997'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug INFLIXIMAB is Phase III for the indiciation
        EFO_0003780 and targets the gene ENSG00000232810 at this locus (485164bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 31058178
    locus_GRCh38:
      chromosome: '6'
      position: 31090401
  trait_info:
    ontology:
    - EFO_0003780
    reported_trait_name: Behcet's disease
    standard_trait_name: Behcet's syndrome
- association_info:
    ancestry:
    - European=781
    gwas_catalog_id: GCST000448
    neg_log_pval: 10.301029995663981
    otg_id: GCST000448
    pubmed_id: '19620980'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug VINCRISTINE is Phase III for the indiciation
        EFO_0000096 and targets the gene ENSG00000196230 at this locus (380827bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000196230
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 31074030
    locus_GRCh38:
      chromosome: '6'
      position: 31106253
  trait_info:
    ontology:
    - EFO_0000096
    reported_trait_name: Follicular lymphoma
    standard_trait_name: neoplasm of mature B-cells
- association_info:
    ancestry:
    - European=1048
    gwas_catalog_id: GCST005541
    neg_log_pval: 26.096910013008056
    otg_id: GCST005541
    pubmed_id: '26651848'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug ADALIMUMAB is Phase II for the indiciation
        Orphanet_797 and targets the gene ENSG00000232810 at this locus (463327bp
        away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 31080016
    locus_GRCh38:
      chromosome: '6'
      position: 31112239
  trait_info:
    ontology:
    - Orphanet_797
    reported_trait_name: Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome)
    standard_trait_name: Sarcoidosis
- association_info:
    ancestry:
    - European=1048
    gwas_catalog_id: GCST005541
    neg_log_pval: 26.096910013008056
    otg_id: GCST005541
    pubmed_id: '26651848'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug INFLIXIMAB is Phase III for the indiciation
        Orphanet_797 and targets the gene ENSG00000232810 at this locus (463327bp
        away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 31080016
    locus_GRCh38:
      chromosome: '6'
      position: 31112239
  trait_info:
    ontology:
    - Orphanet_797
    reported_trait_name: Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome)
    standard_trait_name: Sarcoidosis
- association_info:
    ancestry:
    - European=40187
    gwas_catalog_id: GCST004749
    neg_log_pval: 15.301029995663981
    otg_id: GCST004749
    pubmed_id: '28604730'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug VINCRISTINE is Phase III for the indiciation
        EFO_0001071 and targets the gene ENSG00000196230 at this locus (388002bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000196230
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 31081205
    locus_GRCh38:
      chromosome: '6'
      position: 31113428
  trait_info:
    ontology:
    - EFO_0001071
    reported_trait_name: Lung cancer in ever smokers
    standard_trait_name: lung carcinoma
- association_info:
    ancestry:
    - European=40187
    gwas_catalog_id: GCST004749
    neg_log_pval: 15.301029995663981
    otg_id: GCST004749
    pubmed_id: '28604730'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug IXABEPILONE is Phase II for the indiciation
        EFO_0001071 and targets the gene ENSG00000196230 at this locus (388002bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000196230
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 31081205
    locus_GRCh38:
      chromosome: '6'
      position: 31113428
  trait_info:
    ontology:
    - EFO_0001071
    reported_trait_name: Lung cancer in ever smokers
    standard_trait_name: lung carcinoma
- association_info:
    ancestry:
    - European=8970
    - African American or Afro-Caribbean=2025
    gwas_catalog_id: GCST003833
    neg_log_pval: 10.698970004336019
    otg_id: GCST003833
    pubmed_id: '27611488'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug ETANERCEPT is Phase II for the indiciation
        EFO_0000270 and targets the gene ENSG00000232810 at this locus (455197bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 31088145
    locus_GRCh38:
      chromosome: '6'
      position: 31120368
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Adult asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - Other=978
    - European=1112
    gwas_catalog_id: GCST006575
    neg_log_pval: 9.698970004336019
    otg_id: GCST006575_3
    pubmed_id: '25604533'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug INFLIXIMAB is Phase II for the indiciation
        EFO_1001857 and targets the gene ENSG00000232810 at this locus (453635bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 31089708
    locus_GRCh38:
      chromosome: '6'
      position: 31121931
  trait_info:
    ontology:
    - EFO_1001857
    reported_trait_name: Takayasu arteritis [Turkish]
    standard_trait_name: Takayasu arteritis
- association_info:
    ancestry:
    - East Asian=1098
    gwas_catalog_id: GCST001768
    neg_log_pval: 19.69897000433602
    otg_id: GCST001768
    pubmed_id: '23001997'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug INFLIXIMAB is Phase III for the indiciation
        EFO_0003780 and targets the gene ENSG00000232810 at this locus (443766bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 31099577
    locus_GRCh38:
      chromosome: '6'
      position: 31131800
  trait_info:
    ontology:
    - EFO_0003780
    reported_trait_name: Behcet's disease
    standard_trait_name: Behcet's syndrome
- association_info:
    ancestry:
    - East Asian=1098
    gwas_catalog_id: GCST001768
    neg_log_pval: 19.69897000433602
    otg_id: GCST001768
    pubmed_id: '23001997'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug COLCHICINE is Phase II for the indiciation
        EFO_0003780 and targets the gene ENSG00000196230 at this locus (406375bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000196230
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 31099577
    locus_GRCh38:
      chromosome: '6'
      position: 31131800
  trait_info:
    ontology:
    - EFO_0003780
    reported_trait_name: Behcet's disease
    standard_trait_name: Behcet's syndrome
- association_info:
    ancestry:
    - Other=1097
    - NR=150064
    gwas_catalog_id: GCST003048
    neg_log_pval: 9.0
    otg_id: GCST003048
    pubmed_id: '26198764'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug INFLIXIMAB is Phase IV for the indiciation
        EFO_0000692 and targets the gene ENSG00000232810 at this locus (440378bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 31102964
    locus_GRCh38:
      chromosome: '6'
      position: 31135187
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - NR=150064
    - European=70017
    gwas_catalog_id: GCST007257
    neg_log_pval: 9.698970004336019
    otg_id: GCST007257
    pubmed_id: '30626913'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug INFLIXIMAB is Phase IV for the indiciation
        EFO_0003761 and targets the gene ENSG00000232810 at this locus (437929bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 31105413
    locus_GRCh38:
      chromosome: '6'
      position: 31137636
  trait_info:
    ontology:
    - EFO_0003761
    reported_trait_name: Broad depression or schizophrenia
    standard_trait_name: unipolar depression
- association_info:
    ancestry:
    - NR=150064
    - European=70017
    gwas_catalog_id: GCST007257
    neg_log_pval: 9.698970004336019
    otg_id: GCST007257
    pubmed_id: '30626913'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug INFLIXIMAB is Phase IV for the indiciation
        EFO_0000692 and targets the gene ENSG00000232810 at this locus (437929bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 31105413
    locus_GRCh38:
      chromosome: '6'
      position: 31137636
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Broad depression or schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - European=9641
    gwas_catalog_id: GCST002140
    neg_log_pval: 10.0
    otg_id: GCST002140
    pubmed_id: '23955597'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug PACLITAXEL is Phase II for the indiciation
        EFO_0001378 and targets the gene ENSG00000196230 at this locus (414055bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000196230
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 31107258
    locus_GRCh38:
      chromosome: '6'
      position: 31139481
  trait_info:
    ontology:
    - EFO_0001378
    reported_trait_name: Multiple myeloma
    standard_trait_name: multiple myeloma
- association_info:
    ancestry:
    - European=9641
    gwas_catalog_id: GCST002140
    neg_log_pval: 10.0
    otg_id: GCST002140
    pubmed_id: '23955597'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug VINCRISTINE is Phase III for the indiciation
        EFO_0001378 and targets the gene ENSG00000196230 at this locus (414055bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000196230
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 31107258
    locus_GRCh38:
      chromosome: '6'
      position: 31139481
  trait_info:
    ontology:
    - EFO_0001378
    reported_trait_name: Multiple myeloma
    standard_trait_name: multiple myeloma
- association_info:
    ancestry:
    - East Asian=1310
    gwas_catalog_id: GCST000529
    neg_log_pval: 66.39794000867204
    otg_id: GCST000529
    pubmed_id: '19915573'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug ADALIMUMAB is Phase IV for the indiciation
        EFO_0000729 and targets the gene ENSG00000232810 at this locus (431987bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 31111356
    locus_GRCh38:
      chromosome: '6'
      position: 31143579
  trait_info:
    ontology:
    - EFO_0000729
    reported_trait_name: Ulcerative colitis
    standard_trait_name: ulcerative colitis
- association_info:
    ancestry:
    - East Asian=1310
    gwas_catalog_id: GCST000529
    neg_log_pval: 66.39794000867204
    otg_id: GCST000529
    pubmed_id: '19915573'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug CERTOLIZUMAB PEGOL is Phase II for the
        indiciation EFO_0000729 and targets the gene ENSG00000232810 at this locus
        (431987bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 31111356
    locus_GRCh38:
      chromosome: '6'
      position: 31143579
  trait_info:
    ontology:
    - EFO_0000729
    reported_trait_name: Ulcerative colitis
    standard_trait_name: ulcerative colitis
- association_info:
    ancestry:
    - European=241704
    gwas_catalog_id: GCST004483
    neg_log_pval: 16.522878745280337
    otg_id: GCST004483
    pubmed_id: '27363682'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug VINORELBINE is Phase II for the indiciation
        EFO_0001378 and targets the gene ENSG00000196230 at this locus (423324bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000196230
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 31116526
    locus_GRCh38:
      chromosome: '6'
      position: 31148749
  trait_info:
    ontology:
    - EFO_0001378
    reported_trait_name: Multiple myeloma
    standard_trait_name: multiple myeloma
- association_info:
    ancestry:
    - European=241704
    gwas_catalog_id: GCST004483
    neg_log_pval: 16.522878745280337
    otg_id: GCST004483
    pubmed_id: '27363682'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug VINCRISTINE is Phase III for the indiciation
        EFO_0001378 and targets the gene ENSG00000196230 at this locus (423324bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000196230
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 31116526
    locus_GRCh38:
      chromosome: '6'
      position: 31148749
  trait_info:
    ontology:
    - EFO_0001378
    reported_trait_name: Multiple myeloma
    standard_trait_name: multiple myeloma
- association_info:
    ancestry:
    - European=13560
    gwas_catalog_id: GCST001148
    neg_log_pval: 7.522878745280337
    otg_id: GCST001148
    pubmed_id: '21743467'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug CABAZITAXEL is Phase IV for the indiciation
        EFO_0001663 and targets the gene ENSG00000196230 at this locus (425308bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000196230
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 31118511
    locus_GRCh38:
      chromosome: '6'
      position: 31150734
  trait_info:
    ontology:
    - EFO_0001663
    reported_trait_name: Prostate cancer
    standard_trait_name: prostate carcinoma
- association_info:
    ancestry:
    - European=13560
    gwas_catalog_id: GCST001148
    neg_log_pval: 7.522878745280337
    otg_id: GCST001148
    pubmed_id: '21743467'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug IXABEPILONE is Phase II for the indiciation
        EFO_0001663 and targets the gene ENSG00000196230 at this locus (425308bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000196230
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 31118511
    locus_GRCh38:
      chromosome: '6'
      position: 31150734
  trait_info:
    ontology:
    - EFO_0001663
    reported_trait_name: Prostate cancer
    standard_trait_name: prostate carcinoma
- association_info:
    ancestry:
    - European=13560
    gwas_catalog_id: GCST001148
    neg_log_pval: 7.522878745280337
    otg_id: GCST001148
    pubmed_id: '21743467'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug VINBLASTINE is Phase III for the indiciation
        EFO_0001663 and targets the gene ENSG00000196230 at this locus (425308bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000196230
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 31118511
    locus_GRCh38:
      chromosome: '6'
      position: 31150734
  trait_info:
    ontology:
    - EFO_0001663
    reported_trait_name: Prostate cancer
    standard_trait_name: prostate carcinoma
- association_info:
    ancestry:
    - European=2305
    gwas_catalog_id: GCST001181
    neg_log_pval: 7.698970004336019
    otg_id: GCST001181
    pubmed_id: '21801394'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug INFLIXIMAB is Phase II for the indiciation
        EFO_0004775 and targets the gene ENSG00000232810 at this locus (406890bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 31136453
    locus_GRCh38:
      chromosome: '6'
      position: 31168676
  trait_info:
    ontology:
    - EFO_0004775
    reported_trait_name: Drug-induced Stevens-Johnson syndrome or toxic epidermal
      necrolysis (SJS/TEN)
    standard_trait_name: toxic epidermal necrolysis
- association_info:
    ancestry:
    - European=2305
    gwas_catalog_id: GCST001181
    neg_log_pval: 7.698970004336019
    otg_id: GCST001181
    pubmed_id: '21801394'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug ETANERCEPT is Phase III for the indiciation
        EFO_0004276 and targets the gene ENSG00000232810 at this locus (406890bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 31136453
    locus_GRCh38:
      chromosome: '6'
      position: 31168676
  trait_info:
    ontology:
    - EFO_0004276
    reported_trait_name: Drug-induced Stevens-Johnson syndrome or toxic epidermal
      necrolysis (SJS/TEN)
    standard_trait_name: Stevens-Johnson syndrome
- association_info:
    ancestry:
    - European=2305
    gwas_catalog_id: GCST001181
    neg_log_pval: 7.522878745280337
    otg_id: GCST001181
    pubmed_id: '21801394'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug ETANERCEPT is Phase III for the indiciation
        EFO_0004276 and targets the gene ENSG00000232810 at this locus (401097bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 31142245
    locus_GRCh38:
      chromosome: '6'
      position: 31174468
  trait_info:
    ontology:
    - EFO_0004276
    reported_trait_name: Drug-induced Stevens-Johnson syndrome or toxic epidermal
      necrolysis (SJS/TEN)
    standard_trait_name: Stevens-Johnson syndrome
- association_info:
    ancestry:
    - European=2305
    gwas_catalog_id: GCST001181
    neg_log_pval: 7.522878745280337
    otg_id: GCST001181
    pubmed_id: '21801394'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug INFLIXIMAB is Phase II for the indiciation
        EFO_0004775 and targets the gene ENSG00000232810 at this locus (401097bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 31142245
    locus_GRCh38:
      chromosome: '6'
      position: 31174468
  trait_info:
    ontology:
    - EFO_0004775
    reported_trait_name: Drug-induced Stevens-Johnson syndrome or toxic epidermal
      necrolysis (SJS/TEN)
    standard_trait_name: toxic epidermal necrolysis
- association_info:
    ancestry:
    - European=1712
    - African American or Afro-Caribbean=1233
    - Hispanic or Latin American=677
    gwas_catalog_id: GCST000863
    neg_log_pval: 15.397940008672037
    otg_id: GCST000863_2
    pubmed_id: '21051598'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug VINCRISTINE is Phase III for the indiciation
        EFO_0000180 and targets the gene ENSG00000196230 at this locus (450379bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000196230
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 31143582
    locus_GRCh38:
      chromosome: '6'
      position: 31175805
  trait_info:
    ontology:
    - EFO_0000180
    reported_trait_name: HIV-1 control [EA]
    standard_trait_name: HIV-1 infection
- association_info:
    ancestry:
    - East Asian=2271
    gwas_catalog_id: GCST000321
    neg_log_pval: 207.69897000433602
    otg_id: GCST000321
    pubmed_id: '19169255'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug ETANERCEPT is Phase IV for the indiciation
        EFO_0000676 and targets the gene ENSG00000232810 at this locus (387557bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 31155785
    locus_GRCh38:
      chromosome: '6'
      position: 31188008
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - East Asian=2271
    gwas_catalog_id: GCST000321
    neg_log_pval: 207.69897000433602
    otg_id: GCST000321
    pubmed_id: '19169255'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug CERTOLIZUMAB PEGOL is Phase III for the
        indiciation EFO_0000676 and targets the gene ENSG00000232810 at this locus
        (387557bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 31155785
    locus_GRCh38:
      chromosome: '6'
      position: 31188008
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - East Asian=2271
    gwas_catalog_id: GCST000321
    neg_log_pval: 207.69897000433602
    otg_id: GCST000321
    pubmed_id: '19169255'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tubulin inhibitor drug PACLITAXEL is Phase II for the indiciation
        EFO_0000676 and targets the gene ENSG00000196230 at this locus (462582bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000196230
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 31155785
    locus_GRCh38:
      chromosome: '6'
      position: 31188008
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=1951
    gwas_catalog_id: GCST001737
    neg_log_pval: 9.698970004336019
    otg_id: GCST001737_7
    pubmed_id: '23144326'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug INFLIXIMAB is Phase III for the indiciation
        EFO_0000341 and targets the gene ENSG00000232810 at this locus (302912bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 31240431
    locus_GRCh38:
      chromosome: '6'
      position: 31272654
  trait_info:
    ontology:
    - EFO_0000341
    reported_trait_name: Chronic obstructive pulmonary disease-related biomarkers
      [SP-D]
    standard_trait_name: chronic obstructive pulmonary disease
- association_info:
    ancestry:
    - European=1951
    gwas_catalog_id: GCST001737
    neg_log_pval: 9.698970004336019
    otg_id: GCST001737_7
    pubmed_id: '23144326'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug ETANERCEPT is Phase II for the indiciation
        EFO_0000341 and targets the gene ENSG00000232810 at this locus (302912bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 31240431
    locus_GRCh38:
      chromosome: '6'
      position: 31272654
  trait_info:
    ontology:
    - EFO_0000341
    reported_trait_name: Chronic obstructive pulmonary disease-related biomarkers
      [SP-D]
    standard_trait_name: chronic obstructive pulmonary disease
- association_info:
    ancestry:
    - European=1460
    gwas_catalog_id: GCST000835
    neg_log_pval: 71.69897000433602
    otg_id: GCST000835
    pubmed_id: '20953186'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug INFLIXIMAB is Phase IV for the indiciation
        EFO_0003778 and targets the gene ENSG00000232810 at this locus (302233bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 31241109
    locus_GRCh38:
      chromosome: '6'
      position: 31273332
  trait_info:
    ontology:
    - EFO_0003778
    reported_trait_name: Psoriatic arthritis
    standard_trait_name: psoriatic arthritis
- association_info:
    ancestry:
    - European=1460
    gwas_catalog_id: GCST000835
    neg_log_pval: 71.69897000433602
    otg_id: GCST000835
    pubmed_id: '20953186'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug ONERCEPT is Phase III for the indiciation
        EFO_0003778 and targets the gene ENSG00000232810 at this locus (302233bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 31241109
    locus_GRCh38:
      chromosome: '6'
      position: 31273332
  trait_info:
    ontology:
    - EFO_0003778
    reported_trait_name: Psoriatic arthritis
    standard_trait_name: psoriatic arthritis
- association_info:
    ancestry:
    - Other=978
    - European=1112
    gwas_catalog_id: GCST006575
    neg_log_pval: 9.0
    otg_id: GCST006575_2
    pubmed_id: '25604533'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug INFLIXIMAB is Phase II for the indiciation
        EFO_1001857 and targets the gene ENSG00000232810 at this locus (301152bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 31242191
    locus_GRCh38:
      chromosome: '6'
      position: 31274414
  trait_info:
    ontology:
    - EFO_1001857
    reported_trait_name: Takayasu arteritis [EA]
    standard_trait_name: Takayasu arteritis
- association_info:
    ancestry:
    - European=2759
    gwas_catalog_id: GCST000322
    neg_log_pval: 100.0
    otg_id: GCST000322
    pubmed_id: '19169254'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug CERTOLIZUMAB PEGOL is Phase III for the
        indiciation EFO_0000676 and targets the gene ENSG00000232810 at this locus
        (290418bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 31252925
    locus_GRCh38:
      chromosome: '6'
      position: 31285148
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=6880
    gwas_catalog_id: GCST003270
    neg_log_pval: 98.69897000433602
    otg_id: GCST003270
    pubmed_id: '26626624'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug GOLIMUMAB is Phase IV for the indiciation
        EFO_0003778 and targets the gene ENSG00000232810 at this locus (290418bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 31252925
    locus_GRCh38:
      chromosome: '6'
      position: 31285148
  trait_info:
    ontology:
    - EFO_0003778
    reported_trait_name: Psoriatic arthritis
    standard_trait_name: psoriatic arthritis
- association_info:
    ancestry:
    - European=2759
    gwas_catalog_id: GCST000322
    neg_log_pval: 100.0
    otg_id: GCST000322
    pubmed_id: '19169254'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug ETANERCEPT is Phase IV for the indiciation
        EFO_0000676 and targets the gene ENSG00000232810 at this locus (290418bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 31252925
    locus_GRCh38:
      chromosome: '6'
      position: 31285148
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=1618
    gwas_catalog_id: GCST000836
    neg_log_pval: 31.397940008672037
    otg_id: GCST000836
    pubmed_id: '20953188'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug CERTOLIZUMAB PEGOL is Phase III for the
        indiciation EFO_0000676 and targets the gene ENSG00000232810 at this locus
        (290418bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 31252925
    locus_GRCh38:
      chromosome: '6'
      position: 31285148
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=1618
    gwas_catalog_id: GCST000836
    neg_log_pval: 31.397940008672037
    otg_id: GCST000836
    pubmed_id: '20953188'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug ETANERCEPT is Phase IV for the indiciation
        EFO_0000676 and targets the gene ENSG00000232810 at this locus (290418bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 31252925
    locus_GRCh38:
      chromosome: '6'
      position: 31285148
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=6880
    gwas_catalog_id: GCST003270
    neg_log_pval: 98.69897000433602
    otg_id: GCST003270
    pubmed_id: '26626624'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug ONERCEPT is Phase III for the indiciation
        EFO_0003778 and targets the gene ENSG00000232810 at this locus (290418bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 31252925
    locus_GRCh38:
      chromosome: '6'
      position: 31285148
  trait_info:
    ontology:
    - EFO_0003778
    reported_trait_name: Psoriatic arthritis
    standard_trait_name: psoriatic arthritis
- association_info:
    ancestry:
    - East Asian=2546
    gwas_catalog_id: GCST000692
    neg_log_pval: 32.69897000433602
    otg_id: GCST000692
    pubmed_id: '20526339'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug ETANERCEPT is Phase II for the indiciation
        EFO_0004208 and targets the gene ENSG00000232810 at this locus (284506bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 31258837
    locus_GRCh38:
      chromosome: '6'
      position: 31291060
  trait_info:
    ontology:
    - EFO_0004208
    reported_trait_name: Vitiligo
    standard_trait_name: Vitiligo
- association_info:
    ancestry:
    - European=2198
    gwas_catalog_id: GCST007043
    neg_log_pval: 36.0
    otg_id: GCST007043
    pubmed_id: '30552173'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug GOLIMUMAB is Phase IV for the indiciation
        EFO_0003778 and targets the gene ENSG00000232810 at this locus (277590bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 31265752
    locus_GRCh38:
      chromosome: '6'
      position: 31297975
  trait_info:
    ontology:
    - EFO_0003778
    reported_trait_name: Psoriatic arthritis
    standard_trait_name: psoriatic arthritis
- association_info:
    ancestry:
    - European=2198
    gwas_catalog_id: GCST007043
    neg_log_pval: 36.0
    otg_id: GCST007043
    pubmed_id: '30552173'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug ONERCEPT is Phase III for the indiciation
        EFO_0003778 and targets the gene ENSG00000232810 at this locus (277590bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 31265752
    locus_GRCh38:
      chromosome: '6'
      position: 31297975
  trait_info:
    ontology:
    - EFO_0003778
    reported_trait_name: Psoriatic arthritis
    standard_trait_name: psoriatic arthritis
- association_info:
    ancestry:
    - European=8941
    gwas_catalog_id: GCST003268
    neg_log_pval: 311.69897000433605
    otg_id: GCST003268
    pubmed_id: '26626624'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug ETANERCEPT is Phase IV for the indiciation
        EFO_1001494 and targets the gene ENSG00000232810 at this locus (277252bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 31266090
    locus_GRCh38:
      chromosome: '6'
      position: 31298313
  trait_info:
    ontology:
    - EFO_1001494
    reported_trait_name: Psoriasis vulgaris
    standard_trait_name: psoriasis vulgaris
- association_info:
    ancestry:
    - East Asian=2644
    gwas_catalog_id: GCST003360
    neg_log_pval: 22.045757490560675
    otg_id: GCST003360
    pubmed_id: '26891255'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug ADALIMUMAB is Phase IV for the indiciation
        EFO_0000384 and targets the gene ENSG00000232810 at this locus (273649bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 31269693
    locus_GRCh38:
      chromosome: '6'
      position: 31301916
  trait_info:
    ontology:
    - EFO_0000384
    reported_trait_name: Crohn's disease
    standard_trait_name: Crohn's disease
- association_info:
    ancestry:
    - European=7353
    gwas_catalog_id: GCST000833
    neg_log_pval: 213.39794000867204
    otg_id: GCST000833
    pubmed_id: '20953190'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug INFLIXIMAB is Phase IV for the indiciation
        EFO_0000676 and targets the gene ENSG00000232810 at this locus (268787bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 31274555
    locus_GRCh38:
      chromosome: '6'
      position: 31306778
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=7353
    gwas_catalog_id: GCST000833
    neg_log_pval: 213.39794000867204
    otg_id: GCST000833
    pubmed_id: '20953190'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug CERTOLIZUMAB PEGOL is Phase III for the
        indiciation EFO_0000676 and targets the gene ENSG00000232810 at this locus
        (268787bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 31274555
    locus_GRCh38:
      chromosome: '6'
      position: 31306778
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=6297
    gwas_catalog_id: GCST003269
    neg_log_pval: 206.39794000867204
    otg_id: GCST003269
    pubmed_id: '26626624'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug CERTOLIZUMAB PEGOL is Phase III for the
        indiciation EFO_0000676 and targets the gene ENSG00000232810 at this locus
        (268787bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 31274555
    locus_GRCh38:
      chromosome: '6'
      position: 31306778
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Cutaneous psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=737
    gwas_catalog_id: GCST000173
    neg_log_pval: 38.69897000433602
    otg_id: GCST000173
    pubmed_id: '18369459'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug INFLIXIMAB is Phase IV for the indiciation
        EFO_0000676 and targets the gene ENSG00000232810 at this locus (268787bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 31274555
    locus_GRCh38:
      chromosome: '6'
      position: 31306778
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=737
    gwas_catalog_id: GCST000173
    neg_log_pval: 38.69897000433602
    otg_id: GCST000173
    pubmed_id: '18369459'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug CERTOLIZUMAB PEGOL is Phase III for the
        indiciation EFO_0000676 and targets the gene ENSG00000232810 at this locus
        (268787bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 31274555
    locus_GRCh38:
      chromosome: '6'
      position: 31306778
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=6297
    gwas_catalog_id: GCST003269
    neg_log_pval: 206.39794000867204
    otg_id: GCST003269
    pubmed_id: '26626624'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug INFLIXIMAB is Phase IV for the indiciation
        EFO_0000676 and targets the gene ENSG00000232810 at this locus (268787bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 31274555
    locus_GRCh38:
      chromosome: '6'
      position: 31306778
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Cutaneous psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - East Asian=2569
    gwas_catalog_id: GCST006984
    neg_log_pval: 33.39794000867204
    otg_id: GCST006984
    pubmed_id: '30498034'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug INFLIXIMAB is Phase II for the indiciation
        EFO_1001857 and targets the gene ENSG00000232810 at this locus (263125bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 31280218
    locus_GRCh38:
      chromosome: '6'
      position: 31312441
  trait_info:
    ontology:
    - EFO_1001857
    reported_trait_name: Takayasu arteritis
    standard_trait_name: Takayasu arteritis
- association_info:
    ancestry:
    - European=606
    gwas_catalog_id: GCST000165
    neg_log_pval: 9.0
    otg_id: GCST000165
    pubmed_id: '18364390'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug ETANERCEPT is Phase IV for the indiciation
        EFO_0000676 and targets the gene ENSG00000232810 at this locus (231017bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 31312326
    locus_GRCh38:
      chromosome: '6'
      position: 31344549
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=606
    gwas_catalog_id: GCST000165
    neg_log_pval: 9.0
    otg_id: GCST000165
    pubmed_id: '18364390'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug CERTOLIZUMAB PEGOL is Phase III for the
        indiciation EFO_0000676 and targets the gene ENSG00000232810 at this locus
        (231017bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 31312326
    locus_GRCh38:
      chromosome: '6'
      position: 31344549
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - Other=1097
    - NR=150064
    gwas_catalog_id: GCST003048
    neg_log_pval: 19.096910013008056
    otg_id: GCST003048
    pubmed_id: '26198764'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug INFLIXIMAB is Phase IV for the indiciation
        EFO_0000692 and targets the gene ENSG00000232810 at this locus (222075bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 31321267
    locus_GRCh38:
      chromosome: '6'
      position: 31353490
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - Other=1828
    - Greater Middle Eastern (Middle Eastern / North African / Persian)=1176
    gwas_catalog_id: GCST007844
    neg_log_pval: 119.22184874961636
    otg_id: GCST007844_4
    pubmed_id: '30946743'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug CERTOLIZUMAB PEGOL is Phase IV for the
        indiciation EFO_0003898 and targets the gene ENSG00000232810 at this locus
        (221214bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 31322129
    locus_GRCh38:
      chromosome: '6'
      position: 31354352
  trait_info:
    ontology:
    - EFO_0003898
    reported_trait_name: Ankylosing spondylitis [Turkish]
    standard_trait_name: ankylosing spondylitis
- association_info:
    ancestry:
    - European=157242
    gwas_catalog_id: GCST003987
    neg_log_pval: 16.0
    otg_id: GCST003987
    pubmed_id: '27182965'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug ADALIMUMAB is Phase II for the indiciation
        EFO_0000270 and targets the gene ENSG00000232810 at this locus (221145bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 31322197
    locus_GRCh38:
      chromosome: '6'
      position: 31354420
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=341215
    gwas_catalog_id: GCST007798
    neg_log_pval: 59.69897000433602
    otg_id: GCST007798
    pubmed_id: '30929738'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug ADALIMUMAB is Phase II for the indiciation
        EFO_0000270 and targets the gene ENSG00000232810 at this locus (221145bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 31322197
    locus_GRCh38:
      chromosome: '6'
      position: 31354420
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - Other=1828
    - Greater Middle Eastern (Middle Eastern / North African / Persian)=1176
    gwas_catalog_id: GCST007844
    neg_log_pval: 90.04575749056067
    otg_id: GCST007844_3
    pubmed_id: '30946743'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug ETANERCEPT is Phase IV for the indiciation
        EFO_0003898 and targets the gene ENSG00000232810 at this locus (217409bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 31325933
    locus_GRCh38:
      chromosome: '6'
      position: 31358156
  trait_info:
    ontology:
    - EFO_0003898
    reported_trait_name: Ankylosing spondylitis [Iranian]
    standard_trait_name: ankylosing spondylitis
- association_info:
    ancestry:
    - European=4806
    gwas_catalog_id: GCST000961
    neg_log_pval: 8.0
    otg_id: GCST000961
    pubmed_id: '21254220'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug INFLIXIMAB is Phase II for the indiciation
        EFO_0000289 and targets the gene ENSG00000232810 at this locus (215641bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 31327701
    locus_GRCh38:
      chromosome: '6'
      position: 31359924
  trait_info:
    ontology:
    - EFO_0000289
    reported_trait_name: Bipolar disorder [addtive]
    standard_trait_name: bipolar disorder
- association_info:
    ancestry:
    - European=7193
    gwas_catalog_id: GCST000563
    neg_log_pval: 303.30102999566395
    otg_id: GCST000563
    pubmed_id: '20062062'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug ADALIMUMAB is Phase IV for the indiciation
        EFO_0003898 and targets the gene ENSG00000232810 at this locus (207242bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 31336100
    locus_GRCh38:
      chromosome: '6'
      position: 31368323
  trait_info:
    ontology:
    - EFO_0003898
    reported_trait_name: Ankylosing spondylitis
    standard_trait_name: ankylosing spondylitis
- association_info:
    ancestry:
    - East Asian=1098
    gwas_catalog_id: GCST001768
    neg_log_pval: 9.698970004336019
    otg_id: GCST001768
    pubmed_id: '23001997'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug INFLIXIMAB is Phase III for the indiciation
        EFO_0003780 and targets the gene ENSG00000232810 at this locus (206925bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 31336418
    locus_GRCh38:
      chromosome: '6'
      position: 31368641
  trait_info:
    ontology:
    - EFO_0003780
    reported_trait_name: Behcet's disease
    standard_trait_name: Behcet's syndrome
- association_info:
    ancestry:
    - European=22647
    - East Asian=3117
    gwas_catalog_id: GCST005529
    neg_log_pval: 100.0
    otg_id: GCST005529_3
    pubmed_id: '23749187'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug INFLIXIMAB is Phase IV for the indiciation
        EFO_0003898 and targets the gene ENSG00000232810 at this locus (198427bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 31344916
    locus_GRCh38:
      chromosome: '6'
      position: 31377139
  trait_info:
    ontology:
    - EFO_0003898
    reported_trait_name: Ankylosing spondylitis [EA]
    standard_trait_name: ankylosing spondylitis
- association_info:
    ancestry:
    - European, East Asian, African American or Afro-Caribbean, Hispanic or Latin
      American, NR=257811
    gwas_catalog_id: GCST007692
    neg_log_pval: 15.698970004336019
    otg_id: GCST007692_13
    pubmed_id: '30804561'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug ETANERCEPT is Phase II for the indiciation
        EFO_0000341 and targets the gene ENSG00000232810 at this locus (194823bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 31348519
    locus_GRCh38:
      chromosome: '6'
      position: 31380742
  trait_info:
    ontology:
    - EFO_0000341
    reported_trait_name: Chronic obstructive pulmonary disease [conditional on rs2284174]
    standard_trait_name: chronic obstructive pulmonary disease
- association_info:
    ancestry:
    - European, East Asian, African American or Afro-Caribbean, Hispanic or Latin
      American, NR=257811
    gwas_catalog_id: GCST007692
    neg_log_pval: 15.698970004336019
    otg_id: GCST007692_13
    pubmed_id: '30804561'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug INFLIXIMAB is Phase III for the indiciation
        EFO_0000341 and targets the gene ENSG00000232810 at this locus (194823bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 31348519
    locus_GRCh38:
      chromosome: '6'
      position: 31380742
  trait_info:
    ontology:
    - EFO_0000341
    reported_trait_name: Chronic obstructive pulmonary disease [conditional on rs2284174]
    standard_trait_name: chronic obstructive pulmonary disease
- association_info:
    ancestry:
    - Other=978
    - European=1112
    gwas_catalog_id: GCST006575
    neg_log_pval: 7.698970004336019
    otg_id: GCST006575_3
    pubmed_id: '25604533'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug INFLIXIMAB is Phase II for the indiciation
        EFO_1001857 and targets the gene ENSG00000232810 at this locus (192130bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 31351212
    locus_GRCh38:
      chromosome: '6'
      position: 31383435
  trait_info:
    ontology:
    - EFO_1001857
    reported_trait_name: Takayasu arteritis [Turkish]
    standard_trait_name: Takayasu arteritis
- association_info:
    ancestry:
    - European=7156
    gwas_catalog_id: GCST002357
    neg_log_pval: 8.045757490560675
    otg_id: GCST002357
    pubmed_id: '24532677'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-beta inhibitor drug PATECLIZUMAB is Phase II for the indiciation
        EFO_0000685 and targets the gene ENSG00000226979 at this locus (186502bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000226979
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 31353329
    locus_GRCh38:
      chromosome: '6'
      position: 31385552
  trait_info:
    ontology:
    - EFO_0000685
    reported_trait_name: Rheumatoid arthritis (ACPA-negative)
    standard_trait_name: rheumatoid arthritis
- association_info:
    ancestry:
    - European=7156
    gwas_catalog_id: GCST002357
    neg_log_pval: 8.045757490560675
    otg_id: GCST002357
    pubmed_id: '24532677'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug PLACULUMAB is Phase II for the indiciation
        EFO_0000685 and targets the gene ENSG00000232810 at this locus (190014bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 31353329
    locus_GRCh38:
      chromosome: '6'
      position: 31385552
  trait_info:
    ontology:
    - EFO_0000685
    reported_trait_name: Rheumatoid arthritis (ACPA-negative)
    standard_trait_name: rheumatoid arthritis
- association_info:
    ancestry:
    - European=7156
    gwas_catalog_id: GCST002357
    neg_log_pval: 8.045757490560675
    otg_id: GCST002357
    pubmed_id: '24532677'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug ADALIMUMAB is Phase IV for the indiciation
        EFO_0000685 and targets the gene ENSG00000232810 at this locus (190014bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 31353329
    locus_GRCh38:
      chromosome: '6'
      position: 31385552
  trait_info:
    ontology:
    - EFO_0000685
    reported_trait_name: Rheumatoid arthritis (ACPA-negative)
    standard_trait_name: rheumatoid arthritis
- association_info:
    ancestry:
    - Other=788
    - European=659
    gwas_catalog_id: GCST006863
    neg_log_pval: 15.221848749616356
    otg_id: GCST006863
    pubmed_id: '23830517'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug INFLIXIMAB is Phase II for the indiciation
        EFO_1001857 and targets the gene ENSG00000232810 at this locus (189105bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 31354238
    locus_GRCh38:
      chromosome: '6'
      position: 31386461
  trait_info:
    ontology:
    - EFO_1001857
    reported_trait_name: Takayasu arteritis
    standard_trait_name: Takayasu arteritis
- association_info:
    ancestry:
    - Other=978
    - European=1112
    gwas_catalog_id: GCST006575
    neg_log_pval: 14.522878745280337
    otg_id: GCST006575_2
    pubmed_id: '25604533'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug INFLIXIMAB is Phase II for the indiciation
        EFO_1001857 and targets the gene ENSG00000232810 at this locus (189105bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 31354238
    locus_GRCh38:
      chromosome: '6'
      position: 31386461
  trait_info:
    ontology:
    - EFO_1001857
    reported_trait_name: Takayasu arteritis [EA]
    standard_trait_name: Takayasu arteritis
- association_info:
    ancestry:
    - European=2930
    gwas_catalog_id: GCST007361
    neg_log_pval: 17.30102999566398
    otg_id: GCST007361
    pubmed_id: '25200001'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug CERTOLIZUMAB PEGOL is Phase IV for the
        indiciation EFO_0003898 and targets the gene ENSG00000232810 at this locus
        (183053bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 31360289
    locus_GRCh38:
      chromosome: '6'
      position: 31392512
  trait_info:
    ontology:
    - EFO_0003898
    reported_trait_name: Acute anterior uveitis in ankylosing spondylitis
    standard_trait_name: ankylosing spondylitis
- association_info:
    ancestry:
    - European=1073
    gwas_catalog_id: GCST002876
    neg_log_pval: 22.0
    otg_id: GCST002876
    pubmed_id: '25936594'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug ETANERCEPT is Phase III for the indiciation
        EFO_0001359 and targets the gene ENSG00000232810 at this locus (178635bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 31364707
    locus_GRCh38:
      chromosome: '6'
      position: 31396930
  trait_info:
    ontology:
    - EFO_0001359
    reported_trait_name: Type 1 diabetes and autoimmune thyroid diseases
    standard_trait_name: insulin-dependent diabetes mellitus
- association_info:
    ancestry:
    - European=1073
    gwas_catalog_id: GCST002876
    neg_log_pval: 22.0
    otg_id: GCST002876
    pubmed_id: '25936594'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug INFLIXIMAB is Phase II for the indiciation
        EFO_0001359 and targets the gene ENSG00000232810 at this locus (178635bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 31364707
    locus_GRCh38:
      chromosome: '6'
      position: 31396930
  trait_info:
    ontology:
    - EFO_0001359
    reported_trait_name: Type 1 diabetes and autoimmune thyroid diseases
    standard_trait_name: insulin-dependent diabetes mellitus
- association_info:
    ancestry:
    - European=11802
    gwas_catalog_id: GCST001149
    neg_log_pval: 200.0
    otg_id: GCST001149_2
    pubmed_id: '21743469'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug ADALIMUMAB is Phase IV for the indiciation
        EFO_0003898 and targets the gene ENSG00000232810 at this locus (177556bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 31365787
    locus_GRCh38:
      chromosome: '6'
      position: 31398010
  trait_info:
    ontology:
    - EFO_0003898
    reported_trait_name: Ankylosing spondylitis [less than]
    standard_trait_name: ankylosing spondylitis
- association_info:
    ancestry:
    - European=2305
    gwas_catalog_id: GCST001181
    neg_log_pval: 8.698970004336019
    otg_id: GCST001181
    pubmed_id: '21801394'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug INFLIXIMAB is Phase II for the indiciation
        EFO_0004775 and targets the gene ENSG00000232810 at this locus (135514bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 31407828
    locus_GRCh38:
      chromosome: '6'
      position: 31440051
  trait_info:
    ontology:
    - EFO_0004775
    reported_trait_name: Drug-induced Stevens-Johnson syndrome or toxic epidermal
      necrolysis (SJS/TEN)
    standard_trait_name: toxic epidermal necrolysis
- association_info:
    ancestry:
    - European=2305
    gwas_catalog_id: GCST001181
    neg_log_pval: 8.698970004336019
    otg_id: GCST001181
    pubmed_id: '21801394'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug ETANERCEPT is Phase III for the indiciation
        EFO_0004276 and targets the gene ENSG00000232810 at this locus (135514bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 31407828
    locus_GRCh38:
      chromosome: '6'
      position: 31440051
  trait_info:
    ontology:
    - EFO_0004276
    reported_trait_name: Drug-induced Stevens-Johnson syndrome or toxic epidermal
      necrolysis (SJS/TEN)
    standard_trait_name: Stevens-Johnson syndrome
- association_info:
    ancestry:
    - European=737
    gwas_catalog_id: GCST000173
    neg_log_pval: 25.69897000433602
    otg_id: GCST000173
    pubmed_id: '18369459'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug ADALIMUMAB is Phase IV for the indiciation
        EFO_0000676 and targets the gene ENSG00000232810 at this locus (111563bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 31431780
    locus_GRCh38:
      chromosome: '6'
      position: 31464003
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=737
    gwas_catalog_id: GCST000173
    neg_log_pval: 25.69897000433602
    otg_id: GCST000173
    pubmed_id: '18369459'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug CERTOLIZUMAB PEGOL is Phase III for the
        indiciation EFO_0000676 and targets the gene ENSG00000232810 at this locus
        (111563bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 31431780
    locus_GRCh38:
      chromosome: '6'
      position: 31464003
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=6434
    gwas_catalog_id: GCST003092
    neg_log_pval: 44.52287874528034
    otg_id: GCST003092
    pubmed_id: '26291516'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug INFLIXIMAB is Phase II for the indiciation
        EFO_0000783 and targets the gene ENSG00000232810 at this locus (109011bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 31434331
    locus_GRCh38:
      chromosome: '6'
      position: 31466554
  trait_info:
    ontology:
    - EFO_0000783
    reported_trait_name: Myositis
    standard_trait_name: myositis
- association_info:
    ancestry:
    - European=16582
    gwas_catalog_id: GCST006052
    neg_log_pval: 75.22184874961636
    otg_id: GCST006052
    pubmed_id: '26362759'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug INFLIXIMAB is Phase II for the indiciation
        EFO_0003063 and targets the gene ENSG00000232810 at this locus (108976bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 31434366
    locus_GRCh38:
      chromosome: '6'
      position: 31466589
  trait_info:
    ontology:
    - EFO_0003063
    reported_trait_name: Polymyositis
    standard_trait_name: polymyositis
- association_info:
    ancestry:
    - European=6434
    gwas_catalog_id: GCST003092
    neg_log_pval: 44.69897000433602
    otg_id: GCST003092
    pubmed_id: '26291516'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug INFLIXIMAB is Phase II for the indiciation
        EFO_0000783 and targets the gene ENSG00000232810 at this locus (108976bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 31434366
    locus_GRCh38:
      chromosome: '6'
      position: 31466589
  trait_info:
    ontology:
    - EFO_0000783
    reported_trait_name: Myositis
    standard_trait_name: myositis
- association_info:
    ancestry:
    - European=6434
    gwas_catalog_id: GCST003092
    neg_log_pval: 44.69897000433602
    otg_id: GCST003092
    pubmed_id: '26291516'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug INFLIXIMAB is Phase II for the indiciation
        EFO_0000783 and targets the gene ENSG00000232810 at this locus (108721bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 31434621
    locus_GRCh38:
      chromosome: '6'
      position: 31466844
  trait_info:
    ontology:
    - EFO_0000783
    reported_trait_name: Myositis
    standard_trait_name: myositis
- association_info:
    ancestry:
    - European=6434
    gwas_catalog_id: GCST003092
    neg_log_pval: 42.52287874528034
    otg_id: GCST003092
    pubmed_id: '26291516'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug INFLIXIMAB is Phase II for the indiciation
        EFO_0000783 and targets the gene ENSG00000232810 at this locus (100560bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 31442782
    locus_GRCh38:
      chromosome: '6'
      position: 31475005
  trait_info:
    ontology:
    - EFO_0000783
    reported_trait_name: Myositis
    standard_trait_name: myositis
- association_info:
    ancestry:
    - South Asian=1225
    gwas_catalog_id: GCST002453
    neg_log_pval: 14.698970004336019
    otg_id: GCST002453
    pubmed_id: '24837172'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug INFLIXIMAB is Phase IV for the indiciation
        EFO_0000729 and targets the gene ENSG00000232810 at this locus (94481bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 31448862
    locus_GRCh38:
      chromosome: '6'
      position: 31481085
  trait_info:
    ontology:
    - EFO_0000729
    reported_trait_name: Ulcerative colitis
    standard_trait_name: ulcerative colitis
- association_info:
    ancestry:
    - South Asian=1225
    gwas_catalog_id: GCST002453
    neg_log_pval: 14.698970004336019
    otg_id: GCST002453
    pubmed_id: '24837172'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug CERTOLIZUMAB PEGOL is Phase II for the
        indiciation EFO_0000729 and targets the gene ENSG00000232810 at this locus
        (94481bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 31448862
    locus_GRCh38:
      chromosome: '6'
      position: 31481085
  trait_info:
    ontology:
    - EFO_0000729
    reported_trait_name: Ulcerative colitis
    standard_trait_name: ulcerative colitis
- association_info:
    ancestry:
    - European=6434
    gwas_catalog_id: GCST003092
    neg_log_pval: 48.30102999566398
    otg_id: GCST003092
    pubmed_id: '26291516'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug INFLIXIMAB is Phase II for the indiciation
        EFO_0000783 and targets the gene ENSG00000232810 at this locus (94366bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 31448976
    locus_GRCh38:
      chromosome: '6'
      position: 31481199
  trait_info:
    ontology:
    - EFO_0000783
    reported_trait_name: Myositis
    standard_trait_name: myositis
- association_info:
    ancestry:
    - European=10564
    gwas_catalog_id: GCST001436
    neg_log_pval: 7.698970004336019
    otg_id: GCST001436_2
    pubmed_id: '22399527'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug ETANERCEPT is Phase II for the indiciation
        EFO_0000195 and targets the gene ENSG00000232810 at this locus (94366bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 31448976
    locus_GRCh38:
      chromosome: '6'
      position: 31481199
  trait_info:
    ontology:
    - EFO_0000195
    reported_trait_name: Metabolic syndrome [HDL]
    standard_trait_name: metabolic syndrome
- association_info:
    ancestry:
    - European=6434
    gwas_catalog_id: GCST003092
    neg_log_pval: 49.0
    otg_id: GCST003092
    pubmed_id: '26291516'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug INFLIXIMAB is Phase II for the indiciation
        EFO_0000783 and targets the gene ENSG00000232810 at this locus (91507bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 31451836
    locus_GRCh38:
      chromosome: '6'
      position: 31484059
  trait_info:
    ontology:
    - EFO_0000783
    reported_trait_name: Myositis
    standard_trait_name: myositis
- association_info:
    ancestry:
    - African unspecified, African American or Afro-Caribbean=8204
    - European=127669
    - East Asian=5215
    - Hispanic or Latin American=1398
    gwas_catalog_id: GCST005212
    neg_log_pval: 11.045757490560675
    otg_id: GCST005212
    pubmed_id: '29273806'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug GOLIMUMAB is Phase II for the indiciation
        EFO_0000270 and targets the gene ENSG00000232810 at this locus (70622bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 31472720
    locus_GRCh38:
      chromosome: '6'
      position: 31504943
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=6434
    gwas_catalog_id: GCST003092
    neg_log_pval: 47.39794000867204
    otg_id: GCST003092
    pubmed_id: '26291516'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug INFLIXIMAB is Phase II for the indiciation
        EFO_0000783 and targets the gene ENSG00000232810 at this locus (66885bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 31476458
    locus_GRCh38:
      chromosome: '6'
      position: 31508681
  trait_info:
    ontology:
    - EFO_0000783
    reported_trait_name: Myositis
    standard_trait_name: myositis
- association_info:
    ancestry:
    - East Asian=1005
    gwas_catalog_id: GCST001239
    neg_log_pval: 7.698970004336019
    otg_id: GCST001239
    pubmed_id: '21912425'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug ETANERCEPT is Phase III for the indiciation
        EFO_0004276 and targets the gene ENSG00000232810 at this locus (37863bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 31505480
    locus_GRCh38:
      chromosome: '6'
      position: 31537703
  trait_info:
    ontology:
    - EFO_0004276
    reported_trait_name: Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS-TEN)
    standard_trait_name: Stevens-Johnson syndrome
- association_info:
    ancestry:
    - European=6434
    gwas_catalog_id: GCST003092
    neg_log_pval: 48.52287874528034
    otg_id: GCST003092
    pubmed_id: '26291516'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug INFLIXIMAB is Phase II for the indiciation
        EFO_0000783 and targets the gene ENSG00000232810 at this locus (37863bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 31505480
    locus_GRCh38:
      chromosome: '6'
      position: 31537703
  trait_info:
    ontology:
    - EFO_0000783
    reported_trait_name: Myositis
    standard_trait_name: myositis
- association_info:
    ancestry:
    - East Asian=1005
    gwas_catalog_id: GCST001239
    neg_log_pval: 7.698970004336019
    otg_id: GCST001239
    pubmed_id: '21912425'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug INFLIXIMAB is Phase II for the indiciation
        EFO_0004775 and targets the gene ENSG00000232810 at this locus (37863bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 31505480
    locus_GRCh38:
      chromosome: '6'
      position: 31537703
  trait_info:
    ontology:
    - EFO_0004775
    reported_trait_name: Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS-TEN)
    standard_trait_name: toxic epidermal necrolysis
- association_info:
    ancestry:
    - European=6434
    gwas_catalog_id: GCST003092
    neg_log_pval: 48.221848749616356
    otg_id: GCST003092
    pubmed_id: '26291516'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug INFLIXIMAB is Phase II for the indiciation
        EFO_0000783 and targets the gene ENSG00000232810 at this locus (29095bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 31514247
    locus_GRCh38:
      chromosome: '6'
      position: 31546470
  trait_info:
    ontology:
    - EFO_0000783
    reported_trait_name: Myositis
    standard_trait_name: myositis
- association_info:
    ancestry:
    - European=21389
    gwas_catalog_id: GCST000879
    neg_log_pval: 10.397940008672037
    otg_id: GCST000879
    pubmed_id: '21102463'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug INFLIXIMAB is Phase IV for the indiciation
        EFO_0000384 and targets the gene ENSG00000232810 at this locus (1034bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 31542308
    locus_GRCh38:
      chromosome: '6'
      position: 31574531
  trait_info:
    ontology:
    - EFO_0000384
    reported_trait_name: Crohn's disease
    standard_trait_name: Crohn's disease
- association_info:
    ancestry:
    - European=1073
    gwas_catalog_id: GCST002876
    neg_log_pval: 22.69897000433602
    otg_id: GCST002876
    pubmed_id: '25936594'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug GOLIMUMAB is Phase II for the indiciation
        EFO_0001359 and targets the gene ENSG00000232810 at this locus (22356bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 31568469
    locus_GRCh38:
      chromosome: '6'
      position: 31600692
  trait_info:
    ontology:
    - EFO_0001359
    reported_trait_name: Type 1 diabetes and autoimmune thyroid diseases
    standard_trait_name: insulin-dependent diabetes mellitus
- association_info:
    ancestry:
    - European=1073
    gwas_catalog_id: GCST002876
    neg_log_pval: 22.69897000433602
    otg_id: GCST002876
    pubmed_id: '25936594'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug ETANERCEPT is Phase III for the indiciation
        EFO_0001359 and targets the gene ENSG00000232810 at this locus (22356bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 31568469
    locus_GRCh38:
      chromosome: '6'
      position: 31600692
  trait_info:
    ontology:
    - EFO_0001359
    reported_trait_name: Type 1 diabetes and autoimmune thyroid diseases
    standard_trait_name: insulin-dependent diabetes mellitus
- association_info:
    ancestry:
    - Other=978
    - European=1112
    gwas_catalog_id: GCST006575
    neg_log_pval: 9.0
    otg_id: GCST006575_3
    pubmed_id: '25604533'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug INFLIXIMAB is Phase II for the indiciation
        EFO_1001857 and targets the gene ENSG00000232810 at this locus (24557bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 31570670
    locus_GRCh38:
      chromosome: '6'
      position: 31602893
  trait_info:
    ontology:
    - EFO_1001857
    reported_trait_name: Takayasu arteritis [Turkish]
    standard_trait_name: Takayasu arteritis
- association_info:
    ancestry:
    - European=69395
    gwas_catalog_id: GCST001238
    neg_log_pval: 10.0
    otg_id: GCST001238
    pubmed_id: '21909115'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug INFLIXIMAB is Phase IV for the indiciation
        EFO_0000537 and targets the gene ENSG00000232810 at this locus (70254bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 31616366
    locus_GRCh38:
      chromosome: '6'
      position: 31648589
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Hypertension
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - East Asian=700
    gwas_catalog_id: GCST001203
    neg_log_pval: 9.522878745280337
    otg_id: GCST001203
    pubmed_id: '21844665'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug OZORALIZUMAB is Phase II for the indiciation
        EFO_0000685 and targets the gene ENSG00000232810 at this locus (76494bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 31622606
    locus_GRCh38:
      chromosome: '6'
      position: 31654829
  trait_info:
    ontology:
    - EFO_0000685
    reported_trait_name: Rheumatoid arthritis
    standard_trait_name: rheumatoid arthritis
- association_info:
    ancestry:
    - East Asian=700
    gwas_catalog_id: GCST001203
    neg_log_pval: 9.522878745280337
    otg_id: GCST001203
    pubmed_id: '21844665'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-beta inhibitor drug PATECLIZUMAB is Phase II for the indiciation
        EFO_0000685 and targets the gene ENSG00000226979 at this locus (80506bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000226979
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 31622606
    locus_GRCh38:
      chromosome: '6'
      position: 31654829
  trait_info:
    ontology:
    - EFO_0000685
    reported_trait_name: Rheumatoid arthritis
    standard_trait_name: rheumatoid arthritis
- association_info:
    ancestry:
    - East Asian=700
    gwas_catalog_id: GCST001203
    neg_log_pval: 9.522878745280337
    otg_id: GCST001203
    pubmed_id: '21844665'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug ADALIMUMAB is Phase IV for the indiciation
        EFO_0000685 and targets the gene ENSG00000232810 at this locus (76494bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 31622606
    locus_GRCh38:
      chromosome: '6'
      position: 31654829
  trait_info:
    ontology:
    - EFO_0000685
    reported_trait_name: Rheumatoid arthritis
    standard_trait_name: rheumatoid arthritis
- association_info:
    ancestry:
    - European=3037
    gwas_catalog_id: GCST000142
    neg_log_pval: 51.69897000433602
    otg_id: GCST000142
    pubmed_id: '18204446'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug ETANERCEPT is Phase II for the indiciation
        EFO_0002690 and targets the gene ENSG00000232810 at this locus (174921bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 31721033
    locus_GRCh38:
      chromosome: '6'
      position: 31753256
  trait_info:
    ontology:
    - EFO_0002690
    reported_trait_name: Systemic lupus erythematosus
    standard_trait_name: systemic lupus erythematosus
- association_info:
    ancestry:
    - European=2734
    gwas_catalog_id: GCST004053
    neg_log_pval: 8.301029995663981
    otg_id: GCST004053
    pubmed_id: '28067912'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug ADALIMUMAB is Phase IV for the indiciation
        EFO_0000384 and targets the gene ENSG00000232810 at this locus (187838bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: CAG
    locus_GRCh37:
      chromosome: '6'
      position: 31733950
    locus_GRCh38:
      chromosome: '6'
      position: 31766173
  trait_info:
    ontology:
    - EFO_0000384
    reported_trait_name: Poor prognosis in Crohn's disease
    standard_trait_name: Crohn's disease
- association_info:
    ancestry:
    - European=1048
    gwas_catalog_id: GCST005541
    neg_log_pval: 31.397940008672037
    otg_id: GCST005541
    pubmed_id: '26651848'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug GOLIMUMAB is Phase II for the indiciation
        Orphanet_797 and targets the gene ENSG00000232810 at this locus (203029bp
        away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 31749142
    locus_GRCh38:
      chromosome: '6'
      position: 31781365
  trait_info:
    ontology:
    - Orphanet_797
    reported_trait_name: Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome)
    standard_trait_name: Sarcoidosis
- association_info:
    ancestry:
    - European=1048
    gwas_catalog_id: GCST005541
    neg_log_pval: 31.397940008672037
    otg_id: GCST005541
    pubmed_id: '26651848'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug INFLIXIMAB is Phase III for the indiciation
        Orphanet_797 and targets the gene ENSG00000232810 at this locus (203029bp
        away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 31749142
    locus_GRCh38:
      chromosome: '6'
      position: 31781365
  trait_info:
    ontology:
    - Orphanet_797
    reported_trait_name: Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome)
    standard_trait_name: Sarcoidosis
- association_info:
    ancestry:
    - East Asian=45528
    gwas_catalog_id: GCST007201
    neg_log_pval: 19.30102999566398
    otg_id: GCST007201_2
    pubmed_id: '30285260'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug INFLIXIMAB is Phase IV for the indiciation
        EFO_0000692 and targets the gene ENSG00000232810 at this locus (241055bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 31787167
    locus_GRCh38:
      chromosome: '6'
      position: 31819390
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia [EA]
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - Other=1097
    - NR=150064
    gwas_catalog_id: GCST003048
    neg_log_pval: 18.154901959985743
    otg_id: GCST003048
    pubmed_id: '26198764'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug INFLIXIMAB is Phase IV for the indiciation
        EFO_0000692 and targets the gene ENSG00000232810 at this locus (280592bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 31826705
    locus_GRCh38:
      chromosome: '6'
      position: 31858928
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - East Asian=2546
    gwas_catalog_id: GCST000692
    neg_log_pval: 48.0
    otg_id: GCST000692
    pubmed_id: '20526339'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug ETANERCEPT is Phase II for the indiciation
        EFO_0004208 and targets the gene ENSG00000232810 at this locus (290954bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 31837066
    locus_GRCh38:
      chromosome: '6'
      position: 31869289
  trait_info:
    ontology:
    - EFO_0004208
    reported_trait_name: Vitiligo
    standard_trait_name: Vitiligo
- association_info:
    ancestry:
    - European=3163
    gwas_catalog_id: GCST002463
    neg_log_pval: 20.096910013008056
    otg_id: GCST002463
    pubmed_id: '24871463'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug ETANERCEPT is Phase II for the indiciation
        EFO_0002690 and targets the gene ENSG00000232810 at this locus (324214bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 31870326
    locus_GRCh38:
      chromosome: '6'
      position: 31902549
  trait_info:
    ontology:
    - EFO_0002690
    reported_trait_name: Systemic lupus erythematosus
    standard_trait_name: systemic lupus erythematosus
- association_info:
    ancestry:
    - European=13574
    - NR=2380
    gwas_catalog_id: GCST004521
    neg_log_pval: 15.698970004336019
    otg_id: GCST004521
    pubmed_id: '28540026'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug INFLIXIMAB is Phase IV for the indiciation
        EFO_0000692 and targets the gene ENSG00000232810 at this locus (335197bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 31881309
    locus_GRCh38:
      chromosome: '6'
      position: 31913532
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Autism spectrum disorder or schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - European=3105
    gwas_catalog_id: GCST004873
    neg_log_pval: 7.698970004336019
    otg_id: GCST004873
    pubmed_id: '28881265'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug INFLIXIMAB is Phase II for the indiciation
        EFO_0001065 and targets the gene ENSG00000232810 at this locus (337844bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 31883957
    locus_GRCh38:
      chromosome: '6'
      position: 31916180
  trait_info:
    ontology:
    - EFO_0001065
    reported_trait_name: Endometriosis
    standard_trait_name: endometriosis
- association_info:
    ancestry:
    - South Asian=1225
    gwas_catalog_id: GCST002453
    neg_log_pval: 13.301029995663981
    otg_id: GCST002453
    pubmed_id: '24837172'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug CERTOLIZUMAB PEGOL is Phase II for the
        indiciation EFO_0000729 and targets the gene ENSG00000232810 at this locus
        (371428bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 31917540
    locus_GRCh38:
      chromosome: '6'
      position: 31949763
  trait_info:
    ontology:
    - EFO_0000729
    reported_trait_name: Ulcerative colitis
    standard_trait_name: ulcerative colitis
- association_info:
    ancestry:
    - South Asian=1225
    gwas_catalog_id: GCST002453
    neg_log_pval: 13.301029995663981
    otg_id: GCST002453
    pubmed_id: '24837172'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug INFLIXIMAB is Phase IV for the indiciation
        EFO_0000729 and targets the gene ENSG00000232810 at this locus (371428bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 31917540
    locus_GRCh38:
      chromosome: '6'
      position: 31949763
  trait_info:
    ontology:
    - EFO_0000729
    reported_trait_name: Ulcerative colitis
    standard_trait_name: ulcerative colitis
- association_info:
    ancestry:
    - European=1073
    gwas_catalog_id: GCST002876
    neg_log_pval: 24.30102999566398
    otg_id: GCST002876
    pubmed_id: '25936594'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug ETANERCEPT is Phase III for the indiciation
        EFO_0001359 and targets the gene ENSG00000232810 at this locus (372748bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 31918860
    locus_GRCh38:
      chromosome: '6'
      position: 31951083
  trait_info:
    ontology:
    - EFO_0001359
    reported_trait_name: Type 1 diabetes and autoimmune thyroid diseases
    standard_trait_name: insulin-dependent diabetes mellitus
- association_info:
    ancestry:
    - European=1073
    gwas_catalog_id: GCST002876
    neg_log_pval: 24.30102999566398
    otg_id: GCST002876
    pubmed_id: '25936594'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug GOLIMUMAB is Phase II for the indiciation
        EFO_0001359 and targets the gene ENSG00000232810 at this locus (372748bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 31918860
    locus_GRCh38:
      chromosome: '6'
      position: 31951083
  trait_info:
    ontology:
    - EFO_0001359
    reported_trait_name: Type 1 diabetes and autoimmune thyroid diseases
    standard_trait_name: insulin-dependent diabetes mellitus
- association_info:
    ancestry:
    - European=2198
    gwas_catalog_id: GCST007043
    neg_log_pval: 13.397940008672037
    otg_id: GCST007043
    pubmed_id: '30552173'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug ADALIMUMAB is Phase IV for the indiciation
        EFO_0003778 and targets the gene ENSG00000232810 at this locus (389945bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 31936057
    locus_GRCh38:
      chromosome: '6'
      position: 31968280
  trait_info:
    ontology:
    - EFO_0003778
    reported_trait_name: Psoriatic arthritis
    standard_trait_name: psoriatic arthritis
- association_info:
    ancestry:
    - European=2198
    gwas_catalog_id: GCST007043
    neg_log_pval: 13.397940008672037
    otg_id: GCST007043
    pubmed_id: '30552173'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug ONERCEPT is Phase III for the indiciation
        EFO_0003778 and targets the gene ENSG00000232810 at this locus (389945bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 31936057
    locus_GRCh38:
      chromosome: '6'
      position: 31968280
  trait_info:
    ontology:
    - EFO_0003778
    reported_trait_name: Psoriatic arthritis
    standard_trait_name: psoriatic arthritis
- association_info:
    ancestry:
    - NR=150064
    - European=70017
    gwas_catalog_id: GCST007257
    neg_log_pval: 12.0
    otg_id: GCST007257
    pubmed_id: '30626913'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug INFLIXIMAB is Phase IV for the indiciation
        EFO_0000692 and targets the gene ENSG00000232810 at this locus (401348bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 31947460
    locus_GRCh38:
      chromosome: '6'
      position: 31979683
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Broad depression or schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - NR=150064
    - European=70017
    gwas_catalog_id: GCST007257
    neg_log_pval: 12.0
    otg_id: GCST007257
    pubmed_id: '30626913'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug INFLIXIMAB is Phase IV for the indiciation
        EFO_0003761 and targets the gene ENSG00000232810 at this locus (401348bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 31947460
    locus_GRCh38:
      chromosome: '6'
      position: 31979683
  trait_info:
    ontology:
    - EFO_0003761
    reported_trait_name: Broad depression or schizophrenia
    standard_trait_name: unipolar depression
- association_info:
    ancestry:
    - East Asian=5057
    - European=10995
    gwas_catalog_id: GCST003622
    neg_log_pval: 100.69897000433602
    otg_id: GCST003622_3
    pubmed_id: '27399966'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug ETANERCEPT is Phase II for the indiciation
        EFO_0002690 and targets the gene ENSG00000232810 at this locus (483092bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 32029205
    locus_GRCh38:
      chromosome: '6'
      position: 32061428
  trait_info:
    ontology:
    - EFO_0002690
    reported_trait_name: Systemic lupus erythematosus [EA]
    standard_trait_name: systemic lupus erythematosus
- association_info:
    ancestry:
    - European=18264
    - African American or Afro-Caribbean=5422
    - Hispanic or Latin American=3888
    gwas_catalog_id: GCST005752
    neg_log_pval: 116.22184874961636
    otg_id: GCST005752
    pubmed_id: '28714469'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug ETANERCEPT is Phase II for the indiciation
        EFO_0002690 and targets the gene ENSG00000232810 at this locus (492437bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 32038550
    locus_GRCh38:
      chromosome: '6'
      position: 32070773
  trait_info:
    ontology:
    - EFO_0002690
    reported_trait_name: Systemic lupus erythematosus
    standard_trait_name: systemic lupus erythematosus
- association_info:
    ancestry:
    - East Asian=9469
    gwas_catalog_id: GCST002627
    neg_log_pval: 10.397940008672037
    otg_id: GCST002627
    pubmed_id: '25249183'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: TNF-alpha inhibitor drug INFLIXIMAB is Phase IV for the indiciation
        EFO_0000537 and targets the gene ENSG00000232810 at this locus (498738bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000232810
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 32044851
    locus_GRCh38:
      chromosome: '6'
      position: 32077074
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Hypertension
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - African American or Afro-Caribbean=2308
    gwas_catalog_id: GCST006959
    neg_log_pval: 7.3979400086720375
    otg_id: GCST006959_3
    pubmed_id: '30423114'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: MAP kinase p38 alpha inhibitor drug LOSMAPIMOD is Phase II for
        the indiciation EFO_0000685 and targets the gene ENSG00000112062 at this locus
        (276642bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000112062
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 36355654
    locus_GRCh38:
      chromosome: '6'
      position: 36387877
  trait_info:
    ontology:
    - EFO_0000685
    reported_trait_name: Rheumatoid arthritis [EA]
    standard_trait_name: rheumatoid arthritis
- association_info:
    ancestry:
    - African American or Afro-Caribbean=2308
    gwas_catalog_id: GCST006959
    neg_log_pval: 8.698970004336019
    otg_id: GCST006959
    pubmed_id: '30423114'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: MAP kinase p38 alpha inhibitor drug LOSMAPIMOD is Phase II for
        the indiciation EFO_0000685 and targets the gene ENSG00000112062 at this locus
        (276642bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000112062
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 36355654
    locus_GRCh38:
      chromosome: '6'
      position: 36387877
  trait_info:
    ontology:
    - EFO_0000685
    reported_trait_name: Rheumatoid arthritis
    standard_trait_name: rheumatoid arthritis
- association_info:
    ancestry:
    - East Asian=191764
    gwas_catalog_id: GCST007847
    neg_log_pval: 13.397940008672037
    otg_id: GCST007847
    pubmed_id: '30718926'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Glucagon-like peptide 1 receptor agonist drug DULAGLUTIDE is Phase
        IV for the indiciation EFO_0001360 and targets the gene ENSG00000112164 at
        this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000112164
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: AAAAG
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 39039140
    locus_GRCh38:
      chromosome: '6'
      position: 39071364
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - East Asian=191764
    gwas_catalog_id: GCST007847
    neg_log_pval: 13.397940008672037
    otg_id: GCST007847
    pubmed_id: '30718926'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Glucagon-like peptide 1 receptor agonist drug TASPOGLUTIDE is Phase
        III for the indiciation EFO_0001360 and targets the gene ENSG00000112164 at
        this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000112164
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 39039140
    locus_GRCh38:
      chromosome: '6'
      position: 39071364
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - East Asian=191764
    gwas_catalog_id: GCST007847
    neg_log_pval: 13.397940008672037
    otg_id: GCST007847
    pubmed_id: '30718926'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Glucagon-like peptide 1 receptor agonist drug TASPOGLUTIDE is Phase
        III for the indiciation EFO_0001360 and targets the gene ENSG00000112164 at
        this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000112164
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: AAAAG
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 39039140
    locus_GRCh38:
      chromosome: '6'
      position: 39071364
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - East Asian=191764
    gwas_catalog_id: GCST007847
    neg_log_pval: 13.397940008672037
    otg_id: GCST007847
    pubmed_id: '30718926'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Glucagon-like peptide 1 receptor agonist drug DULAGLUTIDE is Phase
        IV for the indiciation EFO_0001360 and targets the gene ENSG00000112164 at
        this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000112164
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 39039140
    locus_GRCh38:
      chromosome: '6'
      position: 39071364
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - East Asian=191764
    gwas_catalog_id: GCST007847
    neg_log_pval: 13.397940008672037
    otg_id: GCST007847
    pubmed_id: '30718926'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Glucagon-like peptide 1 receptor agonist drug DULAGLUTIDE is Phase
        IV for the indiciation EFO_0001360 and targets the gene ENSG00000112164 at
        this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000112164
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: AG
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 39039140
    locus_GRCh38:
      chromosome: '6'
      position: 39071364
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - East Asian=191764
    gwas_catalog_id: GCST007847
    neg_log_pval: 13.397940008672037
    otg_id: GCST007847
    pubmed_id: '30718926'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Glucagon-like peptide 1 receptor agonist drug TASPOGLUTIDE is Phase
        III for the indiciation EFO_0001360 and targets the gene ENSG00000112164 at
        this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000112164
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: AG
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 39039140
    locus_GRCh38:
      chromosome: '6'
      position: 39071364
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - African American or Afro-Caribbean=2908
    - Hispanic or Latin American=3615
    - South Asian=23156
    - Greater Middle Eastern (Middle Eastern / North African / Persian)=754
    - East Asian=9396
    - European=126630
    gwas_catalog_id: GCST003117
    neg_log_pval: 7.522878745280337
    otg_id: GCST003117
    pubmed_id: '26343387'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Glucagon-like peptide 1 receptor agonist drug EXENATIDE is Phase
        IV for the indiciation EFO_0000612 and targets the gene ENSG00000112164 at
        this locus (65370bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000112164
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 39124448
    locus_GRCh38:
      chromosome: '6'
      position: 39156672
  trait_info:
    ontology:
    - EFO_0000612
    reported_trait_name: Myocardial infarction
    standard_trait_name: myocardial infarction
- association_info:
    ancestry:
    - European=141217
    - African American or Afro-Caribbean=3139
    - Hispanic or Latin American=4095
    - South Asian=25557
    - Greater Middle Eastern (Middle Eastern / North African / Persian)=2268
    - East Asian=11323
    gwas_catalog_id: GCST003116
    neg_log_pval: 7.698970004336019
    otg_id: GCST003116
    pubmed_id: '26343387'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Glucagon-like peptide 1 receptor agonist drug EXENATIDE is Phase
        III for the indiciation EFO_0000378 and targets the gene ENSG00000112164 at
        this locus (75021bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000112164
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 39134099
    locus_GRCh38:
      chromosome: '6'
      position: 39166323
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - NR=296525
    gwas_catalog_id: GCST005194
    neg_log_pval: 11.117418546445549
    otg_id: GCST005194
    pubmed_id: '29212778'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Glucagon-like peptide 1 receptor agonist drug EXENATIDE is Phase
        III for the indiciation EFO_0000378 and targets the gene ENSG00000112164 at
        this locus (115843bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000112164
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 39174922
    locus_GRCh38:
      chromosome: '6'
      position: 39207146
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - NR=250736
    gwas_catalog_id: GCST005196
    neg_log_pval: 11.522878745280337
    otg_id: GCST005196
    pubmed_id: '29212778'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Glucagon-like peptide 1 receptor agonist drug EXENATIDE is Phase
        III for the indiciation EFO_0000378 and targets the gene ENSG00000112164 at
        this locus (115843bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000112164
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 39174922
    locus_GRCh38:
      chromosome: '6'
      position: 39207146
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - East Asian=191764
    gwas_catalog_id: GCST007847
    neg_log_pval: 9.0
    otg_id: GCST007847
    pubmed_id: '30718926'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Glucagon-like peptide 1 receptor agonist drug LIXISENATIDE is Phase
        IV for the indiciation EFO_0001360 and targets the gene ENSG00000112164 at
        this locus (223292bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000112164
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 39282371
    locus_GRCh38:
      chromosome: '6'
      position: 39314595
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - East Asian=191764
    gwas_catalog_id: GCST007847
    neg_log_pval: 9.0
    otg_id: GCST007847
    pubmed_id: '30718926'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Glucagon-like peptide 1 receptor agonist drug TASPOGLUTIDE is Phase
        III for the indiciation EFO_0001360 and targets the gene ENSG00000112164 at
        this locus (223292bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000112164
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 39282371
    locus_GRCh38:
      chromosome: '6'
      position: 39314595
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - East Asian=15000
    - South East Asian=2034
    - Asian unspecified=1783
    gwas_catalog_id: GCST001351
    neg_log_pval: 7.698970004336019
    otg_id: GCST001351
    pubmed_id: '22158537'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Glucagon-like peptide 1 receptor agonist drug TASPOGLUTIDE is Phase
        III for the indiciation EFO_0001360 and targets the gene ENSG00000112164 at
        this locus (224972bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000112164
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 39284050
    locus_GRCh38:
      chromosome: '6'
      position: 39316274
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - East Asian=15000
    - South East Asian=2034
    - Asian unspecified=1783
    gwas_catalog_id: GCST001351
    neg_log_pval: 7.698970004336019
    otg_id: GCST001351
    pubmed_id: '22158537'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Glucagon-like peptide 1 receptor agonist drug LIRAGLUTIDE is Phase
        IV for the indiciation EFO_0001360 and targets the gene ENSG00000112164 at
        this locus (224972bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000112164
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 39284050
    locus_GRCh38:
      chromosome: '6'
      position: 39316274
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=140254
    gwas_catalog_id: GCST006085
    neg_log_pval: 7.522878745280337
    otg_id: GCST006085
    pubmed_id: '29892016'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Vascular endothelial growth factor A inhibitor drug BEVACIZUMAB
        is Phase II for the indiciation EFO_0001663 and targets the gene ENSG00000112715
        at this locus (43324bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000112715
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 43694598
    locus_GRCh38:
      chromosome: '6'
      position: 43726861
  trait_info:
    ontology:
    - EFO_0001663
    reported_trait_name: Prostate cancer
    standard_trait_name: prostate carcinoma
- association_info:
    ancestry:
    - NR=296525
    gwas_catalog_id: GCST005194
    neg_log_pval: 11.39848321634999
    otg_id: GCST005194
    pubmed_id: '29212778'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Equilibrative nucleoside transporter 1 inhibitor drug DIPYRIDAMOLE
        is Phase IV for the indiciation EFO_0000378 and targets the gene ENSG00000112759
        at this locus (428369bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000112759
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 43758873
    locus_GRCh38:
      chromosome: '6'
      position: 43791136
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - NR=250736
    gwas_catalog_id: GCST005196
    neg_log_pval: 11.698970004336019
    otg_id: GCST005196
    pubmed_id: '29212778'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Equilibrative nucleoside transporter 1 inhibitor drug DIPYRIDAMOLE
        is Phase IV for the indiciation EFO_0000378 and targets the gene ENSG00000112759
        at this locus (428369bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000112759
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 43758873
    locus_GRCh38:
      chromosome: '6'
      position: 43791136
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - NR=547261
    gwas_catalog_id: GCST005195
    neg_log_pval: 8.3767507096021
    otg_id: GCST005195
    pubmed_id: '29212778'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Equilibrative nucleoside transporter 1 inhibitor drug DIPYRIDAMOLE
        is Phase IV for the indiciation EFO_0000378 and targets the gene ENSG00000112759
        at this locus (428369bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000112759
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 43758873
    locus_GRCh38:
      chromosome: '6'
      position: 43791136
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - European=33976
    gwas_catalog_id: GCST003219
    neg_log_pval: 14.0
    otg_id: GCST003219_2
    pubmed_id: '26691988'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Vascular endothelial growth factor A inhibitor drug BROLUCIZUMAB
        is Phase III for the indiciation EFO_0001365 and targets the gene ENSG00000112715
        at this locus (72403bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000112715
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 43826627
    locus_GRCh38:
      chromosome: '6'
      position: 43858890
  trait_info:
    ontology:
    - EFO_0001365
    reported_trait_name: Advanced age-related macular degeneration [EA]
    standard_trait_name: age-related macular degeneration
- association_info:
    ancestry:
    - European=55115
    - South Asian=229
    - East Asian=4150
    gwas_catalog_id: GCST001884
    neg_log_pval: 15.045757490560675
    otg_id: GCST001884
    pubmed_id: '23455636'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Vascular endothelial growth factor A inhibitor drug BROLUCIZUMAB
        is Phase III for the indiciation EFO_0001365 and targets the gene ENSG00000112715
        at this locus (72403bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000112715
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 43826627
    locus_GRCh38:
      chromosome: '6'
      position: 43858890
  trait_info:
    ontology:
    - EFO_0001365
    reported_trait_name: Age-related macular degeneration
    standard_trait_name: age-related macular degeneration
- association_info:
    ancestry:
    - European=33976
    gwas_catalog_id: GCST003219
    neg_log_pval: 14.0
    otg_id: GCST003219_2
    pubmed_id: '26691988'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Vascular endothelial growth factor A inhibitor drug BEVACIZUMAB
        is Phase III for the indiciation EFO_0004683 and targets the gene ENSG00000112715
        at this locus (72403bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000112715
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 43826627
    locus_GRCh38:
      chromosome: '6'
      position: 43858890
  trait_info:
    ontology:
    - EFO_0004683
    reported_trait_name: Advanced age-related macular degeneration [EA]
    standard_trait_name: wet macular degeneration
- association_info:
    ancestry:
    - European=33976
    gwas_catalog_id: GCST003219
    neg_log_pval: 14.0
    otg_id: GCST003219_2
    pubmed_id: '26691988'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Vascular endothelial growth factor A inhibitor drug RANIBIZUMAB
        is Phase IV for the indiciation EFO_0004683 and targets the gene ENSG00000112715
        at this locus (72403bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000112715
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 43826627
    locus_GRCh38:
      chromosome: '6'
      position: 43858890
  trait_info:
    ontology:
    - EFO_0004683
    reported_trait_name: Advanced age-related macular degeneration [EA]
    standard_trait_name: wet macular degeneration
- association_info:
    ancestry:
    - European=33976
    gwas_catalog_id: GCST003219
    neg_log_pval: 14.0
    otg_id: GCST003219_2
    pubmed_id: '26691988'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Vascular endothelial growth factor A inhibitor drug RANIBIZUMAB
        is Phase IV for the indiciation EFO_0001365 and targets the gene ENSG00000112715
        at this locus (72403bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000112715
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 43826627
    locus_GRCh38:
      chromosome: '6'
      position: 43858890
  trait_info:
    ontology:
    - EFO_0001365
    reported_trait_name: Advanced age-related macular degeneration [EA]
    standard_trait_name: age-related macular degeneration
- association_info:
    ancestry:
    - European=55115
    - South Asian=229
    - East Asian=4150
    gwas_catalog_id: GCST001884
    neg_log_pval: 15.045757490560675
    otg_id: GCST001884
    pubmed_id: '23455636'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Vascular endothelial growth factor A inhibitor drug RANIBIZUMAB
        is Phase IV for the indiciation EFO_0001365 and targets the gene ENSG00000112715
        at this locus (72403bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000112715
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 43826627
    locus_GRCh38:
      chromosome: '6'
      position: 43858890
  trait_info:
    ontology:
    - EFO_0001365
    reported_trait_name: Age-related macular degeneration
    standard_trait_name: age-related macular degeneration
- association_info:
    ancestry:
    - European=6728
    gwas_catalog_id: GCST001100
    neg_log_pval: 8.045757490560675
    otg_id: GCST001100
    pubmed_id: '21665990'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Vascular endothelial growth factor A inhibitor drug BROLUCIZUMAB
        is Phase III for the indiciation EFO_0001365 and targets the gene ENSG00000112715
        at this locus (74358bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000112715
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 43828582
    locus_GRCh38:
      chromosome: '6'
      position: 43860845
  trait_info:
    ontology:
    - EFO_0001365
    reported_trait_name: Age-related macular degeneration
    standard_trait_name: age-related macular degeneration
- association_info:
    ancestry:
    - European=6728
    gwas_catalog_id: GCST001100
    neg_log_pval: 8.045757490560675
    otg_id: GCST001100
    pubmed_id: '21665990'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Vascular endothelial growth factor A inhibitor drug CONBERCEPT
        is Phase IV for the indiciation EFO_0001365 and targets the gene ENSG00000112715
        at this locus (74358bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000112715
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 43828582
    locus_GRCh38:
      chromosome: '6'
      position: 43860845
  trait_info:
    ontology:
    - EFO_0001365
    reported_trait_name: Age-related macular degeneration
    standard_trait_name: age-related macular degeneration
- association_info:
    ancestry:
    - East Asian=7810
    gwas_catalog_id: GCST002766
    neg_log_pval: 17.221848749616356
    otg_id: GCST002766
    pubmed_id: '25629512'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Vascular endothelial growth factor A inhibitor drug BEVACIZUMAB
        is Phase III for the indiciation EFO_0004683 and targets the gene ENSG00000112715
        at this locus (216603bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000112715
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 43970827
    locus_GRCh38:
      chromosome: '6'
      position: 44003090
  trait_info:
    ontology:
    - EFO_0004683
    reported_trait_name: Exudative age-related macular degeneration
    standard_trait_name: wet macular degeneration
- association_info:
    ancestry:
    - East Asian=7810
    gwas_catalog_id: GCST002766
    neg_log_pval: 17.221848749616356
    otg_id: GCST002766
    pubmed_id: '25629512'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Vascular endothelial growth factor A inhibitor drug AFLIBERCEPT
        is Phase IV for the indiciation EFO_0004683 and targets the gene ENSG00000112715
        at this locus (216603bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000112715
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 43970827
    locus_GRCh38:
      chromosome: '6'
      position: 44003090
  trait_info:
    ontology:
    - EFO_0004683
    reported_trait_name: Exudative age-related macular degeneration
    standard_trait_name: wet macular degeneration
- association_info:
    ancestry:
    - East Asian=5683
    gwas_catalog_id: GCST001681
    neg_log_pval: 15.0
    otg_id: GCST001681
    pubmed_id: '23028356'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Equilibrative nucleoside transporter 1 inhibitor drug DIPYRIDAMOLE
        is Phase II for the indiciation EFO_0000685 and targets the gene ENSG00000112759
        at this locus (31032bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000112759
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 44232920
    locus_GRCh38:
      chromosome: '6'
      position: 44265183
  trait_info:
    ontology:
    - EFO_0000685
    reported_trait_name: Rheumatoid arthritis
    standard_trait_name: rheumatoid arthritis
- association_info:
    ancestry:
    - East Asian=20965
    gwas_catalog_id: GCST001454
    neg_log_pval: 18.221848749616356
    otg_id: GCST001454
    pubmed_id: '22446963'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Equilibrative nucleoside transporter 1 inhibitor drug DIPYRIDAMOLE
        is Phase II for the indiciation EFO_0000685 and targets the gene ENSG00000112759
        at this locus (31032bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000112759
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 44232920
    locus_GRCh38:
      chromosome: '6'
      position: 44265183
  trait_info:
    ontology:
    - EFO_0000685
    reported_trait_name: Rheumatoid arthritis
    standard_trait_name: rheumatoid arthritis
- association_info:
    ancestry:
    - African American or Afro-Caribbean=2308
    gwas_catalog_id: GCST006959
    neg_log_pval: 7.522878745280337
    otg_id: GCST006959_3
    pubmed_id: '30423114'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Equilibrative nucleoside transporter 1 inhibitor drug DIPYRIDAMOLE
        is Phase II for the indiciation EFO_0000685 and targets the gene ENSG00000112759
        at this locus (32034bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000112759
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 44233921
    locus_GRCh38:
      chromosome: '6'
      position: 44266184
  trait_info:
    ontology:
    - EFO_0000685
    reported_trait_name: Rheumatoid arthritis [EA]
    standard_trait_name: rheumatoid arthritis
- association_info:
    ancestry:
    - African American or Afro-Caribbean=2308
    gwas_catalog_id: GCST006959
    neg_log_pval: 18.69897000433602
    otg_id: GCST006959
    pubmed_id: '30423114'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Equilibrative nucleoside transporter 1 inhibitor drug DIPYRIDAMOLE
        is Phase II for the indiciation EFO_0000685 and targets the gene ENSG00000112759
        at this locus (32034bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000112759
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 44233921
    locus_GRCh38:
      chromosome: '6'
      position: 44266184
  trait_info:
    ontology:
    - EFO_0000685
    reported_trait_name: Rheumatoid arthritis
    standard_trait_name: rheumatoid arthritis
- association_info:
    ancestry:
    - European=58284
    - East Asian=22515
    gwas_catalog_id: GCST002318
    neg_log_pval: 19.0
    otg_id: GCST002318
    pubmed_id: '24390342'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Equilibrative nucleoside transporter 1 inhibitor drug DIPYRIDAMOLE
        is Phase II for the indiciation EFO_0000685 and targets the gene ENSG00000112759
        at this locus (32034bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000112759
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 44233921
    locus_GRCh38:
      chromosome: '6'
      position: 44266184
  trait_info:
    ontology:
    - EFO_0000685
    reported_trait_name: Rheumatoid arthritis
    standard_trait_name: rheumatoid arthritis
- association_info:
    ancestry:
    - European=58284
    - East Asian=22515
    gwas_catalog_id: GCST002318
    neg_log_pval: 12.698970004336019
    otg_id: GCST002318_3
    pubmed_id: '24390342'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Equilibrative nucleoside transporter 1 inhibitor drug DIPYRIDAMOLE
        is Phase II for the indiciation EFO_0000685 and targets the gene ENSG00000112759
        at this locus (32034bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000112759
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 44233921
    locus_GRCh38:
      chromosome: '6'
      position: 44266184
  trait_info:
    ontology:
    - EFO_0000685
    reported_trait_name: Rheumatoid arthritis [East Asian]
    standard_trait_name: rheumatoid arthritis
- association_info:
    ancestry:
    - European=58284
    - East Asian=22515
    gwas_catalog_id: GCST002318
    neg_log_pval: 7.522878745280337
    otg_id: GCST002318_2
    pubmed_id: '24390342'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Equilibrative nucleoside transporter 1 inhibitor drug DIPYRIDAMOLE
        is Phase II for the indiciation EFO_0000685 and targets the gene ENSG00000112759
        at this locus (32034bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000112759
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 44233921
    locus_GRCh38:
      chromosome: '6'
      position: 44266184
  trait_info:
    ontology:
    - EFO_0000685
    reported_trait_name: Rheumatoid arthritis [EA]
    standard_trait_name: rheumatoid arthritis
- association_info:
    ancestry:
    - African American or Afro-Caribbean=2308
    gwas_catalog_id: GCST006959
    neg_log_pval: 12.045757490560675
    otg_id: GCST006959_4
    pubmed_id: '30423114'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Equilibrative nucleoside transporter 1 inhibitor drug DIPYRIDAMOLE
        is Phase II for the indiciation EFO_0000685 and targets the gene ENSG00000112759
        at this locus (32034bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000112759
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 44233921
    locus_GRCh38:
      chromosome: '6'
      position: 44266184
  trait_info:
    ontology:
    - EFO_0000685
    reported_trait_name: Rheumatoid arthritis [East Asian]
    standard_trait_name: rheumatoid arthritis
- association_info:
    ancestry:
    - European=2406
    gwas_catalog_id: GCST001659
    neg_log_pval: 7.301029995663981
    otg_id: GCST001659
    pubmed_id: '22941190'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Equilibrative nucleoside transporter 1 inhibitor drug DIPYRIDAMOLE
        is Phase IV for the indiciation EFO_0000712 and targets the gene ENSG00000112759
        at this locus (392271bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000112759
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 44594159
    locus_GRCh38:
      chromosome: '6'
      position: 44626422
  trait_info:
    ontology:
    - EFO_0000712
    reported_trait_name: Stroke (ischemic) [LAA]
    standard_trait_name: cerebrovascular accident
- association_info:
    ancestry:
    - European, Asian unspecified, African American or Afro-Caribbean, Greater Middle
      Eastern (Middle Eastern / North African / Persian), Oceanian, Native American,
      Other admixed ancestry=22156
    gwas_catalog_id: GCST004963
    neg_log_pval: 178.0
    otg_id: GCST004963
    pubmed_id: '28753643'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: LDL-associated phospholipase A2 inhibitor drug DARAPLADIB is Phase
        III for the indiciation EFO_0005672 and targets the gene ENSG00000146070 at
        this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000146070
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 46677098
    locus_GRCh38:
      chromosome: '6'
      position: 46709361
  trait_info:
    ontology:
    - EFO_0005672
    reported_trait_name: Lipoprotein phospholipase A2 activity in cardiovascular disease
    standard_trait_name: acute coronary syndrome
- association_info:
    ancestry:
    - European, Asian unspecified, African American or Afro-Caribbean, Greater Middle
      Eastern (Middle Eastern / North African / Persian), Oceanian, Native American,
      Other admixed ancestry=10874
    gwas_catalog_id: GCST004966
    neg_log_pval: 46.096910013008056
    otg_id: GCST004966
    pubmed_id: '28753643'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: LDL-associated phospholipase A2 inhibitor drug DARAPLADIB is Phase
        III for the indiciation EFO_0005672 and targets the gene ENSG00000146070 at
        this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000146070
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 46677098
    locus_GRCh38:
      chromosome: '6'
      position: 46709361
  trait_info:
    ontology:
    - EFO_0005672
    reported_trait_name: Lipoprotein-associated phospholipase A2 activity change in
      response to darapladib treatment in cardiovascular disease
    standard_trait_name: acute coronary syndrome
- association_info:
    ancestry:
    - European=11181
    gwas_catalog_id: GCST003180
    neg_log_pval: 7.698970004336019
    otg_id: GCST003180
    pubmed_id: '26542096'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin 17A inhibitor drug SECUKINUMAB is Phase II for the
        indiciation EFO_0000274 and targets the gene ENSG00000112115 at this locus
        (236700bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000112115
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 52292136
    locus_GRCh38:
      chromosome: '6'
      position: 52427338
  trait_info:
    ontology:
    - EFO_0000274
    reported_trait_name: Atopic march
    standard_trait_name: atopic eczema
- association_info:
    ancestry:
    - European=204641
    - East Asian=4262
    gwas_catalog_id: GCST004549
    neg_log_pval: 7.3979400086720375
    otg_id: GCST004549
    pubmed_id: '28537267'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha agonist drug ETHINYL ESTRADIOL is Phase
        IV for the indiciation EFO_0001065 and targets the gene ENSG00000091831 at
        this locus (161816bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 151816011
    locus_GRCh38:
      chromosome: '6'
      position: 151494876
  trait_info:
    ontology:
    - EFO_0001065
    reported_trait_name: Endometriosis
    standard_trait_name: endometriosis
- association_info:
    ancestry:
    - European=204641
    - East Asian=4262
    gwas_catalog_id: GCST004549
    neg_log_pval: 7.3979400086720375
    otg_id: GCST004549
    pubmed_id: '28537267'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha agonist drug ESTRADIOL is Phase III for
        the indiciation EFO_0001065 and targets the gene ENSG00000091831 at this locus
        (161816bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 151816011
    locus_GRCh38:
      chromosome: '6'
      position: 151494876
  trait_info:
    ontology:
    - EFO_0001065
    reported_trait_name: Endometriosis
    standard_trait_name: endometriosis
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 8.287247628480976
    otg_id: NEALE2_20002_1065
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha agonist drug ESTRADIOL is Phase III for
        the indiciation EFO_0000537 and targets the gene ENSG00000091831 at this locus
        (67422bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: AAC
    locus_GRCh37:
      chromosome: '6'
      position: 151910404
    locus_GRCh38:
      chromosome: '6'
      position: 151589269
  trait_info:
    ontology:
    - EFO_0000537
    reported_trait_name: Hypertension | non-cancer illness code, self-reported
    standard_trait_name: hypertension
- association_info:
    ancestry:
    - European=22627
    gwas_catalog_id: GCST001937
    neg_log_pval: 20.69897000433602
    otg_id: GCST001937
    pubmed_id: '23535729'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha agonist drug ESTRADIOL is Phase II for
        the indiciation EFO_0000305 and targets the gene ENSG00000091831 at this locus
        (63714bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 151914113
    locus_GRCh38:
      chromosome: '6'
      position: 151592978
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=22627
    gwas_catalog_id: GCST001937
    neg_log_pval: 20.69897000433602
    otg_id: GCST001937
    pubmed_id: '23535729'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha agonist drug ETHINYL ESTRADIOL is Phase
        III for the indiciation EFO_0000305 and targets the gene ENSG00000091831 at
        this locus (63714bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 151914113
    locus_GRCh38:
      chromosome: '6'
      position: 151592978
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=22627
    gwas_catalog_id: GCST001937
    neg_log_pval: 20.69897000433602
    otg_id: GCST001937
    pubmed_id: '23535729'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha modulator drug TAMOXIFEN is Phase IV for
        the indiciation EFO_0000305 and targets the gene ENSG00000091831 at this locus
        (63714bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 151914113
    locus_GRCh38:
      chromosome: '6'
      position: 151592978
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=19291
    gwas_catalog_id: GCST003845
    neg_log_pval: 19.0
    otg_id: GCST003845
    pubmed_id: '27117709'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha agonist drug ESTRADIOL is Phase II for
        the indiciation EFO_0000305 and targets the gene ENSG00000091831 at this locus
        (58970bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 151918856
    locus_GRCh38:
      chromosome: '6'
      position: 151597721
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=33864
    gwas_catalog_id: GCST004950
    neg_log_pval: 26.154901959985743
    otg_id: GCST004950
    pubmed_id: '25751625'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha modulator drug TAMOXIFEN is Phase IV for
        the indiciation EFO_0000305 and targets the gene ENSG00000091831 at this locus
        (58970bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 151918856
    locus_GRCh38:
      chromosome: '6'
      position: 151597721
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=33864
    gwas_catalog_id: GCST004950
    neg_log_pval: 26.154901959985743
    otg_id: GCST004950
    pubmed_id: '25751625'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha agonist drug ESTRADIOL is Phase II for
        the indiciation EFO_0000305 and targets the gene ENSG00000091831 at this locus
        (58970bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 151918856
    locus_GRCh38:
      chromosome: '6'
      position: 151597721
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=33864
    gwas_catalog_id: GCST004950
    neg_log_pval: 26.154901959985743
    otg_id: GCST004950
    pubmed_id: '25751625'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha agonist drug ETHINYL ESTRADIOL is Phase
        III for the indiciation EFO_0000305 and targets the gene ENSG00000091831 at
        this locus (58970bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 151918856
    locus_GRCh38:
      chromosome: '6'
      position: 151597721
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=19291
    gwas_catalog_id: GCST003845
    neg_log_pval: 19.0
    otg_id: GCST003845
    pubmed_id: '27117709'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha modulator drug TAMOXIFEN is Phase IV for
        the indiciation EFO_0000305 and targets the gene ENSG00000091831 at this locus
        (58970bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 151918856
    locus_GRCh38:
      chromosome: '6'
      position: 151597721
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=19291
    gwas_catalog_id: GCST003845
    neg_log_pval: 19.0
    otg_id: GCST003845
    pubmed_id: '27117709'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha agonist drug ETHINYL ESTRADIOL is Phase
        III for the indiciation EFO_0000305 and targets the gene ENSG00000091831 at
        this locus (58970bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 151918856
    locus_GRCh38:
      chromosome: '6'
      position: 151597721
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=688809
    gwas_catalog_id: GCST006477
    neg_log_pval: 9.154901959985743
    otg_id: GCST006477
    pubmed_id: '29942085'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha agonist drug ETHINYL ESTRADIOL is Phase
        II for the indiciation EFO_0003761 and targets the gene ENSG00000091831 at
        this locus (52320bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 151925507
    locus_GRCh38:
      chromosome: '6'
      position: 151604372
  trait_info:
    ontology:
    - EFO_0003761
    reported_trait_name: Depression
    standard_trait_name: unipolar depression
- association_info:
    ancestry:
    - European=688809
    gwas_catalog_id: GCST006477
    neg_log_pval: 9.154901959985743
    otg_id: GCST006477
    pubmed_id: '29942085'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha agonist drug ESTRADIOL is Phase IV for
        the indiciation EFO_0003761 and targets the gene ENSG00000091831 at this locus
        (52320bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 151925507
    locus_GRCh38:
      chromosome: '6'
      position: 151604372
  trait_info:
    ontology:
    - EFO_0003761
    reported_trait_name: Depression
    standard_trait_name: unipolar depression
- association_info:
    ancestry:
    - European=15566
    gwas_catalog_id: GCST005075
    neg_log_pval: 11.522878745280337
    otg_id: GCST005075
    pubmed_id: '29058716'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha agonist drug ESTRADIOL is Phase II for
        the indiciation EFO_0000305 and targets the gene ENSG00000091831 at this locus
        (35633bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 151942194
    locus_GRCh38:
      chromosome: '6'
      position: 151621059
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast Cancer in BRCA1 mutation carriers
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=15566
    gwas_catalog_id: GCST005075
    neg_log_pval: 11.522878745280337
    otg_id: GCST005075
    pubmed_id: '29058716'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha agonist drug ETHINYL ESTRADIOL is Phase
        III for the indiciation EFO_0000305 and targets the gene ENSG00000091831 at
        this locus (35633bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 151942194
    locus_GRCh38:
      chromosome: '6'
      position: 151621059
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast Cancer in BRCA1 mutation carriers
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=15566
    gwas_catalog_id: GCST005075
    neg_log_pval: 11.522878745280337
    otg_id: GCST005075
    pubmed_id: '29058716'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha modulator drug TAMOXIFEN is Phase IV for
        the indiciation EFO_0000305 and targets the gene ENSG00000091831 at this locus
        (35633bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 151942194
    locus_GRCh38:
      chromosome: '6'
      position: 151621059
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast Cancer in BRCA1 mutation carriers
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=19291
    gwas_catalog_id: GCST003845
    neg_log_pval: 27.397940008672037
    otg_id: GCST003845
    pubmed_id: '27117709'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha modulator drug TAMOXIFEN is Phase IV for
        the indiciation EFO_0000305 and targets the gene ENSG00000091831 at this locus
        (31674bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 151946152
    locus_GRCh38:
      chromosome: '6'
      position: 151625017
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=19291
    gwas_catalog_id: GCST003845
    neg_log_pval: 27.397940008672037
    otg_id: GCST003845
    pubmed_id: '27117709'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha agonist drug ETHINYL ESTRADIOL is Phase
        III for the indiciation EFO_0000305 and targets the gene ENSG00000091831 at
        this locus (31674bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 151946152
    locus_GRCh38:
      chromosome: '6'
      position: 151625017
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=19291
    gwas_catalog_id: GCST003845
    neg_log_pval: 27.397940008672037
    otg_id: GCST003845
    pubmed_id: '27117709'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha antagonist drug SR16234 is Phase II for
        the indiciation EFO_0000305 and targets the gene ENSG00000091831 at this locus
        (31674bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 151946152
    locus_GRCh38:
      chromosome: '6'
      position: 151625017
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=39387
    gwas_catalog_id: GCST001930
    neg_log_pval: 15.301029995663981
    otg_id: GCST001930
    pubmed_id: '23535733'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha antagonist drug SR16234 is Phase II for
        the indiciation EFO_0000305 and targets the gene ENSG00000091831 at this locus
        (29461bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 151948366
    locus_GRCh38:
      chromosome: '6'
      position: 151627231
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=39387
    gwas_catalog_id: GCST001930
    neg_log_pval: 15.301029995663981
    otg_id: GCST001930
    pubmed_id: '23535733'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha modulator drug TAMOXIFEN is Phase IV for
        the indiciation EFO_0000305 and targets the gene ENSG00000091831 at this locus
        (29461bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 151948366
    locus_GRCh38:
      chromosome: '6'
      position: 151627231
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - East Asian=13905
    gwas_catalog_id: GCST003520
    neg_log_pval: 14.154901959985743
    otg_id: GCST003520
    pubmed_id: '27354352'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha agonist drug ETHINYL ESTRADIOL is Phase
        III for the indiciation EFO_0000305 and targets the gene ENSG00000091831 at
        this locus (29461bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 151948366
    locus_GRCh38:
      chromosome: '6'
      position: 151627231
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - East Asian=13905
    gwas_catalog_id: GCST003520
    neg_log_pval: 14.154901959985743
    otg_id: GCST003520
    pubmed_id: '27354352'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha antagonist drug SR16234 is Phase II for
        the indiciation EFO_0000305 and targets the gene ENSG00000091831 at this locus
        (29461bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 151948366
    locus_GRCh38:
      chromosome: '6'
      position: 151627231
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - East Asian=13905
    gwas_catalog_id: GCST003520
    neg_log_pval: 14.154901959985743
    otg_id: GCST003520
    pubmed_id: '27354352'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha modulator drug TAMOXIFEN is Phase IV for
        the indiciation EFO_0000305 and targets the gene ENSG00000091831 at this locus
        (29461bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 151948366
    locus_GRCh38:
      chromosome: '6'
      position: 151627231
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=33864
    gwas_catalog_id: GCST004950
    neg_log_pval: 23.221848749616356
    otg_id: GCST004950
    pubmed_id: '25751625'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha agonist drug ETHINYL ESTRADIOL is Phase
        III for the indiciation EFO_0000305 and targets the gene ENSG00000091831 at
        this locus (29461bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 151948366
    locus_GRCh38:
      chromosome: '6'
      position: 151627231
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=2727
    gwas_catalog_id: GCST001916
    neg_log_pval: 8.301029995663981
    otg_id: GCST001916
    pubmed_id: '23544013'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha modulator drug TAMOXIFEN is Phase IV for
        the indiciation EFO_0000305 and targets the gene ENSG00000091831 at this locus
        (29461bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 151948366
    locus_GRCh38:
      chromosome: '6'
      position: 151627231
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast Cancer in BRCA1 mutation carriers
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=39387
    gwas_catalog_id: GCST001930
    neg_log_pval: 15.301029995663981
    otg_id: GCST001930
    pubmed_id: '23535733'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha agonist drug ETHINYL ESTRADIOL is Phase
        III for the indiciation EFO_0000305 and targets the gene ENSG00000091831 at
        this locus (29461bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 151948366
    locus_GRCh38:
      chromosome: '6'
      position: 151627231
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=33864
    gwas_catalog_id: GCST004950
    neg_log_pval: 23.221848749616356
    otg_id: GCST004950
    pubmed_id: '25751625'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha antagonist drug SR16234 is Phase II for
        the indiciation EFO_0000305 and targets the gene ENSG00000091831 at this locus
        (29461bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 151948366
    locus_GRCh38:
      chromosome: '6'
      position: 151627231
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=33864
    gwas_catalog_id: GCST004950
    neg_log_pval: 23.221848749616356
    otg_id: GCST004950
    pubmed_id: '25751625'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha modulator drug TAMOXIFEN is Phase IV for
        the indiciation EFO_0000305 and targets the gene ENSG00000091831 at this locus
        (29461bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 151948366
    locus_GRCh38:
      chromosome: '6'
      position: 151627231
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - East Asian=3027
    gwas_catalog_id: GCST000343
    neg_log_pval: 14.698970004336019
    otg_id: GCST000343
    pubmed_id: '19219042'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha modulator drug TAMOXIFEN is Phase IV for
        the indiciation EFO_0000305 and targets the gene ENSG00000091831 at this locus
        (29461bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 151948366
    locus_GRCh38:
      chromosome: '6'
      position: 151627231
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - East Asian=3027
    gwas_catalog_id: GCST000343
    neg_log_pval: 14.698970004336019
    otg_id: GCST000343
    pubmed_id: '19219042'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha agonist drug ETHINYL ESTRADIOL is Phase
        III for the indiciation EFO_0000305 and targets the gene ENSG00000091831 at
        this locus (29461bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 151948366
    locus_GRCh38:
      chromosome: '6'
      position: 151627231
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - East Asian=3027
    gwas_catalog_id: GCST000343
    neg_log_pval: 14.698970004336019
    otg_id: GCST000343
    pubmed_id: '19219042'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha antagonist drug SR16234 is Phase II for
        the indiciation EFO_0000305 and targets the gene ENSG00000091831 at this locus
        (29461bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 151948366
    locus_GRCh38:
      chromosome: '6'
      position: 151627231
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=2727
    gwas_catalog_id: GCST001916
    neg_log_pval: 8.301029995663981
    otg_id: GCST001916
    pubmed_id: '23544013'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha agonist drug ETHINYL ESTRADIOL is Phase
        III for the indiciation EFO_0000305 and targets the gene ENSG00000091831 at
        this locus (29461bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 151948366
    locus_GRCh38:
      chromosome: '6'
      position: 151627231
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast Cancer in BRCA1 mutation carriers
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=2727
    gwas_catalog_id: GCST001916
    neg_log_pval: 8.301029995663981
    otg_id: GCST001916
    pubmed_id: '23544013'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha antagonist drug SR16234 is Phase II for
        the indiciation EFO_0000305 and targets the gene ENSG00000091831 at this locus
        (29461bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 151948366
    locus_GRCh38:
      chromosome: '6'
      position: 151627231
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast Cancer in BRCA1 mutation carriers
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=401447
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 15.344861565188618
    otg_id: SAIGE_174
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha modulator drug TAMOXIFEN is Phase IV for
        the indiciation EFO_0000305 and targets the gene ENSG00000091831 at this locus
        (28021bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 151949806
    locus_GRCh38:
      chromosome: '6'
      position: 151628671
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=401447
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 15.344861565188618
    otg_id: SAIGE_174
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha agonist drug ETHINYL ESTRADIOL is Phase
        III for the indiciation EFO_0000305 and targets the gene ENSG00000091831 at
        this locus (28021bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 151949806
    locus_GRCh38:
      chromosome: '6'
      position: 151628671
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=401447
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 15.344861565188618
    otg_id: SAIGE_174
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha antagonist drug BRILANESTRANT is Phase
        II for the indiciation EFO_0000305 and targets the gene ENSG00000091831 at
        this locus (28021bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 151949806
    locus_GRCh38:
      chromosome: '6'
      position: 151628671
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=330828
    neg_log_pval: 12.785156151952302
    otg_id: NEALE2_20110_5
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha modulator drug TAMOXIFEN is Phase IV for
        the indiciation EFO_0000305 and targets the gene ENSG00000091831 at this locus
        (25495bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 151952332
    locus_GRCh38:
      chromosome: '6'
      position: 151631197
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer | illnesses of mother
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=330828
    neg_log_pval: 12.785156151952302
    otg_id: NEALE2_20110_5
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha agonist drug ESTRADIOL is Phase II for
        the indiciation EFO_0000305 and targets the gene ENSG00000091831 at this locus
        (25495bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 151952332
    locus_GRCh38:
      chromosome: '6'
      position: 151631197
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer | illnesses of mother
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=330828
    neg_log_pval: 12.785156151952302
    otg_id: NEALE2_20110_5
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha agonist drug ETHINYL ESTRADIOL is Phase
        III for the indiciation EFO_0000305 and targets the gene ENSG00000091831 at
        this locus (25495bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 151952332
    locus_GRCh38:
      chromosome: '6'
      position: 151631197
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer | illnesses of mother
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=139274
    gwas_catalog_id: GCST004988
    neg_log_pval: 7.895171596346344
    otg_id: GCST004988
    pubmed_id: '29059683'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha antagonist drug SR16234 is Phase II for
        the indiciation EFO_0000305 and targets the gene ENSG00000091831 at this locus
        (25181bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 151952645
    locus_GRCh38:
      chromosome: '6'
      position: 151631510
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=139274
    gwas_catalog_id: GCST004988
    neg_log_pval: 7.895171596346344
    otg_id: GCST004988
    pubmed_id: '29059683'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha agonist drug ETHINYL ESTRADIOL is Phase
        III for the indiciation EFO_0000305 and targets the gene ENSG00000091831 at
        this locus (25181bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 151952645
    locus_GRCh38:
      chromosome: '6'
      position: 151631510
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=139274
    gwas_catalog_id: GCST004988
    neg_log_pval: 7.895171596346344
    otg_id: GCST004988
    pubmed_id: '29059683'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha modulator drug TAMOXIFEN is Phase IV for
        the indiciation EFO_0000305 and targets the gene ENSG00000091831 at this locus
        (25181bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 151952645
    locus_GRCh38:
      chromosome: '6'
      position: 151631510
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - Hispanic or Latin American=4710
    gwas_catalog_id: GCST002662
    neg_log_pval: 17.045757490560675
    otg_id: GCST002662
    pubmed_id: '25327703'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha agonist drug ETHINYL ESTRADIOL is Phase
        III for the indiciation EFO_0000305 and targets the gene ENSG00000091831 at
        this locus (22992bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 151954834
    locus_GRCh38:
      chromosome: '6'
      position: 151633699
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - Hispanic or Latin American=4710
    gwas_catalog_id: GCST002662
    neg_log_pval: 17.045757490560675
    otg_id: GCST002662
    pubmed_id: '25327703'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha modulator drug TAMOXIFEN is Phase IV for
        the indiciation EFO_0000305 and targets the gene ENSG00000091831 at this locus
        (22992bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 151954834
    locus_GRCh38:
      chromosome: '6'
      position: 151633699
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - Hispanic or Latin American=4710
    gwas_catalog_id: GCST002662
    neg_log_pval: 17.045757490560675
    otg_id: GCST002662
    pubmed_id: '25327703'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha agonist drug ESTRADIOL is Phase II for
        the indiciation EFO_0000305 and targets the gene ENSG00000091831 at this locus
        (22992bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 151954834
    locus_GRCh38:
      chromosome: '6'
      position: 151633699
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=139274
    gwas_catalog_id: GCST004988
    neg_log_pval: 53.54668165995296
    otg_id: GCST004988
    pubmed_id: '29059683'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha antagonist drug BRILANESTRANT is Phase
        II for the indiciation EFO_0000305 and targets the gene ENSG00000091831 at
        this locus (21912bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 151955914
    locus_GRCh38:
      chromosome: '6'
      position: 151634779
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=139274
    gwas_catalog_id: GCST004988
    neg_log_pval: 53.54668165995296
    otg_id: GCST004988
    pubmed_id: '29059683'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha agonist drug ETHINYL ESTRADIOL is Phase
        III for the indiciation EFO_0000305 and targets the gene ENSG00000091831 at
        this locus (21912bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 151955914
    locus_GRCh38:
      chromosome: '6'
      position: 151634779
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=139274
    gwas_catalog_id: GCST004988
    neg_log_pval: 53.54668165995296
    otg_id: GCST004988
    pubmed_id: '29059683'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha modulator drug TAMOXIFEN is Phase IV for
        the indiciation EFO_0000305 and targets the gene ENSG00000091831 at this locus
        (21912bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 151955914
    locus_GRCh38:
      chromosome: '6'
      position: 151634779
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=32530
    - African American or Afro-Caribbean=3748
    gwas_catalog_id: GCST001683
    neg_log_pval: 9.698970004336019
    otg_id: GCST001683
    pubmed_id: '22976474'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha antagonist drug BRILANESTRANT is Phase
        II for the indiciation EFO_0000305 and targets the gene ENSG00000091831 at
        this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 151987357
    locus_GRCh38:
      chromosome: '6'
      position: 151666222
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=32530
    - African American or Afro-Caribbean=3748
    gwas_catalog_id: GCST001683
    neg_log_pval: 9.698970004336019
    otg_id: GCST001683
    pubmed_id: '22976474'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha modulator drug TAMOXIFEN is Phase IV for
        the indiciation EFO_0000305 and targets the gene ENSG00000091831 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 151987357
    locus_GRCh38:
      chromosome: '6'
      position: 151666222
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=32530
    - African American or Afro-Caribbean=3748
    gwas_catalog_id: GCST001683
    neg_log_pval: 9.698970004336019
    otg_id: GCST001683
    pubmed_id: '22976474'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha agonist drug ETHINYL ESTRADIOL is Phase
        III for the indiciation EFO_0000305 and targets the gene ENSG00000091831 at
        this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 151987357
    locus_GRCh38:
      chromosome: '6'
      position: 151666222
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=139274
    gwas_catalog_id: GCST004988
    neg_log_pval: 18.080451241031152
    otg_id: GCST004988
    pubmed_id: '29059683'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha modulator drug TAMOXIFEN is Phase IV for
        the indiciation EFO_0000305 and targets the gene ENSG00000091831 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 152020390
    locus_GRCh38:
      chromosome: '6'
      position: 151699255
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=139274
    gwas_catalog_id: GCST004988
    neg_log_pval: 18.080451241031152
    otg_id: GCST004988
    pubmed_id: '29059683'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha antagonist drug BRILANESTRANT is Phase
        II for the indiciation EFO_0000305 and targets the gene ENSG00000091831 at
        this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 152020390
    locus_GRCh38:
      chromosome: '6'
      position: 151699255
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=139274
    gwas_catalog_id: GCST004988
    neg_log_pval: 18.080451241031152
    otg_id: GCST004988
    pubmed_id: '29059683'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha agonist drug ETHINYL ESTRADIOL is Phase
        III for the indiciation EFO_0000305 and targets the gene ENSG00000091831 at
        this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 152020390
    locus_GRCh38:
      chromosome: '6'
      position: 151699255
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=401447
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 7.47755576649368
    otg_id: SAIGE_174
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha agonist drug ETHINYL ESTRADIOL is Phase
        III for the indiciation EFO_0000305 and targets the gene ENSG00000091831 at
        this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 152034820
    locus_GRCh38:
      chromosome: '6'
      position: 151713685
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=401447
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 7.47755576649368
    otg_id: SAIGE_174
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha modulator drug TAMOXIFEN is Phase IV for
        the indiciation EFO_0000305 and targets the gene ENSG00000091831 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 152034820
    locus_GRCh38:
      chromosome: '6'
      position: 151713685
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=401447
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 7.47755576649368
    otg_id: SAIGE_174
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha antagonist drug BRILANESTRANT is Phase
        II for the indiciation EFO_0000305 and targets the gene ENSG00000091831 at
        this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 152034820
    locus_GRCh38:
      chromosome: '6'
      position: 151713685
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=139274
    gwas_catalog_id: GCST004988
    neg_log_pval: 25.84893674664625
    otg_id: GCST004988
    pubmed_id: '29059683'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha agonist drug ETHINYL ESTRADIOL is Phase
        III for the indiciation EFO_0000305 and targets the gene ENSG00000091831 at
        this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 152432902
    locus_GRCh38:
      chromosome: '6'
      position: 152111767
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=139274
    gwas_catalog_id: GCST004988
    neg_log_pval: 25.84893674664625
    otg_id: GCST004988
    pubmed_id: '29059683'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha modulator drug TAMOXIFEN is Phase IV for
        the indiciation EFO_0000305 and targets the gene ENSG00000091831 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 152432902
    locus_GRCh38:
      chromosome: '6'
      position: 152111767
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=139274
    gwas_catalog_id: GCST004988
    neg_log_pval: 25.84893674664625
    otg_id: GCST004988
    pubmed_id: '29059683'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha antagonist drug BRILANESTRANT is Phase
        II for the indiciation EFO_0000305 and targets the gene ENSG00000091831 at
        this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 152432902
    locus_GRCh38:
      chromosome: '6'
      position: 152111767
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=401447
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 12.767003889607846
    otg_id: SAIGE_174
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha modulator drug TAMOXIFEN is Phase IV for
        the indiciation EFO_0000305 and targets the gene ENSG00000091831 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 152437016
    locus_GRCh38:
      chromosome: '6'
      position: 152115881
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=401447
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 12.767003889607846
    otg_id: SAIGE_174
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha antagonist drug BRILANESTRANT is Phase
        II for the indiciation EFO_0000305 and targets the gene ENSG00000091831 at
        this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 152437016
    locus_GRCh38:
      chromosome: '6'
      position: 152115881
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=401447
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 12.767003889607846
    otg_id: SAIGE_174
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha agonist drug ETHINYL ESTRADIOL is Phase
        III for the indiciation EFO_0000305 and targets the gene ENSG00000091831 at
        this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 152437016
    locus_GRCh38:
      chromosome: '6'
      position: 152115881
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=204641
    - East Asian=4262
    gwas_catalog_id: GCST004549
    neg_log_pval: 7.698970004336019
    otg_id: GCST004549
    pubmed_id: '28537267'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha agonist drug ETHINYL ESTRADIOL is Phase
        IV for the indiciation EFO_0001065 and targets the gene ENSG00000091831 at
        this locus (103260bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 152554014
    locus_GRCh38:
      chromosome: '6'
      position: 152232879
  trait_info:
    ontology:
    - EFO_0001065
    reported_trait_name: Endometriosis
    standard_trait_name: endometriosis
- association_info:
    ancestry:
    - European=204641
    - East Asian=4262
    gwas_catalog_id: GCST004549
    neg_log_pval: 7.698970004336019
    otg_id: GCST004549
    pubmed_id: '28537267'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha agonist drug ESTRADIOL is Phase III for
        the indiciation EFO_0001065 and targets the gene ENSG00000091831 at this locus
        (103260bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 152554014
    locus_GRCh38:
      chromosome: '6'
      position: 152232879
  trait_info:
    ontology:
    - EFO_0001065
    reported_trait_name: Endometriosis
    standard_trait_name: endometriosis
- association_info:
    ancestry:
    - European=204641
    - East Asian=4262
    gwas_catalog_id: GCST004549
    neg_log_pval: 7.698970004336019
    otg_id: GCST004549_2
    pubmed_id: '28537267'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha agonist drug ETHINYL ESTRADIOL is Phase
        IV for the indiciation EFO_0001065 and targets the gene ENSG00000091831 at
        this locus (103260bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 152554014
    locus_GRCh38:
      chromosome: '6'
      position: 152232879
  trait_info:
    ontology:
    - EFO_0001065
    reported_trait_name: Endometriosis [EA]
    standard_trait_name: endometriosis
- association_info:
    ancestry:
    - European=204641
    - East Asian=4262
    gwas_catalog_id: GCST004549
    neg_log_pval: 7.698970004336019
    otg_id: GCST004549_2
    pubmed_id: '28537267'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha agonist drug ESTRADIOL is Phase III for
        the indiciation EFO_0001065 and targets the gene ENSG00000091831 at this locus
        (103260bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 152554014
    locus_GRCh38:
      chromosome: '6'
      position: 152232879
  trait_info:
    ontology:
    - EFO_0001065
    reported_trait_name: Endometriosis [EA]
    standard_trait_name: endometriosis
- association_info:
    ancestry:
    - European=539925
    gwas_catalog_id: GCST006462
    neg_log_pval: 23.045757490560675
    otg_id: GCST006462
    pubmed_id: '30194396'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha agonist drug ESTRADIOL is Phase III for
        the indiciation EFO_0000731 and targets the gene ENSG00000091831 at this locus
        (111518bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 152562271
    locus_GRCh38:
      chromosome: '6'
      position: 152241136
  trait_info:
    ontology:
    - EFO_0000731
    reported_trait_name: Uterine fibroids
    standard_trait_name: uterine fibroid
- association_info:
    ancestry:
    - European=33181
    gwas_catalog_id: GCST003962
    neg_log_pval: 7.3979400086720375
    otg_id: GCST003962
    pubmed_id: '28072414'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha modulator drug TAMOXIFEN is Phase III for
        the indiciation EFO_0000289 and targets the gene ENSG00000091831 at this locus
        (263852bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 152714606
    locus_GRCh38:
      chromosome: '6'
      position: 152393471
  trait_info:
    ontology:
    - EFO_0000289
    reported_trait_name: Bipolar disorder
    standard_trait_name: bipolar disorder
- association_info:
    ancestry:
    - European=61220
    gwas_catalog_id: GCST001877
    neg_log_pval: 8.397940008672037
    otg_id: GCST001877_3
    pubmed_id: '23453885'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha agonist drug ESTRADIOL is Phase II for
        the indiciation EFO_0000692 and targets the gene ENSG00000091831 at this locus
        (339820bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 152790573
    locus_GRCh38:
      chromosome: '6'
      position: 152469438
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Autism spectrum disorder, attention deficit-hyperactivity
      disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
      [Modelling analysis]
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - European=61220
    gwas_catalog_id: GCST001877
    neg_log_pval: 8.397940008672037
    otg_id: GCST001877_3
    pubmed_id: '23453885'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha modulator drug TAMOXIFEN is Phase III for
        the indiciation EFO_0000289 and targets the gene ENSG00000091831 at this locus
        (339820bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 152790573
    locus_GRCh38:
      chromosome: '6'
      position: 152469438
  trait_info:
    ontology:
    - EFO_0000289
    reported_trait_name: Autism spectrum disorder, attention deficit-hyperactivity
      disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
      [Modelling analysis]
    standard_trait_name: bipolar disorder
- association_info:
    ancestry:
    - European=61220
    gwas_catalog_id: GCST001877
    neg_log_pval: 8.397940008672037
    otg_id: GCST001877_3
    pubmed_id: '23453885'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha agonist drug ESTRADIOL is Phase IV for
        the indiciation EFO_0003761 and targets the gene ENSG00000091831 at this locus
        (339820bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 152790573
    locus_GRCh38:
      chromosome: '6'
      position: 152469438
  trait_info:
    ontology:
    - EFO_0003761
    reported_trait_name: Autism spectrum disorder, attention deficit-hyperactivity
      disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
      [Modelling analysis]
    standard_trait_name: unipolar depression
- association_info:
    ancestry:
    - European=61220
    gwas_catalog_id: GCST001877
    neg_log_pval: 8.397940008672037
    otg_id: GCST001877_3
    pubmed_id: '23453885'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Estrogen receptor alpha agonist drug ETHINYL ESTRADIOL is Phase
        II for the indiciation EFO_0003761 and targets the gene ENSG00000091831 at
        this locus (339820bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000091831
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 152790573
    locus_GRCh38:
      chromosome: '6'
      position: 152469438
  trait_info:
    ontology:
    - EFO_0003761
    reported_trait_name: Autism spectrum disorder, attention deficit-hyperactivity
      disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
      [Modelling analysis]
    standard_trait_name: unipolar depression
- association_info:
    ancestry:
    - European=1027
    - African American or Afro-Caribbean=383
    gwas_catalog_id: GCST004136
    neg_log_pval: 7.522878745280337
    otg_id: GCST004136
    pubmed_id: '28115739'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Mu opioid receptor agonist drug MORPHINE is Phase IV for the indiciation
        EFO_0005611 and targets the gene ENSG00000112038 at this locus (306493bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000112038
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 154025139
    locus_GRCh38:
      chromosome: '6'
      position: 153704004
  trait_info:
    ontology:
    - EFO_0005611
    reported_trait_name: Methadone dose in opioid dependence [AA]
    standard_trait_name: opioid dependence
- association_info:
    ancestry:
    - European=1027
    - African American or Afro-Caribbean=383
    gwas_catalog_id: GCST004136
    neg_log_pval: 7.522878745280337
    otg_id: GCST004136
    pubmed_id: '28115739'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Mu opioid receptor agonist drug TRAMADOL is Phase III for the indiciation
        EFO_0005611 and targets the gene ENSG00000112038 at this locus (306493bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000112038
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 154025139
    locus_GRCh38:
      chromosome: '6'
      position: 153704004
  trait_info:
    ontology:
    - EFO_0005611
    reported_trait_name: Methadone dose in opioid dependence [AA]
    standard_trait_name: opioid dependence
- association_info:
    ancestry:
    - European=1027
    - African American or Afro-Caribbean=383
    gwas_catalog_id: GCST004136
    neg_log_pval: 7.522878745280337
    otg_id: GCST004136
    pubmed_id: '28115739'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Mu opioid receptor antagonist drug NALDEMEDINE is Phase II for
        the indiciation EFO_0005611 and targets the gene ENSG00000112038 at this locus
        (306493bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000112038
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 154025139
    locus_GRCh38:
      chromosome: '6'
      position: 153704004
  trait_info:
    ontology:
    - EFO_0005611
    reported_trait_name: Methadone dose in opioid dependence [AA]
    standard_trait_name: opioid dependence
- association_info:
    ancestry:
    - NR=296525
    gwas_catalog_id: GCST005194
    neg_log_pval: 88.32422165832591
    otg_id: GCST005194
    pubmed_id: '29212778'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Plasminogen activator drug UROKINASE is Phase IV for the indiciation
        EFO_0000378 and targets the gene ENSG00000122194 at this locus (371740bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000122194
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 160751531
    locus_GRCh38:
      chromosome: '6'
      position: 160330499
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - NR=250736
    gwas_catalog_id: GCST005196
    neg_log_pval: 30.522878745280337
    otg_id: GCST005196
    pubmed_id: '29212778'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Plasminogen activator drug UROKINASE is Phase IV for the indiciation
        EFO_0000378 and targets the gene ENSG00000122194 at this locus (211675bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000122194
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 160911596
    locus_GRCh38:
      chromosome: '6'
      position: 160490564
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - European=408458
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 19.416801226031378
    otg_id: SAIGE_411
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Plasminogen activator drug UROKINASE is Phase IV for the indiciation
        EFO_0000378 and targets the gene ENSG00000122194 at this locus (211675bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000122194
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 160911596
    locus_GRCh38:
      chromosome: '6'
      position: 160490564
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Ischemic heart disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - European=388806
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 11.869666231504993
    otg_id: SAIGE_411_2
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Plasminogen activator drug STREPTOKINASE is Phase III for the indiciation
        EFO_0000612 and targets the gene ENSG00000122194 at this locus (211675bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000122194
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 160911596
    locus_GRCh38:
      chromosome: '6'
      position: 160490564
  trait_info:
    ontology:
    - EFO_0000612
    reported_trait_name: Myocardial infarction
    standard_trait_name: myocardial infarction
- association_info:
    ancestry:
    - European=388806
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 11.869666231504993
    otg_id: SAIGE_411_2
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Plasminogen activator drug TENECTEPLASE is Phase IV for the indiciation
        EFO_0000612 and targets the gene ENSG00000122194 at this locus (211675bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000122194
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 160911596
    locus_GRCh38:
      chromosome: '6'
      position: 160490564
  trait_info:
    ontology:
    - EFO_0000612
    reported_trait_name: Myocardial infarction
    standard_trait_name: myocardial infarction
- association_info:
    ancestry:
    - NR=296525
    gwas_catalog_id: GCST005194
    neg_log_pval: 31.75870261289001
    otg_id: GCST005194
    pubmed_id: '29212778'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Plasminogen activator drug UROKINASE is Phase IV for the indiciation
        EFO_0000378 and targets the gene ENSG00000122194 at this locus (211675bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000122194
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 160911596
    locus_GRCh38:
      chromosome: '6'
      position: 160490564
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - NR=547261
    gwas_catalog_id: GCST005195
    neg_log_pval: 28.657577319177793
    otg_id: GCST005195
    pubmed_id: '29212778'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Plasminogen activator drug UROKINASE is Phase IV for the indiciation
        EFO_0000378 and targets the gene ENSG00000122194 at this locus (211675bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000122194
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 160911596
    locus_GRCh38:
      chromosome: '6'
      position: 160490564
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - European=15666
    gwas_catalog_id: GCST006405
    neg_log_pval: 11.522878745280337
    otg_id: GCST006405
    pubmed_id: '30003307'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Plasminogen inhibitor drug TRANEXAMIC ACID is Phase IV for the
        indiciation EFO_0000378 and targets the gene ENSG00000122194 at this locus
        (126153bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000122194
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 160997118
    locus_GRCh38:
      chromosome: '6'
      position: 160576086
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease in diabetes
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 28.71524000401907
    otg_id: NEALE2_20002_1075
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Plasminogen activator drug ALTEPLASE is Phase IV for the indiciation
        EFO_0000612 and targets the gene ENSG00000122194 at this locus (117660bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000122194
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 161005610
    locus_GRCh38:
      chromosome: '6'
      position: 160584578
  trait_info:
    ontology:
    - EFO_0000612
    reported_trait_name: Heart attack/myocardial infarction | non-cancer illness code,
      self-reported
    standard_trait_name: myocardial infarction
- association_info:
    ancestry:
    - NR=296525
    gwas_catalog_id: GCST005194
    neg_log_pval: 153.0096611452124
    otg_id: GCST005194
    pubmed_id: '29212778'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Plasminogen inhibitor drug TRANEXAMIC ACID is Phase IV for the
        indiciation EFO_0000378 and targets the gene ENSG00000122194 at this locus
        (117660bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000122194
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 161005610
    locus_GRCh38:
      chromosome: '6'
      position: 160584578
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - European=408458
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 61.367542707815275
    otg_id: SAIGE_411
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Plasminogen inhibitor drug TRANEXAMIC ACID is Phase IV for the
        indiciation EFO_0000378 and targets the gene ENSG00000122194 at this locus
        (117660bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000122194
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 161005610
    locus_GRCh38:
      chromosome: '6'
      position: 160584578
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Ischemic heart disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 28.71524000401907
    otg_id: NEALE2_20002_1075
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Plasminogen activator drug STREPTOKINASE is Phase III for the indiciation
        EFO_0000612 and targets the gene ENSG00000122194 at this locus (117660bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000122194
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 161005610
    locus_GRCh38:
      chromosome: '6'
      position: 160584578
  trait_info:
    ontology:
    - EFO_0000612
    reported_trait_name: Heart attack/myocardial infarction | non-cancer illness code,
      self-reported
    standard_trait_name: myocardial infarction
- association_info:
    ancestry:
    - European=388806
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 40.28149831113272
    otg_id: SAIGE_411_2
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Plasminogen activator drug ALTEPLASE is Phase IV for the indiciation
        EFO_0000612 and targets the gene ENSG00000122194 at this locus (117660bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000122194
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 161005610
    locus_GRCh38:
      chromosome: '6'
      position: 160584578
  trait_info:
    ontology:
    - EFO_0000612
    reported_trait_name: Myocardial infarction
    standard_trait_name: myocardial infarction
- association_info:
    ancestry:
    - NR=547261
    gwas_catalog_id: GCST005195
    neg_log_pval: 119.20065945054642
    otg_id: GCST005195
    pubmed_id: '29212778'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Plasminogen inhibitor drug TRANEXAMIC ACID is Phase IV for the
        indiciation EFO_0000378 and targets the gene ENSG00000122194 at this locus
        (117660bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000122194
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 161005610
    locus_GRCh38:
      chromosome: '6'
      position: 160584578
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - European=388806
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 40.28149831113272
    otg_id: SAIGE_411_2
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Plasminogen activator drug STREPTOKINASE is Phase III for the indiciation
        EFO_0000612 and targets the gene ENSG00000122194 at this locus (117660bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000122194
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 161005610
    locus_GRCh38:
      chromosome: '6'
      position: 160584578
  trait_info:
    ontology:
    - EFO_0000612
    reported_trait_name: Myocardial infarction
    standard_trait_name: myocardial infarction
- association_info:
    ancestry:
    - NR=250736
    gwas_catalog_id: GCST005196
    neg_log_pval: 153.52287874528034
    otg_id: GCST005196
    pubmed_id: '29212778'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Plasminogen inhibitor drug TRANEXAMIC ACID is Phase IV for the
        indiciation EFO_0000378 and targets the gene ENSG00000122194 at this locus
        (117660bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000122194
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 161005610
    locus_GRCh38:
      chromosome: '6'
      position: 160584578
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - European=141217
    - African American or Afro-Caribbean=3139
    - Hispanic or Latin American=4095
    - South Asian=25557
    - Greater Middle Eastern (Middle Eastern / North African / Persian)=2268
    - East Asian=11323
    gwas_catalog_id: GCST003116
    neg_log_pval: 38.30102999566398
    otg_id: GCST003116
    pubmed_id: '26343387'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Plasminogen inhibitor drug TRANEXAMIC ACID is Phase IV for the
        indiciation EFO_0000378 and targets the gene ENSG00000122194 at this locus
        (117660bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000122194
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 161005610
    locus_GRCh38:
      chromosome: '6'
      position: 160584578
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - NR=250736
    gwas_catalog_id: GCST005196
    neg_log_pval: 10.522878745280337
    otg_id: GCST005196
    pubmed_id: '29212778'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Plasminogen activator drug UROKINASE is Phase IV for the indiciation
        EFO_0000378 and targets the gene ENSG00000122194 at this locus (117194bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000122194
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 161006077
    locus_GRCh38:
      chromosome: '6'
      position: 160585045
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - NR=250736
    gwas_catalog_id: GCST005196
    neg_log_pval: 10.522878745280337
    otg_id: GCST005196
    pubmed_id: '29212778'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Plasminogen activator drug UROKINASE is Phase IV for the indiciation
        EFO_0000378 and targets the gene ENSG00000122194 at this locus (117194bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000122194
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 161006077
    locus_GRCh38:
      chromosome: '6'
      position: 160585045
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - African American or Afro-Caribbean=2908
    - Hispanic or Latin American=3615
    - South Asian=23156
    - Greater Middle Eastern (Middle Eastern / North African / Persian)=754
    - East Asian=9396
    - European=126630
    gwas_catalog_id: GCST003117
    neg_log_pval: 26.045757490560675
    otg_id: GCST003117
    pubmed_id: '26343387'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Plasminogen activator drug TENECTEPLASE is Phase IV for the indiciation
        EFO_0000612 and targets the gene ENSG00000122194 at this locus (113152bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000122194
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 161010118
    locus_GRCh38:
      chromosome: '6'
      position: 160589086
  trait_info:
    ontology:
    - EFO_0000612
    reported_trait_name: Myocardial infarction
    standard_trait_name: myocardial infarction
- association_info:
    ancestry:
    - African American or Afro-Caribbean=2908
    - Hispanic or Latin American=3615
    - South Asian=23156
    - Greater Middle Eastern (Middle Eastern / North African / Persian)=754
    - East Asian=9396
    - European=126630
    gwas_catalog_id: GCST003117
    neg_log_pval: 26.045757490560675
    otg_id: GCST003117
    pubmed_id: '26343387'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Plasminogen activator drug RETEPLASE is Phase III for the indiciation
        EFO_0000612 and targets the gene ENSG00000122194 at this locus (113152bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000122194
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 161010118
    locus_GRCh38:
      chromosome: '6'
      position: 160589086
  trait_info:
    ontology:
    - EFO_0000612
    reported_trait_name: Myocardial infarction
    standard_trait_name: myocardial infarction
- association_info:
    ancestry:
    - European, NR=63731
    gwas_catalog_id: GCST004787
    neg_log_pval: 48.69897000433602
    otg_id: GCST004787
    pubmed_id: '28714975'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Plasminogen activator drug UROKINASE is Phase IV for the indiciation
        EFO_0000378 and targets the gene ENSG00000122194 at this locus (113152bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000122194
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 161010118
    locus_GRCh38:
      chromosome: '6'
      position: 160589086
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease (myocardial infarction, percutaneous
      transluminal coronary angioplasty, coronary artery bypass grafting, angina or
      chromic ischemic heart disease)
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - NR=123388
    gwas_catalog_id: GCST002287
    neg_log_pval: 11.698970004336019
    otg_id: GCST002287
    pubmed_id: '24262325'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Plasminogen activator drug ALTEPLASE is Phase IV for the indiciation
        EFO_0000712 and targets the gene ENSG00000122194 at this locus (113152bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000122194
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 161010118
    locus_GRCh38:
      chromosome: '6'
      position: 160589086
  trait_info:
    ontology:
    - EFO_0000712
    reported_trait_name: Coronary artery disease or ischemic stroke
    standard_trait_name: cerebrovascular accident
- association_info:
    ancestry:
    - European=360420
    neg_log_pval: 27.967377210462196
    otg_id: NEALE2_6150_1
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Plasminogen activator drug RETEPLASE is Phase III for the indiciation
        EFO_0000612 and targets the gene ENSG00000122194 at this locus (113152bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000122194
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 161010118
    locus_GRCh38:
      chromosome: '6'
      position: 160589086
  trait_info:
    ontology:
    - EFO_0000612
    reported_trait_name: Heart attack | vascular/heart problems diagnosed by doctor
    standard_trait_name: myocardial infarction
- association_info:
    ancestry:
    - European=360420
    neg_log_pval: 27.967377210462196
    otg_id: NEALE2_6150_1
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Plasminogen activator drug TENECTEPLASE is Phase IV for the indiciation
        EFO_0000612 and targets the gene ENSG00000122194 at this locus (113152bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000122194
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 161010118
    locus_GRCh38:
      chromosome: '6'
      position: 160589086
  trait_info:
    ontology:
    - EFO_0000612
    reported_trait_name: Heart attack | vascular/heart problems diagnosed by doctor
    standard_trait_name: myocardial infarction
- association_info:
    ancestry:
    - NR=123388
    gwas_catalog_id: GCST002287
    neg_log_pval: 11.698970004336019
    otg_id: GCST002287
    pubmed_id: '24262325'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Plasminogen activator drug RETEPLASE is Phase II for the indiciation
        EFO_0000712 and targets the gene ENSG00000122194 at this locus (113152bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000122194
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 161010118
    locus_GRCh38:
      chromosome: '6'
      position: 160589086
  trait_info:
    ontology:
    - EFO_0000712
    reported_trait_name: Coronary artery disease or ischemic stroke
    standard_trait_name: cerebrovascular accident
- association_info:
    ancestry:
    - NR=123388
    gwas_catalog_id: GCST002287
    neg_log_pval: 11.698970004336019
    otg_id: GCST002287
    pubmed_id: '24262325'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Plasminogen activator drug DESMOTEPLASE is Phase III for the indiciation
        EFO_0000712 and targets the gene ENSG00000122194 at this locus (113152bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000122194
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 161010118
    locus_GRCh38:
      chromosome: '6'
      position: 160589086
  trait_info:
    ontology:
    - EFO_0000712
    reported_trait_name: Coronary artery disease or ischemic stroke
    standard_trait_name: cerebrovascular accident
- association_info:
    ancestry:
    - NR=547261
    gwas_catalog_id: GCST005195
    neg_log_pval: 76.85387196432177
    otg_id: GCST005195
    pubmed_id: '29212778'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Plasminogen activator drug UROKINASE is Phase IV for the indiciation
        EFO_0000378 and targets the gene ENSG00000122194 at this locus (110257bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000122194
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 161013013
    locus_GRCh38:
      chromosome: '6'
      position: 160591981
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - European=388806
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 25.059981844992336
    otg_id: SAIGE_411_2
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Plasminogen activator drug STREPTOKINASE is Phase III for the indiciation
        EFO_0000612 and targets the gene ENSG00000122194 at this locus (110257bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000122194
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 161013013
    locus_GRCh38:
      chromosome: '6'
      position: 160591981
  trait_info:
    ontology:
    - EFO_0000612
    reported_trait_name: Myocardial infarction
    standard_trait_name: myocardial infarction
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 17.90926593057954
    otg_id: NEALE2_20002_1075
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Plasminogen activator drug STREPTOKINASE is Phase III for the indiciation
        EFO_0000612 and targets the gene ENSG00000122194 at this locus (110257bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000122194
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 161013013
    locus_GRCh38:
      chromosome: '6'
      position: 160591981
  trait_info:
    ontology:
    - EFO_0000612
    reported_trait_name: Heart attack/myocardial infarction | non-cancer illness code,
      self-reported
    standard_trait_name: myocardial infarction
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 17.90926593057954
    otg_id: NEALE2_20002_1075
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Plasminogen activator drug UROKINASE is Phase IV for the indiciation
        EFO_0000612 and targets the gene ENSG00000122194 at this locus (110257bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000122194
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 161013013
    locus_GRCh38:
      chromosome: '6'
      position: 160591981
  trait_info:
    ontology:
    - EFO_0000612
    reported_trait_name: Heart attack/myocardial infarction | non-cancer illness code,
      self-reported
    standard_trait_name: myocardial infarction
- association_info:
    ancestry:
    - European=408458
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 42.36957212497498
    otg_id: SAIGE_411
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Plasminogen activator drug UROKINASE is Phase IV for the indiciation
        EFO_0000378 and targets the gene ENSG00000122194 at this locus (110257bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000122194
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 161013013
    locus_GRCh38:
      chromosome: '6'
      position: 160591981
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Ischemic heart disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - European=388806
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 25.059981844992336
    otg_id: SAIGE_411_2
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Plasminogen activator drug UROKINASE is Phase IV for the indiciation
        EFO_0000612 and targets the gene ENSG00000122194 at this locus (110257bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000122194
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 161013013
    locus_GRCh38:
      chromosome: '6'
      position: 160591981
  trait_info:
    ontology:
    - EFO_0000612
    reported_trait_name: Myocardial infarction
    standard_trait_name: myocardial infarction
- association_info:
    ancestry:
    - NR=296525
    gwas_catalog_id: GCST005194
    neg_log_pval: 9.409046764812015
    otg_id: GCST005194
    pubmed_id: '29212778'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Plasminogen inhibitor drug TRANEXAMIC ACID is Phase IV for the
        indiciation EFO_0000378 and targets the gene ENSG00000122194 at this locus
        (105907bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000122194
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 161017363
    locus_GRCh38:
      chromosome: '6'
      position: 160596331
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - NR=250736
    gwas_catalog_id: GCST005196
    neg_log_pval: 7.698970004336019
    otg_id: GCST005196
    pubmed_id: '29212778'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Plasminogen inhibitor drug TRANEXAMIC ACID is Phase IV for the
        indiciation EFO_0000378 and targets the gene ENSG00000122194 at this locus
        (35407bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000122194
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 161087863
    locus_GRCh38:
      chromosome: '6'
      position: 160666831
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - African American or Afro-Caribbean=2908
    - Hispanic or Latin American=3615
    - South Asian=23156
    - Greater Middle Eastern (Middle Eastern / North African / Persian)=754
    - East Asian=9396
    - European=126630
    gwas_catalog_id: GCST003117
    neg_log_pval: 23.69897000433602
    otg_id: GCST003117
    pubmed_id: '26343387'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Plasminogen activator drug TENECTEPLASE is Phase IV for the indiciation
        EFO_0000612 and targets the gene ENSG00000122194 at this locus (15127bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000122194
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 161108144
    locus_GRCh38:
      chromosome: '6'
      position: 160687112
  trait_info:
    ontology:
    - EFO_0000612
    reported_trait_name: Myocardial infarction
    standard_trait_name: myocardial infarction
- association_info:
    ancestry:
    - African American or Afro-Caribbean=2908
    - Hispanic or Latin American=3615
    - South Asian=23156
    - Greater Middle Eastern (Middle Eastern / North African / Persian)=754
    - East Asian=9396
    - European=126630
    gwas_catalog_id: GCST003117
    neg_log_pval: 23.69897000433602
    otg_id: GCST003117
    pubmed_id: '26343387'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Plasminogen activator drug RETEPLASE is Phase III for the indiciation
        EFO_0000612 and targets the gene ENSG00000122194 at this locus (15127bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000122194
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 161108144
    locus_GRCh38:
      chromosome: '6'
      position: 160687112
  trait_info:
    ontology:
    - EFO_0000612
    reported_trait_name: Myocardial infarction
    standard_trait_name: myocardial infarction
- association_info:
    ancestry:
    - European=360420
    neg_log_pval: 17.657683931817257
    otg_id: NEALE2_6150_1
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Plasminogen activator drug ALTEPLASE is Phase IV for the indiciation
        EFO_0000612 and targets the gene ENSG00000122194 at this locus (11570bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000122194
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 161111700
    locus_GRCh38:
      chromosome: '6'
      position: 160690668
  trait_info:
    ontology:
    - EFO_0000612
    reported_trait_name: Heart attack | vascular/heart problems diagnosed by doctor
    standard_trait_name: myocardial infarction
- association_info:
    ancestry:
    - European=360420
    neg_log_pval: 17.657683931817257
    otg_id: NEALE2_6150_1
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Plasminogen activator drug STREPTOKINASE is Phase III for the indiciation
        EFO_0000612 and targets the gene ENSG00000122194 at this locus (11570bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000122194
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 161111700
    locus_GRCh38:
      chromosome: '6'
      position: 160690668
  trait_info:
    ontology:
    - EFO_0000612
    reported_trait_name: Heart attack | vascular/heart problems diagnosed by doctor
    standard_trait_name: myocardial infarction
- association_info:
    ancestry:
    - NR=250736
    gwas_catalog_id: GCST005196
    neg_log_pval: 91.30102999566398
    otg_id: GCST005196
    pubmed_id: '29212778'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Plasminogen inhibitor drug TRANEXAMIC ACID is Phase IV for the
        indiciation EFO_0000378 and targets the gene ENSG00000122194 at this locus
        (11570bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000122194
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 161111700
    locus_GRCh38:
      chromosome: '6'
      position: 160690668
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - NR=296525
    gwas_catalog_id: GCST005194
    neg_log_pval: 96.70114692359029
    otg_id: GCST005194
    pubmed_id: '29212778'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Plasminogen inhibitor drug TRANEXAMIC ACID is Phase IV for the
        indiciation EFO_0000378 and targets the gene ENSG00000122194 at this locus
        (11570bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000122194
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 161111700
    locus_GRCh38:
      chromosome: '6'
      position: 160690668
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - European=141217
    - African American or Afro-Caribbean=3139
    - Hispanic or Latin American=4095
    - South Asian=25557
    - Greater Middle Eastern (Middle Eastern / North African / Persian)=2268
    - East Asian=11323
    gwas_catalog_id: GCST003116
    neg_log_pval: 31.69897000433602
    otg_id: GCST003116
    pubmed_id: '26343387'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Plasminogen inhibitor drug TRANEXAMIC ACID is Phase IV for the
        indiciation EFO_0000378 and targets the gene ENSG00000122194 at this locus
        (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000122194
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '6'
      position: 161123451
    locus_GRCh38:
      chromosome: '6'
      position: 160702419
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 8.507692295087963
    otg_id: NEALE2_20002_1111
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-6 inhibitor drug SIRUKUMAB is Phase II for the indiciation
        EFO_0000270 and targets the gene ENSG00000136244 at this locus (11870bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000136244
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: AT
    locus_GRCh37:
      chromosome: '7'
      position: 22783490
    locus_GRCh38:
      chromosome: '7'
      position: 22743871
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma | non-cancer illness code, self-reported
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=360527
    neg_log_pval: 9.229103089046006
    otg_id: NEALE2_6152_8
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Interleukin-6 inhibitor drug SIRUKUMAB is Phase II for the indiciation
        EFO_0000270 and targets the gene ENSG00000136244 at this locus (11870bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000136244
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: AT
    locus_GRCh37:
      chromosome: '7'
      position: 22783490
    locus_GRCh38:
      chromosome: '7'
      position: 22743871
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma | blood clot, dvt, bronchitis, emphysema, asthma,
      rhinitis, eczema, allergy diagnosed by doctor
    standard_trait_name: asthma
- association_info:
    ancestry:
    - East Asian=191764
    gwas_catalog_id: GCST007847
    neg_log_pval: 11.301029995663981
    otg_id: GCST007847
    pubmed_id: '30718926'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Niemann-Pick C1-like protein 1 inhibitor drug EZETIMIBE is Phase
        IV for the indiciation EFO_0001360 and targets the gene ENSG00000015520 at
        this locus (377278bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000015520
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '7'
      position: 44174857
    locus_GRCh38:
      chromosome: '7'
      position: 44135258
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European, NR=735838
    gwas_catalog_id: GCST007545
    neg_log_pval: 7.698970004336019
    otg_id: GCST007545
    pubmed_id: '30525989'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Niemann-Pick C1-like protein 1 inhibitor drug EZETIMIBE is Phase
        IV for the indiciation EFO_0000378 and targets the gene ENSG00000015520 at
        this locus (335997bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000015520
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '7'
      position: 44216137
    locus_GRCh38:
      chromosome: '7'
      position: 44176538
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease and triglyceride levels (multivariate
      analysis)
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - East Asian=7696
    gwas_catalog_id: GCST001965
    neg_log_pval: 9.522878745280337
    otg_id: GCST001965_2
    pubmed_id: '23575436'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Niemann-Pick C1-like protein 1 inhibitor drug EZETIMIBE is Phase
        IV for the indiciation EFO_0001360 and targets the gene ENSG00000015520 at
        this locus (323067bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000015520
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '7'
      position: 44229068
    locus_GRCh38:
      chromosome: '7'
      position: 44189469
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Glycemic traits [2-hPG]
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - East Asian=7696
    gwas_catalog_id: GCST001965
    neg_log_pval: 17.30102999566398
    otg_id: GCST001965_3
    pubmed_id: '23575436'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Niemann-Pick C1-like protein 1 inhibitor drug EZETIMIBE is Phase
        IV for the indiciation EFO_0001360 and targets the gene ENSG00000015520 at
        this locus (323067bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000015520
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '7'
      position: 44229068
    locus_GRCh38:
      chromosome: '7'
      position: 44189469
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Glycemic traits [FPG]
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - East Asian=7696
    gwas_catalog_id: GCST001965
    neg_log_pval: 8.522878745280337
    otg_id: GCST001965
    pubmed_id: '23575436'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Niemann-Pick C1-like protein 1 inhibitor drug EZETIMIBE is Phase
        IV for the indiciation EFO_0001360 and targets the gene ENSG00000015520 at
        this locus (323067bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000015520
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '7'
      position: 44229068
    locus_GRCh38:
      chromosome: '7'
      position: 44189469
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Glycemic traits [1-hPG]
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=10564
    gwas_catalog_id: GCST001436
    neg_log_pval: 12.397940008672037
    otg_id: GCST001436
    pubmed_id: '22399527'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Niemann-Pick C1-like protein 1 inhibitor drug EZETIMIBE is Phase
        IV for the indiciation EFO_0000195 and targets the gene ENSG00000015520 at
        this locus (320918bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000015520
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '7'
      position: 44231216
    locus_GRCh38:
      chromosome: '7'
      position: 44191617
  trait_info:
    ontology:
    - EFO_0000195
    reported_trait_name: Metabolic syndrome [GLU]
    standard_trait_name: metabolic syndrome
- association_info:
    ancestry:
    - European=655666
    - South Asian=3650
    gwas_catalog_id: GCST006867
    neg_log_pval: 8.397940008672037
    otg_id: GCST006867
    pubmed_id: '30054458'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Niemann-Pick C1-like protein 1 inhibitor drug EZETIMIBE is Phase
        IV for the indiciation EFO_0001360 and targets the gene ENSG00000015520 at
        this locus (303306bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000015520
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '7'
      position: 44248828
    locus_GRCh38:
      chromosome: '7'
      position: 44209229
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=10564
    gwas_catalog_id: GCST001436
    neg_log_pval: 10.045757490560675
    otg_id: GCST001436
    pubmed_id: '22399527'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Niemann-Pick C1-like protein 1 inhibitor drug EZETIMIBE is Phase
        IV for the indiciation EFO_0000195 and targets the gene ENSG00000015520 at
        this locus (292263bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000015520
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '7'
      position: 44259871
    locus_GRCh38:
      chromosome: '7'
      position: 44220272
  trait_info:
    ontology:
    - EFO_0000195
    reported_trait_name: Metabolic syndrome [GLU]
    standard_trait_name: metabolic syndrome
- association_info:
    ancestry:
    - European=10564
    gwas_catalog_id: GCST001436
    neg_log_pval: 10.045757490560675
    otg_id: GCST001436
    pubmed_id: '22399527'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Niemann-Pick C1-like protein 1 inhibitor drug EZETIMIBE is Phase
        IV for the indiciation EFO_0000195 and targets the gene ENSG00000015520 at
        this locus (292263bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000015520
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '7'
      position: 44259871
    locus_GRCh38:
      chromosome: '7'
      position: 44220272
  trait_info:
    ontology:
    - EFO_0000195
    reported_trait_name: Metabolic syndrome [GLU]
    standard_trait_name: metabolic syndrome
- association_info:
    ancestry:
    - European=459000
    gwas_catalog_id: GCST007072
    neg_log_pval: 7.301029995663981
    otg_id: GCST007072
    pubmed_id: '30595370'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Niemann-Pick C1-like protein 1 inhibitor drug EZETIMIBE is Phase
        IV for the indiciation EFO_0000319 and targets the gene ENSG00000015520 at
        this locus (1072bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000015520
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '7'
      position: 44581986
    locus_GRCh38:
      chromosome: '7'
      position: 44542387
  trait_info:
    ontology:
    - EFO_0000319
    reported_trait_name: Cardiovascular disease
    standard_trait_name: cardiovascular system disease
- association_info:
    ancestry:
    - European=459000
    gwas_catalog_id: GCST007072
    neg_log_pval: 7.301029995663981
    otg_id: GCST007072
    pubmed_id: '30595370'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Cyclophilin A modulator drug CYCLOSPORINE is Phase IV for the indiciation
        EFO_0000319 and targets the gene ENSG00000196262 at this locus (254293bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000196262
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '7'
      position: 44581986
    locus_GRCh38:
      chromosome: '7'
      position: 44542387
  trait_info:
    ontology:
    - EFO_0000319
    reported_trait_name: Cardiovascular disease
    standard_trait_name: cardiovascular system disease
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 14.154901959985743
    otg_id: NEALE2_20002_1473
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Niemann-Pick C1-like protein 1 inhibitor drug EZETIMIBE is Phase
        IV for the indiciation HP_0003124 and targets the gene ENSG00000015520 at
        this locus (3637bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000015520
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '7'
      position: 44584551
    locus_GRCh38:
      chromosome: '7'
      position: 44544952
  trait_info:
    ontology:
    - HP_0003124
    reported_trait_name: High cholesterol | non-cancer illness code, self-reported
    standard_trait_name: Hypercholesterolemia
- association_info:
    ancestry:
    - European=26405
    gwas_catalog_id: GCST000964
    neg_log_pval: 9.097453220686008
    otg_id: GCST000964
    pubmed_id: '21297633'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Cyclophilin A modulator drug CYCLOSPORINE is Phase IV for the indiciation
        EFO_0000729 and targets the gene ENSG00000196262 at this locus (224051bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000196262
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '7'
      position: 44612229
    locus_GRCh38:
      chromosome: '7'
      position: 44572630
  trait_info:
    ontology:
    - EFO_0000729
    reported_trait_name: Ulcerative colitis
    standard_trait_name: ulcerative colitis
- association_info:
    ancestry:
    - NR=296525
    gwas_catalog_id: GCST005194
    neg_log_pval: 7.438898616350944
    otg_id: GCST005194
    pubmed_id: '29212778'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Niemann-Pick C1-like protein 1 inhibitor drug EZETIMIBE is Phase
        IV for the indiciation EFO_0000378 and targets the gene ENSG00000015520 at
        this locus (497064bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000015520
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '7'
      position: 45077978
    locus_GRCh38:
      chromosome: '7'
      position: 45038379
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: Coronary artery disease
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - NR=15094
    gwas_catalog_id: GCST006480
    neg_log_pval: 11.154901959985743
    otg_id: GCST006480_2
    pubmed_id: '30152087'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Epidermal growth factor receptor erbB1 inhibitor drug LAPATINIB
        is Phase II for the indiciation EFO_0000519 and targets the gene ENSG00000146648
        at this locus (170431bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000146648
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '7'
      position: 54916280
    locus_GRCh38:
      chromosome: '7'
      position: 54848587
  trait_info:
    ontology:
    - EFO_0000519
    reported_trait_name: Glioblastoma (age-stratified) [Below median age-at-diagnosis]
    standard_trait_name: glioblastoma multiforme
- association_info:
    ancestry:
    - NR=15094
    gwas_catalog_id: GCST006480
    neg_log_pval: 15.397940008672037
    otg_id: GCST006480
    pubmed_id: '30152087'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Epidermal growth factor receptor erbB1 inhibitor drug LAPATINIB
        is Phase II for the indiciation EFO_0000519 and targets the gene ENSG00000146648
        at this locus (170431bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000146648
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '7'
      position: 54916280
    locus_GRCh38:
      chromosome: '7'
      position: 54848587
  trait_info:
    ontology:
    - EFO_0000519
    reported_trait_name: Glioblastoma (age-stratified) [Above median age-at-diagnosis]
    standard_trait_name: glioblastoma multiforme
- association_info:
    ancestry:
    - European=24381
    gwas_catalog_id: GCST004349
    neg_log_pval: 33.30102999566398
    otg_id: GCST004349
    pubmed_id: '28346443'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Epidermal growth factor receptor erbB1 binding agent drug DEPATUXIZUMAB
        MAFODOTIN is Phase III for the indiciation EFO_0000519 and targets the gene
        ENSG00000146648 at this locus (170431bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000146648
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '7'
      position: 54916280
    locus_GRCh38:
      chromosome: '7'
      position: 54848587
  trait_info:
    ontology:
    - EFO_0000519
    reported_trait_name: Glioblastoma
    standard_trait_name: glioblastoma multiforme
- association_info:
    ancestry:
    - NR=15094
    gwas_catalog_id: GCST006480
    neg_log_pval: 11.154901959985743
    otg_id: GCST006480_2
    pubmed_id: '30152087'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Epidermal growth factor receptor erbB1 binding agent drug DEPATUXIZUMAB
        MAFODOTIN is Phase III for the indiciation EFO_0000519 and targets the gene
        ENSG00000146648 at this locus (170431bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000146648
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '7'
      position: 54916280
    locus_GRCh38:
      chromosome: '7'
      position: 54848587
  trait_info:
    ontology:
    - EFO_0000519
    reported_trait_name: Glioblastoma (age-stratified) [Below median age-at-diagnosis]
    standard_trait_name: glioblastoma multiforme
- association_info:
    ancestry:
    - European=9218
    gwas_catalog_id: GCST003220
    neg_log_pval: 10.221848749616356
    otg_id: GCST003220
    pubmed_id: '26424050'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Epidermal growth factor receptor erbB1 inhibitor drug LAPATINIB
        is Phase II for the indiciation EFO_0000519 and targets the gene ENSG00000146648
        at this locus (170431bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000146648
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '7'
      position: 54916280
    locus_GRCh38:
      chromosome: '7'
      position: 54848587
  trait_info:
    ontology:
    - EFO_0000519
    reported_trait_name: Glioblastoma
    standard_trait_name: glioblastoma multiforme
- association_info:
    ancestry:
    - European=24381
    gwas_catalog_id: GCST004349
    neg_log_pval: 33.30102999566398
    otg_id: GCST004349
    pubmed_id: '28346443'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Epidermal growth factor receptor erbB1 inhibitor drug LAPATINIB
        is Phase II for the indiciation EFO_0000519 and targets the gene ENSG00000146648
        at this locus (170431bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000146648
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '7'
      position: 54916280
    locus_GRCh38:
      chromosome: '7'
      position: 54848587
  trait_info:
    ontology:
    - EFO_0000519
    reported_trait_name: Glioblastoma
    standard_trait_name: glioblastoma multiforme
- association_info:
    ancestry:
    - NR=15094
    gwas_catalog_id: GCST006480
    neg_log_pval: 11.698970004336019
    otg_id: GCST006480_3
    pubmed_id: '30152087'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Epidermal growth factor receptor erbB1 binding agent drug DEPATUXIZUMAB
        MAFODOTIN is Phase III for the indiciation EFO_0000519 and targets the gene
        ENSG00000146648 at this locus (170431bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000146648
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '7'
      position: 54916280
    locus_GRCh38:
      chromosome: '7'
      position: 54848587
  trait_info:
    ontology:
    - EFO_0000519
    reported_trait_name: Glioblastoma (age-stratified) [Median age-at-diagnosis]
    standard_trait_name: glioblastoma multiforme
- association_info:
    ancestry:
    - European=24381
    gwas_catalog_id: GCST004349
    neg_log_pval: 33.30102999566398
    otg_id: GCST004349
    pubmed_id: '28346443'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Epidermal growth factor receptor erbB1 inhibitor drug MAB-425 is
        Phase II for the indiciation EFO_0000326 and targets the gene ENSG00000146648
        at this locus (170431bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000146648
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '7'
      position: 54916280
    locus_GRCh38:
      chromosome: '7'
      position: 54848587
  trait_info:
    ontology:
    - EFO_0000326
    reported_trait_name: Glioblastoma
    standard_trait_name: central nervous system cancer
- association_info:
    ancestry:
    - European=24009
    gwas_catalog_id: GCST004348
    neg_log_pval: 7.698970004336019
    otg_id: GCST004348
    pubmed_id: '28346443'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Epidermal growth factor receptor erbB1 inhibitor drug MAB-425 is
        Phase II for the indiciation EFO_0000326 and targets the gene ENSG00000146648
        at this locus (170431bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000146648
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '7'
      position: 54916280
    locus_GRCh38:
      chromosome: '7'
      position: 54848587
  trait_info:
    ontology:
    - EFO_0000326
    reported_trait_name: Non-glioblastoma glioma
    standard_trait_name: central nervous system cancer
- association_info:
    ancestry:
    - NR=15094
    gwas_catalog_id: GCST006480
    neg_log_pval: 15.397940008672037
    otg_id: GCST006480
    pubmed_id: '30152087'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Epidermal growth factor receptor erbB1 binding agent drug DEPATUXIZUMAB
        MAFODOTIN is Phase III for the indiciation EFO_0000519 and targets the gene
        ENSG00000146648 at this locus (170431bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000146648
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '7'
      position: 54916280
    locus_GRCh38:
      chromosome: '7'
      position: 54848587
  trait_info:
    ontology:
    - EFO_0000519
    reported_trait_name: Glioblastoma (age-stratified) [Above median age-at-diagnosis]
    standard_trait_name: glioblastoma multiforme
- association_info:
    ancestry:
    - NR=15094
    gwas_catalog_id: GCST006480
    neg_log_pval: 11.698970004336019
    otg_id: GCST006480_3
    pubmed_id: '30152087'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Epidermal growth factor receptor erbB1 inhibitor drug LAPATINIB
        is Phase II for the indiciation EFO_0000519 and targets the gene ENSG00000146648
        at this locus (170431bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000146648
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '7'
      position: 54916280
    locus_GRCh38:
      chromosome: '7'
      position: 54848587
  trait_info:
    ontology:
    - EFO_0000519
    reported_trait_name: Glioblastoma (age-stratified) [Median age-at-diagnosis]
    standard_trait_name: glioblastoma multiforme
- association_info:
    ancestry:
    - European=11582
    gwas_catalog_id: GCST003228
    neg_log_pval: 10.698970004336019
    otg_id: GCST003228
    pubmed_id: '26424050'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Epidermal growth factor receptor erbB1 inhibitor drug MAB-425 is
        Phase II for the indiciation EFO_0000326 and targets the gene ENSG00000146648
        at this locus (170431bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000146648
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '7'
      position: 54916280
    locus_GRCh38:
      chromosome: '7'
      position: 54848587
  trait_info:
    ontology:
    - EFO_0000326
    reported_trait_name: Glioma
    standard_trait_name: central nervous system cancer
- association_info:
    ancestry:
    - European=30659
    gwas_catalog_id: GCST004347
    neg_log_pval: 26.397940008672037
    otg_id: GCST004347
    pubmed_id: '28346443'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Epidermal growth factor receptor erbB1 inhibitor drug MAB-425 is
        Phase II for the indiciation EFO_0000326 and targets the gene ENSG00000146648
        at this locus (170431bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000146648
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '7'
      position: 54916280
    locus_GRCh38:
      chromosome: '7'
      position: 54848587
  trait_info:
    ontology:
    - EFO_0000326
    reported_trait_name: Glioma
    standard_trait_name: central nervous system cancer
- association_info:
    ancestry:
    - European=9218
    gwas_catalog_id: GCST003220
    neg_log_pval: 10.221848749616356
    otg_id: GCST003220
    pubmed_id: '26424050'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Epidermal growth factor receptor erbB1 binding agent drug DEPATUXIZUMAB
        MAFODOTIN is Phase III for the indiciation EFO_0000519 and targets the gene
        ENSG00000146648 at this locus (170431bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000146648
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '7'
      position: 54916280
    locus_GRCh38:
      chromosome: '7'
      position: 54848587
  trait_info:
    ontology:
    - EFO_0000519
    reported_trait_name: Glioblastoma
    standard_trait_name: glioblastoma multiforme
- association_info:
    ancestry:
    - NR=15094
    gwas_catalog_id: GCST006480
    neg_log_pval: 8.698970004336019
    otg_id: GCST006480_3
    pubmed_id: '30152087'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Epidermal growth factor receptor erbB1 inhibitor drug GEFITINIB
        is Phase II for the indiciation EFO_0000519 and targets the gene ENSG00000146648
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000146648
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '7'
      position: 55134872
    locus_GRCh38:
      chromosome: '7'
      position: 55067179
  trait_info:
    ontology:
    - EFO_0000519
    reported_trait_name: Glioblastoma (age-stratified) [Median age-at-diagnosis]
    standard_trait_name: glioblastoma multiforme
- association_info:
    ancestry:
    - European=24381
    gwas_catalog_id: GCST004349
    neg_log_pval: 22.30102999566398
    otg_id: GCST004349
    pubmed_id: '28346443'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Epidermal growth factor receptor erbB1 inhibitor drug GEFITINIB
        is Phase II for the indiciation EFO_0000519 and targets the gene ENSG00000146648
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000146648
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '7'
      position: 55134872
    locus_GRCh38:
      chromosome: '7'
      position: 55067179
  trait_info:
    ontology:
    - EFO_0000519
    reported_trait_name: Glioblastoma
    standard_trait_name: glioblastoma multiforme
- association_info:
    ancestry:
    - European=24381
    gwas_catalog_id: GCST004349
    neg_log_pval: 22.30102999566398
    otg_id: GCST004349
    pubmed_id: '28346443'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Epidermal growth factor receptor erbB1 inhibitor drug NIMOTUZUMAB
        is Phase III for the indiciation EFO_0000519 and targets the gene ENSG00000146648
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000146648
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '7'
      position: 55134872
    locus_GRCh38:
      chromosome: '7'
      position: 55067179
  trait_info:
    ontology:
    - EFO_0000519
    reported_trait_name: Glioblastoma
    standard_trait_name: glioblastoma multiforme
- association_info:
    ancestry:
    - NR=15094
    gwas_catalog_id: GCST006480
    neg_log_pval: 10.698970004336019
    otg_id: GCST006480
    pubmed_id: '30152087'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Epidermal growth factor receptor erbB1 inhibitor drug NIMOTUZUMAB
        is Phase III for the indiciation EFO_0000519 and targets the gene ENSG00000146648
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000146648
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '7'
      position: 55134872
    locus_GRCh38:
      chromosome: '7'
      position: 55067179
  trait_info:
    ontology:
    - EFO_0000519
    reported_trait_name: Glioblastoma (age-stratified) [Above median age-at-diagnosis]
    standard_trait_name: glioblastoma multiforme
- association_info:
    ancestry:
    - NR=15094
    gwas_catalog_id: GCST006480
    neg_log_pval: 10.698970004336019
    otg_id: GCST006480
    pubmed_id: '30152087'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Epidermal growth factor receptor erbB1 inhibitor drug GEFITINIB
        is Phase II for the indiciation EFO_0000519 and targets the gene ENSG00000146648
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000146648
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '7'
      position: 55134872
    locus_GRCh38:
      chromosome: '7'
      position: 55067179
  trait_info:
    ontology:
    - EFO_0000519
    reported_trait_name: Glioblastoma (age-stratified) [Above median age-at-diagnosis]
    standard_trait_name: glioblastoma multiforme
- association_info:
    ancestry:
    - European=24381
    gwas_catalog_id: GCST004349
    neg_log_pval: 22.30102999566398
    otg_id: GCST004349
    pubmed_id: '28346443'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Epidermal growth factor receptor erbB1 inhibitor drug GEFITINIB
        is Phase II for the indiciation EFO_0000326 and targets the gene ENSG00000146648
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000146648
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '7'
      position: 55134872
    locus_GRCh38:
      chromosome: '7'
      position: 55067179
  trait_info:
    ontology:
    - EFO_0000326
    reported_trait_name: Glioblastoma
    standard_trait_name: central nervous system cancer
- association_info:
    ancestry:
    - NR=15094
    gwas_catalog_id: GCST006480
    neg_log_pval: 8.698970004336019
    otg_id: GCST006480_3
    pubmed_id: '30152087'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Epidermal growth factor receptor erbB1 inhibitor drug NIMOTUZUMAB
        is Phase III for the indiciation EFO_0000519 and targets the gene ENSG00000146648
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000146648
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '7'
      position: 55134872
    locus_GRCh38:
      chromosome: '7'
      position: 55067179
  trait_info:
    ontology:
    - EFO_0000519
    reported_trait_name: Glioblastoma (age-stratified) [Median age-at-diagnosis]
    standard_trait_name: glioblastoma multiforme
- association_info:
    ancestry:
    - NR=15094
    gwas_catalog_id: GCST006480
    neg_log_pval: 9.698970004336019
    otg_id: GCST006480
    pubmed_id: '30152087'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Epidermal growth factor receptor erbB1 inhibitor drug GEFITINIB
        is Phase II for the indiciation EFO_0000519 and targets the gene ENSG00000146648
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000146648
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '7'
      position: 55159349
    locus_GRCh38:
      chromosome: '7'
      position: 55091656
  trait_info:
    ontology:
    - EFO_0000519
    reported_trait_name: Glioblastoma (age-stratified) [Above median age-at-diagnosis]
    standard_trait_name: glioblastoma multiforme
- association_info:
    ancestry:
    - NR=15094
    gwas_catalog_id: GCST006480
    neg_log_pval: 9.698970004336019
    otg_id: GCST006480
    pubmed_id: '30152087'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Epidermal growth factor receptor erbB1 inhibitor drug NIMOTUZUMAB
        is Phase III for the indiciation EFO_0000519 and targets the gene ENSG00000146648
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000146648
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '7'
      position: 55159349
    locus_GRCh38:
      chromosome: '7'
      position: 55091656
  trait_info:
    ontology:
    - EFO_0000519
    reported_trait_name: Glioblastoma (age-stratified) [Above median age-at-diagnosis]
    standard_trait_name: glioblastoma multiforme
- association_info:
    ancestry:
    - NR=361315
    - European=446238
    gwas_catalog_id: GCST007342
    neg_log_pval: 13.045757490560675
    otg_id: GCST007342
    pubmed_id: '30718901'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Voltage-gated calcium channel modulator drug PREGABALIN is Phase
        III for the indiciation EFO_0003761 and targets the gene ENSG00000153956 at
        this locus (381311bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000153956
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '7'
      position: 82454404
    locus_GRCh38:
      chromosome: '7'
      position: 82825088
  trait_info:
    ontology:
    - EFO_0003761
    reported_trait_name: Depression
    standard_trait_name: unipolar depression
- association_info:
    ancestry:
    - European=6507
    gwas_catalog_id: GCST004486
    neg_log_pval: 7.522878745280337
    otg_id: GCST004486
    pubmed_id: '28540843'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Voltage-gated calcium channel modulator drug PREGABALIN is Phase
        III for the indiciation EFO_0003761 and targets the gene ENSG00000153956 at
        this locus (395281bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000153956
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: A
    locus_GRCh37:
      chromosome: '7'
      position: 82468374
    locus_GRCh38:
      chromosome: '7'
      position: 82839058
  trait_info:
    ontology:
    - EFO_0003761
    reported_trait_name: Major depressive disorder
    standard_trait_name: unipolar depression
- association_info:
    ancestry:
    - European=6507
    gwas_catalog_id: GCST004486
    neg_log_pval: 7.522878745280337
    otg_id: GCST004486
    pubmed_id: '28540843'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Voltage-gated calcium channel modulator drug PREGABALIN is Phase
        III for the indiciation EFO_0003761 and targets the gene ENSG00000153956 at
        this locus (395281bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000153956
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '7'
      position: 82468374
    locus_GRCh38:
      chromosome: '7'
      position: 82839058
  trait_info:
    ontology:
    - EFO_0003761
    reported_trait_name: Major depressive disorder
    standard_trait_name: unipolar depression
- association_info:
    ancestry:
    - Other=1097
    - NR=150064
    gwas_catalog_id: GCST003048
    neg_log_pval: 10.154901959985743
    otg_id: GCST003048
    pubmed_id: '26198764'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Metabotropic glutamate receptor 3 agonist drug POMAGLUMETAD METHIONIL
        is Phase III for the indiciation EFO_0000692 and targets the gene ENSG00000198822
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000198822
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '7'
      position: 86427626
    locus_GRCh38:
      chromosome: '7'
      position: 86798310
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - East Asian=45528
    gwas_catalog_id: GCST007201
    neg_log_pval: 9.397940008672037
    otg_id: GCST007201
    pubmed_id: '30285260'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Metabotropic glutamate receptor 3 agonist drug POMAGLUMETAD METHIONIL
        is Phase III for the indiciation EFO_0000692 and targets the gene ENSG00000198822
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000198822
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '7'
      position: 86427626
    locus_GRCh38:
      chromosome: '7'
      position: 86798310
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - East Asian=45528
    gwas_catalog_id: GCST007201
    neg_log_pval: 9.522878745280337
    otg_id: GCST007201_2
    pubmed_id: '30285260'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Metabotropic glutamate receptor 3 agonist drug POMAGLUMETAD METHIONIL
        is Phase III for the indiciation EFO_0000692 and targets the gene ENSG00000198822
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000198822
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '7'
      position: 86427626
    locus_GRCh38:
      chromosome: '7'
      position: 86798310
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia [EA]
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - European=105318
    gwas_catalog_id: GCST006803
    neg_log_pval: 13.397940008672037
    otg_id: GCST006803
    pubmed_id: '29483656'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Metabotropic glutamate receptor 3 agonist drug POMAGLUMETAD METHIONIL
        is Phase III for the indiciation EFO_0000692 and targets the gene ENSG00000198822
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000198822
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '7'
      position: 86427626
    locus_GRCh38:
      chromosome: '7'
      position: 86798310
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - European=82315
    - East Asian=5219
    gwas_catalog_id: GCST002539
    neg_log_pval: 9.522878745280337
    otg_id: GCST002539
    pubmed_id: '25056061'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Metabotropic glutamate receptor 3 agonist drug POMAGLUMETAD METHIONIL
        is Phase III for the indiciation EFO_0000692 and targets the gene ENSG00000198822
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000198822
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '7'
      position: 86427626
    locus_GRCh38:
      chromosome: '7'
      position: 86798310
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - European=13574
    - NR=2380
    gwas_catalog_id: GCST004521
    neg_log_pval: 10.0
    otg_id: GCST004521
    pubmed_id: '28540026'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Metabotropic glutamate receptor 3 agonist drug POMAGLUMETAD METHIONIL
        is Phase III for the indiciation EFO_0000692 and targets the gene ENSG00000198822
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000198822
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '7'
      position: 86427626
    locus_GRCh38:
      chromosome: '7'
      position: 86798310
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Autism spectrum disorder or schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - East Asian=26026
    - European=82315
    gwas_catalog_id: GCST004946
    neg_log_pval: 9.522878745280337
    otg_id: GCST004946
    pubmed_id: '28991256'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Metabotropic glutamate receptor 3 agonist drug POMAGLUMETAD METHIONIL
        is Phase III for the indiciation EFO_0000692 and targets the gene ENSG00000198822
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000198822
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '7'
      position: 86427626
    locus_GRCh38:
      chromosome: '7'
      position: 86798310
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - East Asian=45528
    gwas_catalog_id: GCST007201
    neg_log_pval: 7.522878745280337
    otg_id: GCST007201
    pubmed_id: '30285260'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Metabotropic glutamate receptor 3 agonist drug POMAGLUMETAD METHIONIL
        is Phase III for the indiciation EFO_0000692 and targets the gene ENSG00000198822
        at this locus (305241bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000198822
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: T
    locus_GRCh37:
      chromosome: '7'
      position: 86799441
    locus_GRCh38:
      chromosome: '7'
      position: 87170125
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - African unspecified=224
    - European=367
    gwas_catalog_id: GCST005028
    neg_log_pval: 8.0
    otg_id: GCST005028_2
    pubmed_id: '29064472'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Acetylcholinesterase inhibitor drug GALANTAMINE is Phase IV for
        the indiciation EFO_0000692 and targets the gene ENSG00000087085 at this locus
        (200123bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000087085
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '7'
      position: 100287495
    locus_GRCh38:
      chromosome: '7'
      position: 100689872
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Pursuit maintenance gain in psychotic disorders [African]
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - African unspecified=224
    - European=367
    gwas_catalog_id: GCST005028
    neg_log_pval: 8.0
    otg_id: GCST005028_2
    pubmed_id: '29064472'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Acetylcholinesterase inhibitor drug GALANTAMINE is Phase II for
        the indiciation EFO_0005411 and targets the gene ENSG00000087085 at this locus
        (200123bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000087085
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '7'
      position: 100287495
    locus_GRCh38:
      chromosome: '7'
      position: 100689872
  trait_info:
    ontology:
    - EFO_0005411
    reported_trait_name: Pursuit maintenance gain in psychotic disorders [African]
    standard_trait_name: schizoaffective disorder
- association_info:
    ancestry:
    - African unspecified=224
    - European=367
    gwas_catalog_id: GCST005028
    neg_log_pval: 8.0
    otg_id: GCST005028_2
    pubmed_id: '29064472'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Acetylcholinesterase inhibitor drug GALANTAMINE is Phase IV for
        the indiciation EFO_0000289 and targets the gene ENSG00000087085 at this locus
        (200123bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000087085
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '7'
      position: 100287495
    locus_GRCh38:
      chromosome: '7'
      position: 100689872
  trait_info:
    ontology:
    - EFO_0000289
    reported_trait_name: Pursuit maintenance gain in psychotic disorders [African]
    standard_trait_name: bipolar disorder
- association_info:
    ancestry:
    - African unspecified=224
    - European=367
    gwas_catalog_id: GCST005028
    neg_log_pval: 8.0
    otg_id: GCST005028_2
    pubmed_id: '29064472'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Acetylcholinesterase inhibitor drug DONEPEZIL is Phase IV for the
        indiciation EFO_0005411 and targets the gene ENSG00000087085 at this locus
        (200123bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000087085
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '7'
      position: 100287495
    locus_GRCh38:
      chromosome: '7'
      position: 100689872
  trait_info:
    ontology:
    - EFO_0005411
    reported_trait_name: Pursuit maintenance gain in psychotic disorders [African]
    standard_trait_name: schizoaffective disorder
- association_info:
    ancestry:
    - African unspecified=224
    - European=367
    gwas_catalog_id: GCST005028
    neg_log_pval: 8.0
    otg_id: GCST005028_2
    pubmed_id: '29064472'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Acetylcholinesterase inhibitor drug GALANTAMINE is Phase II for
        the indiciation EFO_0005411 and targets the gene ENSG00000087085 at this locus
        (188633bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000087085
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '7'
      position: 100298984
    locus_GRCh38:
      chromosome: '7'
      position: 100701361
  trait_info:
    ontology:
    - EFO_0005411
    reported_trait_name: Pursuit maintenance gain in psychotic disorders [African]
    standard_trait_name: schizoaffective disorder
- association_info:
    ancestry:
    - African unspecified=224
    - European=367
    gwas_catalog_id: GCST005028
    neg_log_pval: 8.0
    otg_id: GCST005028_2
    pubmed_id: '29064472'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Acetylcholinesterase inhibitor drug GALANTAMINE is Phase IV for
        the indiciation EFO_0000692 and targets the gene ENSG00000087085 at this locus
        (188633bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000087085
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '7'
      position: 100298984
    locus_GRCh38:
      chromosome: '7'
      position: 100701361
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: Pursuit maintenance gain in psychotic disorders [African]
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - African unspecified=224
    - European=367
    gwas_catalog_id: GCST005028
    neg_log_pval: 8.0
    otg_id: GCST005028_2
    pubmed_id: '29064472'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Acetylcholinesterase inhibitor drug GALANTAMINE is Phase IV for
        the indiciation EFO_0000289 and targets the gene ENSG00000087085 at this locus
        (188633bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000087085
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '7'
      position: 100298984
    locus_GRCh38:
      chromosome: '7'
      position: 100701361
  trait_info:
    ontology:
    - EFO_0000289
    reported_trait_name: Pursuit maintenance gain in psychotic disorders [African]
    standard_trait_name: bipolar disorder
- association_info:
    ancestry:
    - African unspecified=224
    - European=367
    gwas_catalog_id: GCST005028
    neg_log_pval: 8.0
    otg_id: GCST005028_2
    pubmed_id: '29064472'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Acetylcholinesterase inhibitor drug DONEPEZIL is Phase IV for the
        indiciation EFO_0005411 and targets the gene ENSG00000087085 at this locus
        (188633bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000087085
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '7'
      position: 100298984
    locus_GRCh38:
      chromosome: '7'
      position: 100701361
  trait_info:
    ontology:
    - EFO_0005411
    reported_trait_name: Pursuit maintenance gain in psychotic disorders [African]
    standard_trait_name: schizoaffective disorder
- association_info:
    ancestry:
    - European=139274
    gwas_catalog_id: GCST004988
    neg_log_pval: 15.979638717352293
    otg_id: GCST004988
    pubmed_id: '29059683'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Serine/threonine-protein kinase B-raf inhibitor drug SORAFENIB
        is Phase III for the indiciation EFO_0000305 and targets the gene ENSG00000157764
        at this locus (476824bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000157764
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '7'
      position: 139942304
    locus_GRCh38:
      chromosome: '7'
      position: 140242504
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast cancer
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - European=1030836
    gwas_catalog_id: GCST006414
    neg_log_pval: 10.674484336636851
    otg_id: GCST006414
    pubmed_id: '30061737'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: HERG blocker drug AMIODARONE is Phase IV for the indiciation EFO_0000275
        and targets the gene ENSG00000055118 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000055118
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '7'
      position: 150661409
    locus_GRCh38:
      chromosome: '7'
      position: 150964321
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=537409
    - East Asian=36792
    - African American or Afro-Caribbean=8967
    - Hispanic or Latin American=5022
    gwas_catalog_id: GCST006061
    neg_log_pval: 10.045757490560675
    otg_id: GCST006061_3
    pubmed_id: '29892015'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: HERG blocker drug AZD7009 is Phase II for the indiciation EFO_0000275
        and targets the gene ENSG00000055118 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000055118
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '7'
      position: 150661409
    locus_GRCh38:
      chromosome: '7'
      position: 150964321
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation [EA]
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=537409
    - East Asian=36792
    - African American or Afro-Caribbean=8967
    - Hispanic or Latin American=5022
    gwas_catalog_id: GCST006061
    neg_log_pval: 9.154901959985743
    otg_id: GCST006061
    pubmed_id: '29892015'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: HERG blocker drug AMIODARONE is Phase IV for the indiciation EFO_0000275
        and targets the gene ENSG00000055118 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000055118
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '7'
      position: 150661409
    locus_GRCh38:
      chromosome: '7'
      position: 150964321
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=537409
    - East Asian=36792
    - African American or Afro-Caribbean=8967
    - Hispanic or Latin American=5022
    gwas_catalog_id: GCST006061
    neg_log_pval: 9.154901959985743
    otg_id: GCST006061
    pubmed_id: '29892015'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: HERG blocker drug AZD7009 is Phase II for the indiciation EFO_0000275
        and targets the gene ENSG00000055118 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000055118
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '7'
      position: 150661409
    locus_GRCh38:
      chromosome: '7'
      position: 150964321
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=1030836
    gwas_catalog_id: GCST006414
    neg_log_pval: 10.674484336636851
    otg_id: GCST006414
    pubmed_id: '30061737'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: HERG blocker drug AZD7009 is Phase II for the indiciation EFO_0000275
        and targets the gene ENSG00000055118 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000055118
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '7'
      position: 150661409
    locus_GRCh38:
      chromosome: '7'
      position: 150964321
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=537409
    - East Asian=36792
    - African American or Afro-Caribbean=8967
    - Hispanic or Latin American=5022
    gwas_catalog_id: GCST006061
    neg_log_pval: 10.045757490560675
    otg_id: GCST006061_3
    pubmed_id: '29892015'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: HERG blocker drug AMIODARONE is Phase IV for the indiciation EFO_0000275
        and targets the gene ENSG00000055118 at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000055118
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '7'
      position: 150661409
    locus_GRCh38:
      chromosome: '7'
      position: 150964321
  trait_info:
    ontology:
    - EFO_0000275
    reported_trait_name: Atrial fibrillation [EA]
    standard_trait_name: atrial fibrillation
- association_info:
    ancestry:
    - European=459000
    gwas_catalog_id: GCST007072
    neg_log_pval: 48.69897000433602
    otg_id: GCST007072
    pubmed_id: '30595370'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: HERG blocker drug SOTALOL is Phase IV for the indiciation EFO_0000319
        and targets the gene ENSG00000055118 at this locus (14774bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000055118
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '7'
      position: 150690176
    locus_GRCh38:
      chromosome: '7'
      position: 150993088
  trait_info:
    ontology:
    - EFO_0000319
    reported_trait_name: Cardiovascular disease
    standard_trait_name: cardiovascular system disease
- association_info:
    ancestry:
    - European=241704
    gwas_catalog_id: GCST004483
    neg_log_pval: 8.0
    otg_id: GCST004483
    pubmed_id: '27363682'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Cyclin-dependent kinase 5 inhibitor drug DINACICLIB is Phase II
        for the indiciation EFO_0001378 and targets the gene ENSG00000164885 at this
        locus (195958bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000164885
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '7'
      position: 150950940
    locus_GRCh38:
      chromosome: '7'
      position: 151253854
  trait_info:
    ontology:
    - EFO_0001378
    reported_trait_name: Multiple myeloma
    standard_trait_name: multiple myeloma
- association_info:
    ancestry:
    - European=33394
    gwas_catalog_id: GCST005527
    neg_log_pval: 7.481235531320022
    otg_id: GCST005527
    pubmed_id: '23143594'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tyrosine-protein kinase JAK2 inhibitor drug RUXOLITINIB is Phase
        II for the indiciation EFO_0000676 and targets the gene ENSG00000096968 at
        this locus (12463bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000096968
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '9'
      position: 4971927
    locus_GRCh38:
      chromosome: '9'
      position: 4971927
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Psoriasis
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=86475
    gwas_catalog_id: GCST005537
    neg_log_pval: 42.30102999566398
    otg_id: GCST005537
    pubmed_id: '26974007'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tyrosine-protein kinase JAK2 inhibitor drug RUXOLITINIB is Phase
        II for the indiciation EFO_0000676 and targets the gene ENSG00000096968 at
        this locus (2788bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000096968
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '9'
      position: 4981602
    locus_GRCh38:
      chromosome: '9'
      position: 4981602
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: Chronic inflammatory diseases (ankylosing spondylitis, Crohn's
      disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
      [subset analysis]
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - East Asian=5057
    - European=10995
    gwas_catalog_id: GCST003622
    neg_log_pval: 16.69897000433602
    otg_id: GCST003622
    pubmed_id: '27399966'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Tyrosine-protein kinase JAK2 inhibitor drug BARICITINIB is Phase
        III for the indiciation EFO_0002690 and targets the gene ENSG00000096968 at
        this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000096968
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '9'
      position: 4984530
    locus_GRCh38:
      chromosome: '9'
      position: 4984530
  trait_info:
    ontology:
    - EFO_0002690
    reported_trait_name: Systemic lupus erythematosus
    standard_trait_name: systemic lupus erythematosus
- association_info:
    ancestry:
    - East Asian=5057
    - European=10995
    gwas_catalog_id: GCST003622
    neg_log_pval: 13.397940008672037
    otg_id: GCST003622_2
    pubmed_id: '27399966'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Tyrosine-protein kinase JAK2 inhibitor drug BARICITINIB is Phase
        III for the indiciation EFO_0002690 and targets the gene ENSG00000096968 at
        this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000096968
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '9'
      position: 4984530
    locus_GRCh38:
      chromosome: '9'
      position: 4984530
  trait_info:
    ontology:
    - EFO_0002690
    reported_trait_name: Systemic lupus erythematosus [Chinese]
    standard_trait_name: systemic lupus erythematosus
- association_info:
    ancestry:
    - European=401535
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 16.707743928643524
    otg_id: SAIGE_200_1
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Tyrosine-protein kinase JAK2 inhibitor drug RUXOLITINIB is Phase
        IV for the indiciation EFO_0002429 and targets the gene ENSG00000096968 at
        this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000096968
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '9'
      position: 5049092
    locus_GRCh38:
      chromosome: '9'
      position: 5049092
  trait_info:
    ontology:
    - EFO_0002429
    reported_trait_name: Polycythemia vera
    standard_trait_name: polycythemia vera
- association_info:
    ancestry:
    - European=401535
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 16.707743928643524
    otg_id: SAIGE_200_1
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tyrosine-protein kinase JAK2 inhibitor drug LESTAURTINIB is Phase
        II for the indiciation EFO_0002429 and targets the gene ENSG00000096968 at
        this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000096968
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '9'
      position: 5049092
    locus_GRCh38:
      chromosome: '9'
      position: 5049092
  trait_info:
    ontology:
    - EFO_0002429
    reported_trait_name: Polycythemia vera
    standard_trait_name: polycythemia vera
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 19.559482903933304
    otg_id: NEALE2_20002_1438
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Tyrosine-protein kinase JAK2 inhibitor drug RUXOLITINIB is Phase
        IV for the indiciation EFO_0002429 and targets the gene ENSG00000096968 at
        this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000096968
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '9'
      position: 5049092
    locus_GRCh38:
      chromosome: '9'
      position: 5049092
  trait_info:
    ontology:
    - EFO_0002429
    reported_trait_name: Polycythaemia vera | non-cancer illness code, self-reported
    standard_trait_name: polycythemia vera
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 19.559482903933304
    otg_id: NEALE2_20002_1438
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tyrosine-protein kinase JAK2 inhibitor drug LESTAURTINIB is Phase
        II for the indiciation EFO_0002429 and targets the gene ENSG00000096968 at
        this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000096968
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '9'
      position: 5049092
    locus_GRCh38:
      chromosome: '9'
      position: 5049092
  trait_info:
    ontology:
    - EFO_0002429
    reported_trait_name: Polycythaemia vera | non-cancer illness code, self-reported
    standard_trait_name: polycythemia vera
- association_info:
    ancestry:
    - European=3198
    gwas_catalog_id: GCST002840
    neg_log_pval: 10.0
    otg_id: GCST002840
    pubmed_id: '25849990'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tyrosine-protein kinase JAK2 inhibitor drug PACRITINIB is Phase
        II for the indiciation EFO_0004251 and targets the gene ENSG00000096968 at
        this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000096968
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '9'
      position: 5063296
    locus_GRCh38:
      chromosome: '9'
      position: 5063296
  trait_info:
    ontology:
    - EFO_0004251
    reported_trait_name: Myeloproliferative neoplasms
    standard_trait_name: myeloproliferative disorder
- association_info:
    ancestry:
    - European=3198
    gwas_catalog_id: GCST002840
    neg_log_pval: 10.0
    otg_id: GCST002840
    pubmed_id: '25849990'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Tyrosine-protein kinase JAK2 inhibitor drug RUXOLITINIB is Phase
        III for the indiciation EFO_0004251 and targets the gene ENSG00000096968 at
        this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000096968
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '9'
      position: 5063296
    locus_GRCh38:
      chromosome: '9'
      position: 5063296
  trait_info:
    ontology:
    - EFO_0004251
    reported_trait_name: Myeloproliferative neoplasms
    standard_trait_name: myeloproliferative disorder
- association_info:
    ancestry:
    - European=3323
    gwas_catalog_id: GCST000357
    neg_log_pval: 19.397940008672037
    otg_id: GCST000357
    pubmed_id: '19287384'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Tyrosine-protein kinase JAK2 inhibitor drug RUXOLITINIB is Phase
        III for the indiciation EFO_0004251 and targets the gene ENSG00000096968 at
        this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000096968
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '9'
      position: 5070831
    locus_GRCh38:
      chromosome: '9'
      position: 5070831
  trait_info:
    ontology:
    - EFO_0004251
    reported_trait_name: Myeloproliferative neoplasms
    standard_trait_name: myeloproliferative disorder
- association_info:
    ancestry:
    - European=3323
    gwas_catalog_id: GCST000357
    neg_log_pval: 19.397940008672037
    otg_id: GCST000357
    pubmed_id: '19287384'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tyrosine-protein kinase JAK2 inhibitor drug PACRITINIB is Phase
        II for the indiciation EFO_0004251 and targets the gene ENSG00000096968 at
        this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000096968
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '9'
      position: 5070831
    locus_GRCh38:
      chromosome: '9'
      position: 5070831
  trait_info:
    ontology:
    - EFO_0004251
    reported_trait_name: Myeloproliferative neoplasms
    standard_trait_name: myeloproliferative disorder
- association_info:
    ancestry:
    - European=86475
    gwas_catalog_id: GCST005537
    neg_log_pval: 8.221848749616356
    otg_id: GCST005537
    pubmed_id: '26974007'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Sigma opioid receptor agonist drug DEXTROMETHORPHAN is Phase IV
        for the indiciation EFO_0000729 and targets the gene ENSG00000147955 at this
        locus (72455bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000147955
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '9'
      position: 34710260
    locus_GRCh38:
      chromosome: '9'
      position: 34710263
  trait_info:
    ontology:
    - EFO_0000729
    reported_trait_name: Chronic inflammatory diseases (ankylosing spondylitis, Crohn's
      disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
      [subset analysis]
    standard_trait_name: ulcerative colitis
- association_info:
    ancestry:
    - European=86475
    gwas_catalog_id: GCST005537
    neg_log_pval: 8.221848749616356
    otg_id: GCST005537
    pubmed_id: '26974007'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Sigma opioid receptor agonist drug DEXTROMETHORPHAN is Phase IV
        for the indiciation EFO_0000384 and targets the gene ENSG00000147955 at this
        locus (72455bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000147955
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '9'
      position: 34710260
    locus_GRCh38:
      chromosome: '9'
      position: 34710263
  trait_info:
    ontology:
    - EFO_0000384
    reported_trait_name: Chronic inflammatory diseases (ankylosing spondylitis, Crohn's
      disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)
      [subset analysis]
    standard_trait_name: Crohn's disease
- association_info:
    ancestry:
    - European=116538
    gwas_catalog_id: GCST007564
    neg_log_pval: 10.096910013008056
    otg_id: GCST007564
    pubmed_id: '29785011'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Sigma opioid receptor agonist drug DEXTROMETHORPHAN is Phase IV
        for the indiciation EFO_0000270 and targets the gene ENSG00000147955 at this
        locus (251638bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000147955
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '9'
      position: 34889444
    locus_GRCh38:
      chromosome: '9'
      position: 34889447
  trait_info:
    ontology:
    - EFO_0000270
    reported_trait_name: Asthma or allergic disease (pleiotropy)
    standard_trait_name: asthma
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 14.698970004336019
    otg_id: NEALE2_20002_1473
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: ATP-binding cassette sub-family A member 1 inhibitor drug PROBUCOL
        is Phase IV for the indiciation HP_0003124 and targets the gene ENSG00000165029
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000165029
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '9'
      position: 107664301
    locus_GRCh38:
      chromosome: '9'
      position: 104902020
  trait_info:
    ontology:
    - HP_0003124
    reported_trait_name: High cholesterol | non-cancer illness code, self-reported
    standard_trait_name: Hypercholesterolemia
- association_info:
    ancestry:
    - European=408878
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 7.73754891026957
    otg_id: SAIGE_272_1
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: ATP-binding cassette sub-family A member 1 inhibitor drug PROBUCOL
        is Phase IV for the indiciation EFO_0003774 and targets the gene ENSG00000165029
        at this locus (0bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000165029
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '9'
      position: 107665978
    locus_GRCh38:
      chromosome: '9'
      position: 104903697
  trait_info:
    ontology:
    - EFO_0003774
    reported_trait_name: Hyperlipidemia
    standard_trait_name: hyperlipidemia
- association_info:
    ancestry:
    - European=38053
    gwas_catalog_id: GCST000987
    neg_log_pval: 10.397940008672037
    otg_id: GCST000987
    pubmed_id: '21383967'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Complement C5 inhibitor drug ECULIZUMAB is Phase IV for the indiciation
        EFO_0000540 and targets the gene ENSG00000106804 at this locus (74113bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000106804
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '9'
      position: 123640500
    locus_GRCh38:
      chromosome: '9'
      position: 120878222
  trait_info:
    ontology:
    - EFO_0000540
    reported_trait_name: Celiac disease or Rheumatoid arthritis
    standard_trait_name: immune system disease
- association_info:
    ancestry:
    - European=314072
    neg_log_pval: 7.955550400347374
    otg_id: NEALE2_20107_3
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Tyrosine-protein kinase ABL inhibitor drug IMATINIB is Phase II
        for the indiciation EFO_0001071 and targets the gene ENSG00000097007 at this
        locus (238206bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000097007
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: GT
    locus_GRCh37:
      chromosome: '9'
      position: 133351128
    locus_GRCh38:
      chromosome: '9'
      position: 130475741
  trait_info:
    ontology:
    - EFO_0001071
    reported_trait_name: Lung cancer | illnesses of father
    standard_trait_name: lung carcinoma
- association_info:
    ancestry:
    - European=1125
    gwas_catalog_id: GCST000250
    neg_log_pval: 10.301029995663981
    otg_id: GCST000250
    pubmed_id: '18849991'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Androgen Receptor antagonist drug CB-03-01 is Phase II for the
        indiciation EFO_0004191 and targets the gene ENSG00000169083 at this locus
        (252890bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169083
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: X
      position: 66510984
    locus_GRCh38:
      chromosome: X
      position: 67291142
  trait_info:
    ontology:
    - EFO_0004191
    reported_trait_name: Male-pattern baldness
    standard_trait_name: androgenetic alopecia
- association_info:
    ancestry:
    - European=1198
    gwas_catalog_id: GCST001297
    neg_log_pval: 21.522878745280337
    otg_id: GCST001297
    pubmed_id: '22032556'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Androgen Receptor antagonist drug CB-03-01 is Phase II for the
        indiciation EFO_0004191 and targets the gene ENSG00000169083 at this locus
        (200857bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169083
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: X
      position: 66563018
    locus_GRCh38:
      chromosome: X
      position: 67343176
  trait_info:
    ontology:
    - EFO_0004191
    reported_trait_name: Male-pattern baldness
    standard_trait_name: androgenetic alopecia
- association_info:
    ancestry:
    - European=12806
    gwas_catalog_id: GCST001548
    neg_log_pval: 90.69897000433602
    otg_id: GCST001548
    pubmed_id: '22693459'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Androgen Receptor antagonist drug CB-03-01 is Phase II for the
        indiciation EFO_0004191 and targets the gene ENSG00000169083 at this locus
        (200857bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169083
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: X
      position: 66563018
    locus_GRCh38:
      chromosome: X
      position: 67343176
  trait_info:
    ontology:
    - EFO_0004191
    reported_trait_name: Male-pattern baldness
    standard_trait_name: androgenetic alopecia
- association_info:
    ancestry:
    - European=13560
    gwas_catalog_id: GCST001148
    neg_log_pval: 8.0
    otg_id: GCST001148
    pubmed_id: '21743467'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Androgen Receptor antagonist drug CYPROTERONE ACETATE is Phase
        III for the indiciation EFO_0001663 and targets the gene ENSG00000169083 at
        this locus (71090bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169083
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: X
      position: 67021550
    locus_GRCh38:
      chromosome: X
      position: 67801708
  trait_info:
    ontology:
    - EFO_0001663
    reported_trait_name: Prostate cancer
    standard_trait_name: prostate carcinoma
- association_info:
    ancestry:
    - European=13560
    gwas_catalog_id: GCST001148
    neg_log_pval: 8.0
    otg_id: GCST001148
    pubmed_id: '21743467'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Androgen Receptor antagonist drug ABIRATERONE is Phase IV for the
        indiciation EFO_0001663 and targets the gene ENSG00000169083 at this locus
        (71090bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169083
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: X
      position: 67021550
    locus_GRCh38:
      chromosome: X
      position: 67801708
  trait_info:
    ontology:
    - EFO_0001663
    reported_trait_name: Prostate cancer
    standard_trait_name: prostate carcinoma
- association_info:
    ancestry:
    - European=13560
    gwas_catalog_id: GCST001148
    neg_log_pval: 8.0
    otg_id: GCST001148
    pubmed_id: '21743467'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Androgen Receptor agonist drug TESTOSTERONE ENANTHATE is Phase
        II for the indiciation EFO_0001663 and targets the gene ENSG00000169083 at
        this locus (71090bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169083
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: X
      position: 67021550
    locus_GRCh38:
      chromosome: X
      position: 67801708
  trait_info:
    ontology:
    - EFO_0001663
    reported_trait_name: Prostate cancer
    standard_trait_name: prostate carcinoma
- association_info:
    ancestry:
    - European=140254
    gwas_catalog_id: GCST006085
    neg_log_pval: 9.0
    otg_id: GCST006085
    pubmed_id: '29892016'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: High
      curated_by: Ed Mountjoy
      description: Androgen Receptor antagonist drug ABIRATERONE is Phase IV for the
        indiciation EFO_0001663 and targets the gene ENSG00000169083 at this locus
        (71090bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169083
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_IV
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_IV
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: X
      position: 67021550
    locus_GRCh38:
      chromosome: X
      position: 67801708
  trait_info:
    ontology:
    - EFO_0001663
    reported_trait_name: Prostate cancer
    standard_trait_name: prostate carcinoma
- association_info:
    ancestry:
    - European=140254
    gwas_catalog_id: GCST006085
    neg_log_pval: 9.0
    otg_id: GCST006085
    pubmed_id: '29892016'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Androgen Receptor agonist drug TESTOSTERONE ENANTHATE is Phase
        II for the indiciation EFO_0001663 and targets the gene ENSG00000169083 at
        this locus (71090bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169083
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: X
      position: 67021550
    locus_GRCh38:
      chromosome: X
      position: 67801708
  trait_info:
    ontology:
    - EFO_0001663
    reported_trait_name: Prostate cancer
    standard_trait_name: prostate carcinoma
- association_info:
    ancestry:
    - European=140254
    gwas_catalog_id: GCST006085
    neg_log_pval: 9.0
    otg_id: GCST006085
    pubmed_id: '29892016'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Medium
      curated_by: Ed Mountjoy
      description: Androgen Receptor antagonist drug CYPROTERONE ACETATE is Phase
        III for the indiciation EFO_0001663 and targets the gene ENSG00000169083 at
        this locus (71090bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169083
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_III
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_III
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: X
      position: 67021550
    locus_GRCh38:
      chromosome: X
      position: 67801708
  trait_info:
    ontology:
    - EFO_0001663
    reported_trait_name: Prostate cancer
    standard_trait_name: prostate carcinoma
- association_info:
    ancestry:
    - European=43590
    gwas_catalog_id: GCST005116
    neg_log_pval: 34.52287874528034
    otg_id: GCST005116
    pubmed_id: '29146897'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Androgen Receptor antagonist drug CB-03-01 is Phase II for the
        indiciation EFO_0004191 and targets the gene ENSG00000169083 at this locus
        (413341bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000169083
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: X
      position: 67363801
    locus_GRCh38:
      chromosome: X
      position: 68143959
  trait_info:
    ontology:
    - EFO_0004191
    reported_trait_name: Male-pattern baldness
    standard_trait_name: androgenetic alopecia
- association_info:
    ancestry:
    - European=16753
    gwas_catalog_id: GCST003097
    neg_log_pval: 8.0
    otg_id: GCST003097
    pubmed_id: '26301688'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: CD40 ligand inhibitor drug DAPIROLIZUMAB PEGOL is Phase II for
        the indiciation EFO_0002690 and targets the gene ENSG00000102245 at this locus
        (64575bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000102245
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: X
      position: 135665778
    locus_GRCh38:
      chromosome: X
      position: 136583619
  trait_info:
    ontology:
    - EFO_0002690
    reported_trait_name: Pediatric autoimmune diseases
    standard_trait_name: systemic lupus erythematosus
- association_info:
    ancestry:
    - European=258962
    gwas_catalog_id: GCST003390
    neg_log_pval: 12.154901959985743
    otg_id: GCST003390
    pubmed_id: '26908601'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Coagulation factor VIII inhibitor drug DROTRECOGIN ALFA (ACTIVATED)
        is Phase II for the indiciation EFO_0003827 and targets the gene ENSG00000185010
        at this locus (23583bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000185010
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: X
      position: 154278797
    locus_GRCh38:
      chromosome: X
      position: 155050522
  trait_info:
    ontology:
    - EFO_0003827
    reported_trait_name: Thrombosis
    standard_trait_name: pulmonary embolism
- association_info:
    ancestry:
    - European=258962
    gwas_catalog_id: GCST003390
    neg_log_pval: 12.154901959985743
    otg_id: GCST003390
    pubmed_id: '26908601'
  gold_standard_info:
    evidence:
    - class: drug
      confidence: Low
      curated_by: Ed Mountjoy
      description: Coagulation factor VIII inhibitor drug TB-402 is Phase II for the
        indiciation EFO_0004286 and targets the gene ENSG00000185010 at this locus
        (23583bp away).
      source: ChEMBL - Open Targets Evidence 19.06
    gene_id: ENSG00000185010
    highest_confidence: Low
  metadata:
    comments: Gold-standard derived from drug-indication pairs in ChEMBL
    date_added: '2019-07-29'
    reviewed_by: Ed Mountjoy
    set_label: ChEMBL_II
    submitted_by: Ed Mountjoy
    tags:
    - drug
    - ChEMBL
    - ChEMBL_II
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: X
      position: 154278797
    locus_GRCh38:
      chromosome: X
      position: 155050522
  trait_info:
    ontology:
    - EFO_0004286
    reported_trait_name: Thrombosis
    standard_trait_name: venous thromboembolism
- association_info:
    ancestry:
    - European=407701
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 8.20690839982342
    otg_id: SAIGE_250_2
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000183049 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000183049 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000183049
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '10'
      position: 12250620
    locus_GRCh38:
      chromosome: '10'
      position: 12208621
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - East Asian=191764
    gwas_catalog_id: GCST007847
    neg_log_pval: 26.096910013008056
    otg_id: GCST007847
    pubmed_id: '30718926'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000183049 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000183049 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000183049
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '10'
      position: 12302607
    locus_GRCh38:
      chromosome: '10'
      position: 12260608
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=655666
    - South Asian=3650
    gwas_catalog_id: GCST006867
    neg_log_pval: 16.69897000433602
    otg_id: GCST006867
    pubmed_id: '30054458'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000183049 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000183049 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000183049
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 12307894
    locus_GRCh38:
      chromosome: '10'
      position: 12265895
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=70127
    gwas_catalog_id: GCST005413
    neg_log_pval: 9.42712839779952
    otg_id: GCST005413
    pubmed_id: '29358691'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000183049 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000183049 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000183049
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 12307894
    locus_GRCh38:
      chromosome: '10'
      position: 12265895
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=459000
    gwas_catalog_id: GCST007077
    neg_log_pval: 13.397940008672037
    otg_id: GCST007077
    pubmed_id: '30595370'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000183049 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000183049 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000183049
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 12307894
    locus_GRCh38:
      chromosome: '10'
      position: 12265895
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - East Asian=41646
    gwas_catalog_id: GCST003400
    neg_log_pval: 12.0
    otg_id: GCST003400_2
    pubmed_id: '26818947'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000183049 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000183049 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000183049
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 12307894
    locus_GRCh38:
      chromosome: '10'
      position: 12265895
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes [Japanese]
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - East Asian=3712
    gwas_catalog_id: GCST001666
    neg_log_pval: 8.154901959985743
    otg_id: GCST001666
    pubmed_id: '22961080'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000183049 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000183049 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000183049
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 12307894
    locus_GRCh38:
      chromosome: '10'
      position: 12265895
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=69033
    - East Asian=18817
    - South Asian=20019
    - Hispanic or Latin American=2583
    gwas_catalog_id: GCST002352
    neg_log_pval: 8.522878745280337
    otg_id: GCST002352
    pubmed_id: '24509480'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000183049 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000183049 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000183049
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 12307894
    locus_GRCh38:
      chromosome: '10'
      position: 12265895
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - South Asian=13532
    - European=20298
    - NR=149821
    gwas_catalog_id: GCST004894
    neg_log_pval: 28.522878745280337
    otg_id: GCST004894
    pubmed_id: '28869590'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000183049 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000183049 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000183049
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 12307894
    locus_GRCh38:
      chromosome: '10'
      position: 12265895
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - South Asian=13532
    - European=20298
    - NR=149821
    gwas_catalog_id: GCST004894
    neg_log_pval: 9.522878745280337
    otg_id: GCST004894_2
    pubmed_id: '28869590'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000183049 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000183049 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000183049
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 12307894
    locus_GRCh38:
      chromosome: '10'
      position: 12265895
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes [EA]
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - East Asian=2729
    gwas_catalog_id: GCST000796
    neg_log_pval: 8.0
    otg_id: GCST000796
    pubmed_id: '20862305'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000183049 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000183049 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000183049
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '10'
      position: 12314997
    locus_GRCh38:
      chromosome: '10'
      position: 12272998
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=10128
    gwas_catalog_id: GCST000167
    neg_log_pval: 10.0
    otg_id: GCST000167
    pubmed_id: '18372903'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000183049 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000183049 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000183049
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '10'
      position: 12328010
    locus_GRCh38:
      chromosome: '10'
      position: 12286011
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - East Asian=191764
    gwas_catalog_id: GCST007847
    neg_log_pval: 8.522878745280337
    otg_id: GCST007847
    pubmed_id: '30718926'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000122859
        at this locus. There is a single line of pertubation evidence (3P) linking
        T2D to ENSG00000122859 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000122859
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '10'
      position: 71273357
    locus_GRCh38:
      chromosome: '10'
      position: 69513601
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=459000
    gwas_catalog_id: GCST007077
    neg_log_pval: 8.522878745280337
    otg_id: GCST007077
    pubmed_id: '30595370'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000122859
        at this locus. There is a single line of pertubation evidence (3P) linking
        T2D to ENSG00000122859 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000122859
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 71332301
    locus_GRCh38:
      chromosome: '10'
      position: 69572545
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=70127
    gwas_catalog_id: GCST005413
    neg_log_pval: 8.073297505817354
    otg_id: GCST005413
    pubmed_id: '29358691'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000122859
        at this locus. There is a single line of pertubation evidence (3P) linking
        T2D to ENSG00000122859 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000122859
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '10'
      position: 71465928
    locus_GRCh38:
      chromosome: '10'
      position: 69706172
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=655666
    - South Asian=3650
    gwas_catalog_id: GCST006867
    neg_log_pval: 8.154901959985743
    otg_id: GCST006867
    pubmed_id: '30054458'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000122859
        at this locus. There is a single line of pertubation evidence (3P) linking
        T2D to ENSG00000122859 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000122859
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '10'
      position: 71469514
    locus_GRCh38:
      chromosome: '10'
      position: 69709758
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - South Asian=13532
    - European=20298
    - NR=149821
    gwas_catalog_id: GCST004894
    neg_log_pval: 10.522878745280337
    otg_id: GCST004894_2
    pubmed_id: '28869590'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000108175 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000108175 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000108175
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '10'
      position: 80942631
    locus_GRCh38:
      chromosome: '10'
      position: 79182874
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes [EA]
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=69033
    - East Asian=18817
    - South Asian=20019
    - Hispanic or Latin American=2583
    gwas_catalog_id: GCST002352
    neg_log_pval: 9.698970004336019
    otg_id: GCST002352
    pubmed_id: '24509480'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000108175 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000108175 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000108175
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '10'
      position: 80942631
    locus_GRCh38:
      chromosome: '10'
      position: 79182874
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - South Asian=13532
    - European=20298
    - NR=149821
    gwas_catalog_id: GCST004894
    neg_log_pval: 19.69897000433602
    otg_id: GCST004894
    pubmed_id: '28869590'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000108175 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000108175 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000108175
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '10'
      position: 80942631
    locus_GRCh38:
      chromosome: '10'
      position: 79182874
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=69033
    gwas_catalog_id: GCST005047
    neg_log_pval: 9.619788758288394
    otg_id: GCST005047
    pubmed_id: '22885922'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000108175 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000108175 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000108175
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '10'
      position: 80942631
    locus_GRCh38:
      chromosome: '10'
      position: 79182874
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - East Asian=41646
    gwas_catalog_id: GCST003400
    neg_log_pval: 7.522878745280337
    otg_id: GCST003400_2
    pubmed_id: '26818947'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000108175 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000108175 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000108175
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '10'
      position: 80943841
    locus_GRCh38:
      chromosome: '10'
      position: 79184084
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes [Japanese]
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=459000
    gwas_catalog_id: GCST007077
    neg_log_pval: 14.221848749616356
    otg_id: GCST007077
    pubmed_id: '30595370'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000108175 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000108175 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000108175
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '10'
      position: 80952826
    locus_GRCh38:
      chromosome: '10'
      position: 79193069
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=407701
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 15.025949097207123
    otg_id: SAIGE_250_2
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000108175 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000108175 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000108175
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 80954785
    locus_GRCh38:
      chromosome: '10'
      position: 79195028
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=655666
    - South Asian=3650
    gwas_catalog_id: GCST006867
    neg_log_pval: 10.522878745280337
    otg_id: GCST006867
    pubmed_id: '30054458'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000108175 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000108175 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000108175
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '10'
      position: 80964975
    locus_GRCh38:
      chromosome: '10'
      position: 79205218
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=459000
    gwas_catalog_id: GCST007077
    neg_log_pval: 10.698970004336019
    otg_id: GCST007077
    pubmed_id: '30595370'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000148737 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000148737 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000148737
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 114737777
    locus_GRCh38:
      chromosome: '10'
      position: 112978018
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=455607
    gwas_catalog_id: GCST006868
    neg_log_pval: 10.397940008672037
    otg_id: GCST006868
    pubmed_id: '30054458'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000148737 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000148737 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000148737
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 114737777
    locus_GRCh38:
      chromosome: '10'
      position: 112978018
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=56799
    - African American or Afro-Caribbean=3571
    - East Asian=4735
    - Hispanic or Latin American=6499
    gwas_catalog_id: GCST003619
    neg_log_pval: 52.221848749616356
    otg_id: GCST003619
    pubmed_id: '27189021'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000148737 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000148737 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000148737
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '10'
      position: 114754071
    locus_GRCh38:
      chromosome: '10'
      position: 112994312
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=407701
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 135.64397414280688
    otg_id: SAIGE_250_2
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000148737 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000148737 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000148737
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '10'
      position: 114754071
    locus_GRCh38:
      chromosome: '10'
      position: 112994312
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - East Asian=41646
    gwas_catalog_id: GCST003400
    neg_log_pval: 22.522878745280337
    otg_id: GCST003400_2
    pubmed_id: '26818947'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000148737 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000148737 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000148737
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '10'
      position: 114754071
    locus_GRCh38:
      chromosome: '10'
      position: 112994312
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes [Japanese]
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=4862
    gwas_catalog_id: GCST000025
    neg_log_pval: 48.0
    otg_id: GCST000025_2
    pubmed_id: '17463249'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000148737 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000148737 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000148737
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '10'
      position: 114754088
    locus_GRCh38:
      chromosome: '10'
      position: 112994329
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes [DGI+FUSION+WTCCC]
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - East Asian=191764
    gwas_catalog_id: GCST007847
    neg_log_pval: 48.52287874528034
    otg_id: GCST007847
    pubmed_id: '30718926'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000148737 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000148737 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000148737
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '10'
      position: 114754088
    locus_GRCh38:
      chromosome: '10'
      position: 112994329
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 28.732802449449522
    otg_id: NEALE2_20002_1223
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000148737 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000148737 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000148737
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '10'
      position: 114754784
    locus_GRCh38:
      chromosome: '10'
      position: 112995025
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes | non-cancer illness code, self-reported
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=4862
    gwas_catalog_id: GCST000277
    neg_log_pval: 15.221848749616356
    otg_id: GCST000277_2
    pubmed_id: '19056611'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000148737 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000148737 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000148737
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 114758349
    locus_GRCh38:
      chromosome: '10'
      position: 112998590
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes [obese]
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - NR=60647
    gwas_catalog_id: GCST001550
    neg_log_pval: 39.69897000433602
    otg_id: GCST001550
    pubmed_id: '22693455'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000148737 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000148737 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000148737
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 114758349
    locus_GRCh38:
      chromosome: '10'
      position: 112998590
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes [Lean]
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=459000
    gwas_catalog_id: GCST007077
    neg_log_pval: 202.52287874528034
    otg_id: GCST007077
    pubmed_id: '30595370'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000148737 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000148737 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000148737
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 114758349
    locus_GRCh38:
      chromosome: '10'
      position: 112998590
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=69033
    gwas_catalog_id: GCST005047
    neg_log_pval: 74.10790539730952
    otg_id: GCST005047
    pubmed_id: '22885922'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000148737 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000148737 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000148737
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 114758349
    locus_GRCh38:
      chromosome: '10'
      position: 112998590
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - South Asian=1616
    gwas_catalog_id: GCST001809
    neg_log_pval: 74.04575749056067
    otg_id: GCST001809_3
    pubmed_id: '23300278'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000148737 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000148737 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000148737
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 114758349
    locus_GRCh38:
      chromosome: '10'
      position: 112998590
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes [South Asian, East Asian, Europeans]
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=997
    gwas_catalog_id: GCST000049
    neg_log_pval: 7.301029995663981
    otg_id: GCST000049
    pubmed_id: '17668382'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000148737 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000148737 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000148737
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 114758349
    locus_GRCh38:
      chromosome: '10'
      position: 112998590
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - South Asian=1616
    gwas_catalog_id: GCST001809
    neg_log_pval: 34.52287874528034
    otg_id: GCST001809_5
    pubmed_id: '23300278'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000148737 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000148737 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000148737
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 114758349
    locus_GRCh38:
      chromosome: '10'
      position: 112998590
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes [South Asians]
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - East Asian=26805
    gwas_catalog_id: GCST002128
    neg_log_pval: 14.698970004336019
    otg_id: GCST002128
    pubmed_id: '23945395'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000148737 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000148737 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000148737
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 114758349
    locus_GRCh38:
      chromosome: '10'
      position: 112998590
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - Hispanic or Latin American=7746
    gwas_catalog_id: GCST004758
    neg_log_pval: 11.0
    otg_id: GCST004758
    pubmed_id: '28254843'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000148737 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000148737 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000148737
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 114758349
    locus_GRCh38:
      chromosome: '10'
      position: 112998590
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - South Asian=2128
    gwas_catalog_id: GCST001759
    neg_log_pval: 35.0
    otg_id: GCST001759_2
    pubmed_id: '23209189'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000148737 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000148737 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000148737
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 114758349
    locus_GRCh38:
      chromosome: '10'
      position: 112998590
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes [Indo-European South Asians]
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - African American or Afro-Caribbean=23827
    gwas_catalog_id: GCST002560
    neg_log_pval: 93.39794000867204
    otg_id: GCST002560
    pubmed_id: '25102180'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000148737 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000148737 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000148737
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 114758349
    locus_GRCh38:
      chromosome: '10'
      position: 112998590
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=10128
    gwas_catalog_id: GCST000167
    neg_log_pval: 22.522878745280337
    otg_id: GCST000167
    pubmed_id: '18372903'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000148737 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000148737 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000148737
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 114758349
    locus_GRCh38:
      chromosome: '10'
      position: 112998590
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=655666
    - South Asian=3650
    gwas_catalog_id: GCST006867
    neg_log_pval: 347.0
    otg_id: GCST006867
    pubmed_id: '30054458'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000148737 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000148737 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000148737
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 114758349
    locus_GRCh38:
      chromosome: '10'
      position: 112998590
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - South Asian=1616
    gwas_catalog_id: GCST001809
    neg_log_pval: 21.221848749616356
    otg_id: GCST001809
    pubmed_id: '23300278'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000148737 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000148737 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000148737
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 114758349
    locus_GRCh38:
      chromosome: '10'
      position: 112998590
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes [All Punjabi]
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=4805
    - African American or Afro-Caribbean=1683
    gwas_catalog_id: GCST001326
    neg_log_pval: 14.698970004336019
    otg_id: GCST001326
    pubmed_id: '22101970'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000148737 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000148737 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000148737
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 114758349
    locus_GRCh38:
      chromosome: '10'
      position: 112998590
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=70127
    gwas_catalog_id: GCST005413
    neg_log_pval: 93.92081875395237
    otg_id: GCST005413
    pubmed_id: '29358691'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000148737 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000148737 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000148737
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 114758349
    locus_GRCh38:
      chromosome: '10'
      position: 112998590
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - South Asian=13532
    - European=20298
    - NR=149821
    gwas_catalog_id: GCST004894
    neg_log_pval: 183.69897000433602
    otg_id: GCST004894_2
    pubmed_id: '28869590'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000148737 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000148737 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000148737
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 114758349
    locus_GRCh38:
      chromosome: '10'
      position: 112998590
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes [EA]
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=69033
    - East Asian=18817
    - South Asian=20019
    - Hispanic or Latin American=2583
    gwas_catalog_id: GCST002352
    neg_log_pval: 74.09691001300806
    otg_id: GCST002352
    pubmed_id: '24509480'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000148737 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000148737 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000148737
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 114758349
    locus_GRCh38:
      chromosome: '10'
      position: 112998590
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=1376
    gwas_catalog_id: GCST000478
    neg_log_pval: 30.0
    otg_id: GCST000478
    pubmed_id: '19734900'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000148737 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000148737 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000148737
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 114758349
    locus_GRCh38:
      chromosome: '10'
      position: 112998590
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - NR=60647
    gwas_catalog_id: GCST001550
    neg_log_pval: 20.397940008672037
    otg_id: GCST001550_2
    pubmed_id: '22693455'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000148737 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000148737 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000148737
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 114758349
    locus_GRCh38:
      chromosome: '10'
      position: 112998590
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes [Obese]
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - Hispanic or Latin American=8214
    gwas_catalog_id: GCST002317
    neg_log_pval: 14.0
    otg_id: GCST002317
    pubmed_id: '24390345'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000148737 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000148737 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000148737
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 114758349
    locus_GRCh38:
      chromosome: '10'
      position: 112998590
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - African American or Afro-Caribbean=23827
    gwas_catalog_id: GCST002560
    neg_log_pval: 43.30102999566398
    otg_id: GCST002560_2
    pubmed_id: '25102180'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000148737 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000148737 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000148737
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 114758349
    locus_GRCh38:
      chromosome: '10'
      position: 112998590
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes [AA]
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=2931
    gwas_catalog_id: GCST000028
    neg_log_pval: 48.0
    otg_id: GCST000028
    pubmed_id: '17463246'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000148737 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000148737 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000148737
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 114758349
    locus_GRCh38:
      chromosome: '10'
      position: 112998590
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=47117
    gwas_catalog_id: GCST000712
    neg_log_pval: 50.69897000433602
    otg_id: GCST000712
    pubmed_id: '20581827'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000148737 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000148737 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000148737
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 114758349
    locus_GRCh38:
      chromosome: '10'
      position: 112998590
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - East Asian=1022
    gwas_catalog_id: GCST000383
    neg_log_pval: 11.096910013008056
    otg_id: GCST000383
    pubmed_id: '19401414'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000148737 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000148737 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000148737
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 114758349
    locus_GRCh38:
      chromosome: '10'
      position: 112998590
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=4862
    gwas_catalog_id: GCST000277
    neg_log_pval: 29.045757490560675
    otg_id: GCST000277
    pubmed_id: '19056611'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000148737 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000148737 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000148737
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 114758349
    locus_GRCh38:
      chromosome: '10'
      position: 112998590
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes [non-obese]
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=2335
    gwas_catalog_id: GCST000024
    neg_log_pval: 8.0
    otg_id: GCST000024
    pubmed_id: '17463248'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000148737 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000148737 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000148737
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 114758349
    locus_GRCh38:
      chromosome: '10'
      position: 112998590
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - South Asian=1616
    gwas_catalog_id: GCST001809
    neg_log_pval: 18.522878745280337
    otg_id: GCST001809_2
    pubmed_id: '23300278'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000148737 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000148737 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000148737
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 114758349
    locus_GRCh38:
      chromosome: '10'
      position: 112998590
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes [Punjabi Sikhs]
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=1947
    gwas_catalog_id: GCST007221
    neg_log_pval: 10.522878745280337
    otg_id: GCST007221
    pubmed_id: '30470734'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000148737 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000148737 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000148737
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 114758349
    locus_GRCh38:
      chromosome: '10'
      position: 112998590
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=8686
    gwas_catalog_id: GCST000027
    neg_log_pval: 9.698970004336019
    otg_id: GCST000027
    pubmed_id: '17460697'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000148737 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000148737 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000148737
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 114758349
    locus_GRCh38:
      chromosome: '10'
      position: 112998590
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - South Asian=1616
    gwas_catalog_id: GCST001809
    neg_log_pval: 37.69897000433602
    otg_id: GCST001809_4
    pubmed_id: '23300278'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000148737 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000148737 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000148737
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 114758349
    locus_GRCh38:
      chromosome: '10'
      position: 112998590
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes [South Asians, East Asians]
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=1275
    gwas_catalog_id: GCST000012
    neg_log_pval: 33.69897000433602
    otg_id: GCST000012
    pubmed_id: '17293876'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000148737 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000148737 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000148737
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 114758349
    locus_GRCh38:
      chromosome: '10'
      position: 112998590
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - South Asian=13532
    - European=20298
    - NR=149821
    gwas_catalog_id: GCST004894
    neg_log_pval: 22.522878745280337
    otg_id: GCST004894_3
    pubmed_id: '28869590'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000148737 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000148737 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000148737
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 114758349
    locus_GRCh38:
      chromosome: '10'
      position: 112998590
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes [South Asian]
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=117775
    gwas_catalog_id: GCST006801
    neg_log_pval: 44.15490195998574
    otg_id: GCST006801
    pubmed_id: '26961502'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000148737 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000148737 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000148737
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 114758349
    locus_GRCh38:
      chromosome: '10'
      position: 112998590
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes [additive model]
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - South Asian=13532
    - European=20298
    - NR=149821
    gwas_catalog_id: GCST004894
    neg_log_pval: 219.0
    otg_id: GCST004894
    pubmed_id: '28869590'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000148737 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000148737 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000148737
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '10'
      position: 114758349
    locus_GRCh38:
      chromosome: '10'
      position: 112998590
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=390054
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 11.145693958198919
    otg_id: SAIGE_250_23
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000148737 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000148737 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000148737
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: A
      reference: T
    locus_GRCh37:
      chromosome: '10'
      position: 114798893
    locus_GRCh38:
      chromosome: '10'
      position: 113039134
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes with ophthalmic manifestations
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=655666
    - South Asian=3650
    gwas_catalog_id: GCST006867
    neg_log_pval: 12.397940008672037
    otg_id: GCST006867
    pubmed_id: '30054458'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000148737 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000148737 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000148737
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '10'
      position: 114880342
    locus_GRCh38:
      chromosome: '10'
      position: 113120583
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=459000
    gwas_catalog_id: GCST007077
    neg_log_pval: 8.397940008672037
    otg_id: GCST007077
    pubmed_id: '30595370'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000148737 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000148737 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000148737
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '10'
      position: 114880342
    locus_GRCh38:
      chromosome: '10'
      position: 113120583
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - Hispanic or Latin American=8658
    gwas_catalog_id: GCST006145
    neg_log_pval: 13.221848749616356
    otg_id: GCST006145
    pubmed_id: '28838971'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000167244
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000167244 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000167244
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 2161530
    locus_GRCh38:
      chromosome: '11'
      position: 2140300
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - African American or Afro-Caribbean=23827
    gwas_catalog_id: GCST002560
    neg_log_pval: 7.522878745280337
    otg_id: GCST002560_2
    pubmed_id: '25102180'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000167244
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000167244 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000167244
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 2178670
    locus_GRCh38:
      chromosome: '11'
      position: 2157440
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes [AA]
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=459000
    gwas_catalog_id: GCST007077
    neg_log_pval: 10.154901959985743
    otg_id: GCST007077
    pubmed_id: '30595370'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000167244
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000167244 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000167244
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '11'
      position: 2197112
    locus_GRCh38:
      chromosome: '11'
      position: 2175882
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - East Asian=191764
    gwas_catalog_id: GCST007847
    neg_log_pval: 12.522878745280337
    otg_id: GCST007847
    pubmed_id: '30718926'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000167244
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000167244 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000167244
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '11'
      position: 2197286
    locus_GRCh38:
      chromosome: '11'
      position: 2176056
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - South Asian=13532
    - European=20298
    - NR=149821
    gwas_catalog_id: GCST004894
    neg_log_pval: 10.522878745280337
    otg_id: GCST004894
    pubmed_id: '28869590'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000167244
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000167244 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000167244
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 2213166
    locus_GRCh38:
      chromosome: '11'
      position: 2191936
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - East Asian=41646
    gwas_catalog_id: GCST003400
    neg_log_pval: 11.0
    otg_id: GCST003400
    pubmed_id: '26818947'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000167244
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000167244 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000167244
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 2215089
    locus_GRCh38:
      chromosome: '11'
      position: 2193859
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - East Asian=41646
    gwas_catalog_id: GCST003400
    neg_log_pval: 7.698970004336019
    otg_id: GCST003400_2
    pubmed_id: '26818947'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000167244
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000167244 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000167244
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 2215089
    locus_GRCh38:
      chromosome: '11'
      position: 2193859
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes [Japanese]
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - East Asian=191764
    gwas_catalog_id: GCST007847
    neg_log_pval: 9.0
    otg_id: GCST007847_2
    pubmed_id: '30718926'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000167244
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000167244 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000167244
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 2291050
    locus_GRCh38:
      chromosome: '11'
      position: 2269820
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes [Conditioned]
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=407701
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 9.896196279044043
    otg_id: SAIGE_250_2
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000187486
        at this locus. There is a single line of regulatory evidence (3R) linking
        T2D to ENSG00000187486 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000187486 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000187486
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 17408404
    locus_GRCh38:
      chromosome: '11'
      position: 17386857
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - South Asian=13532
    - European=20298
    - NR=149821
    gwas_catalog_id: GCST004894
    neg_log_pval: 20.0
    otg_id: GCST004894
    pubmed_id: '28869590'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000187486
        at this locus. There is a single line of regulatory evidence (3R) linking
        T2D to ENSG00000187486 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000187486 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000187486
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 17408630
    locus_GRCh38:
      chromosome: '11'
      position: 17387083
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=69033
    - East Asian=18817
    - South Asian=20019
    - Hispanic or Latin American=2583
    gwas_catalog_id: GCST002352
    neg_log_pval: 10.522878745280337
    otg_id: GCST002352
    pubmed_id: '24509480'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000187486
        at this locus. There is a single line of regulatory evidence (3R) linking
        T2D to ENSG00000187486 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000187486 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000187486
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 17408630
    locus_GRCh38:
      chromosome: '11'
      position: 17387083
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    gwas_catalog_id: GCST007517
    neg_log_pval: 16.397940008672037
    otg_id: GCST007517
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000187486
        at this locus. There is a single line of regulatory evidence (3R) linking
        T2D to ENSG00000187486 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000187486 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000187486
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 17408630
    locus_GRCh38:
      chromosome: '11'
      position: 17387083
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - South Asian=13532
    - European=20298
    - NR=149821
    gwas_catalog_id: GCST004894
    neg_log_pval: 13.096910013008056
    otg_id: GCST004894_2
    pubmed_id: '28869590'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000187486
        at this locus. There is a single line of regulatory evidence (3R) linking
        T2D to ENSG00000187486 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000187486 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000187486
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 17408630
    locus_GRCh38:
      chromosome: '11'
      position: 17387083
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes [EA]
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    gwas_catalog_id: GCST007518
    neg_log_pval: 21.30102999566398
    otg_id: GCST007518
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000187486
        at this locus. There is a single line of regulatory evidence (3R) linking
        T2D to ENSG00000187486 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000187486 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000187486
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 17408630
    locus_GRCh38:
      chromosome: '11'
      position: 17387083
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes (adjusted for BMI)
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=69033
    gwas_catalog_id: GCST005047
    neg_log_pval: 10.494850021680094
    otg_id: GCST005047
    pubmed_id: '22885922'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000187486
        at this locus. There is a single line of regulatory evidence (3R) linking
        T2D to ENSG00000187486 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000187486 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000187486
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 17408630
    locus_GRCh38:
      chromosome: '11'
      position: 17387083
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=655666
    - South Asian=3650
    gwas_catalog_id: GCST006867
    neg_log_pval: 19.69897000433602
    otg_id: GCST006867
    pubmed_id: '30054458'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000187486
        at this locus. There is a single line of regulatory evidence (3R) linking
        T2D to ENSG00000187486 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000187486 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000187486
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 17408630
    locus_GRCh38:
      chromosome: '11'
      position: 17387083
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=4862
    gwas_catalog_id: GCST000025
    neg_log_pval: 10.301029995663981
    otg_id: GCST000025_2
    pubmed_id: '17463249'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000187486
        at this locus. There is a single line of regulatory evidence (3R) linking
        T2D to ENSG00000187486 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000187486 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000187486
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 17408630
    locus_GRCh38:
      chromosome: '11'
      position: 17387083
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes [DGI+FUSION+WTCCC]
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=2335
    gwas_catalog_id: GCST000024
    neg_log_pval: 10.154901959985743
    otg_id: GCST000024_2
    pubmed_id: '17463248'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000187486
        at this locus. There is a single line of regulatory evidence (3R) linking
        T2D to ENSG00000187486 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000187486 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000187486
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '11'
      position: 17409572
    locus_GRCh38:
      chromosome: '11'
      position: 17388025
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes [DGI+FUSION+WTCCC]
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    - South Asian, East Asian, African American or Afro-Caribbean, Hispanic or Latin
      American=153287
    gwas_catalog_id: GCST007515
    neg_log_pval: 21.221848749616356
    otg_id: GCST007515
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000187486
        at this locus. There is a single line of regulatory evidence (3R) linking
        T2D to ENSG00000187486 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000187486 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000187486
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '11'
      position: 17409572
    locus_GRCh38:
      chromosome: '11'
      position: 17388025
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=2931
    gwas_catalog_id: GCST000028
    neg_log_pval: 10.154901959985743
    otg_id: GCST000028
    pubmed_id: '17463246'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000187486
        at this locus. There is a single line of regulatory evidence (3R) linking
        T2D to ENSG00000187486 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000187486 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000187486
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '11'
      position: 17409572
    locus_GRCh38:
      chromosome: '11'
      position: 17388025
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    - South Asian, East Asian, African American or Afro-Caribbean, Hispanic or Latin
      American=153287
    gwas_catalog_id: GCST007516
    neg_log_pval: 21.69897000433602
    otg_id: GCST007516
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000187486
        at this locus. There is a single line of regulatory evidence (3R) linking
        T2D to ENSG00000187486 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000187486 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000187486
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '11'
      position: 17409572
    locus_GRCh38:
      chromosome: '11'
      position: 17388025
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes (adjusted for BMI)
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=4862
    gwas_catalog_id: GCST000277
    neg_log_pval: 9.0
    otg_id: GCST000277
    pubmed_id: '19056611'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000187486
        at this locus. There is a single line of regulatory evidence (3R) linking
        T2D to ENSG00000187486 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000187486 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000187486
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '11'
      position: 17409572
    locus_GRCh38:
      chromosome: '11'
      position: 17388025
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes [non-obese]
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=459000
    gwas_catalog_id: GCST007077
    neg_log_pval: 11.698970004336019
    otg_id: GCST007077
    pubmed_id: '30595370'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000187486
        at this locus. There is a single line of regulatory evidence (3R) linking
        T2D to ENSG00000187486 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000187486 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000187486
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 17411821
    locus_GRCh38:
      chromosome: '11'
      position: 17390274
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    - South Asian, East Asian, African American or Afro-Caribbean, Hispanic or Latin
      American=153287
    gwas_catalog_id: GCST007516
    neg_log_pval: 9.301029995663981
    otg_id: GCST007516
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000214530 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000214530 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000214530
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 72408055
    locus_GRCh38:
      chromosome: '11'
      position: 72697010
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes (adjusted for BMI)
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    - South Asian, East Asian, African American or Afro-Caribbean, Hispanic or Latin
      American=153287
    gwas_catalog_id: GCST007515
    neg_log_pval: 7.301029995663981
    otg_id: GCST007515
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000214530 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000214530 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000214530
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 72408055
    locus_GRCh38:
      chromosome: '11'
      position: 72697010
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    gwas_catalog_id: GCST007518
    neg_log_pval: 8.698970004336019
    otg_id: GCST007518
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000214530 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000214530 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000214530
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 72408055
    locus_GRCh38:
      chromosome: '11'
      position: 72697010
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes (adjusted for BMI)
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - East Asian=191764
    gwas_catalog_id: GCST007847
    neg_log_pval: 11.0
    otg_id: GCST007847
    pubmed_id: '30718926'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000214530 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000214530 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000214530
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '11'
      position: 72428172
    locus_GRCh38:
      chromosome: '11'
      position: 72717127
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - South Asian=13532
    - European=20298
    - NR=149821
    gwas_catalog_id: GCST004894
    neg_log_pval: 16.522878745280337
    otg_id: GCST004894
    pubmed_id: '28869590'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000214530 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000214530 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000214530
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '11'
      position: 72433098
    locus_GRCh38:
      chromosome: '11'
      position: 72722053
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=655666
    - South Asian=3650
    gwas_catalog_id: GCST006867
    neg_log_pval: 24.045757490560675
    otg_id: GCST006867
    pubmed_id: '30054458'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000214530 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000214530 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000214530
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '11'
      position: 72433098
    locus_GRCh38:
      chromosome: '11'
      position: 72722053
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=47117
    gwas_catalog_id: GCST000712
    neg_log_pval: 22.0
    otg_id: GCST000712
    pubmed_id: '20581827'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000214530 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000214530 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000214530
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '11'
      position: 72433098
    locus_GRCh38:
      chromosome: '11'
      position: 72722053
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - South Asian=13532
    - European=20298
    - NR=149821
    gwas_catalog_id: GCST004894
    neg_log_pval: 13.0
    otg_id: GCST004894_2
    pubmed_id: '28869590'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000214530 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000214530 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000214530
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '11'
      position: 72433098
    locus_GRCh38:
      chromosome: '11'
      position: 72722053
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes [EA]
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=459000
    gwas_catalog_id: GCST007077
    neg_log_pval: 16.522878745280337
    otg_id: GCST007077
    pubmed_id: '30595370'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000214530 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000214530 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000214530
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: A
    locus_GRCh37:
      chromosome: '11'
      position: 72460762
    locus_GRCh38:
      chromosome: '11'
      position: 72749717
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=407701
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 8.269217724333611
    otg_id: SAIGE_250_2
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000214530 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000214530 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000214530
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: A
    locus_GRCh37:
      chromosome: '11'
      position: 72460762
    locus_GRCh38:
      chromosome: '11'
      position: 72749717
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=69033
    gwas_catalog_id: GCST005047
    neg_log_pval: 8.193820026016112
    otg_id: GCST005047
    pubmed_id: '22885922'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000134640
        at this locus. There is a single line of regulatory evidence (3R) linking
        T2D to ENSG00000134640 at this locus. There is a single line of pertubation
        evidence (3P) linking T2D to ENSG00000134640 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000134640
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '11'
      position: 92668975
    locus_GRCh38:
      chromosome: '11'
      position: 92935809
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=47117
    gwas_catalog_id: GCST000712
    neg_log_pval: 14.096910013008056
    otg_id: GCST000712
    pubmed_id: '20581827'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000134640
        at this locus. There is a single line of regulatory evidence (3R) linking
        T2D to ENSG00000134640 at this locus. There is a single line of pertubation
        evidence (3P) linking T2D to ENSG00000134640 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000134640
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 92673828
    locus_GRCh38:
      chromosome: '11'
      position: 92940662
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - South Asian=13532
    - European=20298
    - NR=149821
    gwas_catalog_id: GCST004894
    neg_log_pval: 17.397940008672037
    otg_id: GCST004894
    pubmed_id: '28869590'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000134640
        at this locus. There is a single line of regulatory evidence (3R) linking
        T2D to ENSG00000134640 at this locus. There is a single line of pertubation
        evidence (3P) linking T2D to ENSG00000134640 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000134640
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 92708710
    locus_GRCh38:
      chromosome: '11'
      position: 92975544
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=407701
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 9.154901959985743
    otg_id: SAIGE_250_2
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000134640
        at this locus. There is a single line of regulatory evidence (3R) linking
        T2D to ENSG00000134640 at this locus. There is a single line of pertubation
        evidence (3P) linking T2D to ENSG00000134640 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000134640
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 92708710
    locus_GRCh38:
      chromosome: '11'
      position: 92975544
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=655666
    - South Asian=3650
    gwas_catalog_id: GCST006867
    neg_log_pval: 29.221848749616356
    otg_id: GCST006867
    pubmed_id: '30054458'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000134640
        at this locus. There is a single line of regulatory evidence (3R) linking
        T2D to ENSG00000134640 at this locus. There is a single line of pertubation
        evidence (3P) linking T2D to ENSG00000134640 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000134640
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 92708710
    locus_GRCh38:
      chromosome: '11'
      position: 92975544
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=459000
    gwas_catalog_id: GCST007077
    neg_log_pval: 15.698970004336019
    otg_id: GCST007077
    pubmed_id: '30595370'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000134640
        at this locus. There is a single line of regulatory evidence (3R) linking
        T2D to ENSG00000134640 at this locus. There is a single line of pertubation
        evidence (3P) linking T2D to ENSG00000134640 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000134640
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 92708710
    locus_GRCh38:
      chromosome: '11'
      position: 92975544
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - South Asian=13532
    - European=20298
    - NR=149821
    gwas_catalog_id: GCST004894
    neg_log_pval: 15.522878745280337
    otg_id: GCST004894_2
    pubmed_id: '28869590'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000134640
        at this locus. There is a single line of regulatory evidence (3R) linking
        T2D to ENSG00000134640 at this locus. There is a single line of pertubation
        evidence (3P) linking T2D to ENSG00000134640 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000134640
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 92708710
    locus_GRCh38:
      chromosome: '11'
      position: 92975544
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes [EA]
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=70127
    gwas_catalog_id: GCST005413
    neg_log_pval: 8.870954940112043
    otg_id: GCST005413
    pubmed_id: '29358691'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: The is a likely causal T2D variant (2C) for ENSG00000118971 at
        this locus. There is a single line of regulatory evidence (3R) linking T2D
        to ENSG00000118971 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000118971 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000118971
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '12'
      position: 4328521
    locus_GRCh38:
      chromosome: '12'
      position: 4219355
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - South Asian=13532
    - European=20298
    - NR=149821
    gwas_catalog_id: GCST004894
    neg_log_pval: 7.522878745280337
    otg_id: GCST004894
    pubmed_id: '28869590'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: The is a likely causal T2D variant (2C) for ENSG00000118971 at
        this locus. There is a single line of regulatory evidence (3R) linking T2D
        to ENSG00000118971 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000118971 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000118971
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '12'
      position: 4374373
    locus_GRCh38:
      chromosome: '12'
      position: 4265207
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - South Asian=13532
    - European=20298
    - NR=149821
    gwas_catalog_id: GCST004894
    neg_log_pval: 7.698970004336019
    otg_id: GCST004894_2
    pubmed_id: '28869590'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: The is a likely causal T2D variant (2C) for ENSG00000118971 at
        this locus. There is a single line of regulatory evidence (3R) linking T2D
        to ENSG00000118971 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000118971 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000118971
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '12'
      position: 4374373
    locus_GRCh38:
      chromosome: '12'
      position: 4265207
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes [EA]
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=407701
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 9.65169513695184
    otg_id: SAIGE_250_2
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: The is a likely causal T2D variant (2C) for ENSG00000118971 at
        this locus. There is a single line of regulatory evidence (3R) linking T2D
        to ENSG00000118971 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000118971 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000118971
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '12'
      position: 4384696
    locus_GRCh38:
      chromosome: '12'
      position: 4275530
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=459000
    gwas_catalog_id: GCST007077
    neg_log_pval: 30.69897000433602
    otg_id: GCST007077
    pubmed_id: '30595370'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: The is a likely causal T2D variant (2C) for ENSG00000118971 at
        this locus. There is a single line of regulatory evidence (3R) linking T2D
        to ENSG00000118971 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000118971 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000118971
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '12'
      position: 4384844
    locus_GRCh38:
      chromosome: '12'
      position: 4275678
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=407701
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 24.4145392704915
    otg_id: SAIGE_250_2
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: The is a likely causal T2D variant (2C) for ENSG00000118971 at
        this locus. There is a single line of regulatory evidence (3R) linking T2D
        to ENSG00000118971 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000118971 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000118971
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '12'
      position: 4384844
    locus_GRCh38:
      chromosome: '12'
      position: 4275678
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 8.217634170939927
    otg_id: NEALE2_20002_1223
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: The is a likely causal T2D variant (2C) for ENSG00000118971 at
        this locus. There is a single line of regulatory evidence (3R) linking T2D
        to ENSG00000118971 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000118971 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000118971
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '12'
      position: 4384844
    locus_GRCh38:
      chromosome: '12'
      position: 4275678
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes | non-cancer illness code, self-reported
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=655666
    - South Asian=3650
    gwas_catalog_id: GCST006867
    neg_log_pval: 9.698970004336019
    otg_id: GCST006867
    pubmed_id: '30054458'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: The is a likely causal T2D variant (2C) for ENSG00000118971 at
        this locus. There is a single line of regulatory evidence (3R) linking T2D
        to ENSG00000118971 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000118971 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000118971
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '12'
      position: 4406281
    locus_GRCh38:
      chromosome: '12'
      position: 4297115
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    - South Asian, East Asian, African American or Afro-Caribbean, Hispanic or Latin
      American=153287
    gwas_catalog_id: GCST007516
    neg_log_pval: 7.698970004336019
    otg_id: GCST007516
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000087448 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000087448 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000087448
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '12'
      position: 27867727
    locus_GRCh38:
      chromosome: '12'
      position: 27714794
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes (adjusted for BMI)
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    gwas_catalog_id: GCST007517
    neg_log_pval: 8.698970004336019
    otg_id: GCST007517
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000087448 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000087448 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000087448
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '12'
      position: 27867727
    locus_GRCh38:
      chromosome: '12'
      position: 27714794
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    gwas_catalog_id: GCST007518
    neg_log_pval: 7.522878745280337
    otg_id: GCST007518
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000087448 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000087448 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000087448
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '12'
      position: 27867727
    locus_GRCh38:
      chromosome: '12'
      position: 27714794
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes (adjusted for BMI)
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    - South Asian, East Asian, African American or Afro-Caribbean, Hispanic or Latin
      American=153287
    gwas_catalog_id: GCST007515
    neg_log_pval: 11.0
    otg_id: GCST007515
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000087448 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000087448 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000087448
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '12'
      position: 27867727
    locus_GRCh38:
      chromosome: '12'
      position: 27714794
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - East Asian=191764
    gwas_catalog_id: GCST007847
    neg_log_pval: 13.154901959985743
    otg_id: GCST007847
    pubmed_id: '30718926'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000087448 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000087448 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000087448
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '12'
      position: 27963507
    locus_GRCh38:
      chromosome: '12'
      position: 27810574
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - South Asian=13532
    - European=20298
    - NR=149821
    gwas_catalog_id: GCST004894
    neg_log_pval: 11.045757490560675
    otg_id: GCST004894
    pubmed_id: '28869590'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000087448 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000087448 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000087448
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '12'
      position: 27965150
    locus_GRCh38:
      chromosome: '12'
      position: 27812217
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=655666
    - South Asian=3650
    gwas_catalog_id: GCST006867
    neg_log_pval: 16.0
    otg_id: GCST006867
    pubmed_id: '30054458'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000087448 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000087448 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000087448
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '12'
      position: 27965150
    locus_GRCh38:
      chromosome: '12'
      position: 27812217
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - South Asian=13532
    - European=20298
    - NR=149821
    gwas_catalog_id: GCST004894
    neg_log_pval: 9.698970004336019
    otg_id: GCST004894_2
    pubmed_id: '28869590'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000087448 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000087448 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000087448
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '12'
      position: 27965150
    locus_GRCh38:
      chromosome: '12'
      position: 27812217
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes [EA]
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - East Asian=191764
    gwas_catalog_id: GCST007847
    neg_log_pval: 8.0
    otg_id: GCST007847
    pubmed_id: '30718926'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000075035
        at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000075035
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '12'
      position: 108613151
    locus_GRCh38:
      chromosome: '12'
      position: 108219374
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    - South Asian, East Asian, African American or Afro-Caribbean, Hispanic or Latin
      American=153287
    gwas_catalog_id: GCST007515
    neg_log_pval: 7.522878745280337
    otg_id: GCST007515
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000075035
        at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000075035
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '12'
      position: 108618630
    locus_GRCh38:
      chromosome: '12'
      position: 108224853
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - East Asian=191764
    gwas_catalog_id: GCST007847
    neg_log_pval: 11.221848749616356
    otg_id: GCST007847
    pubmed_id: '30718926'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000135100
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000135100 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000135100
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '12'
      position: 121327809
    locus_GRCh38:
      chromosome: '12'
      position: 120890006
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - Hispanic or Latin American=2584
    gwas_catalog_id: GCST001070
    neg_log_pval: 7.698970004336019
    otg_id: GCST001070
    pubmed_id: '21573907'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000135100
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000135100 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000135100
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '12'
      position: 121402932
    locus_GRCh38:
      chromosome: '12'
      position: 120965129
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    - South Asian, East Asian, African American or Afro-Caribbean, Hispanic or Latin
      American=153287
    gwas_catalog_id: GCST007515
    neg_log_pval: 11.0
    otg_id: GCST007515
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000135100
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000135100 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000135100
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '12'
      position: 121416650
    locus_GRCh38:
      chromosome: '12'
      position: 120978847
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    - South Asian, East Asian, African American or Afro-Caribbean, Hispanic or Latin
      American=153287
    gwas_catalog_id: GCST007516
    neg_log_pval: 9.698970004336019
    otg_id: GCST007516
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000135100
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000135100 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000135100
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '12'
      position: 121416650
    locus_GRCh38:
      chromosome: '12'
      position: 120978847
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes (adjusted for BMI)
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=459000
    gwas_catalog_id: GCST007077
    neg_log_pval: 7.698970004336019
    otg_id: GCST007077
    pubmed_id: '30595370'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000135100
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000135100 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000135100
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '12'
      position: 121429194
    locus_GRCh38:
      chromosome: '12'
      position: 120991391
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=655666
    - South Asian=3650
    gwas_catalog_id: GCST006867
    neg_log_pval: 13.698970004336019
    otg_id: GCST006867
    pubmed_id: '30054458'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000135100
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000135100 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000135100
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '12'
      position: 121456616
    locus_GRCh38:
      chromosome: '12'
      position: 121018813
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - South Asian=13532
    - European=20298
    - NR=149821
    gwas_catalog_id: GCST004894
    neg_log_pval: 8.522878745280337
    otg_id: GCST004894_2
    pubmed_id: '28869590'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000135100
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000135100 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000135100
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: A
      reference: T
    locus_GRCh37:
      chromosome: '12'
      position: 121460686
    locus_GRCh38:
      chromosome: '12'
      position: 121022883
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes [EA]
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=47117
    gwas_catalog_id: GCST000712
    neg_log_pval: 7.698970004336019
    otg_id: GCST000712
    pubmed_id: '20581827'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000135100
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000135100 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000135100
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: A
      reference: T
    locus_GRCh37:
      chromosome: '12'
      position: 121460686
    locus_GRCh38:
      chromosome: '12'
      position: 121022883
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - South Asian=13532
    - European=20298
    - NR=149821
    gwas_catalog_id: GCST004894
    neg_log_pval: 9.0
    otg_id: GCST004894
    pubmed_id: '28869590'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000135100
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000135100 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000135100
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: A
      reference: T
    locus_GRCh37:
      chromosome: '12'
      position: 121460686
    locus_GRCh38:
      chromosome: '12'
      position: 121022883
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=655666
    - South Asian=3650
    gwas_catalog_id: GCST006867
    neg_log_pval: 8.698970004336019
    otg_id: GCST006867
    pubmed_id: '30054458'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: The is a likely causal T2D variant (2C) for ENSG00000150967 at
        this locus. There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000150967 at this locus. There is a single line of pertubation evidence
        (3P) linking T2D to ENSG00000150967 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000150967
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '12'
      position: 123491572
    locus_GRCh38:
      chromosome: '12'
      position: 123007025
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=69033
    - East Asian=18817
    - South Asian=20019
    - Hispanic or Latin American=2583
    gwas_catalog_id: GCST002352
    neg_log_pval: 8.0
    otg_id: GCST002352
    pubmed_id: '24509480'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: The is a likely causal T2D variant (2C) for ENSG00000150967 at
        this locus. There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000150967 at this locus. There is a single line of pertubation evidence
        (3P) linking T2D to ENSG00000150967 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000150967
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '12'
      position: 123640853
    locus_GRCh38:
      chromosome: '12'
      position: 123156306
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=655666
    - South Asian=3650
    gwas_catalog_id: GCST006867
    neg_log_pval: 7.698970004336019
    otg_id: GCST006867
    pubmed_id: '30054458'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000205502 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000205502 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000205502
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '15'
      position: 62383155
    locus_GRCh38:
      chromosome: '15'
      position: 62090956
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - East Asian=191764
    gwas_catalog_id: GCST007847
    neg_log_pval: 16.69897000433602
    otg_id: GCST007847
    pubmed_id: '30718926'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000205502 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000205502 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000205502
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '15'
      position: 62394264
    locus_GRCh38:
      chromosome: '15'
      position: 62102065
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - South Asian=13532
    - European=20298
    - NR=149821
    gwas_catalog_id: GCST004894
    neg_log_pval: 8.301029995663981
    otg_id: GCST004894
    pubmed_id: '28869590'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000205502 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000205502 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000205502
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '15'
      position: 62396389
    locus_GRCh38:
      chromosome: '15'
      position: 62104190
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - East Asian=7541
    gwas_catalog_id: GCST000787
    neg_log_pval: 13.045757490560675
    otg_id: GCST000787
    pubmed_id: '20818381'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000205502 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000205502 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000205502
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '15'
      position: 62396389
    locus_GRCh38:
      chromosome: '15'
      position: 62104190
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - East Asian=41646
    gwas_catalog_id: GCST003400
    neg_log_pval: 8.301029995663981
    otg_id: GCST003400_2
    pubmed_id: '26818947'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000205502 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000205502 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000205502
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '15'
      position: 62409070
    locus_GRCh38:
      chromosome: '15'
      position: 62116871
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes [Japanese]
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=407701
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 7.627087997029894
    otg_id: SAIGE_250_2
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: The is a likely causal T2D variant (2C) for ENSG00000177508 at
        this locus. There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000177508 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000177508 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000177508
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '16'
      position: 54490811
    locus_GRCh38:
      chromosome: '16'
      position: 54456899
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=655666
    - South Asian=3650
    gwas_catalog_id: GCST006867
    neg_log_pval: 17.69897000433602
    otg_id: GCST006867
    pubmed_id: '30054458'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000050820 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000050820 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000050820
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '16'
      position: 75243772
    locus_GRCh38:
      chromosome: '16'
      position: 75209874
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=407701
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 8.449771646944907
    otg_id: SAIGE_250_2
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000050820 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000050820 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000050820
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '16'
      position: 75245937
    locus_GRCh38:
      chromosome: '16'
      position: 75212039
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=459000
    gwas_catalog_id: GCST007077
    neg_log_pval: 13.397940008672037
    otg_id: GCST007077
    pubmed_id: '30595370'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000050820 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000050820 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000050820
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '16'
      position: 75246035
    locus_GRCh38:
      chromosome: '16'
      position: 75212137
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - South Asian=13532
    - European=20298
    - NR=149821
    gwas_catalog_id: GCST004894
    neg_log_pval: 9.301029995663981
    otg_id: GCST004894_2
    pubmed_id: '28869590'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000050820 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000050820 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000050820
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '16'
      position: 75247245
    locus_GRCh38:
      chromosome: '16'
      position: 75213347
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes [EA]
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - East Asian=26805
    gwas_catalog_id: GCST002128
    neg_log_pval: 12.096910013008056
    otg_id: GCST002128
    pubmed_id: '23945395'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000174326
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000174326 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000174326
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '17'
      position: 6940393
    locus_GRCh38:
      chromosome: '17'
      position: 7037074
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - Hispanic or Latin American=8214
    gwas_catalog_id: GCST002317
    neg_log_pval: 14.301029995663981
    otg_id: GCST002317
    pubmed_id: '24390345'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000174326
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000174326 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000174326
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '17'
      position: 6945087
    locus_GRCh38:
      chromosome: '17'
      position: 7041768
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - East Asian=41646
    gwas_catalog_id: GCST003400
    neg_log_pval: 10.096910013008056
    otg_id: GCST003400_2
    pubmed_id: '26818947'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000174326
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000174326 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000174326
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '17'
      position: 6945483
    locus_GRCh38:
      chromosome: '17'
      position: 7042164
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes [Japanese]
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - East Asian=191764
    gwas_catalog_id: GCST007847
    neg_log_pval: 15.221848749616356
    otg_id: GCST007847
    pubmed_id: '30718926'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000174326
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000174326 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000174326
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '17'
      position: 6947453
    locus_GRCh38:
      chromosome: '17'
      position: 7044134
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - East Asian=191764
    gwas_catalog_id: GCST007847
    neg_log_pval: 13.301029995663981
    otg_id: GCST007847
    pubmed_id: '30718926'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000166603
        at this locus. There is a single line of regulatory evidence (3R) linking
        T2D to ENSG00000166603 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000166603 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000166603
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '18'
      position: 57838401
    locus_GRCh38:
      chromosome: '18'
      position: 60171168
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - South Asian=13532
    - European=20298
    - NR=149821
    gwas_catalog_id: GCST004894
    neg_log_pval: 9.301029995663981
    otg_id: GCST004894_2
    pubmed_id: '28869590'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000166603
        at this locus. There is a single line of regulatory evidence (3R) linking
        T2D to ENSG00000166603 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000166603 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000166603
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '18'
      position: 57884750
    locus_GRCh38:
      chromosome: '18'
      position: 60217517
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes [EA]
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - South Asian=13532
    - European=20298
    - NR=149821
    gwas_catalog_id: GCST004894
    neg_log_pval: 11.522878745280337
    otg_id: GCST004894
    pubmed_id: '28869590'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000166603
        at this locus. There is a single line of regulatory evidence (3R) linking
        T2D to ENSG00000166603 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000166603 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000166603
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '18'
      position: 57884750
    locus_GRCh38:
      chromosome: '18'
      position: 60217517
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=655666
    - South Asian=3650
    gwas_catalog_id: GCST006867
    neg_log_pval: 11.301029995663981
    otg_id: GCST006867
    pubmed_id: '30054458'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000166603
        at this locus. There is a single line of regulatory evidence (3R) linking
        T2D to ENSG00000166603 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000166603 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000166603
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '18'
      position: 57884750
    locus_GRCh38:
      chromosome: '18'
      position: 60217517
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=69033
    - East Asian=18817
    - South Asian=20019
    - Hispanic or Latin American=2583
    gwas_catalog_id: GCST002352
    neg_log_pval: 7.522878745280337
    otg_id: GCST002352
    pubmed_id: '24509480'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000166603
        at this locus. There is a single line of regulatory evidence (3R) linking
        T2D to ENSG00000166603 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000166603 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000166603
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '18'
      position: 57884750
    locus_GRCh38:
      chromosome: '18'
      position: 60217517
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    gwas_catalog_id: GCST007517
    neg_log_pval: 9.698970004336019
    otg_id: GCST007517
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000213996
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000213996 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000213996
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '19'
      position: 19379549
    locus_GRCh38:
      chromosome: '19'
      position: 19268740
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    - South Asian, East Asian, African American or Afro-Caribbean, Hispanic or Latin
      American=153287
    gwas_catalog_id: GCST007516
    neg_log_pval: 14.522878745280337
    otg_id: GCST007516
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000213996
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000213996 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000213996
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '19'
      position: 19379549
    locus_GRCh38:
      chromosome: '19'
      position: 19268740
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes (adjusted for BMI)
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    - South Asian, East Asian, African American or Afro-Caribbean, Hispanic or Latin
      American=153287
    gwas_catalog_id: GCST007515
    neg_log_pval: 11.301029995663981
    otg_id: GCST007515
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000213996
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000213996 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000213996
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '19'
      position: 19379549
    locus_GRCh38:
      chromosome: '19'
      position: 19268740
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    gwas_catalog_id: GCST007518
    neg_log_pval: 12.0
    otg_id: GCST007518
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000213996
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000213996 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000213996
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '19'
      position: 19379549
    locus_GRCh38:
      chromosome: '19'
      position: 19268740
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes (adjusted for BMI)
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=655666
    - South Asian=3650
    gwas_catalog_id: GCST006867
    neg_log_pval: 11.397940008672037
    otg_id: GCST006867
    pubmed_id: '30054458'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000213996
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000213996 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000213996
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '19'
      position: 19407718
    locus_GRCh38:
      chromosome: '19'
      position: 19296909
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=56799
    - African American or Afro-Caribbean=3571
    - East Asian=4735
    - Hispanic or Latin American=6499
    gwas_catalog_id: GCST003619
    neg_log_pval: 8.154901959985743
    otg_id: GCST003619
    pubmed_id: '27189021'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000130203
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000130203 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000130203
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '19'
      position: 45392254
    locus_GRCh38:
      chromosome: '19'
      position: 44888997
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=407701
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 7.72584215073632
    otg_id: SAIGE_250_2
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000010310
        at this locus. There is a single line of regulatory evidence (3R) linking
        T2D to ENSG00000010310 at this locus. There is a single line of pertubation
        evidence (3P) linking T2D to ENSG00000010310 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000010310
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '19'
      position: 46147527
    locus_GRCh38:
      chromosome: '19'
      position: 45644269
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=459000
    gwas_catalog_id: GCST007077
    neg_log_pval: 12.698970004336019
    otg_id: GCST007077
    pubmed_id: '30595370'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000010310
        at this locus. There is a single line of regulatory evidence (3R) linking
        T2D to ENSG00000010310 at this locus. There is a single line of pertubation
        evidence (3P) linking T2D to ENSG00000010310 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000010310
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '19'
      position: 46150182
    locus_GRCh38:
      chromosome: '19'
      position: 45646924
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=655666
    - South Asian=3650
    gwas_catalog_id: GCST006867
    neg_log_pval: 15.522878745280337
    otg_id: GCST006867
    pubmed_id: '30054458'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000010310
        at this locus. There is a single line of regulatory evidence (3R) linking
        T2D to ENSG00000010310 at this locus. There is a single line of pertubation
        evidence (3P) linking T2D to ENSG00000010310 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000010310
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '19'
      position: 46158513
    locus_GRCh38:
      chromosome: '19'
      position: 45655255
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - East Asian=191764
    gwas_catalog_id: GCST007847
    neg_log_pval: 18.522878745280337
    otg_id: GCST007847
    pubmed_id: '30718926'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000010310
        at this locus. There is a single line of regulatory evidence (3R) linking
        T2D to ENSG00000010310 at this locus. There is a single line of pertubation
        evidence (3P) linking T2D to ENSG00000010310 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000010310
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '19'
      position: 46166604
    locus_GRCh38:
      chromosome: '19'
      position: 45663346
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - South Asian=13532
    - European=20298
    - NR=149821
    gwas_catalog_id: GCST004894
    neg_log_pval: 11.522878745280337
    otg_id: GCST004894
    pubmed_id: '28869590'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000010310
        at this locus. There is a single line of regulatory evidence (3R) linking
        T2D to ENSG00000010310 at this locus. There is a single line of pertubation
        evidence (3P) linking T2D to ENSG00000010310 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000010310
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '19'
      position: 46172278
    locus_GRCh38:
      chromosome: '19'
      position: 45669020
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    - South Asian, East Asian, African American or Afro-Caribbean, Hispanic or Latin
      American=153287
    gwas_catalog_id: GCST007516
    neg_log_pval: 11.154901959985743
    otg_id: GCST007516
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000010310
        at this locus. There is a single line of regulatory evidence (3R) linking
        T2D to ENSG00000010310 at this locus. There is a single line of pertubation
        evidence (3P) linking T2D to ENSG00000010310 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000010310
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '19'
      position: 46181392
    locus_GRCh38:
      chromosome: '19'
      position: 45678134
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes (adjusted for BMI)
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    gwas_catalog_id: GCST007518
    neg_log_pval: 11.522878745280337
    otg_id: GCST007518
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000010310
        at this locus. There is a single line of regulatory evidence (3R) linking
        T2D to ENSG00000010310 at this locus. There is a single line of pertubation
        evidence (3P) linking T2D to ENSG00000010310 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000010310
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '19'
      position: 46181392
    locus_GRCh38:
      chromosome: '19'
      position: 45678134
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes (adjusted for BMI)
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    gwas_catalog_id: GCST007518
    neg_log_pval: 14.0
    otg_id: GCST007518
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000084734
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000084734 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000084734
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '2'
      position: 27730940
    locus_GRCh38:
      chromosome: '2'
      position: 27508073
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes (adjusted for BMI)
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    - South Asian, East Asian, African American or Afro-Caribbean, Hispanic or Latin
      American=153287
    gwas_catalog_id: GCST007515
    neg_log_pval: 24.30102999566398
    otg_id: GCST007515
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000084734
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000084734 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000084734
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '2'
      position: 27730940
    locus_GRCh38:
      chromosome: '2'
      position: 27508073
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    gwas_catalog_id: GCST007517
    neg_log_pval: 15.0
    otg_id: GCST007517
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000084734
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000084734 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000084734
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '2'
      position: 27730940
    locus_GRCh38:
      chromosome: '2'
      position: 27508073
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=459000
    gwas_catalog_id: GCST007077
    neg_log_pval: 15.0
    otg_id: GCST007077
    pubmed_id: '30595370'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000084734
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000084734 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000084734
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '2'
      position: 27730940
    locus_GRCh38:
      chromosome: '2'
      position: 27508073
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    - South Asian, East Asian, African American or Afro-Caribbean, Hispanic or Latin
      American=153287
    gwas_catalog_id: GCST007516
    neg_log_pval: 17.522878745280337
    otg_id: GCST007516
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000084734
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000084734 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000084734
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '2'
      position: 27730940
    locus_GRCh38:
      chromosome: '2'
      position: 27508073
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes (adjusted for BMI)
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - East Asian=191764
    gwas_catalog_id: GCST007847
    neg_log_pval: 14.397940008672037
    otg_id: GCST007847
    pubmed_id: '30718926'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000084734
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000084734 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000084734
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '2'
      position: 27734972
    locus_GRCh38:
      chromosome: '2'
      position: 27512105
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - South Asian=13532
    - European=20298
    - NR=149821
    gwas_catalog_id: GCST004894
    neg_log_pval: 16.69897000433602
    otg_id: GCST004894
    pubmed_id: '28869590'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000084734
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000084734 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000084734
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '2'
      position: 27741237
    locus_GRCh38:
      chromosome: '2'
      position: 27518370
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=655666
    - South Asian=3650
    gwas_catalog_id: GCST006867
    neg_log_pval: 20.30102999566398
    otg_id: GCST006867
    pubmed_id: '30054458'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000084734
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000084734 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000084734
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '2'
      position: 27741237
    locus_GRCh38:
      chromosome: '2'
      position: 27518370
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=407701
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 11.072116589669292
    otg_id: SAIGE_250_2
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000084734
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000084734 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000084734
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '2'
      position: 27742603
    locus_GRCh38:
      chromosome: '2'
      position: 27519736
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - East Asian=15000
    - South East Asian=2034
    - Asian unspecified=1783
    gwas_catalog_id: GCST001351
    neg_log_pval: 11.0
    otg_id: GCST001351
    pubmed_id: '22158537'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000101076
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000101076 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000101076
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '20'
      position: 42946966
    locus_GRCh38:
      chromosome: '20'
      position: 44318326
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=69033
    gwas_catalog_id: GCST005047
    neg_log_pval: 7.698970004336019
    otg_id: GCST005047
    pubmed_id: '22885922'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000101076
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000101076 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000101076
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '20'
      position: 42964514
    locus_GRCh38:
      chromosome: '20'
      position: 44335874
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - South Asian=13532
    - European=20298
    - NR=149821
    gwas_catalog_id: GCST004894
    neg_log_pval: 9.397940008672037
    otg_id: GCST004894
    pubmed_id: '28869590'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000101076
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000101076 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000101076
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '20'
      position: 42989267
    locus_GRCh38:
      chromosome: '20'
      position: 44360627
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - South Asian=20019
    gwas_catalog_id: GCST001213
    neg_log_pval: 9.522878745280337
    otg_id: GCST001213
    pubmed_id: '21874001'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000101076
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000101076 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000101076
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '20'
      position: 42989267
    locus_GRCh38:
      chromosome: '20'
      position: 44360627
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=69033
    - East Asian=18817
    - South Asian=20019
    - Hispanic or Latin American=2583
    gwas_catalog_id: GCST002352
    neg_log_pval: 7.301029995663981
    otg_id: GCST002352
    pubmed_id: '24509480'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000101076
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000101076 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000101076
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '20'
      position: 42989267
    locus_GRCh38:
      chromosome: '20'
      position: 44360627
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - East Asian=191764
    gwas_catalog_id: GCST007847
    neg_log_pval: 8.397940008672037
    otg_id: GCST007847
    pubmed_id: '30718926'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000101076
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000101076 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000101076
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '20'
      position: 42989777
    locus_GRCh38:
      chromosome: '20'
      position: 44361137
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=655666
    - South Asian=3650
    gwas_catalog_id: GCST006867
    neg_log_pval: 7.698970004336019
    otg_id: GCST006867
    pubmed_id: '30054458'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000101076
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000101076 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000101076
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '20'
      position: 43001721
    locus_GRCh38:
      chromosome: '20'
      position: 44373081
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    - South Asian, East Asian, African American or Afro-Caribbean, Hispanic or Latin
      American=153287
    gwas_catalog_id: GCST007515
    neg_log_pval: 7.522878745280337
    otg_id: GCST007515
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000101076
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000101076 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000101076
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '20'
      position: 43042364
    locus_GRCh38:
      chromosome: '20'
      position: 44413724
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=459000
    gwas_catalog_id: GCST007077
    neg_log_pval: 10.698970004336019
    otg_id: GCST007077
    pubmed_id: '30595370'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000101076
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000101076 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000101076
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '20'
      position: 43042364
    locus_GRCh38:
      chromosome: '20'
      position: 44413724
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    - South Asian, East Asian, African American or Afro-Caribbean, Hispanic or Latin
      American=153287
    gwas_catalog_id: GCST007516
    neg_log_pval: 7.301029995663981
    otg_id: GCST007516
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000101076
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000101076 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000101076
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '20'
      position: 43042364
    locus_GRCh38:
      chromosome: '20'
      position: 44413724
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes (adjusted for BMI)
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    - South Asian, East Asian, African American or Afro-Caribbean, Hispanic or Latin
      American=153287
    gwas_catalog_id: GCST007516
    neg_log_pval: 10.522878745280337
    otg_id: GCST007516
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000100344
        at this locus. There is a single line of pertubation evidence (3P) linking
        T2D to ENSG00000100344 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000100344
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '22'
      position: 44324727
    locus_GRCh38:
      chromosome: '22'
      position: 43928847
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes (adjusted for BMI)
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    gwas_catalog_id: GCST007518
    neg_log_pval: 7.522878745280337
    otg_id: GCST007518
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000100344
        at this locus. There is a single line of pertubation evidence (3P) linking
        T2D to ENSG00000100344 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000100344
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '22'
      position: 44324727
    locus_GRCh38:
      chromosome: '22'
      position: 43928847
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes (adjusted for BMI)
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    - South Asian, East Asian, African American or Afro-Caribbean, Hispanic or Latin
      American=153287
    gwas_catalog_id: GCST007515
    neg_log_pval: 9.698970004336019
    otg_id: GCST007515
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000100344
        at this locus. There is a single line of pertubation evidence (3P) linking
        T2D to ENSG00000100344 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000100344
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '22'
      position: 44324727
    locus_GRCh38:
      chromosome: '22'
      position: 43928847
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=655666
    - South Asian=3650
    gwas_catalog_id: GCST006867
    neg_log_pval: 9.522878745280337
    otg_id: GCST006867
    pubmed_id: '30054458'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000100344
        at this locus. There is a single line of pertubation evidence (3P) linking
        T2D to ENSG00000100344 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000100344
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '22'
      position: 44377442
    locus_GRCh38:
      chromosome: '22'
      position: 43981562
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=459000
    gwas_catalog_id: GCST007077
    neg_log_pval: 11.0
    otg_id: GCST007077
    pubmed_id: '30595370'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000132170
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000132170 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000132170
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 12329783
    locus_GRCh38:
      chromosome: '3'
      position: 12288284
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=69033
    gwas_catalog_id: GCST005047
    neg_log_pval: 8.795880017344075
    otg_id: GCST005047
    pubmed_id: '22885922'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000132170
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000132170 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000132170
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 12392272
    locus_GRCh38:
      chromosome: '3'
      position: 12350773
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    gwas_catalog_id: GCST007518
    neg_log_pval: 16.0
    otg_id: GCST007518
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000132170
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000132170 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000132170
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 12393125
    locus_GRCh38:
      chromosome: '3'
      position: 12351626
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes (adjusted for BMI)
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    - South Asian, East Asian, African American or Afro-Caribbean, Hispanic or Latin
      American=153287
    gwas_catalog_id: GCST007515
    neg_log_pval: 17.0
    otg_id: GCST007515
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000132170
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000132170 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000132170
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 12393125
    locus_GRCh38:
      chromosome: '3'
      position: 12351626
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - South Asian=13532
    - European=20298
    - NR=149821
    gwas_catalog_id: GCST004894
    neg_log_pval: 13.698970004336019
    otg_id: GCST004894_2
    pubmed_id: '28869590'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000132170
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000132170 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000132170
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 12393125
    locus_GRCh38:
      chromosome: '3'
      position: 12351626
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes [EA]
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    gwas_catalog_id: GCST007517
    neg_log_pval: 11.301029995663981
    otg_id: GCST007517
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000132170
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000132170 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000132170
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 12393125
    locus_GRCh38:
      chromosome: '3'
      position: 12351626
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    - South Asian, East Asian, African American or Afro-Caribbean, Hispanic or Latin
      American=153287
    gwas_catalog_id: GCST007516
    neg_log_pval: 18.522878745280337
    otg_id: GCST007516
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000132170
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000132170 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000132170
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 12393125
    locus_GRCh38:
      chromosome: '3'
      position: 12351626
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes (adjusted for BMI)
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=69033
    - East Asian=18817
    - South Asian=20019
    - Hispanic or Latin American=2583
    gwas_catalog_id: GCST002352
    neg_log_pval: 9.221848749616356
    otg_id: GCST002352
    pubmed_id: '24509480'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000132170
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000132170 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000132170
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 12393125
    locus_GRCh38:
      chromosome: '3'
      position: 12351626
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - South Asian=13532
    - European=20298
    - NR=149821
    gwas_catalog_id: GCST004894
    neg_log_pval: 18.69897000433602
    otg_id: GCST004894
    pubmed_id: '28869590'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000132170
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000132170 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000132170
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 12393125
    locus_GRCh38:
      chromosome: '3'
      position: 12351626
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=655666
    - South Asian=3650
    gwas_catalog_id: GCST006867
    neg_log_pval: 23.69897000433602
    otg_id: GCST006867
    pubmed_id: '30054458'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000132170
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000132170 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000132170
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 12394840
    locus_GRCh38:
      chromosome: '3'
      position: 12353341
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=70127
    gwas_catalog_id: GCST005413
    neg_log_pval: 15.357832365595055
    otg_id: GCST005413
    pubmed_id: '29358691'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000132170
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000132170 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000132170
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '3'
      position: 12396913
    locus_GRCh38:
      chromosome: '3'
      position: 12355414
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=655666
    - South Asian=3650
    gwas_catalog_id: GCST006867
    neg_log_pval: 7.698970004336019
    otg_id: GCST006867
    pubmed_id: '30054458'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: The is a likely causal T2D variant (2C) for ENSG00000163581 at
        this locus. There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000163581 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000163581 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000163581
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '3'
      position: 170766618
    locus_GRCh38:
      chromosome: '3'
      position: 171048829
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - South Asian=13532
    - European=20298
    - NR=149821
    gwas_catalog_id: GCST004894
    neg_log_pval: 14.096910013008056
    otg_id: GCST004894_2
    pubmed_id: '28869590'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000109501
        at this locus. There are multiple lines of regulatory evidence (2R) linking
        T2D to ENSG00000109501 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000109501 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000109501
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '4'
      position: 6270056
    locus_GRCh38:
      chromosome: '4'
      position: 6268329
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes [EA]
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=1376
    gwas_catalog_id: GCST000478
    neg_log_pval: 8.0
    otg_id: GCST000478
    pubmed_id: '19734900'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000109501
        at this locus. There are multiple lines of regulatory evidence (2R) linking
        T2D to ENSG00000109501 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000109501 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000109501
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '4'
      position: 6270056
    locus_GRCh38:
      chromosome: '4'
      position: 6268329
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - South Asian=13532
    - European=20298
    - NR=149821
    gwas_catalog_id: GCST004894
    neg_log_pval: 15.0
    otg_id: GCST004894
    pubmed_id: '28869590'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000109501
        at this locus. There are multiple lines of regulatory evidence (2R) linking
        T2D to ENSG00000109501 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000109501 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000109501
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '4'
      position: 6270056
    locus_GRCh38:
      chromosome: '4'
      position: 6268329
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=69033
    - East Asian=18817
    - South Asian=20019
    - Hispanic or Latin American=2583
    gwas_catalog_id: GCST002352
    neg_log_pval: 8.698970004336019
    otg_id: GCST002352
    pubmed_id: '24509480'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000109501
        at this locus. There are multiple lines of regulatory evidence (2R) linking
        T2D to ENSG00000109501 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000109501 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000109501
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '4'
      position: 6289986
    locus_GRCh38:
      chromosome: '4'
      position: 6288259
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=407701
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 18.367542707815275
    otg_id: SAIGE_250_2
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000109501
        at this locus. There are multiple lines of regulatory evidence (2R) linking
        T2D to ENSG00000109501 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000109501 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000109501
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '4'
      position: 6299914
    locus_GRCh38:
      chromosome: '4'
      position: 6298187
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    gwas_catalog_id: GCST007518
    neg_log_pval: 16.69897000433602
    otg_id: GCST007518
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000109501
        at this locus. There are multiple lines of regulatory evidence (2R) linking
        T2D to ENSG00000109501 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000109501 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000109501
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '4'
      position: 6302519
    locus_GRCh38:
      chromosome: '4'
      position: 6300792
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes (adjusted for BMI)
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    - South Asian, East Asian, African American or Afro-Caribbean, Hispanic or Latin
      American=153287
    gwas_catalog_id: GCST007516
    neg_log_pval: 20.154901959985743
    otg_id: GCST007516
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000109501
        at this locus. There are multiple lines of regulatory evidence (2R) linking
        T2D to ENSG00000109501 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000109501 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000109501
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '4'
      position: 6302519
    locus_GRCh38:
      chromosome: '4'
      position: 6300792
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes (adjusted for BMI)
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=459000
    gwas_catalog_id: GCST007077
    neg_log_pval: 17.522878745280337
    otg_id: GCST007077
    pubmed_id: '30595370'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000109501
        at this locus. There are multiple lines of regulatory evidence (2R) linking
        T2D to ENSG00000109501 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000109501 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000109501
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '4'
      position: 6302519
    locus_GRCh38:
      chromosome: '4'
      position: 6300792
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    - South Asian, East Asian, African American or Afro-Caribbean, Hispanic or Latin
      American=153287
    gwas_catalog_id: GCST007515
    neg_log_pval: 24.0
    otg_id: GCST007515
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000109501
        at this locus. There are multiple lines of regulatory evidence (2R) linking
        T2D to ENSG00000109501 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000109501 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000109501
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '4'
      position: 6302519
    locus_GRCh38:
      chromosome: '4'
      position: 6300792
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    gwas_catalog_id: GCST007517
    neg_log_pval: 19.154901959985743
    otg_id: GCST007517
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000109501
        at this locus. There are multiple lines of regulatory evidence (2R) linking
        T2D to ENSG00000109501 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000109501 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000109501
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '4'
      position: 6302519
    locus_GRCh38:
      chromosome: '4'
      position: 6300792
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=655666
    - South Asian=3650
    gwas_catalog_id: GCST006867
    neg_log_pval: 33.221848749616356
    otg_id: GCST006867
    pubmed_id: '30054458'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000109501
        at this locus. There are multiple lines of regulatory evidence (2R) linking
        T2D to ENSG00000109501 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000109501 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000109501
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '4'
      position: 6303022
    locus_GRCh38:
      chromosome: '4'
      position: 6301295
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=47117
    gwas_catalog_id: GCST000712
    neg_log_pval: 7.522878745280337
    otg_id: GCST000712
    pubmed_id: '20581827'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000109501
        at this locus. There are multiple lines of regulatory evidence (2R) linking
        T2D to ENSG00000109501 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000109501 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000109501
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '4'
      position: 6303022
    locus_GRCh38:
      chromosome: '4'
      position: 6301295
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=69033
    gwas_catalog_id: GCST005047
    neg_log_pval: 8.366531544420413
    otg_id: GCST005047
    pubmed_id: '22885922'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000109501
        at this locus. There are multiple lines of regulatory evidence (2R) linking
        T2D to ENSG00000109501 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000109501 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000109501
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '4'
      position: 6303955
    locus_GRCh38:
      chromosome: '4'
      position: 6302228
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - East Asian=191764
    gwas_catalog_id: GCST007847
    neg_log_pval: 7.698970004336019
    otg_id: GCST007847
    pubmed_id: '30718926'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000109501
        at this locus. There are multiple lines of regulatory evidence (2R) linking
        T2D to ENSG00000109501 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000109501 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000109501
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '4'
      position: 6333669
    locus_GRCh38:
      chromosome: '4'
      position: 6331942
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=455607
    gwas_catalog_id: GCST006868
    neg_log_pval: 8.397940008672037
    otg_id: GCST006868
    pubmed_id: '30054458'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000154122
        at this locus. There is a single line of pertubation evidence (3P) linking
        T2D to ENSG00000154122 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000154122
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 14751305
    locus_GRCh38:
      chromosome: '5'
      position: 14751196
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=407701
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 7.723538195826756
    otg_id: SAIGE_250_2
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000154122
        at this locus. There is a single line of pertubation evidence (3P) linking
        T2D to ENSG00000154122 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000154122
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 14751305
    locus_GRCh38:
      chromosome: '5'
      position: 14751196
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=459000
    gwas_catalog_id: GCST007077
    neg_log_pval: 12.522878745280337
    otg_id: GCST007077
    pubmed_id: '30595370'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000154122
        at this locus. There is a single line of pertubation evidence (3P) linking
        T2D to ENSG00000154122 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000154122
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 14768092
    locus_GRCh38:
      chromosome: '5'
      position: 14767983
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=655666
    - South Asian=3650
    gwas_catalog_id: GCST006867
    neg_log_pval: 8.522878745280337
    otg_id: GCST006867
    pubmed_id: '30054458'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000154122
        at this locus. There is a single line of pertubation evidence (3P) linking
        T2D to ENSG00000154122 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000154122
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '5'
      position: 14847331
    locus_GRCh38:
      chromosome: '5'
      position: 14847222
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    - South Asian, East Asian, African American or Afro-Caribbean, Hispanic or Latin
      American=153287
    gwas_catalog_id: GCST007515
    neg_log_pval: 14.698970004336019
    otg_id: GCST007515
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000152359
        at this locus. There is a single line of pertubation evidence (3P) linking
        T2D to ENSG00000152359 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000152359
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 75003678
    locus_GRCh38:
      chromosome: '5'
      position: 75707853
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=655666
    - South Asian=3650
    gwas_catalog_id: GCST006867
    neg_log_pval: 7.522878745280337
    otg_id: GCST006867
    pubmed_id: '30054458'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000152359
        at this locus. There is a single line of pertubation evidence (3P) linking
        T2D to ENSG00000152359 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000152359
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 75003678
    locus_GRCh38:
      chromosome: '5'
      position: 75707853
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    gwas_catalog_id: GCST007517
    neg_log_pval: 11.301029995663981
    otg_id: GCST007517
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000152359
        at this locus. There is a single line of pertubation evidence (3P) linking
        T2D to ENSG00000152359 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000152359
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 75003678
    locus_GRCh38:
      chromosome: '5'
      position: 75707853
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=655666
    - South Asian=3650
    gwas_catalog_id: GCST006867
    neg_log_pval: 17.0
    otg_id: GCST006867
    pubmed_id: '30054458'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000145730
        at this locus. There are multiple lines of regulatory evidence (2R) linking
        T2D to ENSG00000145730 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000145730 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000145730
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 102100576
    locus_GRCh38:
      chromosome: '5'
      position: 102764872
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=459000
    gwas_catalog_id: GCST007077
    neg_log_pval: 8.397940008672037
    otg_id: GCST007077
    pubmed_id: '30595370'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000145730
        at this locus. There are multiple lines of regulatory evidence (2R) linking
        T2D to ENSG00000145730 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000145730 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000145730
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 102247916
    locus_GRCh38:
      chromosome: '5'
      position: 102912212
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=407701
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 11.85078088734462
    otg_id: SAIGE_250_2
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000145730
        at this locus. There are multiple lines of regulatory evidence (2R) linking
        T2D to ENSG00000145730 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000145730 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000145730
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 102331465
    locus_GRCh38:
      chromosome: '5'
      position: 102995761
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=455607
    gwas_catalog_id: GCST006868
    neg_log_pval: 13.397940008672037
    otg_id: GCST006868
    pubmed_id: '30054458'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000145730
        at this locus. There are multiple lines of regulatory evidence (2R) linking
        T2D to ENSG00000145730 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000145730 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000145730
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 102338739
    locus_GRCh38:
      chromosome: '5'
      position: 103003035
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=407701
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 11.021363051615525
    otg_id: SAIGE_250_2
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000145730
        at this locus. There are multiple lines of regulatory evidence (2R) linking
        T2D to ENSG00000145730 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000145730 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000145730
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 102338739
    locus_GRCh38:
      chromosome: '5'
      position: 103003035
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    gwas_catalog_id: GCST007518
    neg_log_pval: 12.397940008672037
    otg_id: GCST007518
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000145730
        at this locus. There are multiple lines of regulatory evidence (2R) linking
        T2D to ENSG00000145730 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000145730 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000145730
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 102338811
    locus_GRCh38:
      chromosome: '5'
      position: 103003107
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes (adjusted for BMI)
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    - South Asian, East Asian, African American or Afro-Caribbean, Hispanic or Latin
      American=153287
    gwas_catalog_id: GCST007516
    neg_log_pval: 14.154901959985743
    otg_id: GCST007516
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000145730
        at this locus. There are multiple lines of regulatory evidence (2R) linking
        T2D to ENSG00000145730 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000145730 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000145730
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 102338811
    locus_GRCh38:
      chromosome: '5'
      position: 103003107
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes (adjusted for BMI)
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    gwas_catalog_id: GCST007517
    neg_log_pval: 11.221848749616356
    otg_id: GCST007517
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000145730
        at this locus. There are multiple lines of regulatory evidence (2R) linking
        T2D to ENSG00000145730 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000145730 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000145730
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 102338811
    locus_GRCh38:
      chromosome: '5'
      position: 103003107
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    - South Asian, East Asian, African American or Afro-Caribbean, Hispanic or Latin
      American=153287
    gwas_catalog_id: GCST007515
    neg_log_pval: 16.0
    otg_id: GCST007515
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000145730
        at this locus. There are multiple lines of regulatory evidence (2R) linking
        T2D to ENSG00000145730 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000145730 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000145730
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 102338811
    locus_GRCh38:
      chromosome: '5'
      position: 103003107
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=459000
    gwas_catalog_id: GCST007077
    neg_log_pval: 15.397940008672037
    otg_id: GCST007077
    pubmed_id: '30595370'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000145730
        at this locus. There are multiple lines of regulatory evidence (2R) linking
        T2D to ENSG00000145730 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000145730 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000145730
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 102422968
    locus_GRCh38:
      chromosome: '5'
      position: 103087264
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - East Asian=191764
    gwas_catalog_id: GCST007847
    neg_log_pval: 7.522878745280337
    otg_id: GCST007847
    pubmed_id: '30718926'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000124782
        at this locus. There is a single line of pertubation evidence (3P) linking
        T2D to ENSG00000124782 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000124782
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 7226959
    locus_GRCh38:
      chromosome: '6'
      position: 7226726
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    - South Asian, East Asian, African American or Afro-Caribbean, Hispanic or Latin
      American=153287
    gwas_catalog_id: GCST007515
    neg_log_pval: 13.0
    otg_id: GCST007515
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000124782
        at this locus. There is a single line of pertubation evidence (3P) linking
        T2D to ENSG00000124782 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000124782
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 7231843
    locus_GRCh38:
      chromosome: '6'
      position: 7231610
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    gwas_catalog_id: GCST007518
    neg_log_pval: 12.698970004336019
    otg_id: GCST007518
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000124782
        at this locus. There is a single line of pertubation evidence (3P) linking
        T2D to ENSG00000124782 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000124782
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 7231843
    locus_GRCh38:
      chromosome: '6'
      position: 7231610
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes (adjusted for BMI)
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    - South Asian, East Asian, African American or Afro-Caribbean, Hispanic or Latin
      American=153287
    gwas_catalog_id: GCST007516
    neg_log_pval: 16.69897000433602
    otg_id: GCST007516
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000124782
        at this locus. There is a single line of pertubation evidence (3P) linking
        T2D to ENSG00000124782 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000124782
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 7231843
    locus_GRCh38:
      chromosome: '6'
      position: 7231610
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes (adjusted for BMI)
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    gwas_catalog_id: GCST007517
    neg_log_pval: 11.698970004336019
    otg_id: GCST007517
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000124782
        at this locus. There is a single line of pertubation evidence (3P) linking
        T2D to ENSG00000124782 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000124782
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 7231843
    locus_GRCh38:
      chromosome: '6'
      position: 7231610
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=459000
    gwas_catalog_id: GCST007077
    neg_log_pval: 14.698970004336019
    otg_id: GCST007077
    pubmed_id: '30595370'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000124782
        at this locus. There is a single line of pertubation evidence (3P) linking
        T2D to ENSG00000124782 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000124782
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 7231843
    locus_GRCh38:
      chromosome: '6'
      position: 7231610
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=407701
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 8.844663962534938
    otg_id: SAIGE_250_2
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000124782
        at this locus. There is a single line of pertubation evidence (3P) linking
        T2D to ENSG00000124782 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000124782
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 7231843
    locus_GRCh38:
      chromosome: '6'
      position: 7231610
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=69033
    - East Asian=18817
    - South Asian=20019
    - Hispanic or Latin American=2583
    gwas_catalog_id: GCST002352
    neg_log_pval: 9.0
    otg_id: GCST002352
    pubmed_id: '24509480'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000124782
        at this locus. There is a single line of pertubation evidence (3P) linking
        T2D to ENSG00000124782 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000124782
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 7258617
    locus_GRCh38:
      chromosome: '6'
      position: 7258384
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=655666
    - South Asian=3650
    gwas_catalog_id: GCST006867
    neg_log_pval: 10.522878745280337
    otg_id: GCST006867
    pubmed_id: '30054458'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000124782
        at this locus. There is a single line of pertubation evidence (3P) linking
        T2D to ENSG00000124782 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000124782
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 7281654
    locus_GRCh38:
      chromosome: '6'
      position: 7281421
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - South Asian=13532
    - European=20298
    - NR=149821
    gwas_catalog_id: GCST004894
    neg_log_pval: 7.698970004336019
    otg_id: GCST004894
    pubmed_id: '28869590'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000124782
        at this locus. There is a single line of pertubation evidence (3P) linking
        T2D to ENSG00000124782 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000124782
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 7290437
    locus_GRCh38:
      chromosome: '6'
      position: 7290204
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - South Asian=13532
    - European=20298
    - NR=149821
    gwas_catalog_id: GCST004894
    neg_log_pval: 9.0
    otg_id: GCST004894_2
    pubmed_id: '28869590'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000124782
        at this locus. There is a single line of pertubation evidence (3P) linking
        T2D to ENSG00000124782 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000124782
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 7290437
    locus_GRCh38:
      chromosome: '6'
      position: 7290204
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes [EA]
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - South Asian=13532
    - European=20298
    - NR=149821
    gwas_catalog_id: GCST004894
    neg_log_pval: 11.698970004336019
    otg_id: GCST004894_2
    pubmed_id: '28869590'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000136267 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000136267 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000136267
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '7'
      position: 14898282
    locus_GRCh38:
      chromosome: '7'
      position: 14858657
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes [EA]
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - South Asian=13532
    - European=20298
    - NR=149821
    gwas_catalog_id: GCST004894
    neg_log_pval: 12.0
    otg_id: GCST004894
    pubmed_id: '28869590'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000136267 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000136267 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000136267
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '7'
      position: 14898282
    locus_GRCh38:
      chromosome: '7'
      position: 14858657
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - East Asian=191764
    gwas_catalog_id: GCST007847
    neg_log_pval: 11.698970004336019
    otg_id: GCST007847
    pubmed_id: '30718926'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000136267 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000136267 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000136267
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '7'
      position: 14898282
    locus_GRCh38:
      chromosome: '7'
      position: 14858657
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=655666
    - South Asian=3650
    gwas_catalog_id: GCST006867
    neg_log_pval: 14.698970004336019
    otg_id: GCST006867
    pubmed_id: '30054458'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000136267 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000136267 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000136267
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '7'
      position: 14898282
    locus_GRCh38:
      chromosome: '7'
      position: 14858657
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=69033
    gwas_catalog_id: GCST005047
    neg_log_pval: 8.221848749616356
    otg_id: GCST005047
    pubmed_id: '22885922'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000136267 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000136267 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000136267
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '7'
      position: 15053589
    locus_GRCh38:
      chromosome: '7'
      position: 15013964
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=459000
    gwas_catalog_id: GCST007077
    neg_log_pval: 14.0
    otg_id: GCST007077
    pubmed_id: '30595370'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000136267 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000136267 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000136267
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '7'
      position: 15063926
    locus_GRCh38:
      chromosome: '7'
      position: 15024301
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=407701
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 12.492144128304169
    otg_id: SAIGE_250_2
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000136267 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000136267 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000136267
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '7'
      position: 15063926
    locus_GRCh38:
      chromosome: '7'
      position: 15024301
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=655666
    - South Asian=3650
    gwas_catalog_id: GCST006867
    neg_log_pval: 18.522878745280337
    otg_id: GCST006867
    pubmed_id: '30054458'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000136267 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000136267 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000136267
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '7'
      position: 15064255
    locus_GRCh38:
      chromosome: '7'
      position: 15024630
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - South Asian=13532
    - European=20298
    - NR=149821
    gwas_catalog_id: GCST004894
    neg_log_pval: 9.0
    otg_id: GCST004894
    pubmed_id: '28869590'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Ed Mountjoy
      description: There are multiple lines of regulatory evidence (2R) linking T2D
        to ENSG00000136267 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000136267 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000136267
    highest_confidence: Medium
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '7'
      position: 15064309
    locus_GRCh38:
      chromosome: '7'
      position: 15024684
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - East Asian=191764
    gwas_catalog_id: GCST007847
    neg_log_pval: 11.301029995663981
    otg_id: GCST007847
    pubmed_id: '30718926'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000106633
        at this locus. There is a single line of regulatory evidence (3R) linking
        T2D to ENSG00000106633 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000106633 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000106633
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '7'
      position: 44174857
    locus_GRCh38:
      chromosome: '7'
      position: 44135258
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=655666
    - South Asian=3650
    gwas_catalog_id: GCST006867
    neg_log_pval: 8.397940008672037
    otg_id: GCST006867
    pubmed_id: '30054458'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000106633
        at this locus. There is a single line of regulatory evidence (3R) linking
        T2D to ENSG00000106633 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000106633 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000106633
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '7'
      position: 44248828
    locus_GRCh38:
      chromosome: '7'
      position: 44209229
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - East Asian=15000
    - South East Asian=2034
    - Asian unspecified=1783
    gwas_catalog_id: GCST001351
    neg_log_pval: 10.301029995663981
    otg_id: GCST001351
    pubmed_id: '22158537'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000106331
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000106331 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000106331
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '7'
      position: 127164958
    locus_GRCh38:
      chromosome: '7'
      position: 127524904
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - East Asian=41646
    gwas_catalog_id: GCST003400
    neg_log_pval: 9.096910013008056
    otg_id: GCST003400_2
    pubmed_id: '26818947'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000106331
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000106331 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000106331
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '7'
      position: 127237312
    locus_GRCh38:
      chromosome: '7'
      position: 127597258
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes [Japanese]
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - East Asian=1639
    gwas_catalog_id: GCST001919
    neg_log_pval: 9.698970004336019
    otg_id: GCST001919
    pubmed_id: '23532257'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000106331
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000106331 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000106331
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '7'
      position: 127246903
    locus_GRCh38:
      chromosome: '7'
      position: 127606849
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes [East Asian]
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    - South Asian, East Asian, African American or Afro-Caribbean, Hispanic or Latin
      American=153287
    gwas_catalog_id: GCST007516
    neg_log_pval: 12.397940008672037
    otg_id: GCST007516
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000106331
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000106331 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000106331
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '7'
      position: 127253550
    locus_GRCh38:
      chromosome: '7'
      position: 127613496
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes (adjusted for BMI)
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    - South Asian, East Asian, African American or Afro-Caribbean, Hispanic or Latin
      American=153287
    gwas_catalog_id: GCST007515
    neg_log_pval: 11.698970004336019
    otg_id: GCST007515
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000106331
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000106331 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000106331
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '7'
      position: 127253550
    locus_GRCh38:
      chromosome: '7'
      position: 127613496
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - East Asian=191764
    gwas_catalog_id: GCST007847
    neg_log_pval: 73.39794000867204
    otg_id: GCST007847
    pubmed_id: '30718926'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000106331
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000106331 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000106331
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '7'
      position: 127253550
    locus_GRCh38:
      chromosome: '7'
      position: 127613496
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=655666
    - South Asian=3650
    gwas_catalog_id: GCST006867
    neg_log_pval: 8.0
    otg_id: GCST006867
    pubmed_id: '30054458'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000130675
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000130675 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000130675
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '7'
      position: 156983847
    locus_GRCh38:
      chromosome: '7'
      position: 157191153
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    - South Asian, East Asian, African American or Afro-Caribbean, Hispanic or Latin
      American=153287
    gwas_catalog_id: GCST007515
    neg_log_pval: 8.154901959985743
    otg_id: GCST007515
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000175445
        at this locus. There is a single line of regulatory evidence (3R) linking
        T2D to ENSG00000175445 at this locus. There is a single line of pertubation
        evidence (3P) linking T2D to ENSG00000175445 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000175445
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '8'
      position: 19819724
    locus_GRCh38:
      chromosome: '8'
      position: 19962213
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=655666
    - South Asian=3650
    gwas_catalog_id: GCST006867
    neg_log_pval: 7.522878745280337
    otg_id: GCST006867
    pubmed_id: '30054458'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000175445
        at this locus. There is a single line of regulatory evidence (3R) linking
        T2D to ENSG00000175445 at this locus. There is a single line of pertubation
        evidence (3P) linking T2D to ENSG00000175445 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000175445
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '8'
      position: 19852310
    locus_GRCh38:
      chromosome: '8'
      position: 19994799
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - East Asian=191764
    gwas_catalog_id: GCST007847
    neg_log_pval: 7.522878745280337
    otg_id: GCST007847
    pubmed_id: '30718926'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000164756
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000164756 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000164756
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '8'
      position: 118024315
    locus_GRCh38:
      chromosome: '8'
      position: 117012076
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=56799
    - African American or Afro-Caribbean=3571
    - East Asian=4735
    - Hispanic or Latin American=6499
    gwas_catalog_id: GCST003619
    neg_log_pval: 11.0
    otg_id: GCST003619
    pubmed_id: '27189021'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000164756
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000164756 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000164756
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '8'
      position: 118184783
    locus_GRCh38:
      chromosome: '8'
      position: 117172544
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    gwas_catalog_id: GCST007517
    neg_log_pval: 29.221848749616356
    otg_id: GCST007517
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000164756
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000164756 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000164756
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '8'
      position: 118184783
    locus_GRCh38:
      chromosome: '8'
      position: 117172544
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - East Asian=1022
    gwas_catalog_id: GCST000383
    neg_log_pval: 13.698970004336019
    otg_id: GCST000383
    pubmed_id: '19401414'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000164756
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000164756 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000164756
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '8'
      position: 118184783
    locus_GRCh38:
      chromosome: '8'
      position: 117172544
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    - South Asian, East Asian, African American or Afro-Caribbean, Hispanic or Latin
      American=153287
    gwas_catalog_id: GCST007515
    neg_log_pval: 46.69897000433602
    otg_id: GCST007515
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000164756
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000164756 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000164756
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '8'
      position: 118184783
    locus_GRCh38:
      chromosome: '8'
      position: 117172544
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=70127
    gwas_catalog_id: GCST005413
    neg_log_pval: 14.522878745280337
    otg_id: GCST005413
    pubmed_id: '29358691'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000164756
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000164756 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000164756
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '8'
      position: 118184783
    locus_GRCh38:
      chromosome: '8'
      position: 117172544
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    gwas_catalog_id: GCST007518
    neg_log_pval: 35.096910013008056
    otg_id: GCST007518
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000164756
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000164756 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000164756
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '8'
      position: 118184783
    locus_GRCh38:
      chromosome: '8'
      position: 117172544
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes (adjusted for BMI)
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - South Asian=13532
    - European=20298
    - NR=149821
    gwas_catalog_id: GCST004894
    neg_log_pval: 41.39794000867204
    otg_id: GCST004894
    pubmed_id: '28869590'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000164756
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000164756 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000164756
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '8'
      position: 118184783
    locus_GRCh38:
      chromosome: '8'
      position: 117172544
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - South Asian=13532
    - European=20298
    - NR=149821
    gwas_catalog_id: GCST004894
    neg_log_pval: 21.69897000433602
    otg_id: GCST004894_2
    pubmed_id: '28869590'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000164756
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000164756 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000164756
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '8'
      position: 118184783
    locus_GRCh38:
      chromosome: '8'
      position: 117172544
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes [EA]
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=298957
    - South Asian, East Asian, African American or Afro-Caribbean, Hispanic or Latin
      American=153287
    gwas_catalog_id: GCST007516
    neg_log_pval: 47.0
    otg_id: GCST007516
    pubmed_id: '29632382'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000164756
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000164756 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000164756
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '8'
      position: 118184783
    locus_GRCh38:
      chromosome: '8'
      position: 117172544
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes (adjusted for BMI)
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=407701
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 19.041914151478913
    otg_id: SAIGE_250_2
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000164756
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000164756 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000164756
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '8'
      position: 118184783
    locus_GRCh38:
      chromosome: '8'
      position: 117172544
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=2335
    gwas_catalog_id: GCST000024
    neg_log_pval: 7.301029995663981
    otg_id: GCST000024_2
    pubmed_id: '17463248'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000164756
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000164756 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000164756
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '8'
      position: 118184783
    locus_GRCh38:
      chromosome: '8'
      position: 117172544
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes [DGI+FUSION+WTCCC]
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - East Asian=191764
    gwas_catalog_id: GCST007847
    neg_log_pval: 29.522878745280337
    otg_id: GCST007847
    pubmed_id: '30718926'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000164756
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000164756 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000164756
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '8'
      position: 118184783
    locus_GRCh38:
      chromosome: '8'
      position: 117172544
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=4862
    gwas_catalog_id: GCST000025
    neg_log_pval: 7.301029995663981
    otg_id: GCST000025_2
    pubmed_id: '17463249'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000164756
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000164756 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000164756
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '8'
      position: 118184783
    locus_GRCh38:
      chromosome: '8'
      position: 117172544
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes [DGI+FUSION+WTCCC]
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=2931
    gwas_catalog_id: GCST000028
    neg_log_pval: 7.301029995663981
    otg_id: GCST000028
    pubmed_id: '17463246'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000164756
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000164756 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000164756
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '8'
      position: 118184783
    locus_GRCh38:
      chromosome: '8'
      position: 117172544
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - East Asian=41646
    gwas_catalog_id: GCST003400
    neg_log_pval: 12.045757490560675
    otg_id: GCST003400_2
    pubmed_id: '26818947'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000164756
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000164756 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000164756
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '8'
      position: 118184783
    locus_GRCh38:
      chromosome: '8'
      position: 117172544
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes [Japanese]
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=459000
    gwas_catalog_id: GCST007077
    neg_log_pval: 23.69897000433602
    otg_id: GCST007077
    pubmed_id: '30595370'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000164756
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000164756 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000164756
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '8'
      position: 118185025
    locus_GRCh38:
      chromosome: '8'
      position: 117172786
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=47117
    gwas_catalog_id: GCST000712
    neg_log_pval: 8.0
    otg_id: GCST000712
    pubmed_id: '20581827'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000164756
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000164756 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000164756
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '8'
      position: 118185025
    locus_GRCh38:
      chromosome: '8'
      position: 117172786
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=655666
    - South Asian=3650
    gwas_catalog_id: GCST006867
    neg_log_pval: 51.69897000433602
    otg_id: GCST006867
    pubmed_id: '30054458'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000164756
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000164756 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000164756
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '8'
      position: 118185025
    locus_GRCh38:
      chromosome: '8'
      position: 117172786
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - NR=60647
    gwas_catalog_id: GCST001550
    neg_log_pval: 7.3979400086720375
    otg_id: GCST001550
    pubmed_id: '22693455'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000164756
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000164756 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000164756
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '8'
      position: 118185025
    locus_GRCh38:
      chromosome: '8'
      position: 117172786
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes [Lean]
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=69033
    - East Asian=18817
    - South Asian=20019
    - Hispanic or Latin American=2583
    gwas_catalog_id: GCST002352
    neg_log_pval: 17.69897000433602
    otg_id: GCST002352
    pubmed_id: '24509480'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000164756
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000164756 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000164756
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '8'
      position: 118185025
    locus_GRCh38:
      chromosome: '8'
      position: 117172786
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=69033
    gwas_catalog_id: GCST005047
    neg_log_pval: 15.2518119729938
    otg_id: GCST005047
    pubmed_id: '22885922'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000164756
        at this locus. There are multiple lines of pertubation evidence (2P) linking
        T2D to ENSG00000164756 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000164756
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '8'
      position: 118220270
    locus_GRCh38:
      chromosome: '8'
      position: 117208031
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - East Asian=15000
    - South East Asian=2034
    - Asian unspecified=1783
    gwas_catalog_id: GCST001351
    neg_log_pval: 13.698970004336019
    otg_id: GCST001351
    pubmed_id: '22158537'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000107249
        at this locus. There is a single line of regulatory evidence (3R) linking
        T2D to ENSG00000107249 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000107249 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000107249
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '9'
      position: 4287466
    locus_GRCh38:
      chromosome: '9'
      position: 4287466
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - South Asian=13532
    - European=20298
    - NR=149821
    gwas_catalog_id: GCST004894
    neg_log_pval: 7.522878745280337
    otg_id: GCST004894
    pubmed_id: '28869590'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000107249
        at this locus. There is a single line of regulatory evidence (3R) linking
        T2D to ENSG00000107249 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000107249 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000107249
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '9'
      position: 4287466
    locus_GRCh38:
      chromosome: '9'
      position: 4287466
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - East Asian=191764
    gwas_catalog_id: GCST007847
    neg_log_pval: 11.096910013008056
    otg_id: GCST007847
    pubmed_id: '30718926'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000107249
        at this locus. There is a single line of regulatory evidence (3R) linking
        T2D to ENSG00000107249 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000107249 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000107249
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '9'
      position: 4289050
    locus_GRCh38:
      chromosome: '9'
      position: 4289050
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=69033
    gwas_catalog_id: GCST005047
    neg_log_pval: 7.468521082957745
    otg_id: GCST005047
    pubmed_id: '22885922'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000107249
        at this locus. There is a single line of regulatory evidence (3R) linking
        T2D to ENSG00000107249 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000107249 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000107249
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '9'
      position: 4290085
    locus_GRCh38:
      chromosome: '9'
      position: 4290085
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=459000
    gwas_catalog_id: GCST007077
    neg_log_pval: 8.301029995663981
    otg_id: GCST007077
    pubmed_id: '30595370'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000107249
        at this locus. There is a single line of regulatory evidence (3R) linking
        T2D to ENSG00000107249 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000107249 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000107249
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '9'
      position: 4291928
    locus_GRCh38:
      chromosome: '9'
      position: 4291928
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - European=655666
    - South Asian=3650
    gwas_catalog_id: GCST006867
    neg_log_pval: 14.522878745280337
    otg_id: GCST006867
    pubmed_id: '30054458'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000107249
        at this locus. There is a single line of regulatory evidence (3R) linking
        T2D to ENSG00000107249 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000107249 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000107249
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '9'
      position: 4291928
    locus_GRCh38:
      chromosome: '9'
      position: 4291928
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    ancestry:
    - East Asian=3712
    gwas_catalog_id: GCST001666
    neg_log_pval: 11.221848749616356
    otg_id: GCST001666
    pubmed_id: '22961080'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Ed Mountjoy
      description: The is a confirmed causal T2D variant (1C) for ENSG00000107249
        at this locus. There is a single line of regulatory evidence (3R) linking
        T2D to ENSG00000107249 at this locus. There are multiple lines of pertubation
        evidence (2P) linking T2D to ENSG00000107249 at this locus.
      source: Type 2 Diabetes Knowledge Portal Effector Genes
    gene_id: ENSG00000107249
    highest_confidence: High
  metadata:
    comments: Gold-standard derived from the list of effector genes at the T2D Knowledge
      Portal
    date_added: '2019-07-17'
    reviewed_by: Ed Mountjoy
    set_label: 'T2D Knowledge Portal '
    submitted_by: Ed Mountjoy
    tags:
    - T2D
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '9'
      position: 4293150
    locus_GRCh38:
      chromosome: '9'
      position: 4293150
  trait_info:
    ontology:
    - EFO_0001360
    reported_trait_name: Type 2 diabetes
    standard_trait_name: type II diabetes mellitus
- association_info:
    gwas_catalog_id: GCST000760
    otg_id: GCST000760
    pubmed_id: '20686565'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Maya Ghoussaini
      description: eQTLs in human liver, subcutaneous adipocytes, SORT1 expression
        arrays, EMSA
      pubmed_id: '20686566'
    - class: functional experimental
      confidence: High
      curated_by: Maya Ghoussaini
      description: 'Original publication looked at variant rs12740374 using the following
        methods: Luciferase, siRNA, gene knockdown and overexpression, measuring lipids
        and lipoproteins'
      pubmed_id: '20686566'
    gene_id: ENSG00000134243
    highest_confidence: High
  metadata:
    comments: 'Cohort: MDC-CC & PARC '
    date_added: '2019-11-08'
    reviewed_by: Maya Ghoussaini
    set_label: otg_curated_191108
    submitted_by: Maya Ghoussaini
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '1'
      position: 109818306
    locus_GRCh38:
      chromosome: '1'
      position: 109275684
  trait_info:
    ontology:
    - EFO_0000612
    reported_trait_name: Myocardial infarction
    standard_trait_name: myocardial infarction
- association_info:
    gwas_catalog_id: GCST000489
    otg_id: GCST000489
    pubmed_id: '19767754'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: Medium
      curated_by: Maya Ghoussaini
      description: ' 3C prostate cancer'
      pubmed_id: '21814516'
    gene_id: ENSG00000136997
    highest_confidence: Medium
  metadata:
    comments: 'Cohort: PRACTICAL '
    date_added: '2019-11-08'
    reviewed_by: Maya Ghoussaini
    set_label: otg_curated_191108
    submitted_by: Maya Ghoussaini
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '8'
      position: 128323181
    locus_GRCh38:
      chromosome: '8'
      position: 127310936
  trait_info:
    ontology:
    - EFO_0001663
    reported_trait_name: Prostate carcinoma
    standard_trait_name: prostate carcinoma
- association_info:
    gwas_catalog_id: GCST000489
    otg_id: GCST000489
    pubmed_id: '19767754'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Maya Ghoussaini
      description: ChIP-seq, 3C prostate cancer, expression
      pubmed_id: '21814516'
    gene_id: ENSG00000249859
    highest_confidence: High
  metadata:
    comments: 'Cohort: PRACTICAL'
    date_added: '2019-11-08'
    reviewed_by: Maya Ghoussaini
    set_label: otg_curated_191108
    submitted_by: Maya Ghoussaini
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '8'
      position: 128323181
    locus_GRCh38:
      chromosome: '8'
      position: 127310936
  trait_info:
    ontology:
    - EFO_0001663
    reported_trait_name: Prostate carcinoma
    standard_trait_name: prostate carcinoma
- association_info:
    gwas_catalog_id: GCST004950
    otg_id: GCST004950
    pubmed_id: '25751625'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Maya Ghoussaini
      description: eQTL, 3C in breast cancer
      pubmed_id: '23540573'
    - class: functional experimental
      confidence: High
      curated_by: Maya Ghoussaini
      description: 'Original publication looked at variant rs554219 using the following
        methods: Luciferase'
      pubmed_id: '23540573'
    gene_id: ENSG00000110092
    highest_confidence: High
  metadata:
    comments: 'Cohort: BCAC'
    date_added: '2019-11-08'
    reviewed_by: Maya Ghoussaini
    set_label: otg_curated_191108
    submitted_by: Maya Ghoussaini
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 69331642
    locus_GRCh38:
      chromosome: '11'
      position: 69516874
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast carcinoma
    standard_trait_name: breast carcinoma
- association_info:
    gwas_catalog_id: GCST004950
    otg_id: GCST004950
    pubmed_id: '25751625'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Maya Ghoussaini
      description: eQTL, 3C in breast cancer
      pubmed_id: '23540573'
    - class: functional experimental
      confidence: High
      curated_by: Maya Ghoussaini
      description: 'Original publication looked at variant rs78540526 using the following
        methods: Luciferase'
      pubmed_id: '23540573'
    gene_id: ENSG00000110092
    highest_confidence: High
  metadata:
    comments: 'Cohort: BCAC'
    date_added: '2019-11-08'
    reviewed_by: Maya Ghoussaini
    set_label: otg_curated_191108
    submitted_by: Maya Ghoussaini
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 69331418
    locus_GRCh38:
      chromosome: '11'
      position: 69516650
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast carcinoma
    standard_trait_name: breast carcinoma
- association_info:
    gwas_catalog_id: GCST004950
    otg_id: GCST004950
    pubmed_id: '25751625'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Maya Ghoussaini
      description: eQTL, 3C in breast cancer
      pubmed_id: '23540573'
    - class: functional experimental
      confidence: High
      curated_by: Maya Ghoussaini
      description: 'Original publication looked at variant rs75915166 using the following
        methods: Luciferase'
      pubmed_id: '23540573'
    gene_id: ENSG00000110092
    highest_confidence: High
  metadata:
    comments: 'Cohort: BCAC'
    date_added: '2019-11-08'
    reviewed_by: Maya Ghoussaini
    set_label: otg_curated_191108
    submitted_by: Maya Ghoussaini
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 69379161
    locus_GRCh38:
      chromosome: '11'
      position: 69564393
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast carcinoma
    standard_trait_name: breast carcinoma
- association_info:
    gwas_catalog_id: GCST000150
    otg_id: GCST000150
    pubmed_id: '18245381'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Maya Ghoussaini
      description: 3C, ChIP-seq, allele-specific expression, TALENs
      pubmed_id: '24115442'
    - class: functional experimental
      confidence: High
      curated_by: Maya Ghoussaini
      description: 'Original publication looked at variant rs1427407, rs7606173 using
        the following methods: reporter assays, transgenic mouse models'
      pubmed_id: '24115442'
    gene_id: ENSG00000119866
    highest_confidence: High
  metadata:
    comments: 'Cohort: SCD'
    date_added: '2019-11-08'
    reviewed_by: Maya Ghoussaini
    set_label: otg_curated_191108
    submitted_by: Maya Ghoussaini
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '2'
      position: 60720246
    locus_GRCh38:
      chromosome: '2'
      position: 60493111
  trait_info:
    ontology:
    - EFO_0004576
    reported_trait_name: Fetal hemoglobin levels
    standard_trait_name: fetal hemoglobin measurement
- association_info:
    gwas_catalog_id: GCST007039
    otg_id: GCST007039
    pubmed_id: '30595370'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Maya Ghoussaini
      description: 4C-seq in mouse and zebrafish embryoe, 3C adult mouse brain, CHIA-PET
        ENCODE, human fibroblasts and MCF7, eQTL in brains, KO IRX3
      pubmed_id: '24646999'
    - class: functional experimental
      confidence: High
      curated_by: Maya Ghoussaini
      description: 'Original publication looked at variant Not specified: they refer
        to region of association using the following methods: reporter assays of fragments
        to assess enhancer activity'
      pubmed_id: '24646999'
    gene_id: ENSG00000177508
    highest_confidence: High
  metadata:
    comments: 'Cohort: GIANT'
    date_added: '2019-11-08'
    reviewed_by: Maya Ghoussaini
    set_label: otg_curated_191108
    submitted_by: Maya Ghoussaini
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '16'
      position: 53800954
    locus_GRCh38:
      chromosome: '16'
      position: 53767042
  trait_info:
    ontology:
    - EFO_0001073
    reported_trait_name: Obesity/T2D
    standard_trait_name: obesity
- association_info:
    gwas_catalog_id: GCST004988
    otg_id: GCST004988
    pubmed_id: '29059683'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Maya Ghoussaini
      description: eQTL, 3C in breast cancer
      pubmed_id: '25248036'
    - class: functional experimental
      confidence: High
      curated_by: Maya Ghoussaini
      description: 'Original publication looked at variant rs4442975 using the following
        methods: Luciferase'
      pubmed_id: '25248036'
    gene_id: ENSG00000115461
    highest_confidence: High
  metadata:
    comments: 'Cohort: BCAC'
    date_added: '2019-11-08'
    reviewed_by: Maya Ghoussaini
    set_label: otg_curated_191108
    submitted_by: Maya Ghoussaini
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '2'
      position: 217920769
    locus_GRCh38:
      chromosome: '2'
      position: 217056046
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast carcinoma
    standard_trait_name: breast carcinoma
- association_info:
    gwas_catalog_id: GCST007039
    otg_id: GCST007039
    pubmed_id: '30595370'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Maya Ghoussaini
      description: eQTL, 3C, 4C, mouse work, epigenomic data in 127 cells, eQTLs
      pubmed_id: '26287746'
    - class: functional experimental
      confidence: High
      curated_by: Maya Ghoussaini
      description: 'Original publication looked at variant rs1421085 using the following
        methods: CRISPR in patients samples and mice followed by cellular phenotyping,
        knockdown and overexpression'
      pubmed_id: '26287746'
    gene_id: ENSG00000176842
    highest_confidence: High
  metadata:
    comments: 'Cohort: Obesity '
    date_added: '2019-11-08'
    reviewed_by: Maya Ghoussaini
    set_label: otg_curated_191108
    submitted_by: Maya Ghoussaini
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '16'
      position: 53800954
    locus_GRCh38:
      chromosome: '16'
      position: 53767042
  trait_info:
    ontology:
    - EFO_0001073
    reported_trait_name: Obesity
    standard_trait_name: obesity
- association_info:
    gwas_catalog_id: GCST007039
    otg_id: GCST007039
    pubmed_id: '30595370'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Maya Ghoussaini
      description: eQTL, 3C, 4C, mouse work, epigenomic data in 127 cells, eQTLs
      pubmed_id: '26287746'
    - class: functional experimental
      confidence: High
      curated_by: Maya Ghoussaini
      description: 'Original publication looked at variant rs1421085 using the following
        methods: CRISPR in patients samples and mice followed by cellular phenotyping,
        knockdown and overexpression'
      pubmed_id: '26287746'
    gene_id: ENSG00000177508
    highest_confidence: High
  metadata:
    comments: 'Cohort: Obesity '
    date_added: '2019-11-08'
    reviewed_by: Maya Ghoussaini
    set_label: otg_curated_191108
    submitted_by: Maya Ghoussaini
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '16'
      position: 53800954
    locus_GRCh38:
      chromosome: '16'
      position: 53767042
  trait_info:
    ontology:
    - EFO_0001073
    reported_trait_name: Obesity
    standard_trait_name: obesity
- association_info:
    gwas_catalog_id: GCST001445
    otg_id: GCST001445_2
    pubmed_id: '22438815'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Maya Ghoussaini
      description: Allele-specific qRT-PCR, Overlap with epigenetic marks, EMSA, SB,
        eQTL, Chip-qRT-PCR
      pubmed_id: '27096366'
    gene_id: ENSG00000145335
    highest_confidence: High
  metadata:
    comments: 'Cohort: PD'
    date_added: '2019-11-08'
    reviewed_by: Maya Ghoussaini
    set_label: otg_curated_191108
    submitted_by: Maya Ghoussaini
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '4'
      position: 90637601
    locus_GRCh38:
      chromosome: '4'
      position: 89716450
  trait_info:
    ontology:
    - EFO_0002508
    reported_trait_name: Parkinson's disease
    standard_trait_name: Parkinson's disease
- association_info:
    gwas_catalog_id: GCST000750
    otg_id: GCST000750
    pubmed_id: '20676098'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Maya Ghoussaini
      description: allele-specific Chip-qPCR, RNA immunoprecip, Chromatin conformation
        capture, eQTL
      pubmed_id: '27526323'
    - class: functional experimental
      confidence: High
      curated_by: Maya Ghoussaini
      description: 'Original publication looked at variant rs7463708 using the following
        methods: SiRNA, site-directed mutgenesis + reporter assays, mouse xenograft'
      pubmed_id: '27526323'
    gene_id: ENSG00000253438
    highest_confidence: High
  metadata:
    comments: 'Cohort: PC'
    date_added: '2019-11-08'
    reviewed_by: Maya Ghoussaini
    set_label: otg_curated_191108
    submitted_by: Maya Ghoussaini
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '8'
      position: 128103937
    locus_GRCh38:
      chromosome: '8'
      position: 127091692
  trait_info:
    ontology:
    - EFO_0001663
    reported_trait_name: Prostate carcinoma
    standard_trait_name: prostate carcinoma
- association_info:
    gwas_catalog_id: GCST003845
    otg_id: GCST003845
    pubmed_id: '27117709'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Maya Ghoussaini
      description: eQTL, 3C , overlap with reg elements
      pubmed_id: '27601076'
    - class: functional experimental
      confidence: High
      curated_by: Maya Ghoussaini
      description: 'Original publication looked at variant rs56069439 using the following
        methods: Luciferase'
      pubmed_id: '27601076'
    gene_id: ENSG00000127220
    highest_confidence: High
  metadata:
    comments: 'Cohort: BCAC & OCAC'
    date_added: '2019-11-08'
    reviewed_by: Maya Ghoussaini
    set_label: otg_curated_191108
    submitted_by: Maya Ghoussaini
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '19'
      position: 17393925
    locus_GRCh38:
      chromosome: '19'
      position: 17283116
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: 'Breast Cancer '
    standard_trait_name: breast carcinoma
- association_info:
    gwas_catalog_id: GCST003845
    otg_id: GCST003845
    pubmed_id: '27117709'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Maya Ghoussaini
      description: eQTL, 3C , overlap with reg elements
      pubmed_id: '27601076'
    - class: functional experimental
      confidence: High
      curated_by: Maya Ghoussaini
      description: 'Original publication looked at variant rs56069439 using the following
        methods: Luciferase'
      pubmed_id: '27601076'
    gene_id: ENSG00000160117
    highest_confidence: High
  metadata:
    comments: 'Cohort: BCAC & OCAC'
    date_added: '2019-11-08'
    reviewed_by: Maya Ghoussaini
    set_label: otg_curated_191108
    submitted_by: Maya Ghoussaini
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '19'
      position: 17393925
    locus_GRCh38:
      chromosome: '19'
      position: 17283116
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: 'Breast Cancer '
    standard_trait_name: breast carcinoma
- association_info:
    gwas_catalog_id: GCST004462
    otg_id: GCST004462
    pubmed_id: '28346442'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Maya Ghoussaini
      description: eQTL, 3C , overlap with reg elements
      pubmed_id: '27601076'
    - class: functional experimental
      confidence: High
      curated_by: Maya Ghoussaini
      description: 'Original publication looked at variant rs56069439 using the following
        methods: Luciferase'
      pubmed_id: '27601076'
    gene_id: ENSG00000127220
    highest_confidence: High
  metadata:
    comments: 'Cohort: BCAC & OCAC'
    date_added: '2019-11-08'
    reviewed_by: Maya Ghoussaini
    set_label: otg_curated_191108
    submitted_by: Maya Ghoussaini
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '19'
      position: 17390291
    locus_GRCh38:
      chromosome: '19'
      position: 17279482
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Ovarian cancer
    standard_trait_name: breast carcinoma
- association_info:
    gwas_catalog_id: GCST004462
    otg_id: GCST004462
    pubmed_id: '28346442'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Maya Ghoussaini
      description: eQTL, 3C , overlap with reg elements
      pubmed_id: '27601076'
    - class: functional experimental
      confidence: High
      curated_by: Maya Ghoussaini
      description: 'Original publication looked at variant rs56069439 using the following
        methods: Luciferase'
      pubmed_id: '27601076'
    gene_id: ENSG00000160117
    highest_confidence: High
  metadata:
    comments: 'Cohort: BCAC & OCAC'
    date_added: '2019-11-08'
    reviewed_by: Maya Ghoussaini
    set_label: otg_curated_191108
    submitted_by: Maya Ghoussaini
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '19'
      position: 17390291
    locus_GRCh38:
      chromosome: '19'
      position: 17279482
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Ovarian cancer
    standard_trait_name: breast carcinoma
- association_info:
    gwas_catalog_id: GCST004988
    otg_id: GCST004988
    pubmed_id: '29059683'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Maya Ghoussaini
      description: eQTL, allele-specific qPCR, chromatin conformation caprure (3C),
        allele-specific 3C, overlap with epigenetics marks
      pubmed_id: '27640304'
    - class: functional experimental
      confidence: High
      curated_by: Maya Ghoussaini
      description: 'Original publication looked at variant rs10941679 using the following
        methods: luciferase (no allele-specific effect), EMSA and supershift (allele-specific
        effect)'
      pubmed_id: '27640304'
    gene_id: ENSG00000070193
    highest_confidence: High
  metadata:
    comments: 'Cohort: BCAC'
    date_added: '2019-11-08'
    reviewed_by: Maya Ghoussaini
    set_label: otg_curated_191108
    submitted_by: Maya Ghoussaini
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 44706498
    locus_GRCh38:
      chromosome: '5'
      position: 44706396
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast carcinoma
    standard_trait_name: breast carcinoma
- association_info:
    gwas_catalog_id: GCST004988
    otg_id: GCST004988
    pubmed_id: '29059683'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Maya Ghoussaini
      description: eQTL, allele-specific qPCR, chromatin conformation caprure (3C),
        allele-specific 3C, overlap with epigenetics marks
      pubmed_id: '27640304'
    - class: functional experimental
      confidence: High
      curated_by: Maya Ghoussaini
      description: 'Original publication looked at variant rs10941679 using the following
        methods: luciferase (no allele-specific effect), EMSA and supershift (allele-specific
        effect)'
      pubmed_id: '27640304'
    gene_id: ENSG00000112996
    highest_confidence: High
  metadata:
    comments: 'Cohort: BCAC'
    date_added: '2019-11-08'
    reviewed_by: Maya Ghoussaini
    set_label: otg_curated_191108
    submitted_by: Maya Ghoussaini
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 44706498
    locus_GRCh38:
      chromosome: '5'
      position: 44706396
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast carcinoma
    standard_trait_name: breast carcinoma
- association_info:
    gwas_catalog_id: GCST000760
    otg_id: GCST000760
    pubmed_id: '20686565'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Maya Ghoussaini
      description: eQTL
      pubmed_id: '28388432'
    - class: functional experimental
      confidence: High
      curated_by: Maya Ghoussaini
      description: 'Original publication looked at variant rs2277862 using the following
        methods: CRISPR'
      pubmed_id: '28388432'
    gene_id: ENSG00000214078
    highest_confidence: High
  metadata:
    comments: 'Cohort: PhLiPS Study'
    date_added: '2019-11-08'
    reviewed_by: Maya Ghoussaini
    set_label: otg_curated_191108
    submitted_by: Maya Ghoussaini
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '20'
      position: 34152782
    locus_GRCh38:
      chromosome: '20'
      position: 35564866
  trait_info:
    ontology:
    - EFO_0004529
    reported_trait_name: Blood lipid (HDL, LDL, TG, PP, …)
    standard_trait_name: lipid measurement
- association_info:
    gwas_catalog_id: GCST002221
    otg_id: GCST002221
    pubmed_id: '24097068'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Maya Ghoussaini
      description: eQTL
      pubmed_id: '28388432'
    - class: functional experimental
      confidence: High
      curated_by: Maya Ghoussaini
      description: 'Original publication looked at variant rs10889356 using the following
        methods: CRISPR'
      pubmed_id: '28388432'
    gene_id: ENSG00000116641
    highest_confidence: High
  metadata:
    comments: 'Cohort: PhLiPS Study'
    date_added: '2019-11-08'
    reviewed_by: Maya Ghoussaini
    set_label: otg_curated_191108
    submitted_by: Maya Ghoussaini
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '1'
      position: 63145439
    locus_GRCh38:
      chromosome: '1'
      position: 62679768
  trait_info:
    ontology:
    - EFO_0004529
    reported_trait_name: Blood lipid (HDL, LDL, TG, PP, …)
    standard_trait_name: lipid measurement
- association_info:
    gwas_catalog_id: GCST002221
    otg_id: GCST002221
    pubmed_id: '24097068'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Maya Ghoussaini
      description: eQTL
      pubmed_id: '28388432'
    - class: functional experimental
      confidence: High
      curated_by: Maya Ghoussaini
      description: 'Original publication looked at variant rs10889356 using the following
        methods: CRISPR'
      pubmed_id: '28388432'
    gene_id: ENSG00000132855
    highest_confidence: High
  metadata:
    comments: 'Cohort: PhLiPS Study'
    date_added: '2019-11-08'
    reviewed_by: Maya Ghoussaini
    set_label: otg_curated_191108
    submitted_by: Maya Ghoussaini
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '1'
      position: 63145439
    locus_GRCh38:
      chromosome: '1'
      position: 62679768
  trait_info:
    ontology:
    - EFO_0004529
    reported_trait_name: Blood lipid (HDL, LDL, TG, PP, …)
    standard_trait_name: lipid measurement
- association_info:
    gwas_catalog_id: GCST002221
    otg_id: GCST002221
    pubmed_id: '24097068'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Maya Ghoussaini
      description: eQTL
      pubmed_id: '28388432'
    - class: functional experimental
      confidence: High
      curated_by: Maya Ghoussaini
      description: 'Original publication looked at variant rs10872142 using the following
        methods: CRISPR'
      pubmed_id: '28388432'
    gene_id: ENSG00000111816
    highest_confidence: High
  metadata:
    comments: 'Cohort: PhLiPS Study'
    date_added: '2019-11-08'
    reviewed_by: Maya Ghoussaini
    set_label: otg_curated_191108
    submitted_by: Maya Ghoussaini
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 116337503
    locus_GRCh38:
      chromosome: '6'
      position: 116016340
  trait_info:
    ontology:
    - EFO_0004529
    reported_trait_name: Blood lipid (HDL, LDL, TG, PP, …)
    standard_trait_name: lipid measurement
- association_info:
    gwas_catalog_id: GCST004441
    otg_id: GCST004441
    pubmed_id: '27989323'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Maya Ghoussaini
      description: NLRC4-inflammasome hyperactivity causes infantile-onset Macrophage
        Activation Syndrome and enterocolitis with extraordinary serum IL-18 elevation
        (NLRC4-MAS). Herein, we report a critically ill infant with severe, refractory
        NLRC4-MAS who showed sustained response to treatment with experimental IL-18
        inhibition.
      pubmed_id: '27876626'
    gene_id: ENSG00000091106
    highest_confidence: High
  metadata:
    comments: 'Cohort: Breast cancer driver genes'
    date_added: '2019-11-08'
    reviewed_by: Maya Ghoussaini
    set_label: otg_curated_191108
    submitted_by: Maya Ghoussaini
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '2'
      position: 32489851
    locus_GRCh38:
      chromosome: '2'
      position: 32264782
  trait_info:
    ontology:
    - EFO_0004581
    reported_trait_name: Interleukin-18 levels
    standard_trait_name: interleukin 18 measurement
- association_info:
    gwas_catalog_id: GCST003845
    otg_id: GCST003845
    pubmed_id: '27117709'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Maya Ghoussaini
      description: Breast cancer driver genes
      pubmed_id: '00000000'
    gene_id: ENSG00000171094
    highest_confidence: High
  metadata:
    comments: 'Cohort: Breast cancer driver genes'
    date_added: '2019-11-08'
    reviewed_by: Maya Ghoussaini
    set_label: otg_curated_191108
    submitted_by: Maya Ghoussaini
  sentinel_variant:
    alleles:
      alternative: T
      reference: A
    locus_GRCh37:
      chromosome: '2'
      position: 29119585
    locus_GRCh38:
      chromosome: '2'
      position: 28896719
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast carcinoma
    standard_trait_name: breast carcinoma
- association_info:
    gwas_catalog_id: GCST004988
    otg_id: GCST004988
    pubmed_id: '29059683'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Maya Ghoussaini
      description: Breast cancer driver genes
      pubmed_id: '00000000'
    gene_id: ENSG00000171681
    highest_confidence: High
  metadata:
    comments: 'Cohort: Breast cancer driver genes'
    date_added: '2019-11-08'
    reviewed_by: Maya Ghoussaini
    set_label: otg_curated_191108
    submitted_by: Maya Ghoussaini
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '12'
      position: 14413931
    locus_GRCh38:
      chromosome: '12'
      position: 14260997
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast carcinoma
    standard_trait_name: breast carcinoma
- association_info:
    gwas_catalog_id: GCST005077
    otg_id: GCST005077
    pubmed_id: '29058716'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Maya Ghoussaini
      description: Breast cancer driver genes
      pubmed_id: '00000000'
    gene_id: ENSG00000149311
    highest_confidence: High
  metadata:
    comments: 'Cohort: Breast cancer driver genes'
    date_added: '2019-11-08'
    reviewed_by: Maya Ghoussaini
    set_label: otg_curated_191108
    submitted_by: Maya Ghoussaini
  sentinel_variant:
    alleles:
      alternative: GA
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 108345515
    locus_GRCh38:
      chromosome: '11'
      position: 108474788
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast carcinoma
    standard_trait_name: breast carcinoma
- association_info:
    gwas_catalog_id: GCST004988
    otg_id: GCST004988
    pubmed_id: '29059683'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Maya Ghoussaini
      description: Breast cancer driver genes
      pubmed_id: '00000000'
    gene_id: ENSG00000139618
    highest_confidence: High
  metadata:
    comments: 'Cohort: Breast cancer driver genes'
    date_added: '2019-11-08'
    reviewed_by: Maya Ghoussaini
    set_label: otg_curated_191108
    submitted_by: Maya Ghoussaini
  sentinel_variant:
    alleles:
      alternative: T
      reference: A
    locus_GRCh37:
      chromosome: '13'
      position: 32972626
    locus_GRCh38:
      chromosome: '13'
      position: 32398489
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast carcinoma
    standard_trait_name: breast carcinoma
- association_info:
    gwas_catalog_id: GCST004988
    otg_id: GCST004988
    pubmed_id: '29059683'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Maya Ghoussaini
      description: Breast cancer driver genes
      pubmed_id: '00000000'
    gene_id: ENSG00000064012
    highest_confidence: High
  metadata:
    comments: 'Cohort: Breast cancer driver genes'
    date_added: '2019-11-08'
    reviewed_by: Maya Ghoussaini
    set_label: otg_curated_191108
    submitted_by: Maya Ghoussaini
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '2'
      position: 202123430
    locus_GRCh38:
      chromosome: '2'
      position: 201258707
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast carcinoma
    standard_trait_name: breast carcinoma
- association_info:
    gwas_catalog_id: GCST004988
    otg_id: GCST004988
    pubmed_id: '29059683'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Maya Ghoussaini
      description: Breast cancer driver genes
      pubmed_id: '00000000'
    gene_id: ENSG00000110092
    highest_confidence: High
  metadata:
    comments: 'Cohort: Breast cancer driver genes'
    date_added: '2019-11-08'
    reviewed_by: Maya Ghoussaini
    set_label: otg_curated_191108
    submitted_by: Maya Ghoussaini
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 69331418
    locus_GRCh38:
      chromosome: '11'
      position: 69516650
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast carcinoma
    standard_trait_name: breast carcinoma
- association_info:
    gwas_catalog_id: GCST005077
    otg_id: GCST005077
    pubmed_id: '29058716'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Maya Ghoussaini
      description: Breast cancer driver genes
      pubmed_id: '00000000'
    gene_id: ENSG00000105173
    highest_confidence: High
  metadata:
    comments: 'Cohort: Breast cancer driver genes'
    date_added: '2019-11-08'
    reviewed_by: Maya Ghoussaini
    set_label: otg_curated_191108
    submitted_by: Maya Ghoussaini
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '19'
      position: 30277729
    locus_GRCh38:
      chromosome: '19'
      position: 29786822
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast carcinoma
    standard_trait_name: breast carcinoma
- association_info:
    gwas_catalog_id: GCST004988
    otg_id: GCST004988
    pubmed_id: '29059683'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Maya Ghoussaini
      description: Breast cancer driver genes
      pubmed_id: '00000000'
    gene_id: ENSG00000183765
    highest_confidence: High
  metadata:
    comments: 'Cohort: Breast cancer driver genes'
    date_added: '2019-11-08'
    reviewed_by: Maya Ghoussaini
    set_label: otg_curated_191108
    submitted_by: Maya Ghoussaini
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '22'
      position: 29272637
    locus_GRCh38:
      chromosome: '22'
      position: 28876649
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast carcinoma
    standard_trait_name: breast carcinoma
- association_info:
    gwas_catalog_id: GCST005077
    otg_id: GCST005077
    pubmed_id: '29058716'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Maya Ghoussaini
      description: Breast cancer driver genes
      pubmed_id: '00000000'
    gene_id: ENSG00000005339
    highest_confidence: High
  metadata:
    comments: 'Cohort: Breast cancer driver genes'
    date_added: '2019-11-08'
    reviewed_by: Maya Ghoussaini
    set_label: otg_curated_191108
    submitted_by: Maya Ghoussaini
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '16'
      position: 4106788
    locus_GRCh38:
      chromosome: '16'
      position: 4056787
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast carcinoma
    standard_trait_name: breast carcinoma
- association_info:
    gwas_catalog_id: GCST004988
    otg_id: GCST004988
    pubmed_id: '29059683'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Maya Ghoussaini
      description: Breast cancer driver genes
      pubmed_id: '00000000'
    gene_id: ENSG00000257923
    highest_confidence: High
  metadata:
    comments: 'Cohort: Breast cancer driver genes'
    date_added: '2019-11-08'
    reviewed_by: Maya Ghoussaini
    set_label: otg_curated_191108
    submitted_by: Maya Ghoussaini
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '7'
      position: 101552440
    locus_GRCh38:
      chromosome: '7'
      position: 101909160
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast carcinoma
    standard_trait_name: breast carcinoma
- association_info:
    gwas_catalog_id: GCST004988
    otg_id: GCST004988
    pubmed_id: '29059683'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Maya Ghoussaini
      description: Breast cancer driver genes
      pubmed_id: '00000000'
    gene_id: ENSG00000119772
    highest_confidence: High
  metadata:
    comments: 'Cohort: Breast cancer driver genes'
    date_added: '2019-11-08'
    reviewed_by: Maya Ghoussaini
    set_label: otg_curated_191108
    submitted_by: Maya Ghoussaini
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '2'
      position: 25129473
    locus_GRCh38:
      chromosome: '2'
      position: 24906604
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast carcinoma
    standard_trait_name: breast carcinoma
- association_info:
    gwas_catalog_id: GCST004988
    otg_id: GCST004988
    pubmed_id: '29059683'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Maya Ghoussaini
      description: Breast cancer driver genes
      pubmed_id: '00000000'
    gene_id: ENSG00000091831
    highest_confidence: High
  metadata:
    comments: 'Cohort: Breast cancer driver genes'
    date_added: '2019-11-08'
    reviewed_by: Maya Ghoussaini
    set_label: otg_curated_191108
    submitted_by: Maya Ghoussaini
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 151955914
    locus_GRCh38:
      chromosome: '6'
      position: 151634779
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast carcinoma
    standard_trait_name: breast carcinoma
- association_info:
    gwas_catalog_id: GCST004988
    otg_id: GCST004988
    pubmed_id: '29059683'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Maya Ghoussaini
      description: Breast cancer driver genes
      pubmed_id: '00000000'
    gene_id: ENSG00000066468
    highest_confidence: High
  metadata:
    comments: 'Cohort: Breast cancer driver genes'
    date_added: '2019-11-08'
    reviewed_by: Maya Ghoussaini
    set_label: otg_curated_191108
    submitted_by: Maya Ghoussaini
  sentinel_variant:
    alleles:
      alternative: G
      reference: GC
    locus_GRCh37:
      chromosome: '10'
      position: 123340431
    locus_GRCh38:
      chromosome: '10'
      position: 121580917
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast carcinoma
    standard_trait_name: breast carcinoma
- association_info:
    gwas_catalog_id: GCST004988
    otg_id: GCST004988
    pubmed_id: '29059683'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Maya Ghoussaini
      description: Breast cancer driver genes
      pubmed_id: '00000000'
    gene_id: ENSG00000107485
    highest_confidence: High
  metadata:
    comments: 'Cohort: Breast cancer driver genes'
    date_added: '2019-11-08'
    reviewed_by: Maya Ghoussaini
    set_label: otg_curated_191108
    submitted_by: Maya Ghoussaini
  sentinel_variant:
    alleles:
      alternative: T
      reference: TG
    locus_GRCh37:
      chromosome: '10'
      position: 9088113
    locus_GRCh38:
      chromosome: '10'
      position: 9046150
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast carcinoma
    standard_trait_name: breast carcinoma
- association_info:
    gwas_catalog_id: GCST003845
    otg_id: GCST003845
    pubmed_id: '27117709'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Maya Ghoussaini
      description: Breast cancer driver genes
      pubmed_id: '00000000'
    gene_id: ENSG00000102554
    highest_confidence: High
  metadata:
    comments: 'Cohort: Breast cancer driver genes'
    date_added: '2019-11-08'
    reviewed_by: Maya Ghoussaini
    set_label: otg_curated_191108
    submitted_by: Maya Ghoussaini
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '13'
      position: 73957681
    locus_GRCh38:
      chromosome: '13'
      position: 73383544
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast carcinoma
    standard_trait_name: breast carcinoma
- association_info:
    gwas_catalog_id: GCST004988
    otg_id: GCST004988
    pubmed_id: '29059683'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Maya Ghoussaini
      description: Breast cancer driver genes
      pubmed_id: '00000000'
    gene_id: ENSG00000095015
    highest_confidence: High
  metadata:
    comments: 'Cohort: Breast cancer driver genes'
    date_added: '2019-11-08'
    reviewed_by: Maya Ghoussaini
    set_label: otg_curated_191108
    submitted_by: Maya Ghoussaini
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 56027240
    locus_GRCh38:
      chromosome: '5'
      position: 56731413
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast carcinoma
    standard_trait_name: breast carcinoma
- association_info:
    gwas_catalog_id: GCST004988
    otg_id: GCST004988
    pubmed_id: '29059683'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Maya Ghoussaini
      description: Breast cancer driver genes
      pubmed_id: '00000000'
    gene_id: ENSG00000136997
    highest_confidence: High
  metadata:
    comments: 'Cohort: Breast cancer driver genes'
    date_added: '2019-11-08'
    reviewed_by: Maya Ghoussaini
    set_label: otg_curated_191108
    submitted_by: Maya Ghoussaini
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '8'
      position: 128372172
    locus_GRCh38:
      chromosome: '8'
      position: 127359926
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast carcinoma
    standard_trait_name: breast carcinoma
- association_info:
    gwas_catalog_id: GCST004988
    otg_id: GCST004988
    pubmed_id: '29059683'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Maya Ghoussaini
      description: Breast cancer driver genes
      pubmed_id: '00000000'
    gene_id: ENSG00000196712
    highest_confidence: High
  metadata:
    comments: 'Cohort: Breast cancer driver genes'
    date_added: '2019-11-08'
    reviewed_by: Maya Ghoussaini
    set_label: otg_curated_191108
    submitted_by: Maya Ghoussaini
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '17'
      position: 29180996
    locus_GRCh38:
      chromosome: '17'
      position: 30853978
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast carcinoma
    standard_trait_name: breast carcinoma
- association_info:
    gwas_catalog_id: GCST004988
    otg_id: GCST004988
    pubmed_id: '29059683'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Maya Ghoussaini
      description: Breast cancer driver genes
      pubmed_id: '00000000'
    gene_id: ENSG00000152217
    highest_confidence: High
  metadata:
    comments: 'Cohort: Breast cancer driver genes'
    date_added: '2019-11-08'
    reviewed_by: Maya Ghoussaini
    set_label: otg_curated_191108
    submitted_by: Maya Ghoussaini
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '18'
      position: 42411803
    locus_GRCh38:
      chromosome: '18'
      position: 44831838
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast carcinoma
    standard_trait_name: breast carcinoma
- association_info:
    gwas_catalog_id: GCST004988
    otg_id: GCST004988
    pubmed_id: '29059683'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Maya Ghoussaini
      description: Breast cancer driver genes
      pubmed_id: '00000000'
    gene_id: ENSG00000135111
    highest_confidence: High
  metadata:
    comments: 'Cohort: Breast cancer driver genes'
    date_added: '2019-11-08'
    reviewed_by: Maya Ghoussaini
    set_label: otg_curated_191108
    submitted_by: Maya Ghoussaini
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '12'
      position: 115106688
    locus_GRCh38:
      chromosome: '12'
      position: 114668883
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast carcinoma
    standard_trait_name: breast carcinoma
- association_info:
    gwas_catalog_id: GCST004988
    otg_id: GCST004988
    pubmed_id: '29059683'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Maya Ghoussaini
      description: Breast cancer driver genes
      pubmed_id: '00000000'
    gene_id: ENSG00000168769
    highest_confidence: High
  metadata:
    comments: 'Cohort: Breast cancer driver genes'
    date_added: '2019-11-08'
    reviewed_by: Maya Ghoussaini
    set_label: otg_curated_191108
    submitted_by: Maya Ghoussaini
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '4'
      position: 106073509
    locus_GRCh38:
      chromosome: '4'
      position: 105152352
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast carcinoma
    standard_trait_name: breast carcinoma
- association_info:
    gwas_catalog_id: GCST004988
    otg_id: GCST004988
    pubmed_id: '29059683'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Maya Ghoussaini
      description: Breast cancer driver genes
      pubmed_id: '00000000'
    gene_id: ENSG00000163513
    highest_confidence: High
  metadata:
    comments: 'Cohort: Breast cancer driver genes'
    date_added: '2019-11-08'
    reviewed_by: Maya Ghoussaini
    set_label: otg_curated_191108
    submitted_by: Maya Ghoussaini
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 30684907
    locus_GRCh38:
      chromosome: '3'
      position: 30643415
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast carcinoma
    standard_trait_name: breast carcinoma
- association_info:
    gwas_catalog_id: GCST004988
    otg_id: GCST004988
    pubmed_id: '29059683'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Maya Ghoussaini
      description: Breast cancer driver genes
      pubmed_id: '00000000'
    gene_id: ENSG00000185650
    highest_confidence: High
  metadata:
    comments: 'Cohort: Breast cancer driver genes'
    date_added: '2019-11-08'
    reviewed_by: Maya Ghoussaini
    set_label: otg_curated_191108
    submitted_by: Maya Ghoussaini
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '14'
      position: 68979835
    locus_GRCh38:
      chromosome: '14'
      position: 68513118
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast carcinoma
    standard_trait_name: breast carcinoma
- association_info:
    gwas_catalog_id: GCST004988
    otg_id: GCST004988
    pubmed_id: '29059683'
  gold_standard_info:
    evidence:
    - class: functional observational
      confidence: High
      curated_by: Maya Ghoussaini
      description: Breast cancer driver genes
      pubmed_id: '00000000'
    gene_id: ENSG00000183779
    highest_confidence: High
  metadata:
    comments: 'Cohort: Breast cancer driver genes'
    date_added: '2019-11-08'
    reviewed_by: Maya Ghoussaini
    set_label: otg_curated_191108
    submitted_by: Maya Ghoussaini
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '8'
      position: 36849946
    locus_GRCh38:
      chromosome: '8'
      position: 36992428
  trait_info:
    ontology:
    - EFO_0000305
    reported_trait_name: Breast carcinoma
    standard_trait_name: breast carcinoma
- association_info:
    ancestry:
    - East Asian=1999
    gwas_catalog_id: GCST006137
    neg_log_pval: 18.397940008672037
    otg_id: GCST006137
    pubmed_id: '29953918'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: enzyme involved in folate metabolism
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000177000
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '1'
      position: 11856378
    locus_GRCh38:
      chromosome: '1'
      position: 11796321
  trait_info:
    ontology:
    - EFO_0005111
    reported_trait_name: 'metabolite: folate'
    standard_trait_name: folic acid measurement
- association_info:
    ancestry:
    - European=404196
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 10.97061622231479
    otg_id: SAIGE_594_1
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: phosphatase
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000162551
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '1'
      position: 21904374
    locus_GRCh38:
      chromosome: '1'
      position: 21577881
  trait_info:
    ontology:
    - EFO_0004253
    reported_trait_name: calculus of kidney and ureter
    standard_trait_name: nephrolithiasis
- association_info:
    ancestry:
    - European=215551
    - African American or Afro-Caribbean=57332
    - Hispanic or Latin American=24743
    gwas_catalog_id: GCST006612
    neg_log_pval: 256.52287874528037
    otg_id: GCST006612
    pubmed_id: '30275531'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: PCSK9 regulates LDL via LDLR
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000169174
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '1'
      position: 55505647
    locus_GRCh38:
      chromosome: '1'
      position: 55039974
  trait_info:
    ontology:
    - EFO_0004611
    reported_trait_name: 'treatment: statin use'
    standard_trait_name: low density lipoprotein cholesterol measurement
- association_info:
    ancestry:
    - European=359241
    neg_log_pval: 7.33164017904141
    otg_id: NEALE2_6151_5
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: important function in bone marrow cells in the regenerative response
        of bone and cartilage after injulry
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000116678
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '1'
      position: 66110284
    locus_GRCh38:
      chromosome: '1'
      position: 65644601
  trait_info:
    ontology:
    - EFO_0009515
    reported_trait_name: wrist fracture
    standard_trait_name: wrist fracture
- association_info:
    ancestry:
    - European=393873
    gwas_catalog_id: GCST007091
    neg_log_pval: 14.397940008672037
    otg_id: GCST007091
    pubmed_id: '30664745'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: collagen gene, involved in ossification
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000060718
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '1'
      position: 103572927
    locus_GRCh38:
      chromosome: '1'
      position: 103107371
  trait_info:
    ontology:
    - EFO_1000786
    reported_trait_name: arthrosis of hip
    standard_trait_name: osteoarthritis, hip
- association_info:
    ancestry:
    - European=25708
    gwas_catalog_id: GCST000679
    neg_log_pval: 70.20616772397125
    otg_id: GCST000679
    pubmed_id: '20453842'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: PTPN22 encodes a protein tyrosine phosphatase involved in immune
        response
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000134242
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '1'
      position: 114377568
    locus_GRCh38:
      chromosome: '1'
      position: 113834946
  trait_info:
    ontology:
    - EFO_0000685
    reported_trait_name: rheumatoid arthritis
    standard_trait_name: rheumatoid arthritis
- association_info:
    ancestry:
    - European=80003
    gwas_catalog_id: GCST007638
    neg_log_pval: 13.096910013008056
    otg_id: GCST007638
    pubmed_id: '30837465'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: PHDGH encodes an enzyme involved in de novo serine biosynthesis
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000092621
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '1'
      position: 120254506
    locus_GRCh38:
      chromosome: '1'
      position: 119711883
  trait_info:
    ontology:
    - EFO_0009767
    reported_trait_name: 'metabolite: glycine'
    standard_trait_name: glycine measurement
- association_info:
    ancestry:
    - European=344728
    neg_log_pval: 307.6526555685888
    otg_id: NEALE2_30260_raw
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: SPTA1 encodes spectrin, a cytoskeleton protein that helps define
        the cell shape
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000163554
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '1'
      position: 158596438
    locus_GRCh38:
      chromosome: '1'
      position: 158626648
  trait_info:
    ontology: []
    reported_trait_name: reticulocyte volume
- association_info:
    ancestry:
    - European=204402
    gwas_catalog_id: GCST007614
    neg_log_pval: 522.3979400086721
    otg_id: GCST007614
    pubmed_id: '30388399'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: gene for the measured protein
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000132693
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '1'
      position: 159678816
    locus_GRCh38:
      chromosome: '1'
      position: 159709026
  trait_info:
    ontology:
    - EFO_0004458
    reported_trait_name: CRP levels
    standard_trait_name: C-reactive protein measurement
- association_info:
    ancestry:
    - European=360527
    neg_log_pval: 182.1308557348547
    otg_id: NEALE2_6152_5
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: Factor V Leiden mutation
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000198734
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '1'
      position: 169519049
    locus_GRCh38:
      chromosome: '1'
      position: 169549811
  trait_info:
    ontology:
    - EFO_0003907
    reported_trait_name: Blood clot in the leg, DVT
    standard_trait_name: deep vein thrombosis
- association_info:
    ancestry:
    - European=393873
    gwas_catalog_id: GCST007091
    neg_log_pval: 9.221848749616356
    otg_id: GCST007091
    pubmed_id: '30664745'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: collagen galactosyltransferase
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000198756
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '1'
      position: 183906245
    locus_GRCh38:
      chromosome: '1'
      position: 183937111
  trait_info:
    ontology:
    - EFO_1000786
    reported_trait_name: arthrosis of hip
    standard_trait_name: osteoarthritis, hip
- association_info:
    ancestry:
    - European=91787
    neg_log_pval: 8.362829604311715
    otg_id: NEALE2_22504
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: MUC5AC encodes one of the principal mucins in lung.  This is the
        protein portion of mucus.
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000215182
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 1113133
    locus_GRCh38:
      chromosome: '11'
      position: 1119225
  trait_info:
    ontology:
    - EFO_0009824
    reported_trait_name: bring up phlegm/sputum/mucus on most days
    standard_trait_name: bringing up phlegm, sputum or mucus on most days, self-reported
- association_info:
    ancestry:
    - European=360527
    neg_log_pval: 19.56919957537582
    otg_id: NEALE2_6152_5
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: encodes thrombin, the final step in the clotting cascade, converting
        fibrinogen to fibrin
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000180210
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 46761055
    locus_GRCh38:
      chromosome: '11'
      position: 46739505
  trait_info:
    ontology:
    - EFO_0003907
    reported_trait_name: Blood clot in the leg, DVT
    standard_trait_name: deep vein thrombosis
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 7.81005233185522
    otg_id: NEALE2_20002_1331
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: TCN1 encodes an intrinsic factor which transports vitamin B12
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000134827
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 59623378
    locus_GRCh38:
      chromosome: '11'
      position: 59855905
  trait_info:
    ontology:
    - EFO_0005576
    reported_trait_name: pernicious anemia
    standard_trait_name: pernicious anemia
- association_info:
    ancestry:
    - European=346527
    neg_log_pval: 7.720768937672716
    otg_id: NEALE2_2000
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: GRM5 encodes a glutamate metabotropic receptor
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000168959
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '11'
      position: 88732956
    locus_GRCh38:
      chromosome: '11'
      position: 88999788
  trait_info:
    ontology:
    - EFO_0009589
    reported_trait_name: worry too long
    standard_trait_name: worry measurement
- association_info:
    ancestry:
    - European=356530
    neg_log_pval: 307.6526555685888
    otg_id: NEALE2_1717
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: pigmentation gene
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000077498
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 89017961
    locus_GRCh38:
      chromosome: '11'
      position: 89284793
  trait_info:
    ontology:
    - EFO_0003784
    reported_trait_name: malignant neoplasms of skin
    standard_trait_name: skin pigmentation
- association_info:
    ancestry:
    - European=356530
    neg_log_pval: 307.6526555685888
    otg_id: NEALE2_1717
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: enzyme in melanin synthesis pathway
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000077498
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '11'
      position: 89017961
    locus_GRCh38:
      chromosome: '11'
      position: 89284793
  trait_info:
    ontology:
    - EFO_0003784
    reported_trait_name: skin color
    standard_trait_name: skin pigmentation
- association_info:
    ancestry:
    - European=401024
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 15.23807216157947
    otg_id: SAIGE_361
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: AT3 is an atypical cadherin in brain, important for neurite outgrowth
        and establishment of polarity in the retina.
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000165323
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 92607866
    locus_GRCh38:
      chromosome: '11'
      position: 92874700
  trait_info:
    ontology:
    - EFO_0005773
    reported_trait_name: retinal detachment
    standard_trait_name: retinal detachment
- association_info:
    ancestry:
    - European=105318
    gwas_catalog_id: GCST006803
    neg_log_pval: 11.698970004336019
    otg_id: GCST006803
    pubmed_id: '29483656'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: DRD2 encodes a dopamine receptor which is the site of action for
        many antipsychotics
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000149295
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '11'
      position: 113392994
    locus_GRCh38:
      chromosome: '11'
      position: 113522272
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - European=393873
    gwas_catalog_id: GCST007091
    neg_log_pval: 24.0
    otg_id: GCST007091
    pubmed_id: '30664745'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: hormone regulating bone development
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000087494
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '12'
      position: 28014970
    locus_GRCh38:
      chromosome: '12'
      position: 27862037
  trait_info:
    ontology:
    - EFO_1000786
    reported_trait_name: arthrosis of hip
    standard_trait_name: osteoarthritis, hip
- association_info:
    ancestry:
    - European=407648
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 7.954677021213342
    otg_id: SAIGE_594
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: TNFS11 may influence circulating calcium levels via bone resorption
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000120659
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: T
      reference: A
    locus_GRCh37:
      chromosome: '13'
      position: 42701739
    locus_GRCh38:
      chromosome: '13'
      position: 42127603
  trait_info:
    ontology:
    - EFO_1000839
    reported_trait_name: urolithiasis
    standard_trait_name: bladder calculus
- association_info:
    ancestry:
    - European=329134
    neg_log_pval: 12.835647144215564
    otg_id: NEALE2_1319
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: OR10G3 probably encodes an olfactory receptor.  Could it relate
        to enjoyment from smelling and eating fruit?
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000169208
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '14'
      position: 22038125
    locus_GRCh38:
      chromosome: '14'
      position: 21569994
  trait_info:
    ontology:
    - EFO_0008111
    reported_trait_name: dried fruit intake
    standard_trait_name: diet measurement
- association_info:
    ancestry:
    - European=205327
    gwas_catalog_id: GCST007020
    neg_log_pval: 13.397940008672037
    otg_id: GCST007020
    pubmed_id: '30573740'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: GSC, Goosecoid Homeobox, an important regulator of pattern formation
        and Wnt signaling
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000133937
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '14'
      position: 95237215
    locus_GRCh38:
      chromosome: '14'
      position: 94770878
  trait_info:
    ontology:
    - EFO_0007825
    reported_trait_name: male balding pattern
    standard_trait_name: balding measurement
- association_info:
    ancestry:
    - European=408823
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 9.1331221856625
    otg_id: SAIGE_172
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: pigmentation gene
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000104044
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '15'
      position: 28230247
    locus_GRCh38:
      chromosome: '15'
      position: 27985101
  trait_info:
    ontology:
    - EFO_0009259
    reported_trait_name: malignant neoplasms of skin
    standard_trait_name: skin carcinoma
- association_info:
    ancestry:
    - European=356530
    neg_log_pval: 314.5809997598978
    otg_id: NEALE2_1717
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: tyrosine transporter
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000104044
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '15'
      position: 28534777
    locus_GRCh38:
      chromosome: '15'
      position: 28289631
  trait_info:
    ontology:
    - EFO_0003784
    reported_trait_name: skin color
    standard_trait_name: skin pigmentation
- association_info:
    ancestry:
    - European=392109
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 16.609064892896622
    otg_id: SAIGE_241_2
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: growth factor involved in thyroid gland development and thyroid
        hormone production
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000140285
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '15'
      position: 49706417
    locus_GRCh38:
      chromosome: '15'
      position: 49414220
  trait_info:
    ontology:
    - MONDO_0000334
    reported_trait_name: non-toxic goitre
    standard_trait_name: multinodular goiter
- association_info:
    ancestry:
    - European=406659
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 9.385102783966865
    otg_id: SAIGE_351
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: SMAD6 encodes a transcription factor important for cartilage and
        bone development
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000137834
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '15'
      position: 67034812
    locus_GRCh38:
      chromosome: '15'
      position: 66742474
  trait_info:
    ontology:
    - EFO_0009387
    reported_trait_name: nerve, nerve root and plexus disorders
    standard_trait_name: peripheral nervous system disease
- association_info:
    ancestry:
    - European=334659
    neg_log_pval: 115.46487811249987
    otg_id: NEALE2_1498
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: caffeine metabolism
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000140465
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '15'
      position: 75027880
    locus_GRCh38:
      chromosome: '15'
      position: 74735539
  trait_info:
    ontology:
    - EFO_0004330
    reported_trait_name: coffee intake
    standard_trait_name: coffee consumption
- association_info:
    ancestry:
    - European=334659
    neg_log_pval: 115.46487811249987
    otg_id: NEALE2_1498
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: caffeine metabolism
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000140465
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '15'
      position: 75027880
    locus_GRCh38:
      chromosome: '15'
      position: 74735539
  trait_info:
    ontology:
    - EFO_0004330
    reported_trait_name: coffee intake
    standard_trait_name: coffee consumption
- association_info:
    ancestry:
    - European=334659
    neg_log_pval: 115.46487811249987
    otg_id: NEALE2_1498
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: caffeine metabolism
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000140505
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '15'
      position: 75027880
    locus_GRCh38:
      chromosome: '15'
      position: 74735539
  trait_info:
    ontology:
    - EFO_0004330
    reported_trait_name: coffee intake
    standard_trait_name: coffee consumption
- association_info:
    ancestry:
    - European=406659
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 7.510041520575165
    otg_id: SAIGE_351
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: ADAMTS17 encodes a extracellular matrix metaloprotease.  By analogy
        with ADAMTS10, ADAMTS17 may also play a role in the maturation of microfibril
        arrays which may contribute to structures in the carpal tunnel of the wrist
        driving risk of carpal tunnel syndrome, the most common plexus disorder
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000140470
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '15'
      position: 100692953
    locus_GRCh38:
      chromosome: '15'
      position: 100152748
  trait_info:
    ontology:
    - EFO_0009387
    reported_trait_name: Nerve, nerve root and plexus disorders
    standard_trait_name: peripheral nervous system disease
- association_info:
    ancestry:
    - European=191843
    gwas_catalog_id: GCST003997
    neg_log_pval: 62.69897000433602
    otg_id: GCST003997
    pubmed_id: '27182965'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: RBFOX1 encodes a transcription factor involved in eye development
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000078328
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: A
      reference: T
    locus_GRCh37:
      chromosome: '16'
      position: 7459347
    locus_GRCh38:
      chromosome: '16'
      position: 7409346
  trait_info:
    ontology:
    - HP_0000545
    reported_trait_name: 6 mm strong meridian angle
    standard_trait_name: Myopia
- association_info:
    ancestry:
    - European=404196
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 18.7594507517174
    otg_id: SAIGE_594_1
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: uromodulin is a highly expressed kidney specific protein.
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000169344
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '16'
      position: 20366507
    locus_GRCh38:
      chromosome: '16'
      position: 20355185
  trait_info:
    ontology:
    - EFO_0004253
    reported_trait_name: calculus of kidney and ureter
    standard_trait_name: nephrolithiasis
- association_info:
    ancestry:
    - European=80003
    gwas_catalog_id: GCST007638
    neg_log_pval: 41.0
    otg_id: GCST007638
    pubmed_id: '30837465'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: GCSH encodes a component of the glycine cleavage system
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000140905
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '16'
      position: 81110903
    locus_GRCh38:
      chromosome: '16'
      position: 81077298
  trait_info:
    ontology:
    - EFO_0009767
    reported_trait_name: 'metabolite: glycine'
    standard_trait_name: glycine measurement
- association_info:
    ancestry:
    - European=350471
    neg_log_pval: 36.053639123304855
    otg_id: NEALE2_30090_raw
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: In addition to GATA1 and GATA2, there are hits for the so-called
        "Friends of GATA" or FOG.  These are additional TFs that heterodimerize with
        GATA1 and GATA2 encoded by ZFPM2 and ZFPM1
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000179588
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '16'
      position: 88559699
    locus_GRCh38:
      chromosome: '16'
      position: 88493291
  trait_info:
    ontology:
    - EFO_0007985
    reported_trait_name: platelet crit
    standard_trait_name: plateletcrit
- association_info:
    ancestry:
    - European=299651
    gwas_catalog_id: GCST006986
    neg_log_pval: 307.69897000433605
    otg_id: GCST006986
    pubmed_id: '30531825'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: melanin production switch
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000258839
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '16'
      position: 89985918
    locus_GRCh38:
      chromosome: '16'
      position: 89919510
  trait_info:
    ontology:
    - EFO_0003924
    reported_trait_name: red hair
    standard_trait_name: hair color
- association_info:
    ancestry:
    - European=353697
    neg_log_pval: 307.6526555685888
    otg_id: NEALE2_1727
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: melanin production switch
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000258839
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '16'
      position: 89986546
    locus_GRCh38:
      chromosome: '16'
      position: 89920138
  trait_info:
    ontology: []
    reported_trait_name: Skin changes due to chronic exposure to nonionizing radiation
- association_info:
    ancestry:
    - European=353697
    neg_log_pval: 307.6526555685888
    otg_id: NEALE2_1727
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: melanin production switch
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000258839
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '16'
      position: 89986546
    locus_GRCh38:
      chromosome: '16'
      position: 89920138
  trait_info:
    ontology: []
    reported_trait_name: skin color
- association_info:
    ancestry:
    - European=350471
    neg_log_pval: 52.04034387198277
    otg_id: NEALE2_30090_raw
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: PAF is a lipid signaling molecule mediating platelet aggregation.
        PAF-AH deactivates PAF. PAFAH1B1 encodes the regulatory subunit of PAF-AH
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000007168
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '17'
      position: 1958536
    locus_GRCh38:
      chromosome: '17'
      position: 2055242
  trait_info:
    ontology:
    - EFO_0007985
    reported_trait_name: platelet crit
    standard_trait_name: plateletcrit
- association_info:
    ancestry:
    - European=408823
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 21.008330992620053
    otg_id: SAIGE_172
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: tumor suppressor
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000141510
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '17'
      position: 7571752
    locus_GRCh38:
      chromosome: '17'
      position: 7668434
  trait_info:
    ontology:
    - EFO_0009259
    reported_trait_name: malignant neoplasms of skin
    standard_trait_name: skin carcinoma
- association_info:
    ancestry:
    - European=426795
    gwas_catalog_id: GCST006980
    neg_log_pval: 40.30102999566398
    otg_id: GCST006980
    pubmed_id: '30598549'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: negative regulator of bone growth via wnt signaling pathway
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000167941
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '17'
      position: 41798855
    locus_GRCh38:
      chromosome: '17'
      position: 43721487
  trait_info:
    ontology:
    - EFO_0003931
    reported_trait_name: wrist fracture
    standard_trait_name: bone fracture
- association_info:
    ancestry:
    - European=446000
    gwas_catalog_id: GCST007066
    neg_log_pval: 94.0
    otg_id: GCST007066
    pubmed_id: '30595370'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: transcription factor involved in limb development
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000121075
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '17'
      position: 59023998
    locus_GRCh38:
      chromosome: '17'
      position: 60946637
  trait_info:
    ontology:
    - EFO_0009270
    reported_trait_name: arthrosis of hip
    standard_trait_name: heel bone mineral density
- association_info:
    ancestry:
    - European=446000
    gwas_catalog_id: GCST007066
    neg_log_pval: 150.0
    otg_id: GCST007066
    pubmed_id: '30595370'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: regulator of bone structure and function
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000177150
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '18'
      position: 13719510
    locus_GRCh38:
      chromosome: '18'
      position: 13719511
  trait_info:
    ontology:
    - EFO_0009270
    reported_trait_name: wrist fracture
    standard_trait_name: heel bone mineral density
- association_info:
    ancestry:
    - European=354736
    neg_log_pval: 81.07626495694595
    otg_id: NEALE2_23120_raw
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: MC4R is a well-known BMI gene.  It influences feeding behavior.
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000166603
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: G
      reference: GTCT
    locus_GRCh37:
      chromosome: '18'
      position: 57850927
    locus_GRCh38:
      chromosome: '18'
      position: 60183694
  trait_info:
    ontology:
    - EFO_0004995
    reported_trait_name: arm fat mass (right)
    standard_trait_name: lean body mass
- association_info:
    ancestry:
    - European=394929
    gwas_catalog_id: GCST006433
    neg_log_pval: 29.096910013008056
    otg_id: GCST006433
    pubmed_id: '30048462'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: TNFRSF11A encodes RANK, a key receptor regulating bone growth
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000141655
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '18'
      position: 60054857
    locus_GRCh38:
      chromosome: '18'
      position: 62387624
  trait_info:
    ontology:
    - EFO_0009270
    reported_trait_name: treatment with alendronate
    standard_trait_name: heel bone mineral density
- association_info:
    ancestry:
    - European=406659
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 10.721246399047171
    otg_id: SAIGE_351
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: ADAMTS10 encodes a extracellular matrix metaloprotease which plays
        a role in the maturation of microfibril arrays which may contribute to structures
        in the carpal tunnel of the wrist driving risk of carpal tunnel syndrome,
        the most common plexus disorder
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000142303
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '19'
      position: 8670147
    locus_GRCh38:
      chromosome: '19'
      position: 8605262
  trait_info:
    ontology:
    - EFO_0009387
    reported_trait_name: Nerve, nerve root and plexus disorders
    standard_trait_name: peripheral nervous system disease
- association_info:
    ancestry:
    - European=215551
    - African American or Afro-Caribbean=57332
    - Hispanic or Latin American=24743
    gwas_catalog_id: GCST006612
    neg_log_pval: 300.0
    otg_id: GCST006612
    pubmed_id: '30275531'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: LDLR is involved in lipoprotein regulation
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000130164
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '19'
      position: 11187324
    locus_GRCh38:
      chromosome: '19'
      position: 11076648
  trait_info:
    ontology:
    - EFO_0004611
    reported_trait_name: 'treatment: statin use'
    standard_trait_name: low density lipoprotein cholesterol measurement
- association_info:
    ancestry:
    - European=360291
    neg_log_pval: 11.684659523372712
    otg_id: NEALE2_1428_3
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: APOE drives LDL-cholesterol levels, perhaps leading to a dietary
        choice to switch from butter to margarine
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000130203
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '19'
      position: 45411941
    locus_GRCh38:
      chromosome: '19'
      position: 44908684
  trait_info:
    ontology:
    - EFO_0008111
    reported_trait_name: margarine intake
    standard_trait_name: diet measurement
- association_info:
    ancestry:
    - European=361141
    neg_log_pval: 78.44592291862462
    otg_id: NEALE2_20003_1140861958
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: APOE involved in lipoprotein regulation
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000130203
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '19'
      position: 45413233
    locus_GRCh38:
      chromosome: '19'
      position: 44909976
  trait_info:
    ontology:
    - CHEBI_9150
    reported_trait_name: 'treatment: statin use'
    standard_trait_name: simvastatin
- association_info:
    ancestry:
    - European=91787
    neg_log_pval: 9.45496765241607
    otg_id: NEALE2_22504
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: FUT2 encodes a fucosyltransferase, responsible for the glycosylation
        portion of mucus
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000176920
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '19'
      position: 49206417
    locus_GRCh38:
      chromosome: '19'
      position: 48703160
  trait_info:
    ontology:
    - EFO_0009824
    reported_trait_name: bring up phlegm/sputum/mucus on most days
    standard_trait_name: bringing up phlegm, sputum or mucus on most days, self-reported
- association_info:
    ancestry:
    - European=350061
    neg_log_pval: 20.08594099932527
    otg_id: NEALE2_30530_raw
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: FGF21 encodes a growth factor that acts on the brain to increase
        reward associated with eating sugar
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000105550
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '19'
      position: 49259529
    locus_GRCh38:
      chromosome: '19'
      position: 48756272
  trait_info:
    ontology:
    - HP_0012603
    reported_trait_name: sodium in urine
    standard_trait_name: Abnormal urine sodium concentration
- association_info:
    ancestry:
    - European=360468
    neg_log_pval: 14.522878745280337
    otg_id: NEALE2_1349
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: FGF21 encodes a growth factor that acts on the brain to increase
        reward associated with eating sugar
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000105550
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '19'
      position: 49259529
    locus_GRCh38:
      chromosome: '19'
      position: 48756272
  trait_info:
    ontology:
    - EFO_0008111
    reported_trait_name: processed meat intake
    standard_trait_name: diet measurement
- association_info:
    ancestry:
    - European=406659
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 7.886056647693163
    otg_id: SAIGE_351
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: EFEMP1 encodes fibulin-3, an extracellular matrix protein with
        a role in elastic fiber production which could directly contribute to the
        properties of the carpal ligament or other structures in the carpal tunnel
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000115380
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: '2'
      position: 56009382
    locus_GRCh38:
      chromosome: '2'
      position: 55782247
  trait_info:
    ontology:
    - EFO_0009387
    reported_trait_name: Nerve, nerve root and plexus disorders
    standard_trait_name: peripheral nervous system disease
- association_info:
    ancestry:
    - European=360806
    neg_log_pval: 9.227682694932648
    otg_id: NEALE2_1418_6
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: LCT encodes lactase, necessary for break down of lactose
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000115850
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '2'
      position: 136707982
    locus_GRCh38:
      chromosome: '2'
      position: 135950412
  trait_info:
    ontology:
    - EFO_0008111
    reported_trait_name: milk intake
    standard_trait_name: diet measurement
- association_info:
    ancestry:
    - European=80003
    gwas_catalog_id: GCST007638
    neg_log_pval: 1631.5228787452804
    otg_id: GCST007638
    pubmed_id: '30837465'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: CPS1 encodes an enzyme acting on the breakdown products of glycine
        catabolism
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000021826
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '2'
      position: 211543055
    locus_GRCh38:
      chromosome: '2'
      position: 210678331
  trait_info:
    ontology:
    - EFO_0009767
    reported_trait_name: 'metabolite: glycine'
    standard_trait_name: glycine measurement
- association_info:
    ancestry:
    - East Asian=110207
    gwas_catalog_id: GCST005980
    neg_log_pval: 1254.5228787452804
    otg_id: GCST005980
    pubmed_id: '29403010'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: the UGT1A1 encodes an enzyme which has UDP-glucuronosyltransferase
        activity against bilirubin
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000241635
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '2'
      position: 234671462
    locus_GRCh38:
      chromosome: '2'
      position: 233762816
  trait_info:
    ontology:
    - EFO_0004570
    reported_trait_name: total bilirubin
    standard_trait_name: bilirubin measurement
- association_info:
    ancestry:
    - European=354798
    neg_log_pval: 10.226191621507935
    otg_id: NEALE2_23114_raw
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: bone morphogenic protein, growth factor influencing bone growth
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000125845
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '20'
      position: 6709838
    locus_GRCh38:
      chromosome: '20'
      position: 6729191
  trait_info:
    ontology:
    - EFO_0004995
    reported_trait_name: leg predicted mass (right)
    standard_trait_name: lean body mass
- association_info:
    ancestry:
    - European=392109
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 10.661543506395395
    otg_id: SAIGE_241_2
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: transcription factor important for thyroid endoderm development
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000125798
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '20'
      position: 22625447
    locus_GRCh38:
      chromosome: '20'
      position: 22644809
  trait_info:
    ontology:
    - MONDO_0000334
    reported_trait_name: non-toxic goitre
    standard_trait_name: multinodular goiter
- association_info:
    ancestry:
    - European=121296
    gwas_catalog_id: GCST005897
    neg_log_pval: 315.0
    otg_id: GCST005897
    pubmed_id: '29739929'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: MC1R antagonist
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000101440
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '20'
      position: 32665748
    locus_GRCh38:
      chromosome: '20'
      position: 34077942
  trait_info:
    ontology:
    - EFO_0004279
    reported_trait_name: Skin changes due to chronic exposure to nonionizing radiation
    standard_trait_name: suntan
- association_info:
    ancestry:
    - European=121296
    gwas_catalog_id: GCST005897
    neg_log_pval: 315.0
    otg_id: GCST005897
    pubmed_id: '29739929'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: MC1R antagonist
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000101440
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '20'
      position: 32665748
    locus_GRCh38:
      chromosome: '20'
      position: 34077942
  trait_info:
    ontology:
    - EFO_0004279
    reported_trait_name: skin color
    standard_trait_name: suntan
- association_info:
    ancestry:
    - European=360527
    neg_log_pval: 9.184008739942152
    otg_id: NEALE2_6152_5
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: protein C receptor, involved in clotting response
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000101000
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: G
      reference: GAA
    locus_GRCh37:
      chromosome: '20'
      position: 33724557
    locus_GRCh38:
      chromosome: '20'
      position: 35136754
  trait_info:
    ontology:
    - EFO_0003907
    reported_trait_name: Blood clot in the leg, DVT
    standard_trait_name: deep vein thrombosis
- association_info:
    ancestry:
    - European=354798
    neg_log_pval: 111.76709786992673
    otg_id: NEALE2_23114_raw
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: GDF5 encodes a growth factor involved in limb and joint development
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000125965
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '20'
      position: 34025756
    locus_GRCh38:
      chromosome: '20'
      position: 35437976
  trait_info:
    ontology:
    - EFO_0004995
    reported_trait_name: leg predicted mass (right)
    standard_trait_name: lean body mass
- association_info:
    ancestry:
    - European=350471
    neg_log_pval: 153.24222071603972
    otg_id: NEALE2_30090_raw
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: TUBB1 which contributes to the structure of the microtubules which
        are important for forming platelets from the megakaryocytes. Rare TUBB1 mutations
        cause congenital macrothrombocytopenia
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000101162
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '20'
      position: 57597971
    locus_GRCh38:
      chromosome: '20'
      position: 59022916
  trait_info:
    ontology:
    - EFO_0007985
    reported_trait_name: platelet crit
    standard_trait_name: plateletcrit
- association_info:
    ancestry:
    - European=350471
    neg_log_pval: 22.632124355053705
    otg_id: NEALE2_30090_raw
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: One nifty analysis in Enrichr is finding upstream transcription
        factors that are enriched for the implicated genes. The top 3 TFs are GATA1
        (upstream of 75 GWAS genes), GATA2 (67 genes) and RUNX1 (91 genes). *All 3
        of these TFs are themselves GWAS hits!*https://
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000159216
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '21'
      position: 36393747
    locus_GRCh38:
      chromosome: '21'
      position: 35021450
  trait_info:
    ontology:
    - EFO_0007985
    reported_trait_name: platelet crit
    standard_trait_name: plateletcrit
- association_info:
    ancestry:
    - European=404196
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 12.095825631715837
    otg_id: SAIGE_594_1
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: a kidney-specific protein inivolved in calcium reabsorption
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000159261
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '21'
      position: 37818871
    locus_GRCh38:
      chromosome: '21'
      position: 36446573
  trait_info:
    ontology:
    - EFO_0004253
    reported_trait_name: calculus of kidney and ureter
    standard_trait_name: nephrolithiasis
- association_info:
    ancestry:
    - European=7824
    gwas_catalog_id: GCST002443
    neg_log_pval: 177.30102999566398
    otg_id: GCST002443_58
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: metabolite is a product of the encoded enzyme
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000093010
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '22'
      position: 19951271
    locus_GRCh38:
      chromosome: '22'
      position: 19963748
  trait_info:
    ontology:
    - EFO_0005664
    reported_trait_name: 'metabolite: methylascorbic acid'
    standard_trait_name: blood metabolite measurement
- association_info:
    ancestry:
    - European=334659
    neg_log_pval: 10.55425572432335
    otg_id: NEALE2_1498
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: response to caffeine
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000128271
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '22'
      position: 24771955
    locus_GRCh38:
      chromosome: '22'
      position: 24375987
  trait_info:
    ontology:
    - EFO_0004330
    reported_trait_name: coffee intake
    standard_trait_name: coffee consumption
- association_info:
    ancestry:
    - European=402950
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 23.554395796726403
    otg_id: SAIGE_571
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: PNPLA3 encodes a triacylglycerol lipase with high expression in
        the liver
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000100344
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '22'
      position: 44324730
    locus_GRCh38:
      chromosome: '22'
      position: 43928850
  trait_info:
    ontology:
    - EFO_0001421
    - EFO_0001422
    reported_trait_name: disease of liver
    standard_trait_name: liver disease
- association_info:
    ancestry:
    - European=7824
    gwas_catalog_id: GCST002443
    neg_log_pval: 17.154901959985743
    otg_id: GCST002443_44
    pubmed_id: '24816252'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: ARSA encodes the enzyme arylsulfatase A
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000100299
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '22'
      position: 51063477
    locus_GRCh38:
      chromosome: '22'
      position: 50625049
  trait_info:
    ontology:
    - EFO_0005664
    reported_trait_name: 'metabolite: O-sulfo-tyrosine'
    standard_trait_name: blood metabolite measurement
- association_info:
    ancestry:
    - European=80003
    gwas_catalog_id: GCST007638
    neg_log_pval: 30.0
    otg_id: GCST007638
    pubmed_id: '30837465'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: ALDH1L1 encodes an enzyme involved in the folate cycle
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000144908
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 125910381
    locus_GRCh38:
      chromosome: '3'
      position: 126191538
  trait_info:
    ontology:
    - EFO_0009767
    reported_trait_name: 'metabolite: glycine'
    standard_trait_name: glycine measurement
- association_info:
    ancestry:
    - European=350471
    neg_log_pval: 10.522430206021097
    otg_id: NEALE2_30090_raw
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: One nifty analysis in Enrichr is finding upstream transcription
        factors that are enriched for the implicated genes. The top 3 TFs are GATA1
        (upstream of 75 GWAS genes), GATA2 (67 genes) and RUNX1 (91 genes). *All 3
        of these TFs are themselves GWAS hits!*https://
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000179348
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 128201889
    locus_GRCh38:
      chromosome: '3'
      position: 128483046
  trait_info:
    ontology:
    - EFO_0007985
    reported_trait_name: platelet crit
    standard_trait_name: plateletcrit
- association_info:
    ancestry:
    - European=350471
    neg_log_pval: 139.91119437332395
    otg_id: NEALE2_30090_raw
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: THPO encodes thrombopoietin, a growth factor driving platelet production
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000090534
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '3'
      position: 184090242
    locus_GRCh38:
      chromosome: '3'
      position: 184372454
  trait_info:
    ontology:
    - EFO_0007985
    reported_trait_name: platelet crit
    standard_trait_name: plateletcrit
- association_info:
    ancestry:
    - European=79366
    gwas_catalog_id: GCST005367
    neg_log_pval: 307.6526555685888
    otg_id: GCST005367
    pubmed_id: '29343764'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: GC encodes the vitamin D binding protein
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000145321
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: C
      reference: G
    locus_GRCh37:
      chromosome: '4'
      position: 72614267
    locus_GRCh38:
      chromosome: '4'
      position: 71748550
  trait_info:
    ontology:
    - EFO_0004631
    reported_trait_name: 'metabolite: vitamin D'
    standard_trait_name: vitamin D measurement
- association_info:
    ancestry:
    - European=941280
    gwas_catalog_id: GCST007461
    neg_log_pval: 307.69897000433605
    otg_id: GCST007461
    pubmed_id: '30643251'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: alcohol metabolism
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000196616
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '4'
      position: 100239319
    locus_GRCh38:
      chromosome: '4'
      position: 99318162
  trait_info:
    ontology:
    - EFO_0007878
    reported_trait_name: average weekly red wine intake
    standard_trait_name: alcohol consumption measurement
- association_info:
    ancestry:
    - European=941280
    gwas_catalog_id: GCST007461
    neg_log_pval: 307.69897000433605
    otg_id: GCST007461
    pubmed_id: '30643251'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: encodes alcohol dehydrogenase, regulating clearance rate for alcohol
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000196616
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '4'
      position: 100239319
    locus_GRCh38:
      chromosome: '4'
      position: 99318162
  trait_info:
    ontology:
    - EFO_0007878
    reported_trait_name: alcohol consumption
    standard_trait_name: alcohol consumption measurement
- association_info:
    ancestry:
    - European=360527
    neg_log_pval: 23.63941415920316
    otg_id: NEALE2_6152_5
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: Factor XI, a protease in the clotting cascade
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000088926
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: G
      reference: T
    locus_GRCh37:
      chromosome: '4'
      position: 187188094
    locus_GRCh38:
      chromosome: '4'
      position: 186266940
  trait_info:
    ontology:
    - EFO_0003907
    reported_trait_name: Blood clot in the leg, DVT
    standard_trait_name: deep vein thrombosis
- association_info:
    ancestry:
    - European=356530
    neg_log_pval: 307.6526555685888
    otg_id: NEALE2_1717
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: melanocyte-specific transporter
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000164175
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '5'
      position: 33951693
    locus_GRCh38:
      chromosome: '5'
      position: 33951588
  trait_info:
    ontology:
    - EFO_0003784
    reported_trait_name: skin color
    standard_trait_name: skin pigmentation
- association_info:
    ancestry:
    - European=215551
    - African American or Afro-Caribbean=57332
    - Hispanic or Latin American=24743
    gwas_catalog_id: GCST006614
    neg_log_pval: 93.15490195998575
    otg_id: GCST006614
    pubmed_id: '30275531'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: HMGCR encodes an enzyme in the cholesterol biosynthetic pathway
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000113161
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 74656539
    locus_GRCh38:
      chromosome: '5'
      position: 75360714
  trait_info:
    ontology:
    - EFO_0004574
    reported_trait_name: 'treatment: statin use'
    standard_trait_name: total cholesterol measurement
- association_info:
    ancestry:
    - Other=1097
    - NR=150064
    gwas_catalog_id: GCST003048
    neg_log_pval: 9.0
    otg_id: GCST003048
    pubmed_id: '26198764'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: Glutamate receptor involved in synaptic transmissions
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000155511
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 152608619
    locus_GRCh38:
      chromosome: '5'
      position: 153229059
  trait_info:
    ontology:
    - EFO_0000692
    reported_trait_name: schizophrenia
    standard_trait_name: schizophrenia
- association_info:
    ancestry:
    - European=205327
    gwas_catalog_id: GCST007020
    neg_log_pval: 266.39794000867204
    otg_id: GCST007020
    pubmed_id: '30573740'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: EBF1 contributes to hair growth through regulation of adipocyte
        maturation in the skin
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000164330
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '5'
      position: 158343969
    locus_GRCh38:
      chromosome: '5'
      position: 158916961
  trait_info:
    ontology:
    - EFO_0007825
    reported_trait_name: hair.balding pattern 4
    standard_trait_name: balding measurement
- association_info:
    ancestry:
    - European=6880
    gwas_catalog_id: GCST003270
    neg_log_pval: 24.0
    otg_id: GCST003270
    pubmed_id: '26626624'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: cytokine involved in immune response
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000113302
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 158764478
    locus_GRCh38:
      chromosome: '5'
      position: 159337470
  trait_info:
    ontology:
    - EFO_0003778
    reported_trait_name: psoriatic arthropathy
    standard_trait_name: psoriatic arthritis
- association_info:
    ancestry:
    - European=404196
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 12.014124642691606
    otg_id: SAIGE_594_1
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: a kidney specific sodium/phosphate transporter
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000131183
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '5'
      position: 176799992
    locus_GRCh38:
      chromosome: '5'
      position: 177372991
  trait_info:
    ontology:
    - EFO_0004253
    reported_trait_name: calculus of kidney and ureter
    standard_trait_name: nephrolithiasis
- association_info:
    ancestry:
    - European=121296
    gwas_catalog_id: GCST005897
    neg_log_pval: 581.0
    otg_id: GCST005897
    pubmed_id: '29739929'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: IRF4 encodes a transcription factor involved in skin pigmentation
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000137265
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '6'
      position: 396321
    locus_GRCh38:
      chromosome: '6'
      position: 396321
  trait_info:
    ontology:
    - EFO_0004279
    reported_trait_name: melanocytic naevi
    standard_trait_name: suntan
- association_info:
    ancestry:
    - European=354798
    neg_log_pval: 24.351119148082883
    otg_id: NEALE2_23114_raw
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: bone morphogenic protein, growth factor influencing bone growth
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000153162
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 7706004
    locus_GRCh38:
      chromosome: '6'
      position: 7705771
  trait_info:
    ontology:
    - EFO_0004995
    reported_trait_name: leg predicted mass (right)
    standard_trait_name: lean body mass
- association_info:
    ancestry:
    - European=23986
    gwas_catalog_id: GCST002679
    neg_log_pval: 96.52287874528034
    otg_id: GCST002679
    pubmed_id: '25352340'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: HFE encodes the hemochromatosis
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000010704
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 26093141
    locus_GRCh38:
      chromosome: '6'
      position: 26092913
  trait_info:
    ontology:
    - EFO_0004461
    - EFO_0006332
    reported_trait_name: hemochromatosis
    standard_trait_name: iron biomarker measurement
- association_info:
    ancestry:
    - European=393873
    gwas_catalog_id: GCST007091
    neg_log_pval: 8.522878745280337
    otg_id: GCST007091
    pubmed_id: '30664745'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: bone morphogenic protein, involved in ossification
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000112175
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 55636940
    locus_GRCh38:
      chromosome: '6'
      position: 55772142
  trait_info:
    ontology:
    - EFO_1000786
    reported_trait_name: arthrosis of hip
    standard_trait_name: osteoarthritis, hip
- association_info:
    ancestry:
    - European=287323
    gwas_catalog_id: GCST004346
    neg_log_pval: 41.69897000433602
    otg_id: GCST004346
    pubmed_id: '28537254'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: receptor involved in immune response
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000056972
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: T
      reference: G
    locus_GRCh37:
      chromosome: '6'
      position: 111929862
    locus_GRCh38:
      chromosome: '6'
      position: 111608659
  trait_info:
    ontology:
    - EFO_0000676
    reported_trait_name: psoriatic arthropathy
    standard_trait_name: psoriasis
- association_info:
    ancestry:
    - European=426795
    gwas_catalog_id: GCST006980
    neg_log_pval: 64.04575749056067
    otg_id: GCST006980
    pubmed_id: '30598549'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: activator of wnt signaling pathway, regulator of angiogenesis
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000146374
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: C
      reference: A
    locus_GRCh37:
      chromosome: '6'
      position: 127468274
    locus_GRCh38:
      chromosome: '6'
      position: 127147129
  trait_info:
    ontology:
    - EFO_0003931
    reported_trait_name: wrist fracture
    standard_trait_name: bone fracture
- association_info:
    ancestry:
    - European=334659
    neg_log_pval: 94.49028415733696
    otg_id: NEALE2_1498
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: regulation of caffeine metabolism
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000106546
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '7'
      position: 17284577
    locus_GRCh38:
      chromosome: '7'
      position: 17244953
  trait_info:
    ontology:
    - EFO_0004330
    reported_trait_name: coffee intake
    standard_trait_name: coffee consumption
- association_info:
    ancestry:
    - European=334659
    neg_log_pval: 94.49028415733696
    otg_id: NEALE2_1498
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: regulation of caffeine metabolism
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000106546
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '7'
      position: 17284577
    locus_GRCh38:
      chromosome: '7'
      position: 17244953
  trait_info:
    ontology:
    - EFO_0004330
    reported_trait_name: coffee intake
    standard_trait_name: coffee consumption
- association_info:
    ancestry:
    - European=440328
    - East Asian=45564
    - South Asian=9144
    - African American or Afro-Caribbean=20687
    - Asian unspecified=555
    - Hispanic or Latin American=1247
    gwas_catalog_id: GCST005843
    neg_log_pval: 13.045757490560675
    otg_id: GCST005843
    pubmed_id: '29531354'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: TWIST1 is a transcription factor involved in cranial development
        and cerebral vein formation
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000122691
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '7'
      position: 19049388
    locus_GRCh38:
      chromosome: '7'
      position: 19009765
  trait_info:
    ontology:
    - HP_0002140
    reported_trait_name: stroke
    standard_trait_name: Ischemic stroke
- association_info:
    ancestry:
    - European=80003
    gwas_catalog_id: GCST007638
    neg_log_pval: 33.15490195998574
    otg_id: GCST007638
    pubmed_id: '30837465'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: PSPH encodes an enzyme involved in de novo serine biosynthesis
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000146733
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: C
      reference: T
    locus_GRCh37:
      chromosome: '7'
      position: 56079094
    locus_GRCh38:
      chromosome: '7'
      position: 56011401
  trait_info:
    ontology:
    - EFO_0009767
    reported_trait_name: 'metabolite: glycine'
    standard_trait_name: glycine measurement
- association_info:
    ancestry:
    - European=346635
    neg_log_pval: 9.289347081400459
    otg_id: NEALE2_2247_1
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: SLC26A5 encodes prestin, a critical outer hair cell membrane protein
        essential for mechanical signal transduction
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000170615
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '7'
      position: 103061825
    locus_GRCh38:
      chromosome: '7'
      position: 103421378
  trait_info:
    ontology:
    - EFO_0004238
    reported_trait_name: hearing loss
    standard_trait_name: hearing loss
- association_info:
    ancestry:
    - European=394929
    gwas_catalog_id: GCST006433
    neg_log_pval: 1699.1549019599856
    otg_id: GCST006433
    pubmed_id: '30048462'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: WNT16 encodes a signaling protein involved in regulation of bone
        growth
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000002745
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '7'
      position: 120962164
    locus_GRCh38:
      chromosome: '7'
      position: 121322110
  trait_info:
    ontology:
    - EFO_0009270
    reported_trait_name: wrist fracture
    standard_trait_name: heel bone mineral density
- association_info:
    ancestry:
    - European=394929
    gwas_catalog_id: GCST006433
    neg_log_pval: 1699.1549019599856
    otg_id: GCST006433
    pubmed_id: '30048462'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: WNT16 encodes a signaling protein involved in regulation of bone
        growth
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000002745
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '7'
      position: 120962164
    locus_GRCh38:
      chromosome: '7'
      position: 121322110
  trait_info:
    ontology:
    - EFO_0009270
    reported_trait_name: heel bone mineral density
    standard_trait_name: heel bone mineral density
- association_info:
    ancestry:
    - European=394929
    gwas_catalog_id: GCST006433
    neg_log_pval: 1699.1549019599856
    otg_id: GCST006433
    pubmed_id: '30048462'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: WNT16 encodes a signaling protein involved in regulation of bone
        growth
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000002745
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '7'
      position: 120962164
    locus_GRCh38:
      chromosome: '7'
      position: 121322110
  trait_info:
    ontology:
    - EFO_0009270
    reported_trait_name: Fracture of ankle
    standard_trait_name: heel bone mineral density
- association_info:
    ancestry:
    - European=367725
    gwas_catalog_id: GCST006946
    neg_log_pval: 9.698970004336019
    otg_id: GCST006946
    pubmed_id: '29500382'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: GRM8 encodes a glutamate metabotropic receptor
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000179603
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: T
      reference: A
    locus_GRCh37:
      chromosome: '7'
      position: 126378842
    locus_GRCh38:
      chromosome: '7'
      position: 126738788
  trait_info:
    ontology:
    - EFO_0009589
    reported_trait_name: worry too long
    standard_trait_name: worry measurement
- association_info:
    ancestry:
    - European=257773
    neg_log_pval: 15.933081750658816
    otg_id: NEALE2_1568
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: receptor for bitter taste
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000257138
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: G
      reference: C
    locus_GRCh37:
      chromosome: '7'
      position: 141673345
    locus_GRCh38:
      chromosome: '7'
      position: 141973545
  trait_info:
    ontology:
    - EFO_0007878
    reported_trait_name: average weekly red wine intake
    standard_trait_name: alcohol consumption measurement
- association_info:
    ancestry:
    - European=348284
    neg_log_pval: 43.29265980539296
    otg_id: NEALE2_1309
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: OR2A7 encodes an olfactory receptor that may respond to sweet smells
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000243896
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '7'
      position: 143723137
    locus_GRCh38:
      chromosome: '7'
      position: 144026044
  trait_info:
    ontology:
    - EFO_0008111
    reported_trait_name: fresh fruit intake
    standard_trait_name: diet measurement
- association_info:
    ancestry:
    - European=350471
    neg_log_pval: 80.9294929792367
    otg_id: NEALE2_30090_raw
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: In addition to GATA1 and GATA2, there are hits for the so-called
        "Friends of GATA" or FOG.  These are additional TFs that heterodimerize with
        GATA1 and GATA2 encoded by ZFPM2 and ZFPM1
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000169946
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: T
      reference: A
    locus_GRCh37:
      chromosome: '8'
      position: 106581528
    locus_GRCh38:
      chromosome: '8'
      position: 105569300
  trait_info:
    ontology:
    - EFO_0007985
    reported_trait_name: platelet crit
    standard_trait_name: plateletcrit
- association_info:
    ancestry:
    - European=80003
    gwas_catalog_id: GCST007638
    neg_log_pval: 39.69897000433602
    otg_id: GCST007638
    pubmed_id: '30837465'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: GLDC encodes an enzyme involved glycine catabolism
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000178445
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '9'
      position: 6550024
    locus_GRCh38:
      chromosome: '9'
      position: 6550024
  trait_info:
    ontology:
    - EFO_0009767
    reported_trait_name: 'metabolite: glycine'
    standard_trait_name: glycine measurement
- association_info:
    ancestry:
    - European=356530
    neg_log_pval: 218.9201208247617
    otg_id: NEALE2_1717
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: BNC2 encodes a transcription factor involved in skin pigmentation
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000173068
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: A
      reference: G
    locus_GRCh37:
      chromosome: '9'
      position: 16885017
    locus_GRCh38:
      chromosome: '9'
      position: 16885019
  trait_info:
    ontology:
    - EFO_0003784
    reported_trait_name: melanocytic naevi
    standard_trait_name: skin pigmentation
- association_info:
    ancestry:
    - NR=296525
    gwas_catalog_id: GCST005194
    neg_log_pval: 222.0545314148682
    otg_id: GCST005194
    pubmed_id: '29212778'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: locus associated with increased risk of heart disease
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000147889
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '9'
      position: 22098574
    locus_GRCh38:
      chromosome: '9'
      position: 22098575
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: treatment with nicorandil
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - NR=296525
    gwas_catalog_id: GCST005194
    neg_log_pval: 222.0545314148682
    otg_id: GCST005194
    pubmed_id: '29212778'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: locus associated with increased risk of heart disease
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000147883
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '9'
      position: 22098574
    locus_GRCh38:
      chromosome: '9'
      position: 22098575
  trait_info:
    ontology:
    - EFO_0000378
    reported_trait_name: treatment with nicorandil
    standard_trait_name: coronary artery disease
- association_info:
    ancestry:
    - European=392109
    doi: 10.1038/s41588-018-0184-y
    neg_log_pval: 22.543633966870956
    otg_id: SAIGE_241_2
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: transcription factor exclusively expressed in thyroid, involved
        in thyroid development
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000178919
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: G
      reference: A
    locus_GRCh37:
      chromosome: '9'
      position: 100538470
    locus_GRCh38:
      chromosome: '9'
      position: 97776188
  trait_info:
    ontology:
    - MONDO_0000334
    reported_trait_name: non-toxic goitre
    standard_trait_name: multinodular goiter
- association_info:
    ancestry:
    - European=393873
    gwas_catalog_id: GCST007091
    neg_log_pval: 11.522878745280337
    otg_id: GCST007091
    pubmed_id: '30664745'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: transcription factor involved in limb development
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000136944
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '9'
      position: 129386860
    locus_GRCh38:
      chromosome: '9'
      position: 126624581
  trait_info:
    ontology:
    - EFO_1000786
    reported_trait_name: arthrosis of hip
    standard_trait_name: osteoarthritis, hip
- association_info:
    ancestry:
    - European=360527
    neg_log_pval: 68.43321497559869
    otg_id: NEALE2_6152_5
    url: http://www.nealelab.is/uk-biobank
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: blood type is a risk factor for blood clots
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000175164
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: T
      reference: C
    locus_GRCh37:
      chromosome: '9'
      position: 136143372
    locus_GRCh38:
      chromosome: '9'
      position: 133267960
  trait_info:
    ontology:
    - EFO_0003907
    reported_trait_name: Blood clot in the leg, DVT
    standard_trait_name: deep vein thrombosis
- association_info:
    ancestry:
    - European=205327
    gwas_catalog_id: GCST007020
    neg_log_pval: 282.52287874528037
    otg_id: GCST007020
    pubmed_id: '30573740'
  gold_standard_info:
    evidence:
    - class: expert curated
      confidence: High
      curated_by: Eric Fauman
      description: AR encodes the androgen receptor, important for regulation of hair
        follicles
      source: Eric Fauman's Twitter list based on biological plausability
    gene_id: ENSG00000169083
    highest_confidence: High
  metadata:
    date_added: '2019-07-30'
    reviewed_by: Ed Mountjoy
    set_label: Eric Fauman Twitter
    submitted_by: Eric Fauman
    tags:
    - Fauman
    - Biological plausability
  sentinel_variant:
    alleles:
      alternative: A
      reference: C
    locus_GRCh37:
      chromosome: X
      position: 66670566
    locus_GRCh38:
      chromosome: X
      position: 67450724
  trait_info:
    ontology:
    - EFO_0007825
    reported_trait_name: hair.balding pattern 4
    standard_trait_name: balding measurement
